<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d7" for="edge" attr.name="order" attr.type="long" />
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="clusters" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="&quot;SEC16 HOMOLOG B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SEC16B gene is involved in endoplasmic reticulum export."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40) MEMBER C27&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"DNAJC27, a member of the DnaJ heat shock protein family, plays a role in cellular processes."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CDKAL1 is associated with CDK5 and its function in metabolic regulation."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR AP-2 BETA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TFAP2B acts as a transcription factor influencing gene expression."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;RS543874&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs543874 affects the function of SEC16B gene."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;RS713586&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs713586 is related to the expression levels of DNAJC27 gene."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;RS9356744&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs9356744 influences the activity of CDKAL1 transcription factor."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;RS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"All mentioned identifiers are Single Nucleotide Polymorphisms (SNPs) associated with different genes or gene functions related to obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;ENDOPLASMIC RETICULUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Endoplasmic reticulum is a key organelle involved in protein synthesis and transport."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;CELLULAR PROCESSES&quot;">
      <data key="d0">"BIOLOGICAL FUNCTION"</data>
      <data key="d1">"The DnaJ heat shock protein family contributes to various cellular processes including stress response and protein folding."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;METABOLIC REGULATION&quot;">
      <data key="d0">"MOLECULAR FUNCTION"</data>
      <data key="d1">"CDKAL1 influences metabolic pathways by regulating gene expression."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR ACTIVITY&quot;">
      <data key="d0">"FUNCTIONAL ROLE/</data>
      <data key="d1">"TFAP2B is responsible for regulating the transcription of specific genes."&lt;SEP&gt;Response to Stimuli/</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;SINGLE NUCLEOTIDE POLYMORPHISM (SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These SNPs are variations found within the DNA sequence that can affect gene function and contribute to obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SEC16B (SEC16B)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SEC16 Homolog B plays a role as an endoplasmic reticulum export factor."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;DNAJC27 (DNAJC27)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"DnaJ heat shock protein family member C27 is involved in the process."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;CDKAL1 (CDKAL1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CDK5 regulatory subunit-associated protein 1-like 1 modulates transcription factors related to obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TFAP2B (TFAP2B)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Transcription factor AP-2 Beta is involved in gene regulation and impacts obesity."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;BDNF (BDNF)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Brain-Derived Neurotrophic Factor has a role in neural development and affects the obesity risk through SNPs."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MYL2 (MYL2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Myosin light chain-2 is related to energy expenditure, impacting obesity."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;OLFM4 (OLFM4)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Olfactomedin-4 influences obesity through its gene variants."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;FTO (FTO)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Fat mass- and obesity-associated protein affects metabolism related to obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MC4R (MC4R)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Melanocortin 4 receptor gene plays a role in energy intake regulation and obesity."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;GIPR (GIPR)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Glucose-dependent insulinotropic polypeptide receptor contributes to glucose metabolism, impacting obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MENOPAUSE AGE&quot;">
      <data key="d0">"COVARIATE FACTOR"</data>
      <data key="d1">"Not directly associated with obesity risk but interacts with PRS through gender."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;SLC27A5 (SLC27A5)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Solute Carrier Family 27 Member 5 is involved in lipid metabolism impacting obesity."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MIR1308 (MIR1308)&quot;">
      <data key="d0">"MICRORNA"</data>
      <data key="d1">"MicroRNA-1308 regulates gene expression related to energy balance and obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TSPAN9 (TSPAN9)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tetraspanin 9, also known as CD82, plays a role in cell signaling pathways relevant to obesity."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;ADIPOR1 (ADIPOR1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Adiponectin Receptor 1 modulates glucose metabolism influencing obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;SNP RS9653047&quot;">
      <data key="d0">"ASSOCIATION WITH OBESITY-SPECIFIC GENES"</data>
      <data key="d1">"SNP rs9653047 is linked to regulation of genes like CDH13, SLC27A5, ADIPOR1, and others through its role in metabolic pathways."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;PHC1 (PHC1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Polyhomeotic 1 gene affects chromatin structure contributing to obesity risk via epigenetic mechanisms."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;PRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"PRS was associated with obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;MENARCHE AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Early menarche age interacted with PRS for the obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 35}]</data>
    </node>
    <node id="&quot;BMI&quot;">
      <data key="d0">"BODY MEASUREMENT"</data>
      <data key="d1">"A measure that calculates the body weight divided by height squared to assess if a person is underweight, normal weight, overweight or obese."&lt;SEP&gt;"BMI was higher in participants with an early menarche age compared to those with late menarche age when adjusting for covariates."&lt;SEP&gt;"Baseline characteristics had no association with genotype."&lt;SEP&gt;"Increased BMI was observed in subjects carrying the A-allele of the FTO rs9939609 polymorphism compared to TT subjects."&lt;SEP&gt;"Mean BMI was not significantly different between T2D-ESRD case subjects and nondiabetic control subjects (P = 0.19), suggesting that BMI may not affect their respective conditions."&lt;SEP&gt;"No evidence for interaction with BMI in relation to the association between TCF7L2 gene and the number of risk alleles."&lt;SEP&gt;"Basal BMI level and its change are influenced by obesity predisposing SNPs, GRS, and glycemic status traits."&lt;SEP&gt;"Body mass index is associated with baseline glycemic status and changes over time, influencing health outcomes."&lt;SEP&gt;"Individuals with lower BMI were observed to adhere more to the Mediterranean diet."&lt;SEP&gt;"Mediator in the pathway analysis of genetic loci affecting cardiometabolic phenotypes after adjustment."&lt;SEP&gt;"Body Mass Index (BMI), a measure of adiposity, was assessed and analyzed in the study."&lt;SEP&gt;"BMI had a moderate genetic correlation with snoring, reflecting obesity as a risk factor for both traits."&lt;SEP&gt;"Body mass index (BMI), calculated as weight in kilograms divided by height squared, was significantly lower among women with PCOS compared to controls."&lt;SEP&gt;"Body Mass Index, a measure of body weight relative to height."&lt;SEP&gt;"The association between rs10399931 and BMI was found to be significant (p = 0.03), indicating the genetic variant's potential impact on body mass index."&lt;SEP&gt;"Participants who consumed black or sugared coffee were more likely to have a higher BMI."&lt;SEP&gt;"BMI differed according to the rs671 polymorphism significantly among men."&lt;SEP&gt;"Body Mass Index (BMI) is significantly associated with higher sUA levels and increased HUA risk in both males and females."&lt;SEP&gt;"Asthmatic patients had a significantly higher BMI than the healthy control group."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"NUTRIENT INTAKE AND DIETARY PATTERN"</data>
      <data key="d1">"There was an interaction between PRS and a plant-based diet intake affecting obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LOW PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"In low plant-based diet intake, the genetic impact on BMI was lower compared to participants with high PRS and high plant-based dietary intake."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH PRS ADULTS&quot;">
      <data key="d0">"DISEASE RISK"</data>
      <data key="d1">"Adults with a high PRS were protected against obesity risk when following a high plant-based diet."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LOW PLANT-BASED DIET INTAKE &amp; HIGH PRS&quot;">
      <data key="d0">"OBESITY RISK"</data>
      <data key="d1">"Participants with low plant-based dietary intake and high PRS had higher BMI compared to those with low PRS and high plant-based dietary intake."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;HIGH FRIED-FOOD INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"High fried-food intake was associated with a higher BMI, but the PRS impact was offset in participants with high fried-food intake."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;AVOIDING FRIED-FOOD INTAKE&quot;">
      <data key="d0">"LIFESTYLE CHOICE"</data>
      <data key="d1">"Fried-food intake should be avoided to protect against obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;OBESITY RISK&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"The PRS, diet type (specifically plant-based and fried-food intake), influenced obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;EARLY MENARCHE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Early menarche is a stage of human development characterized by the onset of menstruation."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LATE MENARCHE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Late menarche refers to delayed onset of menstruation, often associated with various health conditions."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;COVARIATES&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY COMPONENT"</data>
      <data key="d1">"BMI, age, sex, and other factors like smoking and alcohol intake were included as covariates in GWAS analysis to adjust for their potential effects on snoring."&lt;SEP&gt;"Covariates are other variables considered in statistical analyses that could influence the relationship being studied."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d0">"RISK FACTOR"</data>
      <data key="d1">"A measure of body size that's calculated using weight and height."&lt;SEP&gt;"BMI is a measure of body fat based on height and weight, used to assess obesity or underweight conditions."&lt;SEP&gt;"A measure that calculates body weight divided by height squared used for assessing if a person is underweight, normal weight, overweight or obese."&lt;SEP&gt;"BMI showed a positive correlation with snoring, with increased BMI associated with increased snoring risk."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;OBESITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A complex condition characterized by the accumulation of excess body fat leading to health risks such as heart disease and type 2 diabetes."&lt;SEP&gt;"A higher prevalence of obesity was noted among subjects with an A-allele (compared to TT subjects) based on the FTO rs9939609 polymorphism in the GP."&lt;SEP&gt;"Obesity is a condition that may be influenced by genetic variations like the FTO SNP and education level."&lt;SEP&gt;"Obesity is a medical condition characterized by an excess of body fat that may impact health negatively."&lt;SEP&gt;"Excess body weight is a risk factor for developing IFG/IGT and T2D, impacting glucose metabolism processes."&lt;SEP&gt;"Obesity is associated with higher serum uric acid (sUA) levels and increased HUA risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;PLANT-BASED DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A plant-based diet primarily consists of foods derived from plants such as fruits, vegetables, legumes, and grains."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"NUTRIENT INTAKE AND DIETARY PATTERN"</data>
      <data key="d1">"Consumption of a high amount of plant-based food items in the diet."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LOW PRS (POLYGENIC RISK SCORE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A low PRS indicates a lower genetic predisposition towards certain health outcomes or diseases."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH PRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A high PRS suggests a higher genetic predisposition to certain health outcomes or disease susceptibility."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LOW FRIED-FOOD INTAKE&quot;">
      <data key="d0">"NUTRIENT INTAKE AND DIETARY PATTERN"</data>
      <data key="d1">"Consumption of a low amount of fried food in the diet, often associated with healthier eating habits."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;OBESOGENIC EFFECTS&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Obesogenic effects refer to actions or factors that contribute to obesity or weight gain."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;GENE&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"A gene's different variants (genotypes) showed varied levels of TAGs."&lt;SEP&gt;"SNPs within these genes may influence their function and impact the obesity risk.")&lt;SEP&gt;"A highly significant variant for total energy expenditure (p = 2.7E-08) was identified for MATK on chromosome 19."&lt;SEP&gt;"Sleeping energy expenditure (p = 6.0E-08) variant was identified for CHRNA3 on chromosome 15."&lt;SEP&gt;"The Gene is involved in various biological processes and can influence disease development."&lt;SEP&gt;"The OPRM1 gene plays a crucial role in mediating pain perception and reward pathways."</data>
      <data key="d0">"GENE"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-5b0cc96debf110f3544685d3b227ff27&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"A genomic variant related to B12 metabolism that may influence its levels."&lt;SEP&gt;"SNPs within these genes may influence their function and impact the obesity risk.")&lt;SEP&gt;"The text doesn't provide details on the genomic variant specific to this context."&lt;SEP&gt;"The specific genotypes or variants that are associated with abnormal blood glucose levels."&lt;SEP&gt;"A specific variant found in this gene has been linked to certain disease susceptibility."&lt;SEP&gt;"The CYP24A1 SNP rs927650 shows suggestive relationship with 25(OH)D levels."&lt;SEP&gt;"The T/T genotype variant is associated with higher sUA levels compared to C/C carriers of the SLC2A9 gene."&lt;SEP&gt;"rs8096658 at the NFATC1 locus has an effect on posterior probability (πC = 0.877) for driving association signals with eGFR."&lt;SEP&gt;"The CC genotype is associated with an increased risk of Colorectal Cancer (CRC)."&lt;SEP&gt;"This variant has been linked to increased risk of hypertension."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40)&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"SNP rs713586 affects the activity levels of DNAJC27 involved in cellular stress response and protein folding.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1 (CDKAL1)&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"SNP rs9356744 impacts the function of CDKAL1, influencing metabolic pathways and energy balance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR AP-2 BETA (TFAP2B)&quot;">
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d1">"The SNP variants affect TFAP2B's ability to regulate gene expression related to obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;&amp; &quot;PRS&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Plant-based diet intake and PRS have an interaction influencing obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;HIGH FRIED-FOOD INTAKE&quot;&amp; &quot;PRS&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Fried-food intake and PRS show interaction where PRS offset the obesity risk effect of high fried-food intake.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;&amp; &quot;LOW PRS&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"A plant-based diet may mitigate obesity risk for individuals with low PRS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REDUCTION IN OBESITY RISK&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"A plant-based diet may mitigate obesity risk for individuals with low PRS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGH FRIED-FOOD INTAKE&quot;&amp; &quot;HIGH PRS&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Despite high PRS, high fried-food intake might not significantly increase obesity risk due to counterbalancing factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OFFSET OF OBESOGENIC EFFECTS&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Despite high PRS, high fried-food intake might not significantly increase obesity risk due to counterbalancing factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor allele frequency was 0.402 in the total population."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;WEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline characteristics had no association with genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;WC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline characteristics had no association with genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;BODY COMPOSITION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline characteristics had no association with genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in fat distribution were observed as a result of different dietary interventions."&lt;SEP&gt;"No associations between the FTO genotypes and these measures were observed."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TRUNK FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes observed in trunk fat percentage are part of overall body composition dynamics in response to diet."&lt;SEP&gt;"No significant genetic effects on changes in fat distribution were found at baseline."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;GENOTYPE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The AA genotype is a genetic variation that affects fat distribution and response to certain diets."&lt;SEP&gt;"The reference genotype and its interaction with diet"&lt;SEP&gt;"Val allele carriers showed higher response bias compared to iso homozygotes in Study 1."&lt;SEP&gt;"The genotype effect of EBNA2 is dependent on specific genotypes at MS risk loci."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-4b4f7d54511e2d8bbf5af6073d25b647&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"All patients were started on a low-protein diet (1.5 g/kg/day of natural protein intake)."&lt;SEP&gt;"The low-protein diet led to less loss in TAT and SAT compared with participants having the AA genotype."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Participants with the AA genotype had a greater decrease in fat distribution when responding to the high-prorotein diet."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TOTAL FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The total fat was observed to change in response to the low-fat diet in our study."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FM% (FAT MASS PERCENTAGE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in fat mass percentage were noted in relation to the low-fat diet, although no genotype-time interactions on changes in fat distribution with the low- or high-fat diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;PERCENTAGE OF TRUNK FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Our study also monitored the changes in percentage of trunk fat in response to dietary interventions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TAT (TOTAL ABDOMINAL TRANSIENT) AND SAT (SUBCUTANEOUS ABDOMINAL TISSUE&quot;)">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The changes in TAT and SAT were observed as part of physiological processes in response to different diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;WAIST&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The risk allele (A) was significantly associated with a smaller change in waist circumference compared to other groups.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;PROTEIN INTAKE&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"High-protein intake was associated with greater weight loss when the AA genotype of the FTO rs1558902 variant is present.")&lt;SEP&gt;"The quantity and quality of proteins included in the daily diet."</data>
      <data key="d0">"PROTEIN CONSUMPTION"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;WEIGHT LOSS&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"High-protein intake was associated with greater weight loss when the AA genotype of the FTO rs1558902 variant is present.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;AA GENOTYPE (FTO RS1558902)">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The risk allele carriers in the high-protein group had greater fat loss compared to non-carriers of the AA genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT LOSS IN HIGH-PROTEIN DIET INTAKE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The risk allele carriers in the high-protein group had greater fat loss compared to non-carriers of the AA genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT LOSS IN LOW-PROTEIN DIET INTAKE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Participants with the AA genotype had less fat loss when assigned to the low-protein diet compared to those without this genotype.")&lt;SEP&gt;"Participants with the AA genotype had less loss of trunk fat and SAT when assigned to the low-protein diet compared to those without this genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION IN HIGH-PROTEIN DIET INTAKE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The risk allele carriers in the high-protein group had greater fat loss in TAT and VAT compared to non-carriers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION IN LOW-PROTEIN DIET INTAKE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Participants with the AA genotype were associated with less fat loss of trunk fat when assigned to the low-protein diet compared to those without this genotype.")&lt;SEP&gt;"Participants with the AA genotype were associated with less loss of SAT when assigned to the low-protein diet compared to those without this genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BODY COMPOSITION CHANGE OVER TIME&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The risk allele carriers who followed a high-protein diet had greater loss in body composition over time.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;FAT LOSS RESPONSE TO HIGH-PROTEIN DIET&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Participants with the AA genotype experienced greater fat loss when consuming a high-protein diet compared to those without this variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT LOSS RESPONSE TO LOW-PROTEIN DIET&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Individuals with the AA genotype experienced less fat loss when consuming a low-protein diet compared to those without this variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT LOSS&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"When following a high-protein diet, participants carrying the AA genotype of the FTO rs1558902 showed greater fat loss compared to other genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"An indicator used in assessing obesity risk along with BMI; influenced by genetic factors like the FTO SNP."&lt;SEP&gt;"The risk allele (A) was significantly associated with a smaller change in waist circumference compared to other groups.")</data>
      <data key="d0">"ANTHROPOMETRIC MEASUREMENT"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;WEIGHT LOSS RESPONSE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"High-protein intake was associated with greater weight loss when the AA genotype of the FTO rs1558902 variant is present.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;BODY COMPOSITION CHANGE OVER TIME RESPONSE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The risk allele carriers who followed a high-protein diet showed greater loss in body composition over time.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;FAT LOSS IN HIGH-PROTEIN DIET RESPONSE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Participants with the AA genotype experienced greater fat loss when consuming a high-protein diet compared to those without this variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT LOSS IN LOW-PROTEIN DIET RESPONSE&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Individuals with the AA genotype experienced less fat loss when consuming a low-protein diet compared to those carrying the variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AA GENOTYPE&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"Among women, the AA genotype group had lower levels of cortisol compared to other genotypes."&lt;SEP&gt;"Individuals having the AA genotype showed greater decrease in fat distribution upon consumption of high-protein diets compared to others.")</data>
      <data key="d0">"GENOTYPE"</data>
    </node>
    <node id="&quot;LOW-FAT DIET&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"Genotype did not show significant interactions with changes in fat distribution when following low-fat diet, as opposed to other dietary patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOW-FAT DIET INTERACTION&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"No significant genotype-time interactions on changes in fat distribution were found when following low-fat diets, highlighting the role of genetic background in dietary responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY PATTERN&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-6264e17a8290bc0a9e24c68c21c1f15c&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"A diet consisting of olive oil, fish, and nuts that was compared with a Healthy Eating group"&lt;SEP&gt;"The response to different diets is influenced by trunk fat percentage dynamics, which are a measure of body composition changes.")&lt;SEP&gt;"No dietary patterns are discussed in the provided context."&lt;SEP&gt;"Host genetics through mbQTLs and mbBTLs interacted with dietary patterns influencing bacterial taxa abundance."&lt;SEP&gt;"A set of eating habits or dietary practices associated with specific health outcomes."&lt;SEP&gt;"This dietary pattern could influence both B12 and folate levels through food intake and might be related to gestational duration."&lt;SEP&gt;"A unique way of eating or consuming food that is characteristic of a particular culture or geographical area."&lt;SEP&gt;"No specific dietary patterns mentioned in the provided text."&lt;SEP&gt;"Eating fresh poultry other than chicken and turkey was identified as a risk factor through the univariate analysis, suggesting a potential dietary pattern affecting Campylobacter infections."&lt;SEP&gt;"Dietary patterns influence the intake of nutrients like folate and can modulate physiological processes related to cardiovascular health."&lt;SEP&gt;"Certain dietary patterns can influence the expression of genomic variants associated with disease risk."&lt;SEP&gt;"The pattern that influences gene expression and nutrient metabolism."&lt;SEP&gt;"Dietary patterns that include certain foods could affect the expression levels of these MS risk genes."</data>
      <data key="d0">"DIETARY PATTERN"</data>
    </node>
    <node id="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO rs9939609 polymorphism is associated with anthropometric variables such as weight, BMI, and waist circumference."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;GP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"General population dietary patterns were not specifically described but are implied to influence obesity risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;OHP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Overweight and obese population, indicating environmental factors impacting obesity such as lifestyle or diet."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;HCR SUBJECTS&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Elderly individuals with high BMI; relevant for studying age-related changes in obesity risk or dietary effects."&lt;SEP&gt;"HCR subjects might refer to another specific group of individuals mentioned in the text, distinct from university study attendees."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;OBESITY PREVALENCE&quot;">
      <data key="d0">"HEALTH INDICATOR"</data>
      <data key="d1">"Percentage of individuals within a population who have obesity, which is influenced by genetic polymorphisms and environmental factors like education level and physical activity (PA)."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;FTO SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO SNP is a variant found in genetic studies related to obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 22}]</data>
    </node>
    <node id="&quot;EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Education level influences the relationship between the FTO SNP and obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;UNIVERSITY STUDIES&quot;">
      <data key="d0">"EDUCATIONAL LEVEL"</data>
      <data key="d1">"University studies are a measure of educational attainment and influence certain health risk associations."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;ASSOCIATION&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"The statistical analysis found an association between education level, FTO SNP, and obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;P FOR INTERACTION&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The P-value of 0.023 indicates statistical significance in the interaction term."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;ADJUSTMENT FOR PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d0">"STATISTICAL ADJUSTMENT"</data>
      <data key="d1">"Additional adjustment for physical activity was considered but not shown in the provided text."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;EDUCATION LEVEL AND FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d1">"The interaction between the FTO SNP and education significantly impacted BMI in GP subjects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION EFFECT&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"An interaction effect occurs when the impact of one independent variable on the dependent variable differs at different levels of another independent variable."&lt;SEP&gt;"The interaction between the FTO SNP and education significantly impacted BMI in GP subjects.")</data>
      <data key="d0">"STATISTICAL TERM"</data>
    </node>
    <node id="&quot;EDUCATION LEVEL&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d1">"Influence of educational attainment on obesity risk, as it interacts with the presence of certain genotypes (such as FTO rs9939609) to impact health outcomes like BMI and obesity prevalence.")&lt;SEP&gt;"Participants with a higher level of education had more adherence to Mediterranean diet."</data>
      <data key="d0">"DEMOGRAPHIC"</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;DISEASE&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"A condition where the body's normal functions are disrupted, leading to symptoms and potential health risks.")&lt;SEP&gt;"IL-1R and IL-6Rα impacts disease severity as mentioned in the text."&lt;SEP&gt;"The determination of obesity risk involves multiple factors including genetic variations and education levels.")&lt;SEP&gt;"The study does not specify the disease directly but implies the involvement of conditions requiring MTX or related to its side effects"&lt;SEP&gt;"A particular illness or medical condition characterized by specific symptoms and pathological changes in the body."&lt;SEP&gt;"This is a condition characterized by abnormal growth of tissue in the lining of the colon or rectum, which could recur during study follow-up."&lt;SEP&gt;"FAAP20 protein accumulation at DNA damage sites depends on a functional UBZ domain and is required for proper recruitment to ICL (interstrand cross-link) sites."&lt;SEP&gt;"The presence of charged residues at positions corresponding to FAAP20-UBZ might suggest that such mutations could lead to certain diseases if they disrupt normal function."&lt;SEP&gt;"Disease was observed to be associated with LYP variants and their impact on T cell proliferation and cytokine production."&lt;SEP&gt;"These genes are associated with or involved in conditions such as multiple sclerosis (MS) and other autoimmune disorders related to immune evasion."</data>
      <data key="d0">"DISEASE"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;OBESITY RISK DETERMINATION&quot;">
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d1">"The FTO SNP plays a role in determining obesity risk, considering factors like education and physical activity.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 22}]</data>
    </node>
    <node id="&quot;ASSOCIATION WITH OBESITY RISK&quot;">
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d1">"Education level is associated with the relationship between genetic variations like the FTO SNP and obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;DISEASE ASSOCIATION&quot;">
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d1">"The statistical estimations regarding disease association do not change after certain adjustments, indicating robustness of findings.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE&quot;">
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"A measure used in research to determine if results are likely due to chance or a genuine effect."&lt;SEP&gt;"The qRT-PCR and microarray data were statistically significant, indicating reliable results."&lt;SEP&gt;"The statistical estimations regarding disease association do not change after certain adjustments, indicating robustness of findings.")&lt;SEP&gt;"The analysis did not find any statistically significant associations between the factors tested and treatment outcomes after adjustments for multiple testing methods."</data>
      <data key="d0">"OUTCOME/ENDPOINT"</data>
    </node>
    <node id="&quot;TCF7L2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene is associated with type 2 diabetes risk and modifies the effect of incretins on insulin secretion."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS7903146 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs7903146 genetic variant in the TCF7L2 gene has been widely studied for its potential interaction with dietary factors and type 2 diabetes risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;T2D (TYPE 2 DIABETES)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T2D is a condition influenced by genetic variants such as those found in the TCF7L2 gene, as well as dietary factors like fiber intake."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;INCREASED CEREAL FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT/</data>
      <data key="d1">Dietary Pattern"</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS10923931 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Molecular Interaction/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;IRS1 RS2943641 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Molecular Interaction"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;GIPR RS10423928 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Dietary Factor/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARΓ VARIANTS RS1801282 AND RS3856806&quot;/">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Molecular Interaction"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;ADH1C *1/*2 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Alcohol Consumption"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HEME IRON INTAKE&quot;">
      <data key="d0">"NUTRIENT"/</data>
      <data key="d1">"The association of heme iron with T2D incidence varied depending on genetic factors like the HFE gene variants, showing variable interactions across different populations."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE VARIANTS RS1799945 AND RS1800562&quot;/">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">heme Iron Intake"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HECTD4 VARIANTS&quot;/">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">micronutrient Consumption"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;GLUT5 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant in the GLUCOSE TRANSPORTER 5 (GLUT5) gene has been found to be linked to an increased risk for type 2 diabetes."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FABP3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Research suggests that alterations in the Fatty Acid Binding Protein 3 (FABP3) gene could impact the development of insulin resistance and, consequently, increase the likelihood of developing type 2 diabetes."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;CDKAL1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Studies have linked genetic variations in the CDKAL1 gene to a heightened risk for both type 1 and type 2 diabetes."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARGC1A VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"/</data>
      <data key="d1">Disease/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;MTHFR VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANTS"</data>
      <data key="d1">"Variants in the MTHFR gene have shown mixed associations with increased or decreased risks for diabetes depending on environmental factors like diet and lifestyle."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;GLUT4 ACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/</data>
      <data key="d1">Disease"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;C-PEPTIDE&quot;">
      <data key="d0">"BIOLOGICAL MARKER"</data>
      <data key="d1">"The measurement of C-peptide levels can be indicative of pancreatic beta-cell function and is used to assess insulin secretion capacity; it’s important for diagnosing both type 1 and type 2 diabetes."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;SGLT1 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR ACTIVITY/</data>
      <data key="d1">Disease"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARG VARIANT RS3856806&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Disease"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;KCNJ11 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Mutations or polymorphisms in the KCNJ11 gene encoding the insulin receptor are linked with both type 1 and type 2 diabetes, affecting glucose homeostasis."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARGC1A HAPLOTYPE&quot;">
      <data key="d0">"GENETIC HAPLOTYPE/</data>
      <data key="d1">Disease"/</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE RS1799945 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The H63D variant in the HFE gene has been associated with increased risk of type 2 diabetes (T2D) among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HFE RS1800562 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C282Y variant in the HFE gene was also observed in association studies, but its interaction with T2D risk in EPIC-InterAct wasn't significant."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;EPIC-INTERACT STUDY&quot;">
      <data key="d0">"DIETARY STUDY"</data>
      <data key="d1">"Observational studies conducted through EPIC-InterAct have been used to assess the interactions between specific HFE variants and dietary factors on T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HOMO SAPIENS HFE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HFE gene is associated with iron metabolism and has variants linked to T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MEN AND WOMEN POPULATION GROUPS&quot;">
      <data key="d0">"SAMPLE POPULATION"</data>
      <data key="d1">"Male and female populations were studied for genetic interactions with dietary factors affecting T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;GLYCEMIC INDEX&quot;">
      <data key="d0">"BIOLOGICAL MEASURE"</data>
      <data key="d1">"A measure of how quickly carbohydrates in foods raise blood sugar levels."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;GLYCATED HEMOGLOBIN (HBA1C)&quot;">
      <data key="d0">"LABORATORY TEST"</data>
      <data key="d1">"A test that provides a measure of average blood glucose control over the previous 2-3 months."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS (T2D)&quot;">
      <data key="d0">"MEDICAL CONDITION"</data>
      <data key="d1">"A metabolic disorder characterized by high levels of blood sugar due to insulin resistance or insufficient production of insulin."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HERITABILITY&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The proportion of variation in a trait that can be attributed to genetic factors."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;POPULATION GENOMICS&quot;">
      <data key="d0">"FIELD OF STUDY"</data>
      <data key="d1">"A field which studies the genetic structure and dynamics of populations across large geographic areas."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;GENETIC PREDISPOSITION&quot;">
      <data key="d0">"BIOLOGICAL TRAIT"</data>
      <data key="d1">"The presence of certain genes that may increase a person's risk for developing specific diseases or conditions."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;EPIGENETICS&quot;">
      <data key="d0">"FIELD OF STUDY"</data>
      <data key="d1">"A subfield of biology that studies changes in gene function and expression that do not involve changes to the DNA sequence itself."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Close to 6 million SNPs, and expression data from 38,839 probes within 23,704 genes were included in the analysis."&lt;SEP&gt;"The changes in mRNA levels during high-salt exposure and in CKD models provide insights into how environmental stressors affect gene regulation."&lt;SEP&gt;"The process by which information from a gene is translated into a functional product, usually a protein."&lt;SEP&gt;"EBNA2 affects the expression level of several genes that are at risk for MS, impacting their physiological processes."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-f7bf38c7a21b86ad85fa360a21bfb447&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;POLYGENIC RISK SCORES (PRS)&quot;">
      <data key="d0">"STATISTICAL TOOL"</data>
      <data key="d1">"A tool used in genetics to assess the combined effect of multiple genetic variants on disease risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISM&quot;">
      <data key="d0">"BIOLOGICAL VARIANT"</data>
      <data key="d1">"Variants in DNA sequences that occur frequently within a population and are not due to errors during replication."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;GG-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Persons with this genotype and non-risk haplotype seem to be unresponsive to change in LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;NON-RISK HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Non-risk haplotype of the four SLC2A2 variants is associated with responsiveness to PA or changes in LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LTPA&quot;">
      <data key="d0">"PHYSICAL ACTIVITY"</data>
      <data key="d1">"Change in LTPA affects persons with GG-genotype and non-risk haplotype."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RISK ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Persons with this allele seem to be unresponsive to change in LTPA, in contrast to those with GG-genotype."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Weight loss interventions can reduce T2D incidence among persons with specific genetic variants."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;DIABETES PREVENTION PROGRAM (DPP)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"DPP study indicates that weight loss intervention may modify diabetes risk development."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;DOUBLE PODOCYTE STUDY (DPS)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"DPS study suggests similar findings for genetic variants and reduced T2D incidence post-intervention."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372 RISK TT-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Participants with this genotype showed lower T2D incidence in intervention group compared to control, albeit interaction test not significant."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS7903146 RISK T-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Similar findings were reported for persons with this allele by DPP and Asti study but the corresponding interaction tests weren't significant."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ENPP1 RS1044498 DIABETOGENIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Weight loss intervention was associated with reduced T2D incidence among persons with this variant, though a trend for interaction was found."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;MC4R RS17066829&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An interaction between this genetic variant and weight loss interventions resulted in a lower T2D incidence among participants."&lt;SEP&gt;"Trend for interaction between weight loss intervention and this variant was observed in certain studies."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;PPARΓ RS1152003 CC-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Persons with this genotype showed lower T2D incidence after weight loss intervention compared to reference genotypes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TNFΑ RS1800629 GG-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The weight loss intervention resulted in a lower T2D incidence among persons with this genotype."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;ADRA2B GLU9-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Trend for interaction between weight loss intervention and this allele was found in DPS study."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LIPC RS2070895 A-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The weight loss intervention resulted in a lower T2D incidence among persons with this allele compared to reference genotypes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS1044498 DIABETOGENIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Persons with this variant showed a reduced T2D incidence due to weight loss intervention, although an interaction trend was detected."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS1152003 CC-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Participants with the CC-genotype showed lower T2D risk after undergoing a weight loss intervention, as indicated by both DPP and DPS studies."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS1800629 GG-VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The weight loss intervention resulted in reduced T2D incidence for persons with this variant, as shown in the DPS study."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;GLU9-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A trend indicating an interaction between ADRA2B Glu9-allele and weight loss interventions was found in the DPS analysis."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS2070895 A-VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Participants with this variant showed a lower T2D incidence after participating in a weight loss intervention, according to both DPP and DPS findings."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;DIETARY EXPOSURE&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"19 out of 66 eligible publications reported statistically significant G × E interactions for incident T2D risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANT&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Potential G × D interaction was found with genetic variants in the TCF7L2 gene.")&lt;SEP&gt;"Variation detected in association studies with T1D susceptibility."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
    </node>
    <node id="&quot;T2D RISK&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Potential G × D interaction was found with genetic variants in the TCF7L2 gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;G × E INTERACTION&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Interaction of fiber and whole grain with genetic variants was frequently investigated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WHOLE GRAIN&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Interaction of fiber and whole grain with genetic variants was frequently investigated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EUROPEAN DESCENDANTS&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Mainly European descendants were included in NHS and HPFS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SAMPLE RECRUITMENT&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Mainly European descendants were included in NHS and HPFS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARTICIPANTS AGE&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Most studies had participants aged over 40 years.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SAMPLE SIZE&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Most studies had participants aged over 40 years.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLLOW-UP TIME&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Follow-up time ranged from four to 26 years, with more than eight years in most studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;YEARS RANGE&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Follow-up time ranged from four to 26 years, with more than eight years in most studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ETHNICITY&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Cultural and genetic background factored into the analysis."&lt;SEP&gt;"Studies were conducted on populations of mainly or only European ethnicity.")&lt;SEP&gt;"The ethnic distribution significantly affects the prevalence and characteristics of glucose tolerance in different populations."&lt;SEP&gt;"Ethnicity also interacts with rs182549 and affects the abundance of Bifidobacterium."&lt;SEP&gt;"White (93%), non-Hispanic (97%)"</data>
      <data key="d0">"DEMOGRAPHIC"</data>
    </node>
    <node id="&quot;POPULATIONS&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Studies were conducted on populations of mainly or only European ethnicity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERVENTION IN DPP&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"In DPP, participants received individual advice to reduce weight through lower fat and calorie intake along with higher physical activity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE-INTERVENTION&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"In DPP, participants received individual advice to reduce weight through lower fat and calorie intake along with higher physical activity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERVENTION IN DPS&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"In DPS, the intervention guided participants to reduce weight by increasing physical activity and following a recommended diet.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY RECOMMENDATIONS&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"In DPP, participants were advised on Mediterranean dietary patterns with extra-virgin olive oil or mixed nuts as alternatives to low-fat diets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE FACTORS - DPP&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"In DPP, participants were advised on Mediterranean dietary patterns with extra-virgin olive oil or mixed nuts as alternatives to low-fat diets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE FACTORS - PREDIMED&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"PREDIMED participants were randomized into two Mediterranean-diet groups which consumed extra virgin olive oil (1 L/week) or mixed nuts (30 g/day).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDITERRANEAN-DIET GROUPS&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"PREDIMED participants were randomized into two Mediterranean-diet groups which consumed extra virgin olive oil (1 L/week) or mixed nuts (30 g/day).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FIBER INTAKE&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Higher intake of cereal fiber is associated with lower T2D incidence among individuals carrying the rs7903146 CC-genotype but not for those with the risk T-allele.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7903146 VARIANT&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Higher intake of cereal fiber is associated with lower T2D incidence among individuals carrying the rs7903146 CC-genotype but not for those with the risk T-allele.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FIBRE INTAKE&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The variants rs10923931 in NOTCH2 and rs4457053 in ZBED3 have been associated with interactions involving fibre intake but were not consistently replicated across studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10923931 VARIANT&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The variants rs10923931 in NOTCH2 and rs4457053 in ZBED3 have been associated with interactions involving fibre intake but were not consistently replicated across studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The IRS1 rs2943641 genetic variant has been associated with insulin sensitivity and type 2 diabetes, though its findings have not been validated in other studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2943641 VARIANT&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The IRS1 rs2943641 genetic variant has been associated with insulin sensitivity and type 2 diabetes, though its findings have not been validated in other studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The GIPR rs10423928 variant has shown interaction with insulin secretion and type 2 diabetes but could not be replicated in all studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10423928 VARIANT&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The GIPR rs10423928 variant has shown interaction with insulin secretion and type 2 diabetes but could not be replicated in all studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT INTAKE&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The PPARγ variants were linked to a trend for interaction with fat intake but could not be consistently replicated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1801282 AND RS3856806 VARIANTS&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The PPARγ variants were linked to a trend for interaction with fat intake but could not be consistently replicated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADH1C *1/*2 VARIANT&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The ADH1C*2-allele was associated with lower diabetes risk among alcohol-consuming US women, contrasting its role in men.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The ADH1C*2-allele was associated with lower diabetes risk among alcohol-consuming US women, contrasting its role in men.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEME IRON INTAKE&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Higher heme iron intake was associated with increased T2D risk among women carrying specific HFE gene variants but not for men.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D (TYPE 2 DIABETES)&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Higher heme iron intake was associated with increased T2D risk among women carrying specific HFE gene variants but not for men.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC FACTOR INTERACTION/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">Environmental Factor"/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PPARGC1A VARIANT&quot;/">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">Environmental Factor"/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D RISK IN WOMEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The H63D variant was found to increase the risk of T2D specifically among women, based on data from EPIC-InterAct and DPP studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH HFE RS1799945 VARIANT IN WOMEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A similar trend to increased risk of T2D was observed for women with the H63D variant, though not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH HFE RS1800562 VARIANT IN WOMEN (TREND BUT NOT SIGNIFICANT)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"While a similar trend was noted for women and the C282Y variant, the interaction did not reach significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH HFE RS1799945 VARIANT IN MEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"In EPIC-InterAct study for men population group, an interaction was found to be significant between the H63D variant and T2D risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEN POPULATION GROUP (EPIC-INTERACT)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"In EPIC-InterAct study for men population group, an interaction was found to be significant between the H63D variant and T2D risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEN POPULATION GROUP (DPP)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A similar but not confirmed trend of increased T2D risk was found among men carrying the H63D variant through DPP study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH SLC40A1 RS744653 VARIANT IN MEN AND TMPRSS6 RS855791 IN TOTAL SAMPLE (BORDERLINE SIGNIFICANCE)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Heme iron intake showed interactions with the SLC40A1 variant rs744653 for men, and with TMPRSS6 variant rs855791 across both sexes when not reaching a strong significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY PATTERNS: WESTERN &amp; MEDITERRANEAN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Dietary patterns that reflect either Western or Mediterranean diet were associated differently with T2D risk, influenced by specific genetic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH GENETIC VARIANTS IN T2D RISK&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Dietary patterns that reflect either Western or Mediterranean diet were associated differently with T2D risk, influenced by specific genetic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH T2D-GRS IN MEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"High intake of red and processed meat increased T2D risk among men with high genetic risk scores.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RED AND PROCESSED MEAT INTAKE (HPFS)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"High intake of red and processed meat increased T2D risk among men with high genetic risk scores.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MARGINALLY NONSIGNIFICANT INTERACTION WITH GIPR VARIANT RS10423928 IN MEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A marginally nonsignificant interaction was found between olive oil intake and the GIPR variant rs10423928.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OLIVE OIL INTAKE (EPIC-INTERACT)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A marginally nonsignificant interaction was found between olive oil intake and the GIPR variant rs10423928.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE LCT GENE VARIANTS (DANISH STUDY)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Carriers of the lactase persistence LCT rs4988235 T-allele had higher T2D risk than lactose nonpersistence CC-genotype carriers, with differences observed based on milk consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MILK CONSUMPTION IN T2D RISK&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Carriers of the lactase persistence LCT rs4988235 T-allele had higher T2D risk than lactose nonpersistence CC-genotype carriers, with differences observed based on milk consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COFFEE INTAKE (EPIC-INTERACT &amp; KARE)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Findings from EPIC-InterAct and KARE suggest that coffee intake interacts differently with certain genetic variants for T2D risk, either reducing or increasing the risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH SOME GENETIC VARIANTS IN T2D RISK&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Findings from EPIC-InterAct and KARE suggest that coffee intake interacts differently with certain genetic variants for T2D risk, either reducing or increasing the risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COFFEE INTAKE (EPIC-INTERACT)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A stronger T2D risk-lowering effect of coffee intake was observed among individuals carrying the T allele of the TCF7L2 variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH TCF7L2 VARIANT RS12255372 IN MEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A stronger T2D risk-lowering effect of coffee intake was observed among individuals carrying the T allele of the TCF7L2 variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MILK CONSUMPTION (KARE)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Coffee consumers with specific genetic variants (rs4402960 T-allele, rs7754840 G-allele, rs5215 CC-genotype) showed a reduced combined prediabetes and T2D risk compared to non-consumers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REDUCTION IN COMBINED PREDIABETES AND T2D RISK FOR COFFEE CONSUMERS&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Coffee consumers with specific genetic variants (rs4402960 T-allele, rs7754840 G-allele, rs5215 CC-genotype) showed a reduced combined prediabetes and T2D risk compared to non-consumers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION WITH HIGH T2D-GRS IN MEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A Western dietary pattern was associated with higher T2D risk only among individuals with a high genetic score for T2D, but not among those with a low score.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WESTERN DIETARY PATTERN (HPFS)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A Western dietary pattern was associated with higher T2D risk only among individuals with a high genetic score for T2D, but not among those with a low score.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET (EPIC-INTERACT)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A Mediterranean diet score showed no interaction with the risk of developing type 2 diabetes according to genetic scores.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO INTERACTION WITH T2D-GRS&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"A Mediterranean diet score showed no interaction with the risk of developing type 2 diabetes according to genetic scores.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MODIFYING EFFECT ON T2D RISK BY GENETIC VARIANTS&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The protective effect of physical activity against T2D was modified by certain genetic variants, with stronger effects observed in individuals not adhering to a high genetic risk score for T2D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PA (PHYSICAL ACTIVITY)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The protective effect of physical activity against T2D was modified by certain genetic variants, with stronger effects observed in individuals not adhering to a high genetic risk score for T2D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WEAKENED PROTECTIVE EFFECT OF HIGHER PA ON T2D INCIDENCE (SWEDISH MALMÖ PROGRAM)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"In the Swedish Malmö preventive program, lower protective effects of higher physical activity against T2D incidence were observed among individuals with a specific genetic variant for HNF1B.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED LTPA RESULTING IN LOWER T2D INCIDENCE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"An increase in leisure-time physical activity was associated with lower T2D incidence among individuals with certain genetic variants, such as the Glu12 allele of ADRA2B, GG genotype of ABCC8 rs3758947, and non-risk haplotype of four SLC2A2 variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REDUCED LEISURE-TIME PHYSICAL ACTIVITY ASSOCIATED WITH HIGHER T2D INCIDENCE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"Decreased leisure-time physical activity was associated with higher T2D incidence among individuals carrying the PPARγ rs1801282 Ala- and rs17036314 C-alleles, GG genotype of PPARγ, or non-risk haplotype of four SLC2A2 variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLYCOGEN STORAGE DISEASE PROTEIN 1 (IRS1)&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"In NHS, women carrying the IRS1 rs1522813 A-allele who were physically inactive had a higher risk of developing T2D compared to those with GG-genotype but active.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED RISK WITH LOW PA AND T2D RISK A1 ALLELE IN WOMEN&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"In NHS, women carrying the IRS1 rs1522813 A-allele who were physically inactive had a higher risk of developing T2D compared to those with GG-genotype but active.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANTS&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e&lt;SEP&gt;chunk-180ca3d6d27d84b30ebf5d20f135de18&lt;SEP&gt;chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"Interaction between specific genetic variants and weight loss interventions can influence diabetes risk.")&lt;SEP&gt;"The genetic variants played a role in influencing microbiome composition, affecting causality estimation during Mendelian Randomization."&lt;SEP&gt;"Several genetic variants within the CNR1 gene were found to influence CB1 receptor levels and, subsequently, affect alcohol seeking behavior."</data>
      <data key="d0">"BIOCHEMICAL COMPONENT"</data>
    </node>
    <node id="&quot;DIABETES INCIDENCE&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d1">"Participants with certain risk genotypes showed reduced T2D incidence after weight loss intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK GENOTYPES&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d1">"Participants with certain risk genotypes showed reduced T2D incidence after weight loss intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANTS &amp; WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d1">"The DPP study indicates that certain genetic variants influence the effectiveness of weight loss interventions in diabetes risk reduction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCF7L2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs7903146 discovered within the TCF7L2 gene has a consistent direction of effect with published GWAS data on BMI at baseline."&lt;SEP&gt;"The TCF7L2 gene is associated with the count of risk alleles."&lt;SEP&gt;"The study reports an association with the rs7903146 variant in TCF7L2 gene, having a high odds ratio (OR 1.38 [95% CI 1.23–1.54], P = 1.25 × 10−8)."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;RS7903146&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"SNP rs7903146 discovered within the TCF7L2 gene has a consistent direction of effect with published GWAS data on BMI at baseline."&lt;SEP&gt;"The genomic variant rs7903146 in the TCF7L2 gene is analyzed in this study."&lt;SEP&gt;"This variant in TCF7L2 gene shows a significant association with type 2 diabetes (T2D) as per the analysis."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;WFS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The rs10010131 variant in WFS1 gene was found to be associated, although not consistently as reported in previous European studies."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS10010131&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) in the WFS1 gene showed an association with T2D."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CDKAL1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The rs10946398 variant in CDKAL1 gene was associated with T2D, consistent with previous findings."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 52}]</data>
    </node>
    <node id="&quot;RS10946398&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP of the CDKAL1 gene was found to associate with risk for T2D in this study."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 52}]</data>
    </node>
    <node id="&quot;JAZF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The rs864745 variant in JAZF1 gene showed association, consistent with earlier reports."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 52}]</data>
    </node>
    <node id="&quot;RS864745&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This particular genomic variant of the JAZF1 gene was found associated with risk for T2D based on this study's findings."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 52}]</data>
    </node>
    <node id="&quot;ADAMTS9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs4607103 in ADAMTS9 was associated but had an opposite direction of effect compared to European studies, pointing towards a unique genetic interaction."&lt;SEP&gt;"The rs4607103 variant in ADAMTS9 gene exhibited association; however, its direction of effect was opposite to that reported in European samples."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 49}]</data>
    </node>
    <node id="&quot;RS4607103&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant found in the ADAMTS9 gene had an opposing direction of association compared to earlier European findings."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 49}]</data>
    </node>
    <node id="&quot;T2D-ESRD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Set 1 comprised a higher percentage of women compared to the control group, with T2D-ESRD (type 2 diabetes and end-stage renal disease) case subjects having an older mean age at enrollment than controls."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;T2D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T2D patients were identified in the cohort, and certain genetic variants were tested against this disease."&lt;SEP&gt;"The meta-analysis showed consistent results across sets 1 and 2 in relation to rs7903146 variant of TCF7L2 gene, indicating association with risk for type 2 diabetes."&lt;SEP&gt;"Type 2 diabetes is a metabolic disorder characterized by high blood sugar due to insulin resistance or insufficient production of insulin."&lt;SEP&gt;"Type 2 diabetes associated with the G-allele of rs1183910 in HNF1A and increased CRP levels."&lt;SEP&gt;"Type 2 diabetes has been linked to certain lead SNPs through analysis of individuals contributing to trans-ethnic meta-analysis."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;NUMBER OF TCF7L2 RISK VARIANTS&quot;">
      <data key="d0">"COUNT OF RISK ALLELES"</data>
      <data key="d1">"The count of risk alleles associated with the TCF7L2 gene's genetic variants was considered for analysis."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 50}]</data>
    </node>
    <node id="&quot;AGE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Age (years) is a variable that characterizes individuals enrolled in the study."&lt;SEP&gt;"Age had a significant association with snoring, with each year increasing odds of snoring by 1.011 (95% CI: 1.009-1.012)."&lt;SEP&gt;"Demographic factor adjusted when analyzing results."&lt;SEP&gt;"Evidence for interaction with age in relation to the association between TCF7L2 gene and the number of risk alleles is not found."&lt;SEP&gt;"There is a positive association between age and the prevalence of IFG/IGT and T2D, with older individuals being more prone to these conditions."&lt;SEP&gt;"Younger individuals showed a tendency towards adhering more to the Mediterranean diet compared to older individuals."&lt;SEP&gt;"The age of women was considered an environmental factor when analyzing the data, which could influence the results due to its impact on various biological processes related to cancer risk."&lt;SEP&gt;"Measure of age in years."&lt;SEP&gt;"Age shows an interaction with rs182549, affecting Bifidobacterium abundance differently in different age groups."&lt;SEP&gt;"No statistically significant interaction was found between age and selenium's impact on colorectal cancer risk, emphasizing the importance of other factors."&lt;SEP&gt;"No statistically significant interaction was found between age and selenium's impact on colorectal cancer risk."&lt;SEP&gt;"Participants who consumed black coffee or sugared coffee were more likely to be younger."&lt;SEP&gt;"There was a significant difference in age distribution between different genotypes."&lt;SEP&gt;"Patients were a mean age of 60 years (SD=10)"&lt;SEP&gt;"Symptoms and vital signs were measured in the participants during the study."&lt;SEP&gt;"Average age was slightly higher for asthmatic patients compared to healthy controls in this study."&lt;SEP&gt;"The age variable was considered as a covariate during pooled association analysis."&lt;SEP&gt;"The entity 'age' has a relationship with other entities indicating its influence on HIV disease progression."&lt;SEP&gt;"The entity 'age' has a relationship with other entities indicating the influence of age in HIV disease progression."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;SEX&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Gender influences glycemic status; females tend to have a higher frequency of NGT compared to males."&lt;SEP&gt;"Interaction with sex regarding the relationship between the TCF7L2 gene's genetic variants and count of risk alleles was also explored but found insignificant."&lt;SEP&gt;"Gender was considered a variable in adjustment factors."&lt;SEP&gt;"Women tended to adhere more to the Mediterranean diet than men."&lt;SEP&gt;"Sex showed an even stronger association with snoring, with males having a relative risk ratio of 2.264 compared to females."&lt;SEP&gt;"Sex was considered as a covariate in the adjusted analyses for treatment response."&lt;SEP&gt;"Sex is another demographic characteristic of the study participants."&lt;SEP&gt;"The entity 'sex' has a relation to HIV disease progression, suggesting its role is considered in disease risk assessment."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-8f23bd741f82dc8ca1e2600d790b690f&lt;SEP&gt;chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-2c91cdebb36ef064eb01a7021a961302&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;DEGREE OF AFRICAN ANCESTRY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The degree of African ancestry was considered but found not to have an effect on the relationship between the TCF7L2 gene's genetic variants and count of risk alleles."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;SEX RATIO&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"Set 1 had a higher percentage of women compared to controls, indicating potential sex-based disparities in T2D and ESRD associations.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;AGE AT ENROLLMENT&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The enrollment age difference between T2D-ESRD case subjects and controls was observed, potentially influencing study outcomes or the progression of conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;AGE AT DIAGNOSIS&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"Diagnosis age disparity between T2D and ESRD subjects was observed, possibly influencing outcomes or disease management.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;RS7903146+ADAMTS9+CDKAL1+JAZF1&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The combined variants rs7903146 in TCF7L2, ADAMTS9, CDKAL1 and JAZF1 genes showed association with type 2 diabetes (T2D), highlighting genetic contributions to multiple risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;RS864745+JAZF1&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The combined variants rs864745 in JAZF1 gene showed association with T2D through this study, emphasizing genetic factors in diabetes risk assessment.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;RISK FACTOR CONTRIBUTION&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"This study's results highlighted contributions of various risk factors to T2D and ESRD, underscoring interplay between conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;RS7903146+ADAMTS9+CDKAL1+JAZF1+RS864745+RS10946398&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The combined genetic variants rs7903146 in TCF7L2, ADAMTS9, CDKAL1, JAZF1 and rs864745 and rs10946398 in other genes were associated with type 2 diabetes (T2D), emphasizing the role of genetic polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;ADAMTS9+CDKAL1+JAZF1&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"SNPs rs4607103 and rs10946398 were found associated with T2D through this study, indicating genetic variability in diabetes risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4607103+RS10946398&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"SNPs rs4607103 and rs10946398 were found associated with T2D through this study, indicating genetic variability in diabetes risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL PARAMETERS&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"This study's findings underscored the importance of clinical parameters in assessing T2D and ESRD, emphasizing their interrelation.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;ADAMTS9+CDKAL1+T2D-ESRD CLINICAL PARAMETERS&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"SNPs rs864745, JAZF1, rs4607103 and rs10946398 were found associated with T2D and ESRD through this study, highlighting the importance of genetic factors in disease assessments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS864745+JAZF1+RS4607103+RS10946398&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"SNPs rs864745, JAZF1, rs4607103 and rs10946398 were found associated with T2D and ESRD through this study, highlighting the importance of genetic factors in disease assessments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7903146+ADAMTS9+CDKAL1+JAZF1+RS864745+RS10946398+RS4607103+RS10946398+RS864745&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The combined genetic variants rs7903146 in TCF7L2, ADAMTS9, CDKAL1, JAZF1, rs864745 and rs10946398 showed association with type 2 diabetes (T2D), indicating complex genetic interplay.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;INTERACTION&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"No evidence for interaction between age and the association between TCF7L2 gene and the number of risk alleles was found.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;NGT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Normal glucose tolerance is a condition where individuals have normal fasting plasma glucose levels."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;IFG/IGT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Impaired fasting glucose/impaired glucose tolerance indicates abnormal glucose metabolism."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"FPG levels are directly related to glucose metabolism and can indicate metabolic health."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TWO-HOUR PLASMA GLUCOSE (2HPG)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Increased 2hPG levels suggest abnormalities in post-meal glycemic control, indicative of insulin sensitivity issues."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;GLYCEMIC STATUS TRANSITION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Transitioning from NGT to IFG/IGT or T2D is associated with changes in BMI and metabolic health parameters."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;CHANGE IN FPG LEVELS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Changes in FPG levels are linked to BMI change, possibly through effects on insulin sensitivity and glucose metabolism processes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;CHANGE IN 2HPG LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alterations in post-meal glucose levels can affect BMI and metabolic health outcomes, reflecting dietary or lifestyle impacts."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;LIFESTYLE FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Dietary habits, physical activity levels, sleep patterns, and stress management affect the development of glucose tolerance disorders."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;AGE OF ONSET&quot;">
      <data key="d0">"TEMPORAL PROCESS"</data>
      <data key="d1">"The age at which individuals develop NGT, IFG/IGT, or T2D can influence the progression of metabolic health issues."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"IRF1's involvement suggests a potential molecular interaction between the SNP block and insulin resistance mechanisms."&lt;SEP&gt;"Impaired insulin sensitivity contributes to the development of IFG/IGT and progression towards T2D."&lt;SEP&gt;"Insulin resistance was indicated by higher fasting insulin levels and HOMA-IR scores among women with PCOS."&lt;SEP&gt;"The proximity of rs7574352 to the IRF1 gene might suggest a link between this variant and insulin resistance or metabolic disorders."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;METABOLIC SYNDROME&quot;">
      <data key="d0">"INDICATORS OF METABOLIC SYNDROME"</data>
      <data key="d1">"A cluster of conditions—high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels—that increase a person's risk for heart disease, stroke, and diabetes."&lt;SEP&gt;"The presence of metabolic syndrome increases the likelihood of developing IFG/IGT and T2D due to shared pathophysiological mechanisms."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Alcohol consumption was very heavy for both groups at time of conception and continued to be so across pregnancy."&lt;SEP&gt;"Excessive alcohol intake is linked to impaired glucose tolerance and can influence the progression towards diabetes."&lt;SEP&gt;"The quantity and frequency of alcohol consumption in the diet."&lt;SEP&gt;"There was no significant difference in alcohol consumption between the case and control groups."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A higher rate of hypertension was noted among HUA cases compared to controls."&lt;SEP&gt;"A state of high blood pressure that was considered as one of the covariates."&lt;SEP&gt;"Coexisting hypertension can exacerbate glucose intolerance and increase the risk of developing diabetes."&lt;SEP&gt;"Hypertension contributes to sUA level elevation and increases the risk of hyperuricemia (HUA)."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;FTO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genes among the 12 identified pleiotropic loci associated with CRP."&lt;SEP&gt;"SNP rs9939609 located in the FTO gene is associated with BMI at baseline."&lt;SEP&gt;"Linked to alcohol consumption, which can affect sleep patterns including snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TAL1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs2984618 found in the TAL1 gene shows a significant association with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GRS&quot;">
      <data key="d0">"GENETIC RISK SCORE"</data>
      <data key="d1">"A Genetic Risk Score (GRS) that ranged from 0 to 9 was calculated based on multiple polymorphisms"&lt;SEP&gt;"The Genotype Risk Score (GRS) is significantly associated with increased BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;RS9939609&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The SNP rs9939609 located in the FTO gene is associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS2984618&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"SNP rs2984618 found in the TAL1 gene shows a significant association with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMIC&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"An increase in fasting plasma glucose levels shows a positive association with BMI changes, possibly through metabolic pathways affecting fat accumulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE PROGRESSION&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Transitioning from NGT to IFG/IGT or T2D is associated with disease progression and increased health risks.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI CHANGE&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Fasting plasma glucose and two-hour post-meal glucose levels are negatively correlated with BMI at baseline but positively related to BMI change, indicating complex metabolic interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FPG AND 2HPG LEVELS&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Fasting plasma glucose and two-hour post-meal glucose levels are negatively correlated with BMI at baseline but positively related to BMI change, indicating complex metabolic interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BASELINE GLYCEMIC STATUS&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Participants with NGT display lower changes in BMI compared to IFG/IGT or T2D subjects, highlighting protective effects of normal glucose tolerance on body weight maintenance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHANGE IN BMI&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Participants with NGT display lower changes in BMI compared to IFG/IGT or T2D subjects, highlighting protective effects of normal glucose tolerance on body weight maintenance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG/IGT TRANSITION&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Transitioning from NGT to IFG/IGT increases the risk of developing obesity and metabolic disorders due to higher baseline BMI and BMI change.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED RISK&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Transitioning from NGT to IFG/IGT increases the risk of developing obesity and metabolic disorders due to higher baseline BMI and BMI change.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREVENTIVE EFFECT&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Maintaining normal glucose tolerance over time has a protective effect on body weight management compared to transitioning stages of impaired glycemic status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STABLE NGT&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Maintaining normal glucose tolerance over time has a protective effect on body weight management compared to transitioning stages of impaired glycemic status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The rs1011527 SNP in the LEPR gene interacts significantly with FPG on baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;RS1011527 SNP IN LEPR&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The rs1011527 SNP in the LEPR gene interacts significantly with FPG on baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 36}]</data>
    </node>
    <node id="&quot;MTHFR 1298A&gt;C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFR gene carries a polymorphism at position 1298 where the nucleotide A is replaced by C."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MS 2756A&gt;G&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MS (Methylenetetrahydrofolate dehydrogenase, NADH-dependent) gene carries a polymorphism at position 2756 where the nucleotide A is replaced by G."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"MTX (Methotrexate) related neurotoxicity is an adverse effect observed in patients undergoing treatment with Methotrexate, which occurred in 7 out of the study participants."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;DIVERGT BATTERY&quot;">
      <data key="d0">"TEST BATTERY"</data>
      <data key="d1">"DIVERGT battery is a comprehensive neuropsychological test battery used for assessing cognitive functions such as attention and processing speed."&lt;SEP&gt;"The DIVERGT battery might have been considered as part of assessing cognitive function but was not associated with GRS"</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;PEDIATRIC ONCOLOGY GROUP (POG) PROTOCOLS&quot;">
      <data key="d0">"PROTOCOL"</data>
      <data key="d1">"POG protocols refer to the clinical trial protocols conducted by the Pediatric Oncology Group, which were primarily utilized in the study's treatment of patients."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PEGDH&quot;">
      <data key="d0">"TEST MEASURE"</data>
      <data key="d1">"PEGDH activity was not related to the GRS suggesting it may not be involved in the pathway related to MTX-related neurotoxicity or disease impact"&lt;SEP&gt;"PEGDH is a component part of PEGNDH test that assesses working memory and attention span."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;DIG&quot;">
      <data key="d0">"TEST MEASURE"</data>
      <data key="d1">"This measures an individual's cognitive ability in the domain of Working Memory, particularly focusing on encoding and retrieval processes."&lt;SEP&gt;9</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;CFL&quot;">
      <data key="d0">"TEST MEASURE"</data>
      <data key="d1">"CFL (Cognitive Functioning Level) test evaluates executive functions which include cognitive flexibility, inhibition control, planning, working memory, attention, and cognitive processing speed."&lt;SEP&gt;10</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;TMTA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Impaired TMTA scores were observed in patients who had MTX-related neurotoxicity"&lt;SEP&gt;"TMTA (Trail Making Test A) assesses focused attention and processing speed."&lt;SEP&gt;"TMTA performance may be negatively influenced by MTX-related neurotoxic events"&lt;SEP&gt;"TMTA seems to have been negatively impacted by MTX-related neurotoxicity, as indicated in the study"</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;TMTB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Low TMTB performance was associated with GRS ≥ 6, indicating potential disease impact"&lt;SEP&gt;"TMTB (Trail Making Test B) evaluates shifting attention and processing speed."&lt;SEP&gt;"TMTB scores were significantly different based on GRS, suggesting potential involvement in neurodegenerative processes related to MTX use"&lt;SEP&gt;"TMTB was significantly lower in patients with a GRS ≥ 6 compared to those with a GRS &lt; 6"</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;SHMT 1420C&gt;T POLYMORPHISM&quot;">
      <data key="d0">"POLYMORPHISM"</data>
      <data key="d1">"The SHMT 1420C&gt;T is a genetic variant found within the Serine Hydroxymethyltransferase (SHMT) gene, influencing its activity and potentially impacting folate metabolism."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTRR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFR Trapping Reaction Reductase (MTRR) gene is essential for methylcobalamin-dependent reactions in the body's folate cycle."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TMTA TEST&quot;">
      <data key="d0">"TEST"</data>
      <data key="d1">"Trail Making Test A assesses attention and cognitive processing speed."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TMTB TEST&quot;">
      <data key="d0">"TEST"</data>
      <data key="d1">"Trail Making Test B evaluates executive functions, particularly working memory and cognitive flexibility."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;COGNITIVE FUNCTIONING LEVEL (CFL) TEST&quot;">
      <data key="d0">"TEST"</data>
      <data key="d1">"The Cognitive Functioning Level (CFL) test is designed to measure various components of cognitive function including attention span, memory retention, and processing speed."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PEGNDH TEST&quot;">
      <data key="d0">"TEST"</data>
      <data key="d1">"This test evaluates the performance in certain areas related to working memory and attention processes, particularly sensitive to the impact of MTHFR polymorphisms."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;COGNITIVE FLEXIBILITY&quot;">
      <data key="d0">"SKILL"/"FUNCTION"</data>
      <data key="d1">"Cognitive flexibility involves the ability to adapt thinking styles or responses according to different situations or tasks."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;INHIBITION CONTROL&quot;">
      <data key="d0">"SKILL"/"FUNCTION"</data>
      <data key="d1">"This skill involves suppressing impulses and reactions, particularly in response to distractions or when switching between tasks."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PLANNING SKILLS&quot;">
      <data key="d0">"SKILL"/"FUNCTION"</data>
      <data key="d1">"Planning is the ability to think ahead, set objectives, and organize actions towards achieving these goals."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;WORKING MEMORY&quot;">
      <data key="d0">"MEMORY TYPE"</data>
      <data key="d1">"The capacity to temporarily hold and manipulate information in mind while performing tasks."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;ATTENTION&quot;">
      <data key="d0">"COGNITIVE PROCESS"</data>
      <data key="d1">"The ability to focus on specific stimuli or tasks while filtering out distractions."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTX&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"MTX is a drug that may be associated with early neurotoxicity"&lt;SEP&gt;"MTX is associated with neurotoxicity and has been used to calculate genetic risk score"</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;PEGNDH&quot;">
      <data key="d0">"METABOLIC PATHWAY"&lt;|"PEGNDH ACTIVITY DID NOT SHOW A SIGNIFICANT ASSOCIATION WITH TMT PERFORMANCE, IMPLYING IT MIGHT BE SEPARATE FROM MTX'S IMPACT ON COGNITION"</data>
      <data key="d1">8</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;SLC30A8 RS13266634&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C risk allele at SLC30A8 rs13266634 was significantly associated with higher fasting proinsulin levels."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING PROINSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The association between the SLC30A8 risk allele and fasting proinsulin levels was observed."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DPP COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The study population included individuals from DPP (Diabetes Prevention Program) cohort."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;SLIMFAST INSULIN&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"An alternative term for fasting insulin metabolism that was part of the analysis context."&lt;SEP&gt;"Fasting insulin is a metabolic pathway involved in glucose regulation."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING GLUCOSE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A baseline measurement used for adjusting variables related to insulin levels."&lt;SEP&gt;"Baseline fasting glucose levels were considered as one of the covariates for adjusting variables."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;SLC30A8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The study focused on the SLC30A8 gene and its risk allele at rs13266634."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;LIFESTYLE INTERVENTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"One of the active intervention groups was a lifestyle intervention group."&lt;SEP&gt;"Type of treatment group that involved changes in lifestyle habits."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;METFORMIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"One of the treatment modalities tested for lowering proinsulin levels."&lt;SEP&gt;"The metformin intervention group had similar proinsulin levels compared to the troglitazone group at year 1."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TROGLITAZONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Another active intervention group was the troglitazone group, which also showed a decrease in proinsulin levels."&lt;SEP&gt;"Another medication used as a control or alternative in the study."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DPP INTERVENTIONS&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"After 1 year of randomised DPP intervention, fasting proinsulin levels were significantly decreased."&lt;SEP&gt;"The primary intervention conducted over one year."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;GENOTYPE × TREATMENT INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Exploration of whether genetic predispositions modify treatment response."&lt;SEP&gt;"There was no significant interaction between genotype and the effectiveness of any treatment."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TREATMENT EFFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Result or change observed post-intervention application."&lt;SEP&gt;"The effectiveness of different treatments on reducing proinsulin levels after DPP interventions."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;SLC30A8 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The locus was considered when analyzing the association between SLC30A8 risk alleles and fasting proinsulin levels after adjusting for other variables."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;PROINSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting proinsulin levels were studied for associations with genetic factors."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DPP (DIABETES PREVENTION PROGRAM)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A major study cohort involving dietary intervention in diabetes prevention."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;INTERVENTION GROUPS&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Groups that underwent different treatments as part of the DPP program."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;PLACEBO GROUP&quot;">
      <data key="d0">"CONTROL TREATMENT"</data>
      <data key="d1">"The group receiving no active treatment, serving as a baseline for comparison."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;1 YEAR&quot;">
      <data key="d0">"TIME PERIOD"</data>
      <data key="d1">"A significant time duration considered in assessing changes post-intervention."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING INSULIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fasting insulin levels were notably higher in women with PCOS compared to control subjects, indicating insulin resistance."&lt;SEP&gt;"Part of the body's response to maintain glucose levels, used for adjusting analysis."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;PLACEBO GROUP EFFECT&quot;">
      <data key="d0">"CONTROL EFFECT"</data>
      <data key="d1">"Reference point to measure against treatment effects in intervention groups."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;AGE, SEX AND ETHNICITY ADJUSTMENT&quot;">
      <data key="d0">"STATISTICAL ADJUSTMENT FACTORS"</data>
      <data key="d1">"Common demographic variables considered for statistical analyses."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DIETARY PATTERN EXPOSURE&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The DPP cohort was exposed to certain dietary patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DPP COHORT INDIVIDUALS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The DPP cohort was exposed to certain dietary patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADJUSTMENT FACTOR&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Baseline fasting insulin was used as an adjustment factor for statistical analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BASELINE FASTING INSULIN&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Baseline fasting insulin was used as an adjustment factor for statistical analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACTIVE INTERVENTION GROUPS (LIFESTYLE, METFORMIN, TROGLITAZONE)&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The active interventions had a significant impact on lowering fasting proinsulin levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DRUG RESPONSE COMPARISON&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The metformin and troglitazone intervention groups showed similar but distinct drug responses in terms of decreasing proinsulin levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METFORMIN AND TROGLITAZONE INTERVENTION GROUPS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The metformin and troglitazone intervention groups showed similar but distinct drug responses in terms of decreasing proinsulin levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION AFTER TREATMENT&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"After DPP interventions, the association between SLC30A8 risk alleles and fasting proinsulin levels was no longer statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE AT SLC30A8 LOCUS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"After DPP interventions, the association between SLC30A8 risk alleles and fasting proinsulin levels was no longer statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPACT&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Impact of lifestyle changes on fasting proinsulin levels following DPP interventions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE INTERVENTION EFFECTS&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Impact of lifestyle changes on fasting proinsulin levels following DPP interventions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPARISON&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Comparative analysis between the drug effects of metformin and troglitazone on proinsulin levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METFORMIN VS. TROGLITAZONE&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Comparative analysis between the drug effects of metformin and troglitazone on proinsulin levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE AT SLC30A8 LOCUS INTERACTION&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The influence of specific genotypes on the effectiveness of diabetes interventions over time.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MODULATION&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The influence of specific genotypes on the effectiveness of diabetes interventions over time.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-DEPENDENCY&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"How different treatment responses are influenced by varying age levels within study participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT RESPONSES WITH AGE ADJUSTMENT&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"How different treatment responses are influenced by varying age levels within study participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENDER-EFFECT&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The influence of sex on the body's response to proinsulin levels post-intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEX DIFFERENCES IN PROINSULIN RESPONSE&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"The influence of sex on the body's response to proinsulin levels post-intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CULTURAL-EFFECT&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"How ethnicity impacts the effectiveness of diabetes prevention interventions and outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ETHNICITY-BASED TREATMENT OUTCOMES&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"How ethnicity impacts the effectiveness of diabetes prevention interventions and outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HC DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The high carbohydrate diet increases the expression of PNPLA3 in mouse liver."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;LE (LIPID EMULSION)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Inclusion of lipid emulsion in the HC diet prevents the induction of PNPLA3 mRNA dose-dependently."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;PNPLA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PNPLA3 gene does not respond to insulin and glucagon in HepG2 cells."&lt;SEP&gt;"The expression of PNPLA3 is increased by the high carbohydrate diet and attenuated by lipid emulsions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;PNPLA3 MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript levels of PNPLA3 correlate with liver total TG content in mice fed a high carbohydrate diet."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;SREBP1C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SREBP1c shows a similar expression pattern to that of PNPLA3, and it is correlated with ACC-1 mRNA and PNPLA3 mRNA."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;ACC-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Acetyl-CoA Carboxylase 1 (ACC-1), a fatty acid synthase involved in lipid synthesis, had similar expression patterns to PNPLA3."&lt;SEP&gt;"Both SREBP1c and ACC-1 mRNA show a similar expression pattern and correlation to PNPLA3, indicating they are involved in the lipogenic pathway."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;PNPLA2 (ATGL)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The expression of PNPLA2 (ATGL) is not different among diets, as it can break down TG."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HF DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Mice fed HF diet developed fatty liver with increased hepatic TG content and suppressed PNPLA3 mRNA levels compared to the LF diet group."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;EXERCISE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Our in vivo data suggested that exercise may stimulate glucagon secretion, which could potentially decrease PNPLA3 gene expression."&lt;SEP&gt;"Voluntary exercise reduces PNPLA3 mRNA levels in mice fed HF diet, decreasing both SREBP1c and ACC-1 gene expression as well."&lt;SEP&gt;"Voluntary exercise reduces SREBP1c and ACC-1 mRNA levels in mice fed HF diet, suggesting a role in modulating metabolic pathways related to energy expenditure and fat metabolism."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;GLUCOSE&quot;">
      <data key="d0">"BLOOD GLUCOSE LEVEL"</data>
      <data key="d1">"Glucose regulates PNPLA3 gene expression in HepG2 cells, where it can induce or suppress the level of expression based on depletion-refeeding conditions."&lt;SEP&gt;"The amount of glucose present in the blood, which is essential for providing energy to the body's cells. High levels can indicate diabetes or other metabolic disorders."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;SREBP1C MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"SREBP1c transcription is regulated by diet, with increased expression on HC diet compared to NC and controlled for by LE."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;ACC-1 MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"ACC-1 mRNA levels are correlated with PNPLA3 and SREBP1c mRNA in mouse liver, indicating coordinated regulation of lipogenic pathways."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;FAS (FATTY ACID SYNTHASE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAS gene expression does not differ between LF and HF diet groups but may influence lipid synthesis as part of the lipogenic pathway."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;INSULIN&quot;">
      <data key="d0">"HORMONE/</data>
      <data key="d1">"Hormone produced by the pancreas that helps regulate blood sugar levels."&lt;SEP&gt;"Studies conducted with adipocytes have shown that the PNPLA3 gene expression is regulated by insulin, which increased promoter activity of PNPLA3 gene in Chinese hamster ovary cells."&lt;SEP&gt;"SNPs were associated with insulin levels, related to metabolic syndrome development."&lt;SEP&gt;"The level of insulin produced and/or circulating in the bloodstream, often used as an indicator of metabolic health or the risk for developing diabetes."&lt;SEP&gt;|&gt;Metabolic Pathway"/"Cellular Process"/"Environmental Factor/</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;GLUCAGON&quot;">
      <data key="d0">"HORMONE"</data>
      <data key="d1">"It was hypothesized that exercise may stimulate glucagon secretion and decrease PNPLA3 gene expression but our data showed that treatment of HepG2 cells with 100 nM glucagon in low glucose medium had no effect on PNPLA3 mRNA expression."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Several unsaturated fatty acids were investigated for their effect on PNPLA3 gene expression. Linoleic acid (LA), oleic acid (OA), and α-linolenic acid (ALA) were the major components of Intralipid used in our studies. The results showed that treatment with fatty acids such as OA, LA, EPA, DHA or their combination significantly suppressed PNPLA3 gene expression."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;EICOSAPENTAENOIC ACID&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"EPA and DHA were two long-chain polyunsaturated fatty acids found to suppress PNPLA3 gene expression under both low and high glucose conditions."&lt;SEP&gt;"Long-chain polyunsaturated fatty acid EPA suppressed PNPLA3 gene expression under both low and high glucose conditions similar to docosahexaenoic acid (DHA)."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;FAS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Fatty Acid Synthase (FAS) is a key enzyme in lipogenesis, which was found to be upregulated by insulin stimulation but showed no change when PNPLA3 mRNA expression was decreased."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;FATTY ACID SYNTHASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"FAS is an enzyme that converts acetyl-CoA into malonyl-CoA and then further to palmitoyl-CoA during fatty acid synthesis; its expression was observed to be upregulated by insulin but unaffected when PNPLA3 mRNA level was reduced."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ACETYL-COA CARBOXYLASE 1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ACC-1 is a protein that catalyzes the first committed step in fatty acid synthesis and its expression patterns were similar to those of PNPLA3."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;EXOGENOUS FATTY ACID&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Directly added exogenous fatty acids like oleic acid (OA) had effects on PNPLA3 gene expression, decreasing it when co-administered with PNPLA3 siRNA but not alone or under high glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d3">[{"level": 0, "cluster": 19}]</data>
    </node>
    <node id="&quot;INTRALIPID®&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The diet containing Intralipid® was used in our studies to induce a condition that completely reversed the induction of PNPLA3 by HC-diet, indicating its role in modulating fatty acid metabolism and potentially affecting PNPLA3 gene expression."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LINOLEIC ACID&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"One of the components of Intralipid® (and major unsaturated fatty acids), Linoleic Acid (LA) when treated directly with HepG2 cells, suppressed PNPLA3 gene expression under both low and high glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;Α-LINOLENIC ACID&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"Another component of Intralipid®, α-linolenic Acid (ALA), did not affect PNPLA3 gene expression regardless of glucose concentration, differentiating it from other fatty acids that suppressed the expression of PNPLA3."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;DOCOSAHEXAENOIC ACID&quot;">
      <data key="d0">"FATTY ACID"</data>
      <data key="d1">"Another long-chain polyunsaturated fatty acid, DHA also suppressed PNPLA3 gene expression under the same conditions as EPA."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;PNPLA3 GENE&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Studies indicated that insulin increased promoter activity of PNPLA3 gene in Chinese hamster ovary cells but incubation with 10 nM insulin for 24 h did not increase PNPLA3 mRNA compared to control cells.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 46}]</data>
    </node>
    <node id="&quot;A2M&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A2M is a gene that plays roles in multiple molecular biological processes. Its expression can be influenced by environmental factors."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARID5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ARID5B is another gene with roles and interactions similar to those of other genes in the list, potentially participating in signaling pathways and cellular functions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARRDC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ARRDC4 is a gene involved in processes like A2M, ARID5B, and others, possibly contributing to biological systems or functions related to cell metabolism or signal transduction."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;EPHA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EPHA4 shares characteristics with other genes listed, likely playing roles similar to those described for ISOC1, LDLRAP1, LRRN3, etc., in different cellular and biological contexts."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FBXO32&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FBXO32 is a gene that interacts with others on the list, possibly involved in processes related to protein degradation or cell regulation."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FOXO1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FoxO1 has been found to be up-regulated and plays significant roles in depression-related pathways when combined with certain environmental factors."&lt;SEP&gt;"FoxO1 is a gene involved in the activation of hippocampal progenitor stem cells following cortisol exposure."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HSF2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HSF2 is a gene that might contribute to stress response or repair mechanisms, similar to other listed genes but distinct by its role in specific cellular processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ISOC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ISOC1 has been modulated with changes in different conditions and interacts with other listed genes as part of complex biological pathways."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LDLRAP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LDLRAP1 is involved in lipid metabolism processes, possibly interacting with others to affect cellular functions or response to stimuli."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LRRN3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LRRN3 shows similarities in biological roles as other genes listed but contributes uniquely through its specific interactions and functions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;MYO1D&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MYO1D interacts with others, contributing to processes related to muscle function or cellular dynamics, based on the context provided."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PIK3C2B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PIK3C2B is a gene that plays roles similar to other listed genes in signaling pathways and potentially cell regulation, with interactions dependent on environmental factors."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PPAP2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PPAP2A is another gene whose expression or functions might be influenced by various conditions and can interact with others for specific biological outcomes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SAMD12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SAMD12, like other genes listed, likely has roles in molecular processes but contributes uniquely through its interactions and biological functions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SERINC5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SERINC5 is a gene that interacts with others on the list, potentially participating in diverse cellular pathways or biological mechanisms."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TGF-Β1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TGF-β1 plays roles in multiple biological processes, often in response to environmental stimuli and interacting with other genes for various outcomes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL2 is a gene involved in apoptosis regulation, possibly interacting with other genes through signaling pathways."&lt;SEP&gt;"Related to snoring, insomnia, and sleep-related traits like daytime dozing or excessive sleepiness."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL9 contributes to various cellular processes similar to BCL2 and other listed genes but uniquely participates in specific interactions or biological mechanisms."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LEF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LEF1 acts as a transcriptional co-factor influencing gene expression, showing roles similar to ARID5B and others in complex signaling pathways."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LIN54&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LIN54 is involved in the regulation of cell cycle progression or other biological processes related to cell dynamics through interactions with proteins like MYO1D."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PGAP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PGAP1 interacts with others, possibly contributing to glycosylation processes or affecting protein function and interaction networks."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"283 cardiometabolic SNPs with p-values smaller than expected under the null hypothesis in CRP GWAS."&lt;SEP&gt;"The text mentions an 1 SNP with emotional abuse."&lt;SEP&gt;"A SNP in the intronic region of C21orf34 detected for respiratory quotient (RQ) during sleep."&lt;SEP&gt;"Single nucleotide polymorphisms (SNPs) are variations at a specific position of the genome that may interact with genes to affect ovarian cancer risk."&lt;SEP&gt;"7 SNPs were initially identified in the 128 tagging SNPs, including specific SNPs from MTHFD2, BHMT2, NOS3, and SLC19A1 genes."&lt;SEP&gt;"A variation in a single DNA building block at a specific position in the genome."&lt;SEP&gt;"Single Nucleotide Polymorphism used to construct allelic scores for 'Age at first tooth' and 'Number of teeth'."&lt;SEP&gt;"The minor allele of each Single Nucleotide Polymorphism (SNP) is associated with a lower risk when combined with type 2 diabetes."&lt;SEP&gt;"Single Nucleotide Polymorphisms that were studied for their causal effects on birthweight and B12/folate levels."&lt;SEP&gt;"Single Nucleotide Polymorphisms were identified as functionally related through the GRAIL analysis."&lt;SEP&gt;"We investigated six MS risk SNPs (all previously identified as eQTLs in LCLs, with evidence implicating EBNA2 binding) and found that EBNA2 binds dependent on the MS risk allele at five loci."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-7efd4f037425eeac77e329347b16beb2&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17&lt;SEP&gt;chunk-0ce38a2d49e01ec790464306e01de9b4&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;EMOTIONAL ABUSE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Emotional abuse is an environmental factor that affects the activation of FoxO1 in hippocampal progenitor cells following cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CORTISOL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cortisol, a stress hormone, is involved in the negative effect of stress on neurogenesis and activates FoxO1 gene expression."&lt;SEP&gt;"The pattern of cortisol levels varied by sex based on the ALDH2 rs671 genotypes."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;FOXO1 MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The level of FoxO1 transcript was significantly increased following treatment with cortisol."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;AS1842856&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"AS1842856 is a cell-permeable inhibitor of FoxO1 which can completely inhibit the cortisol-induced upregulation of FoxO1 and the reduction in neuronal proliferation."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The inhibition of AS1842856 counteracts the cortisol-induced reduction in neuronal proliferation, indicating a role for FoxO1 signaling."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SGK-1 is a stress-responsive gene that mediates glucocorticoid effects on brain function and the negative impact of cortisol on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;GLUCOCORTICOID EFFECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The effect of glucocorticoids like cortisol on brain function is mediated by SGK-1, which was found to be elevated following stress and cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;STRESSED RATS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Stress in animal models (stressed rats) led to the elevation of SGK1 mRNA levels."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;DEPRESSED PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Similar to stressed rats, depressed patients showed elevated SGK1 levels when exposed to cortisol, highlighting the relevance of this pathway in neurological disorders."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SUPPLEMENTARY TABLE 9&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Table not shown, but it may contain details on dietary patterns related to emotional abuse."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;IMMORTALIZED, MULTIPOTENT HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The established model for testing effects of stress and cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;DEPRESSION IN A DISH&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Represents the testing of depression-related changes using an in vitro cell line model."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;24 H TREATMENT&quot;">
      <data key="d0">"TEMPORAL PROCESS"</data>
      <data key="d1">"Duration for which cells were treated with cortisol, indicating time frame of study."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;100 ΜM CORTISOL&quot;">
      <data key="d0">"DOSE/QUANTITY"</data>
      <data key="d1">"Cortisol concentration used during the experiment."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;100 NM AS1842856&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Concentration of the FoxO1 inhibitor in the cell culture experiments."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;1-WAY ANOVA&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A statistical test used to determine if there are differences among group means."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;FC = + 3.9 AND P &lt; 0.0001&quot;">
      <data key="d0">"STATISTICAL SIGNIFICANCE"</data>
      <data key="d1">"Indicates a significant increase in FoxO1 mRNA levels with a very low probability of the result occurring by chance."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;BRDU + CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells that have incorporated BrdU, used to measure proliferation rates."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;FC = + 3.7 AND P &lt; 0.0001&quot;">
      <data key="d0">"STATISTICAL SIGNIFICANCE"</data>
      <data key="d1">"Indicates a significant increase in SGK-1 mRNA levels with low probability of chance occurrence, as per previous studies."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;AS1842856 ALONE DID NOT EXERT ANY EFFECTS&quot;">
      <data key="d0">"OUTCOME/RESULT"</data>
      <data key="d1">"No effect observed when AS1842856 was used without cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;STRESS&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"The FoxO1 gene is activated following stress exposure and cortisol treatment, indicating a role in mediating negative effects on neurogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL-INDUCED CHANGES&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"AS1842856 is able to counteract cortisol-induced reduction in neuronal proliferation, indicating its role in modulating glucocorticoid effects.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL-INDUCED CHANGES IN NEUROGENESIS&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"SGK-1 is involved in mediating glucocorticoid effects, specifically cortisol's negative impact on neurogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SGK-1&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"SGK-1 is involved in mediating glucocorticoid effects, specifically cortisol's negative impact on neurogenesis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EMOTIONAL ABUSE (SEE SUPPLEMENTARY TABLE 9)&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"The table may provide details about dietary patterns associated with emotional abuse, although not explicitly mentioned.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS-INDUCED UPREGULATION&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"The mRNA levels of FoxO1 are upregulated following stress and cortisol exposure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL-INDUCED REDUCTION IN NEURONAL PROLIFERATION (BRDU + CELLS)&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"Cortisol was found to reduce neuronal proliferation, as indicated by decreased BrdU+ cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME/EFFECT&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"Cortisol was found to reduce neuronal proliferation, as indicated by decreased BrdU+ cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;24 H CORTISOL TREATMENT&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"A 24-hour exposure to cortisol led to an increase in the expression of SGK1 mRNA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EFFECT ON SGK1 MRNA&quot;">
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d1">"A 24-hour exposure to cortisol led to an increase in the expression of SGK1 mRNA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4771122&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs4771122 had the lowest p-value (.0035) among all SNPs for association with long-term weight loss after bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;LONG TERM WEIGHT LOSS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The primary outcome of interest in this study, which examines the relationship between selected genetic variants and long-term weight loss after bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;WEIGHT OBSERVATIONS&quot;">
      <data key="d0">"DATA POINT"</data>
      <data key="d1">"Quantitative data points collected one-year or more after surgical intervention to assess changes in weight."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;FOLLOW-UP LENGTH&quot;">
      <data key="d0">"DURATION"</data>
      <data key="d1">"Time period since the surgery during which measurements were taken, averaging around 5.6 years with some as long as 9.5 years."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;81 (85%) PARTICIPANTS WERE FEMALE&quot;">
      <data key="d0">"DEMOGRAPHIC VARIABLE"</data>
      <data key="d1">"Proportion of female participants reflecting typical demographics of bariatric surgery patients."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;34 SNPS&quot;">
      <data key="d0">"GENETIC VARIANT LIST"</data>
      <data key="d1">"Total number of Single Nucleotide Polymorphisms analyzed in the study, with rs4771122 being one that showed significant association."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;ADDITIONAL COPIES OF THE MINOR (G) ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific genetic variants associated with more weight loss in this study; each additional copy correlated with a larger percentage weight lost."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PRE-SURGICAL BMI&quot;">
      <data key="d0">"BODY MASS INDEX"</data>
      <data key="d1">"A measure indicating participants' weight-to-height ratio before surgery, considered as a covariate when assessing associations."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;NADIR PERCENT WEIGHT LOSS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Minimum percentage of weight lost by each participant during their post-surgery journey."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;SELF-IDENTIFIED BLACKS GENOTYPED&quot;">
      <data key="d0">"GENETIC SAMPLE GROUP"</data>
      <data key="d1">"Subgroup of participants used to assess the association between rs4771122 and outcomes in this demographic, with no significant associations found."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PRE-SURGICAL WEIGHT&quot;">
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d1">"Additional copies were associated with increased pre-surgical weight in this study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP RS4771122&quot;">
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d1">"rs4771122 was nominally significantly associated with nadir percent weight loss.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;2 YEAR PERCENT WEIGHT LOSS&quot;">
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d1">"SNP rs4771122 showed association with 2-year percent weight loss.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GCK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GCK plays a role in MODY (Maturity-Onset Diabetes of the Young) by carrying variants associated with diabetes."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK-MODY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"GCK-MODY is a type of diabetes that can be diagnosed through genetic variants in GCK gene."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A specific interaction between two or more biological macromolecules involved in various cellular functions."&lt;SEP&gt;"ACMG guidelines were used for assessing pathogenicity of novel GCK variants."&lt;SEP&gt;"This molecular interaction is implied in the text but not fully detailed."&lt;SEP&gt;"The interaction between two or more molecules that can affect biological function."&lt;SEP&gt;"An interaction between genetic variants that affect nutrient metabolism and environmental factors such as diet."&lt;SEP&gt;"The proteins interact as part of vitamin D metabolism pathway to regulate hormone levels in the body."&lt;SEP&gt;"The text describes multiple SNPs associated with changes in baseline and MTD hemoglobin F levels; however, these associations are separate entities rather than a molecular interaction for Delta HbF."&lt;SEP&gt;"Lifestyle choices and environmental exposures can impact the interaction between folate metabolism and NOS1 protein activity."&lt;SEP&gt;"These molecules interact with EBNA2 or other components in the EBV latency III program, influencing gene expression and immune evasion."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-3cf4e094a5312845a1cc4da4304d4bdf&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A missense mutation was one of the types identified through sequence analysis."&lt;SEP&gt;"The p.His317Gln variant was predicted as a moderately conserved sequence change through in-silico tools."&lt;SEP&gt;"These proteins are mentioned in the text. However, their specific types (e.g., cytokine receptors, phagocytic markers) aren't fully specified here."&lt;SEP&gt;"The Protein encoded by the Gene functions in metabolic pathways and interacts with other biological entities."&lt;SEP&gt;"SENP1 expression (messenger RNA (mRNA) and protein)"&lt;SEP&gt;"A specific protein produced from the gene's mRNA transcript, involved in various cellular processes."&lt;SEP&gt;"These are enzymes involved in vitamin D metabolism, specifically 1α-hydroxylation of vitamin D3 (CYP27B1) and hydroxylation steps that regulate the concentration of 1,25(OH)2D (CYP24A1)."&lt;SEP&gt;"These MS risk genes produce proteins that may interact with EBNA2 and be involved in immune evasion mechanisms."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-658df2fc2f9361a65ff1d22464744763&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;CLINICAL INFORMATION&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Clinical findings were similar for probands who carry GCK variants, compared to those described previously.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROBANDS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Clinical findings were similar for probands who carry GCK variants, compared to those described previously.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GCK VARIANTS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Sequence analysis identified 134 GCK variants in probands from the year 2008 to 2018.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEQUENCE ANALYSIS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Sequence analysis identified 134 GCK variants in probands from the year 2008 to 2018.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CO-SEGREGATION WITH THE DIABETES PHENOTYPE&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Establishing co-segregation confirmed that the diabetes phenotype is indeed associated with specific genetic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARENTAL OR EXTENDED FAMILY DNA&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Establishing co-segregation confirmed that the diabetes phenotype is indeed associated with specific genetic variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREDICTIVE TOOLS&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Seven VUS were predicted to be damaging by in-silico tools, but they did not satisfy pathogenic or likely pathogenic classification requirements due to lack of segregation and/or phenotypic data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VUS (VARIANTS OF UNCERTAIN SIGNIFICANCE)&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Seven VUS were predicted to be damaging by in-silico tools, but they did not satisfy pathogenic or likely pathogenic classification requirements due to lack of segregation and/or phenotypic data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL PHENOTYPE&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"One proband had mild fasting hyperglycemia and stable HbA1c level despite being identified with this genetic change, indicating that the clinical manifestation might not always match genetic data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MD ADHERENCE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Mediterranean diet adherence categories categorized 33%, 51%, and 16% individuals."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Mediterranean diet emphasizes plant-based foods, olive oil, and moderate consumption of fish and dairy products with lower red meat intake."&lt;SEP&gt;"The adherence to the Mediterranean diet was generally higher in women, younger individuals with lower BMI and WC, more physically active people, and those with a higher level of education."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;TAG CONCENTRATIONS&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"In medium and high MD adherence categories, TAG concentrations were significantly lower."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;HDL-C CONCENTRATIONS&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"HDL-C (high-density lipoprotein cholesterol) concentrations were higher in medium and high MD adherence compared to the lowest category."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"The apoB:apoA-1 ratio was significantly lower in medium and high MD adherence categories."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;HBA1C CONCENTRATION&quot;">
      <data key="d0">"METABOLIC MARKER"</data>
      <data key="d1">"HbA1c (glycated hemoglobin) concentration was lower with an increased Mediterranean diet adherence."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"A lifestyle factor that further modulates cardiovascular health in relation to genetic factors."&lt;SEP&gt;"Physical activity levels were controlled for in the statistical analysis."&lt;SEP&gt;"Physical activity was found to be lower among cases compared to controls, potentially affecting health outcomes."&lt;SEP&gt;"Physical activity was related to higher adherence of MD among individuals."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;WC (WAIST CIRCUMFERENCE)&quot;">
      <data key="d0">"BODY MEASUREMENT"</data>
      <data key="d1">"Lower WC was associated with higher adherence to Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 32}]</data>
    </node>
    <node id="&quot;SMOKING STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Non-smokers tend to consume fewer drinks compared to smokers but doesn't significantly moderate medication, genotype effects related to alcohol self-administration."&lt;SEP&gt;"Smoking status was considered as an environmental factor when analyzing outcomes."&lt;SEP&gt;"Whether or not a person is currently smoking tobacco products."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;SMOKER&quot;">
      <data key="d0">"CATEGORY OF ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The category 'smoker' represents a specific instance of smoking status in the environmental factor context."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;NON-SMOKER&quot;">
      <data key="d0">"CATEGORY OF ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The category 'non-smoker' represents another instance of smoking status in the environmental factor context."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;TAG LEVELS&quot;">
      <data key="d0">"BIOLOGICAL PARAMETER"/"PHYSIOLOGICAL PROCESS"/"METABOLIC PATHWAY"/"OUTCOME"/"RESPONSE VARIABLE"/"MEASURE OF HEALTH STATUS"</data>
      <data key="d1">"There were differences by genotype in TAG levels, which could indicate differences in lipid metabolism or health status."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"A gene-diet interaction was examined to see if there were significant interactions between genetics and diet, however no such interactions were found.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY PATTERN AND SMOKING STATUS&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"Smoking status was considered alongside dietary patterns to assess potential interactions on health outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE/ENVIRONMENTAL FACTOR INTERACTION&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"Smoking status was considered alongside dietary patterns to assess potential interactions on health outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Congenital Hyperinsulinism (CHI) is a disorder characterized by excessive insulin secretion from pancreatic beta cells, typically associated with hypoglycemia."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;MACROSOMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Macrosomia refers to a newborn that is significantly larger than average for its gestational age or postconceptional age."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GLUD1 gene was detected in patients with hypoglycaemia, HI and mild HA."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HETEROZYGOUS MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Three different heterozygous mutations in the GLUD1 gene were identified in five patients."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG322 HIS&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"The p.Arg322 His mutation was found in patients 54, 55 and 56."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;AUTOSOMAL DOMINANT INHERITANCE&quot;">
      <data key="d0">"INHERITANCE PATTERN"</data>
      <data key="d1">"The p.Arg322 His mutation is autosomal and dominantly inherited from their father."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"The p.Ser498Leu mutation was found in patient 52."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"The p.Asn463Asp mutation was found in patient 53."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SERUM AMMONIA CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The serum ammonia concentration of this group of patients was 85-184 µmol/l."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HI/HA SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HI/HA syndrome due to a GLUD1 genetic defect"</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;LONG-TERM STABLE GLYCAEMIC CONTROL&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Of 65 patients, 40 (61.5%) achieved long-term stable glycaemic control by diazoxide alone."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Side effects of the diazoxide treatment were observed in 32 (80%) patients."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;GASTROINTESTINAL DISTURBANCES&quot;">
      <data key="d0">"SIDE EFFECTS"</data>
      <data key="d1">"Gastrointestinal disturbances such as nausea, vomiting, severe gastrointestinal upset and poor appetite occurred in 69%"</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPERTRICHOSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Different degrees of hypertrichosis occurred in 55% (22/40) of patients during clinical follow-up."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"Effective diazoxide therapy had to be stopped because of thrombocytopenic purpura."&lt;SEP&gt;"Thrombocytopenic purpura necessitated stopping diazoxide treatment due to severe blood cell counts issues."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d0">"SURGERY"</data>
      <data key="d1">"Nine patients were treated with subtotal pancreatectomy, and one patient underwent pancreatectomy twice."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY&quot;">
      <data key="d0">"SURGERY"</data>
      <data key="d1">"Pancreatectomy was performed in 10 patients who were unresponsive to drugs."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"One patient (patient 7) who underwent surgery at two months of age developed diabetes mellitus at five years of age and was treated with insulin."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;INSULIN TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Two cases still had mild hypoglycaemia after surgery; one (patient 4) was successfully managed with regular daytime and overnight feedings, the other (patient 9) was treated with diazoxide."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SEVERE HYPOGLYCAEMIA&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"There were three diazoxide-unresponsive patients: one patient died of multiorgan failure and two patients abandoned the treatment and died of severe hypoglycemia after three to seven days at home."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;NOS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NOS2 gene plays a role in immune responses and is involved in oxidative stress."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;CATECHOLAMINE SYNTHESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Dysregulation of the NOS1 gene can impact catecholamine synthesis, impacting cardiovascular health."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;NEURAL CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"The genomic variant in the NOS1 gene may affect neural cells specifically, influencing cognitive function and hypertension risk."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;COGNITIVE FUNCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cognition is a broad term encompassing mental abilities like memory, learning, attention span, processing speed, and problem-solving."&lt;SEP&gt;"NOS1 protein interactions with neurotransmitters contribute to cognitive processes and are influenced by dietary patterns."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE RISK FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Lifestyle factors, such as smoking and stress, can exacerbate the relationship between NOS1 gene variants and cardiovascular disease risk."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DRUG RESISTANCE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Certain epigenetic modifications of the GLUD1 gene may lead to drug resistance in patients with HI/HA syndrome."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hypoglycemia resulting from GLUD1 mutations can be managed through a low-protein diet or medications like diazoxide."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;INSULIN DEPENDENCY&quot;">
      <data key="d0">"THERAPY RESPONSE"</data>
      <data key="d1">"The development of diabetes mellitus after surgery might require insulin therapy for long-term management."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;MULTIORGAN FAILURE&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"One patient who experienced multiorgan failure required intensive care and may have had other underlying health conditions."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SURGERY RESPONSE&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Subtotal pancreatectomy is effective in patients unresponsive to drug therapy, such as diazoxide.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME OF SURGERY&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Some patients developed diabetes mellitus after surgery and required insulin treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAZOXIDE UNRESPONSIVENESS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Three patients were unresponsive to diazoxide therapy, leading to severe hypoglycemia and subsequent death.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOS1 GENE VARIANTS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Genetic variations in NOS1 may exacerbate or mitigate risk for cardiovascular diseases through interaction with lifestyle factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY PATTERNS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Dietary choices and intake of certain nutrients can influence how NOS1 functions, affecting cognitive health.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DRUG THERAPY EFFECTIVENESS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Changes in GLUD1 gene expression through epigenetic mechanisms can impact the effectiveness of diazoxide treatment for HI/HA syndrome.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EPIGENETIC MODIFICATIONS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Changes in GLUD1 gene expression through epigenetic mechanisms can impact the effectiveness of diazoxide treatment for HI/HA syndrome.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY INTERVENTIONS&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Implementing a low-protein diet is an effective management strategy for patients experiencing hypoglycemia due to GLUD1 mutations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Implementing a low-protein diet is an effective management strategy for patients experiencing hypoglycemia due to GLUD1 mutations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES MELLITUS DEVELOPMENT&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"The development of diabetes mellitus after surgery indicates a possible long-term complication requiring specific therapeutic interventions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SURGERY OUTCOME&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"The development of diabetes mellitus after surgery indicates a possible long-term complication requiring specific therapeutic interventions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMORBIDITY&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Multiorgan failure might be linked to other underlying health conditions or complications in patients undergoing complex surgical procedures.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPY RESPONSE&quot;">
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d1">"Treatment outcomes can involve insulin dependency as a result of the management strategies for diabetes mellitus post-surgery.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAC&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Levels of AcAc across glucose tolerance categories."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;BHB&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Levels of BHB across glucose tolerance categories."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;FPG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Evaluation in the Fasting Plasma Glucose (FPG) category."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;2HPG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Evaluation in the 2-hour plasma glucose (2hPG) category."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IFG&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Indicates individuals who have impaired fasting glucose, one of the stages leading to T2DM."&lt;SEP&gt;"Individuals with Impaired Fasting Glycemia (IFG)."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;NONDIABETIC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Nondiabetic individuals. The reference category for glucose tolerance tests."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IGT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Indicates individuals who have impaired glucose tolerance, another stage leading to T2DM."&lt;SEP&gt;"Individuals with Impaired Glucose Tolerance (IGT)."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;NEWLY DETECTED DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Diabetes diagnosed after baseline, not previously known."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;NOS1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The NOS1 protein is involved in vascular function and interacts with folate metabolism."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A key nutrient found in leafy greens that affects nitric oxide production."&lt;SEP&gt;"Folate is a nutrient found in leafy greens, which are important for cardiovascular health."&lt;SEP&gt;"Folate is another nutrient closely related to B12, particularly in the context of maternal health and newborn's birthweight."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;LEAFY GREENS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Folate is abundant in leafy green vegetables."&lt;SEP&gt;"Leafy greens are a food source rich in folate, contributing to cardiovascular health through its impact on metabolic pathways."&lt;SEP&gt;"This food source provides a rich intake of the above-mentioned nutrient."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An external condition that affects the health status of an organism, including climate and pollutants."&lt;SEP&gt;"An external factor, such as temperature, pollution, or lifestyle choices, which impacts health outcomes."&lt;SEP&gt;"Dietary patterns and physical activity that modulate glucose metabolism and affect the relationship between KBs, glucose tolerance."&lt;SEP&gt;"The context doesn't suggest any environmental factors are relevant to this activity."&lt;SEP&gt;"The interaction of an environmental factor with maternal nutrition could affect the length of pregnancy."&lt;SEP&gt;"No specific environmental factors mentioned within this context."&lt;SEP&gt;"The expression levels of CHAT may be influenced by environmental factors."&lt;SEP&gt;"Exposure to environmental factors can impact these MS risk genes through various mechanisms, including EBNA2 interaction."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;STATINS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Drug therapy used for managing cardiovascular disease risk."&lt;SEP&gt;"Drugs like statins may be used to manage the risk of diseases related to poor gene and dietary interactions."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;PERSONALIZED THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Personalized therapies based on genetic factors."&lt;SEP&gt;"Therapies designed based on genetic profiles and nutritional data are being explored for cardiovascular health management."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY&quot;">
      <data key="d0">"BIOMEDICAL PARAMETER"</data>
      <data key="d1">"Poor insulin sensitivity, often seen in metabolic disorders like diabetes, can affect fat metabolism and lead to high triglycerides."&lt;SEP&gt;"Refers to how well your body uses insulin."&lt;SEP&gt;"The association of rs7574352 with IRF1 could potentially influence insulin sensitivity through its impact on metabolic pathways."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Process by which the pancreas secretes insulin into the bloodstream."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;MATSUDA INSULIN SENSITIVITY INDEX&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Measure of insulin sensitivity based on glucose and insulin levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;RS780094&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The C allele of rs780094 in GCKR gene showed association with increased levels of BHB and AcAc."), ("relationship"</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACAC&quot;&amp; &quot;INSULIN SENSITIVITY&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"AcAc levels are inversely associated with insulin sensitivity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BHB&quot;&amp; &quot;INSULIN SENSITIVITY&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"BHB levels remain inversely associated with insulin sensitivity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAC&quot;&amp; &quot;INSULIN SECRETION&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"High AcAc levels could weaken or eliminate the association of insulin secretion and development of hyperglycemia and diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BHB&quot;&amp; &quot;INSULIN SECRETION&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"Similar results are obtained when comparing highest quartile of glucose AUC to three lowest quartiles, indicating an inverse relationship with BHB levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAC&quot;&amp; &quot;DEVELOPMENT OF HYPERGLYCEMIA&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"Highest quartile AcAc predicts conversion to type 2 diabetes (OR 1.32 [95% CI 1.00–1.74], P = 0.047).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREDICTOR&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"Highest quartile AcAc predicts conversion to type 2 diabetes (OR 1.32 [95% CI 1.00–1.74], P = 0.047).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BHB&quot;&amp; &quot;DEVELOPMENT OF HYPERGLYCEMIA&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"Highest quartile BHB also predicts conversion to type 2 diabetes, albeit with less statistical significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene location for associations involving T2D and CRP."&lt;SEP&gt;"Location for SNPs related to T2D, CRP, and CAD."&lt;SEP&gt;"One of 12 genes located within or close to pleiotropic loci associated with CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;HNF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another one of the 12 genes related to pleiotropic loci associated with CRP."&lt;SEP&gt;"SNPs associated with CRP, CAD risk reduction for G-allele of rs1183910, and T2D."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GCKR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GCKR is associated with kidney function through its genetic variations."&lt;SEP&gt;"Involved in fructose-2,6-bisphosphate aldolase regulation, associated with risk of T2D and CAD."&lt;SEP&gt;"Located within or close to a pleiotropic locus associated with CRP."&lt;SEP&gt;"One of the genes involved in associations with cardiometabolic SNPs."&lt;SEP&gt;"The gene GCKR is associated with increased risk of CKD, and its variant p.Pro446Leu has been shown to result in altered de novo triglyceride and cholesterol synthesis and export as well as decreased plasma glucose concentrations."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL6R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer."&lt;SEP&gt;"Another gene identified as part of pleiotropic loci related to CRP."&lt;SEP&gt;"Part of genetic regions with pleiotropic effects on CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PP1R3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located within one of the 12 pleiotropic loci for CRP association."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HNF4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associations found with T2D and possibly other cardiometabolic phenotypes."&lt;SEP&gt;"Part of a pleiotropic locus associated with CRP."&lt;SEP&gt;"Part of multiple associations including T2D, CAD, and CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PABPC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located near a pleiotropic locus related to CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;BCL7B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Identified in multiple associations with different outcomes."&lt;SEP&gt;"One of the genes within or close to pleiotropic loci for CRP association."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TMEM18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene part of one of the pleiotropic loci found to be linked to CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PLTP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located near a pleiotropic locus related to CRP association."&lt;SEP&gt;"One of the genetic regions without significant association with CRP after correction for multiple testing."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;MC4R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Among 12 identified pleiotropic loci associated with CRP."&lt;SEP&gt;"Another gene with pleiotropic effects on CRP but not significantly associated with it after adjustment."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10 RS11513913&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Near IL1F10 gene on chromosome 6, identified with p-value of 4.0×10^-6 as a novel association."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HNF4A RS2781790&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Located near HNF4A gene on chromosome 3, this SNP was found with p-value = 5.6×10^-6 as an association."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;BCL7B RS2824302&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Close to BCL7B gene on chromosome 9, identified with p-value of 7.3×10^-6 as a novel signal."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;FTO RS12544258&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"In the first intron of FTO gene on chromosome 16, this SNP shows an association with CRP with p-value of 3.0×10^-7."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;APOC1 RS2999767&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A variant located within APOC1 locus identified with a p-value below 5.0×10^-8 as a significant association."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GCKR RS3747261&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"In the GCKR gene region on chromosome 9, this SNP has an association with CRP at a p-value of 3.4×10^-6."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HNF1A RS10811655&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"This variant near HNF1A locus shows significance in CRP GWAS with p-value = 2.9×10^-6."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GCKR RS732022&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Located near GCKR gene on chromosome 10, this SNP was identified as associated with CRP with a p-value of 4.8×10^-7."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL6R RS5739889&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Identified in the IL6R locus on chromosome 2 with a p-value below 1.0×10^-5 as an association for CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Identified in associations with CRP and CAD."&lt;SEP&gt;"Not identified in previous analysis but associated with CRP and CAD."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PPP1R3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Identified in associations with CRP and cardiometabolic phenotypes."&lt;SEP&gt;"Identified in multiple associations including T2D, CAD, and CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PABPC&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in pleiotropic effects on CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CAD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Coronary Artery Disease is a condition where CAD represents significant clinical interest."&lt;SEP&gt;"Coronary artery disease (CAD) was influenced by the differences explained by the genomic variant rs20417."&lt;SEP&gt;"Coronary artery disease associated with certain genetic SNPs."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;CRP&quot;">
      <data key="d0">"NUTRIENT"/"CLINICAL PARAMETER"</data>
      <data key="d1">"C-reactive protein (CRP) is an acute-phase reactant that increases during inflammation and can be elevated in conditions like cancer."&lt;SEP&gt;"C-reactive protein (CRP), as an acute-phase reactant that increases during inflammation, showed no clear or consistent association with ovarian cancer in the combined analyses."&lt;SEP&gt;"CRP is the subject of analysis regarding its pleiotropic relationships with other cardiometabolic phenotypes and SNPs."&lt;SEP&gt;"Increased CRP levels are linked to the G-allele of rs1183910 in HNF1A and decreased risk of CAD for A-allele of rs4420638 in APOC1."&lt;SEP&gt;"Increased CRP levels showed associations with several SNPs, potentially reflecting inflammation status."&lt;SEP&gt;"One of the genes with SNPs associated with risk of ovarian cancer."&lt;SEP&gt;"Individuals who develop diabetes typically have higher CRP levels."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;HBA1C&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Mediator in the pathway analysis of genetic loci affecting cardiometabolic phenotypes after adjustment."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CHOLESTEROL&quot;">
      <data key="d0">"NUTRIENT/DIETARY PATTERN"</data>
      <data key="d1">"High levels of cholesterol is linked to increased sUA level and HUA risk."&lt;SEP&gt;"One of several factors that could mediate pleiotropic effects, especially when adjusted for other variables."&lt;SEP&gt;"The cholesterol levels were not specified but were likely measured"</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;FXR/RXR ACTIVATION&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"One of several significant pathways identified in pathway analysis involving pleiotropic genes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;LXR/RXR ACTIVATION&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"Significantly enriched canonical pathway in the pathway analysis involving pleiotropic genes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MODY SIGNALING&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"Another significantly enriched canonical pathway identified from the pathway analysis."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HEPATIC CHOLESTASIS&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"Enriched pathway indicating an association between certain genetic variants and hepatic dysfunction."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;ACUTE PHASE RESPONSE SIGNALING&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"Significantly enriched pathway related to inflammation and immune system response in the context of pleiotropic effects."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;FABP2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Linked to increased risk of CAD and dyslipidemia through pleiotropic effects."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;LPL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Low-density lipoprotein receptor-related protein 1, involved in lipid metabolism and associated with CRP levels."&lt;SEP&gt;"The LPL gene codes for lipoprotein lipase, which plays critical roles in fat metabolism and triglyceride levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;ADAMTS7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Plays a role in angiogenesis and inflammation, associated with CAD risk through pleiotropic mechanisms."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MTHFD1L&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Enzyme involved in folate metabolism, linked to CRP levels and T2D."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;APOE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Important for lipoprotein metabolism, with SNPs showing associations with increased CAD risk."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;IL17F&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cytokine gene associated with inflammation response and pleiotropic effects on CRP and HDL-cholesterol."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;AHCY&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in docosahexaenoic acid synthesis, linked to lower CRP levels and improved cardiometabolic health."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;SREBF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Regulates genes involved in cholesterol synthesis, showing associations with T2D risk."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CRP SNPS IN CAD GWAS&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"The lead SNP in CAD GWAS shows low LD (r^2 = 0.52) with top hit in CRP GWAS, indicating potential pleiotropic effects.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4420638&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs4420638, located near APOC1 gene, shows a strong association with type 2 diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;G-ALLELE OF RS1183910&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"The G-allele of the SNP rs1183910 in HNF1A gene is associated with lower risk of coronary artery disease, while its A-allele increases serum CRP levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDIATED PLEIOTROPY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"After adjusting for CRP, the effect of SNP associated with FTO on cardiometabolic phenotypes mainly goes through BMI, suggesting mediated pleiotropy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HDL-CHOLESTEROL&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"After adjusting for multiple factors, the effect of BCL7B on HDL-cholesterol is still noticeable but mostly mediated through lipid variables.")&lt;SEP&gt;"For BCL7B and HDL-cholesterol levels, lipid variables appear to be the most important mediators after adjustment.")&lt;SEP&gt;"High-density lipoprotein cholesterol levels, part of the lipid profile test."</data>
      <data key="d0">"LABORATORY TEST"</data>
    </node>
    <node id="&quot;TRIGLYCERIDES&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Adjustments for CRP led to a considerable decrease in the estimate of association between PABPC4 and triglyceride levels.")&lt;SEP&gt;"The amount of triglycerides present in the blood. Triglycerides are a type of fat stored in adipose tissue that can be converted into energy by the body."</data>
      <data key="d0">"BLOOD TRIGLYCERIDE LEVELS"</data>
    </node>
    <node id="&quot;RS3764260&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs3764260 near IL1F10 gene shows significant association with CRP levels and inflammation.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;RS12581299&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs12581299 in FABP2 gene is associated with increased risk of T2D.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;G-ALLELE OF RS7041&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"The G-allele of SNP rs7041 in LPL gene shows association with CAD susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS5698321&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs5698321 near MTHFD1L gene affects HDL-cholesterol levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS17429505&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs17429505 in ADAMTS7 gene is associated with CAD risk through pleiotropic mechanisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS638982&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNP rs638982 near SREBF1 gene shows association with T2D susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP miR-34b/c rs4938723 was successfully genotyped for patients with IA and controls."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP TP53 Arg72Pro was also genotyped along with miR-34b/c rs4938723."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;IA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study focused on 164 patients with IA and a control group of 426 individuals."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 AND TP53 ARG72PRO&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Carriers with the combined genotypes of miR-34b/c rs4938723CC and TP53 Arg72Pro CG/CC/GG had a decreased risk of IA compared to other combined genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENDER&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"A gender identifier, typically male or female."&lt;SEP&gt;"Stratification analysis by gender did not find any association between the two SNPs and IA risk.")&lt;SEP&gt;"Selenium's protective effect against colorectal tumors is stronger in men compared to women."&lt;SEP&gt;"The majority of patients were female (55%)"</data>
      <data key="d0">"DEMOGRAPHIC"</data>
    </node>
    <node id="&quot;NUMBER OF ANEURYSMS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"No association between the number of aneurysms and miR-34b/c rs4938723 genotypes was observed.")&lt;SEP&gt;"No significant association between miR-34b/c rs4938723 and the number of aneurysms was observed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUMBER OF ANEURYSMS IN CASES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Association between miR-34b/c rs4938723 genotypes and IA, but not with the number of aneurysms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HARDY WEINBERG EQUILIBRIUM&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Genotype frequencies of miR-34b/c rs4938723 met the Hardy Weinberg equilibrium requirements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RATIO BETWEEN GROUPS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The sex ratio differed, with a higher proportion of female cases relative to male participants.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;DECREASE RISK OF IA&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The CC genotype of miR-34b/c rs4938723 was associated with a lower risk of IA compared to TT genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMBINED GENOTYPES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Carriers with the combined genotypes rs4938723CC and TP53 Arg72Pro CG/CC/GG had a reduced risk of IA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANALYSIS METHOD&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Gender was used as a variable for stratified analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LEVEL OF SIGNIFICANCE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"P-values for significant associations ranged from 0.004 to 0.006.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P-VALUE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"P-values for significant associations ranged from 0.004 to 0.006.")&lt;SEP&gt;"The statistical measure that evaluates the strength of association between genotypes and disease risk."</data>
      <data key="d0">"STATISTICAL MEASURE"</data>
    </node>
    <node id="&quot;PERSONALIZATION OF THERAPY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Not specified in the text, no relationship mentioned.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUBJECTS NUMBER&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Total sample size was comprised of cases and controls amounting to 590 participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH DISEASE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Two SNPs—miR-34b/c rs4938723 and TP53 Arg72Pro were analyzed for their potential association with IA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-0d49552280a277a8a26456d06f8f26a8&lt;SEP&gt;chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Common SNPs were tested for association with age at first tooth and number of teeth."&lt;SEP&gt;"Two SNPs—miR-34b/c rs4938723 and TP53 Arg72Pro were analyzed for their potential association with IA.")&lt;SEP&gt;"These were crucial in identifying causal relationships as they supported the estimation of causality."&lt;SEP&gt;"The associations with the 23 SNPs tested did not reach statistical significance after adjustments for multiple testing."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-055177812e320344d131432b292111b0&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d1">"Assessment of genotypic frequencies to confirm random mating and no evolutionary pressures.")&lt;SEP&gt;"Studies had to be in Hardy-Weinberg equilibrium for statistical analyses, with some subgroups not fulfilling this condition, thus affecting the results."&lt;SEP&gt;"No strong evidence for departure from Hardy-Weinberg equilibrium was found except nominally in Romania."</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;TEST TYPE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Assessment of genotypic frequencies to confirm random mating and no evolutionary pressures.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR FOR IA&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"SNPs miR-34b/c rs4938723 and TP53 Arg72Pro were considered in the IA risk assessment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANCE LEVEL&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"A p-value less than 0.05 was considered statistically significant for some associations, as seen in miR-34b/c rs4938723 association with IA risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GROUP FOCUS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"No specific emphasis was placed on ancestry groups, with the study including participants from diverse backgrounds.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INDIVIDUALS ANCESTRY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"No specific emphasis was placed on ancestry groups, with the study including participants from diverse backgrounds.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUMBER OF CONTROLS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The control group was substantially larger than the case group (164 vs. 426 participants).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SAMPLE SIZE COMPARISON&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The control group was substantially larger than the case group (164 vs. 426 participants).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY POPULATION DIVERSITY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study involved individuals from different demographic groups, though no specific diversity measures were stated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIETY OF PARTICIPANTS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study involved individuals from different demographic groups, though no specific diversity measures were stated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGES RANGE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study did not specify the age distribution among either cases or controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHARACTERISTICS OF SAMPLE POPULATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study did not specify the age distribution among either cases or controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENDER PROPORTION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The sex ratio showed an imbalance, with more females than males among the study participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUMBER OF CASES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The number of cases with IA was 164, which constituted a smaller subgroup compared to the control population (426).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFIC GROUP SIZE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The number of cases with IA was 164, which constituted a smaller subgroup compared to the control population (426).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANCESTRY BACKGROUND&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study did not include any data regarding the ancestral backgrounds of participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESEARCH METHODOLOGY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study utilized a case-control approach to compare individuals with IA against those without it.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY DESIGN&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study utilized a case-control approach to compare individuals with IA against those without it.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESEARCH ANALYTICAL PROCESS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study likely involved statistical tools including Hardy Weinberg equilibrium test, P-value computation for assessing significance, etc., although specific details were not given.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL METHODOLOGY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study likely involved statistical tools including Hardy Weinberg equilibrium test, P-value computation for assessing significance, etc., although specific details were not given.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESEARCH OBJECTIVE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study aimed at determining if genetic variants could predict or influence the incidence of IA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SCIENTIFIC INQUIRY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study aimed at determining if genetic variants could predict or influence the incidence of IA.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK DETERMINANTS FOR DISEASE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study included genetic variables like miR-34b/c rs4938723 and TP53 Arg72Pro, alongside other potential risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP VARIABLES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study included genetic variables like miR-34b/c rs4938723 and TP53 Arg72Pro, alongside other potential risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HERITAGE VARIABILITY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The study did not specify the ethnic or ancestral diversity among participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DATA ANALYSIS PROCESS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Findings were interpreted statistically, comparing case and control groups for identifying potential risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL EVALUATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Findings were interpreted statistically, comparing case and control groups for identifying potential risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCE ON RESEARCH OUTCOMES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While the study included gender as an analysis variable, it found no consistent sex-specific associations with IA risk based on genetic markers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEX FACTOR&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While the study included gender as an analysis variable, it found no consistent sex-specific associations with IA risk based on genetic markers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHARACTERISTICS OF PARTICIPANTS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The sample encompassed both case and control groups that differed in terms of genetic risk factors, sex ratio, age range, etc., though exact details were not provided.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY SAMPLE PROFILES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The sample encompassed both case and control groups that differed in terms of genetic risk factors, sex ratio, age range, etc., though exact details were not provided.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DETERMINING STATISTICAL RELEVANCE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Results with P-values less than 0.05 were considered statistically significant and worthy of further investigation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANCE THRESHOLD FOR P-VALUES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Results with P-values less than 0.05 were considered statistically significant and worthy of further investigation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC DATA ANALYSIS RIGOR&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Rigorous approaches were taken with genetic data validation and statistical significance determination to ensure the robustness of findings.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QUALITY ASSURANCE IN RESEARCH METHODOLOGY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Rigorous approaches were taken with genetic data validation and statistical significance determination to ensure the robustness of findings.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HERITAGE INFLUENCE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While ancestry was indirectly relevant through the sample's diversity, its direct impact on genetic findings for IA was not specifically addressed or analyzed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME DETERMINANTS IN GENETIC RESEARCH&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While ancestry was indirectly relevant through the sample's diversity, its direct impact on genetic findings for IA was not specifically addressed or analyzed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENDER-SPECIFIC ANALYSIS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"In the context of IA risk, no distinct gender-specific effects were discerned in relation to genetic markers such as miR-34b/c rs4938723 or TP53 Arg72Pro.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP INFLUENCE ON DISEASE RISK&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"In the context of IA risk, no distinct gender-specific effects were discerned in relation to genetic markers such as miR-34b/c rs4938723 or TP53 Arg72Pro.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXAMINATION TECHNIQUES FOR VARIABLES&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"A mix of statistical analyses was employed to identify patterns or associations in the data related to genetic markers and IA disease prevalence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL TOOLS USED&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"A mix of statistical analyses was employed to identify patterns or associations in the data related to genetic markers and IA disease prevalence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HERITAGE GENETICS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While the impact of specific genes was explored through SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro, ancestral genetic influences were not a focal point.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCE ON DISEASE SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While the impact of specific genes was explored through SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro, ancestral genetic influences were not a focal point.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEX DISTRIBUTION IMPACT&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Analysis of genetic markers did not highlight any sex-specific patterns or differences that could significantly influence IA risk based on the data provided.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DETERMINING GENETIC ASSOCIATIONS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Genetic links identified required a statistical significance ascertained through P-values below the established threshold to be considered reliable.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE CRITERION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Genetic links identified required a statistical significance ascertained through P-values below the established threshold to be considered reliable.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENDER ROLE IN HEREDITARY IMPACT&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While sex could indirectly affect how genetic heritage influences IA risk, its specific effect was not a central focus given the study's concentration on SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDIATION OF GENETIC INFLUENCE ON DISEASE RISK&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While sex could indirectly affect how genetic heritage influences IA risk, its specific effect was not a central focus given the study's concentration on SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSESSING GENETIC MARKER ASSOCIATIONS WITH DISEASE RISK&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Ancestry diversity was not considered in the assessment of genetic markers' relevance to IA risk, potentially missing nuanced insights into how different populations may differently respond based on their unique genetic makeup.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HERITAGE DIVERSITY INTERPRETATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Ancestry diversity was not considered in the assessment of genetic markers' relevance to IA risk, potentially missing nuanced insights into how different populations may differently respond based on their unique genetic makeup.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DETERMINING CORRELATION WITH DISEASE&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Finding a correlation between genomic factors and IA disease states required statistical evidence with P-values below the specified threshold for reliability.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE CRITERIA FOR GENOMIC FACTORS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Finding a correlation between genomic factors and IA disease states required statistical evidence with P-values below the specified threshold for reliability.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC MARKERS FOR RISK ASSESSMENT&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"SNPs were considered possible influencers of IA risk through statistical methods, seeking evidence that they could be linked to disease prevalence or predisposition within the sample populations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POTENTIAL INFLUENCERS IN DISEASE STATE DETERMINATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"SNPs were considered possible influencers of IA risk through statistical methods, seeking evidence that they could be linked to disease prevalence or predisposition within the sample populations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENDER INFLUENCE ON GENETIC MARKER CORRELATIONS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While sex could theoretically affect the correlations between specific SNPs and IA, its impact was not a primary focus given the study's emphasis on establishing associations rather than exploring nuanced gender-related dynamics.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POTENTIAL MODIFIERS IN SNP-AIA RISK ASSOCIATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While sex could theoretically affect the correlations between specific SNPs and IA, its impact was not a primary focus given the study's emphasis on establishing associations rather than exploring nuanced gender-related dynamics.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANCESTRY CONSIDERATION IN GENETIC MARKER CORRELATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Given the primary focus on SNPs, no explicit analysis was conducted into how ancestral backgrounds might influence the relevance or predictive power of genetic markers in IA risk determination.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RELEVANCE TO DISEASE RISK ASSESSMENT&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Given the primary focus on SNPs, no explicit analysis was conducted into how ancestral backgrounds might influence the relevance or predictive power of genetic markers in IA risk determination.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRELATION WITH DISEASE PREVALENCE DETERMINATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Genomic factors were evaluated for their correlation with disease prevalence using statistical methods like P-values and the Hardy Weinberg equilibrium test, seeking evidence that they could be predictive of IA risk based on data from case versus control groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL ASSESSMENT IN GENOMIC FACTOR EVALUATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Genomic factors were evaluated for their correlation with disease prevalence using statistical methods like P-values and the Hardy Weinberg equilibrium test, seeking evidence that they could be predictive of IA risk based on data from case versus control groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCE IN DISEASE RISK ASSESSMENT THROUGH SNPS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While sex was acknowledged as part of the population characteristics, its role did not feature prominently in the direct correlation assessments between genetic markers and IA risk based on the methodology employed by the study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEX ROLE IN GENETIC MARKER CORRELATION EVALUATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"While sex was acknowledged as part of the population characteristics, its role did not feature prominently in the direct correlation assessments between genetic markers and IA risk based on the methodology employed by the study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HERITAGE DIVERSITY'S ROLE IN GENETIC MARKER CORRELATION EVALUATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Given the study's focus on establishing correlations rather than exploring nuanced population dynamics, heritage diversity was not a primary factor considered when assessing the relevance of genetic markers like miR-34b/c rs4938723 and TP53 Arg72Pro in IA risk determinations through statistical means.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RELEVANCE TO DISEASE RISK THROUGH STATISTICAL ASSESSMENT&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"Given the study's focus on establishing correlations rather than exploring nuanced population dynamics, heritage diversity was not a primary factor considered when assessing the relevance of genetic markers like miR-34b/c rs4938723 and TP53 Arg72Pro in IA risk determinations through statistical means.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANCE IN DISEASE STATE EVALUATION THROUGH COMPARATIVE ANALYSIS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"To assess the meaningful impact of genetic factors on IA disease states, P-value thresholds were applied during comparative case-control analyses involving SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro to determine if they significantly correlated with disease prevalence or predisposition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL CRITERIA FOR GENETIC FACTOR IMPACT DETERMINATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"To assess the meaningful impact of genetic factors on IA disease states, P-value thresholds were applied during comparative case-control analyses involving SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro to determine if they significantly correlated with disease prevalence or predisposition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRELATION DETERMINATION FOR DISEASE PREVALENCE THROUGH STATISTICAL ANALYSIS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The evaluation process sought to ascertain if specific genetic markers could contribute meaningfully to IA risk determinations by analyzing their correlations with case versus control populations, potentially factoring in sex or heritage diversity as secondary considerations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC MARKER EVALUATION IN RISK ASSESSMENT&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The evaluation process sought to ascertain if specific genetic markers could contribute meaningfully to IA risk determinations by analyzing their correlations with case versus control populations, potentially factoring in sex or heritage diversity as secondary considerations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRELATION ASSESSMENT FOR DISEASE STATE DETERMINATION THROUGH STATISTICAL ANALYSIS&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The process involved applying statistical tools like P-values and Hardy Weinberg equilibrium tests to assess if correlations exist between specific SNPs and IA disease states, with sex or heritage diversity factored into secondary analyses rather than being the primary focus in determining genetic marker significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE IN GENETIC MARKER CORRELATION EVALUATION&quot;">
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
      <data key="d1">"The process involved applying statistical tools like P-values and Hardy Weinberg equilibrium tests to assess if correlations exist between specific SNPs and IA disease states, with sex or heritage diversity factored into secondary analyses rather than being the primary focus in determining genetic marker significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A Genome-Wide Association Study that investigates the relationship between genetic variants and birthweight."&lt;SEP&gt;"A genome-wide association study (GWAS) was conducted on children from Hispanic families to identify obesity-related traits associated with genetic variants."&lt;SEP&gt;"Genome-wide association study conducted for 'Age at first tooth', resulting in allelic score construction."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FFM&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Fat-free mass (FFM) was measured as part of body composition assessment."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;FM&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Body fat mass (FM) was measured to assess adiposity and body composition."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;INADL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A nonsynonymous single nucleotide polymorphism (SNP; rs1056513, G1178S (NP_005790.2)) in the INADL gene on chromosome 1 was associated with body weight and body composition."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;COL4A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant of COL4A1 on chromosome 13 was related to weight z-score change during the study."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MTNR1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant of MTNR1B on chromosome 11 showed strong association with fasting glucose levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;APOA5-ZNF259&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"Intronic and 3′UTR variants in the APOA5-ZNF259 region on chromosome 11 were associated with triglyceride levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;PCSK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant of PCSK2 on chromosome 20 was linked to total antioxidants."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RNASE1&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"Variants in the flanking 3′UTR regions of RNASE1 on chromosome 14 were associated with urinary nitrogen excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ASS1P11&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"An intronic variant of ASS1P11 on chromosome 7 was related to creatinine excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GCH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in the intron of GCH1 on chromosome 14 associated with urinary dopamine: creatinine ratio."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;KLKB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A nonsynonymous SNP (rs3733402, S143T (NP_000883.2)) in KLKB1 on chromosome 4 was related to serum free IGF-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MPRIP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP of MPRIP on chromosome 17 was associated with serum IGFBP-3 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;XPA/FOXE1 (TTF-2)&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"A block of twenty-three SNPs in the flanking 5′UTR region of XPA/FOXE1 (TTF-2) on chromosome 9 was highly associated with serum TSH levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DARC&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A nonsynonymous SNP (rs12075, G42D (NP_002027.2)) and an intronic variant of DARC on chromosome 1 were found to be strongly associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GREB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Coding variants in GREB1 on chromosome 2 were identified as related to MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DFNB31&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant of DFNB31 on chromosome 9 was linked with MCP-1 levels, among other inflammation markers."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CCR3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in the 3′UTR region for CCR3 showed high association with MCP1 and related inflammation markers."&lt;SEP&gt;"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;RASGEF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the intronic region of RASGEF1A on chromosome 9 were associated with MCP-1, among other inflammation-related SNPs."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ABO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP of ABO was strongly related to IL-6 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TMEM229B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in TMEM229B on chromosome 14 showed significance for ad libitum energy intake at dinner."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in ARHGAP11A on chromosome 15 was associated with sleep duration."&lt;SEP&gt;"An intronic variant of ARHGAP11A on chromosome 15 was related to sleep duration, which affects energy expenditure and substrate utilization."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;C21ORF34&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 was detected as associated with respiratory quotient (RQ) during sleep, impacting energy metabolism."&lt;SEP&gt;"A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;PCOS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries."&lt;SEP&gt;"Polycystic ovary syndrome (PCOS), a common endocrine disorder in women, showed a link with specific SNPs."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic metabolic disease marked by elevated blood sugar levels due to insufficient production or use of insulin."&lt;SEP&gt;"Autoimmune responses in the pancreas can lead to diabetes, characterized by insulin deficiency due to immunological destruction of pancreatic β cells."&lt;SEP&gt;"SNPs were found to be associated with type 2 diabetes and insulin resistance."&lt;SEP&gt;"The presence or absence of diabetes was also included as a covariate in the models."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;OBSTRUCTIVE SLEEP APNEA&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"An intronic variant of the ELK1 gene was linked to obstructive sleep apnea."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High-density lipoprotein (HDL) cholesterol is a type of cholesterol that helps remove excess cholesterol from the body."&lt;SEP&gt;"SNPs were associated with HDL (high-density lipoprotein) cholesterol levels, impacting cardiovascular risk."&lt;SEP&gt;"rs4988235 showed a modestly lower HDL cholesterol level, suggesting an impact on lipid metabolism."&lt;SEP&gt;"rs4988235 was associated with lower HDL cholesterol, suggesting an impact on lipid metabolism."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;LDL CHOLESTEROL&quot;">
      <data key="d0">"BIOMARKER"</data>
      <data key="d1">"Certain SNPs were related to LDL (low-density lipoprotein) cholesterol, influencing heart disease risk."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;AST&quot;">
      <data key="d0">"ENZYME"</data>
      <data key="d1">"Variants were found to be linked with AST (aspartate aminotransferase), indicating liver health."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ALT&quot;">
      <data key="d0">"ENZYME"</data>
      <data key="d1">"SNPs influenced ALT (alanine transaminase) levels, relevant for liver function assessment."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;LDL-P&quot;">
      <data key="d0">"BIOMARKER"</data>
      <data key="d1">"An intron variant of the PCSK9 gene was related to LDL-particle size distribution (LDL-P), impacting atherogenicity."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;C-REACTIVE PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SNPs correlated with CRP levels were found, indicating inflammation and risk for chronic diseases."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GAMMA-GLUTAMYL TRANSFERASE&quot;">
      <data key="d0">"ENZYME"</data>
      <data key="d1">"Variants influenced Gamma-glutamyl transferase (GGT) activity, reflecting liver health and metabolism."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;IGF-1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A variant in KLKB1 was found linked to serum IGF-1 (insulin-like growth factor 1), indicating growth and health status."&lt;SEP&gt;"Insulin-like growth factor 1 (IGF-1) is a peptide hormone that plays a role in cell proliferation and survival."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;IGFBP-3&quot;">
      <data key="d0">"HORMONE"</data>
      <data key="d1">"SNPs affecting MPRIP influenced IGFBP-3 levels, impacting metabolism of insulin-like growth factors."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TSH&quot;">
      <data key="d0">"HORMONE"</data>
      <data key="d1">"Twenty-three SNPs in the flanking 5'UTR region of XPA/FOXE1 were associated with serum TSH (thyroid-stimulating hormone) levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;MCP-1&quot;">
      <data key="d0">"CHEMOKINE"</data>
      <data key="d1">"MCP-1 plays a role in recruiting leukocytes into the inflamed colonic tissue."&lt;SEP&gt;"SNPs related to MCP-1 (monocyte chemoattractant protein 1), a key cytokine in inflammation and immune response."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;IL-6&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"An intron variant of ABO was associated with IL-6 levels, indicating inflammation status and health risks."&lt;SEP&gt;"IL-6 is a pro-inflammatory cytokine that impacts T cell function and disease severity."&lt;SEP&gt;"IL-6, like IL-1β and TNF-α, is increased in colitis and contributes to the intensification of the Th17 response."&lt;SEP&gt;"Increased levels of IL-1 and IL-6 from LPMφs can impact Th17 cell maturation in diseased mice."&lt;SEP&gt;"The gene expression levels of IL-6, TNF-α and IL-1β were increased in the SENP1 knockdown cells."&lt;SEP&gt;|&gt;Disease"/"Inflammation"</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;INFLAMMATION MARKER&quot;">
      <data key="d0">"MARKER"</data>
      <data key="d1">"Multiple genetic variants were linked to various inflammation markers, highlighting their role in disease risk."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASUREMENT"</data>
      <data key="d1">"A SNP within the intron of C21orf34 was associated with RQ during sleep, reflecting metabolic rate and substrate utilization."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RPL7P3&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A variant was identified for accelerometer-measured light activity in the 5′UTR region of RPL7P3 on chromosome 9."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CTCFL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Sedentary-light activity was measured in the 3′UTR of CTCFL on chromosome 20."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;MATK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A highly significant variant for total energy expenditure (p = 2.7E-08) was identified for MATK on chromosome 19."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CHRNA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Sleeping energy expenditure (p = 6.0E-08) variant was identified for CHRNA3 on chromosome 15."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;INTRONIC VARIANT&quot;">
      <data key="d0">"ARHGAP11A 15TH CHROMOSOME"</data>
      <data key="d1">"An intronic variant in ARHGAP11A on chromosome 15 was associated with sleep duration."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant identified for accelerometer-measured light activity in the 5′UTR region of RPL7P3 on chromosome 9."&lt;SEP&gt;"Sedentary-light activity was measured in the 3′UTR of CTCFL on chromosome 20."&lt;SEP&gt;"Data demonstrate LYP variants, 620R and 620W, result in similar levels of effector cytokine secretion."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEP DURATION&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Shorter sleep duration was associated with higher snoring prevalence in the sample."&lt;SEP&gt;"The intronic variant in ARHGAP11A on chromosome 15 was associated with sleep duration.")</data>
      <data key="d0">"RISK FACTOR"</data>
    </node>
    <node id="&quot;RQ (RESPIRATORY QUOTIENT)&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 detected for RQ during sleep.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Accelerometer-measured light activity variant was found in the 5′UTR region of RPL7P3.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RPL7P3 5′UTR&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Accelerometer-measured light activity variant was found in the 5′UTR region of RPL7P3.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTCFL 3′UTR&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sedentary-light activity was measured in the 3′UTR of CTCFL on chromosome 20.")&lt;SEP&gt;"Sedentary-light activity was measured using CTCFL's 3′UTR sequence on chromosome 20.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sedentary-light activity was measured in the 3′UTR of CTCFL on chromosome 20.")&lt;SEP&gt;"Sedentary-light activity was measured using CTCFL's 3′UTR sequence on chromosome 20.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATK CHROMOSOME 19&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A highly significant variant identified for total energy expenditure (p = 2.7E-08) was associated with MATK on chromosome 19.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A highly significant variant identified for total energy expenditure (p = 2.7E-08) was associated with MATK on chromosome 19.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHRNA3 CHROMOSOME 15&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sleeping energy expenditure variant identified for CHRNA3 on chromosome 15.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sleeping energy expenditure variant identified for CHRNA3 on chromosome 15.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATK 19TH CHROMOSOME&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A highly significant variant associated with total energy expenditure (p = 2.7E-08) was identified for MATK on chromosome 19.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHRNA3 15TH CHROMOSOME&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Sleeping energy expenditure variant identified for CHRNA3 on chromosome 15.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C21ORF34 INTRONIC REGION&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"A SNP in the C21orf34 intronic region detected for RQ during sleep.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ARHGAP11A 15TH CHROMOSOME&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"An intronic variant in ARHGAP11A on chromosome 15 was associated with sleep duration.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RPL7P3 5′UTR REGION&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Accelerometer-measured light activity variant found in the RPL7P3 5′UTR region.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOBR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The APOBR gene encodes a protein that plays a role in lipid metabolism."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS74949322&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide variant located in the coding region of the APOBR gene."&lt;SEP&gt;"Located in the un-translated region (UTR) or intronic regions and has no significant functional impact."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS151233&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant found within the APOBR gene, affecting the amino acid sequence of its protein product."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS149271&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous variant in the coding region of the APOBR gene, with no impact on the resulting amino acid sequence."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS3833080&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutates the amino acid sequence by deleting several residues and is located within a repeat region."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS180743&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A non-synonymous variant that causes an amino acid change, creating a new amino acid residue (Pro428Ala)."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS151174&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Synonymous variant found in the APOBR gene."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS40831&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous variant found in the APOBR gene, with a minor allele frequency of 0.023."&lt;SEP&gt;"A synonymous variant within the coding region of the APOBR gene."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS61738759&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another synonymous variant identified in the APOBR gene."&lt;SEP&gt;"Located at the 1.3kb intron of APOBR gene."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS40833&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous variant present within the coding sequence of the APOBR gene."&lt;SEP&gt;"Located close to rs368546180 with high linkage disequilibrium (LD) and associated with obesity."&lt;SEP&gt;"This variant has been observed in multiple studies near or overlapping with rs149271, showing commonalities in association with obesity."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS142786317&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Identified as a variant in the un-translated region or intronic part of the APOBR gene."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS368546180&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutates the amino acid sequence by introducing an 9bp deletion, disrupting three residues, and is located near rs3833080."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS200751685&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located in the coding region of APOBR gene but details not specified."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS200743&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant associated with obesity, showing high LD with rs3833080 and rs149271."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS26905922&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located in the 3' untranslated region (UTR) of the APOBR gene, its function is unclear but associated with obesity."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS149782&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is found within an exon of the APOBR gene and has been linked to obesity."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS61365071&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant that resides in a CpG island close to the start codon of the APOBR gene, potentially influencing promoter activity."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS40827&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located near rs368546180 and rs149271 on chromosome 1p34.1 with low minor allele frequency in lean individuals."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS1807642&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous variant found in the coding region of APOBR gene with high linkage disequilibrium (LD) with rs151233."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS2993674&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is identified within an intron near exon 10 of the APOBR gene and has implications for splicing regulation."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS8111918&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located in a non-coding region adjacent to the APOBR gene with unclear functional relevance but related obesity risk."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS40832&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous variant within coding sequence of APOBR gene that is associated with high LD with rs151174."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS61738760&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant near the 5' UTR region of APOBR gene showing low minor allele frequency in lean subjects."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS200751691&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located close to the 3' end of APOBR gene but specific details about its function are not specified."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS61738762&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant found within the APOBR gene's intronic region, potentially impacting gene regulation mechanisms."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS142786317: C.*118_*119DELCA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs142786317 variant results in the deletion of the nucleotides CA at positions *118 and *119, leading to changes in transcription factor binding sites, splicing enhancer and silencer binding sites, or both."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SULT1A1 is a gene involved in the detection of variants that may affect its function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;NON-SYNONYMOUS SNPS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Seven non-synonymous Single Nucleotide Polymorphisms (SNPs) were found in the coding region of SULT1A1, which could potentially change amino acids and influence protein function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4149403: P.ILE7THR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs4149403 leads to an isoleucine (Ile) to threonine (Thr) substitution at position 7, which might affect protein stability and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS10797300: P.PRO19LEU&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs10797300 results in a proline (Pro) to leucine (Leu) substitution at position 19, potentially impacting protein structure and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS145008170: P.SER44ASN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs145008170 leads to a serine (Ser) to aspartic acid (Asn) change at position 44, which might affect protein conformation and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4987024: P.TYR62PHE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs4987024 results in a tyrosine (Tyr) to phenylalanine (Phe) substitution at position 62, potentially influencing protein stability and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS142241142: P.ALA164VAL&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs142241142 leads to an alanine (Ala) to valine (Val) change at position 164, which could impact protein activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS1059491: P.ASN235THR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs1059491 causes a asparagine (Asn) to threonine (Thr) substitution at position 235, potentially affecting protein structure and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS75191166: P.LYS282GLY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs75191166 results in a lysine (Lys) to glycine (Gly) change at position 282, which might impact protein stability and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4149406: C.148+34T/C&quot;">
      <data key="d0">"NON-CODING VARIANT"</data>
      <data key="d1">"The variant rs4149406 alters the nucleotide composition (+34 relative to position 148) in the 3' untranslated region."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS3743963: C.500−19T/C&quot;">
      <data key="d0">"NON-CODING VARIANT"</data>
      <data key="d1">"The variant rs3743963 changes nucleotides at a position near to exon 2, affecting splice sites or transcription factor binding."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS710410: C.*7T/C&quot;">
      <data key="d0">"NON-CODING VARIANT"</data>
      <data key="d1">"The variant rs710410 introduces a substitution (+7 relative to the first codon) impacting possible transcription factor binding or splicing enhancer sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS762634: C.*14A&gt;G&quot;">
      <data key="d0">"NON-CODING VARIANT"</data>
      <data key="d1">"The variant rs762634 alters the nucleotides near the start of an exon, which might influence splice sites or transcription factor binding."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS145790611: C.241+39G/A&quot;">
      <data key="d0">"NON-CODING VARIANT"</data>
      <data key="d1">"The variant rs145790611 changes the nucleotides (+39 relative to exon 5) potentially impacting splicing or transcription factor binding."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;C.3536C&gt;G&quot;">
      <data key="d0">"UNKNOWN VARIANT"</data>
      <data key="d1">"An unknown variant detected in the 3' untranslated region of TUFM, previously not documented."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS7187776: C.-55T&gt;C&quot;">
      <data key="d0">"INTRONIC VARIANT"</data>
      <data key="d1">"The variant rs7187776 introduces a substitution near -55 relative to exon 2's beginning, potentially affecting splicing or transcription factor binding."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4788099: C.817+13T&gt;C&quot;">
      <data key="d0">"INTRONIC VARIANT"</data>
      <data key="d1">"The variant rs4788099 results in a substitution near +13 relative to exon 6's start, potentially impacting splicing or transcription factor binding."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS8061877: C.248−18G&gt;A&quot;">
      <data key="d0">"INTRONIC VARIANT"</data>
      <data key="d1">"The variant rs8061877 changes nucleotides at position -18 relative to exon 3's end, potentially affecting transcription factor binding."&lt;SEP&gt;"The variant rs8061877 results in a substitution at position -18 relative to exon 3, potentially affecting transcription factor binding."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS61737565: C.922+29C&gt;G&quot;">
      <data key="d0">"INTRONIC VARIANT"</data>
      <data key="d1">"The variant rs61737565 introduces a substitution near +29 relative to exon 8's start, possibly affecting transcription factor binding or splicing sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;G.28854194C/G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An unknown variant introduced by g.28854194C/G, not previously documented.")("entity"&lt;SEP&gt;"The genomic variant g.28854194C/G causes changes in splice enhancer binding sites and splicing silencer sites as predicted by three programs (S1 Table)."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;RS228540: P.PRO116ALA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs228540 results in a proline (Pro) to alanine (Ala) substitution at position 116, which might affect protein stability and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS739728: P.THR162ILE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs739728 leads to a threonine (Thr) to isoleucine (Ile) substitution at position 162, which could impact protein conformation and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS141420: P.SER19GLY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs141420 results in a serine (Ser) to glycine (Gly) substitution at position 19, potentially influencing protein stability and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS157783: P.LEU26MET&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs157783 leads to a leucine (Leu) to methionine (Met) change at position 26, which could affect protein activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS49170: P.GLU108GLY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs49170 results in an glutamic acid (Glu) to glycine (Gly) substitution at position 108, potentially impacting protein conformation and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS236589: P.ALA31THR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs236589 causes an alanine (Ala) to threonine (Thr) substitution at position 31, potentially affecting protein structure and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS76301: P.GLU67GLY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs76301 results in a glutamic acid (Glu) to glycine (Gly) substitution at position 67, which might impact protein stability and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS80492: P.PRO85LEU&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs80492 leads to a proline (Pro) to leucine (Leu) change at position 85, potentially influencing protein structure and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS73681: P.TYR142CYS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs73681 causes a tyrosine (Tyr) to cysteine (Cys) substitution at position 142, which could affect protein stability and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS695: P.SER27PHE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs695 results in a serine (Ser) to phenylalanine (Phe) substitution at position 27, potentially impacting protein conformation and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS14306: P.LEU38MET&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs14306 leads to a leucine (Leu) to methionine (Met) change at position 38, which could affect protein activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS75981: P.ALA52THR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs75981 results in an alanine (Ala) to threonine (Thr) substitution at position 52, potentially influencing protein structure and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS66340: P.PRO60SER&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs66340 leads to a proline (Pro) to serine (Ser) change at position 60, which could impact protein stability and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS75982: P.LEU61GLN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs75982 results in a leucine (Leu) to glutamine (Gln) substitution at position 61, potentially affecting protein conformation and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS640: P.VAL71ILE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs640 leads to a valine (Val) to isoleucine (Ile) change at position 71, which could influence protein activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS5238: P.TYR98CYS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs5238 results in a tyrosine (Tyr) to cysteine (Cys) substitution at position 98, potentially impacting protein stability and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS764: P.SER100PHE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs764 leads to a serine (Ser) to phenylalanine (Phe) change at position 100, which could affect protein conformation and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS23659: P.PRO102ALA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs23659 causes a proline (Pro) to alanine (Ala) substitution at position 102, potentially affecting protein stability and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS740: P.LEU113GLN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs740 results in a leucine (Leu) to glutamine (Gln) substitution at position 113, which might impact protein conformation and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS665: P.THR123ILE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs665 leads to a threonine (Thr) to isoleucine (Ile) change at position 123, potentially influencing protein structure and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS742: P.PHE129GLU&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs742 results in a phenylalanine (Phe) to glutamic acid (Glu) substitution at position 129, potentially impacting protein conformation and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS653: P.TYR130SER&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs653 leads to a tyrosine (Tyr) to serine (Ser) change at position 130, which could affect protein stability and activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS743: P.LEU132GLY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs743 results in a leucine (Leu) to glycine (Gly) substitution at position 132, potentially affecting protein conformation and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS649: P.VAL140MET&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs649 leads to a valine (Val) to methionine (Met) change at position 140, which could influence protein activity."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS738: P.PRO152LEU&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The SNP rs738 causes a proline (Pro) to leucine (Leu) substitution at position 152, potentially affecting protein structure and function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS61737565&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs61737565 is located at position c.922+29C&gt;G in a TUFM gene."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;TUFM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Five variants are found in the TUFM gene, which may affect splicing regulator or transcription factor binding sites."&lt;SEP&gt;"The TUFM gene includes the non-coding 3’ UTR region which contains a genomic variant g.28854194C/G."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;RS8061877&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs8061877 disrupts a transcription factor binding site for SRY, HFH 2, and HMG-IY (TFSearch and Consite)."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICING REGULATOR&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Splicing regulators are involved in altering splicing sites due to specific genomic variants like rs61737565."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Transcription factors can be affected by certain genomic variants leading to altered binding sites such as rs8061877."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICE ENHANCER BINDING SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Changes in splice enhancer sites are caused by specific genomic variants like g.28854194C/G within a gene."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICING SILENCER SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Splicing silencer sites can be altered due to the presence of certain genomic variants, as seen with rs61737565 and g.28854194C/G in TUFM."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;CODING REGION&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Although it is non-coding, the 3’ UTR can still influence gene expression, which is impacted by genomic variants such as g.28854194C/G within TUFM."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;NON-CODING REGIONS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The presence of specific genomic variants can affect non-coding parts of the gene like the 3’ UTR, which plays a role in regulating gene expression."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;GENOMIC VARIANT RS61737565&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The genomic variant rs61737565 affects the TUFM gene by altering splicing regulator or transcription factor binding sites.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TUFM GENE&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The genomic variant rs61737565 affects the TUFM gene by altering splicing regulator or transcription factor binding sites.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT RS8061877&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The genomic variant rs8061877 disrupts the binding of transcription factors SRY, HFH 2, and HMG-IY in the TUFM gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT G.28854194C/G&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The genomic variant g.28854194C/G causes changes in splice enhancer and splicing silencer sites within the TUFM gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NON-CODING 3’ UTR OF TUFM&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The non-coding 3’ UTR region of TUFM contains genomic variant g.28854194C/G which affects the gene function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITES&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Disruption of transcription factor binding sites occurs due to rs8061877 variant, influencing gene regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPLICE ENHANCER AND SPLICING SILENCER SITES&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"g.28854194C/G affects splice sites via changes in enhancer and silencer regions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE EXPRESSION REGULATION&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"The non-coding 3’ UTR can impact gene expression independently or through interactions with genomic variants like g.28854194C/G.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALOX15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALOX15, a gene involved in arachidonic acid metabolism and immune response, was not significantly associated with ovarian cancer risk in the combined analysis."&lt;SEP&gt;"Analysis of 162 successfully genotyped SNPs in approximately 900 epithelial ovarian cancer cases and 1,000 controls."&lt;SEP&gt;"The ALOX15 gene encodes an arachidonate 5-lipoxygenase, which is involved in various physiological processes related to inflammation and metabolism."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;ALOX5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Association between rs1864414 and ovarian cancer was confirmed in combined analysis."&lt;SEP&gt;"Association with risk of ovarian cancer found for rs1864414 (OR 0.77, p=0.004) and rs743507 (OR 0.79, p=0.003)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Included in analysis of 21 SNPs associated with risk of ovarian cancer."&lt;SEP&gt;"The IL18 gene encodes interleukin 1 alpha, which plays a role in the inflammatory response and cancer development."&lt;SEP&gt;"The IL18 gene encoding interleukin 1 alpha plays a role in the inflammatory response but showed null or inconsistent associations with ovarian cancer based on the phase of studies."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Suggests associations with decreased risk of ovarian cancer (OR 0.90, p=0.005)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NOS3 is one of the genes being studied for its role in folate metabolism and its association with childhood ALL."&lt;SEP&gt;"NOS3 rs3918186 is a SNP in the NOS3 gene that was analyzed for its association with childhood acute lymphoblastic leukemia (ALL)."&lt;SEP&gt;"rs743507 (OR 0.79, p=0.003) associated with risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;PTGS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Association suggested for rs2282169 in combined analyses."&lt;SEP&gt;"The PTGS1 gene encodes prostaglandin-endoperoxide synthase 1."&lt;SEP&gt;"The PTGS1 gene was associated with ovarian cancer risk through its variant rs2282169, suggesting a potential link between prostaglandin-endoperoxide synthase 1 and ovarian cancer predisposition."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;ALOX12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CCL11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CCL3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CXCL16&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL15RA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1RN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL4R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL7R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL8RA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL8RB&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No association was observed in analysis of SNPs in this gene."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;TLR2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Analysis within this gene did not suggest associations between genotype and risk of ovarian cancer (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;TNF&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No association was observed in analysis of SNPs in this gene (p’s &gt; 0.10)."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;BRCA1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in BRCA1 have been shown to increase the risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;BRCA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs in BRCA2 are associated with an increased risk of ovarian cancer, especially in patients with a family history of the disease."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTEN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Mutations or variants in PTEN have been linked to a higher risk of ovarian cancer, particularly among BRCA1 carriers."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;SMAD4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs in SMAD4 have been implicated as potential genetic markers for the predisposition to ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CDH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Mutations or variants in CDH1 have been found to increase the likelihood of ovarian cancer, particularly when present alongside other genetic markers like BRCA2 mutations."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;BARD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in BARD1 have been associated with a higher risk of developing ovarian cancer, especially among women carrying BRCA2 mutations."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CHEK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Polymorphisms in CHEK2 have been linked to an elevated risk for developing ovarian cancer, especially among women with inherited BRCA1 mutations."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL1B is a gene that encodes interleukin 1, beta."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant rs7596684 in IL1B gene may be associated with increased risk of ovarian cancer, based on some preliminary findings."&lt;SEP&gt;"The genomic variant rs7596684 in the IL1B gene has been associated with ovarian cancer risk."&lt;SEP&gt;"The genomic variant rs7596684 within IL1B gene shows a potential association with ovarian cancer, which was partly identified in the text."&lt;SEP&gt;"The genomic variant rs7596684, located in the IL1B gene, was found to have a significant association with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;RS2282169&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Although rs2282169 in PTGS1 has been associated with ovarian cancer, this information was not directly mentioned; it is an implication of the initial genomic variant's significance."&lt;SEP&gt;"The association between rs2282169 variant in PTGS1 gene and ovarian cancer risk is a partially identified linkage that was mentioned only implicitly."&lt;SEP&gt;"The genomic variant rs2282169 in the PTGS1 gene has been suggested to associate with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;CCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CCL2 gene codes for a chemokine that plays roles in immune response, inflammation, and cancer progression."&lt;SEP&gt;"The CCL2 gene encoding chemokine, which is involved in immune response and inflammation, showed null or inconsistent results for its association with ovarian cancer across different study phases."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 6 (IL6), an important cytokine that influences inflammation, was not found to have a consistent or significant association with ovarian cancer in the combined analyses."&lt;SEP&gt;"The IL6 gene codes for interleukin-6, an important cytokine involved in the immune response and inflammation that can influence cancer progression."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;OVARIAN CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease under investigation related to the genetic variants and their association with cancer risk."&lt;SEP&gt;"Ovarian cancer is a type of malignancy that affects the ovaries and has multiple risk factors including genetic predispositions, age, and environmental exposures like smoking or diet."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;HETEROGENEITY FOR CLEAR CELL, MUCINOUS, AND ENDOMETRIOID SUBTYPES (IL1A RS17561)&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"Significant associations were present in clear cell, mucinous, and endometrioid subtypes, suggesting different risk profiles.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P=0.03&quot;">
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d1">"Significant associations were present in clear cell, mucinous, and endometrioid subtypes, suggesting different risk profiles.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACK OF ASSOCIATION&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"No strong evidence suggests that ALOX15 plays a significant role in increasing the risk of ovarian cancer as per the study phases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY PHASES&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"Results on the relationship between CCL2 and ovarian cancer risk were mixed throughout different study phases, indicating uncertain associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACK OF CONSISTENT ASSOCIATION&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"The relationship between CRP and ovarian cancer risk was ambiguous due to inconsistent findings across study phases.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 29}]</data>
    </node>
    <node id="&quot;PHASE OF STUDIES&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"The relationship between IL18 and ovarian cancer risk was unclear due to varying results across different stages of research phases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2282169&quot;&amp; &quot;OVARIAN CANCER RISK&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"The variant rs2282169 in PTGS1 gene appears to be linked with ovarian cancer risk, although this was not explicitly stated in the text.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7596684&quot;&amp;&quot;OVARIAN CANCER RISK&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"A possible link exists between rs7596684 variant within IL1B gene and increased risk of ovarian cancer based on some findings, though this was not fully elucidated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2282169&quot;&amp;&quot;POTENTIAL OVARIAN CANCER LINKAGE&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"A potential connection exists between rs2282169 variant in PTGS1 gene and ovarian cancer, though this was not extensively detailed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7596684&quot;&amp;&quot;POTENTIAL INCREASED OVARIAN CANCER RISK&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"A preliminary linkage between rs7596684 variant in IL1B gene and potential increase in risk of ovarian cancer is suggested by some observations, though these were not thoroughly explained.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTHFD2 gene plays a role in the folate metabolic pathway."&lt;SEP&gt;"MTHFD2 genes were among the folate metabolic genes included in the analysis."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BHMT2 gene also contributes to the folate metabolic pathway analyzed for childhood ALL risk association."&lt;SEP&gt;"BHMT2 genes were among the folate metabolic genes included in the analysis."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SLC19A1 gene was among the folate metabolic genes with a tagging SNP analyzed for association with childhood ALL."&lt;SEP&gt;"SLC19A1 is another gene involved in the folate metabolic pathways and was evaluated in relation to childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RS3918186&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"NOS3 rs3918186 had a Bayes Factor of 7.38, indicating it was significantly associated with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RS1051266&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"For each copy of the minor allele of SLC19A1 rs1051266, there was a 2.07 times risk of developing childhood ALL."&lt;SEP&gt;"SLC19A1 rs1051266 showed less evidence for association with childhood ALL compared to NOS3 rs3918186, as its Bayes Factor was lower."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The study focused on tagging SNPs of 16 folate metabolic genes for associations with childhood acute lymphoblastic leukemia (ALL)."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The research aimed to identify genetic factors, including SNPs in folate metabolism-related genes, associated with the risk of developing childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TABLE 2&quot;">
      <data key="d0">"DATA TABLE"</data>
      <data key="d1">"This table summarizes the population characteristics of childhood ALL cases, including gender, participation rate, triad completeness, and racial/ethnic group distribution."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TABLE 3&quot;">
      <data key="d0">"DATA TABLE"</data>
      <data key="d1">"Table 3 includes information on the initial screening of SNPs from folate metabolic genes like MTHFD2, BHMT2, NOS3, and SLC19A1."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TABLE 4&quot;">
      <data key="d0">"DATA TABLE"</data>
      <data key="d1">"Table 4 presents the results of the final analysis, including Bayes Factors for SNPs associated with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;OR (ODDS RATIO)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The odds ratio is used to quantify the strength of association between specific SNPs and the risk of developing childhood ALL based on the data."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;95% CI (CONFIDENCE INTERVAL)&quot;">
      <data key="d0">"STATISTICAL INTERVAL"</data>
      <data key="d1">"A 95% confidence interval provides a range within which we can be confident that the true value lies for statistical measures such as odds ratios or Bayes Factors."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;POSTERIOR PROBABILITY&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"This measure reflects the updated probability of an SNP being included in the model after considering all available evidence and data."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;INITIAL SCREENING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The initial screening process involved analyzing tagging SNPs from folate metabolic genes to identify those with a high posterior probability for further examination."&lt;SEP&gt;"There were no group differences in initial screening or randomization."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FINAL ANALYSIS&quot;">
      <data key="d0">"STUDY PROCESS"</data>
      <data key="d1">"The final analysis consisted of more in-depth evaluation of selected SNPs that passed the initial screening stage based on their statistical significance and relevance."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs are variations in a single DNA building block at specific positions in the genome, which were analyzed for associations with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;PRIOR ODDS&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Prior odds represent the likelihood of an event occurring before considering any new evidence or data."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;ASSOCATION&quot;">
      <data key="d0">"STATISTICAL TERM"</data>
      <data key="d1">"In this context, association refers to the relationship between specific SNPs in folate metabolic genes and the risk of developing childhood ALL based on statistical analysis."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 RS3918186&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"NOS3 rs3918186 showed a significant association with an increased risk of childhood ALL based on Bayes Factors and odds ratios.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLC19A1 RS1051266&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"While SLC19A1 rs1051266 had some evidence for association, the strength was weaker than that of NOS3 rs3918186.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INITIAL SCREENING CRITERIA&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"The data from Table 2 were used as criteria for selecting which SNPs would proceed to initial screening based on their relevance and completeness.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TABLE 2 POPULATION CHARACTERISTICS&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"The data from Table 2 were used as criteria for selecting which SNPs would proceed to initial screening based on their relevance and completeness.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INITIAL SCREENING PROCESS&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"SNPs initially identified in the study underwent an initial screening process, where those with a high posterior probability were selected for further analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP INITIAL IDENTIFICATION&quot;">
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d1">"SNPs initially identified in the study underwent an initial screening process, where those with a high posterior probability were selected for further analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FADS1/2 HAPLOTYPE&quot;">
      <data key="d0">"GENETIC HAPLOTYPE"</data>
      <data key="d1">"A set of genetic variations located together on a chromosome that are usually inherited together."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MINOR ALLELE FREQUENCY&quot;">
      <data key="d0">"FREQUENCY OF MINOR ALLELE"</data>
      <data key="d1">"The proportion of times the less common form (minor allele) is found at a particular genetic locus in a population."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;RACE&quot;">
      <data key="d0">"CATEGORICAL DEMOGRAPHIC VARIABLE"</data>
      <data key="d1">"Identifying variable for different racial groups."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;AA CONCENTRATION&quot;">
      <data key="d0">"LEVELS OF ALPHA-LINOLENIC ACID"</data>
      <data key="d1">"The level of alpha-linolenic acid (ALA) in the blood serum or colon tissue."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;EPA&quot;">
      <data key="d0">"EICOSAPENTAENOIC ACID"</data>
      <data key="d1">"A long-chain omega-3 fatty acid found primarily in oily fish and krill oil."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 FATTY ACIDS&quot;">
      <data key="d0">"LONG CHAIN OMEGA-3 FATTY ACIDS"</data>
      <data key="d1">"Fatty acids that are longer than 18 carbon atoms, with an odd number of carbon atoms greater than or equal to 20, and have three double bonds in the trans configuration."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;DIETARY AA INTAKE&quot;">
      <data key="d0">"ALPHA LINOLENIC ACID INTAKE"</data>
      <data key="d1">"The amount of alpha-linolenic acid (ALA) included in the diet."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 FATTY ACIDS INTAKE&quot;">
      <data key="d0">"INTAKE OF LONG CHAIN OMEGA 3 FATTY ACIDS"</data>
      <data key="d1">"The amount of long-chain omega-3 fatty acids, specifically EPA and DHA, consumed through diet."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;DIETARY INTERVENTION&quot;">
      <data key="d0">"NUTRITIONAL INTERVENTION PROGRAM"</data>
      <data key="d1">"A structured program designed to modify dietary habits through education or supplementation to improve health outcomes."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SERUM AA CONCENTRATION&quot;">
      <data key="d0">"ALPHA LINOLENIC ACID CONCENTRATION IN BLOOD SERUM"</data>
      <data key="d1">"The level of alpha-linolenic acid present in blood serum."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;COLON FATTY ACID CONCENTRATIONS&quot;">
      <data key="d0">"FATTY ACIDS LEVELS IN COLON"</data>
      <data key="d1">"Changes observed in colon fatty acid concentrations due to diet"&lt;SEP&gt;"Levels of fatty acids found within the colon tissue, specifically 20:4n-6, 18:3n-3 and 20:4n-6 concentration."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;TOTAL CHOLESTEROL&quot;">
      <data key="d0">"TOTAL CHOLESTEROL LEVEL"</data>
      <data key="d1">"The total amount of cholesterol in the blood, which includes both high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol levels."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LOW DENSITY LIPOPROTEINS&quot;">
      <data key="d0">"LOW-DENSITY LIPOPROTEIN (LDL)"</data>
      <data key="d1">"A type of lipoprotein that transports cholesterol from the liver to cells throughout the body, often referred to as 'bad' cholesterol due to its potential role in heart disease."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;HIGH DENSITY LIPOPROTEINS&quot;">
      <data key="d0">"HIGH-DENSITY LIPOPROTEIN (HDL)"</data>
      <data key="d1">"A type of lipoprotein that helps remove cholesterol from cells and transport it back to the liver, often referred to as 'good' cholesterol."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;CRP (C-REACTIVE PROTEIN)&quot;">
      <data key="d0">"C-REACTIVE PROTEIN"</data>
      <data key="d1">"A protein found in the bloodstream that increases during inflammation and infection. Elevated CRP levels may indicate an increased risk of heart disease or other inflammatory conditions."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FATTY ACID COMPOSITION&quot;">
      <data key="d0">"COLON FATTY ACID PROFILE"</data>
      <data key="d1">"The types and amounts of fatty acids present in colon tissue."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;OMEGA-3 INDEX&quot;">
      <data key="d0">"LEVELS OF N-3 FATTY ACIDS IN THE RED BLOOD CELL MEMBRANE PHOSPHOLIPIDS"</data>
      <data key="d1">"The ratio of EPA (Eicosapentaenoic acid) + DHA (Docosahexaenoic acid) to total n-6 and n-3 fatty acids present in red blood cells."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FATTY ACID TRANSLOCASE 1&quot;">
      <data key="d0">"FA/TLC1 PROTEIN EXPRESSION"</data>
      <data key="d1">"The level of expression of the Fatty Acid Translocase 1 protein, which is involved in transport of long chain fatty acids into cells."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;EPA CONVERSION EFFICIENCY&quot;">
      <data key="d0">"EFFICIENCY OF EPA SYNTHESIS"</data>
      <data key="d1">"The proportionate ability to convert dietary EPA into longer-chain n-3 fatty acids like DHA."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;DIETARY FIBER INTAKE&quot;">
      <data key="d0">"FIBER INTAKE"</data>
      <data key="d1">"The total amount of dietary fiber consumed in the diet."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;CALCIUM INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lower calcium intake was found in cases compared to controls, potentially affecting nutritional status."&lt;SEP&gt;"The level or amount of calcium taken from food sources."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SELENIUM INTAKE&quot;">
      <data key="d0">"SE INTAKE"</data>
      <data key="d1">"The dietary intake of selenium, an essential mineral for human health."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;VITAMIN C INTAKE&quot;">
      <data key="d0">"VC INTAKE"</data>
      <data key="d1">"The consumption of Vitamin C through dietary sources."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET ADHERENCE&quot;">
      <data key="d0">"ADHERENCE TO MEDITERRANEAN DIET"</data>
      <data key="d1">"The degree to which a person follows the principles and components of the traditional Mediterranean diet."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;REGULAR EXERCISE&quot;">
      <data key="d0">"PHYSICAL ACTIVITY LEVEL"</data>
      <data key="d1">"The frequency, intensity, duration, and type of regular physical activity performed by an individual."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;COFFEE INTAKE&quot;">
      <data key="d0">"CAFFEINE CONSUMPTION"</data>
      <data key="d1">"The amount of caffeine consumed through coffee, tea or other sources."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MEDICATION USE&quot;">
      <data key="d0">"PHARMACOLOGICAL USE"</data>
      <data key="d1">"The prescription drugs or supplements being taken by an individual on a regular basis."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;STRESS LEVELS&quot;">
      <data key="d0">"PSYCHOLOGICAL STRESS LEVEL"</data>
      <data key="d1">"The subjective and objective measures of stress experienced by individuals."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SLEEP QUALITY&quot;">
      <data key="d0">"QUALITY OF SLEEP"</data>
      <data key="d1">"The adequacy, efficiency, continuity, and restfulness of sleep in an individual."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;INFLAMMATORY MARKERS&quot;">
      <data key="d0">"MARKERS OF INFLAMMATION"</data>
      <data key="d1">"Levels or presence of various substances in the blood that indicate an inflammatory response within the body."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;20:4, N-6 (AA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A type of polyunsaturated fatty acid that significantly decreased in serum"</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MUFA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Monounsaturated fatty acids that increased significantly in both groups"</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;N-3 PUFA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A type of polyunsaturated fatty acid that significantly increased in both groups"</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;SERUM 18:2 N-6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A type of polyunsaturated fatty acid that significantly decreased in serum"</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;HEALTHY EATING GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A diet with a focus on fruits, vegetables, whole grains, and lean proteins that was compared to the Mediterranean group"</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;BASELINE CHARACTERISTICS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The relationship between the presence of a specific SNP and various baseline characteristics (gender, race, age, BMI).")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;GENOTYPING SUCCESS RATE&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The correlation between successful genotyping and minor allele frequency in SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MINOR ALLELE FREQUENCIES&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The correlation between successful genotyping and minor allele frequency in SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY INTAKES&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The predictive relationship of dietary intake on serum levels of specific fatty acids (AA, EPA).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FATTY ACID CONCENTRATIONS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The predictive relationship of dietary intake on serum levels of specific fatty acids (AA, EPA).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE GROUP&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"The association between genotype and BMI in the baseline demographics.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;DIETARY INTERVENTION EFFECTS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"How changes in dietary intake during an intervention affect serum levels of various fatty acids.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON AA CONCENTRATIONS&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Mean colon AA concentrations differed significantly between diet arms at 6 months for subjects without minor alleles in the FADS1/2 gene cluster.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIET ARM&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Mean colon AA concentrations differed significantly between diet arms at 6 months for subjects without minor alleles in the FADS1/2 gene cluster.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COLON CONCENTRATIONS&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"There was a significant interaction of genotype by diet for AA concentrations in the colon.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO GENOTYPE-DIET INTERACTION&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"No significant genotype-by-diet interactions were found for EPA concentration.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDITERRANEAN GROUP&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Serum 20:4, n-6 (AA) concentration significantly decreased in the Mediterranean group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO MINOR ALLELES&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Mean colon AA concentrations were estimated to be 16% (95% CI = [5%, 26%]) lower for the Healthy Eating arm than the Mediterranean arm at 6 months.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UK BIOBANK&quot;">
      <data key="d0">"POPULATION-BASED DISCOVERY SAMPLE"</data>
      <data key="d1">"408,317 individuals of white British ancestry were included in this study."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SNORING&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"This population-based study used self-reported snoring as the main outcome measure based on partner or housemate complaints."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;SLEEP APNOEA&quot;">
      <data key="d0">"COMORBID CONDITION"</data>
      <data key="d1">"The prevalence of sleep apnoea was higher among those reporting snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SOCIOECONOMIC STATUS (SES)&quot;">
      <data key="d0">"RISK FACTOR"</data>
      <data key="d1">"A lower SES was linked to an increased risk of snoring in males only."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SMOKING FREQUENCY&quot;">
      <data key="d0">"RISK FACTOR"</data>
      <data key="d1">"Smoking frequency showed a positive correlation with snoring prevalence, particularly in females and to some extent in males."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 26}]</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION FREQUENCY&quot;">
      <data key="d0">"RISK FACTOR"</data>
      <data key="d1">"Alcohol consumption was positively correlated with snoring, though this association was weaker compared to smoking."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;WHOLE-BODY FAT MASS&quot;">
      <data key="d0">"RISK FACTOR"</data>
      <data key="d1">"There was a correlation between whole-body fat mass and snoring prevalence, indicating obesity as a risk factor."&lt;SEP&gt;"Whole-body fat mass was another trait with a moderate genetic correlation to snoring, related to obesity."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A GWAS was conducted on 408,317 individuals to identify genetic variants related to snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SNP HERITABILITY&quot;">
      <data key="d0">"MEASURE OF GENETIC CONTRIBUTION"</data>
      <data key="d1">"The SNP heritability for snoring was estimated at 9.9% (SE=0.39%) indicating the genetic influence on the trait."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 10}]</data>
    </node>
    <node id="&quot;GENETIC CORRELATION&quot;">
      <data key="d0">"ASSOCIATION MEASURE"</data>
      <data key="d1">"GWAS results showed specific genetic correlations between snoring and various traits beyond sleep apnea, including measures of BMI, heart disease, lung function, psychiatric conditions, and more."&lt;SEP&gt;"Sleep apnoea showed a high genetic correlation of 0.78 with snoring, suggesting shared genetic factors between the two conditions."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;ALCOHOL INTAKE FREQUENCY&quot;">
      <data key="d0">"CORRELATED TRAIT"</data>
      <data key="d1">"Alcohol intake frequency had a weak positive genetic correlation with snoring, indicating potential influence."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SLEEP DISORDERS&quot;">
      <data key="d0">"CORRELATED TRAITS"</data>
      <data key="d1">"Traits such as sleep apnoea and excessive daytime sleepiness showed moderate to high genetic correlations with snoring, reflecting common underlying mechanisms."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;NEUROTICISM&quot;">
      <data key="d0">"CORRELATED TRAIT"</data>
      <data key="d1">"The trait of neuroticism was negatively correlated with snoring, possibly indicating a protective effect against snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;HEART RATE&quot;">
      <data key="d0">"CORRELATED TRAIT"</data>
      <data key="d1">"There was no genetic correlation between heart rate and snoring in this study, suggesting no shared genetic basis."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;PARTNER&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Partners or housemates' complaints were used as an indicator for snoring in this study."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;HOUSEMATE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Complaints from housemates were also considered when assessing snoring prevalence."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;GWAS ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY COMPONENT"</data>
      <data key="d1">"The Genome-Wide Association Study adjusted for basic covariates such as BMI, sex, age, and other risk factors like smoking and alcohol consumption when analyzing genetic associations with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;FOLLOW-UP SENSITIVITY ANALYSIS&quot;">
      <data key="d0">"SUPPLEMENTARY METHODOLOGY COMPONENT"</data>
      <data key="d1">"This analysis was performed to examine the impact of adjusting for BMI on associations with previously identified genetic variants related to snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;BMI ADJUSTMENT EFFECTS&quot;">
      <data key="d0">"IMPACT OF METHODOLOGICAL INTERVENTION"</data>
      <data key="d1">"Adjusting for BMI changed the signal at some genetic loci associated with snoring, highlighting potential confounding effects in GWAS analysis."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;ADJUSTED GENETIC CORRELATIONS&quot;">
      <data key="d0">"OUTCOME OF METHODOLOGICAL INTERVENTION"</data>
      <data key="d1">"After adjusting for BMI, the genetic correlation between snoring and traits like sleep apnea showed small increases, suggesting that confounding by BMI was reduced."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;UNADJUSTED VS. ADJUSTED GWAS&quot;">
      <data key="d0">"METHODOLOGICAL COMPARISON OUTCOME"</data>
      <data key="d1">"Comparing the unadjusted to adjusted GWAS revealed a high degree of similarity in results, supporting the robustness of findings despite accounting for BMI."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;DLEU7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"13 chromosome gene associated with snoring and nocturnal hypoxia."&lt;SEP&gt;"Closely linked with MSRB3 in genome-wide significant SNPs; 13 chromosome gene."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MSRB3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"12 chromosome gene associated with snoring and nocturnal hypoxia."&lt;SEP&gt;"Another 12 chromosome gene identified from positional and eQTL mapping related to snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;BCL11B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Previously linked to smoking, another risk factor for snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SMG6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Previously associated with coffee consumption; caffeine can influence sleep and snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ROBO2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Related to chronotype, impacting sleep schedules and snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NSUN3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One of the prioritized genes for snoring, associated with smoking and alcohol consumption."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNAP91&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene from the prioritization list related to snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;BLC11B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Previously associated with smoking, a factor that can increase snoring risk."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;RNA5SP471&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Linked with alcohol consumption and possibly affects sleep patterns, including snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SND1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Also found to be associated with alcohol consumption and related to snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;LMO4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Related to insomnia, a condition often linked to snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NARCOLEPSY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurological disorder that might influence sleep patterns and snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;RS199797821&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant was identified as genome-wide significant SNP for snoring, has an effect size that differs significantly between sexes, and correlates highly with cross-sex genetic correlation."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RS200391180&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant identified as genome-wide significant for snoring, also shows a significantly different effect size between sexes but in the same direction."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;H2SNP: 8.77% (SE = 0.54%)&quot;">
      <data key="d0">"SNP HERITABILITY ON THE LIABILITY SCALE FOR MALES"</data>
      <data key="d1">"Heritability quantifies the proportion of variation in a trait that is due to genetic factors, here calculated with standard error."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;H2SNP: 12.42% (SE = 0.57%)&quot;">
      <data key="d0">"SNP HERITABILITY ON THE LIABILITY SCALE FOR FEMALES"</data>
      <data key="d1">"Heritability quantifies the proportion of variation in a trait that is due to genetic factors, here calculated with standard error."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RS199797821 AND RS200391180&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The lead SNPs are part of molecular interactions within the genome which influence snoring traits."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;CROSS-SEX GENETIC CORRELATION: RG = 0.914 (SE = 0.033, P-VALUE = 1.91 × 10−160)&quot;">
      <data key="d0">"GENETIC CORRELATION"</data>
      <data key="d1">"High level of similarity in the effect sizes between males and females for these SNPs."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SELF-REPORTED RECENT SNORING (PREVALENCE: 32%)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The prevalence of self-reported recent snoring is calculated here, with a higher occurrence observed in males compared to females."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RECENT SNORING PGS DECILE (HIGHEST VS. LOWEST)&quot;">
      <data key="d0">"PROGNOSTIC SCORE"</data>
      <data key="d1">"This score was associated with increased risk for reporting recent snoring and potential obstructive sleep apnea based on sample prevalence."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;FREQUENCY OF SNORING SEVERITY&quot;">
      <data key="d0">"VARIABLE"</data>
      <data key="d1">"An indicator reflecting the different levels or intensity of snoring."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RECENT SNORING VARIANCE EXPLAINED BY PGS (FIG. 6C)&quot;">
      <data key="d0">"VARIANCE"</data>
      <data key="d1">"The predictive power of the PGS for recent snoring was assessed, contributing to understanding genetic influence on this trait.")("entity"</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;LEAD SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Key single nucleotide polymorphisms identified as significant contributors to snoring traits."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;GENETIC CORRELATION WITH SNORING&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Sleep apnoea showed a high genetic correlation (rG = 0.78) with snoring, indicating shared genetic factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP HERITABILITY FOR SLEEP APNOEA&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"The SNP heritability for sleep apnoea was positively correlated with BMI's heritability (rG = 0.683), reflecting obesity as a risk factor.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 9}]</data>
    </node>
    <node id="&quot;GENETIC CORRELATION WITH SLEEP APNOEA&quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"While alcohol consumption was not significantly genetically correlated with snoring, it might have had an indirect effect on sleep apnoea through shared risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADJUSTED GWAS&quot;">
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d1">"The genetic correlation between the adjusted genome-wide association study (GWAS) and snoring shows high consistency.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;NOCTURNAL HYPOXIA&quot;">
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d1">"Genetic correlation between nocturnal hypoxia measures such as minimum SpO2 and average SpO2 shows small increases in relation with snoring after adjusting for BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 33}]</data>
    </node>
    <node id="&quot;HEART ATTACK&quot;">
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d1">"GWAS results suggest a possible bidirectional causal relationship between BMI and heart attack; BMI causes an increase in the risk of heart attack, which could be linked to snoring through sleep disruption or other factors.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;VDBP SINGLE NUCLEOTIDE POLYMORPHISMS (SNPS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs are genetic variations in VDBP that may influence vitamin D metabolism."&lt;SEP&gt;"SNPs were analyzed for their distribution among mothers and neonates."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MOTHERS AND NEONATES&quot;">
      <data key="d0">"MOTHER AND NEONATE"</data>
      <data key="d1">"Demographic, dietary and biochemical data from mothers and neonates are presented in Table 1."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Maternal VDBP polymorphisms were considered for different genotypes (Table 2)."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MOTHERS AND NEONATES DYADS&quot;">
      <data key="d0">"MOTHER AND NEONATE DYAD"</data>
      <data key="d1">"The study involves comparing mothers and their respective neonates to analyze the relationship between maternal genotypes and neonatal outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;UVB RADIATION EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to UVB radiation affects vitamin D synthesis in skin, which is influenced by VDBP polymorphisms."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;WEEKS OF GESTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Gestation length can impact vitamin D status due to differences in maternal metabolism and sunlight exposure."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT (CM)&quot;">
      <data key="d0">"PHYSICAL MEASUREMENT"</data>
      <data key="d1">"Height is a physical characteristic that might influence vitamin D synthesis or requirement."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI PRE-PREGNANCY (KG/M2)&quot;">
      <data key="d0">"BODY MASS INDEX BEFORE PREGNANCY"</data>
      <data key="d1">"Pre-pregnancy BMI affects metabolic health and may influence vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI TERMINAL (KG/M2)&quot;">
      <data key="d0">"BODY MASS INDEX AFTER PREGNANCY"</data>
      <data key="d1">"Post-pregnancy BMI reflects changes in metabolism that could impact vitamin D levels."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL 25(OH)D CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT CONCENTRATION"</data>
      <data key="d1">"Levels of maternal serum 25-hydroxyvitamin D reflect her vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL 25(OH)D CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT CONCENTRATION"</data>
      <data key="d1">"Levels of neonatal serum 25-hydroxyvitamin D indicate their vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VDBP GENOTYPES (CC FOR RS2298850 AND CC FOR RS4588)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific maternal VDBP genotypes may correlate with higher maternal vitamin D levels during delivery, as compared to others."&lt;SEP&gt;"Specific maternal VDBP genotypes showed an association with higher vitamin D levels during delivery, based on p-values."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL 25(OH)D CUT-OFFS AT BIRTH (≥50 NMOL/L VS. ≤50 NMOL/L AND ≥25 VS. ≤25 NMOL/L)&quot;">
      <data key="d0">"THRESHOLDS FOR VITAMIN D STATUS"</data>
      <data key="d1">"Cut-off points of neonatal vitamin D concentrations define different states of vitamin D equilibrium."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS AT BIRTH (CUT-OFFS AT BIRTH ≤25 VS. ≥25 NMOL/L, ≤50 VS. ≥50 NMOL/L AND ≥75 NMOL/L VS. ≤75 NMOL/L)&quot;">
      <data key="d0">"THRESHOLDS FOR VITAMIN D STATUS"</data>
      <data key="d1">"Different maternal vitamin D statuses were compared with VDBP genotypes using various cut-off points."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL 25(OH)D CONCENTRATIONS, WITH RESPECT TO MATERNAL VDBP GENOTYPE DISTRIBUTION&quot;">
      <data key="d0">"ASSOCIATION BETWEEN GENOTYPE AND OUTCOME"</data>
      <data key="d1">"The neonatal vitamin D status varied based on the genetic makeup of their mother's VDBP polymorphisms, using cut-offs of 25 and 50 nmol/L."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Maternal vitamin D concentrations were analyzed in relation to her genotypes for VDBP polymorphisms.")&lt;SEP&gt;"The vitamin D status of mothers was analyzed in relation to their VDBP polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOTHERS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Maternal vitamin D concentrations were analyzed in relation to her genotypes for VDBP polymorphisms.")&lt;SEP&gt;"The vitamin D status of mothers was analyzed in relation to their VDBP polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D STATUS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The health and developmental outcomes of neonates were compared with their mothers' VDBP genotypes, looking at cut-offs of 25 and 50 nmol/L for vitamin D.")&lt;SEP&gt;"Vitamin D status of neonates was also assessed with respect to their VDBP polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATES&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The health and developmental outcomes of neonates were compared with their mothers' VDBP genotypes, looking at cut-offs of 25 and 50 nmol/L for vitamin D.")&lt;SEP&gt;"Vitamin D status of neonates was also assessed with respect to their VDBP polymorphisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE PERCENTAGE DISTRIBUTIONS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Percentage distribution of genotypes based on VDBP polymorphisms for mothers and neonates are presented (Table 2).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CUT-OFFS AT BIRTH (≥50 NMOL/L VS. ≤50 NMOL/L AND ≥25 VS. ≤25 NMOL/L)&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Vitamin D cut-offs at birth were compared with maternal VDBP polymorphisms (Table 7).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGHER VITAMIN D CONCENTRATIONS DURING DELIVERY&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Mothers with specific VDBP genotypes tended to have higher vitamin D concentrations at birth compared to other genotypes (p = 0.05 and p = 0.04 respectively, as seen in Table 8).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VDBP POLYMORPHISMS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Neonatal vitamin D status was not significantly different based on maternal VDBP genotypes with cut-offs of 25 and 50 nmol/L at birth (Table 9 and Table 10).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS DURING DELIVERY&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Certain maternal VDBP genotypes were associated with higher vitamin D levels when the mother delivered (Table 8).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION BETWEEN GENOTYPE AND OUTCOME&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Neonatal vitamin D statuses were compared with different maternal VDBP genotypes based on birth cut-offs for vitamin D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D CUT-OFFS AT BIRTH (25 VS. 50 NMOL/L)&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Neonatal vitamin D statuses were compared with different maternal VDBP genotypes based on birth cut-offs for vitamin D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D CONCENTRATIONS DURING DELIVERY&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Specific maternal VDBP genotypes tended to have higher vitamin D levels at the time of delivery compared to other genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FREE TESTOSTERONE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Free testosterone is a form of circulating androgen hormone that may influence metabolism and reproductive function. Higher levels were observed among women with PCOS."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;BIOACTIVE TESTOSTERONE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Bioactive testosterone, an active form of the androgenic hormone, showed significant differences between women with PCOS and controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;HOMA-IR (HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The homeostatic model assessment of insulin resistance (HOMA-IR) was found significantly elevated among women with PCOS, an indicator of insulin resistance."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;SHBG (SEX HORMONE BINDING GLOBULIN)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Lower levels of SHBG, a protein that binds to androgen hormones, were observed in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TSH (THYROID STIMULATING HORMONE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Though within normal range, TSH was higher among women with PCOS compared to control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGFA SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Vascular Endothelial Growth Factor A (VEGFA) Single Nucleotide Polymorphisms were analyzed in relation to the presence of PCOS."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS3025020 (-583T&gt;C)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The VEGFA SNP rs3025020 showed a higher frequency of the C allele among women with PCOS, potentially affecting expression levels."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS2010963 (-634C&gt;G)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Another VEGFA SNP, rs2010963, had differential genotype distribution between cases and controls, indicating possible influence on protein function."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;ANTI-INFLAMMATORY IL-10&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There was no correlation between either VEGFA SNP (rs3025020 or rs2010963) and the levels of anti-inflammatory cytokine IL-10 among PCOS women."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;PRO-INFLAMMATORY TNFΑ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Correlation analysis did not reveal any correlation between either VEGFA SNP (rs3025020 or rs2010963) and pro-inflammatory cytokine TNFα among PCOS women."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;ERYTHROCYTE SEDIMENTATION RATE (ESR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In the model including rs2010963, there was a negative association between the presence of the minor allele (C) and ESR."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;HOMA-IR&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Elevated HOMA-IR was seen in women with PCOS, reflecting insulin resistance.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;SHBG&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Lower levels of SHBG were noted among women with PCOS compared to controls.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 45}]</data>
    </node>
    <node id="&quot;ESR&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Among the model including rs2010963, women with the minor allele (C) showed lower erythrocyte sedimentation rate (ESR).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY 1&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"No significant difference found on self-report measures among genotype groups."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;RESPONSE BIAS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A main effect of Condition on response bias was observed; participants showed reduced bias towards frequently rewarded stimuli under stress conditions."&lt;SEP&gt;"A significant main effect of Condition for response bias due to reduced response bias toward the more frequently rewarded stimulus in the stress condition."&lt;SEP&gt;"Study 1 found a main effect of Genotype on response bias during different blocks."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;BLOCK&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Blocks influenced participants' response bias and behavior according to reinforcement contingencies in Study 1."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;STUDY 2&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genotype groups did not differ significantly on any demographic or self-report variables, but shock intensity was lower for val carriers compared to iso homozygotes."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;STAI SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A significant main effect of Condition and Time was observed for STAI scores, indicating heightened stress perception during the stress condition."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;STUDY 1/">
      <data key="d0">DISEASE"</data>
      <data key="d1">"No significant difference found on self-report measures among genotype groups."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;GENOTYPE/">
      <data key="d0">"SNP"/"ASSOCIATION"</data>
      <data key="d1">"The CT60A/G variant was linked with lower CTLA4 mRNA levels in individuals, indicating a role in genetic risk for autoimmune disorders."&lt;SEP&gt;"Val allele carriers showed higher response bias compared to iso homozygotes in Study 1."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;CONDITION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Stress manipulation was successful; participants reported elevated anxiety and negative affect, and had more non-specific SC responses in the stress relative to no-stress condition."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;GENOTYPE × CONDITION INTERACTION&quot;">
      <data key="d0">"INTERACTION"</data>
      <data key="d1">"The val allele explained unique variance in stress-induced response bias reductions, suggesting genetic predisposition influences adaptation to stress."&lt;SEP&gt;"This effect was qualified by a Genotype × Condition interaction, indicating that val carriers had significantly lower response bias in the stress condition compared to iso homozygotes."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;STRESS CONDITION&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Val carriers exhibited lower response bias specifically under the stress condition compared to no-stress conditions; this was not statistically significant for iso homozygotes."&lt;SEP&gt;"Val carriers tended to have lower response bias in the stress relative to no-stress condition; the correlation between stress and no-stress response bias was not significant in either group."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;DISCRIMINABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Elevated discriminability emerged due to elevated discriminability in Blocks 3 and 2 relative to Block 1, both p &lt; .02."&lt;SEP&gt;"Enhanced discriminability in Blocks 3 and 2 relative to Block 1 indicated improved sensitivity to stimuli differences during stressed states."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;BLOCK 1, BLOCK 2, AND BLOCK 3&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differences in discriminability occurred between Blocks 1, 2, and 3; Blocks 2 and 3 had elevated discriminability compared to Block 1."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;BLOCK DISCRIMINABILITY&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Differences in discriminability were evident between Conditions 3 and 2, both of which showed elevated values compared to Condition 1.")&lt;SEP&gt;"Enhanced performance was noted in Conditions/Blocks with elevated discriminability compared to the baseline condition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION 3 AND CONDITION 2&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Differences in discriminability were evident between Conditions 3 and 2, both of which showed elevated values compared to Condition 1.")&lt;SEP&gt;"Enhanced performance was noted in Conditions/Blocks with elevated discriminability compared to the baseline condition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COHORT COMPARISON&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers tended to have lower response bias in the stress condition compared to no-stress conditions; this difference was not statistically significant for iso homozygotes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS CONDITION AND NO-STRESS CONDITION&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers tended to have lower response bias in the stress condition compared to no-stress conditions; this difference was not statistically significant for iso homozygotes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BLOCK SEQUENCE EFFECTS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"There were differences between Blocks 1, 2, and 3 in terms of discriminability; Block 2 and Block 3 showed improved performance compared to Block 1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION 1, CONDITION 2 AND CONDITION 3&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"There were differences between Blocks 1, 2, and 3 in terms of discriminability; Block 2 and Block 3 showed improved performance compared to Block 1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION 1&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"For discriminability, a main effect of Block emerged due to elevated discriminability in Blocks 3 and 2 relative to Block 1, both p &lt; .02.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRHR1 SNPS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"These SNPs were recently associated with stress-induced reward learning deficits, which influenced the findings on response bias.")&lt;SEP&gt;"Three CRHR1 SNPs were associated with stress-induced reward learning deficits, which were taken into account as part of the control analyses.")&lt;SEP&gt;"Three CRHR1 SNPs were associated with stress-induced reward learning deficits; these were considered as covariates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"These SNPs were recently associated with stress-induced reward learning deficits, which influenced the findings on response bias.")&lt;SEP&gt;"Three CRHR1 SNPs were associated with stress-induced reward learning deficits, which were taken into account as part of the control analyses.")&lt;SEP&gt;"Three CRHR1 SNPs were associated with stress-induced reward learning deficits; these were considered as covariates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO-STRESS CONDITION&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers had a distinct pattern of response bias reduction in the stress condition relative to no-stress conditions; this relationship held even after accounting for various factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")&lt;SEP&gt;"Val carriers tended to have lower response bias in the stress condition compared to no-stress conditions; this difference was not statistically significant for iso homozygotes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ELEVATED DISCRIMINABILITY&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"An elevated discriminability emerged specifically in Conditions 3 and 2; performance was better than in Condition 1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BLOCK 2 AND BLOCK 3&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Improved performance was noted specifically in Conditions/Blocks where discriminability was elevated.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISCRIMINABILITY, SHOCK INTENSITY, SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Unique variance in response bias reductions was determined after accounting for discriminability, shock intensity, and skin conductance responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESPONSE BIAS REDUCTIONS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Unique variance in response bias reductions was determined after accounting for discriminability, shock intensity, and skin conductance responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION 1, CONDITION 2, AND CONDITION 3&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Performance varied between Conditions/Blocks due to differences in discriminability; Blocks showed enhanced performance compared to the first block.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISCRIMINABILITY AND SHOCK INTENSITY, SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Unique variance was explained by response bias reductions even after factoring in the effects of discriminability and skin conductance responses along with shock intensity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION 3, CONDITION 2, AND CONDITION 1&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"The sequence of conditions influenced performance outcomes; improvements were noted specifically in Conditions/Blocks where performance was enhanced due to increased discriminability.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEQUENCE OF CONDITIONS EFFECTS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"The sequence of conditions influenced performance outcomes; improvements were noted specifically in Conditions/Blocks where performance was enhanced due to increased discriminability.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE-SPECIFIC RESPONSE BIAS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers showed a reduced response bias in the stress condition relative to no-stress conditions; this was observed even after considering various factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPROVED PERFORMANCE&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Enhanced performance was noted specifically in Conditions/Blocks where the discriminability metric was elevated; these blocks showed better performance compared to baseline conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COHORT COMPARISON OF RESPONSE BIAS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers had reduced response bias specifically in the stress condition when compared to no-stress conditions; this relationship held after factoring in discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRHR1 SNPS AND STRESSED CONDITION RESPONSE BIAS REDUCTIONS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"After considering the association of specific CRHR1 SNPs with stress-induced changes, unique variance was identified in response bias reductions during stressed conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UNIQUE VARIANCE IN STRESS-INDUCED CHANGES&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"After considering the association of specific CRHR1 SNPs with stress-induced changes, unique variance was identified in response bias reductions during stressed conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS CONDITION COMPARISON BETWEEN GROUPS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers showed reduced response bias specifically in the stress condition compared to no-stress conditions; this relationship was observed even after considering factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs for both groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VAL AND ISO HETEROZYGOTES RESPONSE BIAS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers showed reduced response bias specifically in the stress condition compared to no-stress conditions; this relationship was observed even after considering factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs for both groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION 3 AND CONDITION 2 EFFECTS COMPARISON&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Within Conditions/Blocks where performance was enhanced due to elevated discriminability, improvements were observed; these conditions showed superior performance compared to baseline states after adjusting for various factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERFORMANCE ENHANCEMENT IN ELEVATED DISCRIMINABILITY CONDITIONS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Within Conditions/Blocks where performance was enhanced due to elevated discriminability, improvements were observed; these conditions showed superior performance compared to baseline states after adjusting for various factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE-SPECIFIC RESPONSE BIAS REDUCTIONS DURING STRESSED CONDITIONS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers exhibited reduced response bias specifically in the stress condition relative to no-stress conditions, a relationship that was maintained after adjusting for factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS CONDITION AND NO-STRESS CONDITION COMPARISON&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers exhibited reduced response bias specifically in the stress condition relative to no-stress conditions, a relationship that was maintained after adjusting for factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERFORMANCE ENHANCEMENT IN SPECIFIC BLOCKS/DAYS/">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Elevated performance within Conditions/Blocks that featured elevated discriminability indicated enhanced outcomes; these instances showed superior performance compared to baseline states, adjusting for various factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE-SPECIFIC RESPONSE BIAS REDUCTIONS DURING STRESSED CONDITIONS AND CRHR1 SNPS ASSOCIATION&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Val carriers' reduced response bias specifically in the stress condition relative to no-stress conditions, which maintained after adjusting for factors like discriminability, shock intensity, skin conductance responses, was further informed by considering specific CRHR1 SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERFORMANCE ENHANCEMENT IN SPECIFIC BLOCKS/CONDITIONS AND DISCRIMINABILITY ASSOCIATION&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Elevated performance within Conditions/Blocks that featured elevated discriminability indicated enhanced outcomes; these instances showed superior performance compared to baseline states, adjusted for various factors including CRHR1 SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Age at first tooth is a physiological process that can be influenced by genetic factors.")&lt;SEP&gt;"Moderate evidence of association with height, driven largely by variants in HMGA2 and BMP4."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;NUMBER OF TEETH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Moderate evidence of association with height, driven largely by variants in HMGA2 and BMP4."&lt;SEP&gt;"Number of teeth is a physiological process that can be influenced by genetic factors.")</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;LOCI&quot;">
      <data key="d0">"GENE/</data>
      <data key="d1">Genomic Variant"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;NOVEL ASSOCIATIONS&quot;">
      <data key="d0">"GENE/</data>
      <data key="d1">Genomic Variant"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;PREVIOUSLY REPORTED GENES/REGIONS&quot;">
      <data key="d0">"GENE/</data>
      <data key="d1">Genomic Variant"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANCE&quot;">
      <data key="d0">"DISEASE/</data>
      <data key="d1">Phenotype"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;ALLELIC SCORE&quot;">
      <data key="d0">"MOLECULAR INTERACTION/</data>
      <data key="d1">"An allelic score constructed from genome-wide significant SNPs for 'Age at first tooth' and 'Number of teeth'."&lt;SEP&gt;Genomic Variant"&lt;SEP&gt;Therapy"</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;SUGGESTIVE LEVELS OF ASSOCIATION&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">Phenotype"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;FAMILY-WISE ERROR RATE&quot;">
      <data key="d0">"STATISTICAL PROCESS/</data>
      <data key="d1">Analysis"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;SECONDARY SIGNALS&quot;">
      <data key="d0">"GENE/</data>
      <data key="d1">Genomic Variant"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;SECONDARY ANALYSIS/">
      <data key="d0">SNP"</data>
      <data key="d1">"Locus/</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;BIOLOGICAL PATHWAYS&quot;">
      <data key="d0">"MOLECULAR MECHANISM/</data>
      <data key="d1">Phenotype"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;PHENOTYPIC PLASTICITY&quot;">
      <data key="d0">"DEVELOPMENT/</data>
      <data key="d1">Genomic Variant"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;HERITABILITY ESTIMATION&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Trait"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;ENVIRONMENTAL INFLUENCE&quot;">
      <data key="d0">"DEVELOPMENT/</data>
      <data key="d1">Phenotype"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CLINICAL RELEVANCE&quot;">
      <data key="d0">"DENTAL HEALTH/</data>
      <data key="d1">Trait"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;GENETIC ARCHITECTURE&quot;">
      <data key="d0">"COMPLEX TRAIT/</data>
      <data key="d1">Phenotype"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;POPULATION STRATIFICATION&quot;">
      <data key="d0">"STATISTICAL ANALYSIS METHOD"</data>
      <data key="d1">"Used PCA (Principal Component Analysis) and STRUCTURE method for identifying population substructure before association tests."&lt;SEP&gt;Study Design"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;META-ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD/</data>
      <data key="d1">Multiple Studies"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;LONGITUDINAL DYNAMICS&quot;">
      <data key="d0">"DEVELOPMENT/</data>
      <data key="d1">Time-Series Data"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;PUBLIC HEALTH IMPLICATIONS&quot;">
      <data key="d0">"POLICY/</data>
      <data key="d1">Dental Health"</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;HEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process moderated by 'Age at first tooth' and 'Number of teeth' allelic scores."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;HMGA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGA2 is associated with the moderate evidence of association between 'Age at first tooth' and height."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;BMP4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BMP4 is associated with the moderate evidence of association between 'Number of teeth' and height."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;PATHWAY ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis using the ALLIGATOR software to determine over-representation of genes in pathways."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;EFFECTIVE NUMBER OF STATISTICAL TESTS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOCUS/">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SECONDARY ANALYSIS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs underwent additional analyses to discern underlying genetic influences beyond the primary associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHWAY&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"SNP association P-value threshold of 0.005 gave significant over-representation of genes in pathways for 'Age at first tooth' GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10RΑTDEL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-10RαTdel mice are generated with a selective deletion of the specific IL-10 receptor in T cells."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;IL-10RΑDCDEL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-10RαDCdel mice have a selective deletion of the IL-10 receptor restricted to dendritic cells."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDEL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-10RαMdel mice lack IL-10 receptor specifically in macrophages."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;WT&quot;">
      <data key="d0">"GENOMIC VARIANT"/"DISEASE"/"NUTRIENT"/"PROTEIN"/"TRANSCRIPT"/"DIETARY PATTERN"/"PHYSIOLOGICAL PROCESS"/"METABOLIC PATHWAY"/"MOLECULAR INTERACTION"/"ENVIRONMENTAL FACTOR"/"DISEASE"</data>
      <data key="d1">Undefined information provided in the text, no direct relation identified.</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;RAG1−/−&quot;">
      <data key="d0">"GENOMIC VARIANT"/"DISEASE"/"NUTRIENT"/"PROTEIN"/"TRANSCRIPT"/"DIETARY PATTERN"/"PHYSIOLOGICAL PROCESS"/"METABOLIC PATHWAY"/"MOLECULAR INTERACTION"/"ENVIRONMENTAL FACTOR"/"DISEASE"</data>
      <data key="d1">"No significant change in disease severity was apparent with neutrophil depletion in IL-10RαMdelRag1−/− mice."&lt;SEP&gt;"Rag1−/− mice are the recipients used in this experiment for inducing and monitoring T cell transfer-mediated colitis."&lt;SEP&gt;Undefined information provided in the text, no direct relation identified.</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RΑDCDELRAG1−/−&quot;">
      <data key="d0">"DIETARY PATTERN"/"PHYSIOLOGICAL PROCESS"/"METABOLIC PATHWAY"/"MOLECULAR INTERACTION/</data>
      <data key="d1">No clear relationship among entities identified in this context.</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/−&quot;">
      <data key="d0">"PROTEIN"/"TRANSCRIPT"/"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Increased numbers and activation of IL-10RαMdelRag1-/- LPMφs."&lt;SEP&gt;"Macrophage-specific deletion of IL-10 receptor leads to intensified colitis."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RΑFL/FLRAG1−/−&quot;">
      <data key="d0">"GENE"/"PROTEIN"/"TRANSCRIPT"</data>
      <data key="d1">"Germline deletion of IL-10Rα does not affect disease outcomes in Rag1−/− mice, suggesting that Mϕ-specific effects are crucial for IL-10’s protective role."</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1+/+&quot;">
      <data key="d0">"DISEASE"/"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">No direct relationship identified among entities mentioned.</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NEUTROPHIL DEPLETION ABSOLUTY AB TREATMENT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"PHYSIOLOGICAL PROCESS"/"METABOLIC PATHWAY"/"MOLECULAR INTERACTION/</data>
      <data key="d1">Depleting neutrophils does not significantly affect histopathology in Rag1−/− recipients, indicating they have a minor protective role.</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MΦ&quot;">
      <data key="d0">"MACROPHAGE"</data>
      <data key="d1">"To isolate the Mφ-specific effect, we depleted neutrophils with specific Ab beginning prior to T cell transfer."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;NEUTROPHIL&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Undetectable in the peripheral blood from αLy6G Ab but not control Ab treated animals throughout the experimental interval."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;ΑLY6G AB&quot;">
      <data key="d0">"ANTIBODY"</data>
      <data key="d1">"To identify causes of the enhanced IL-10RαMdelRag1-/- disease, we first analyzed lamina propria macrophages (LPMφs)."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;LAMINA PROPRIA MACROPHAGE (LPMΦ)&quot;">
      <data key="d0">"MACROPHAGE"</data>
      <data key="d1">"Significantly increased in IL-10RαMdelRag1-/- mice with colitis compared with Rag1-/- controls."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− LPMΦS&quot;">
      <data key="d0">"MACROPHAGE"</data>
      <data key="d1">"These cells showed a uniformly elevated surface expression of activation markers like CD40, CD80 and CD86."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;BRDU INCORPORATION&quot;">
      <data key="d0">"CELL PROCESS"</data>
      <data key="d1">"Unlike for LPMφs, no differences in BrdU incorporation were evident in colonic CD4 T cells, DCs, and neutrophils, or in Mφs from other locations."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;T REGULATORY CELLS (TREG)&quot;">
      <data key="d0">"REGULATORY CELL"</data>
      <data key="d1">"Treg co-transferred with naïve T cells even at a 1:1 ratio were incapable of preventing disease."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MICE AND CONTROL RAG1−/− COLITIC MICE&quot;">
      <data key="d0">"DISEASE STATE COMPARISON"</data>
      <data key="d1">"No differences were observed in Foxp3+ iTreg forming."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;TREG TRANSFERS&quot;">
      <data key="d0">"REGULATORY CELL TRANSFER"</data>
      <data key="d1">"The transferred cells were able to fully suppress disease development in both IL-10RαMdelRag1−/− and Rag1−/− recipients."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;SPLEEN&quot;">
      <data key="d0">"ORGAN"</data>
      <data key="d1">"A &gt;2-fold increase in Treg in the spleens of recipient mice was seen."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD40&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This population showed a uniformly elevated surface expression of CD40, which is an activation marker."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;CD80&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The cells also exhibited enhanced levels of CD80 and CD86 on their surface."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10RΒ−/−RAG2−/− MICE&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"Recent findings have identified defective iTreg formation and Treg function using this model."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;T REGULATORY CELLS (TREGS)&quot;">
      <data key="d0">"REGULATORY CELL"</data>
      <data key="d1">"These cells play a role in the control of immune responses, which was assessed through their ability to prevent disease."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;NAÏVE T CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Transferred naive T cells were used for inducing colitis and assessing Treg function."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10-GFP KNOCK-IN REPORTER MICE&quot;">
      <data key="d0">"GENETIC MODEL"</data>
      <data key="d1">"This mouse line allowed us to analyze IL-10 production during disease development."</data>
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
    </node>
    <node id="&quot;IL-10&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Pre-treatment with IL-10 abrogates induction of activated caspase-1 by LPS and ATP in Rag1−/− Mφs."&lt;SEP&gt;"The IL-10 protein plays a critical role in suppressing pro-inflammatory cytokine production by macrophages and is involved in modulating the Th17 response."&lt;SEP&gt;"Treatment with IL-10 diminished pro-IL-β, undetectable mature IL-1β in Rag1−/− cultures."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;MACROPHAGE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Macrophages produce IL-1β, IL-6, TNF-α, MCP-1, and other cytokines that are increased during colitis. This heightened production is specific to M1-like macrophages in IL-10RαMdelRag1−/− mice."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;TH17 CELL&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Formation of some Th17 cells with Rag1−/− LPMφs, but markedly elevated in IL-10RαMdelRag1−/− Mφs."&lt;SEP&gt;"Th17 cells are critical for the development of colitis, as they increase during disease progression and their absence prevents or attenuates disease severity."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-1Β&quot;">
      <data key="d0">"PROINFLAMMATORY CYTOKINES"/"MOLECULAR INTERACTION"/"CELLULAR PROCESS"/"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">"A pro-inflammatory cytokine whose production is modulated by IL-10."&lt;SEP&gt;"IL-1β is a pro-inflammatory cytokine that is upregulated in colonic inflammation. It plays an essential role in the induction of Th17 cells."&lt;SEP&gt;"Increased IL-1β levels are associated with inflammation and disease in the context of LPMφs' role."&lt;SEP&gt;|&gt;Disease"/"Inflammation"</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;TNF-Α&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">""&lt;SEP&gt;"TNF-α is involved in inflammation and may be produced by Mϕs during disease, contributing to colonic pathology."&lt;SEP&gt;|&gt;Disease"/"Inflammation"&lt;SEP&gt;"Tumor Necrosis Factor-alpha (TNF-α) is a pro-inflammatory cytokine that participates in various inflammatory processes."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;IL-10RΑ&quot;">
      <data key="d0">"RECEPTOR"</data>
      <data key="d1">"The IL-10 receptor (IL-10Rα) on macrophages is critical for the ability of IL-10 to suppress inflammatory responses and modulate immune cell function, especially during colitis."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;IL-17&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-17, along with IL-22, helps regulate inflammation during the recovery from colitis."&lt;SEP&gt;"Increased IL-17 production by T cells has been linked with Th17-mediated inflammation, including in inflamed colons."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;IFN-Γ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IFN-γ is typically associated with the TH1 (helper T) response and can contribute to inflammation but does not seem as significantly involved as IL-17 during colitis."&lt;SEP&gt;"Interferon gamma (IFN-γ) plays a role in Th1 dominant insulitis and leukocyte infiltrations in pancreatic islets of NOD mice."&lt;SEP&gt;"The gene expression of IFN-γ was not affected."&lt;SEP&gt;"Interferon-gamma is a cytokine primarily produced by T helper (Th)1 cells, essential for immune response against pathogens."&lt;SEP&gt;"The expression levels of IFN-γ increased when examining the combined effects of MAPbacteremia presence and specific SNPs on PTPN2/PTPN22 expression in CD subjects compared to non-infected subjects without these SNPs."&lt;SEP&gt;"The expression of IFN-γ was higher in CD subjects with certain genetic variants compared to those without."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;DELRAG1−/− MICE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The delRag1 gene was involved in the colitis response, but alternative pathologic pathways may have also been involved."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TH17 RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Th17 response is fundamental to T cell transfer colitis and involves colonic inflammation."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;RORΓT−/− T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"RORγT, essential for the development of Th17 cells, was proven important in both Rag1−/− and IL-10RαMdelRag1−/− recipients."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6 INDEPENDENT COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IL-6-independent colitis is found in IL-10RαMdelRag1−/− mice, which indicates a different pathogenic mechanism."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6RΑ−/− T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The lack of IL-6 receptor alpha (IL-6Rα) on T cells proved effective in inducing disease pathogenesis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TH17 CELL PERCENTAGES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Th17 cell percentages among CD4+TCR+ T cells were reduced when IL-6Rα−/− T cells are transferred into recipients."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TH17 CELLS IN THE COLON&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The representation of Th17 cells was significantly decreased specifically in IL-10RαMdelRag1−/− mice's colon."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;MLN (MESENTERIC LYMPH NODE)&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"Analysis of T cell responses leading to colonic injury was carried out at the MLNs of recipient mice."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TH17 CELLS IN SPLEENS, MLNS, AND COLONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Differences were identified in absolute numbers of Th17 cells across different organs including spleens, MLNs, and colons."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TOTAL T CELL NUMBER&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"The total T cell number was affected by the transfer combination IL-6Rα−/−→Rag1−/−, leading to decreased numbers in certain organs."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6 RESPONSE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"IL-6 is essential for T cell expansion and colitis development specifically in Rag1−/− mice."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-10 ACTIONS ON MΦS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"IL-10's actions on macrophages (Mφ) generate an IL-6 requirement for autoinflammatory disease and robust T cell expansion."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TH17 DEVELOPMENT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"No differences were identified in the proportions of Th1 cells or Foxp3+CD4+ cells during comparison."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6Β RECEPTOR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL-6β receptor played an essential role in mediating disease pathogenesis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;INTERLEUKIN (IL)-10RΑMDELRAG1 MICE&quot;">
      <data key="d0">"DISEASE VARIANT"</data>
      <data key="d1">"This specific disease variant of mice exhibited a dramatic elevation in IL-1β expression, suggesting it contributes to the disease."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;MACROPHAGES (MΦ)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"The actions on macrophages generated an IL-6 requirement for autoinflammatory disease and robust T cell expansion."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;TRANSFERRED NAIVE T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Naive T cells were transferred into Rag1−/− mice to induce colitis, highlighting their role in the disease process."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6 RECEPTOR Α (IL-6RΑ)&quot;">
      <data key="d0">"CELL SURFACE RECEPTOR"</data>
      <data key="d1">"The absence of IL-6Rα on T cells was found effective in inducing less severe clinical and histologic measures of colitis."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;INTERLEUKIN (IL)-1 RECEPTOR&quot;">
      <data key="d0">"CELL SURFACE RECEPTOR"</data>
      <data key="d1">"The role of this receptor in the impact of IL-1β during induction of colitis was tested and proven essential."</data>
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
    </node>
    <node id="&quot;IL-6RΑ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-6Rα plays a role in disease protection when transferred into recipients."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A Transcript of a gene, which plays a role in protein synthesis and can be influenced by environmental factors."&lt;SEP&gt;"The text doesn't specify any transcripts related to this context."&lt;SEP&gt;"The expression of this transcript in maternal tissues could be involved in the regulation or response to B12 or folate."&lt;SEP&gt;"The protein-coding sequence of a gene that is expressed during development and in normal cellular functions."&lt;SEP&gt;"No transcript information provided for this context."&lt;SEP&gt;"NFATC1 is a transcript that can be affected by genomic variants mapping to its region, impacting gene regulation and disease."&lt;SEP&gt;"The transcript is influenced by dietary patterns and folate intake."&lt;SEP&gt;"The transcript of these MS risk genes play a role in the EBV latency III program."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NUTRIENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A Nutrient that is essential for health and can be part of a Dietary Pattern influencing physiological processes."&lt;SEP&gt;"The text doesn't mention any nutrients related to this context."&lt;SEP&gt;"A key nutrient found in leafy greens, playing a role in nitric oxide production and cardiovascular health."&lt;SEP&gt;"An essential substance required for maintaining proper physiological function in organisms, including vitamins and minerals."&lt;SEP&gt;"The nutrient vitamin D is metabolized by these enzymes to maintain calcium and phosphate levels in blood."&lt;SEP&gt;"The text does not provide information on any specific nutrient that interacts with a gene."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens, which plays a role in cardiovascular health and nitric oxide production."&lt;SEP&gt;"Folate metabolism is influenced by genetic variants in genes like NOS1, which plays a critical role in cardiovascular health."&lt;SEP&gt;"Certain nutrients may influence the expression of these MS risk genes through dietary patterns or other means."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-3cf4e094a5312845a1cc4da4304d4bdf&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323&lt;SEP&gt;chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An internal process occurring in the body that maintains homeostasis and supports life functions."&lt;SEP&gt;"There's no clear reference to a specific physiological process mentioned in the text for this context."&lt;SEP&gt;"The process of B12 absorption and metabolism might have been considered here."&lt;SEP&gt;"The body's functions related to maintaining homeostasis and supporting life activities."&lt;SEP&gt;"The process of converting vitamin D into its active form (1,25(OH)2D) involves CYP27B1 and CYP24A1 proteins."&lt;SEP&gt;"The text mentions that folate metabolism interacts with the NOS1 protein to maintain vascular function; however, this interaction is not fully detailed in the provided information."&lt;SEP&gt;"The interaction between folate metabolism and NOS1 gene is a key physiological process that modulates cardiovascular health."&lt;SEP&gt;"These MS risk genes are involved in various physiological processes relevant to immune response and disease."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-3cf4e094a5312845a1cc4da4304d4bdf&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A sequence of chemical reactions within a cell where molecules are transformed into other molecules."&lt;SEP&gt;"The metabolic pathways aren't explicitly stated here, but IL-1β production could be part of an inflammatory response pathway."&lt;SEP&gt;"A series of biochemical reactions that occur within cells and are responsible for energy production, synthesis of molecules, and degradation of substances."&lt;SEP&gt;"This pathway includes the steps from 25(OH)D to 1,25(OH)2D synthesis using enzymes CYP27B1 and CYP24A1."&lt;SEP&gt;"Disruptions in the nitric oxide synthesis metabolic pathway are associated with an increased risk of developing cardiovascular disease."&lt;SEP&gt;"The metabolic pathways involving these proteins or metabolites may affect the activity of MS risk genes or EBNA2 interaction."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b803830d07bff8ae14550f6458048707&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;TH17 CELLS&quot;">
      <data key="d0">"LYMPHOCYTE SUBSET"</data>
      <data key="d1">"Th17 cells are key in orchestrating the immune response to inflammation."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;CD11B&quot;">
      <data key="d0">"CELL SURFACE MARKER"</data>
      <data key="d1">"A marker for monocytes and macrophages, indicative of inflammatory processes."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;LPMΦS (LUNG PROGENITOR MACROPHAGES)&quot;">
      <data key="d0">"MACROPHAGE SUBTYPE"</data>
      <data key="d1">"Lung progenitor macrophages are crucial in the lung's immune response and inflammation management."&lt;SEP&gt;"Specific type of macrophages that contribute to lung inflammation in autoimmune diseases."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;CASPASE-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Caspase-1 is part of the inflammasome, involved in processing pro-inflammatory cytokines."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;INFLAMMASOMES&quot;">
      <data key="d0">"CELLULAR COMPLEX"</data>
      <data key="d1">"Multi-protein complexes that lead to the activation and maturation of cytokines like IL-1β."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;MLNS (MESENTERIC LYMPH NODE)&quot;">
      <data key="d0">"LYMPHOID ORGAN"</data>
      <data key="d1">"Site of T cell priming where antigen processing occurs before entering the bloodstream."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;BONE MARROW&quot;">
      <data key="d0">"BONE STRUCTURE"</data>
      <data key="d1">"Hematopoietic stem cells develop into various immune cells here, including macrophages and T cells."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;PRO-IL-Β&quot;">
      <data key="d0">"TRANSCRIPT"/"PROTEIN"</data>
      <data key="d1">"Decreased expression of pro-IL-β by IL-10 treatment in Rag1−/− cultures."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;MATURE IL-1Β&quot;">
      <data key="d0">"DISEASE"/"PROTEIN"</data>
      <data key="d1">"Undetectable mature IL-1β levels after IL-10 treatment in Rag1−/− Mφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MΦS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"CYTOKINE RECEPTOR"</data>
      <data key="d1">"Mφs lacking IL-10Rα maintain normal levels of pro-IL-β and mature IL-1β, unlike Rag1−/− Mφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ANTI-IL-10R ANTIBODY&quot;">
      <data key="d0">"DRUG"/"NEUTRALIZING ANTIBODY"</data>
      <data key="d1">"Blockade of the IL-10 receptor increases activated caspase-1 (p20) in Rag1−/− Mφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LPS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"/"STIMULATION"</data>
      <data key="d1">"LPS stimulation leads to a modest increase in activated caspase-1 in Rag1−/− Mφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ATP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"/"STIMULATION"</data>
      <data key="d1">"ATP also stimulates the activation of caspase-1 by LPS-stimulated Rag1−/− Mφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;CASPASE-1 CLEAVAGE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"ACTIVATION"</data>
      <data key="d1">"Pre-treatment with anti-IL-10Rα Ab increases activated caspase-1, indicating a normal restrain by IL-10 on caspase-1 activation in Rag1−/− Mφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TH17 CELL MATURATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"CELLULAR PROCESS"</data>
      <data key="d1">"Increased IL-1 and IL-6 from LPMφs can impact Th17 cell maturation in the presence of naïve T cells with added TGFβ."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ΑIL-6RΑ BLOCKING ANTIBODY&quot;">
      <data key="d0">"DRUG"/"ANTIBODY"</data>
      <data key="d1">"Blocking IL-6 receptor partially inhibits Th17 formation from Rag1−/− LPMφs, but less so from IL-10RαMdelRag1−/−-derived LPMφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-1 SIGNALING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"INHIBITION/</data>
      <data key="d1">"Blocking IL-1 signaling leads to more substantial inhibition of Th17 development in IL-10RαMdel Rag1−/−-derived LPMφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-6R−/− T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"CYTOKINE RECEPTOR"</data>
      <data key="d1">"Transfer of IL-6R−/− T cells results in modest effect on Th17 formation with IL-10RαMdelRag1−/−-derived LPMφs."</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;INCREASED NUMBERS AND ACTIVATION&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"These cells showed a uniformly elevated surface expression of activation markers like CD40, CD80 and CD86.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EFFECT ON IL-10RΑMDELRAG1−/− MICE&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Though no significant difference in histopathology was identified (Fig. 1e, f).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUTROPHIL DEPLETION&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Though no significant difference in histopathology was identified (Fig. 1e, f).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE SUPPRESSION&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Treg transfers led to a &gt;2-fold increase in Treg in the spleens of recipient mice and Treg percentages did not differ between IL-10RαMdelRag1−/− and Rag1−/− recipients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Treg transfers led to a &gt;2-fold increase in Treg in the spleens of recipient mice and Treg percentages did not differ between IL-10RαMdelRag1−/− and Rag1−/− recipients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE MAGNITUDE&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"No influence on disease magnitude when T cell IL-10 production was performed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 PRODUCTION BY TRANSFERRED T CELLS&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"No influence on disease magnitude when T cell IL-10 production was performed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED ACTIVATION MARKERS&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"The cells had a heightened expression of CD40, CD80 and CD86 on their surface.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE SEVERITY COMPARISON&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Significant increase in LPMφ numbers was observed in IL-10RαMdelRag1−/− mice compared to Rag1−/− controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MICE VS. RAG1−/− CONTROLS&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Significant increase in LPMφ numbers was observed in IL-10RαMdelRag1−/− mice compared to Rag1−/− controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE SUPPRESSION CAPABILITY&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Transferred Treg were able to fully suppress disease development regardless of whether the transferred T cells produced IL-10 or not.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREGS VS. T CELLS WITH/WITHOUT IL-10 PRODUCTION&quot;">
      <data key="d2">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d1">"Transferred Treg were able to fully suppress disease development regardless of whether the transferred T cells produced IL-10 or not.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17 CELL TRANSFER&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Transferring Th17 cells into Rag1−/− mice results in colitis development. It also implies a crucial role for Th17 cells in disease pathogenesis, as they are necessary and sufficient for disease progression.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;INCREASED DISEASE SEVERITY&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The IL-10RαMdelRag1−/− mice exhibit exacerbated colitis due to an elevated Th17 response and increased levels of pro-inflammatory cytokines, indicating that the loss of IL-10Rα function influences disease severity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMED COLONS&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Increased Th17 cell presence in inflamed colonic tissues correlates with the development and progression of colitis, highlighting their role in inflammatory bowel disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRO-INFLAMMATORY CYTOKINE&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"IL-1β acts as a pro-inflammatory cytokine that is upregulated during colitis, contributing to inflammation by inducing other pro-inflammatory cytokines and cell recruitment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYTOKINE&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Increased levels of IL-23 are identified alongside IL-1β and IL-6, suggesting a significant role in intensifying the Th17 response during colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-23&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Increased levels of IL-23 are identified alongside IL-1β and IL-6, suggesting a significant role in intensifying the Th17 response during colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD4+IL-17A+ T CELLS&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The percent and absolute numbers of CD4+IL-17A+ T cells are significantly increased in IL-10RαMdel Rag1−/− compared to Rag1−/− mice, indicating an enhanced Th17 response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASE&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The percent and absolute numbers of CD4+IL-17A+ T cells are significantly increased in IL-10RαMdel Rag1−/− compared to Rag1−/− mice, indicating an enhanced Th17 response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GFP+ T CELLS&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"After induction of disease with CD4+CD25−CD45RBhi RORγT-GFP reporter T cells, there is an increased identification of GFP+ T cells in colons at weeks 4 and 8, suggesting the involvement of Th17 cells in the disease process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED EXPRESSION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Elevated production of Th17-promoting cytokines (IL-1β, IL-6, IL-23p19), and other pro-inflammatory markers like iNOS indicates a heightened Th17 response in colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17-ASSOCIATED CYTOKINES&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Elevated production of Th17-promoting cytokines (IL-1β, IL-6, IL-23p19), and other pro-inflammatory markers like iNOS indicates a heightened Th17 response in colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MΦS&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Increased expression of IL-1β, IL-6, IL-23p19, and iNOS specifically within macrophages suggests they are the primary source for increased Th17-associated cytokines and implicates a suppressive role played by IL-10 on these cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFIC EXPRESSION&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"Increased expression of IL-1β, IL-6, IL-23p19, and iNOS specifically within macrophages suggests they are the primary source for increased Th17-associated cytokines and implicates a suppressive role played by IL-10 on these cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREVENT OR ATTENUATE DISEASE&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The transfer of RORγT−/− (Th17 cells deficient) T cells into Rag1−/− and IL-10RαMdelRag1−/− recipients prevents or attenuates colitis, indicating that Th17 cell involvement is essential for disease development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RORΓT−/− T CELLS TRANSFER&quot;">
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d1">"The transfer of RORγT−/− (Th17 cells deficient) T cells into Rag1−/− and IL-10RαMdelRag1−/− recipients prevents or attenuates colitis, indicating that Th17 cell involvement is essential for disease development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RAG1−/− AND IL-10RΑMDELRAG1−/− RECIPIENTS&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"There was a difference in disease development between Rag1−/− and IL-10RαMdelRag1−/− recipients.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;TH17 CELL PERCENTAGES AMONG CD4+TCR+ T CELLS&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"The Th17 response was found to be reduced in the MLNs of Rag1−/− and IL-10RαMdelRag1−/− recipients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESPONSE&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"IL-6Rα signaling supports but is not essential for Th17 formation specifically in the MLNs of both recipient lines.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17 CELL DEVELOPMENT&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"IL-6Rα signaling supports but is not essential for Th17 formation specifically in the MLNs of both recipient lines.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABSOLUTE NUMBERS OF TH17 CELLS ACROSS ORGANS&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"There was a difference in absolute numbers of Th17 cells present between Rag1−/− and IL-10RαMdelRag1−/− recipients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RAG1−/− MICE&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"Rag1−/− mice demonstrated a broad requirement for IL-6 for T cell expansion and development of colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MICE&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"In contrast, IL-10RαMdelRag1−/− mice showed dispensable IL-6 for the development of colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6RΑ−/− T CELLS AND RAG1−/− COMBINATION&quot;">
      <data key="d2">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d1">"The absence of IL-6Rα signaling in T cells induced impaired expansion and lesser disease effect compared to WT T cell transfers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE PROTECTION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Transfer of IL-6Rα deficient T cells shows virtually complete disease protection.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6RΑ TRANSFER&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Transfer of IL-6Rα deficient T cells shows virtually complete disease protection.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-1R TRANSFER&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Transfers of IL-1R deficient T cells show diminished clinical measures compared to WT transfers in Rag1−/− colitis models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REDUCED DISEASE SEVERITY&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Transfers of IL-1R deficient T cells show diminished clinical measures compared to WT transfers in Rag1−/− colitis models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISTINCT DOSE RESPONSE&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"While IL-6 responsiveness affects disease severity in Rag1−/−, IL-1 response impacts both Rag1−/− and IL-10RαMdelRag1−/− models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6RΑ VS. IL-1R TRANSFER IMPACT&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"While IL-6 responsiveness affects disease severity in Rag1−/−, IL-1 response impacts both Rag1−/− and IL-10RαMdelRag1−/− models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REDUCED IN T CELL TRANSFER MODELS&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Transfers of IL-6Rα deficient T cells show reduced Th17 cell proportions compared to WT T cells transfers, specifically in colonic environment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17 CELL PROPORTION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"Transfers of IL-6Rα deficient T cells show reduced Th17 cell proportions compared to WT T cells transfers, specifically in colonic environment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES BETWEEN IL-10RΑMDELRAG1−/− AND RAG1−/− MICE&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"In diseased IL-10RαMdelRag1−/− mice, there's a higher amount of pro-IL-1β compared to Rag1−/− mice in colons.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-1Β PRODUCTION IMPACT&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"In diseased IL-10RαMdelRag1−/− mice, there's a higher amount of pro-IL-1β compared to Rag1−/− mice in colons.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10'S EFFECT ON PRO-IL-1Β LEVELS&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"IL-10 reduces the levels of pro-IL-1β and prevents mature IL-1β formation, as shown in cultured Rag1−/− macrophages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATION BY IL-10 IN MΦS&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"IL-10 reduces the levels of pro-IL-1β and prevents mature IL-1β formation, as shown in cultured Rag1−/− macrophages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYTOKINE INFLUENCE&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"In both Rag1−/− and IL-10RαMdelRag1−/− mice models, IL-6 plays a more critical role in colitis when compared to IL-10 suppression of LPMφs' IL-1β production.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6 AND DISEASE SEVERITY&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"In both Rag1−/− and IL-10RαMdelRag1−/− mice models, IL-6 plays a more critical role in colitis when compared to IL-10 suppression of LPMφs' IL-1β production.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-INFLAMMATORY ACTION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"IL-10 inhibits the production and maturation of pro-inflammatory cytokines like IL-1β, reducing disease severity in colitis models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10'S ROLE&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"IL-10 inhibits the production and maturation of pro-inflammatory cytokines like IL-1β, reducing disease severity in colitis models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 TREATMENT&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Pre-treatment with IL-10 abrogates induction of activated caspase-1 in Rag1−/− Mφs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-IL-10RΑ AB&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Anti-IL-10Rα Ab markedly increases activated caspase-1, indicating normal restraint by IL-10 in Rag1−/− Mφs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LPMΦS&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Increased IL-1 and IL-6 from LPMφs can impact Th17 cell maturation in the presence of naïve T cells with added TGFβ.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17 FORMATION&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Blocking IL-6 receptor partially inhibits Th17 formation from Rag1−/− LPMφs, but less so from IL-10RαMdelRag1−/−-derived LPMφs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17 CELL MATURATION/">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Blocking IL-1 signaling leads to more substantial inhibition of Th17 development in IL-10RαMdel Rag1−/−-derived LPMφs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-IL-6RΑ AB&quot;">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Blocking IL-6 receptor substantially inhibits Th17 development in diseased mice, as shown by IL-6R−/− T cell transfer results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH17 CELL FORMATION/">
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d1">"Blockage of IL-1 receptor pathway leads to more substantial inhibition of Th17 cell development in diseased mice, particularly with IL-10RαMdelRag1−/− LPMφs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TWINSUK&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"The TwinsUK cohort was composed of 1,176 samples including 169 monozygotic (MZ) and 419 dizygotic (DZ) twin pairs used for heritability estimation."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;NETHERLANDS TWIN REGISTRY (NTR)&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"The Netherlands Twin Registry (NTR) cohort was composed of only MZ twins, N=312 individuals, and used to replicate the MZ intraclass correlation coefficient (ICC)."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ALPHA DIVERSITY&quot;">
      <data key="d0">"METRIC"</data>
      <data key="d1">"Richness and Shannon diversity differed significantly across cohorts."&lt;SEP&gt;"The lack of heritability for alpha diversity indices suggests that they might not be influenced by genetics alone."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;EUROPEAN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"One of the twenty cohorts included samples from European ancestry, with a total of N=13,266 participants."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MIDDLE-EASTERN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"One cohort comprised individuals from Middle-Eastern ancestry, including N=481 participants."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;EAST ASIAN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"A cohort consisted of East Asian individuals with a total of N=811 participants."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;AMERICAN HISPANIC/LATIN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"One cohort was composed of American Hispanic or Latin individuals, including N=1,097 participants."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;AFRICAN AMERICAN COHORT&quot;">
      <data key="d0">"COHORT"</data>
      <data key="d1">"The final cohort comprised African-American individuals with a total of N=114 participants."</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;LCT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LCT locus – Bifidobacterium is associated with the abundance of Bifidobacterium."&lt;SEP&gt;"The LCT gene is involved in cell-type specific expression and identified regions associated with DNA modifications."&lt;SEP&gt;"The lactase gene is associated with lactose digestion and metabolism."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;RS182549&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The rs182549 genotype showed a higher abundance of the genus Bifidobacterium in the adult group, but not in the younger group."&lt;SEP&gt;"rs182549, a functional variant for LCT gene."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A higher abundance of the genus Bifidobacterium was also found to potentially have a protective effect on ulcerative colitis."&lt;SEP&gt;"Association of rs182549 with abundance level of Bifidobacterium."&lt;SEP&gt;"The age-genotype interaction was significant in the GEM_v12 and GEM_ICHIP subcohorts, both comprising mostly European individuals."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;LCT 2Q21.3 BLOCK&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A large genomic variant located in the LCT gene and contains several protein-coding genes."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;FUNCTIONAL LCT VARIANT RS4988235&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A functional variant of the LCT gene, which shows a strong association with Bifidobacterium abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;COPSAC2010 COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The COPSAC2010 cohort contributes to heterogeneity in rs182549 association signal."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;TWINSUK COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The TwinsUK cohort showed genome-wide significant mbTLs for several taxa, including high heritability for Bifidobacterium."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Family Peptococcaceae showed heterogeneity across taxa tested."&lt;SEP&gt;"The genomic region rs61841503 affects the abundance of Peptococcaceae, influencing vitamin B12 metabolism and potentially impacting gut inflammation markers."&lt;SEP&gt;"These associations suggest that some members of the gut microbiome community might be affected by genetic variants that regulate the absorption and metabolism of vitamins B2 and B12."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;GEM_V12&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The lack of an LCT mbQTL effect in adults was also observed in another Israel cohort in the study (Personalized Nutrition Project (PNP), 481 adults, Beta = −0.20 [95%CI: −0.61, 0.20])."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COPENHAGEN PROSPECTS STUDIES ON ASTHMA IN CHILDHOOD (COPSAC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The cohorts that reported the lowest LCT effect sizes were the two cohorts of Israeli ethnicity volunteered in Israel (GEM_v24, PNP) and a child cohort."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS35866622&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"This variant was associated with a reduced abundance of the R. torques group and a decreased presence of the R. gnavus group."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS TORQUES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Ruminococcus sp are specialized in the degradation of complex carbohydrates, thereby supporting a link between genetic variation in the FUT2 gene, levels of mucus glycans and the abundance of this taxa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;R2=0.8; D’=0.9&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The tagging NC_000019.9:g.49218060C&gt;T (rs35866622 non-secretor) allele was associated with a reduced abundance of the R. torques group and a decreased presence of the R. gnavus group."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FUT2 encodes the enzyme alpha-1,2-fucosyltransferase, which is responsible for the secretion of fucosylated mucus glycans in the gastrointestinal mucosa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS601338&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Individuals homozygous for the stop-codon (rs601338*A/A, non-secretors) do not express ABO antigens on the intestinal mucosa."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;R. TORQUES GROUP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The tagging NC_000019.9:g.49218060C&gt;T (rs35866622 non-secretor) allele was associated with a reduced abundance of the R. torques group and a decreased presence of the R. gnavus group."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS602075&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The 9q21 locus includes the genes PCSK5, RFK and GCNT1, of which RFK encodes the enzyme that catalyzes the phosphorylation of riboflavin (vitamin B2) and GCNT1 encodes a glycosyltransferase involved in biosynthesis of mucin."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RFK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"These products play major roles in the host-microbiota interactions within the intestine, where they are used by bacteria for their metabolism and involved in the regulation of the host immune defense."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS61841503&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"This association signal affects the abundance of the heritable family Peptostreptococcaceae, which is located in the CUBN gene, the receptor for the complexes of cobalamin (vitamin B12) with gastric intrinsic factor."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;CUBN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CUBN is expressed in the kidneys and the intestinal epithelium and is associated with B12-deficient anemia and albuminuria. Cobalamin is required for host-microbial interactions, and supplementation with cobalamin induced a substantial shift in the microbiota composition of an in vitro colon model."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS7574352&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The genomic variant rs7574352 was associated with the family Peptococcaceae, a taxon negatively associated with gut inflammation markers and ulcerative colitis."&lt;SEP&gt;"The strongest evidence for association was seen for a block of 10 SNPs associated with the family Peptococcaceae, a taxon negatively associated with stool levels of gut inflammation markers."&lt;SEP&gt;"The strongest evidence for association was seen for a block of 10 SNPs associated with the family Peptococcaceae, a taxon negatively associated with stool levels of the gut inflammation markers chromogranin A and calprotectin."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;RS601338&quot;*&quot;RS35866622&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The tagging NC_000019.9:g.49218060C&gt;T (rs35866622 non-secretor) allele was associated with a reduced abundance of the R. torques group and a decreased presence of the R. gnavus group."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS61841503&quot;*&quot;RS7574352&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"This association signal affects the abundance of both Peptococcaceae and Peptostreptococcaceae, which are families of bacteria involved in vitamin B12 metabolism."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE&quot;*&quot;PEPTOSTREPTOCOCCACEAE&quot;">
      <data key="d0">"BACTERIAL FAMILIES"</data>
      <data key="d1">"The genomic regions rs61841503 and rs7574352 affect the abundance of these bacterial families, which are involved in vitamin B12 metabolism."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS61841503&quot;*&quot;PEPTOSTREPTOCOCCACEAE&quot;">
      <data key="d0">"GENOMIC REGION"*"ASSOCIATION SIGNAL"</data>
      <data key="d1">"The genomic region rs61841503 affects the abundance of Peptostreptococcaceae, which are involved in vitamin B12 metabolism and potentially related to changes in gut inflammation markers."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS7574352&quot;*&quot;PEPTOCOCCACEAE&quot;">
      <data key="d0">"ASSOCIATION SIGNAL"*"STOOL INFLAMMATION MARKERS"</data>
      <data key="d1">"The genomic region rs7574352 has a strong association with the abundance of Peptococcaceae bacteria, which can negatively impact stool inflammation markers."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COPD&quot;">
      <data key="d0">"DISEASE"*"RS61841503"*"ASSOCIATION"</data>
      <data key="d1">"The genomic region rs61841503 has been associated with chronic obstructive pulmonary disease (COPD) risk."</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FAMILY PEPTOCOCCACEAE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A block of 10 SNPs including rs7574352 was associated with the family Peptococcaceae, suggesting a potential dietary pattern related to gut health."&lt;SEP&gt;"The association of rs7574352 with the family Peptococcaceae suggests a dietary pattern that might influence gut health."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CHROMOGRANIN A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The LLD phenotype for chromogranin A is negatively correlated with the presence of the association block for rs7574352."&lt;SEP&gt;"rs7574352 was negatively correlated with chromogranin A levels, possibly indicating its role in inflammatory responses."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CALPROTECTIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The LLD phenotype for calprotectin is negatively correlated with the presence of the association block for rs7574352."&lt;SEP&gt;"The association of rs7574352 with calprotectin suggests a link between this variant and gut inflammation markers."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"rs7574352 was associated with ulcerative colitis, a disease linked to gut inflammation markers like chromogranin A and calprotectin."&lt;SEP&gt;"rs7574352 was associated with ulcerative colitis, highlighting its potential role in inflammatory bowel diseases."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;IRF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IRF1 and STAT1 expression changes are associated with T1D susceptibility."&lt;SEP&gt;"The association block of 10 SNPs including rs7574352 is located near the gene IRF1 involved in insulin resistance and type 2 diabetes susceptibility."&lt;SEP&gt;"The genomic region including rs7574352 is near the IRF1 gene, which may influence metabolism and inflammatory processes."&lt;SEP&gt;"The expression levels of this protein were significantly affected by the rs4788084[T] SNP in CD4+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"rs7574352 is associated with type 2 diabetes, linked to IRF1 gene and insulin resistance."&lt;SEP&gt;"rs7574352 was linked with type 2 diabetes, underscoring its potential role in genetic predispositions for metabolic diseases."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 42}]</data>
    </node>
    <node id="&quot;GSEA&quot;">
      <data key="d0">"ANALYSIS METHOD"</data>
      <data key="d1">"GSEA analysis on the genes of mbTLs suggests enrichment for expression in small intestine, brain regions."&lt;SEP&gt;"Gene Set Enrichment Analysis (GSEA) revealed enrichment of genes related to small intestine and brain regions associated with rs7574352."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;TERMINAL ILEUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Small intestine is indicated as a primary physiological process by GSEA."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;SUBSTANIA NIGRA AND PUTAMEN BASAL GANGLIA&quot;">
      <data key="d0">"BRAIN REGIONS"</data>
      <data key="d1">"Enrichment for expression in these brain regions indicates potential neurological processes linked to mbTLs."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;FUMA&quot;">
      <data key="d0">"ANALYSIS METHOD"</data>
      <data key="d1">"FUMA analysis of 20 mbQTL loci returns positional and eQTL genes related to small intestine, brain regions, and insulin resistance."&lt;SEP&gt;"Fine Mapping using the Unified Meta-Analytic approach (FUMA) on rs7574352 suggested associations with various complex traits and diseases."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"GSEA analysis shows enrichment for Bifidobacterium abundance linked to various complex traits and diseases."&lt;SEP&gt;"The analysis suggests that the presence of Bifidobacterium might be influenced by genetic factors related to rs7574352."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;5×10−8 SIGNIFICANCE THRESHOLD&quot;">
      <data key="d0">"STATISTICAL SIGNIFICANCE"</data>
      <data key="d1">"GWAS ATLAS identified SNPs associated with multiple dietary and metabolic phenotypes below the 5×10−8 threshold for significance."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;RS182549 (LCT)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The most pleiotropic variant, rs182549 is associated with obesity, T2DM diagnosis and several nutritional phenotypes in UK Biobank cohort."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;LACTOSE INTOLERANCE&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"The genetic variation at rs7574352 might predispose individuals to lactose intolerance through its impact on gut microbiota and metabolism."&lt;SEP&gt;"rs182549 predisposes individuals to lactose intolerance which is negatively correlated with obesity and positively associated with T2DM."&lt;SEP&gt;"The results of the study provided insights into mechanisms related to lactose intolerance, linking DNA modifications with LCT expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;LCT (GALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The functional variant rs4988235 of the LCT gene is associated with glycemic variability, indicating a link between galactose metabolism and insulin sensitivity."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;SMALL INTESTINE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The GSEA results highlight the involvement of small intestinal processes in mechanisms related to rs7574352."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;SUBSTANTIA NIGRA AND PUTAMEN BASAL GANGLIA&quot;">
      <data key="d0">"BRAIN REGIONS"</data>
      <data key="d1">"GSEA indicated enrichment for gene expression in these brain regions linked with rs7574352, possibly implicating neurological pathways."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;GSEA ENRICHMENT FOR SMALL INTESTINE AND BRAIN REGIONS&quot;">
      <data key="d0">"PATHWAY ENRICHMENT"</data>
      <data key="d1">"The GSEA results showed significant enrichment in biological pathways related to small intestine functions and neurobiological processes linked with rs7574352."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;T2DM DIAGNOSIS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"rs7574352 predisposes individuals to T2DM, which is indicated by a higher likelihood of diagnosis in populations carrying the variant."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;GLYCEMIC VARIABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PARAMETER"</data>
      <data key="d1">"rs7574352 may affect glycemic variability, which is a key indicator of insulin responsiveness in metabolic health."</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;GUT MICROBIAL TAXA&quot;">
      <data key="d0">"MICROBIAL TAXA"</data>
      <data key="d1">"The gut microbial taxa were analyzed using Mendelian Randomization to identify potential causal links with phenotypes."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;DISEASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"We focused on diseases including autoimmune, cardiovascular, metabolic and psychiatric in bi-directional two-sample MR analyses."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;AUTOIMMUNE&quot;">
      <data key="d0">"AUTOIMMUNE DISEASE"</data>
      <data key="d1">"Autoimmune diseases were part of the group for phenotypes analyzed using Mendelian Randomization."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;CARDIOVASCULAR&quot;">
      <data key="d0">"CARDIOVASCULAR DISEASE"</data>
      <data key="d1">"Cardiovascular disease was also included in the group of diseases analyzed."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;METABOLIC&quot;">
      <data key="d0">"METABOLIC DISEASE"</data>
      <data key="d1">"We performed bi-directional two-sample MR analyses on metabolic diseases along with autoimmune and psychiatric conditions."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;PSYCHIATRIC&quot;">
      <data key="d0">"PSYCHIATRIC DISORDER"</data>
      <data key="d1">"The analysis was extended to include psychiatric disorders as part of the phenotypes examined."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;NUTRITIONAL PHENOTYPES&quot;">
      <data key="d0">"NUTRITIONAL PHENOTYPE"</data>
      <data key="d1">"Nutritional phenotypes were also a focus in our bi-directional two-sample MR analyses using Mendelian Randomization."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;HOST GENETICS&quot;">
      <data key="d0">"GENETICS"</data>
      <data key="d1">"Host genetics had an impact on microbiome composition, and this was considered when performing causality estimation using the MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;MICROBIOME COMPOSITION&quot;">
      <data key="d0">"MICROBIOME COMPOSITION"</data>
      <data key="d1">"The composition of the microbiome was influenced by host genetics as part of the study parameters."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;LIMITED IMPACT OF GENETIC VARIANTS ON MICROBIAL TAXA VARIABILITY&quot;">
      <data key="d0">"GENETIC VARIANTS IMPACT"</data>
      <data key="d1">"Our analysis took into account that genetic variants had a limited effect on microbial taxa variation in microbiome composition."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;CAUSALITY ESTIMATION&quot;">
      <data key="d0">"CAUSALITY ESTIMATION"</data>
      <data key="d1">"We conducted several sensitivity analyses to estimate causality using the MR analysis, ensuring to exclude any results confounded by pleiotropy."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;PLEIOTROPY&quot;">
      <data key="d0">"PLEIOTROPY"</data>
      <data key="d1">"We excluded results that showed evidence of being influenced by pleiotropy when estimating causality in our MR analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;RESULTS WITH THREE OR MORE SNPS&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"Only pairs supported by three or more Single Nucleotide Polymorphisms (SNPs) were considered for the final analysis results."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;CAUSAL RELATIONSHIPS&quot;">
      <data key="d0">"CAUSAL RELATIONSHIPS"</data>
      <data key="d1">"We did not find any evidence of causal relationships between microbiome taxa and dietary preferences based on our criteria."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;ACTINOBACTERIA&quot;">
      <data key="d0">"PHYLUM"</data>
      <data key="d1">"A higher abundance of the class Actinobacteria may have a protective effect on ulcerative colitis."&lt;SEP&gt;"Decreases in Actinobacteria phylum were revealed by LEfSe analysis."&lt;SEP&gt;"There's a decrease in the phylum Actinobacteria at baseline, suggesting an alteration in bacterial composition."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;OXALOBACTERACEAE FAMILY&quot;">
      <data key="d0">"MICROBIAL TAXA"</data>
      <data key="d1">"The higher abundance of the Oxalobacteraceae family may be protective against rheumatoid arthritis based on our analysis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;ULCERATIVE COLITIS AND AUTOIMMUNE CONDITIONS&quot;">
      <data key="d0">"AUTOIMMUNE DISEASES"</data>
      <data key="d1">"In our analyses, we found potential protective effects of certain microbial taxa on specific autoimmune conditions like ulcerative colitis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;RHEUMATOID ARTHRITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The analysis revealed a protective effect potentially linked to the abundance of certain bacterial taxa against rheumatoid arthritis."&lt;SEP&gt;"rs1893217 is associated with rheumatoid arthritis."</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM (LD) SCORE REGRESSION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The SNP-based heritability calculated from mbQTL summary statistics using linkage disequilibrium (LD) score regression showed two bacterial taxa, genus Ruminiclostridium 9 and family Peptostreptococcaeae, passing the significance threshold given the number of 211 taxa tested.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The SNP-based heritability calculated from mbQTL summary statistics using linkage disequilibrium (LD) score regression showed two bacterial taxa, genus Ruminiclostridium 9 and family Peptostreptococcaeae, passing the significance threshold given the number of 211 taxa tested.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENUS RUMINICLOSTRIDIUM 9&quot;&amp;&quot;FAMILY PEPTOSTREPTOCOCCAEAE&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The estimation of heritability and SNP-based heritability showed significant correlation across the tested taxa, with correlation coefficient R=0.244.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TWINSUK COHORT&quot;&amp;&quot;MOLECULAR INTERACTION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"In TwinsUK, heritability estimation was performed using the ACE model, which includes additive genetic variance (A), shared environmental factors (C), and non-shared factors plus error (E).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NETHERLANDS TWIN REGISTRY (NTR)&quot;&amp;&quot;HERITABILITY ESTIMATION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The Netherlands Twin Registry cohort was used to replicate the MZ intraclass correlation coefficient (ICC) for heritability estimation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REPLICATION&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The Netherlands Twin Registry cohort was used to replicate the MZ intraclass correlation coefficient (ICC) for heritability estimation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TWINSUK COHORT&quot;&amp;&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"SNP-based heritability estimation from mbQTL summary statistics was performed using linkage disequilibrium (LD) score regression on the TwinsUK cohort.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NETHERLANDS TWIN REGISTRY (NTR)&quot;&amp;&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d1">"The NTR cohort provided replication for the SNP-based heritability estimation done on the TwinsUK cohort.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT LOCUS&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"An LCT locus associated with abundance of Bifidobacterium.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTIONAL LCT VARIANT&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"rs182549 is a proxy for the functional LCT variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HETEROGENEITY&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d1">"The COPSAC2010 cohort contributed to the heterogeneity in rs182549 association signal.")&lt;SEP&gt;"The variation or diversity found among the data due to different factors like genetic variants or environmental influences."</data>
      <data key="d0">"METABOLIC PATHWAY"</data>
    </node>
    <node id="&quot;AGE AND GENOTYPE INTERACTION&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"Age shows an interaction with rs182549, affecting Bifidobacterium abundance differently in different age groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE&quot;&amp; &quot;RS182549&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"Age shows an interaction with rs182549, affecting Bifidobacterium abundance differently in different age groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS182549&quot;&amp; &quot;BIFIDOBACTERIUM&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"Both ethnicity and rs182549 are related to the abundance of Bifidobacterium.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT LOCUS - BIFIDOBACTERIUM&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The LCT locus, associated with abundance of Bifidobacterium through mbQTL mapping.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MBQTL&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"The LCT locus, associated with abundance of Bifidobacterium through mbQTL mapping.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MBBTL&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"mbBTL mapping identified loci associated with the presence or absence of specific bacterial taxa in the gut microbiota.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRESENCE/ABSENCE OF BACTERIAL TAXA&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"mbBTL mapping identified loci associated with the presence or absence of specific bacterial taxa in the gut microbiota.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;META-GWAS&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"No significant hits were found in the meta-GWAS analysis for alpha diversity indices, indicating low genetic influence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COCHRAN’S Q&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"Cochran's Q test showed evidence of heterogeneity across cohorts related to rs182549 association with Bifidobacterium abundance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS182549 HETEROGENEITY&quot;">
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d1">"Cochran's Q test showed evidence of heterogeneity across cohorts related to rs182549 association with Bifidobacterium abundance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT (BIFIDOBACTERIUM)&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"SNP rs182549, associated with Bifidobacterium abundance, has been positively linked to T2DM diagnosis and a family history of the disease.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;T2DM&quot;">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9&lt;SEP&gt;chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"SNP rs182549, associated with Bifidobacterium abundance, has been positively linked to T2DM diagnosis and a family history of the disease.")&lt;SEP&gt;"T2DM group was designated as one of the case groups in relation to blood glucose levels and genetic variants."&lt;SEP&gt;"Type 2 Diabetes Mellitus is the ultimate disease state associated with genetic variants and abnormal blood glucose levels."&lt;SEP&gt;"Type 2 Diabetes Mellitus is a metabolic disorder characterized by high blood sugar levels due to insulin resistance or insufficient insulin production."</data>
      <data key="d0">"DISEASE"/"INFLAMMATION"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;FISH INTAKE HEIGHT&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"The secretor allele at the FUT1/FUT2 locus is associated with fish intake and height in dietary patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUT1/FUT2 LOCUS&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"The secretor allele at the FUT1/FUT2 locus is associated with fish intake and height in dietary patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 VARIANT&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"Functional LCT variant rs4988235 is associated with glycemic variability, an indicator of insulin sensitivity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RAW VEGETABLE INTAKE&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"A nominally significant correlation between Bifidobacterium abundance and raw vegetable intake was observed before multiple testing correction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLELITHIASIS&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"The secretor allele at the FUT1/FUT2 locus is negatively associated with risks of cholelithiasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS35866622, FUT1/FUT2 LOCUS&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"The secretor allele at the FUT1/FUT2 locus is negatively associated with risks of cholelithiasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METABOLIC TRAITS&quot;">
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d1">"Gene-based PheWAS enrichment analysis indicated strong links between the LCT locus and metabolic traits, including BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIMITED IMPACT OF GENETIC VARIANTS&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"The limited effect of genetic variants on microbial taxa variability was considered in sensitivity analyses during our causality estimation process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIAL TAXA VARIABILITY&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"The limited effect of genetic variants on microbial taxa variability was considered in sensitivity analyses during our causality estimation process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAUSAL RELATIONSHIPS IDENTIFIED&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"Causal relationships were only considered if supported by three or more Single Nucleotide Polymorphisms (SNPs).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THREE OR MORE SNPS&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"Causal relationships were only considered if supported by three or more Single Nucleotide Polymorphisms (SNPs).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGHER ABUNDANCE OF ACTINOBACTERIA AND BIFIDOBACTERIUM&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"Actinobacteria and the genus Bifidobacterium may have a protective effect against ulcerative colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTECTIVE EFFECT ON ULCERATIVE COLITIS&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"Actinobacteria and the genus Bifidobacterium may have a protective effect against ulcerative colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGHER ABUNDANCE OF OXALOBACTERACEAE FAMILY&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"The Oxalobacteraceae family's higher abundance may be protective against rheumatoid arthritis, according to our study results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTECTIVE EFFECT ON RHEUMATOID ARTHRITIS&quot;">
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d1">"The Oxalobacteraceae family's higher abundance may be protective against rheumatoid arthritis, according to our study results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"LP is a genetic variant with rs4988235 genotype, which affects various cardiovascular health biomarkers."&lt;SEP&gt;"Minor allele frequencies for rs4988235 within controls were observed in different populations."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;12,722 PARTICIPANTS&quot;">
      <data key="d0">"SAMPLE SIZE"</data>
      <data key="d1">"The study included 12,722 participants, with an average age of 52 years."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;MILK INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Average milk intake was 162 g/day and non-consumption was rare (7.1%) in EPIC-InterAct."&lt;SEP&gt;"Increased intake of milk was positively associated with one additional LP allele."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Consumption of dairy products varied between countries, with lower intake observed in France."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;ITALY&quot;">
      <data key="d0">"COUNTRY"</data>
      <data key="d1">"In Italy, the prevalence of homozygous LP variant was 7.4%, whereas it reached up to 53.9% in Sweden."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;C15:0 AND C17:0&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"rs4988235 genotype influenced levels of total fats, with a moderate increase observed for both C15:0 and C17:0."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;POTATOES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of potatoes was higher in participants with a higher number of LP alleles."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;CEREALS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Participants with LP variant showed lower consumption of cereals compared to those without."&lt;SEP&gt;"The term 'cereal' refers to a broad group of foods that can include grains like wheat, barley, and oats."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;FRUITS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Fruit intake was observed to be influenced by the presence of the LP variant, indicating potential genetic-diet interactions."&lt;SEP&gt;"In contrast, fruit intake was higher among participants with LP variant."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;POULTRY&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Higher intake of poultry was associated with the presence of rs4988235 genotype."&lt;SEP&gt;"The consumption of poultry showed a specific pattern among participants with certain genotypes like rs4988235."&lt;SEP&gt;"In 10 (11.9%) of 84 domestically acquired infections, patients reported eating fresh poultry other than chicken and turkey compared with 4 (9.5%) of 42 infections in persons with travel-related infections."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;NON-ALCOHOLIC BEVERAGES&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"These beverages were found to have varying associations with the LP variant, potentially affecting health outcomes."&lt;SEP&gt;"rs4988235 was linked to higher consumption of non-alcoholic beverages."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;WINE&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Consumption of wine showed a modest negative association with rs4988235 genotype."&lt;SEP&gt;"Wine intake was noted in relation to rs4988235 genotype, suggesting complex interactions between genetics and diet."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;HBA1C LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"rs4988235 did not show significant association with HbA1c levels at baseline."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIABETES RISK FACTORS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Dietary intakes were associated with rs4988235, including potatoes, cereals, fruits, poultry, non-alcoholic beverages, and wine."&lt;SEP&gt;"Dietary patterns associated with rs4988235 variant also affected the risk of developing diabetes."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;LP (RS4988235 T/T GENOTYPE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant plays a role in cardiovascular health through its influence on metabolic pathways and diet."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;PRINCIPAL COMPONENTS&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The principal components method was used to adjust the analysis for genetic structure, reducing bias."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;STUDY CENTRE&quot;">
      <data key="d0">"LOCATION FACTOR"</data>
      <data key="d1">"The EPIC-InterAct study involved multiple centers across different countries, contributing to the sample size and diversity."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;COMPOSITE ENDPOINT&quot;">
      <data key="d0">"CLINICAL OUTCOME"</data>
      <data key="d1">"A combined outcome was used for milk and milk beverages intake to enhance statistical power."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;F STATISTIC&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"A measure of goodness-of-fit indicating the strength of association between variables in regression analysis."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;POTASSIUM INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Increased potato consumption was associated with higher potassium intake, impacting cardiovascular health."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;RS4988235 AND MILK INTAKE&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"The LP genetic variant was positively related to milk consumption, affecting the F-statistic for predicting milk intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 AND PLASMA C15:0/C17:0&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"There was a minor association between rs4988235 and increased levels of saturated fats (C15:0 and C17:0).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 AND POTATO INTAKE&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"Consumption of potatoes was higher in individuals with the LP genetic variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 AND CEREAL INTAKE&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"The intake of cereals was inversely related to the presence of rs4988235 genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 AND FRUIT INTAKE&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"Fruit consumption showed a positive association with LP variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOOD&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"Poultry intake was associated with the presence of rs4988235 genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 AND POULTRY INTAKE&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"Poultry intake was associated with the presence of rs4988235 genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 AND NON-ALCOHOLIC BEVERAGE INTAKE&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"The consumption of non-alcoholic beverages was higher in individuals carrying the LP variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4988235 AND WINE INTAKE&quot;">
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d1">"Wine consumption showed a negative relationship with rs4988235 genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOCIAL CLASS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There were no group differences in social class or maternal education."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL EDUCATION&quot;">
      <data key="d0">"FORMAL EDUCATION LEVEL"</data>
      <data key="d1">"Case mothers had fewer years of formal education compared to control mothers."&lt;SEP&gt;"There were no group differences in social class or maternal education."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914&lt;SEP&gt;chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PERCEIVED STRESS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There were no group differences in perceived stress,"</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DEPRESSION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There were no group differences in depression,"</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NUTRITIONAL STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There were no group differences in nutritional status,"</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DIETARY CALORIC INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"About 30% of both groups were poorly nourished based on their dietary caloric intake."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;AI FOR DIETARY CHOLINE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"More than 70% did not meet the AI for dietary choline intake."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CIGARETTE SMOKING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Both groups smoked about 1/4 pack/day on average,"</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ILLICIT DRUG USE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Illicit drug use was rare, none of the women reported using cocaine, heroin, or methaqualone."&lt;SEP&gt;"Use of illicit drugs other than marijuana was rare."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE USE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Although women who used methamphetamine were excluded at time of recruitment, 4 reported using it later in pregnancy (2 choline, 2 placebo)."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;INFANT AGE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There were no group differences in infant age at the 6.5- and 12-month assessments."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;WEEKS GESTATION AT TIME OF BOOKING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There were no group differences in weeks gestation at time of booking,"</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;RANDOMIZATION DURATION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There were no group differences in duration of choline supplementation."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SEX OF INFANT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Infants differed on sex, with more girls in the choline and more boys in the placebo arm."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION ACROSS PREGNANCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Women continued to drink heavily across pregnancy (≈8-9 drinks/occasion) but reduced their frequency."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CIGARETTE SMOKING FREQUENCY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Both groups reduced smoking frequency to about 1–2 days/week."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE USE LATER IN PREGNANCY&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Although women who used methamphetamine were excluded at time of recruitment, 4 reported using it later in pregnancy (2 choline, 2 placebo)."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;INFANT GA AT TIME OF BOOKING AND RANDOMIZATION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Weeks gestation at randomization ranged from 8.6–26.0 (Median=20.0)").("entity"</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SEX OF INFANTS IN CHOLINE ARM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"More girls were born to mothers in the choline group."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NUMBER OF INFANT ASSESSMENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Assessments were conducted at 6.5 and 12 months."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;INFANTS' EYEBLINK CONDITIONING SCORES&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Choline-treated infants showed a significantly greater increase in percent correct responses across three sessions than the placebo group."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;LINEAR RELATION BETWEEN ADHERENCE AND CONDITIONING&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"There was a clear linear relation between maternal adherence to choline supplementation and eyeblink conditioning, with better adherence leading to higher conditioning scores."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;Z-SCORES AND PERCENTILES FOR BIRTH SIZE MEASURES&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Birth measures showed marked underpercentile values across all groups, reflecting fetal alcohol growth restriction."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CATCH-UP GROWTH IN CHOLINE GROUP&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Infants in the choline group demonstrated significant catch-up growth in weight and head circumference by 6.5 months, which continued at 12 months."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FASD DIAGNOSIS CRITERIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Choline-treated infants had a higher incidence of Fetal Alcohol Spectrum Disorders (8 infants) compared to the placebo group (5 infants)."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;COHEN'S D MEASURE&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Indicated moderate-to-large effect size for FTII processing speed measure in choline treatment arm."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FAS DIAGNOSIS INCIDENCE BY ARM&quot;">
      <data key="d0">"DISEASE DISTRIBUTION"</data>
      <data key="d1">"In the placebo group, 5 infants met criteria for FAS and 2 for PFAS compared to 8 infants with FAS and 2 with PFAS in the choline treatment group."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE OUTLIER&quot;">
      <data key="d0">"OUTLYING DATA POINT"</data>
      <data key="d1">"One maternal outlier was identified with very poor adherence and high percentage correct responses, which had a bivariate effect on the analysis."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;STATISTICAL TEST FOR ADHERENCE-CONDITIONING RELATION&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Mahalanobis distance test identified one bivariate outlier that influenced the linear relation between adherence and eyeblink conditioning scores."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SIGNIFICANCE OF WEIGHT AND HEAD CIRCUMFERENCE PERCENTILES IN CHOLINE GROUP&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Infants in the choline group showed significantly greater increases across age periods compared to the placebo group for weight and head circumference."</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FASD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fetal alcohol spectrum disorder is a condition that affects infants and can be diagnosed based on specific criteria."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A nutrient important for pregnancy health, which has an adequate intake standard (&gt;450 mg/day)."&lt;SEP&gt;"An essential nutrient that plays a critical role in pregnancy and fetal development."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;RS12325817 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant affecting the enzyme PEMT, reducing endogenous choline synthesis."&lt;SEP&gt;"This genomic variant in the enzyme PEMT reduces endogenous choline synthesis."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PEMT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The enzyme PEMT interacts with choline metabolism during pregnancy, influencing dietary intake standards and outcomes."&lt;SEP&gt;"The enzyme that affects choline metabolism and interactions with maternal diet during pregnancy."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;INFANTS&quot;">
      <data key="d0">"SUBJECT POPULATION"</data>
      <data key="d1">"A demographic group composed of individuals who are infants, typically ranging in age from newborns up to around 2 years old."&lt;SEP&gt;"The infants assessed in this study were part of the research sample that met specific criteria for diagnosis or nutritional status."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11&lt;SEP&gt;chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;PLACEBO ARM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A group given a placebo, one component being their usual dietary intake which did not include choline supplementation."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE-TREATED GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A group that received choline supplements as part of their diet during pregnancy."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;MATERNAL DIETARY CHOLINE STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process involving the intake and metabolism of choline in mothers during pregnancy."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE INTAKE DURING PREGNANCY&quot;">
      <data key="d0">"NUTRIENT INTAKE"</data>
      <data key="d1">"Mothers whose intake of choline was adequate (&gt;450 mg/day) during pregnancy."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;UL (UPPER LIMIT)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Upper Limit for dietary choline, which is not exceeded by any infants in this study."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;62 INFANTS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"All the infants assessed were part of this research study, and their outcomes were analyzed based on various criteria."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;INFANTS' HEALTH OUTCOMES&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcripts of the infants involved in this study were used to assess various health outcomes related to their exposure to choline."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PLACEBO GROUP INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"This refers to the typical dietary intake of participants in the placebo arm, which was not supplemented with choline."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE-SUPPLEMENTED GROUP INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The dietary pattern followed by this group included additional choline supplements during pregnancy, which influenced maternal and fetal outcomes."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;MATERNAL NUTRITIONAL STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This encompasses the physical health conditions related to a mother's diet and its impact on her ability to meet the essential nutrient requirements."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE INTAKE THRESHOLD&quot;">
      <data key="d0">"NUTRIENT INTAKE"</data>
      <data key="d1">"The standard amount of choline that is considered adequate for pregnant women, which was not achieved by all in this study."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;UPPER LIMIT (UL)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary limit set to prevent potential harmful effects from excessive intake of a specific nutrient; here referring to choline."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;INFANTS' DEVELOPMENT STAGES&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The study focused on assessing various developmental milestones in infants related to their exposure to choline."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;FASD DIAGNOSIS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The diagnosis of FASD was applied to 32.3% of infants in the choline group compared to 22.6% in the placebo group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL PEMT ENZYME INTERACTION WITH CHOLINE INTAKE&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"Influence of maternal dietary choline status on endogenous choline synthesis when carrying rs12325817 variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE SUPPLEMENTATION IN PREGNANCY&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"Differences in infants' outcomes between those given choline supplements during their mothers' pregnancies versus placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFANTS' NUTRITIONAL AND HEALTH OUTCOMES&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"Differences in infants' outcomes between those given choline supplements during their mothers' pregnancies versus placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INSUFFICIENT VS. ADEQUATE MATERNAL CHOLINE INTAKE DURING PREGNANCY&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The impact of different dietary standards for choline on the health and development of infants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE SUPPLEMENTATION AND FASD DIAGNOSIS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The relationship between choline intake during pregnancy and the prevalence of fetal alcohol spectrum disorders among infants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL CHOLINE STATUS IMPACT ON INFANT HEALTH&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"How maternal dietary choline status affects outcomes for their infants, including growth, development, and disease risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE INTAKE VS. MATERNAL NUTRITIONAL STATUS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The impact of different levels of choline consumption compared to other nutrients in the diet on pregnancy health and infant development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT INTAKE&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The impact of different levels of choline consumption compared to other nutrients in the diet on pregnancy health and infant development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCE OF GENOMIC VARIANT ON ENDOGENOUS CHOLINE SYNTHESIS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"How genetic differences influence how a mother's body produces choline internally during pregnancy, affecting dietary requirements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHOLINE SUPPLEMENTATION AND MATERNAL ENZYME INTERACTIONS&quot;">
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"The study explores the synergistic effects of choline supplementation on enzyme function related to choline metabolism in pregnant mothers carrying a specific genetic variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10886471&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This polymorphism is a genetic marker with a CA repeat sequence and has been studied in relation to splicing enhancers or repressors during gene expression."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;(CA)N&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Short tandem repeats (STR) of the 'CA' nucleotide sequence were analyzed for their function."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;RS10886471 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The single nucleotide polymorphism at this position in rs10886471 was studied."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;PCR&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Polymerase Chain Reaction (PCR) was used to amplify the genomic DNA for sequencing analysis."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;SPECIFIC PRIMERS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Primers specific to the rs10886471 region were designed and used in PCR."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;GLP-1 RECEPTOR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The GLP-1 receptor plays a critical role in glucose metabolism by facilitating insulin secretion."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;OR (95% CI)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The odds ratio with 95% confidence intervals for the association between the genetic variant and T2DM, IFG, or IGT."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;P = 0.001&quot;">
      <data key="d0">"SIGNIFICANCE LEVEL"</data>
      <data key="d1">"Statistically significant p-values indicating strong evidence against null hypothesis of no association between genetic variants and blood glucose groups."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;ALLELE FREQUENCIES&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The genetic variation at rs10886471 influences the frequency of different 'CA' repeat alleles based on glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLELE (CA)16&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The CA16 allele shows an increased risk associated with prediabetes and type 2 diabetes compared to other alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FOR PREDIABETES AND T2DM&quot;">
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d1">"The CA16 allele shows an increased risk associated with prediabetes and type 2 diabetes compared to other alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTROL GROUP&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The NFG group was designated as the control group in relation to comparing with case groups (IFG, IGT, T2DM).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NFG GROUP&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The NFG group was designated as the control group in relation to comparing with case groups (IFG, IGT, T2DM).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;(CA)16 ALLELE&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The (CA)16 allele was used as a reference for comparison when assessing the association of multiple alleles with different blood glucose groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REFERENCE ALLELE&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"The (CA)16 allele was used as a reference for comparison when assessing the association of multiple alleles with different blood glucose groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CASE GROUPS&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"These groups were identified based on their association with genetic variants in relation to abnormal blood glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG, IGT, AND T2DM GROUPS&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"These groups were identified based on their association with genetic variants in relation to abnormal blood glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANTS&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Specific genotypes are negatively correlated with the IFG group based on their association with abnormal blood glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG GROUP&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Specific genotypes are negatively correlated with the IFG group based on their association with abnormal blood glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IGT GROUP&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Specific genotypes show a negative correlation with the IGT group, relating to genetic variants and abnormal blood glucose levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2DM GROUP&quot;">
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d1">"Genetic variants are significantly associated with T2DM, as identified in statistical analyses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM SELENIUM&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum selenium concentration affects colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLORECTAL CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cases of colorectal cancer were diagnosed in the study participants, with some developing cancer in their colon."&lt;SEP&gt;"There is an association observed between the CC genotype and the occurrence of Colorectal Cancer (CRC)."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;GPX4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The single polymorphism rs8178974 in GPX4 gene is associated with increased colorectal cancer risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;NSAIDS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Cases and controls had similar use of non-steroidal anti-inflammatory drugs (NSAIDs), which may influence the results."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;DIETARY FIBER&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Cases had lower dietary fiber intake than controls, possibly related to lifestyle or disease risk factors."&lt;SEP&gt;"Dietary fiber comes from plant-based foods and is important for digestive health, including the prevention of certain chronic diseases."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;COLORECTAL TUMOR&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Tumors of the colon and rectum were classified in studies that measured selenium concentration."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SELENIUM&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum selenium levels showed an inverse association with colorectal tumor risk."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;GPX4 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs8178974 in GPX4 gene is linked to colorectal cancer, but overall gene variation isn't."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;SMOKING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Smoking was found to be slightly higher among cases compared to controls."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;POSTMENOPAUSAL HORMONE USE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"The use of postmenopausal hormones is lower in cases, indicating a potential role in hormone-sensitive conditions."&lt;SEP&gt;"The use of postmenopausal hormones is lower in cases, potentially affecting hormone-sensitive cancers."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;COLORECTAL ADENOMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A strong inverse association exists between serum selenium concentration and the risk of developing colorectal adenomas, highlighting its potential role as a biomarker or preventive factor."&lt;SEP&gt;"Colorectal adenomas were more strongly associated with selenium than cancer, indicating a potential role in early stages of the disease."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;PUBLICATION BIAS&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"A meta-analysis test found no significant publication bias for some variants and ovarian cancer risk, while it showed a marginal bias for one variant."&lt;SEP&gt;"There was evidence for potential publication bias towards finding inverse associations between selenium and colorectal tumors."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;GENDER EFFECT&quot;">
      <data key="d0">"STATISTICAL FACTOR"</data>
      <data key="d1">"Selenium's protective effect against colorectal tumors is stronger in men compared to women, indicating sex-specific differences."</data>
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
    </node>
    <node id="&quot;GPX4 GENE POLYMORPHISM&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"SNP rs8178974 in GPX4 gene is linked to increased colorectal cancer risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;SERUM SELENIUM CONCENTRATION&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"An inverse association exists between serum selenium concentration and the risk of colorectal tumors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELENIUM CONCENTRATION&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"An increased protective effect against colorectal tumors exists for men compared to women, indicating a potential gender-specific differential response to selenium intake.")&lt;SEP&gt;"Selenium's protective effect against colorectal tumors is stronger in men compared to women.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC INTERACTION&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"SNP rs8178974 in GPX4 gene interacts with the risk of colorectal cancer, suggesting genetic predisposition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GPX4 SNPS AND COLORECTAL CANCER&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"SNP rs8178974 in GPX4 gene interacts with the risk of colorectal cancer, suggesting genetic predisposition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE FACTORS (INCLUDING SMOKING AND HORMONE USE)&quot;">
      <data key="d2">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"There is an inverse relationship between serum selenium concentrations and lifestyle factors such as smoking and postmenopausal hormone use.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CARD9 has a role in shaping the bacterial and fungal gut microbiota and is required to control fungal microbiota expansion in colitis."&lt;SEP&gt;"The Card9 gene plays a role in colitis recovery and immune responses."&lt;SEP&gt;"The gut microbiota of Card9−/− mice contributes to the susceptibility of the mice to colitis via impaired tryptophan metabolism leading to defective AHR activation."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;DEXTRAN SULFATE SODIUM (DSS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DSS is an environmental factor that induces colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Card9−/− mice are more susceptible to colitis, as compared to wild-type (WT) mice."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;WEIGHT GAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Recovery from colitis is impaired in Card9−/− mice with delayed weight gain."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;HISTOPATHOLOGIC ALTERATIONS&quot;">
      <data key="d0">"PATHOLOGICAL PROCESS"</data>
      <data key="d1">"Histopathologic alterations refer to changes observed at the microscopic level, suggesting impaired intestinal healing."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;EPITHELIAL CELL PROLIFERATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Decreased epithelial cell proliferation was observed during the recovery period of Card9−/−→GF mice."&lt;SEP&gt;"Epithelial cells show reduced proliferation in Card9−/− mice during colitis recovery."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;APOPTOSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased apoptosis was noted in Card9−/−→GF mice as compared to WT→GF mice."&lt;SEP&gt;"Increased apoptosis, shown by increased staining for cleaved caspase 3, confirms impaired intestinal healing."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;KI67&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The proliferation marker Ki67 is used to assess cell proliferation in tissues."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CLEAVED CASPASE 3&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased staining for cleaved caspase 3 indicates increased apoptosis, which is not beneficial for recovery."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;COLONIC TRANSCRIPTOMES&quot;">
      <data key="d0">"GENOMIC DATA"</data>
      <data key="d1">"Comparison of colon transcriptomes between WT and Card9−/− mice during DSS-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;UPREGULATED GENES&quot;">
      <data key="d0">"TRANSCRIPTOMICS"</data>
      <data key="d1">"The number of upregulated genes is higher in Card9−/− mice compared to WT on day 7, suggesting an imbalance in gene expression."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IMMUNE-RELATED PATHWAYS&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"Pathways related to immune response show dominance, which corresponds to stronger signals in Card9−/− mice during colitis recovery."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;CELL PROLIFERATION AND REPLICATION&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"During the recovery period on day 12, cell proliferation pathways were more activated in WT mice than in Card9−/− mice."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3G&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Reg3g gene encoding REGIII-γ is highly induced and differentially expressed between Card9−/− and WT mice on days 7 and 12."&lt;SEP&gt;"Reg3g gene plays a role in colonic healing and regeneration."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REG3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Reg3b gene contributes to the protection against bacterial infections."&lt;SEP&gt;"Reg3b gene encoding REGIII-β shows similar expression patterns as Reg3g in response to colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;INTERLEUKIN 1 BETA (IL1B)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Il1b gene is also highly induced and differentially expressed between Card9−/− and WT mice on days 7 and 12 during colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-22&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Administration of exogenous IL-22 was sufficient to normalize AHR ligand production and colitis susceptibility in Card9−/− mice."&lt;SEP&gt;"IL-22 plays a major role in mediating recovery from DSS-induced colitis."&lt;SEP&gt;"Interleukin 22 (IL-22) is a cytokine that promotes tissue repair and regeneration."&lt;SEP&gt;"The protein IL-22 plays a role in immune responses and is produced by intraepithelial γδ T cells."&lt;SEP&gt;"IL-22 was similar in T cells of psoriasiform lesions and classical psoriasis."&lt;SEP&gt;"Interleukin-22 promotes skin repair and regeneration; it can also contribute to inflammation in various diseases."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;GUT MICROBIOTA&quot;">
      <data key="d0">"BIOLOGICAL SYSTEM"</data>
      <data key="d1">"The composition of the gut microbiota is altered at both fungal and bacterial levels in Card9−/− mice compared to WT mice."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;FUNGAL LOAD&quot;">
      <data key="d0">"FUNGAL LOAD"</data>
      <data key="d1">"The colonic fungal load peaks earlier and reaches higher values at day 7 in Card9−/− mice during DSS-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;FUNGAL DIVERSITY&quot;">
      <data key="d0">"DIVERSITY METRIC"</data>
      <data key="d1">"Increased resilience of the fungal microbiota is observed in WT mice compared to Card9−/− mice, suggesting stability and adaptability."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;ASCOMYCOTA&quot;">
      <data key="d0">"PHYLUM"</data>
      <data key="d1">"The gut fungal microbiota of WT and Card9−/− mice is dominated by members of Ascomycota, Basidiomycota, and Zygomycota phyla."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;IL-17A&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Interleukin 17A has a protective role in colitis by enhancing the response to IL-22."&lt;SEP&gt;"Interleukin-17A is pro-inflammatory cytokine produced by Th17 cells, involved in autoimmune and inflammatory conditions."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;REGENERATING ISLET-DERIVED PROTEIN III GAMMA (REGIII-Γ)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Reg3g, encoded by the Reg3g gene, functions as a regenerative and repair factor in the gastrointestinal tract."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;ADLERCREUTZIA&quot;">
      <data key="d0">"GENUS"</data>
      <data key="d1">"Decreased Adlercreutzia is observed at baseline in Card9−/− mice microbiota."&lt;SEP&gt;"Differences were observed at baseline including decreases in Adlercreutzia in the Card9−/− mouse microbiota."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;LACTOBACILLUS REUTERI&quot;">
      <data key="d0">"SPECIES"</data>
      <data key="d1">"Decreases in Lactobacillus reuteri were found in the Card9−/− mouse microbiota according to LEfSe analysis."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;BACTERIAL BIODIVERSITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bacterial biodiversity was observed between WT and Card9−/− mice at various time points."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;FUNGAL BIODIVERSITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No differences were noted regarding fungal biodiversity between WT and Card9−/− mice at any of the time points."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTER-KINGDOM RELATIONSHIP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A negative correlation was observed between bacterial and fungal biodiversity in WT mice, suggesting an inter-kingdom relationship."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;ABNORMAL INTERACTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A positive correlation was observed in Card9−/− mice, indicating abnormal interactions within the gut ecosystem between bacteria and fungi."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;GUT HOMEOSTASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Possible consequences on gut homeostasis were suggested by the correlation patterns of gut microbiota and host's immune response."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;BACTERIAL MICROBIOTA&quot;">
      <data key="d0">"MICROBIAL COMPONENT"</data>
      <data key="d1">"The bacterial component was involved in the phenotype observed in Card9−/− mice, but not the fungal component."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;GERM-FREE (GF) MICE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Colonization of WT germ-free mice with microbiota from either WT or Card9−/− mice recaptures the phenotype seen in Card9−/− mice."&lt;SEP&gt;"Microbiota plays a role in colitis susceptibility by influencing tryptophan metabolism and IL-22 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DSS INDUCED INJURY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DSS was used to induce injury and assess recovery response in both models."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;NANOSTRING TECHNOLOGY&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"179 inflammation-associated genes were assessed using NanoString technology for expression levels."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Il22 was one of the most highly downregulated genes in Card9−/−→GF mice as compared to WT→GF mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;CYTOKINE ENCODING GENES&quot;">
      <data key="d0">"GENES"</data>
      <data key="d1">"Cxcl1 and Cxcl5, known IL-22 target genes, were negatively correlated with Il22 expression in Card9−/−→GF mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR ENCODING GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Fos gene encoding a transcription factor was known as an IL-22 target gene and had decreased expression levels in Card9−/−→GF mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INTESTINAL HOMEOSTASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IL-22 has been implicated in intestinal homeostasis, with implications for innate antimicrobial resistance in mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL22 KNOCKOUT MICE&quot;">
      <data key="d0">"MODEL"</data>
      <data key="d1">"Il22−/− mice exhibit susceptibility to DSS-induced colitis and impaired healing during recovery periods similar to Card9−/− mice."</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DENDRITIC CELLS&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Dendritic cells stimulate IL-22-producing cells via IL-23 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;MACROPHAGES&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">"Macrophages are involved in the process of stimulating IL-22-producing cells, alongside dendritic cells."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;MICROBIOTA&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The gut microbiota contributes to colitis susceptibility and its ability to produce AHR ligands is associated with CARD9 and IBD."&lt;SEP&gt;"The gut microbiota contributes to immune responses and affects the production of cytokines like IL-22."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;ALTERED TRYPTOPHAN METABOLISM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Alterations in tryptophan metabolism can influence AHR activation, which is critical for IL-22 production."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INDOLE DERIVATIVES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Tryptophan derivatives like IAA promote local IL-22 production and are ligands for the AHR."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"AHR is involved in the regulation of local IL-22 production, with its activity being modulated by gut microbiota components."&lt;SEP&gt;"The gut microbiota alters the IL-22 signaling pathway via the impairment of tryptophan metabolism which leads to defective AHR activation."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;GUT IMMUNE SYSTEM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The underdevelopment of the gut immune system can lead to decreased levels of AHR ligands like IAA."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;CARD9−/− MOUSE MICROBIOTA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A deficient microbiota contributes to increased colitis sensitivity in Card9−/− mice through impaired tryptophan metabolism."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM DEFECTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The processes involving the metabolism of L-tryptophan, particularly by gut bacteria and host cells like IDO1, are altered in Card9−/− mice."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;INDOLEAMINE 2,3-DIOXYGENASE (IDO1)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"IDO1 plays a role in tryptophan catabolism leading to kynurenine production, which affects IL-22 induction and AHR activity."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR LIGANDS&quot;">
      <data key="d0">"CHEMICAL SUBSTANCE"</data>
      <data key="d1">"Indole derivatives like IAA are ligands for the AHR receptor that promote local IL-22 production and modulate immune responses."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;6-FORMYLINDOLO(3,2-B)CARBAZOLE (FICZ)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Ficz is an agonist of the AHR receptor used to assess its role in mitigating colitis and restoring IL-22 expression."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;GUT MICROBIOTA COMPOSITION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Changes in gut microbiota composition, like those present in Card9−/− mice, can influence host immune responses and inflammatory pathways."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;AHR ACTIVITY&quot;">
      <data key="d0">"BIOLOGICAL FUNCTION"</data>
      <data key="d1">"The activity of the AHR receptor is crucial for the regulation of local cytokine production and immune responses to gut microbiota stimuli."</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Alteration in tryptophan metabolism by the gut microbiota affects AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;KYN&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Subjects with IBD use tryptophan to produce Kyn via IDO1, but their gut microbiota's metabolism of tryptophan is impaired leading to defective AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IDO1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Activated immune cells in the gut produce Kyn through IDO1 activity when they utilize tryptophan."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IBD&quot;(INFLAMMATORY BOWEL DISEASE)">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Defects in AHR activation and changes in tryptophan metabolism are associated with IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;MICROBIOTA DERIVED METABOLITES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The gut microbiota's derived metabolites play a role in AHR activation and IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;FUNGAL MICROBIOTA&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"Alterations in the gut fungal microbiota are observed at both baseline and during colitis, with Card9−/− mice showing a less resilient microbiota compared to WT mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT HEALTH&quot;">
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d1">"Alterations in the gut fungal microbiota are observed at both baseline and during colitis, with Card9−/− mice showing a less resilient microbiota compared to WT mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d1">"Decreases in Adlercreutzia were revealed between baseline Card9−/− mouse microbiota compared to WT microbiota.")&lt;SEP&gt;"Variations observed between patients and controls, contributing to the heterogeneity in results."</data>
      <data key="d0">"MOLECULAR INTERACTION"</data>
    </node>
    <node id="&quot;DECREASES&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"Decreased levels of Lactobacillus reuteri were identified in the Card9−/− mouse microbiota based on LEfSe results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRELATION&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"A negative correlation between bacterial biodiversity was observed between WT and Card9−/− mice across various time points.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO DIFFERENCES&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"No notable differences were found in fungal biodiversity between baseline WT and Card9−/− mouse microbiota at any time point.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARD9−/− MICE&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Impaired tryptophan metabolism leading to defective AHR activation contributes to colitis susceptibility in Card9−/− mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR ACTIVATION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Alteration of the gut microbiota's function affects AHR activation through tryptophan metabolism and IL-22 pathway.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRYPTOPHAN&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Subjects with IBD use tryptophan to produce Kyn via IDO1 activity in their gut immune cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR AGONISTS&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The ability of the microbiota to produce AHR ligands is associated with CARD9, IBD and their metabolic pathways.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBD&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Variants in CARD9 are linked to reduced AHR activation by microbiota-derived metabolites extracted from fecal samples in individuals with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR LIGAND PRODUCTION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Impaired tryptophan metabolism in Card9−/− mice affects AHR ligand production, thus impacting colitis susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GUT IMMUNE CELLS&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Gut immune cells utilize tryptophan via IDO1 to produce Kyn when it comes to AHR activation in individuals with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FECAL SAMPLES&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"Healthy subjects' fecal samples induce higher levels of AHR activation compared to those from patients with IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AHR LIGATION&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The microbiota's tryptophan metabolites are required for the proper AHR ligation process in individuals without IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLITES&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The microbiota's tryptophan metabolites are required for the proper AHR ligation process in individuals without IBD.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10781499&quot;">
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d1">"The genetic variant rs10781499 within CARD9 impacts the interaction with the gut microbiota, affecting AHR activation in IBD patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;Β2M&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with prevalent hypertension and new-onset hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;PREVALENT HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Prevalent hypertension is a condition associated with baseline β2M concentration."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;NEW-ONSET HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"New-onset hypertension risk is positively associated with baseline β2M concentration."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;Β2M CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of measuring beta-2 microglobulin levels in blood."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ODDS RATIO (OR)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"A statistical measure for the association between baseline β2M concentration and hypertension risk."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;CLINICAL COVARIATES&quot;">
      <data key="d0">"COVARIATE"</data>
      <data key="d1">"Variables such as age, sex, BMI, diabetes, smoking status, cholesterol levels, statin use, eGFR, and blood pressure that are considered in multivariable models."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;QUARTILES&quot;">
      <data key="d0">"CLASSIFICATION"</data>
      <data key="d1">"Statistical quartile classification of β2M concentration into four groups."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;MEAN AGE&quot;">
      <data key="d0">"DEMOGRAPHIC VARIABLE"</data>
      <data key="d1">"Average age of participants at baseline."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;WOMEN RATIO (54%)&quot;">
      <data key="d0">"DEMOGRAPHIC PROPORTION"</data>
      <data key="d1">"Proportion of women in the study sample."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;GEE MODEL&quot;">
      <data key="d0">"STATISTICAL MODEL"</data>
      <data key="d1">"Generalized Estimating Equation model used for longitudinal analysis."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;DISCRIMINATION&quot;">
      <data key="d0">"MODEL EVALUATION METRIC"</data>
      <data key="d1">"Measures how well a statistical model predicts new onset hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;INTEGRATED DISCRIMINATION IMPROVEMENT (IDI)&quot;">
      <data key="d0">"RECLASSIFICATION METRIC"</data>
      <data key="d1">"Improvement in the prediction of new onset hypertension after adding β2M to the clinical model."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;NET RECLASSIFICATION INDEX (NRI)&quot;">
      <data key="d0">"RECLASSIFICATION METRIC"</data>
      <data key="d1">"Measures how a model's predictions change when using additional variables like β2M."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;CLINICAL MODEL&quot;">
      <data key="d0">"PREDICTIVE MODEL"</data>
      <data key="d1">"A predictive model consisting of various baseline covariates for hypertension risk assessment."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ALBUMINURIA&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Presence of albumin in urine as an indicator for kidney damage or dysfunction."&lt;SEP&gt;"Presence of albumin in urine, which was considered as a confounding factor when estimating β2M's association with new-onset hypertension."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;EGFR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Estimated glomerular filtration rate, used to assess kidney function and adjust for baseline conditions."&lt;SEP&gt;"The process of estimating glomerular filtration rate (eGFR) across different ancestry groups was found to have genetic associations."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;CIS-EFFECTS (WITHIN 1 MEGABASE)&quot;">
      <data key="d0">"GENETIC TERM"</data>
      <data key="d1">"The effect of a genetic variant on the gene it is located near within its immediate genomic context."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;TRANS-EFFECTS (&gt;1 MEGABASE AWAY)&quot;">
      <data key="d0">"GENETIC TERM"</data>
      <data key="d1">"The effect of a genetic variant that affects a gene located far from where it lies in the genome (greater than 1 mega base distance)."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Expression level of SH2B3 gene, influenced by the rs3184504 polymorphism and related to changes in blood β2M levels."&lt;SEP&gt;"Expression level of SH2B3, which is influenced by β2M levels."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;DECREASED SH2B3 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A reduction in SH2B3 expression as a result of rs3184504 polymorphism."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;CIS-GENETIC VARIATION (WITHIN SH2B3)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Variants that impact gene function within the same chromosome and relatively close to their target genes."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SH2B3 GENE DEFICIENCY (SH2B3−/− MICE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant causing a deficiency in SH2B3 expression by deleting its corresponding gene."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ANGIOTENSIN II-INDUCED HYPERTENSION&quot;">
      <data key="d0">"EXPERIMENTAL CONDITION"</data>
      <data key="d1">"Hypertensive response induced through the administration of angiotensin II to test effects."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;Β2M EXPRESSION INDUCTION&quot;">
      <data key="d0">"BIOLOGICAL RESPONSE"</data>
      <data key="d1">"Increased β2M expression in response to hypertensive stimuli in Sh2b3−/− mice compared to wild-type ones."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;STATINS USE&quot;">
      <data key="d0">"MEDICATION STATUS"</data>
      <data key="d1">"Use of statin medications by participants in relation to β2M concentration and hypertension risk."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;SYSTOLIC BLOOD PRESSURE (BP)&quot;">
      <data key="d0">"LABORATORY MEASUREMENT"</data>
      <data key="d1">"The upper number in blood pressure measurement, indicating the arterial pressure during heart contraction."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;DIASTOLIC BLOOD PRESSURE (BP)&quot;">
      <data key="d0">"LABORATORY MEASUREMENT"</data>
      <data key="d1">"The lower number in blood pressure measurement, indicating the arterial pressure during rest between heartbeats."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;EGFR (ESTIMATED GLOMERULAR FILTRATION RATE)&quot;">
      <data key="d0">"CLINICAL MEASURE"</data>
      <data key="d1">"An estimate of the glomerular filtration rate, measuring how well kidneys filter waste products from blood."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ANGIOTENSIN II&quot;">
      <data key="d0">"PHARMACOLOGICAL AGENT"</data>
      <data key="d1">"A vasoactive hormone that increases blood pressure by causing arteriolar constriction and stimulating aldosterone secretion."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;RS3184504 POLYMORPHISM&quot;">
      <data key="d0">"GENETIC VARIATION"</data>
      <data key="d1">"Specific genetic variation in the human genome, associated with plasma β2M levels and SH2B3 expression."</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
    </node>
    <node id="&quot;ADJUSTMENT FOR CONFOUNDING FACTORS&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"The clinical model adjusts for various confounding factors to assess the independent association between β2M and hypertension.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BASELINE Β2M CONCENTRATION&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"In a longitudinal study, increased baseline β2M concentration is associated with an elevated risk of new-onset hypertension.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LONGITUDINAL ASSOCIATION WITH NEW-ONSET HYPERTENSION&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"In a longitudinal study, increased baseline β2M concentration is associated with an elevated risk of new-onset hypertension.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISCRIMINATION FOR NEW-ONSET HYPERTENSION&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"The addition of β2M to the clinical model improves its ability to discriminate between individuals who will develop new onset hypertension.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAUSAL EFFECT ON Β2M LEVELS&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"Decreased SH2B3 expression leads to higher β2M levels, as indicated by the inverse variance weighted MR analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDIATION THROUGH SH2B3 EXPRESSION&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"The rs3184504 genetic variant may influence β2M levels through its impact on SH2B3 expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED HYPERTENSIVE RESPONSE&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"Deficiency in SH2B3 function is associated with a more severe hypertensive response and renal dysfunction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SH2B3−/− MOUSE MODEL&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"Deficiency in SH2B3 function is associated with a more severe hypertensive response and renal dysfunction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH SH2B3 EXPRESSION&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"The rs3184504 polymorphism influences SH2B3 expression, as indicated by the association between it and SH2B3 gene function in the Mendelian randomization study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CASE INFANT&quot;">
      <data key="d0">"INFANT"</data>
      <data key="d1">"Case infants were more likely to be female than control infants."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;CONTROL INFANT&quot;">
      <data key="d0">"INFANT"</data>
      <data key="d1">"Control infants had a different sex distribution compared to case infants."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;NON-HISPANIC WHITE MOTHER&quot;">
      <data key="d0">"MOTHER"</data>
      <data key="d1">"Non-Hispanic White mothers tended to be older at delivery compared to Hispanic mothers."&lt;SEP&gt;"The racial/ethnic makeup of the study population was consistent within cases and controls for non-Hispanic Whites but varied for Hispanics."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;HISPANIC MOTHER&quot;">
      <data key="d0">"MOTHER"</data>
      <data key="d1">"Hispanic mothers received less formal education than non-Hispanic White mothers."&lt;SEP&gt;"Hispanic mothers were younger than non-Hispanic White mothers but consistent within maternal race/ethnicity."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;FOLIC ACID SUPPLEMENTS&quot;">
      <data key="d0">"NUTRIENT SUPPLEMENT"</data>
      <data key="d1">"Periconceptional use of folic acid supplements was higher among non-Hispanic White mothers compared to Hispanic mothers."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;DAILY DIETARY FOLATE INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN/FOLATE CONSUMPTION"</data>
      <data key="d1">"Amounts and sources of dietary folate consumed daily by mothers were also evaluated."&lt;SEP&gt;"The differences in daily dietary intake of folate were subtle between the studied subgroups."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;COMPOSITE FOLATE INTAKE VARIABLE&quot;">
      <data key="d0">"DIETARY ASSESSMENT"</data>
      <data key="d1">"A composite measure capturing overall folate intake was more similar across groups than single nutrient intake measures."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;DHFR GENE VARIANT&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"</data>
      <data key="d1">"There was no evidence of association between DHFR gene variants and NTD-affected pregnancies in the studied population."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFD1 SNPS RS2236224 AND RS2236225&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The CT genotype for MTHFD1 SNPs was associated with a risk of 1.58 (CI:0.99,2.51) in infants from the lowest folate intake group compared to those with CC genotypes."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFD1 SNP RS11627387 AG GENOTYPE&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The AG genotype for MTHFD1 SNP was associated with a risk of four-fold increase (CI: 2.33,7.75) in NTD risk when maternal folate intake was low compared to GG genotypes."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR SNPS RS1476413, RS1801131 AND RS1801133&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Mothers with low folate intake had a decreased risk of an NTD-affected pregnancy if they carried heterozygous MTHFR SNPs compared to common homozygous mothers."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS669340 CG GENOTYPE&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The CG genotype for SHMT1 was associated with a 31% risk reduction (CI: 0.49,0.96) in NTD-affected pregnancies compared to CC genotypes."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS12939757 AG/AA GENOTYPES AND LOW VS HIGH FOLATE INTAKE&quot;">
      <data key="d0">"SNP INTERACTION"</data>
      <data key="d1">"There was an interaction effect for SHMT1 SNPs associated with risk of NTDs in infants depending on maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS SNP RS502396 OR RS699517 HETEROZYGOUS GENOTYPES AND LOW VS HIGH FOLATE INTAKE&quot;">
      <data key="d0">"SNP INTERACTION"</data>
      <data key="d1">"A gene-folate interaction was associated with a reduced risk of NTDs for mothers in the low folate intake group compared to those in the high intake group."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;GENE-FOLATE INTERACTION FOR TYMS SNPS RS2847153 AND LOW VS HIGH FOLATE INTAKE IN INFANTS&quot;">
      <data key="d0">"SNP INTERACTION"</data>
      <data key="d1">"The gene-folate interaction also had a protective effect on infants with AG genotypes compared to AA genotypes when mothers were on low folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;CASE-CONTROL DESIGN&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"A case-control design was employed to compare characteristics of infants with NTDs to those without."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MATERNAL DEMOGRAPHICS&quot;">
      <data key="d0">"COVARIATES OR EXPLANATORY VARIABLES"</data>
      <data key="d1">"The study considered maternal demographics including age, race/ethnicity, and education level as potential confounding factors."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;PERICONCEPTIONAL FOLIC ACID SUPPLEMENTATION&quot;">
      <data key="d0">"INTERVENTION OR EXPOSURE"</data>
      <data key="d1">"Maternal intake of folic acid supplements before pregnancy was assessed as an intervention or exposure factor."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;COMPOSITE MEASURE FOR FOLATE INTAKE&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"A composite measure combining intake from dietary sources and supplements was used to evaluate overall maternal folate status."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;DHFR GENE VARIANT GENOTYPES&quot;">
      <data key="d0">"GENETIC MARKER OR POLYMORPHISM"</data>
      <data key="d1">"The genotypes of specific polymorphisms in the dihydrofolate reductase (DHFR) gene were examined for their association with NTD risk."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFD1 SNPS RS2236224 AND RS2236225 GENOTYPES&quot;">
      <data key="d0">"SNP OR GENETIC MARKER"</data>
      <data key="d1">"The genotypes of two specific single nucleotide polymorphisms (SNPs) in the MTHFD1 gene were analyzed."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFD1 SNP RS11627387 AG/AA GENOTYPES&quot;">
      <data key="d0">"SNP INTERACTION WITH FOLATE INTAKE"</data>
      <data key="d1">"Interaction between genotypes of a specific SNP and maternal folate intake on NTD risk was studied."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MTHFR SNPS RS1476413, RS1801131 AND RS1801133 GENOTYPES&quot;">
      <data key="d0">"SNP OR GENETIC POLYMORPHISM INTERACTION"</data>
      <data key="d1">"Combinations of genotypes from three specific MTHFR SNPs were investigated for their effect on NTD risk."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;SHMT1 SNP RS669340 CG/CC GENOTYPES&quot;">
      <data key="d0">"GENETIC MARKER OR POLYMORPHISM"</data>
      <data key="d1">"The genotypes of a specific polymorphism in the serine hydroxymethyltransferase 1 (SHMT1) gene were considered as an additional genetic factor."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;TYMS SNP RS2847153 AND RS699517 GENOTYPES&quot;">
      <data key="d0">"SNP OR GENETIC MARKER INTERACTION WITH FOLATE INTAKE"</data>
      <data key="d1">"Combinations of genotypes from specific TYMS SNPs were analyzed for their impact on NTD risk, especially in the context of low maternal folate intake."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;GENE-FOLATE INTERACTION FOR DHFR AND MTHFD1 SNPS&quot;">
      <data key="d0">"INTERACTION EFFECT BETWEEN GENES AND NUTRIENT INTAKE"</data>
      <data key="d1">"The study aimed to uncover whether certain genotypes might interact differently with maternal folic acid intake, affecting NTD risk."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;CASE INFANT VS. CONTROL INFANT COMPARISON&quot;">
      <data key="d0">"OUTCOME COMPARISON"</data>
      <data key="d1">"Comparisons were made between infants classified as cases (with NTDs) and those in the control group without."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;RACIAL/ETHNIC SUBGROUPS&quot;">
      <data key="d0">"COHORT COMPOSITION OR STRATIFICATION FACTOR"</data>
      <data key="d1">"The racial/ethnic composition was considered, with separate analyses for non-Hispanic White vs. Hispanic mothers and infants."</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MATERNAL AGE AT DELIVERY&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"There was an age difference between non-Hispanic White and Hispanic mothers based on supplement use.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HISPANIC MOTHER EDUCATION LEVEL&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"There was a disparity in formal education attainment between Hispanic and non-Hispanic White mothers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NON-HISPANIC WHITE MOTHER EDUCATION LEVEL&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"There was a disparity in formal education attainment between Hispanic and non-Hispanic White mothers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES ACROSS SUBGROUPS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"The composite measure showed subtle differences but more consistency compared to single nutrient intake measures.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLATE INTAKE VARIABLE COMPOSITE MEASURE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"The composite measure showed subtle differences but more consistency compared to single nutrient intake measures.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DHFR GENE VARIANT AND NTD-AFFECTED PREGNANCIES&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"No evidence of association between DHFR gene variants and risk for NTD pregnancies in studied population.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISM ASSOCIATION&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"No evidence of association between DHFR gene variants and risk for NTD pregnancies in studied population.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFANT RISK FACTOR&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"CT genotype was associated with increased risk compared to CC genotypes for infants in lower folate intake groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFD1 SNPS RS2236224 AND RS2236225 CT GENOTYPE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"CT genotype was associated with increased risk compared to CC genotypes for infants in lower folate intake groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFD1 SNP RS11627387 AG/AA GENOTYPES AND LOW FOLATE INTAKE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"AG genotype was associated with four-fold increase risk of NTDs when maternal folate intake was low compared to GG genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NTD RISK FACTOR&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"AG genotype was associated with four-fold increase risk of NTDs when maternal folate intake was low compared to GG genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLATE INTAKE AND RISK OF NTDS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Low folate intake was associated with a decreased risk of an NTD-affected pregnancy if mothers carried heterozygous MTHFR SNPs compared to common homozygous mothers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR SNPS RS1476413, RS1801131 AND RS1801133 HETEROZYGOUS VS COMMON HOMOZYGOUS MOTHERS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Low folate intake was associated with a decreased risk of an NTD-affected pregnancy if mothers carried heterozygous MTHFR SNPs compared to common homozygous mothers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK REDUCTION FOR NTDS IN MOTHERS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"CG genotype was associated with a 31% risk reduction of NTD-affected pregnancies compared to CC genotypes among mothers.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FOR NTDS INTERACTION EFFECT&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"An interaction effect was observed with AG vs AA genotypes in infants depending on maternal folate intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHMT1 SNP RS12939757 AG/AA GENOTYPES AND LOW FOLATE INTAKE IN INFANTS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"An interaction effect was observed with AG vs AA genotypes in infants depending on maternal folate intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK REDUCTION FOR NTDS INTERACTION EFFECT&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Gene-folate interaction was associated with reduced risk of NTDs among mothers on low folate intake compared to high intake group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYMS SNP RS502396 OR RS699517 HETEROZYGOUS GENOTYPES AND LOW FOLATE INTAKE IN MOTHERS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Gene-folate interaction was associated with reduced risk of NTDs among mothers on low folate intake compared to high intake group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FOR NTDS INTERACTION EFFECT IN INFANTS&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"An interaction effect was protective for infants with AG genotypes compared to AA genotypes when mothers were on low folate intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYMS SNPS RS2847153 AND LOW FOLATE INTAKE IN INFANTS, INTERACTION EFFECT FOR AG GENOTYPES&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"An interaction effect was protective for infants with AG genotypes compared to AA genotypes when mothers were on low folate intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS10399931&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs10399931 is a genetic variant without significant association with Type 2 Diabetes after adjusting for age, sex, BMI and glucose tolerance."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;RS4950928&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4950928 is another genomic variant that was not associated with T2D after adjustment for covariates."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLUCOSE (IFG)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IFG was tested with genetic variants but showed no significant associations."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"IGT was investigated for associations with certain genetic variants, though a borderline protective effect was detected for one specific variant."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;SERUM C-PEPTIDE CONCENTRATION&quot;">
      <data key="d0">"QUANTITATIVE TRAIT"</data>
      <data key="d1">"An association was discovered between rs10399931 and serum C-peptide concentration after a 2-hour mark, suggesting its influence on this specific trait."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 37}]</data>
    </node>
    <node id="&quot;RS10546972&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs10546972, another genetic variant of interest, showed no significant association with T2D in our analysis."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;IMPAIRED GLUCOSE REGULATION (IGR)&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"A condition including both IFG and IGT was not associated with specific SNPs except for a borderline protective effect detected for rs12123883."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;CHI3LI HAPLOTYPE BLOCK 1&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"Haplotype block 1 of the CHI3LI gene did not show any significant associations with T2D."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;CHI3LI HAPLOTYPE BLOCK 2&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"Another genomic region of the CHI3LI gene similarly showed no association with Type 2 Diabetes."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 51}]</data>
    </node>
    <node id="&quot;AMD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Aerosolized microdust pneumonitis (AMD) is a condition characterized by lung inflammation and fibrosis, often resulting from exposure to dust particles."&lt;SEP&gt;"Age-related macular degeneration (AMD) is a condition that can be influenced by both genetic factors and lifestyle choices."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;LOW HLS SCORES&quot;">
      <data key="d0">"SCORE"</data>
      <data key="d1">"HLS scores are low when dietary intake does not meet recommended guidelines."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;HIGH HLS SCORES&quot;">
      <data key="d0">"SCORE"</data>
      <data key="d1">"HLS scores are high when dietary intake meets or exceeds recommended guidelines."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;STABLE DIETS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A stable diet is characterized by consistent food and nutrient intake over time."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;Y402H CFH RISK ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Y402H variant of the complement factor H gene (CFH) has been linked to increased risk for AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;A69S RISK ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An additional copy of the A69S CFH risk allele increases odds of AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;G ALLELE OF RS641153 (CFB/C2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The G allele for the single nucleotide polymorphism in the complement factor CFB/C2 gene is associated with increased AMD risk."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS10033900&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No main effect was observed within CAREDS for rs10033900, a variant of CFH related to AMD risk."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS2230199&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Similarly, no main effect was found for rs2230199, another CFH variant linked to AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;CFH GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CFH genotypes refer to the different forms of the CFH gene which can affect susceptibility to AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;LIFESTYLE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Lifestyle is a factor that could potentially interact with genetic factors to influence the risk of age-related macular degeneration (AMD)."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;SI&quot;">
      <data key="d0">"SYNERGY INDEX"</data>
      <data key="d1">"The synergy index is a measure used in this context, indicating the combined effect of two or more factors on disease risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;ARMS2 GENOTYPE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ARMS2 gene carries risk alleles associated with AMD."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;HLS&quot;">
      <data key="d0">"HEALTHY LIFESTYLE SCORE"</data>
      <data key="d1">"The HLS score was used to evaluate adherence to a healthy lifestyle, which could potentially interact with ARMS2 genotypes on AMD risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;CFB/C2&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"There was no evidence for joint effects between lifestyle and variants in the CFB/C2 gene on AMD risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 15}]</data>
    </node>
    <node id="&quot;C3 RS2230199&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"The main effects for SNPs in C3 were absent when examining interactions with lifestyle, indicating limited influence on AMD risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 12}]</data>
    </node>
    <node id="&quot;CFI RS10033900&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"Similar to the C3 SNP, there were no strong indications of interaction between lifestyle and this variant in CFI for AMD risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 16}]</data>
    </node>
    <node id="&quot;CFB/C2 GENE&quot;">
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d1">"The CFB/C2 gene variants were also explored in relation to AMD, but their main effects did not significantly influence AMD risk in combination with HLS.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 14}]</data>
    </node>
    <node id="&quot;1Q24&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A total of 18 SNPs located in 1q24 achieved a suggestive significance."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;12Q24&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A total of 18 SNPs located in 12q24 also achieved a suggestive significance."&lt;SEP&gt;"When we additionally adjusted for baseline BMI, the same 18 significant SNPs were identified as well."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;RS2074356&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"One of the genotyped SNPs considered coffee-related."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;RS11066015&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Another genotyped SNP considered coffee-related."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;RS12229654&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Yet another genotyped SNP considered coffee-related."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;RS11065828&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"One of the imputed SNPs considered coffee-related."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;RS79105258&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The other imputed SNP considered coffee-related."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;HECTD4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located in gene HECTD4, one of the identified genes associated with coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;ACAD10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located in gene ACAD10, another one of the identified genes associated with coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;MYL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located in gene MYL2, yet another identified gene associated with coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;CUX2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Located in gene CUX2, one of the genes associated with coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;MEN&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Participants who were men and had been consuming ≥2 cups/day of black coffee had a lower risk for prediabetes and type 2 diabetes."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;WOMEN&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Although the association was not statistically significant among women, an inverse trend was observed for sugared coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC RISK SCORES&quot;">
      <data key="d0">"QUANTITATIVE MEASURE"</data>
      <data key="d1">"The information on genetic risk scores for participants based on their SNPs associated with coffee consumption."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;ALCOHOL INTAKE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Participants who consumed habitual coffee were also more likely to drink alcohol."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SUGARED COFFEE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Participants who preferred sugared coffee over black coffee were part of the sugared coffee dietary pattern."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;PARTICIPANTS&quot;">
      <data key="d0">"STUDY POPULATION"</data>
      <data key="d1">"The baseline characteristics provided a comprehensive overview of the study population's demographics, behaviors, and health status."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;STATISTICAL ANALYSIS&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A Genome-Wide Association Study was conducted to find the genetic polymorphisms associated with habitual coffee consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL MEASURE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Suggestive significance (p &lt; 1 × 10−5) for genotyped SNPs in GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP AND COFFEE CONSUMPTION&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Genetic polymorphisms identified by GWAS were associated with habitual coffee consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A total of 18 SNPs located in different genomic regions achieved suggestive significance.")&lt;SEP&gt;"Variations within genes related to lipid metabolism can influence an individual's susceptibility to hypertriglyceridemia."</data>
      <data key="d0">"BIOMEDICAL VARIATION"</data>
    </node>
    <node id="&quot;GWAS RESULTS&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"A total of 18 SNPs located in different genomic regions achieved suggestive significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC RISK SCORES AND COFFEE CONSUMPTION&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"An inverse association was more pronounced among individuals with high genetic risk scores for black coffee consumption, but the interaction was not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION AND DIABETES RISK&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Participants who consumed ≥2 cups/day of black or sugared coffee had a lower risk of prediabetes and type 2 diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREVENTION EFFECT&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Participants who consumed ≥2 cups/day of black or sugared coffee had a lower risk of prediabetes and type 2 diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE AND COFFEE CONSUMPTION&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"There was a correlation between age and coffee consumption, with younger participants being more likely to consume black or sugared coffee.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION AND ALCOHOL INTAKE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Coffee consumers tended to have higher rates of alcohol consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COFFEE TYPE AND DIETARY PREFERENCE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Coffee preferences could indicate different dietary patterns or habits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREFERENCE&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Coffee preferences could indicate different dietary patterns or habits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHARACTERISTICS ANALYSIS&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Detailed examination was conducted on the baseline characteristics of the participants for various analyses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY POPULATION ANALYSIS&quot;">
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d1">"Detailed examination was conducted on the baseline characteristics of the participants for various analyses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SENP1 deficient mice show autoimmune mediated damages."&lt;SEP&gt;"SENP1-deficient mice exhibit T1DM phenotype"&lt;SEP&gt;"The SENP1 gene is involved in the development of spontaneous diabetes in NOD mice and human T1DM patients."&lt;SEP&gt;"The gene SENP1 plays a role in autoimmune responses occurring in the pancreases of mice."</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"SENP1 expression (messenger RNA (mRNA) and protein)"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPONECTIN, PDGFRΑ OR AP2/FABP4&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Genetically modified mice with an adipocyte-specific deletion of SENP1"&lt;SEP&gt;"we created genetically modified mice with an adipocyte-specific deletion of SENP1"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;CRE RECOMBINASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"we created genetically modified mice with an adipocyte-specific deletion of SENP1"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PATS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"SENP1-deficient mice were viable after birth. However, these adipocyte-specific SENP1-deficient mice all developed a diabetic phenotype (Fig."&lt;SEP&gt;|&gt;Adipocyte Cells"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;AP2-CRE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"the aP2-Cre has a moderate efficiency in adipocytes with variable degrees of target gene recombination"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;MACROPHAGES OR CAPILLARY ENDOTHELIUM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"in a floxed gene locus-dependent manner"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;FASTING&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"we focused on male mice for further studies"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;SENP1-SMKO&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"SENP1-smKO and SENP1-ecKO mice did not develop a high-glucose phenotype even at the age of 14 weeks"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;VE-CADHERIN-CRE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"specifically deleted in vascular endothelial cells"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GTT AND ITT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"the GTT was prolonged and similar insulin responses were observed"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ISOLATED ISLETS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"glucose-stimulated insulin secretion from SENP1-deficient islets was significantly reduced"</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INSULIN-DEPENDENT DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Insulin-dependent diabetes mellitus results from T-cell-mediated destruction of insulin-producing pancreatic islet β cells."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;T-CELL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Immune cell-specific effector T-cell invasion in the pancreatic tissue attacks the islets and induces cell death."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;Β-HYDROXYBUTYRATE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"KETONE BODY"</data>
      <data key="d1">"Beta-hydroxybutyrate is classified as ketones that are produced in the body when the body loses its ability to absorb glucose properly."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;AUTOANTIGEN NRP-V7-POSITIVE CD8+ T CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"T cells, which are part of the immune system, interact with autoantigens (NRP-V7) from a specific glucose-6-phosphatase catalytic subunit-related protein in pancreatic lymph nodes and spleen."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PEPTIDE FROM ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A peptide derived from the islet-specific glucose-6-phosphatase catalytic subunit interacts with NRP-V7-positive CD8+ T cells."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;INSULIN DEFICIENCY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A consequence of autoimmune damage to pancreatic β cells is the reduction in the production and release of insulin, leading to insulin deficiency."&lt;SEP&gt;|&gt;Disease"/"Type 1 Diabetes"</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES IL-6, TNF-Α, IL-IΒ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"SENP1-deficient mice show elevated levels of proinflammatory cytokines such as IL-6, TNF-α and IL-Iβ before the onset of diabetes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SYSTEMIC AUTOIMMUNE RESPONSES&quot;">
      <data key="d0">"AUTOIMMUNE RESPONSE"</data>
      <data key="d1">"Increased systemic cytokines in SENP1-deficient mice suggest a potential for broader autoimmune reactions."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;DIABETIC PHENOTYPE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The combination of high proinflammatory cytokine levels and altered adipose tissue metabolism can result in the development of diabetes, manifested by diabetic phenotypes such as cardiac function changes and vascular reactivity issues."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ADIPOSE TISSUE&quot;">
      <data key="d0">"BIOMEDICAL STRUCTURE"</data>
      <data key="d1">"Alterations in adipose tissue function can impact lipid metabolism and triglyceride levels."&lt;SEP&gt;"SENP1 deletion affects the expression of certain cytokines specifically in peri-pancreatic adipocytes compared to other types of adipose tissue."&lt;SEP&gt;|&gt;Disease"/"Diabetes"</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES IL-6, TNF-Α AND IL-IΒ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"The production of proinflammatory cytokines is higher in peri-pancreatic adipocytes than in other adipose tissues due to SENP1 deletion."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREAS&quot;">
      <data key="d0">"ORGAN/TISSUE"</data>
      <data key="d1">"SENP1-deficient mice exhibit increased cytokine levels and myocarditis specifically in their pancreases, which are indicative of a prevalent diabetic phenotype."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCL5 (RANTES)&quot;">
      <data key="d0">"CHEMOKINE"</data>
      <data key="d1">"CCL5 plays a role in directing recruitment of immune cells to inflammation sites or autoimmune targets contributing to type-1 diabetes development."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCR5 LIGAND&quot;">
      <data key="d0">"RECEPTOR TYPE"</data>
      <data key="d1">"CCL5 binds to CCR5 receptors, playing an important part in recruiting immune cells that contribute to autoimmune responses and disease onset."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;TYPE-1 DIABETIC DEVELOPMENT&quot;">
      <data key="d0">"PATHOLOGICAL PROCESS"</data>
      <data key="d1">"The upregulation of specific chemokines like CCL5 in pancreatic islets could lead to a cascade of events leading to the development of type-1 diabetes."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SENP1-AP2KO PANCREATIC ADIPOCYTES&quot;">
      <data key="d0">"ADIPOCYTE"</data>
      <data key="d1">"The adipocytes isolated from mice lacking the SENP1 gene at the adipose tissue of pancreas (SENP1-aP2KO). These adipocytes are characterized by smaller cell size and higher number of cells compared to Ctrl adipocytes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CONTROL ADIPOCYTES&quot;">
      <data key="d0">"ADIPOCYTE"</data>
      <data key="d1">"Adipocytes isolated from normal mice, used as a control for the SENP1-aP2KO mice experiments."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IL-6 ANTIBODY&quot;">
      <data key="d0">"ANTIBODY"</data>
      <data key="d1">"Neutralizing antibody against IL-6. Used to reduce upregulation of CCL5 expression."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;TNF ANTIBODY&quot;">
      <data key="d0">"ANTIBODY"</data>
      <data key="d1">"Neutralizing antibody against TNF, used together with the IL-6 antibody in experiments to reduce upregulation of CCL5 expression."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;IL-1Β ANTIBODY&quot;">
      <data key="d0">"ANTIBODY"</data>
      <data key="d1">"Neutralizing antibody against IL-1β, used together with the IL-6 and TNF antibodies in experiments to reduce upregulation of CCL5 expression."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"High levels of local pro-inflammatory cytokines secreted from peripancreatic adipocytes (PATs) induces the expression of CCL5, a chemokine that promotes infiltration of immune cells into pancreas."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;CCL5&quot;">
      <data key="d0">"CHEMOKINE"</data>
      <data key="d1">"CCL5 is expressed in response to high local concentrations of pro-inflammatory cytokines from PATs. It recruits immune cells which cause damages on β-cells in pancreas."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PERI-PANCREATIC ADIPOCYTES (PATS)&quot;">
      <data key="d0">"ADIPOCYTE"</data>
      <data key="d1">"The adipocytes located around the pancreas that are involved in the production and secretion of pro-inflammatory cytokines such as IL-6, TNF or IL-1β. Their augmented release contributes to damages on β cells."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;LOCAL PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"High local concentrations of cytokines secreted by PATs upregulate CCL5 expression and leads to infiltration of immune cells into pancreas, causing damages on β cells."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PANCREATIC DISRUPTION&quot;">
      <data key="d0">"PATHOLOGY"</data>
      <data key="d1">"The process where pancreatic tissues are damaged due to the direct effect of adipocyte-derived cytokines on pancreatic islets."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PANCREATIC ADIPOCYTES FROM SENP1-AP2KO MICE&quot;">
      <data key="d0">"ADIPOCYTE"</data>
      <data key="d1">"Adipocytes isolated from mice with a deletion in the SENP1 gene at the peripheric pancreas (SENP1-aP2KO). Show characteristics of reduced adipogenesis and increased cytokine production."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PPARΓ PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein form of PPARγ, crucial for repressing inflammatory responses via SUMOylation pathway."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PHOSPHORYLATED IKK&quot;">
      <data key="d0">"KINASE"</data>
      <data key="d1">"In the adipocytes with the SENP1 knockdown, phosphorylated IKK levels were increased markedly."&lt;SEP&gt;"The activated form of IκB Kinase which gets phosphorylated during the activation process of NF-κB pathway."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NF-ΚB SUBUNIT P65/RELA&quot;">
      <data key="d0">"SUBUNIT OF NF-ΚB COMPLEX"</data>
      <data key="d1">"The RelA subunit of the NF-κB protein complex that binds to DNA and activates gene transcription during immune response and inflammation processes."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NF-ΚB P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The RelA subunit of the NF-κB protein complex that binds to DNA and activates gene transcription during immune response and inflammation processes."&lt;SEP&gt;"The gene expressions of proinflammatory cytokines from adipocytes were significantly higher in the SENP1 knockdown cells."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP1 SHORT INTERFERING RNA (SIRNA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The adipocytes were transfected with a Ctrl or SENP1 siRNA."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IΚBΑ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IKK, IκBα and NF-κB p65/RelA levels were all significantly upregulated in the SENP1 knockdown cells."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IL-1 Β&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SENP7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NEMO&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The NEMO protein binds Ub through a ββα structure with specific interactions involving Pro21-Val22 residues in the β-loop replaced by Pro398-Lys399 and Glu636-Lys637 respectively, indicating distinct modes of interaction compared to other UBZs."&lt;SEP&gt;(</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IKK&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;DNA DAMAGE AGENT ETOPOSIDE VP16&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;ADIPOCYTES ISOLATED FROM SENP1-AP2KO MICE&quot;">
      <data key="d0">"CELL"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;PHOSPHORYLATED IKK AND P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;CYTOKINE PRODUCTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;DNA DAMAGE INDUCED BY ETOPOSIDE VP16&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SUMOYLATIONS OF NEMO AND P65/RELA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;INCREASED SUMOYLATION IN ADIPOCYTES WITH SENP1 DELETION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;STRESS RESPONSES SUCH AS OXIDATIVE STRESS, INFLAMMATORY STIMULI AND DNA DAMAGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;PHOSPHORYLATION OF IKK AND P65/RELA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;BASAL AND STRESS-INDUCED NEMO SUMOYLATION IN ADIPOCYTES WITH SENP1 DELETION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;FLAG-NEMO MUTANTS (NEMO K277R, K309R OR THE DOUBLE MUTANT)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;SUMO-DEFICIENT NEMO MUTANTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;DOMINANT NEGATIVE FORMS OF SUMOYLATED NEMO&quot;">
      <data key="d0">"ROLE IN REGULATING NF-ΚB SIGNALLING"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;CLINICAL RELEVANCE OF ADIPOCYTE-SPECIFIC SENP1-DEFICIENT MICE TO HUMAN T1DM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">(</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NON-OBESE DIABETIC (NOD) MOUSE&quot;">
      <data key="d0">"MODEL"</data>
      <data key="d1">"The NOD mouse model is widely used for studying type 1 diabetes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS (T1DM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T1DM is an autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;TH1 DOMINANT&quot;">
      <data key="d0">"IMMUNOLOGICAL RESPONSE"</data>
      <data key="d1">"The predominant T-cell response is TH1, leading to inflammation and autoimmunity against beta cells."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;SERUM&quot;">
      <data key="d0">"BODY FLUID"</data>
      <data key="d1">"Blood serum collected from NOD mice with diabetes or human T1DM patients contains increased levels of proinflammatory cytokines."&lt;SEP&gt;"Serum is a liquid component of blood excluding cells, where levels of IL-8 can be measured."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PAT&quot;">
      <data key="d0">"ADIPOSE TISSUE"</data>
      <data key="d1">"PAT stands for perivascular adipose tissue, an important site of inflammation and insulin resistance."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PRE-PROINSULIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Pre-proinsulin is a precursor protein to the production of insulin in beta cells."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An autoimmune disease, like T1DM, occurs when the immune system mistakenly attacks and destroys healthy tissue."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HFD&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"High Fat Diet increased fat weight in all adipose depots, including epididymal fat and PATs."&lt;SEP&gt;|&gt;Metabolic Pathway/</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;CTRL&quot;">
      <data key="d0">"GENOMIC VARIANT"/"MOLECULAR INTERACTION"/"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Control condition under normal chow diet."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;SENP1-AP2KO&quot;">
      <data key="d0">"DISEASE"/"GENOME"/"GENE"/"PROTEIN"/"MOLECULAR INTERACTION"/"CELL"</data>
      <data key="d1">"SENP1 knockout mice with a patern-specific deletion of the SEPP1 gene, impacting adipose tissue development and function."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;EPIDIDYMAL FAT&quot;">
      <data key="d0">"ADIPOSE TISSUE"</data>
      <data key="d1">"A type of adipose tissue found around the testes and bladder in vertebrates."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;ITT&quot;">
      <data key="d0">"ASSAY/</data>
      <data key="d1">|&gt;Cellular Process/</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;BASAL INSULIN&quot;">
      <data key="d0">"CELLULAR PROCESS"/"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">|&gt;Disease"/"Diabetes"</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;GLUCOSE-INSULIN COEFFICIENT&quot;">
      <data key="d0">"CELLULAR PROCESS"/"MOLECULAR INTERACTION"/"EXPERIMENTAL METHOD/</data>
      <data key="d1">|&gt;Functional Test/</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;HEPATIC STEATOSIS&quot;">
      <data key="d0">"DISEASE"/"INFLAMMATION/</data>
      <data key="d1">|&gt;Metabolic Pathway"/"Cellular Process"/"Environmental Factor/</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;FATTY LIVER DISEASE&quot;">
      <data key="d0">"DISEASE"/"INFLAMMATION/</data>
      <data key="d1">|&gt;Metabolic Pathway"/"Cellular Process"/"Environmental Factor/</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The SNP is linked to type 1 diabetes."&lt;SEP&gt;|&gt;Inflammation"/"Cellular Process"</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506&lt;SEP&gt;chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;BETA CELL LOSS&quot;">
      <data key="d0">"CELLULAR PHENOMENON"/"PATHOLOGICAL PROCESS/</data>
      <data key="d1">|&gt;Disease"/"Type 1 Diabetes"</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;SENP1 DEFICIENCY&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"the adipocyte-specific deletion of SENP1")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T1DM&quot;">
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d1">"developed a diabetic phenotype (Fig.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 48}]</data>
    </node>
    <node id="&quot;AUTOIMMUNE RESPONSE&quot;">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7&lt;SEP&gt;chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"Immune cell-specific effector T-cell invasion in the pancreatic tissue attacks the islets and induces cell death.")&lt;SEP&gt;Pathway"/"Mechanism of Disease"/"Condition"</data>
      <data key="d0">"BIOLOGICAL PROCESS/</data>
    </node>
    <node id="&quot;Β CELLS&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"There was a sharp decline in insulin staining and CD31+ vascular area in the islets in SENP1-aP2KO mice (Fig. 3d with quantifications in Fig. 3e), indicating a loss of function in the β cell with disrupted vasculatures.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;MHCII+CD11B+CD11C− MACROPHAGES&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"The distribution of immune cells in the pancreases was determined by fluorescence-activated cell sorting (FACS) analyses with specific surface markers. MHCII+CD11b+CD11c− macrophages, CD3e+ T cells and CD19+ B cells were markedly increased in the pancreases of SENP1-aP2KO versus the Ctrl mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;TH1 (IFN-Γ+CD4+) AND TH17 (IL-17+CD4+) EFFECTOR T-CELL SUBSETS&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"We observed that Th1 (IFN-γ+CD4+) and Th17 (IL-17+CD4+) effector T-cell subsets expanded concomitant with reduction of regulatory T-cell subset (CD4+CD25+Foxp3+) in the pancreatic lymph nodes of SENP1-aP2KO mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACTIVATED DENDRITIC CELLS&quot;">
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d1">"We also observed an increase in activated dendritic cells in the lymph node of pancreases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYTOKINES IL-6, TNF-Α AND IL-IΒ&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Proinflammatory cytokine overproduction serves as the main reason for immunologic tolerance break leading to diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EFFECT ON&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Proinflammatory cytokine overproduction serves as the main reason for immunologic tolerance break leading to diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCEMENT OF&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Deletion of SENP1 gene strongly enhances the expression of pro-inflammatory cytokines in peri-pancreatic adipocytes compared to other adipose depots.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 DELETION&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Deletion of SENP1 gene strongly enhances the expression of pro-inflammatory cytokines in peri-pancreatic adipocytes compared to other adipose depots.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAUSE OF&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"Increased proinflammatory cytokines, cardiac function changes and vascular reactivity issues are potential causes leading to diabetes in SENP1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 28}]</data>
    </node>
    <node id="&quot;UPREGULATION AND LOCALIZATION&quot;">
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d1">"The expression of CCL5 mRNA significantly increases in islets due to secreted cytokines from peri-pancreatic adipocytes, specifically before the onset of diabetes in SENP1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATE PHOSPHO-IKK&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"SENP1 siRNA increased phosphorylation of IKK in adipocytes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 SIRNA&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"SENP1 siRNA increased phosphorylation of IKK in adipocytes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASE PROINFLAMMATORY CYTOKINE EXPRESSION&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"The SENP1 knockdown cells showed significantly higher gene expressions of IL-6, TNF-α and IL-1β compared to Ctrl cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 KNOCKDOWN CELLS&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"The SENP1 knockdown cells showed significantly higher gene expressions of IL-6, TNF-α and IL-1β compared to Ctrl cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPERGLYCAEMIA&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Age-dependent reduction in SENP1 expression correlates with the progression of spontaneous diabetes in NOD mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENP1 EXPRESSION&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Age-dependent reduction in SENP1 expression correlates with the progression of spontaneous diabetes in NOD mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRO-INFLAMMATORY CYTOKINE LEVELS&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Increased plasma levels of proinflammatory cytokines are significantly higher in T1DM patients compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 48}]</data>
    </node>
    <node id="&quot;DIABETES PROGRESSION&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"The Th1 dominant response due to IFN-γ-induced insulitis is associated with diabetes progression in NOD mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TH1 DOMINANT RESPONSE&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"The Th1 dominant response due to IFN-γ-induced insulitis is associated with diabetes progression in NOD mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PANCREATIC CELL DEATH&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Serum from human T1DM patients and NOD mice induces disruption and cell death in pancreatic islets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FROM T1DM PATIENTS&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Serum from human T1DM patients and NOD mice induces disruption and cell death in pancreatic islets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIABETES PHENOTYPES&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Prophylactic insulin therapy only partially ameliorates the development of diabetes phenotypes in SENP1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROPHYLACTIC INSULIN THERAPY&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Prophylactic insulin therapy only partially ameliorates the development of diabetes phenotypes in SENP1-deficient mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BLOOD GLUCOSE&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Administration of an NF-κB activation inhibitor reduces blood glucose levels and attenuates islet damages in SENP1-aP2KO mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NF-ΚB INHIBITORS&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"Administration of an NF-κB activation inhibitor reduces blood glucose levels and attenuates islet damages in SENP1-aP2KO mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGH-FAT DIET (HFD)&quot;">
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d1">"HFD conditions augment the diabetic phenotype in SENP1 deficient mice, affecting fat weight, cell size and number of adipocytes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE&quot;/&quot;T1DM/">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;T2DM"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES&quot;/&quot;PATS/">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;SENP1-aP2KO"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATS/">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;SENP1-aP2KO"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;LIVER INSULIN RESISTANCE&quot;">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;HFD/</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 24}, {"level": 1, "cluster": 47}]</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE/">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;Hyperglycaemia"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HFD/">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;SENP1-aP2KO"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC TRAIT&quot;/&quot;T2DM/">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;Comorbidity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES/">
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d1">|&gt;Insulin Deficiency"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APAI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ApaI variant (rs7975232) evaluated for association with ovarian cancer risk."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;BSMI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The BsmI variant (rs1544410) associated with ovarian cancer risk."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;CAUCASIANS&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">"Studies conducted on the Caucasian population."&lt;SEP&gt;"When the studies were restricted to Caucasians, no significant association between specific genetic variants and ovarian cancer was found."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;FOKI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FokI variant (rs2228570 or rs10735810) showed an increased risk of ovarian cancer."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
    </node>
    <node id="&quot;CDX-2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Cdx-2 is a gene that influences the risk of ovarian cancer based on genetic variations."&lt;SEP&gt;"The Cdx-2 variant evaluated for association with ovarian cancer risk."</data>
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c&lt;SEP&gt;chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;RS11568820&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant rs11568820 in Cdx-2 has been evaluated for its association with ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;JAPANESE SUBGROUP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A Japanese subgroup was part of the study, which showed that this variant may not be associated with risk when conducting the meta-analysis for a Japanese population."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NECC SUBGROUP&quot;">
      <data key="d0">"SUBGROUP STUDY"</data>
      <data key="d1">"The NECC subgroup indicated no significant association between Cdx-2 and ovarian cancer risk based on their genetic data analysis."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;TAQI&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TaqI is a gene that was studied for its association with ovarian cancer risk based on genetic variations."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;RS731236&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant rs731236 in TaqI has been evaluated for its relation to the risk of ovarian cancer."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NORTHERN SWEDEN SUBGROUP&quot;">
      <data key="d0">"SUBGROUP STUDY"</data>
      <data key="d1">"The Northern Sweden subgroup showed that the variant had no significant effect on the risk of ovarian cancer when conducting a separate analysis."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;CLENDENEN ET AL.&quot;">
      <data key="d0">"RESEARCHER/STUDY"</data>
      <data key="d1">"This subgroup study by Clendenen et al. in Northern Sweden contributed to the overall data, but did not show any association with the variant and ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;GENETIC MODEL (DOMINANT)">
      <data key="d0">"ANALYSIS METHODOLOGY"</data>
      <data key="d1">"The dominant genetic model was used to evaluate if there's an increase in risk associated with the presence of specific variants."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;SENSITIVITY TESTS&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"The sensitivity tests showed that no single study had a considerable influence on the overall risk estimates for the variants in question."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d2">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d1">"The FokI variant was significantly associated with an increased risk of ovarian cancer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-1A -889C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The TT genotype of IL-1A -889C&gt;T had a frequency of 1.37 in HNP patients compared to controls."&lt;SEP&gt;"The TT genotype of IL-1A -889C&gt;T was more frequent in HNP patients than controls."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A 238G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CT genotype and T allele of TNF-A 238G&gt;A were more frequent in healthy controls compared to HNP cases."&lt;SEP&gt;"The GG genotype, GA genotype and AA genotype of TNF-A 238G&gt;A did not show any significant association with the risk for HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR TAQI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No difference was observed in the distribution of VDR TaqI genotypes between HNP patients and healthy controls."&lt;SEP&gt;"TT vs. TC+CC, TC vs. TT+CC and OR: 0.94; 95%CI: 0.69, 1.28 were not associated with susceptibility to degenerative disc disease HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;HNP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The results did not show a significant association between the polymorphisms of IL-1A, TNF-A and VDR and the risk of HNPs."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;CC VS. CT+TT&quot;, &quot;CT VS. CC+TT&quot; AND &quot;TT VS. CT+CC&quot;">
      <data key="d0">"GENOTYPE MODELS"</data>
      <data key="d1">"No association was observed between genotypes models and the risk of HNP for IL-1A -889C&gt;T polymorphism."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;GG VS. GA+AA&quot;, &quot;GA VS. GG+AA&quot; AND &quot;AA VS. GG+GA&quot;">
      <data key="d0">"GENOTYPE MODELS"</data>
      <data key="d1">"Pooled estimates for allele distribution and genotype models of TNF-A 238G&gt;A also had no significant association with the risk for HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TT VS. TC+CC&quot;, &quot;TC VS. TT+CC&quot; AND &quot;OR: 2.65; 95%CI: 0.60, 11.85&quot;">
      <data key="d0">"GENOTYPE MODELS"</data>
      <data key="d1">"None of the genotypes for VDR TaqI (rs731236) were associated with susceptibility to degenerative disc disease HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;C ALLELE&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"No significant association was observed between the frequency of C allele and T allele in relation to the risk of HNPs for IL-1A -889C&gt;T polymorphism."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;RS1800587&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant named rs1800587 was studied for its association with IL-1A."&lt;SEP&gt;"The study mentioned that a particular genetic variant, rs1800587, was associated with IL-1A."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;RS361525&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Two studies on TNF-A gene used genomic variation rs361525 to analyze its role in health conditions."&lt;SEP&gt;"Two studies were included that investigated the TNF-A gene using a genomic variant denoted as rs361525."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR (RS731236)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Nine research articles utilized the VDR gene polymorphism, referred to as rs731236, for studying its association with different diseases."&lt;SEP&gt;"Nine studies considered variations in VDR using this specific polymorphism, labeled as rs731236."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;IL-1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The research focused on a genetic variant in IL-1A, which is related to inflammatory responses."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Studies included genomic variations in TNF-A gene, which are involved in immune response and inflammation."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Nine articles investigated variations within the vitamin D receptor (VDR) gene, denoted as rs731236, to understand its link with degenerative disc disease."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;IL-1A -889C&gt;T TT GENOTYPE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"The TT genotype of IL-1A -889C&gt;T was examined for its frequency in HNP patients."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A 238G&gt;A GG GENOTYPE, GA GENOTYPE AND AA GENOTYPE&quot;">
      <data key="d0">"GENOTYPES"</data>
      <data key="d1">"The study evaluated the association between these genotypes of TNF-A 238G&gt;A variant and HNP risk."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR TAQI TT VS. TC+CC, TC VS. TT+CC&quot;">
      <data key="d0">"GENOTYPES COMPARISON"</data>
      <data key="d1">"Comparison was made between different genotypes for VDR TaqI to understand their impact on susceptibility to degenerative disc disease HNP."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;HNP PATIENT FREQUENCY&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"The TT genotype of IL-1A -889C&gt;T was found to be more frequent in HNP patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEALTHY CONTROL FREQUENCY&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"CT and T allele of TNF-A 238G&gt;A were found more frequent among healthy controls compared to HNP cases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNF-A 238G&gt;A CT GENOTYPE AND T ALLELE&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"CT and T allele of TNF-A 238G&gt;A were found more frequent among healthy controls compared to HNP cases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO ASSOCIATION WITH HNP&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"Genotypes of VDR TaqI were not associated with susceptibility to degenerative disc disease HNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDR TAQI TT VS. TC+CC, TC VS. TT+CC AND OR: 2.65; 95%CI: 0.60, 11.85&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"Genotypes of VDR TaqI were not associated with susceptibility to degenerative disc disease HNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-1A -889C&gt;T GENOTYPES CC VS. CT+TT, CT VS. CC+TT AND TT VS. CT+CC&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"The genotypes models of IL-1A -889C&gt;T were not associated with the risk for HNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO ASSOCIATION WITH RISK&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"The genotypes models of IL-1A -889C&gt;T were not associated with the risk for HNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNF-A 238G&gt;A GENOTYPES GG VS. GA+AA, GA VS. GG+AA AND AA VS. GG+GA&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"Pooled estimates of TNF-A 238G&gt;A genotypes were not associated with the risk for HNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VDR TAQI GENOTYPES TT VS. TC+CC, TC VS. TT+CC AND OR: 1.01; 95%CI: 0.55, 1.85&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"None of the genotypes for VDR TaqI were associated with susceptibility to degenerative disc disease HNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION WITH RISK&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"There was no significant association between the C allele and T allele in relation to the risk of HNPs for IL-1A -889C&gt;T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C ALLELE OF IL-1A -889C&gt;T&quot;">
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d1">"There was no significant association between the C allele and T allele in relation to the risk of HNPs for IL-1A -889C&gt;T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IVW ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A method used in the study to combine multiple independent studies on maternal and fetal B12/folate levels and offspring birthweight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSES&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"Analyses performed to test for robustness of results against unmeasured confounding factors."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;LEAVE-ONE-OUT ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A technique used in the study to assess how sensitive the causal effect estimates are to individual SNPs."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;HETEROGENEITY TEST&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"A test conducted to check for variation among results from different studies or groups within a study."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MMACHC VARIANT&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The MMACHC variant (rs12272669) which had little effect in pregnant women at 28 weeks of gestation."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;FUT2 VARIANT&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The FUT2 variant (rs602662), expected to have pleiotropic effects based on prior knowledge."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;MTHFR SNP RS1801133&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism in the MTHFR gene used for assessing potential heterogeneity and its effect."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;BIRTHWEIGHT&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"The weight of the newborn, measured as standard deviations (SD) from the mean weight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;SERUM B12 CONCENTRATIONS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Measures of blood serum levels of vitamin B12, which are assessed for their causal effect on birthweight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;SERUM FOLATE CONCENTRATIONS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Measures of blood serum folate levels, which are associated with offspring birthweight through MR analysis."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;PLEIOTROPY TEST RESULTS&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"Finding no significant evidence for pleiotropic effects from MR Egger regression analysis for both B12 and folate levels on birthweight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;WEAK INSTRUMENT BIAS&quot;">
      <data key="d0">"CRITICAL STATISTICAL ANALYSIS"</data>
      <data key="d1">"Concern over potential bias due to weak instruments, particularly noted for folate analysis results."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;OUTCOME VARIABILITY&quot;">
      <data key="d0">"STUDY FINDING"</data>
      <data key="d1">"Recognition of variability among different study outcomes for B12/folate levels impacting birthweight."</data>
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;B12&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"B12 is a nutrient that affects folate levels and may influence offspring birthweight."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;MATERNAL B12 LEVELS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The level of B12 in a mother might influence the offspring’s birthweight, but no causal effect was detected."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Offspring birthweight can be potentially influenced by maternal health conditions and nutrient levels such as folate and B12."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;CAUSAL EFFECT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The study attempts to detect a causal effect between maternal and offspring's nutritional status (B12 and Folate) and certain health outcomes like birthweight, but found no strong evidence of such effects."</data>
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;B12&quot;&amp;&quot;FOLATE&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"B12 and Folate are nutrients that might have a molecular interaction affecting maternal health and offspring development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAUSAL RELATIONSHIP&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"There is no evidence suggesting a causal effect of maternal B12 levels on offspring birthweight, which indicates that other factors might be more influential in this relationship.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL B12 LEVELS&quot;&amp;&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"There is no evidence suggesting a causal effect of maternal B12 levels on offspring birthweight, which indicates that other factors might be more influential in this relationship.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOLATE LEVELS&quot;&amp;&quot;B12 LEVELS&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"There was a small causal effect detected between folate levels and B12 levels suggesting their interplay in maternal health.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;&amp;&quot;B12 METABOLISM&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"A genomic variant may influence B12 metabolism, affecting its physiological process and levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPT&quot;&amp;&quot;NUTRIENT LEVELS&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"The expression of this transcript could be related to the levels or regulation of nutrients like B12 and folate.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;&amp;&quot;DIETARY PATTERN&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"This environmental factor might correlate with certain dietary patterns that influence nutrient intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT LEVELS&quot;&amp;&quot;GESTATIONAL DURATION&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1">"Alterations in nutrient levels, such as B12 and folate, could potentially affect gestational duration or have been studied for this relationship.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR C677T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"MTHFR C677T is a genetic variant involved in the methionine and folate metabolism pathway."&lt;SEP&gt;"Thirteen articles presented LV patients that were examined for MTHFR C677T."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PAI-1 -675 4G/5G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The PAI-1 -675 4G/5G polymorphism influences the activity of tissue plasminogen activator (tPA) and fibrinolysis."&lt;SEP&gt;"Three studies and two case reports presented assessment of PAI-1 -675 4G/5G in a total of 95 LV patients."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Eighty-five LV patients from 15 studies or case reports were evaluated for Prothrombin G20210A."&lt;SEP&gt;"Prothrombin G20210A is a common variant in the PROTHO2 gene, influencing blood coagulation."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;FACTOR V G1691A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Factor V G1691A affects the function of factor V protein involved in the blood clotting process."&lt;SEP&gt;"The total carrier rate of Factor V G1691A (14.07%) in LV patients was the second lowest among the tested SNPs."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0&lt;SEP&gt;chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;PAI-1 A844G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Compared to PAI-1 -675 4G/5G, the variant PAI-1 A844G has been rarely assessed in LV patients."</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;MTHFR A1298C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTHFR A1298C is another genetic variant affecting the MTHFR enzyme function."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;DHA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"DHA, or docosahexaenoic acid, another omega-3 fatty acid critical for brain function and development, particularly in the retina of the eye."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;OMEGA-6 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Common components like arachidonic acid are part of a class of essential polyunsaturated fatty acids that may compete with omega-3s for enzymatic activities involved in inflammatory pathways."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;WHOLE GRAINS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Consumption of whole grains as part of a dietary pattern provides beneficial nutrients such as fiber, B vitamins, and minerals."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;VEGETARIAN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A vegetarian diet excludes animal-derived foods and relies on fruits, vegetables, legumes, nuts, seeds, and grains for nutrition."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;NEUROTRANSMISSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Communication between neurons through the release of neurotransmitters at synapses is crucial for cognitive function."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;STRESS RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The body's response to stressful situations can be studied in terms of its physiological and biochemical reactions, including hormonal and inflammatory responses."</data>
      <data key="d2">chunk-d0476488384aadcae4630e94d982d2e0</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition that can be influenced by both genetic variants and dietary patterns."&lt;SEP&gt;"A group of disorders affecting the heart and blood vessels, which can lead to conditions like coronary artery disease, stroke, or congestive heart failure."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-d0476488384aadcae4630e94d982d2e0</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;MTHFR 677C&gt;T&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTHFR 677C&gt;T is a gene associated with folate/B12/tHcy metabolism."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;PEMT M175V&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Male infertility was positively associated with being homozygous for the choline pathway enzyme gene phosphatidylethanolamine N-methyltransferase (PEMT) M175V minor V allele."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;TCBLR (CD320)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Male infertility was negatively associated with the B12 transcobalamin receptor gene TCblR variant rs173665 in heterozygous subjects."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SERUM FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum folate concentrations were significantly lower among infertile men compared to fertile controls, particularly among non-users of vitamin supplements."&lt;SEP&gt;"The study compared serum folate measured by two methods: CDC MBA and CDC HPLC-MS/MS."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8&lt;SEP&gt;chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;RCF (RED CELL FOLATE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Red cell folate (RCF) concentrations in non-users of vitamins were also found to be significantly lower among infertile than fertile men, even after adjusting for age and other factors."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;B12 (VITAMIN B12)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"While vitamin B12 levels did not show a significant difference between infertile and fertile groups in the non-user cohort, they were lower among all infertile men compared to fertile controls."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;THCY (HOMOCYSTEINE)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Homocysteine concentrations showed an increase in infertile men compared to fertile controls but did not reach statistical significance."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;CHROMOSOME 12 GENES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The analysis focused on the genotypes of chromosome 12 genes associated with folate/B12/tHcy metabolism."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;CHOLINE PATHWAY ENZYME GENE PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE (PEMT) M175V MINOR V ALLELE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Homozygous for the choline pathway enzyme gene PEMT M175V minor V allele was associated with male infertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;B12 TRANSCOBALAMIN RECEPTOR GENE TCBLR (CD320) VARIANT RS173665&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The heterozygous subjects of the B12 transcobalamin receptor gene TCblR variant rs173665 were negatively associated with male infertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SERUM FOLATE CONCENTRATION BELOW STUDY POPULATION MEDIAN (14.70 NMOL L−1)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Serum folate concentrations were analyzed in individuals whose levels were below the study population median to assess their impact on male fertility."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;SERUM B12 CONCENTRATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Vitamin B12 levels did not significantly differ between infertile and fertile groups among vitamin non-users."</data>
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
    </node>
    <node id="&quot;PEMT M175V MINOR V ALLELE&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"The PEMT M175V minor V allele was associated with male infertility status among homozygous individuals.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;TCBLR (CD320) VARIANT RS173665 IN HETEROZYGOUS SUBJECTS&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"The TCblR variant rs173665 was negatively associated with male infertility status among heterozygous subjects.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;SERUM FOLATE CONCENTRATION BELOW STUDY POPULATION MEDIAN&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"An analysis focusing on individuals with serum folate concentrations below the median revealed no association between these levels and male infertility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE-SPECIFIC NUTRIENT INTERACTION&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"When focusing on the MTHFR 677C&gt;T variant, individuals with serum folate levels below the study population median showed no association with male infertility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR 677C&gt;T VARIANT IN INDIVIDUALS WITH SERUM FOLATE BELOW MEDIAN&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"When focusing on the MTHFR 677C&gt;T variant, individuals with serum folate levels below the study population median showed no association with male infertility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION AND GENETIC POLYMORPHISM&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"In individuals who did not take vitamin supplements, the PEMT M175V minor V allele and the TCblR rs173665 genetic variants showed significant associations with infertility status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEMT M175V MINOR V ALLELE AND TCBLR RS173665 VARIANT IN NON-USERS OF VITAMINS TO FERTILITY STATUS&quot;">
      <data key="d2">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d1">"In individuals who did not take vitamin supplements, the PEMT M175V minor V allele and the TCblR rs173665 genetic variants showed significant associations with infertility status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHMT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This enzyme catalyzes the reversible conversion of serine to glycine, transferring methyl groups to tetrahydrofolate (THF), which is transformed into 5,10-methylenetetrahydrofolate (5,10-CH2-THF). During cellular proliferation, this is the predominant pathway for pyrimidine synthesis."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS1979277&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The G allele of this polymorphism shows a significant increase when compared with controls in TMD patients (OR = 3.99; 95% CI 1.72, 9.25; p = 0,002)."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;SHMT1 RS638416&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C allele and the CC genotype show a very significant increase in TMD patients (OR = 2.80; 95% CI 1.51, 5.21; p = 0,013)."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;MTHFD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTHFD1 encodes a protein that catalyzes three interconversion reactions of one-carbon derivatives of THF for the synthesis of methionine, thymidylate, and purines."&lt;SEP&gt;"This gene encodes a protein with three distinct enzyme activities: catalyzing reactions of one-carbon derivatives of THF for the synthesis of methionine, thymidylate, and purines. It has a trifunctional enzymatic activity conferred by two larger domains."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS2236225&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A transition from G to A results in an alteration of ARG-653-GLN associated with susceptibility to neural tube defects sensitive to folates. The T allele was more frequent among TMD patients (OR = 3.09; 95% CI 1.27, 7.50; p = 0,016)."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;GSTM1 NULL POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The null variant of this gene has been associated with an increase in cancer and male infertility possibly due to greater susceptibility to environmental toxins and carcinogens as well as alterations in toxicity and efficiency of certain substances."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;RS1801394&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The substitution of A by G results in the enzyme with less affinity for the substrate. An increase of the A allele (OR = 2.35; 95% CI 1.10, 5.00; p = 0.037) was observed in TMD patients."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;DRD4-48BPTR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The VNTR polymorphism presents between 2 to 11 repeats in exon 3 of DRD4, which encodes the third intracellular receptor loop and is characterized as short (S-DRD4) or long (L-DRD4) alleles based on the number of repetitions. Statistical differences were observed in genotype frequencies but no significant increase was found for S-DRD4 allele."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;MTRR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MTRR is responsible for the regeneration of Methionine Synthase (MTR) using SAM as a methyl donor."</data>
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223</data>
    </node>
    <node id="&quot;5-METHYLTHF&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The study compared the concentrations of 5-methylTHF under different laboratory conditions."&lt;SEP&gt;"Two types of IH-CAL were used by the laboratories: one using 5-methylTHF and another using folic acid."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;FOLIC ACID CASEI MEDIUM&quot;">
      <data key="d0">"CULTURE MEDIUM"</data>
      <data key="d1">"All laboratories used a standardized Folic Acid Casei Medium as their critical reagent.")</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;FOLIC ACID&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Comparison was also done for folic acid as a nutrient in laboratory settings."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CDC MBA TARGET CONCENTRATION&quot;">
      <data key="d0">"DISEASE/PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The study aimed to compare results with the CDC MBA target concentrations as a reference physiological process or health standard."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;S-FOL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">""&lt;SEP&gt;"S-FOL is one of the two types of folic acid used in laboratory analyses, along with WB-FOL."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;WB-FOL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">""&lt;SEP&gt;"WB-FOL represents another type of folic acid utilized for similar assessments as S-FOL."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CDC MO CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The CDC-MO condition is an environment-related factor in laboratory settings, affecting results compared to other conditions."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CDC CAL CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The CDC-CAL condition represents another environmental influence on laboratory test results when compared to the CDC MO condition."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;IH MO CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The IH-MO condition signifies yet another specific environmental context in which tests were conducted."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;IH CAL CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The IH-CAL condition is a different environmental factor tested, distinct from CDC conditions."</data>
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;MICROORGANISM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">""&lt;SEP&gt;"Microorganisms play a role in the variability of test results and could influence outcomes when comparing different reagents."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c&lt;SEP&gt;chunk-257a38a8ce6582c434f31b023b4a9704</data>
    </node>
    <node id="&quot;CDC MBA TARGET VALUE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">""</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;GROUP 2 LABORATORIES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">""</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;FOLIC ACID CALIBRATOR&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">""</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;IH REAGENTS&quot;">
      <data key="d0">"REAGENT"</data>
      <data key="d1">""</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC REAGENTS&quot;">
      <data key="d0">"REAGENT"</data>
      <data key="d1">""</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CALIBRATOR&quot;">
      <data key="d0">"CONTROL SUBSTANCE"</data>
      <data key="d1">""</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;HARMONIZED CONDITION&quot;">
      <data key="d0">"EXPERIMENTAL SETUP"</data>
      <data key="d1">""</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC HPLC-MS/MS&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"A high Pearson correlation (r = 0.999) was observed between the results of the CDC MBA and CDC HPLC-MS/MS methods for serum folate measurement.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDC MBA&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"A high Pearson correlation (r = 0.999) was observed between the results of the CDC MBA and CDC HPLC-MS/MS methods for serum folate measurement.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LABORATORY PROCEDURES&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"All participating laboratories reported their results using different procedures, such as sample dilution techniques and incubation periods.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM SAMPLES&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"All participating laboratories reported their results using different procedures, such as sample dilution techniques and incubation periods.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LABORATORY VARIABILITY&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"The use of different sample dilutions (1:100 for serum and 1:140 for whole-blood hemolysate by CDC recommended, or lab-specific dilution) influenced the within-laboratory imprecision.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SAMPLE DILUTIONS&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"The use of different sample dilutions (1:100 for serum and 1:140 for whole-blood hemolysate by CDC recommended, or lab-specific dilution) influenced the within-laboratory imprecision.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;37°C INCUBATION&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"Labs incubated their assay plates at 37°C for 42–45 h; an exception was Lab #3 which used only an 18-h incubation period.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSAY STABILITY&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"Labs incubated their assay plates at 37°C for 42–45 h; an exception was Lab #3 which used only an 18-h incubation period.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DATA CONSISTENCY&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"Most laboratories read their plates at 590 nm and carefully controlled timing to ensure consistency across all plates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;READ PLATES AT 590 NM&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"Most laboratories read their plates at 590 nm and carefully controlled timing to ensure consistency across all plates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CALIBRATION ACCURACY&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"A third-order polynomial regression was most commonly used for calibration curve fitting, but other methods were reported as well.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POLYNOMIAL REGRESSION FIT&quot;">
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d1">"A third-order polynomial regression was most commonly used for calibration curve fitting, but other methods were reported as well.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;5-METHYLTHF&quot;/&quot;FOLIC ACID&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Comparison between two types of nutrients (5-methylTHF vs. folic acid) to evaluate their impact on laboratory test results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT/NUTRIENT RELATIONSHIP&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Comparison between two types of nutrients (5-methylTHF vs. folic acid) to evaluate their impact on laboratory test results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDC MBA TARGET CONCENTRATION&quot;/&quot;S-FOL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"S-FOL's comparison against the CDC MBA target value as a reference physiological or health standard.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE/PHYSIOLOGICAL PROCESS-NUTRIENT RELATIONSHIP&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"S-FOL's comparison against the CDC MBA target value as a reference physiological or health standard.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDC MBA TARGET CONCENTRATION&quot;/&quot;WB-FOL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Similar relationship for WB-FOL in comparison with the CDC MBA target.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;S-FOL&quot;/&quot;WB-FOL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Comparison of two transcript forms (S-FOL and WB-FOL) in laboratory conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPT/TRANSCRIPT RELATIONSHIP&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Comparison of two transcript forms (S-FOL and WB-FOL) in laboratory conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDC MO CONDITION&quot;/&quot;CDC CAL CONDITION&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Relation between two different environmental contexts tested for their impact on laboratory results (CDC MO vs CDC CAL).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR/ENVIRONMENTAL FACTOR RELATIONSHIP&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Relation between two different environmental contexts tested for their impact on laboratory results (CDC MO vs CDC CAL).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IH MO CONDITION&quot;/&quot;IH CAL CONDITION&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Comparison of outcomes influenced by distinct environmental conditions (IH MO and IH CAL)." )</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROORGANISM&quot;/&quot;S-FOL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Role of microorganisms in influencing S-FOL results when compared against the CDC MBA target.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION-NUTRIENT RELATIONSHIP&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Role of microorganisms in influencing S-FOL results when compared against the CDC MBA target.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROORGANISM&quot;/&quot;WB-FOL&quot;">
      <data key="d2">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d1">"Similar interaction for WB-FOL and microorganisms during comparisons.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;USE OF IH REAGENTS&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"1. When all labs used IH reagents, the mean difference to CDC MBA target decreased.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;USE OF CDC REAGENTS&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"When CDC reagents were used by all laboratories, the mean ± SD difference to the CDC MBA target decreased.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIMITS OF AGREEMENT&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"The limits indicate where 95% of lab results are expected compared with CDC MBA when using CDC reagents.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RANGE WITHIN WHICH 95% OF RESULTS EXPECTED&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"The limits indicate where 95% of lab results are expected compared with CDC MBA when using CDC reagents.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HARMONIZED CONDITION AND SAME MICROORGANISM/CALIBRATOR&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"All labs, except #6 and #9 showed good agreement under harmonized conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REASONABLE AGREEMENT&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"All labs, except #6 and #9 showed good agreement under harmonized conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIFFERENCES BETWEEN DAY 1 AND DAY 2&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Differences were expected to be approximately ±10–30% for S-FOL and approximately ±20–40% for WB-FOL with harmonized conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LAB #8 - WB-FOL&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Lab #8 showed discrepancies in WB-FOL results between day 1 and day 2.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACK OF AGREEMENT&quot;">
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d1">"Lab #8 showed discrepancies in WB-FOL results between day 1 and day 2.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1695&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GSTP1 gene variant A&gt;G showed a significant link to CSF use during chemotherapy."&lt;SEP&gt;"The frequency of genotypes AA, AG, and GG for controls is 50.00%, 44.00%, and 06.00% respectively."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404&lt;SEP&gt;chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;RS1138272&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The distribution of alleles and genotypes of rs1138272 polymorphism are summarized in Table 2."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;CC&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"The frequency of genotypes CC, CT, and TT for controls is 92.00%, 08.00%, and 00.00% respectively."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;CT&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"While these ratios were calculated 88.00%, 11.00%, and 01.00%, respectively."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;TT&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"The frequency of genotypes CC, CT, and TT for cases is 88.00%, 11.00%, and 01.00% respectively."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;DWALTZ&quot;">
      <data key="d0">"PARAMETER"</data>
      <data key="d1">"In our analysis, dWALTZ was calculated -228.00 which means that the polymorphism reduces the amyloid propensity of the GSTP1 enzyme."&lt;SEP&gt;"The dWALTZ calculation for the Ile105Val polymorphism was -228.00."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;ILE105VAL&quot;">
      <data key="d0">"POLYMORPHISM/SNP"</data>
      <data key="d1">"Based on WALTZ output, the Ile105Val polymorphism decreases the amyloid propensity of the GSTP1 enzyme."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GSTP1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"We evaluated effects of Ile105Val SNP on the function of GSTP1 protein using SNPeffects online software."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GENOTYPE AA, AG, AND GG FOR CONTROLS&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"The frequency ratios were found as 50.00%, 44.00% and 6.00% respectively.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE CC, CT AND TT FOR CONTROLS AND CASES&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"The frequency ratios were found as 92.00%, 08.00% and 00.00% respectively for control group whereas these ratios for cases were calculated 88.00%, 11.00% and 01.00%")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WALTZ OUTPUT&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"The Ile105Val polymorphism decreases the amyloid propensity of the GSTP1 enzyme (dWALTZ was -228.00")&lt;SEP&gt;"The Ile105Val polymorphism reduces the amyloid propensity of the GSTP1 enzyme (dWALTZ was -228.00")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTION&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"We evaluated effects of Ile105Val SNP on the GSTP1 function using SNPeffects online software.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTION AND ENZYME ACTIVITY&quot;">
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d1">"The WALTZ algorithm specifically predicts that Ile105Val polymorphism decreases the amyloid propensity of GSTP1 enzyme.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.R778L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The most prevalent pathogenic variant in China, p.R778L, was found to associate with three haplogroups (A, B, C)."&lt;SEP&gt;"p.R778L is one of the most prevalent pathogenic variants found in WD patients, with an allelic frequency of 31.7%."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.P992L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The haplotype spectrum of p.P992L was more complex, including six haplogroups (D, E, F, G, H, I)."&lt;SEP&gt;"p.P992L has a close allelic frequency to p.R778L and is the second most prevalent variant with an allelic frequency of 15.7%."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.T935M&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The allelic frequency of p.T935M in Fujian province was significantly higher than other regions, indicating a tendency for aggregation."&lt;SEP&gt;"p.T935M presented a uniform state with only one kind of haplogroup on WD chromosomes, haplogroup J."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1&lt;SEP&gt;chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;FUJIAN PROVINCE&quot;">
      <data key="d0">"GEOGRAPHICAL FACTOR"</data>
      <data key="d1">"Fujian province contributes the largest proportion (261, 36.8%) among five major regions with high p.T935M frequency."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;ZHEJIANG&quot;">
      <data key="d0">"GEOGRAPHICAL FACTOR"</data>
      <data key="d1">"Zhejiang has a moderate contribution to the distribution of p.T935M variants."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGSU&quot;">
      <data key="d0">"GEOGRAPHICAL FACTOR"</data>
      <data key="d1">"The number of cases in Jiangsu is significantly lower than other regions, with an allelic frequency of 4.5% for p.T935M."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;SHANGHAI&quot;">
      <data key="d0">"GEOGRAPHICAL FACTOR"</data>
      <data key="d1">"With a small population base and limited data available, Shanghai's contribution to p.T935M prevalence is minimal."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;JIANGXI&quot;">
      <data key="d0">"GEOGRAPHICAL FACTOR"</data>
      <data key="d1">"Jiangxi contributes the smallest proportion among five major regions with an allelic frequency of 2.3% for p.T935M."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.N1015K&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant p.N1015K has an allelic frequency of 2.4%, which indicates its relative rarity among WD patients."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;FUJIAN PROVINCE, ZHEJIANG&quot;">
      <data key="d0">"GEOGRAPHICAL FACTOR"</data>
      <data key="d1">"These provinces have a higher prevalence of p.T935M than Jiangsu and Shanghai due to their unique demographic characteristics and potential historical genetic influences."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.T935M HAPLOTYPE 8 IN FUJIAN PROVINCE&quot;">
      <data key="d0">"HAPLOTYPE SPECIFICITY"</data>
      <data key="d1">"The specific haplotype associated with allele 8 of p.T935M is predominant in the Fujian population, possibly linked to regional ancestry or selective pressures."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.R778L, P.P992L, AND P.S1014P&quot;">
      <data key="d0">"POLYGENIC RISK SCORE"</data>
      <data key="d1">"These variants contribute significantly to the polygenic risk score for WD in Chinese populations, reflecting their cumulative impact on disease susceptibility."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;DISEASE SUSCEPTIBILITY LOCI&quot;">
      <data key="d0">"GWAS RESULTS"</data>
      <data key="d1">"Significant genetic loci identified through genome-wide association studies (GWAS) include the regions harboring p.R778L, p.P992L, and p.T935M, providing insights into genetic risk factors for WD."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;P.T935M IN JIANGXI&quot;">
      <data key="d0">"REGIONAL FREQUENCY VARIANCE"</data>
      <data key="d1">"Despite its minor contribution compared to other regions, the allelic frequency of p.T935M in Jiangxi is 2.3%, highlighting regional variations."</data>
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
    </node>
    <node id="&quot;HAPLOGROUP A&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup A was overwhelmingly common on WD chromosomes (97/100, 97.0%) vs. control ones (17/177, 9.6%, p &lt; 0.01)."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP B&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup B was found to be relatively scarce (1.0%)."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP C&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup C appeared with a frequency of 2.0% when compared with haplogroup A."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP D&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup D appeared sporadically, accounting for 3.4% on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP E&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"It was more common than control ones (72.4% vs. 3.4%, p &lt; 0.01)."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP F&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup F appeared with a frequency of 6.9% on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP G&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup G appeared sporadically, accounting for 3.4% on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP H&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup H appeared with a frequency of 10.3% and 12.5% on WD chromosomes respectively."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP I&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup I appeared sporadically, accounting for 3.4% on WD chromosomes."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP J&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Haplogroup J was the only kind of haplogroup on WD chromosomes with a great significance vs. control ones (100 vs. 15.3%, p &lt; 0.01)."</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;GENETIC MARKER&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Associations between specific alleles at different markers and various haplogroups underscore the interplay between genetic drift, natural selection, and demographic history in shaping genetic diversity within the WD population.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOGROUP ASSOCIATION&quot;">
      <data key="d2">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d1">"Associations between specific alleles at different markers and various haplogroups underscore the interplay between genetic drift, natural selection, and demographic history in shaping genetic diversity within the WD population.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP2C9 STAR VARIANT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP2C9 gene polymorphism that reduces enzyme activity."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1799853&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP in CYP2C9 gene with low minor allele frequency, associated with reduced enzyme activity."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1057910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another SNP in the CYP2C9 gene with low minor allele frequency that impacts enzyme function."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS9923231&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP found to have a low minor allele frequency and its relevance is consistent with previous studies."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371686, RS7900194, RS28371685&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Additional SNPs in the CYP2C9 gene that reduce enzyme activity and were combined into a group due to their low frequency."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP2C9 is an enzyme that plays role in processing vitamin K, affecting the metabolism of drugs like warfarin."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;WARFARIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Vitamin K antagonist used for anticoagulation therapy."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;DVT/PE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Deep vein thrombosis (DVT) and pulmonary embolism (PE), conditions that prompted warfarin use in over half of patients."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;ALGORITHM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The algorithms used to predict the required dose of warfarin based on genetic variants."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;IWPC&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"International Warfarin Pharmacogenetics Consortium; group that developed a set of algorithms for predicting warfarin doses based on genetics."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;AA VALIDATION COHORT&quot;">
      <data key="d0">"VALIDATION COHORT"</data>
      <data key="d1">"Specific subset of patients with African American ancestry used to validate the accuracy of new algorithms."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;INTERNATIONAL WARFARIN PHARMACOGENETICS CONSORTIUM (IWPC)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Group that developed a set of algorithms for predicting warfarin doses based on genetics."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;NOVEL AA ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"The novel AA algorithm significantly outperforms both of the IWPC algorithms in patients with high doses."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"This IWPC algorithm correctly assigns 26% of high-dose patients."&lt;SEP&gt;"This algorithm shows a strong inverse correlation between percent WAA and predicted dose within the 20% therapeutic dose range for patients requiring doses ≥60 mg/week, but our novel AA algorithm does not exhibit such an association."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC CLINICAL ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"This IWPC clinical algorithm correctly assigns only 2% of high-dose patients."&lt;SEP&gt;"This algorithm has a lower correlation compared to the IWPC pharmacogenomics algorithm when dealing with percent WAA and predicted doses within the 20% therapeutic dose range for high-dose patients (≥60 mg/week)."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PREDICTED DOSE&quot;">
      <data key="d0">"ALGORITHM OUTPUT"</data>
      <data key="d1">"The novel AA algorithm was found to provide closer and more precise predicted doses compared to observed doses, as evidenced by lower MAE values."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NNG (NET NUMERICAL GAIN)&quot;">
      <data key="d0">"MEASURE OF CLINICAL BENEFIT"</data>
      <data key="d1">"The NNG was used to compare the clinical benefit of incorporating our novel AA algorithm into practice versus using the IWPC clinical algorithm."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;AIMS (ADMIXTURE INFORMATION METHODS)&quot;">
      <data key="d0">"MEASUREMENT TOOL"</data>
      <data key="d1">"The availability and usage of AIMs have enabled accurate measurement of admixture in AAs, enhancing the performance evaluation of algorithms."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PERCENT WAA (WITHIN ADMIXTURE ACCURACY)&quot;">
      <data key="d0">"PERFORMANCE METRIC"</data>
      <data key="d1">"Our novel AA algorithm shows no significant association with percent WAA, indicating its ability to incorporate population-specific variables effectively."</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;CYP2C9 STAR VARIANT GROUP&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"CYP2C9 genetic variants were grouped due to low frequency, impacting the prediction models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1799853, RS1057910, RS9923231 SNPS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Algorithms considered the impact of low-frequency SNPs on predicting warfarin doses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP2C9 ENZYME&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The CYP2C9 gene polymorphisms influence how algorithms predict drug metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREVIOUS STUDIES&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Studies previously observed low minor allele frequencies for these SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1799853, RS1057910, AND RS9923231 SNPS AND LOW FREQUENCIES&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Studies previously observed low minor allele frequencies for these SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM ACCURACY&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Comparisons of algorithm performance against IWPC methods to assess its validity in predicting warfarin doses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IWPC ALGORITHMS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Comparisons of algorithm performance against IWPC methods to assess its validity in predicting warfarin doses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM PREDICTIVE POWER&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Evaluation of how well each algorithm predicts dosing requirements within the target range.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOVEL AA ALGORITHM, IWPC PHARMACOGENOMICS AND CLINICAL ALGORITHMS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Evaluation of how well each algorithm predicts dosing requirements within the target range.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOW-, INTERMEDIATE- AND HIGH-DOSE PATIENTS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Analysis performed for different groups based on warfarin dosage needs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREDICTIVE ACCURACY IN DOSE SUBGROUPS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Analysis performed for different groups based on warfarin dosage needs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM PERFORMANCE FOR LOW-DOSE PATIENTS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Specific comparison of accuracy in predicting lower doses among the algorithms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM PERFORMANCE FOR INTERMEDIATE-DOSE GROUP&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Similar focus on assessing accuracy with regards to mid-range warfarin dosages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM PERFORMANCE FOR HIGH-DOSE PATIENTS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"A detailed comparison of how well each algorithm performs in predicting higher doses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOVEL AA ALGORITHM COMPARED AGAINST IWPC METHODS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"A detailed comparison of how well each algorithm performs in predicting higher doses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM, CYP2C9 GENE&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The algorithms considered the impact of CYP2C9 genetic variants on predicting appropriate warfarin dosing.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP2C9 ENZYME POLYMORPHISMS AND WARFARIN DOSE PREDICTION&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The algorithms considered the impact of CYP2C9 genetic variants on predicting appropriate warfarin dosing.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM, SNPS&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Some algorithms were more accurate when considering lower-frequency SNPs associated with reduced CYP2C9 activity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP FREQUENCIES AND ALGORITHM PERFORMANCE&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"Some algorithms were more accurate when considering lower-frequency SNPs associated with reduced CYP2C9 activity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM 1 VS. ALGORITHM 2 (IWPC, AA NOVEL)&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The performance of the AA novel algorithm was compared to that of IWPC algorithms in terms of dose prediction precision.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM ACCURACY COMPARISON&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"The performance of the AA novel algorithm was compared to that of IWPC algorithms in terms of dose prediction precision.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRECISION&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"The novel AA algorithm provides higher precision in predicting doses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACCURATE MEASUREMENT OF ADMIXTURE&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"The novel AA algorithm performs well when evaluated with accurate measurements of admixture provided by AIMs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POPULATION-SPECIFIC VARIABLES&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"The novel AA algorithm accounts for and incorporates population-specific variables, which results in better performance when dealing with the broad range of WAA among AAs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INVERSELY CORRELATED PERFORMANCE&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"The IWPC pharmacogenomics algorithm exhibits inversely correlated performance with percent WAA in predicting doses for high-dose patients (≥60 mg/week), unlike our novel AA algorithm.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LOWER CORRELATION&quot;">
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d1">"Compared to the IWPC pharmacogenomics algorithm, our novel AA algorithm has a higher correlation with percent WAA and predicted doses for high-dose patients (≥60 mg/week), indicating superior performance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYP27B1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP27B1 is a gene associated with vitamin D metabolism."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;MINOR ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The text does not provide a comprehensive description for this entity."</data>
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;NITRIC OXIDE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The molecule involved in interactions with several bodily functions."</data>
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESSES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The group of processes that occur within living organisms, including growth and metabolism."</data>
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Conditions that affect organisms externally, including diet and physical activity."</data>
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
    </node>
    <node id="&quot;CARDIOVASCULAR HEALTH&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d1">"Nitric oxide plays a critical role in regulating blood pressure and the health of cardiovascular systems.")&lt;SEP&gt;"Optimal cardiovascular health is influenced by adequate folate intake and proper metabolic pathways involving one-carbon metabolism."</data>
      <data key="d0">"OUTCOME OF BIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;DRUG THERAPY&quot;">
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d1">"Statins can help manage nitric oxide levels to reduce cardiovascular risks.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIFESTYLE FACTOR&quot;">
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d1">"A balanced nutrient profile can influence lifestyle choices in an individual.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT PROFILE&quot;">
      <data key="d2">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d1">"A balanced nutrient profile can influence lifestyle choices in an individual.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C.428_430DELAAG VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a known CYP24A1 variant represented by n=2 samples."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;C.1186C &gt; T VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is another variant of the CYP24A1 gene with n=2 samples in homozygous and heterozygous forms."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;WILD-TYPE (WT)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Samples with known CYP24A1 status were used as positive controls and wt represents their common reference form."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;N = 1 COMPOUND HETEROZYGOUS SAMPLE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"This refers to a single sample carrying both tested variants in the CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS777676129 AMPLICONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"METABOLIC PATHWAY"</data>
      <data key="d1">"These are two different target sequences that amplify common mutant sites, and their Tms were used to differentiate genotypes."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;RS114368325 AMPLICONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"METABOLIC PATHWAY"</data>
      <data key="d1">"Also, these represent another set of target sequences for amplification which is indicative of different genotypes in the CYP24A1 gene."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;NORMALIZED AND TEMPERATURE-SHIFTED AND DIFFERENT PLOT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"/"DISEASE"</data>
      <data key="d1">"These refer to the analysis method used for identifying specific melting behavior related to different CYP24A1 genotypes which may be associated with disease conditions."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DUPLEX ASSAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The dual nature of this assay is utilized for analyzing both amplicons and their Tm profiles together."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DHRMA&quot;">
      <data key="d0">"METHOD"/"DIAGNOSTICS"</data>
      <data key="d1">"This stands for dually hybridization melting analysis that determines the genotype based on melt curve patterns."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;SINGLE PLEX HRMA&quot;">
      <data key="d0">"METHOD"/"DIAGNOSTICS"</data>
      <data key="d1">"A singleplex method used to check genotypes but in this context, it's less specific than the duplex assay."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;SANGER SEQUENCING&quot;">
      <data key="d0">"METHOD"/"DIAGNOSTICS"</data>
      <data key="d1">"This technique confirms or validates the results obtained from dHRMA and HRMA."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DUPLEX-PCR/HRMA&quot;">
      <data key="d0">"METHOD"/"DIAGNOSTICS"</data>
      <data key="d1">"A combination method that combines PCR and HRMA for more efficient detection of genetic variants."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DHRMA RESULTS&quot;/&quot;SANGER SEQUENCING RESULTS/">
      <data key="d0">GENOTYPE ASSIGNMENT"/"VALIDATION AND SENSITIVITY STUDY"</data>
      <data key="d1">"The comparison between dHRMA outcomes with Sanger sequencing for genotype validation and sensitivity tests."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION&quot;/&quot;TM DIFFERENCE/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">metabolic pathway"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS777676129 AMPLICONS&quot;/&quot;RS114368325 AMPLICONS&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">metabolic pathway"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE ASSOCIATION/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">physiological process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NORMALIZED AND TEMPERATURE-SHIFTED AND DIFFERENT PLOT&quot;/&quot;CYP24A1 GENOTYPES&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">physiological process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VALIDATION/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">sensitivity study"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIAGNOSTIC VALIDATION/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">confirmation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DUPLEX-PCR/HRMA&quot;/&quot;10 DNA SAMPLES WITH THE SUSPICION OF IIH&quot;">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">confirmation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFIC GENOTYPING/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">amplicon differentiation"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DUPLEX-PCR/HRMA RESULTS/">
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d1">sequencing results"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL OUTCOME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"At 20 months of age, the patient’s developmental skill levels, as assessed by the Denver Developmental Screening Test II, included gross motor, 5 months; fine motor, 7 months; language, 7 months; and personal-social, 11 months."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;DIAGNOSTIC TESTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A brain MRI at 20 months of age showed atrophy and delayed myelination."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIAL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Median nerve compound motor action potentials were measured, with normal values for a 1- to 2-year-old infant being ≥3.5 mV at the L wrist and ≥3.5 mV at the L elbow."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Median nerve conduction velocity was measured, with normal values for a 1- to 2-year-old infant being ≥35 m/s."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Median nerve sensory action potential measurement yielded a value of 36 μV, where normal values for a 1- to 2-year-old infant are ≥15 μV."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BIOCHEMICAL FINDINGS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Table I summarizes biochemical findings in the proband. His serum copper level was normal; urine b2-microglobulin and plasma catecholamine ratios were also evaluated, but did not match Menkes disease characteristics."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;MOLECULAR ANALYSES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"We confirmed mosaicism for the P1001L mutation in the proband’s genomic DNA. The mutant allele was detected; however, it wasn't found in the mother. This mutation created a novel BsmAI restriction site."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;P1001L MUTATION&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The P1001L mutation indicates mosaicism which is associated with Menkes disease and is present on the patient's DNA; it was not detected in the mother's genomic DNA."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;BSMAI RESTRICTION SITE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The P1001L mutation creates a new BsmAI restriction site, which affects the processing of DNA."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;PCR AND BSMAI DIGESTION&quot;">
      <data key="d0">"BIOCHEMICAL PROCESS"</data>
      <data key="d1">"PCR and BsmAI digestion were performed on the patient's blood and skin fibroblast culture samples to assess mosaicism levels. The wild type allele was less abundant in the fibroblasts compared to the blood."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;WILD TYPE: MUTANT ALLELE RATIO&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Densitometry results showed a wild type:mutant allele ratio of 77:23 for whole blood DNA and 12:88 in fibroblast DNA."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;QUANTITATIVE REAL-TIME PCR (Q-RT-PCR)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Q-RT-PCR experiments showed similar wild type:mutant ratios, with a ratio of 69:31 for blood versus a 12:88 ratio in primary fibroblasts."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CONTROL FOR COMPLETENESS OF BSMAI DIGESTION&quot;">
      <data key="d0">"QUALITY ASSURANCE"</data>
      <data key="d1">"The control for completeness of BsmA1 digestion (ATP7A exon 7) was validated using Q-RT-PCR, indicating a 99% digestion efficiency in these experiments."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;COPPER LEVEL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum copper level was normal."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;B2-MICROGLOBULIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Urine b2-microglobulin, a marker of renal tubular injury due to copper overload, was also normal."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Plasma catecholamine ratios reflect the activity of dopamine-b-hydroxylase, a copper-dependent enzyme."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;DOPAMINE-B-HYDROXYLASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Dopamine-b-hydroxylase is a copper-dependent enzyme that contributes to neurotransmitter synthesis."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MENKES DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Classical Menkes disease is characterized by specific biochemical findings and molecular genetic changes, including elevated ceruloplasmin levels and mutations in the ATP7A gene."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;ATP7A GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ATP7A gene plays a role in copper transport and metabolism; mutations or deletions can lead to Menkes disease."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MOSAICISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The presence of mosaicism means that the individual carries two different cellular populations, each with a different genetic constitution."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;ATP7A EXON 7&quot;">
      <data key="d0">"EXON"</data>
      <data key="d1">"This is a specific part of the ATP7A gene sequence which was used as an indicator for BsmAI restriction site analysis during molecular tests."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;FIBROBLAST CULTURE&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Primary fibroblast cultures are obtained from skin biopsies and used in various biological assays to study cellular functions and responses."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;BIOCHEMICAL PROCESS&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Differences were observed in PCR and BsmAI digestion results between blood and skin fibroblast samples, which may indicate variations in mosaicism levels for the P1001L mutation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QUALITY ASSURANCE&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"A control test was used to ensure the accuracy and completeness of BsmAI digestion through Q-RT-PCR, providing quality assurance in molecular analysis results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CACO-2 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Caco-2 cells are human epithelial-like intestinal cell lines used for studying drug permeability and metabolism."&lt;SEP&gt;"Caco-2 cells are used in drug metabolism studies due to their intestinal-like characteristics."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;DEIODINASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Deiodinase is an enzyme that converts inactive thyroid hormones to active forms, playing a critical role in thyroid hormone regulation."&lt;SEP&gt;"This gene is involved in the conversion of inactive thyroid hormones into active forms."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;HUMAN IDI&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The human form of the deiodinase gene (hID1) does not express at detectable levels under certain conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;RAT IDI CODING SEQUENCES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Coding sequences for rat deiodinase are transfected into Caco-2 cells for study."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 3′UTR&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The 3' untranslated region (UTR) of the GPX4 gene is used to control the expression of rat IDI sequences in transfected Caco-2 cells."&lt;SEP&gt;"The specific 3' UTR found in the GPX4 gene which affects mRNA stability and translation efficiency."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE (SELENIUM)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"An essential nutrient for human health, involved in numerous enzymatic reactions including those involving deiodinase."&lt;SEP&gt;"Selenium is essential for proper thyroid function and plays a role in deiodinase expression."&lt;SEP&gt;"Selenium, an essential nutrient for human health, influences deiodinase expression and function."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;ROS (REACTIVE OXYGEN SPECIES)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Exposure to ROS leads to increases in total reactive oxygen species production."&lt;SEP&gt;"Oxidative stress markers indicating cellular damage from uncontrolled production of reactive oxygen species."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE DEPLETION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Condition where the environment lacks sufficient selenium, affecting cellular functions including thyroid hormone metabolism."&lt;SEP&gt;"Depletion of selenium from the culture medium affects cellular responses and deiodinase expression."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEINS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Selenium is used for synthesis of selenoproteins like glutathione peroxidase (GPx), thioredoxin reductase 1 (TR1), and others."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE-SUPPLEMENTATION MEDIUM&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Supplementation with selenium in the culture medium can affect deiodinase expression differently from regular cell growth conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE-DEPLETED MEDIUM&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Depletion of selenium affects cellular responses, including oxidative stress and GPx activity, under different experimental conditions."&lt;SEP&gt;"Growth conditions under low Se supply have different effects on cell viability compared to supplemented medium."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;CELL VIABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Se-supply levels influence cell viability under oxidative stress, with IDI-C cells being more sensitive."&lt;SEP&gt;"The ability of cells to survive after an oxidative challenge is influenced by deiodinase expression levels and selenoprotein content."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An oxidant used as a challenge agent in cellular experiments, affecting cell viability and ROS production."&lt;SEP&gt;"Tert-butylhydroperoxide was used as an oxidant to challenge the cells and induce a response."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SE COMPETITION THEORY&quot;">
      <data key="d0">"THEORETICAL CONCEPT"</data>
      <data key="d1">"A hypothesis suggesting that differing 3'UTRs (T or C variant) may compete for Se during oxidative stress conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOCYSTEINE INCORPORATION MACHINERY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Machinery involved in the synthesis of selenoproteins, including deiodinase proteins, using selenium."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TRANSFECTED CACO-2 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Cells that have been genetically modified by introducing exogenous DNA, specifically rat IDI coding sequences in this context."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;3′UTR (THREE PRIME UNTRANSLATED REGION)&quot;">
      <data key="d0">"TRANSCRIPT FEATURE"</data>
      <data key="d1">"The region at the 3' end of a gene's mRNA transcript that can influence gene expression and stability."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SE SUPPLEMENTATION&quot;">
      <data key="d0">"DIETARY INTERVENTION"</data>
      <data key="d1">"Administering selenium to improve or restore levels in cases of deficiency."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS&quot;">
      <data key="d0">"PATHOLOGICAL CONDITION"</data>
      <data key="d1">"Increased levels of reactive oxygen species leading to cellular damage and dysfunction."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Increased mean GPx4 mRNA levels are not significantly different in IDI-T compared to IDI-C cells when grown with Se."&lt;SEP&gt;"The increase in GPx4 mRNA levels correlates with sufficient Se availability."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Mean TR1 mRNA levels are similar in IDI-T and IDI-C cells under different Se conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX1&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Mean GPx1 mRNA levels show no difference between IDI-T and IDI-C cells under Se-depleted or supplemented medium."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENOPROTEIN H&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The mRNA for selenoprotein H was found to be significantly lower in IDI-C cells, regardless of the Se supply conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium (Se) is present in the medium and affects cellular viability when supplied at different concentrations."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;EFFECT ON CELL VIABILITY&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Cells under Se-depleted conditions show a greater reduction in viability when challenged with tert-butylhydroperoxide compared to normal medium conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELLULAR RESPONSE&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Cell lines over-expressing either the IDI-T or IDI-C transcripts show lower viability after tert-butylhydroperoxide challenge compared to untransfected cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSFECTED CACO-2 CELLS EXPRESSING IDI-T AND IDI-C TRANSCRIPTS&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Cell lines over-expressing either the IDI-T or IDI-C transcripts show lower viability after tert-butylhydroperoxide challenge compared to untransfected cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE EXPOSURE&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Exposure to tert-butylhydroperoxide leads to an increase in ROS levels, particularly under Se-depleted conditions and differing 3'UTR variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEIODINASE EXPRESSION LEVELS&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"The expression level of the deiodinase gene (both human IDI and rat IDI) affects selenoprotein H mRNA levels under varying selenium supply conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCE ON SELENOPROTEIN H MRNA&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"The expression level of the deiodinase gene (both human IDI and rat IDI) affects selenoprotein H mRNA levels under varying selenium supply conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THEORETICAL MODEL&quot;">
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d1">"Hypothesis suggesting that differing expression levels of rat IDI under se-depleted conditions could influence selenoprotein production differently compared to normal conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHAT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Quantitative RT-PCR revealed the patient, her father and one brother are hemizygous for CHAT."&lt;SEP&gt;"We identified 12 missense and one nonsense mutations in CHAT in 11 kinships."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MISSENSE MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Nine mutations are novel; p.Thr553Asn and p.Ser704Pro were published but not functionally characterized by. p.Ala557Thr was previously reported."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;NONSENSE MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"None of the mutations was detected in 200 to 400 alleles of unrelated control subjects."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;RESIDUES&quot;">
      <data key="d0">"CONSERVED RESIDUE"</data>
      <data key="d1">"All mutated residues are conserved in dog, mouse, rat, and chicken."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;DROSOPHILA&quot;">
      <data key="d0">"CONSERVED INVERTEBRATE"</data>
      <data key="d1">"Four residues (Met202, Trp421, Thr553, and Ala557) are also conserved in Drosophila and C. elegans."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;IMMUNOBLOTS&quot;">
      <data key="d0">"MOLECULAR TECHNIQUE"</data>
      <data key="d1">"Genetically engineered mutant and wild-type CHAT cDNAs were analyzed using immunoblots of cell lysates."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;START SITES&quot;">
      <data key="d0">"TRANSCRIPT VARIANT"</data>
      <data key="d1">"The spinal cord (S-type) ChAT transcript has two alternative start sites that yield 70 kDa and 74 kDa proteins at a constant ratio."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MUTATION ANALYSIS&quot;">
      <data key="d0">"FUNCTIONAL STUDY"</data>
      <data key="d1">"Eight mutants expressed at significantly lower levels than wild-type, and five of these (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, p.Ser572Trp) expressed at &lt;50% of wild-type."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;RATE CONSTANTS&quot;">
      <data key="d0">"KINETIC PARAMETER"</data>
      <data key="d1">"Ten mutations alter one or more rate constants of ChAT activation and two mutations compromise the thermal stability of the mutant protein."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;THERMAL STABILITY&quot;">
      <data key="d0">"MOLECULAR PROPERTY"</data>
      <data key="d1">"The Discussion analyzes the effects of each mutation and interprets them in the context of the atomic structural model of ChAT."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;CONTROL SUBJECTS&quot;">
      <data key="d0">"MUTATION PREVALENCE"</data>
      <data key="d1">"Mutations were not found in control subjects, implying low prevalence among the general population."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;EVOLUTIONARY CONSERVATION&quot;">
      <data key="d0">"CONSERVED RESIDUES ACROSS SPECIES"</data>
      <data key="d1">"The conserved residues across species like Drosophila and C. elegans suggest evolutionary conservation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PROTEIN STABILITY&quot;">
      <data key="d0">"THERMAL STABILITY OF MUTANT PROTEINS"</data>
      <data key="d1">"Two mutations compromise the thermal stability of CHAT proteins, indicating potential instability under varying temperatures."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;GENETIC ENGINEERING&quot;">
      <data key="d0">"WILD-TYPE EXPRESSION COMPARISON"</data>
      <data key="d1">"The expression levels of wild-type CHAT were compared with mutated forms to evaluate genetic engineering impact."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;FUNCTIONAL CHARACTERIZATION&quot;">
      <data key="d0">"KINETIC PARAMETERS AND ACTIVATION"</data>
      <data key="d1">"Ten mutations changed one or more kinetic parameters for ChAT activation, demonstrating altered function."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;STRUCTURAL MODEL&quot;">
      <data key="d0">"ATOMIC STRUCTURAL MODEL OF CHAT"</data>
      <data key="d1">"The atomic structural model provided insights into mutation effects and biological mechanisms."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;FUNCTIONAL IMPACT&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The expression of eight mutants was significantly lower than wild-type; five expressed at less than 50% of wild-type levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MISSENSE MUTATIONS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The expression of eight mutants was significantly lower than wild-type; five expressed at less than 50% of wild-type levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE PREVALENCE&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"None of the mutations were detected in control subjects, suggesting a low prevalence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONSERVED RESIDUES&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Conserved residues across species like Drosophila and C. elegans indicate that certain functions are evolutionarily preserved.")&lt;SEP&gt;"The conserved residues are present across species, including Drosophila and C. elegans, indicating evolutionary conservation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHAT EXPRESSION&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Eight mutants expressed at significantly lower levels than wild-type; five of these (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, p.Ser572Trp) expressed at &lt;50% of wild-type.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN LEVEL IMPACT&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Eight mutants expressed at significantly lower levels than wild-type; five of these (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, p.Ser572Trp) expressed at &lt;50% of wild-type.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KINETIC PARAMETER EFFECT&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Ten mutations alter rate constants for ChAT activation; two compromise thermal stability of mutant proteins.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATION RATE CONSTANTS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Ten mutations alter rate constants for ChAT activation; two compromise thermal stability of mutant proteins.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTROL SUBJECT MUTATIONS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The absence of mutations in control subjects suggests a limited genetic predisposition towards these mutations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATION PREVALENCE&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The absence of mutations in control subjects suggests a limited genetic predisposition towards these mutations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERMAL STABILITY OF MUTANTS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Mutation-induced changes might lead to compromised thermal stability under different temperatures.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WILD-TYPE COMPARISON&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Comparisons were made between wild-type and mutated CHAT proteins to evaluate the impact on expression levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTIONAL PARAMETERS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Mutations altered kinetic parameters involved in ChAT activation, affecting its catalytic efficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KINETIC ACTIVATION CHANGES&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Mutations altered kinetic parameters involved in ChAT activation, affecting its catalytic efficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ATOMIC STRUCTURAL MODEL&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The atomic structural model offered insights into how mutations affect the protein's 3D structure and function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRUCTURAL INSIGHTS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The atomic structural model offered insights into how mutations affect the protein's 3D structure and function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BCL2L11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene annotated to CpG sites which was found to have nominal associations with methylation."&lt;SEP&gt;"BCL2-like 11 [apoptosis facilitator]"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7&lt;SEP&gt;chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;NDUFS7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NADH dehydrogenase [ubiquinone] Fe-S protein 7, 20 kDa"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;EIF3J&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"eukaryotic translation initiation factor 3, subunit J"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;ZNF761&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"zinc finger protein 761"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;PSMG3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"proteasome assembly chaperone 3"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;SEMFA6A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"sema domain, transmembrane domain [TM], and cytoplasmic domain ([semaphorin] 6A"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;TAPBP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TAP binding protein [tapasin]"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;RGL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ral guanine nucleotide dissociation stimulator-like 2 (FDR &lt;0.05)"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CKAP5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"cytoskeleton associated protein 5"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FOSL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FOS-like antigen 2"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FAM20C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"family with sequence similarity 20, member C"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;FRMD6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FERM Domain containing 6"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GGT&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Glutamyltransferase"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CPG ISLAND SHORE&quot;">
      <data key="d0">"FUNCTIONAL REGULATORY ELEMENT"</data>
      <data key="d1">"The CpGs associated with oxidative stress are enriched in CpG island shores compared to all CpGs on the array."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PROMOTER OF GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A larger proportion of phenotype-associated CpGs were located in promoters of genes, thus having the potential to affect transcription from adjacent genes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;REGULOMEDB SCORE 1A-2C&quot;">
      <data key="d0">"FUNCTIONAL REGULATORY REGION"</data>
      <data key="d1">"Twenty-three percentages of sites showed strong evidence being located in a functional regulatory region (RegulomeDB score 1a-2c) based on the analysis using RegulomeDB."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;E2F1&quot;">
      <data key="d0">"GENE/PROTEIN"</data>
      <data key="d1">"We found significant enrichment of four TF binding sites, including E2F1 which is associated with atherosclerosis and coronary heart disease (CHD)."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PHOSPHORYLATION&quot;">
      <data key="d0">"FUNCTIONAL TERM"</data>
      <data key="d1">"Genes annotated to phenotype-associated CpGs are clustered into functional terms relating to phosphorylation and phosphate/phosphorous metabolic processes based on the analysis using DAVID."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PLECKSTRIN DOMAIN&quot;">
      <data key="d0">"FUNCTIONAL TERM"</data>
      <data key="d1">"The clustering of genes includes annotations related to pleckstrin domains, which may indicate pathways involved in oxidative stress."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CIS-MEQTL SNPS&quot;">
      <data key="d0">"GENETIC SEQUENCE VARIANT"</data>
      <data key="d1">"There are significant cis-meQTL SNPs among CpGs associated with oxidative markers, suggesting genetic influence on methylation patterns."&lt;SEP&gt;"We found 28 CpGs associated with oxidative markers that had a significant cis-meQTL (FDR &lt;0.05), suggesting genetic sequence variants contribute to DNA methylation variation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;ASSOCIATION BETWEEN GENOTYPE-PHENOTYPE, GENOTYPE-CPG, AND CPG-PHENOTYPE&quot;">
      <data key="d0">"SUGGESTIVE EVIDENCE OF ASSOCIATION"</data>
      <data key="d1">"We found two instances where associations of genotype-phenotype, genotype-CpG and CpG-phenotype overlapped with nominal p-value &lt;0.001."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CHD AND T2D IN GWAS DATA&quot;">
      <data key="d0">"GENETIC DISEASES"</data>
      <data key="d1">"GWAS data from the CARDIoGRAM consortium for CHD and the DIAGRAM consortium for T2D did not show overrepresentation of nominally significant associations among significant meQTL SNPs, with p-value &lt;0.05."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLAND&quot;">
      <data key="d0">"FUNCTIONAL ELEMENT"</data>
      <data key="d1">"CpG islands associated with oxidative stress markers are enriched compared to all CpGs."&lt;SEP&gt;"Promoter regions where CpG dinucleotides are clustered and often associated with high levels of transcriptional activity."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;PROMOTER&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phenotype-associated CpGs have a higher proportion located in gene promoters."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;REGULOMEDB SCORE 1-2&quot;">
      <data key="d0">"FUNCTIONAL REGULATORY REGION"</data>
      <data key="d1">"A significant percentage of CpGs is identified as being located in functional regulatory regions based on RegulomeDB score."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;E2F1 BINDING SITE&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR BINDING SITE"</data>
      <data key="d1">"Four transcription factor binding sites, including that of E2F1, are significantly enriched among the CpGs associated with oxidative markers."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PHOSPHORYLATION PROCESS&quot;">
      <data key="d0">"CELLULAR PROCESS"</data>
      <data key="d1">"Genes annotated to oxidative stress-associated CpGs cluster into functional terms related to phosphorylation processes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PLECKSTRIN DOMAIN ANNOTATIONS&quot;">
      <data key="d0">"FUNCTIONAL TERM ANNOTATIONS"</data>
      <data key="d1">"The clustering of genes includes annotations associated with pleckstrin domains relevant to oxidative stress responses."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"Analysis of GWAS data for diseases like CHD and T2D in relation to CpG sites does not show significant overrepresentation among the cis-meQTL SNPs associated with oxidative markers."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;GENE ANNOTATION&quot;">
      <data key="d0">"BIOLOGICAL COMPONENT ANNOTATION"</data>
      <data key="d1">"The genes annotated to phenotype-associated CpGs cover a range of biological components including, but not limited to, regulatory elements and cellular processes related to oxidative stress."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CG07547695&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"CpG site cg07547695 associated with rs726430 and BCL2L11 gene."&lt;SEP&gt;"CpG site cg07547695 associated with rs726430, related to the BCL2L11 gene."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CEP55&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene annotated to CpG sites which was found to have nominal associations with methylation."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CG24371383&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"CpG site cg24371383 associated with rs12782691, related to the CEP55 gene."&lt;SEP&gt;"CpG site cg24371383 related to rs12782691 and CEP55 gene."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CPB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene annotated to CpG sites which was found to have nominal associations with methylation."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CG04072156&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"CpG site cg04072156 associated with rs16861015, related to the CPB1 gene."&lt;SEP&gt;"CpG site cg04072156 connected with rs16861015, CPB1 gene, and BCL2L11."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;INTERGENIC SITE ON CHR. 4&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"An intergenic CpG site was found in the analysis."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CG14532755&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"CpG site cg14532755 associated with multiple SNPs on chr. 4."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS726430&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"SNP rs726430 associated with BCL2L11 and CpG site cg07547695."&lt;SEP&gt;"SNP rs726430 linked to BCL2L11 gene and CpG site cg07547695."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS12782691&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"SNP rs12782691 related to CEP55 gene via CpG site cg24371383."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;RS16861015&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"SNP rs16861015 linked with CPB1 and CpG site cg04072156."&lt;SEP&gt;"SNP rs16861015 linked with CPB1 gene and CpG site cg04072156."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;TGSH&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"A CpG site in BCL2L11 was associated with TGSH levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GSH&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"One CpG site in NDUFS7 was significantly linked to GSH levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GSSG/GSH RATIO&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"The methylation at a CpG annotated to EIF3J was found associated with the GSSG/GSH ratio.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OXLDL&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"CpG methylation in SEMFA6A was related to oxLDL levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD&quot;">
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-491fec1ffc43ca0e67c1080702f038a7&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d1">"Compared to healthy controls, CD subjects had a higher presence of MAPbacteremia."&lt;SEP&gt;"Higher methylation at TAPBP CpGs was found associated with CD marker levels.")&lt;SEP&gt;"Inflammatory bowel disease, specifically Crohn's Disease (CD), is the context under which studies have observed altered PTPN2:rs478582 gene expression."&lt;SEP&gt;"The relative gene expression of transcripts related to PTPN2:rs478582 is investigated in individuals with different allele combinations for this SNP."&lt;SEP&gt;"The study involved patients with Celiac Disease (CD) and examined the relation between their condition and gene expressions."</data>
      <data key="d0">"DISEASE"</data>
    </node>
    <node id="&quot;BCD-LDL&quot;">
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d1">"Methylation in the promoter region of RGL2 was found related to BCD-LDL levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CPGS ASSOCIATED WITH OXIDATIVE STRESS&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"CpGs associated with oxidative stress were enriched in CpG island shores and functional regulatory regions based on the analysis using RegulomeDB.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTIONAL REGULATORY ELEMENTS&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"CpGs associated with oxidative stress were enriched in CpG island shores and functional regulatory regions based on the analysis using RegulomeDB.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE-PHENOTYPE, GENOTYPE-CPG, AND CPG-PHENOTYPE ASSOCIATIONS&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"There was modest suggestive evidence of overlap between genotype-phenotype, genotype-CpG, and CpG-phenotype associations for certain CpGs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVERLAP BETWEEN ASSOCIATIONS&quot;">
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d1">"There was modest suggestive evidence of overlap between genotype-phenotype, genotype-CpG, and CpG-phenotype associations for certain CpGs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CPG SITE&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d1">"CpG sites are related when they share SNPs, such as cg07547695 associated with rs726430 and cg04072156 linked to rs16861015.")&lt;SEP&gt;"DNA modification differences at specific CpG sites within the LCT gene suggest epigenetic regulation influencing lactose metabolism and persistence."&lt;SEP&gt;"Significant DNA modification differences at CpG sites suggest regulatory roles affecting gene expression and the establishment of lactase persistence or non-persistence."&lt;SEP&gt;"Specific CpG sites within MCM6 are found to mediate individual differences in LCT mRNA levels, implicating MCM6 as a regulator of lactase expression."&lt;SEP&gt;"Specific CpG sites within the genes exhibit correlations between DNA modification density and LCT mRNA levels, suggesting epigenetic regulation of gene expression."&lt;SEP&gt;"The location on a chromosome where certain nucleotides pair form CpG dinucleotides that play crucial roles in gene regulation and function."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;DISEASE INCIDENCE&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"Increased risk of diseases is associated with specific methylation levels at CpG sites; e.g., higher T2D risk related to hypomethylation in DVL1 and HIST1H4D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METHYLATION LEVEL&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"Increased risk of diseases is associated with specific methylation levels at CpG sites; e.g., higher T2D risk related to hypomethylation in DVL1 and HIST1H4D.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CVD EVENT&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"No significant association was found between methylation levels and incident CVD events.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CG11842944&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"The body of ZNF341 gene is associated with incident T2D, shown by its CpG site cg11842944 methylation level.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ZNF341&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"The body of ZNF341 gene is associated with incident T2D, shown by its CpG site cg11842944 methylation level.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEART FAILURE&quot;">
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d1">"Methylation at a specific CpG site (cg11842944 in ZNF341 gene) showed the strongest association to heart failure among CVD events.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ATP SYNTHASE 6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ATP synthase 6 gene is part of the mitochondrial genome responsible for complex V (ATP synthase) activity in the electron transport chain."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MTDNA 8993T&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An apparently homoplasmic de novo mutation in mtDNA 8993T&gt;G causing an alteration at p.Leu156Arg, responsible for Leigh syndrome due to deficient activity of complex V (ATP synthase)."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;LEIGH SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurological disorder caused by mitochondrial enzyme deficiencies that lead to progressive brain degeneration."&lt;SEP&gt;"An inherited disorder resulting from the deficiency of complex V (ATP synthase) activity, associated with mitochondrial DNA variant 8993T&gt;G."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A validated RFLP assay was used for confirmation on both blood and urine samples from the child."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;CAPILLARY SEQUENCING&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Capillary sequencing methods were utilized for testing DNA isolated from maternal urine and blood to detect mutations, though it may fail in detecting heteroplasmy of less than 10%."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;EXOME SEQUENCING&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Exome enrichment and sequencing was performed on Illumina HiSeq 2000 platform for accurate detection of variants."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MT-ATP6&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The MT-ATP6 transcript is part of the mitochondrial genome encoding ATP synthase activity necessary for proper energy metabolism."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;OMITTING MATERNAL DNA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exclusion of maternal DNA coverage may not be sufficient to detect low levels of heteroplasmy due to insufficient sequencing depth."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NDUFV1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NDUFV1 gene encodes a protein involved in releasing electrons from NADH via complex 1 of the electron transport chain and functions related to proper mitochondrial energy metabolism."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.736G&gt;A, P.GLU246LYS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A missense variant in NDUFV1 gene causing a change at codon Glu246 to Lys, potentially affecting protein function and mitochondrial energy metabolism."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;C.349G&gt;A, P.ALA117THR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another missense variant found in NDUFV1 gene causing a change at codon Ala117 to Thr, predicted to be damaging based on in silico analysis."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NDUFV1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The NDUFV1 protein functions as part of the electron transport chain complex 1 and contains sites for NADH binding and iron-sulfur cluster binding necessary for proper protein activity."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;RECESSIVE INHERITANCE MODEL&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH"</data>
      <data key="d1">"Applying a recessive inheritance model to filter variants helped identify two missense variants in NDUFV1 gene shared by affected siblings, suggesting potential disease causation."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOTES&quot;">
      <data key="d0">"RELATIONSHIP TYPE"</data>
      <data key="d1">"Identifying both infants as compound heterozygotes for the missense variants in NDUFV1 gene suggests they each carry one variant on opposite alleles, further supporting the pathogenicity of these mutations."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MITOCHONDRIAL GENOME&quot;">
      <data key="d0">"MOLECULAR COMPONENT"</data>
      <data key="d1">"A circular DNA molecule containing both protein-coding and non-coding regions, which is specific to mitochondria."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"A series of protein complexes in the inner mitochondrial membrane that facilitate electron transfer during oxidative phosphorylation."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;NADH&quot;">
      <data key="d0">"SUBSTRATE"</data>
      <data key="d1">"A high-energy molecule used as a carrier of hydrogen atoms to drive ATP synthesis in the electron transport chain."&lt;SEP&gt;"NADH is a molecule that functions in the electron transport chain and is involved in metabolic processes."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33&lt;SEP&gt;chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;IN SILICO ANALYSIS&quot;">
      <data key="d0">"COMPUTATIONAL TOOL"</data>
      <data key="d1">"An in-depth computer-based method for predicting protein function and identifying potential disease-related mutations."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;HETEROPLASMY&quot;">
      <data key="d0">"GENETIC PHENOMENON"</data>
      <data key="d1">"The coexistence of two or more different DNA sequences within the mitochondrial genome of a single cell."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;DNA SEQUENCING&quot;">
      <data key="d0">"MOLECULAR TECHNIQUE"</data>
      <data key="d1">"A method used for determining the complete sequence of nucleotides in a DNA molecule."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;ILLUMINA HISEQ 2000&quot;">
      <data key="d0">"SEQUENCING PLATFORM"</data>
      <data key="d1">"A high-throughput sequencing technology platform produced by Illumina, capable of generating large volumes of sequence data efficiently."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;MATERNAL URINE AND BLOOD&quot;">
      <data key="d0">"SAMPLE TYPES"</data>
      <data key="d1">"Biological samples collected for genetic testing, where maternal urine offers a non-invasive alternative to blood for some analyses."</data>
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;GENOTYPING&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The process of identifying specific genotypes or alleles in an individual's DNA sequence, often used in genetic research and diagnostics."&lt;SEP&gt;"The purified cells were subjected to genome-wide gene expression analysis, genotyping and imputation using the 1000 Genomes reference panel."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-b930cdd3706af881cfa771b341af097d</data>
    </node>
    <node id="&quot;FMN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"FMN (Flavin Mononucleotide) is a cofactor that works with NADH and iron-sulfur clusters for proper functioning of complex I."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;IRON–SULFUR CLUSTER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Iron–sulfur clusters are components that help in the proper function of the NADH binding site and FMN."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;GLU246LYS MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Glu246Lys mutation occurs within the FMN-binding site and could be involved in the interaction with NADH."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COMPLEX 1 OF ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This is a protein complex that releases electrons from NADH and facilitates their movement to ubiquinone."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q2 HOMOLOG, PRENYLTRANSFERASE (COQ2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"COQ2's mutations have been associated with coenzyme Q10 deficiency (OMIM #609825)."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NUCLEAR EXOME&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The nuclear exome refers to the part of DNA that can be affected by environmental factors, including diet."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MEAN TARGET NUCLEAR EXOME COVERAGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This process involves sequencing depth and affects how well specific parts of the genome are analyzed."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL DNA (MTDNA)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The mtDNA can be influenced by factors like diet, affecting the number and type of variants found."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;CATEGORY 1–3 VARIANTS&quot;">
      <data key="d0">"VARIANT CLASSIFICATION"</data>
      <data key="d1">"Variants classified as category 1-3 are considered potentially disease-causing or significant in genetic analysis."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;RECESSIVE INHERITANCE PATTERN&quot;">
      <data key="d0">"INHERITANCE TYPE"</data>
      <data key="d1">"This pattern refers to the mode of inheritance where an individual needs two copies of a variant to express a trait or disorder."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;HOMOZYGOUS VARIANTS&quot;&amp; &quot;TWO OR MORE VARIANTS&quot;">
      <data key="d0">"GENETIC CONDITION"</data>
      <data key="d1">"Genes with these variants are typically associated with recessive genetic disorders."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q10 DEFICIENCY (OMIM #609825)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disorder characterized by a deficiency in coenzyme Q10, affecting various biological processes."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;LEBER OPTIC ATROPHY (OMIM #535000)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This is a specific type of Leber's hereditary optic neuropathy, characterized by rapid vision loss in the young adult population."&lt;SEP&gt;"This is one of the disorders that can result from mutations in MT-ND1."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY (OMIM #252010)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition where individuals have defects or deficiencies affecting multiple subunits of respiratory complex I found in both nuclear and mitochondrial DNA."&lt;SEP&gt;"Mutations in MT-ND1 may also lead to deficiencies affecting mitochondrial complexes involved in respiration."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MELAS SYNDROME (OMIM #540000)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Another disorder that can be associated with mutations in genes like MT-ND1, including muscle abnormalities and stroke-like episodes."&lt;SEP&gt;"This specific disorder involves mutations within mtDNA that manifest with a diverse range of symptoms, including neurological issues and muscle abnormalities."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MT-ND1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene encodes a subunit of respiratory complex I involved in mitochondrial energy production."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COMPLEX I OF ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This is a protein complex that includes NADH, FMN and iron–sulfur clusters for electron transport."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;DIDEOXYNUCLEOTIDE PEAKS&quot;">
      <data key="d0">"ANALYTICAL DATA"</data>
      <data key="d1">"These are used to estimate the heteroplasmy level of mitochondrial DNA variants."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;3754C&gt;A MUTATION IN MT-ND1&quot;">
      <data key="d0">"VARIANT TYPE"</data>
      <data key="d1">"This variant causes an arginine codon at position 387 to be replaced by a premature stop codon (X)."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;LEBER OPTIC ATROPHY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A hereditary disease affecting the retina of the eye, often with progressive loss of vision."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition involving deficiencies in multiple subunits encoded by mitochondrial DNA and nuclear genes which affects respiratory chain complexes."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MELAS SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A multisystem disorder caused by mutations in mtDNA with symptoms that vary widely among affected individuals, including neurological deficits."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;RESPIRATORY CHAIN COMPLEXES&quot;">
      <data key="d0">"SYSTEM"</data>
      <data key="d1">"These are part of the mitochondrial electron transport chain involved in cellular respiration."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MUSCLE ABNORMALITIES&quot;">
      <data key="d0">"SYMPTOM GROUP"</data>
      <data key="d1">"MELAS can present with symptoms including muscle weakness and atrophy."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;STROKE-LIKE EPISODES&quot;">
      <data key="d0">"SYMPTOM GROUP"</data>
      <data key="d1">"In MELAS, affected individuals may experience episodic strokes or transient ischemic attacks."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL DNA ENCODED SUBUNITS&quot;">
      <data key="d0">"GENE PRODUCT"</data>
      <data key="d1">"These are components of respiratory complexes I and other mitochondrial enzymes that require correct protein expression for normal function."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;VALIDATION&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"A validated RFLP assay confirmed the findings on DNA from blood and urine samples from the child.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONFIRMATION&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"Capillary sequencing methods were used to confirm the presence of mutations in both maternal urine and blood, though it may fail for heteroplasmy detection at low levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DATA GENERATION&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"Exome enrichment and sequencing on Illumina HiSeq 2000 was performed to generate comprehensive variant data for accurate genotyping.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DETECTION LIMIT&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"Capillary sequencing methods might fail to detect heteroplasmy below 10% even when mutations are present in blood samples.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANTS FILTERING&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"Application of a recessive inheritance model helped filter variants to identify two missense mutations in NDUFV1 gene shared by affected siblings, suggesting potential disease causation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE INTERPRETATION&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"Identifying both infants as compound heterozygotes for the missense variants in NDUFV1 gene suggests they each carry one variant on opposite alleles, further supporting the pathogenicity of these mutations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COQ2&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"The Glu246Lys mutation in the FMN binding site could potentially affect COQ2 function, leading to potential disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COQ2 GENE&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Variants in COQ2 have been linked to coenzyme Q10 deficiency, affecting the body's ability to produce essential compounds.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUCLEAR DNA SEQUENCING DEPTH&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"The depth of nuclear exome sequencing determines the comprehensiveness and accuracy of genetic data analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORS (INCLUDING DIET)&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Changes in dietary patterns can influence the number and type of mitochondrial variants found.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MITOCHONDRIAL VARIANTS&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Changes in dietary patterns can influence the number and type of mitochondrial variants found.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATIONS IN MT-ND1&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Mutations in this gene lead to disorders like Leber optic atrophy, mitochondrial complex I deficiency, and MELAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NADH DEHYDROGENASE SUBUNIT 1 (MT-ND1)&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Mutations in this gene lead to disorders like Leber optic atrophy, mitochondrial complex I deficiency, and MELAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY PATTERN (SPECIFICALLY DIET AFFECTING MTDNA)&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Poor dietary choices may contribute to conditions involving defects in the respiratory chain components of mitochondria.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LEBER OPTIC ATROPHY, MITOCHONDRIAL COMPLEX I DEFICIENCY, MELAS&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"These genetic disorders are associated with mutations within the MT-ND1 gene that is a part of complex I.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC DISORDERS (RECESSIVE INHERITANCE)&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"Genes carrying two homozygous variants or two or more variants are often linked to recessive genetic disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HETEROPLASMY LEVEL&quot;">
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d1">"The heteroplasmic level indicates the mixture of normal and mutant mtDNA, affecting its expression within cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OPRM1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"OPRM1 encodes a mu-opioid receptor."&lt;SEP&gt;"OPRM1 is a gene that plays a role in drug response and alcohol metabolism."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1&lt;SEP&gt;chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;AUDIT SCORE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"AUDIT score is a measure of alcohol use, classified under drinking variables."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;NUMBER OF DRINKING DAYS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The number of drinking days is another measure of alcohol consumption, categorized as drinking variables."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DRINKS PER DRINKING DAY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Drinks consumed per drinking day is a metric for assessing alcohol intake frequency and quantity."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALDH2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ALDH2 variant (rs671) impacts the activity of aldehyde dehydrogenase, affecting alcohol metabolism."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ADH1B&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ADH1B variant (rs1229984) influences the breakdown of alcohol and other alcohols in the body."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DROWSINESS&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"A side effect experienced when taking naltrexone compared to placebo."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;RINGING IN THE EARS&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"This auditory disturbance was observed with naltrexone use compared to placebo."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;NAUSEA&quot;">
      <data key="d0">"SIDE EFFECT"</data>
      <data key="d1">"No significant medication associations were found for nausea among side effects measured by SAFTEE."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;AUDAC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alcohol Craving is influenced by Alcohol Breath Concentration (BrAC) and other factors."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;BRAC&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Alcohol Breath Concentration reflects the metabolic pathway of alcohol in the body."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;CURRENT CIGARETTE SMOKING STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"A binary variable indicating whether a participant is a current smoker."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;BINARY VARIABLE (0=NON-SMOKER, 1=SMOKER)&quot;">
      <data key="d0">"COVARIATE"</data>
      <data key="d1">"Used to represent current cigarette smoking status in statistical models."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ASN40 HOMOZYGOTES + PLACEBO GROUP&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"The Asn40 homozygotes in the placebo group showed effects on alcohol self-administration and consumption compared to other genotypes."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ASP40 CARRIERS&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"Carriers of Asp40 genotype consume significantly fewer drinks as compared to Asn40 homozygotes in alcohol self-administration experiments."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d0">"GENETIC FACTOR"</data>
      <data key="d1">"The ALDH2 genotype plays a role in the pharmacogenetic effects, specifically regarding nicotine smoking status and alcohol consumption."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NICOTINE SMOKING STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Nicotine smoking status is not significantly associated with any of the effects examined such as medication impact on alcohol self-administration or latency to drink."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;TOTAL NUMBER OF DRINKS CONSUMED&quot;">
      <data key="d0">"OUTCOME VARIABLE"</data>
      <data key="d1">"The number of drinks consumed by participants does not have a significant main effect of medication as per Poisson regression analysis."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;LATENCY TO FIRST DRINK&quot;">
      <data key="d0">"OUTCOME VARIABLE"</data>
      <data key="d1">"The time taken for the first drink was significantly influenced by genotype but not by medication, as shown in Cox proportional regression models."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE INTERACTION&quot;">
      <data key="d0">"STATISTICAL INTERACTION"</data>
      <data key="d1">"There is no significant interaction between medication and genotype regarding the effects on alcohol self-administration or latency to first drink as per presented analysis."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;OPRM1 GENOTYPE&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Carriers of different OPRM1 genotypes may exhibit varied responses to medication or alcohol based on their biological mechanisms."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;POISSON REGRESSION ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY"</data>
      <data key="d1">"Poisson regression is utilized for the statistical analysis of count data such as total number of drinks consumed."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;COX PROPORTIONAL REGRESSION MODEL&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY"</data>
      <data key="d1">"A Cox proportional hazards regression model helps assess time-to-event outcomes like latency to drink."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;WALD CHI-SQUARE TEST&quot;">
      <data key="d0">"STATISTICAL TEST"</data>
      <data key="d1">"The Wald chi-square test evaluates the significance of independent variables in logistic and Poisson regression models."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;HAZARD RATIO (HR)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"A Hazard Ratio represents the risk of an event occurring over time when comparing different groups, such as smokers vs non-smokers."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;NON-NORMAL DISTRIBUTION&quot;">
      <data key="d0">"DATA PROPERTY"</data>
      <data key="d1">"The presence of a non-normal data distribution indicates that certain assumptions for certain statistical tests may not be met."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;MAIN EFFECT&quot;">
      <data key="d0">"STATISTICAL TERM"</data>
      <data key="d1">"A main effect in ANOVA refers to the direct influence of one independent variable on the dependent variable, regardless of other variables."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ADH1B GENOTYPE&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Two genetic variants related in influencing alcohol metabolism, drug response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION (NALTREXONE/PLACEBO)&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Differences in side effects experienced when taking naltrexone compared to placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIDE EFFECTS&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Differences in side effects experienced when taking naltrexone compared to placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC FACTOR&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"The ALDH2 genotype's influence extends into environmental factors like smoking status in determining alcohol consumption patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL INTERACTION&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"In the context of the experiments, medication × genotype interaction is not a significant factor for all outcomes as evidenced by analysis results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COVARIATE&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"The ALDH2 genotype is a statistical covariate affecting alcohol consumption in the models.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION EFFECTS&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"The medication's impact on various outcomes was analyzed using chi-square tests for significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL ANALYSIS OUTCOME&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"The medication's impact on various outcomes was analyzed using chi-square tests for significance.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LATENCY TO DRINK&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"Latency to first drink is a key outcome measure in evaluating the timing of alcohol consumption patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME MEASURE&quot;">
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d1">"Latency to first drink is a key outcome measure in evaluating the timing of alcohol consumption patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GG GENOTYPE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"Moderate treatment effect observed only in the GG genotype for both AC t1/2 and GC24."&lt;SEP&gt;"The GG genotype had the highest daily alcohol consumption among men."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GA GENOTYPE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"Among men, the GA genotype group had lower levels of cortisol compared to the GG and AA genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;DAILY ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"EXPOSURE"</data>
      <data key="d1">"Daily alcohol consumption was positively associated with blood cortisol levels in both sexes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;UNIVARIATE MODEL&quot;">
      <data key="d0">"STATISTICAL MODEL"</data>
      <data key="d1">"In univariate model, daily alcohol consumption was positively associated with blood cortisol levels in both sexes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;MULTIVARIATE LINEAR REGRESSION MODELS&quot;">
      <data key="d0">"STATISTICAL MODEL"</data>
      <data key="d1">"After adjustment for covariates like age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol levels remained similar or stronger in men compared to women."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GENETICALLY PREDICTED ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"CAUSAL ESTIMATE"</data>
      <data key="d1">"In MR analysis for men, one standard drink/day of genetically predicted alcohol consumption was associated with an increase of 0.36 (95% CI: 0.21-0.51) in cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSIS&quot;">
      <data key="d0">"QUALITY CONTROL"</data>
      <data key="d1">"A statistical method that evaluates how robust results are to removal or inclusion of individual data points."&lt;SEP&gt;"In sensitivity analysis for men, one standard drink/day elevates cortisol by 0.27 (95% CI: 0.14-0.41)."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;EX-DRINKER&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Ex-drinkers were included in sensitivity analysis."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;STANDARD DRINK/DAY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A standard drink is a measure used to quantify alcohol consumption, equivalent to about 14 grams of pure alcohol."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;RS671 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ALDH2 rs671 polymorphism affects the activity of the aldehyde dehydrogenase enzyme and impacts alcohol metabolism."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;POLYSOMNOGRAPHY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Results from polysomnography were not explicitly mentioned but could be related to sleep patterns or quality, potentially affected by alcohol consumption."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;EDUCATION STATUS&quot;">
      <data key="d0">"VARIABLE"</data>
      <data key="d1">"Education status was included as a covariate in the multivariate models."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;ALDH2 RS671 GENOTYPES&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"The pattern of cortisol levels varied based on the ALDH2 rs671 genotypes by sex.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL LEVEL&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"The pattern of cortisol levels varied based on the ALDH2 rs671 genotypes by sex.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE DISTRIBUTION&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"There was a significant difference in age distribution among different genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPIC VARIANCE&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"There was a significant difference in age distribution among different genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BODY MASS INDEX (BMI)&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"BMI was associated with subgroups as shown by Table 1, where IBS-D had a BMI approximately 4 higher than IBS-C and HV."&lt;SEP&gt;"HUA participants had higher BMI, suggesting possible obesity or overweight conditions."&lt;SEP&gt;"The BMI differed according to the rs671 polymorphism significantly among men.")</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;BLOOD CORTISOL LEVELS&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"In both sexes, daily alcohol consumption was positively associated with blood cortisol levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL LEVEL (MR ANALYSIS)&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"In MR analysis for men, one standard drink/day of genetically predicted alcohol consumption was associated with an increase of 0.36 in cortisol levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORTISOL LEVEL (GENETICALLY PREDICTED ALCOHOL CONSUMPTION)&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"In sensitivity analysis for men, one standard drink/day elevates cortisol by 0.27.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EX-DRINKERS&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"Ex-drinkers could be included in sensitivity analyses considering their genotypic status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS671 GENOTYPES&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"Ex-drinkers could be included in sensitivity analyses considering their genotypic status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC PREDISPOSITION AND ALCOHOL CONSUMPTION&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"The genetically predicted alcohol consumption likely refers to the difference between the actual reported intake and a statistical estimate based on genetic factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALDH2 RS671&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"Both terms refer to different aspects of the same ALDH2 gene polymorphism, with 'ALDH2' being more common in literature but 'rs671' specifying a particular SNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EDUCATION STATUS, HYPERTENSION, DIABETES&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"The inclusion of these covariates is to adjust for confounding factors when assessing the association between alcohol consumption and cortisol levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC FACTORS AND LIFESTYLE&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"Genetic predisposition may influence how individuals engage in lifestyle behaviors such as physical activity.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study population comprised a total of 1026 individuals, including males and females."&lt;SEP&gt;"The term 'individuals' refers to the study participants without genetic data, known as 'controls'."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;PREVALENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HUA (Hyperuricemia) prevalence was found to be 14.71% among the participants."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SERUM CREATININE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increased serum creatinine levels were observed in individuals with HUA, indicating renal function alteration."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;TRIGLYCERIDE (TG)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"High levels of TG were found among participants with HUA, potentially related to dyslipidemia."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;LOW-DENSITY LIPOPROTEIN (LDL)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased LDL levels in HUA cases compared to controls may indicate a disrupted lipid profile."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;DIURETICS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The usage ratio of diuretics showed no significant difference between the two groups."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;FASTING BLOOD GLUCOSE (FBG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FBG levels were not significantly different in HUA cases and controls, suggesting similar insulin sensitivity."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;TOBACCO SMOKING&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"No significant difference in tobacco smoking history was found between the HUA cases and controls."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HISTORY OF DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There were no significant differences in diabetes history between HUA cases and control participants."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SUBJECT&quot;">
      <data key="d0">"DISEASE/CONDITION"/"PARAMETER"/"FACTOR"/"LIFESTYLE"/"ENVIRONMENTAL FACTOR")</data>
      <data key="d1">"Gender/&lt;Age Range&gt;/Ethnicity"</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SLC2A9 RS3733951 C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Individuals with the C allele in the SLC2A9 gene have lower serum uric acid (sUA) levels."&lt;SEP&gt;"The C allele of the SLC2A9 gene is linked to lower serum uric acid (sUA) levels in G/G genotypes compared with T/T genotypes."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;RS2231142 ABCG2 T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The T allele in rs2231142 of the ABCG2 gene increases the risk of hyperuricemia (HUA) especially in males with obesity, hypertension, higher TG levels and lower HDL levels."&lt;SEP&gt;"The T allele of the rs2231142 variant of the ABCG2 gene is associated with higher sUA and HUA risk in males when accounting for cardiovascular risks."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Environmental factors such as obesity, hypertension, high TG levels, low HDL levels are associated with increased sUA level and HUA risk."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;TG LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Triglyceride levels are associated with high sUA level and increase the risk of HUA, especially in males and females with obesity and hypertension."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;HMGCR RS3849267 C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C allele of HMGCR rs3849267 is associated with lower serum uric acid (sUA) levels."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;RS1051730 C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C allele of rs1051730 variant is linked to lower sUA levels and HUA risk."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;ABCG2 RS2231142 T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The T allele in ABCG2 rs2231142 polymorphism increases the risk of hyperuricemia (HUA) especially when accounting for obesity, hypertension and other cardiovascular risks."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;SUA LEVEL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The levels of sUA (serum uric acid) are a part of the metabolic pathway."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;RS2231142 T ALLELE&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The rs2231142 genetic variant is associated with cardiovascular risk."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;HUA RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"High uric acid levels (HUA) are a disease risk factor."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;SLC2A9 RS3733591&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"Increased sUA levels showed a significant association with the Beta coefficient of each copy of risk allele (p=0.002).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;URIC ACID LEVEL&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"Increased sUA levels showed a significant association with the Beta coefficient of each copy of risk allele (p=0.002).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABCG2 RS2231142&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"There was a strong association between the ABCG2 variant's T allele and sUA levels and HUA risk." )</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLC22A12 RS893006&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The distribution of SLC22A12 variants showed no significant association with HUA risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION BETWEEN GENOTYPES AND SUA LEVEL&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The T allele of rs2231142 ABCG2 was associated with sUA levels and HUA in both males and females, while the C risk allele of SLC2A9 was only related to females. The G risk allele of SLC22A12 was associated with sUA level only in males.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATION BETWEEN GENOTYPES AND HUA RISK&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The association between different genotypes and HUA risk differed by gender: the T allele of rs2231142 ABCG2 showed significance, while there was no significant association with SLC22A12 rs893006 variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABCOR2 RS2231142 POLYMORPHISM&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The polymorphism of ABCG2 rs2231142 was significantly associated with sUA levels (p=6.98e-8).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;G/G GENOTYPES&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"In males, the G/G genotypes of the ABCG2 rs2231142 polymorphism had significantly lower sUA levels compared to T/T genotypes (p=4.40e-6).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T/T GENOTYPES&quot;">
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d1">"The G/G genotypes of the ABCG2 rs2231142 polymorphism had significantly lower sUA levels compared to T/T genotypes across all populations (p=6.98e-8).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPERTENSION - ENVIRONMENTAL FACTOR&quot;">
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d1">"High blood pressure heightens the risk for hyperuricemia, which might be due in part to increased serum uric acid concentrations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LRP2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LRP2 gene is associated with kidney function."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NFATC1 plays a central role in inducible gene transcription during immune response and is a downstream target of transplant immunosuppression drug cyclosporine A."&lt;SEP&gt;"The NFATC1 gene has been discovered in a meta-analysis of European ancestry GWASs for eGFR."&lt;SEP&gt;"The renal mRNA expression of NFATC1 was significantly decreased under high-salt diet exposure and showed a trend towards reduction in a CKD model."&lt;SEP&gt;"This gene shows strong signals for association with eGFR and CKD."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;RS57989581&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant at the LRP2 locus was found to be associated with eGFR and leads to kidney function impairment."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS8096658&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A new variant in NFATC1 was identified that is also significant for eGFR, indicating its role in kidney function."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ESRD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"End-stage renal disease (ESRD) is associated with the eGFR-decreasing alleles at various genetic loci."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;T1D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The associations between T1D susceptibility, changes in expression for IRF1 and STAT1 are associated with a specific genetic region."&lt;SEP&gt;"Type 1 diabetes was also found associated with eGFR in GWASs, though not as strongly as type 2 diabetes."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;PDILT-UMOD&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PDILT-UMOD gene locus demonstrates strong associations with both CKD and kidney function, indicating a critical role in these functions."&lt;SEP&gt;"The PDILT-UMOD locus is found to have distinct genetic signals associated with both kidney function and CKD risk, indicating a critical role in these processes."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;UNCX&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another identified genetic variant (rs62435145) associated with increased risk of CKD."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ALMS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALMS1 gene shows nominal evidence of association with CKD, indicating its potential role in renal function related diseases."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS7587577&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant at the ALMS1 gene shows association with CKD risk, contributing to our understanding of genetic factors influencing renal health."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RS77924615&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant rs77924615 at the PDILT-UMOD locus demonstrates strong associations with both kidney function and CKD, highlighting its genetic impact on these processes."&lt;SEP&gt;"This variant at the PDILT-UMOD locus has been implicated in driving association signals for both eGFR and CKD, emphasizing its importance."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;SLC34A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC34A1 gene contributes to eGFR associations."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;DCDC5-MPPED2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene DCDC5-MPPED2 is involved at four variants mapping to 27.9kb, which might have implications for disease susceptibility or function."&lt;SEP&gt;"This genetic locus has significant association signals for both kidney function and related diseases, indicating potential mechanisms in renal health."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;PRKAG2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PRKAG2 gene shows evidence of association with eGFR in diabetic individuals, suggesting a role in diabetes-linked kidney dysfunction."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;RGS14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RGS14 encodes a member of the regulator of G protein signaling family which modulates downstream effects of Gα subunits in kidneys."&lt;SEP&gt;"Rgs14's renal mRNA expression was notably reduced during high salt exposure and approached statistical significance in the CKD model, suggesting altered gene expression under stress conditions.")("entity"</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083&lt;SEP&gt;chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;DROSOPHILA MELANOGASTER (LOCUS)&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"In Drosophila, loco is the closest RGS14 ortholog with reduced expression associated with longer lifespan and stress resistance."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RSK8&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"HDAC inhibitors are involved in kidney function and development, which may suggest their role in kidney disease treatments as they affect histone deacetylases (HDACs)."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;PIPK1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene PIP5K1B has five variants mapping to 3.5kb and could be associated with mechanisms impacting eGFR in the context of genetic fine-mapping and genomic annotation studies."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;NFATC1 (MIM: 602513)&quot;">
      <data key="d0">"DISEASE"/"GENE"</data>
      <data key="d1">"NFATC1 is a gene that plays a central role in inducible gene transcription during immune response, which might be related to transplant immunosuppression drug cyclosporine A."&lt;SEP&gt;"NFATC1 plays a central role in inducible gene transcription during immune response and is a downstream target of the transplant immunosuppression drug cyclosporine A."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RGS14 (MIM: 602513)&quot;">
      <data key="d0">"DISEASE"/"GENE"</data>
      <data key="d1">"RGS14 encodes a member of the regulator of G protein signaling family which modulates downstream effects of Gα subunits and has unknown function in kidneys."&lt;SEP&gt;"RGS14 is a gene encoding a member of the regulator of G protein signaling family, which modulates downstream effects of Gα subunits in kidneys."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;SLC34A1 (MIM: 182309)&quot;">
      <data key="d0">"DISEASE"/"GENE"</data>
      <data key="d1">"SLC34A1 is a gene involved at two variants mapping to 0.6kb, which has been associated with risk of CKD and can influence eGFR through its role in the kidney."&lt;SEP&gt;"SLC34A1 is a gene with variants involved that might have implications for understanding mechanisms related to kidney diseases and functions."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;GCKR (MIM: 600842)&quot;">
      <data key="d0">"DISEASE"/"GENE"</data>
      <data key="d1">"GCKR is a gene with three variants mapping to 11.7kb that has been linked to increased risk of CKD and its p.Pro446Leu variant specifically."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;DCDC5-MPPED2 (MIM: 612321, 600911)&quot;">
      <data key="d0">"DISEASE"/"GENE"</data>
      <data key="d1">"This gene is associated with four variants mapping to 27.9kb that could impact the mechanisms involved in genetic fine-mapping and genomic annotation studies."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;PIPK1B (MIM: 602745)&quot;">
      <data key="d0">"DISEASE"/"GENE"</data>
      <data key="d1">"The gene PIP5K1B has five variants mapping to 3.5kb that are of interest in the context of understanding genetic associations with eGFR."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCOD06164&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"loco mutants with this gene showed improved survival when fed NaCl-supplemented food."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;Y1W1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The y1w1 genomic variant had little effect on viability but was associated with resistance to salt stress in loco mutants."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;LOCOEY-P283&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The locoEY-P283 gene showed similar properties as the locod06164 gene in terms of salt tolerance when fed NaCl-supplemented food."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NACL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The supplementation of diet with varying NaCl concentrations helped to assess the stress resistance of genotypes with the loco mutation."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;NON-NACL-SUPPLEMENTED FOOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There was no baseline difference in viability among genotypes fed non-NaCl supplemented food during testing period."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SURVIVAL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The survival of heterozygous loco mutants was improved on NaCl-supplemented food compared to controls, indicating a role for the gene in resistance to salt stress."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;INBREEDING DEPRESSION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Experiments with hybrid heterogenic backgrounds were conducted to exclude effects of inbreeding depression on findings."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HYBRID HETEROGENIC STRAINS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"These hybrid genotypes were less susceptible to salt stress than their isogenic counterparts, suggesting a role for genetic diversity in adaptation to environmental pressures."&lt;SEP&gt;"These strains were less salt-susceptible than isogenic strains, showing that genetic background impacts salt stress resistance."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;129S6 MOUSE STRAIN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The 129S6 mouse strain's physiological responses were studied under high-salt diet conditions and during CKD models."&lt;SEP&gt;"This strain was used in studies to examine roles of genes NFATC1 and RGS14 under high-salt diet conditions."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HIGH-SALT DIET&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A two-week exposure to a high-salt diet influenced renal mRNA expression of Nfatc1 and Rgs14."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;2-WEEK EXPOSURE&quot;">
      <data key="d0">"TIME PERIOD"</data>
      <data key="d1">"The 2-week duration allowed us to assess changes in gene expression under high-salt conditions."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SUB-TOTAL NEPHRECTOMY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A CKD model using sub-total nephrectomy induced a renal disease state that was associated with altered gene expression of NFATC1 and RGS14."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CKD MODEL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Renal disease susceptibility increased in this model as indicated by the decrease in Rgs14 and Nfatc1 mRNA expressions during CKD conditions."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;HIGH-SALT EXPOSURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"High salt intake was found to affect mRNA expression levels of genes like Nfatc1 and Rgs14, suggesting a complex relationship between dietary factors and gene regulation."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CKD-INDUCED NEPHRECTOMY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Sub-total nephrectomy as part of the CKD model introduced a chronic kidney disease state which altered gene expressions related to renal function."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;SALT SUSCEPTIBILITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"These terms refer to the varying responses of different genotypes towards dietary salt intake, indicating potential genetic determinants for resistance or sensitivity."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;RESISTANCE TO STRESS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The improved survival observed in certain genotypes on NaCl-supplemented food suggests they have natural defenses against environmental stressors like salt."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CAUSE AND EFFECT&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH"</data>
      <data key="d1">"Although not definitively established, the data supports a potential link between dietary factors, gene expression changes, and disease states, implying these elements are interrelated in complex biological pathways."</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;ANCESTRY GROUPS&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"Variability in allele frequencies between different ancestry groups does not affect the allelic effects on eGFR, suggesting a shared genetic basis for this measurement across populations.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 27}, {"level": 1, "cluster": 53}]</data>
    </node>
    <node id="&quot;CKD&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"SNP rs62435145 associated with increased risk of CKD through its influence on kidney function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS62435145&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"SNP rs62435145 associated with increased risk of CKD through its influence on kidney function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D, T1D&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"The NFATC1 gene shows evidence of association with diabetic nephropathy and altered eGFR in both type 1 and type 2 diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CKD, EGFR&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"A collective of genes and specific genetic variations contribute to the complex interplay between CKD risk, eGFR measurements, and underlying pathologies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UNCX, ALMS1, PDILT-UMOD, NFATC1&quot;">
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d1">"A collective of genes and specific genetic variations contribute to the complex interplay between CKD risk, eGFR measurements, and underlying pathologies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAMPYLOBACTER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Campylobacter infections were confirmed in 975 patients; out of these, 18.2% (177 cases) had quinolone-resistant isolates and 0.3% (3 cases) had erythromycin-resistant strains."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE RESISTANCE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Quinolone resistance was significantly associated with the origin of infection; among travelers returning to Denmark, 50.0% (76 out of 152) were infected by quinolone-resistant strains, while domestically acquired infections showed a lower proportion (9.9%, 52 out of 526)."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;TRAVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Foreign travel was linked to higher proportions of quinolone resistance; travel destinations such as Spain and Portugal were specifically mentioned."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Quinolones were the drug class related to the study, with specific emphasis on their efficacy against Campylobacter infections."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;CAMPYLOBACTER COLI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Of the three erythromycin-resistant isolates, two were also quinolone-resistant and originated from travelers returning to Denmark from Spain and Portugal. This indicates possible genetic variations among strains."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;SWIMMING&quot;">
      <data key="d0">"ACTIVITY"</data>
      <data key="d1">"Swimming was another activity associated with an increased risk for quinolone-resistant C. jejuni infection."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;AGE GROUP&quot;">
      <data key="d0">"DEMOGRAPHIC FACTOR"</data>
      <data key="d1">"There were no significant age-related differences in the findings regarding quinolone resistance, though data were collected across different age groups."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;CAMPYLOBACTER JEJUNI&quot;">
      <data key="d0">"SPECIES"</data>
      <data key="d1">"C. jejuni is a type of Campylobacter bacterium that was frequently found as resistant to fluoroquinolones."&lt;SEP&gt;"Most of the human isolates were C. jejuni strains."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;QUINOLONE-SENSITIVE&quot;">
      <data key="d0">"ANTIBIOTIC SENSITIVITY"</data>
      <data key="d1">"The majority (574 out of 975) of Campylobacter infections were sensitive to fluoroquinolones, indicating resistance was more prevalent."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;FLUOROQUINOLONES&quot;">
      <data key="d0">"DRUG CLASS"</data>
      <data key="d1">"Fluoroquinolones are a class of antibiotics commonly used in the treatment and prevention of C. jejuni infections."&lt;SEP&gt;"Infections treated with fluoroquinolones before specimen collection were excluded."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;RIBOGROUP&quot;">
      <data key="d0">"GENETIC GROUPING"</data>
      <data key="d1">"The RiboGroups are used for classifying and grouping strains together based on their ribosomal RNA sequences."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;RESISTANCE PATTERN&quot;">
      <data key="d0">"PHENOTYPIC CHARACTERISTIC"</data>
      <data key="d1">"Quinolone-resistant isolates were characterized by specific patterns indicating the mechanism of resistance."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;SILENT MUTATIONS&quot;">
      <data key="d0">"GENETIC CHARACTERISTIC"</data>
      <data key="d1">"Several silent mutations were identified within the gyrA gene of quinolone-resistant Campylobacter strains, contributing to resistance without altering protein function."</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT CASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study identified 12 quinolone-resistant cases that were domestically acquired."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;AMOXICILLIN-CLAVULANATE&quot;, &quot;AZITHROMYCIN&quot;, &quot;DOXYCYCLINE&quot;, &quot;CLARITHROMYCIN&quot;, &quot;LEVOFLOXACIN&quot;, &quot;COTRIMOXAZOLE&quot;, &quot;SULFAMETHOXAZOLE/TRIMETHOPRIM&quot;, &quot;TETRACYCLINE&quot;">
      <data key="d0">"ANTIMICROBIAL DRUGS"</data>
      <data key="d1">"The study found information on antimicrobial drugs received by 122 of 126 patients."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;C. JEJUNI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Of the human isolates, most (63%) were from Danish-bred food animals; the remaining were imported from France (n=48), Italy (n=7), and the United Kingdom (n=9)."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;FLAVOXATE&quot;, &quot;CLARITHROMYCIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The human isolates were included in a database, compared with Campylobacter isolates obtained from retail food products (chicken [n=139], turkey [n=39], and pork [n=2])"</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;RETAIL FOOD PRODUCTS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Most of the isolates were from Danish-bred food animals."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;BROILER CHICKENS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Three chicken isolates were unknown in origin."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;NONDOMESTIC&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Of 49 isolates from broiler chicken fecal samples, two isolates (4.1%) were nalidixic acid-resistant; one was also erythromycin-resistant."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;NALIDIXIC ACID-RESISTANCE&quot;">
      <data key="d0">"DRUG RESISTANCE"</data>
      <data key="d1">"Five (2.0%) of the 153 C. jejuni isolates and five (18.5%) of the 27 C. coli isolates were resistant to erythromycin."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;ERYTHROMYCIN RESISTANCE&quot;">
      <data key="d0">"DRUG RESISTANCE"</data>
      <data key="d1">"A subanalysis showed that seven (8.0%) of eighty-seven C. jejuni isolates and three (60%) of five C. coli isolates from domestic-raised chicken products were resistant to nalidixic acid."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;C. COLI RESISTANCE&quot;">
      <data key="d0">"DRUG RESISTANCE"</data>
      <data key="d1">"Of the 49 isolates from broiler chicken fecal samples, seven were erythromycin-resistant; one was also nalidixic acid-resistant."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CAMPYLOBACTER ISOLATES&quot;">
      <data key="d0">"BACTERIAL PATHOGEN"</data>
      <data key="d1">"The human isolates were included in a database and compared with Campylobacter isolates obtained from retail food products (chicken [n = 139], turkey [n = 39], and pork [n=2])"</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;C. COLI&quot;">
      <data key="d0">"BACTERIAL STRAIN"</data>
      <data key="d1">"The remaining isolates were C. coli strains."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;QUINALENOXACIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Five (2.0%) of the 153 C. jejuni isolates and one (18.5%) of the 27 C. coli isolates were resistant to quinalenoxacin."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CIPROFLOXACIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"One isolate (a C. jejuni) from domestic chicken products was resistant to both nalidixic acid and ciprofloxacin."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;ERYTHROMYCIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Two isolates were erythromycin-resistant; one of which was also nalidixic acid-resistant."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CLARITHROMYCIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Five (10.2%) isolates (four C. jejuni, one C. coli) were erythromycin-resistant."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT ISOLATES&quot;">
      <data key="d0">"DRUG RESISTANCE PHENOTYPE"</data>
      <data key="d1">"Eighteen subtypes were identified exclusively among quinolone-resistant isolates; five of these 18 subtypes matched those found in retail food products and broiler chickens."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;QUINOLONE-SENSITIVE ISOLATES&quot;">
      <data key="d0">"DRUG SENSITIVITY PHENOTYPE"</data>
      <data key="d1">"One hundred and two (76.7%) subtypes were exclusively among quinolone-sensitive isolates; 34 of these types also matched human isolates, indicating a link between dietary sources and drug sensitivity."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;QUINOLONE-RESISTANT C. JEJUNI&quot;">
      <data key="d0">"DRUG RESISTANCE PHENOTYPE"</data>
      <data key="d1">"Five (20.8%) of the quinolone-resistant isolates were identified among retail food products, broiler chickens, or both; three (14.7%) of these from chicken products."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;DOMESTICALLY ACQUIRED C. JEJUNI ISOLATES&quot;">
      <data key="d0">"CONTEXTUAL LOCATION"</data>
      <data key="d1">"The likelihood that domestically acquired C. jejuni strains had subtypes found in retail food products and broiler chickens was higher than those with quinolone-resistant isolates (270 of 444 vs. 15 of 51, RR = 2.07, CI 1.34 to 3.18, p &lt; 0.001)."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;RISK FACTOR&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Eating specific types of poultry (excluding chicken and turkey) was identified as a risk factor for quinolone-resistant C. jejuni infection based on the case-comparison study.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT APPROACH&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"Fluoroquinolones were recommended as a primary treatment for C. jejuni infections until their ineffectiveness against resistant strains was recognized.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PREVALENCE COMPARISON&quot;">
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d1">"The prevalence of fluoroquinolone resistance was notably higher among travelers compared to domestically acquired cases, as indicated by the study's data analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOMESTICALLY ACQUIRED&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Infections treated with fluoroquinolones before specimen collection were excluded, indicating a distinction between domestically acquired and travel-related infections.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FOODBORNE&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"The majority of human isolates came from Danish-bred food animals, suggesting a connection to foodborne transmission.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORIGIN&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Of the retail food products compared with broiler chickens, most were from domestic sources, which was different than imported isolates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C. JEJUNI ISOLATES FROM RETAIL FOOD PRODUCTS AND BROILER CHICKENS&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Several of the isolates identified as quinolone-resistant or -sensitive matched those found in human patients, indicating a potential shared source.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIMILARITY OR COHORT&quot;">
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d1">"Several of the isolates identified as quinolone-resistant or -sensitive matched those found in human patients, indicating a potential shared source.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS9534511&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is located in HTR2A and affects serotonin receptor activity."&lt;SEP&gt;"This variant is located in HTR2A and is part of the serotonin pathway."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;HTR2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HTR2A encodes a serotonin receptor."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS4938056&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is located in HTR3B and is part of the serotonin pathway."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;HTR3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HTR3B encodes a serotonin receptor."&lt;SEP&gt;"The rs4938056 variant impacts HTR3B, also a serotonin receptor gene."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1998220&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Located in an intronic region of OPRM1, which influences opioid receptor function."&lt;SEP&gt;"This variant is located in an intronic region of OPRM1, which is part of the opioid receptor gene."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS1003921&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant resides in an intronic region of KCNC1, which is related to ion channel activity."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;KCNC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"KCNC1 encodes a voltage-gated potassium channel protein 1."&lt;SEP&gt;"The rs1003921 variant is associated with voltage-gated potassium channel activity."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16116&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This intergenic variant affects NPY neurotransmission regulation pathways."&lt;SEP&gt;"This variant is in an intergenic region downstream of NPY, which is related to neurotransmission regulation."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;NPY&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NPY encodes a neuropeptide Y."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS16870286&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is part of LINC00518, an uncharacterized RNA gene which potentially influences cellular processes."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;LINC00518&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LINC00518 encodes for an uncharacterized protein or functions as a long non-coding RNA."&lt;SEP&gt;"The rs16870286 variant impacts long non-coding RNA LINC00518, possibly affecting gene expression or other cellular processes."</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The social disinhibition score was increased by 0.20 points (95% CI: 0.17–0.23) and by 0.45 points (95% CI: 0.40–0.51), respectively, in association with three SNPs."&lt;SEP&gt;"The social disinhibition score was increased by a certain amount associated with specific SNPs."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"An increase in age is correlated with a higher social disinhibition score.")&lt;SEP&gt;"Increasing age is positively associated with increased social disinhibition score.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;LINGUISTIC ACCULTURATION&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"Higher linguistic acculturation scores are positively related to higher mean social disinhibition scores.")&lt;SEP&gt;"Increased linguistic acculturation positively correlates with social disinhibition scores.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;TAS&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"The total anxiety score (TAS) is significantly and positively associated with social disinhibition.")&lt;SEP&gt;"Total Anxiety Scale (TAS) score is significantly correlated to higher social disinhibition scores.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;DAS&quot;">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"Depression Anxiety Scale (DAS) score shows a positive correlation with the social disinhibition measure.")&lt;SEP&gt;"Depression anxiety score (DAS) is significantly related to increased risk of social disinhibition.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 18}]</data>
    </node>
    <node id="&quot;MINOR ALLELES&quot;">
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d1">"Three of the SNPs were associated with increased risk while three had protective effects on the social disinhibition score.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CNR1 gene is located in a region focused on the rs2023239 variant, which was found near exon 3 as an alternative promoter."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;RS2023239&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs2023239 genetic variant was examined in relation to the rewarding effects of alcohol in a previous study."&lt;SEP&gt;"The rs2023239 genomic variant is located upstream of exon 3 and has been associated with CB1 receptor levels."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e&lt;SEP&gt;chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CB1 RECEPTOR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CB1 receptors modulate the mesocorticolimbic neurocircuitry related to drug-seeking behavior in animals, influenced by genetic variations like rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;POSTMORTEM PFC&quot;">
      <data key="d0">"TISSUE SAMPLE"</data>
      <data key="d1">"Post-mortem human prefrontal cortex (PFC) tissue was analyzed for the association between rs2023239 and CB1 receptor levels."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ANOVA&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"ANOVA was used to compare the relationship of the CT genotype with CB1 binding in Brodmann areas 9 and 10."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CNR1 RECEPTORS&quot;">
      <data key="d0">"MOLECULAR COMPONENT"</data>
      <data key="d1">"CNR1 receptors modulate the mesocorticolimbic neurocircuitry involved in drug-seeking behavior."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL SEEKING BEHAVIOR&quot;">
      <data key="d0">"BEHAVIORAL TRAIT"</data>
      <data key="d1">"The genetic variation affecting CB1 receptor levels was expected to associate with differential activation during alcohol exposure."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;NEUROIMAGING STUDY&quot;">
      <data key="d0">"RESEARCH METHOD"</data>
      <data key="d1">"Neuroimaging data from a recent study were reanalyzed to explore the functional significance of rs2023239 on brain activation."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ANOVA ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"The ANOVA analysis revealed significant differences in CB1 receptor binding between genotypes."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;MEDICATION: OLANZAPINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The study analyzed an effect of the medication olanzapine."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The study compared the effect of cyproheptadine to olanzapine in its analysis."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CLINICAL TRIAL&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"The recent clinical trial analyzed the effects of olanzapine on cue-elicited craving and drinks per drinking day."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CB1 RECEPTOR LEVEL&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"The genetic variant rs2023239 is linked to CB1 receptor levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BRAIN ACTIVATION&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"The rs2023239 variant has been associated with altered brain activation patterns during alcohol exposure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL USE DISORDER SCORE&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"The CT group had a significant correlation between alcohol use disorder scores and certain neural activations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CT GROUP&quot;">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">"The CT group had a significant correlation between alcohol use disorder scores and certain neural activations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REWARD RESPONSE&quot;&lt;|&quot;THE CT GROUP DEMONSTRATED A SIGNIFICANT INCREASE IN REWARD RESPONSE COMPARED TO THE TT GROUP AFTER CONSUMING ALCOHOL.&quot;)">
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d1">14)("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE CT&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"Individuals with the CT genotype reported greater reward from alcoholic beverages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REWARDING EFFECTS&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"Individuals with the CT genotype reported greater reward from alcoholic beverages.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE CT AND CC&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"In an earlier study, individuals with genotypes CT or CC showed this interaction when receiving active control medication (cyproheptadine).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × DRINK INTERACTION&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"In an earlier study, individuals with genotypes CT or CC showed this interaction when receiving active control medication (cyproheptadine).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1 VARIATION AND OLANZAPINE&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"There might be an interaction between CNR1 variation and the effect of olanzapine on alcohol's rewarding impact.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION ON REWARDING EFFECTS OF ALCOHOL&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"There might be an interaction between CNR1 variation and the effect of olanzapine on alcohol's rewarding impact.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × CUE INTERACTION ON CRAVING&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"In a recent clinical trial, the CT genotype showed greater cue-elicited craving when treated with placebo compared to olanzapine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CT GENOTYPE AND TT GENOTYPE&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"In the recent clinical trial, individuals with the CT genotype reported more drinks per drinking day than those with the TT genotype when they were treated with both placebo vs. olanzapine.")&lt;SEP&gt;"Individuals with CT genotype reported more drinks per drinking day than those with TT genotype when treated with placebo versus olanzapine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE × DRINK INTERACTION&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"The analyses revealed a genotype-drink interaction when individuals were treated with olanzapine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE × MEDICATION INTERACTIONS&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"There were no significant genotype x medication interactions on reward from alcohol beverages when cyproheptadine was compared to olanzapine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION: OLANZAPINE AND CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"There were no significant genotype x medication interactions on reward from alcohol beverages when cyproheptadine was compared to olanzapine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION × GENOTYPE × CUE INTERACTION&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"In a recent study, there was a significant medication-genotype-cue interaction for craving when individuals were given different medications (cyproheptadine vs. placebo) compared to olanzapine.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXOGENOUS LIPID METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Involves packaging of dietary fat into chylomicrons in the small intestine, which are later transported to the bloodstream."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ENDOGENOUS LIPID METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Initial step involves hydrolysis of chylomicrons by lipoprotein lipase (LPL)."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPOPROTEIN LPL&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The primary protein involved in breaking down cholesterol and triglycerides in lipoproteins."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Rare autosomal recessive disorder with low prevalence due to a founder effect."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Present in affected individuals, particularly homozygotes or compound heterozygotes of LPL deficiency."&lt;SEP&gt;"This disease is characterized by abnormally high levels of triglycerides in the blood, which can lead to various health complications."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ERUPTIVE XANTHOMAS&quot;">
      <data key="d0">"CLINICAL FEATURE"</data>
      <data key="d1">"Reddish-yellow papular rash that appears during the disease progression."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ABDOMINAL PAIN&quot;">
      <data key="d0">"CLINICAL FEATURE"</data>
      <data key="d1">"A common manifestation of high triglyceride levels, indicating potential health risks or discomfort."&lt;SEP&gt;"Symptom experienced by individuals affected by LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63&lt;SEP&gt;chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HEPATO-SPLENOMEGALY&quot;">
      <data key="d0">"CLINICAL FEATURE"</data>
      <data key="d1">"Enlargement of liver and spleen, often observed in LPL deficiency patients."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;RECURRENT PANCREATITIS&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Repeated episodes of inflammation within the pancreas due to LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPEMIA RETINALIS&quot;">
      <data key="d0">"CONDITION"</data>
      <data key="d1">"Eye condition characterized by cloudy, white vitreous humor caused by high lipid levels in the blood."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;DIETARY FAT RESTRICTION&quot;">
      <data key="d0">"TREATMENT"</data>
      <data key="d1">"Fundamental aspect of therapy for managing LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ENFAPORT LIPIL FORMULA&quot;">
      <data key="d0">"MEDICATION"</data>
      <data key="d1">"Formula with a higher proportion of medium-chain triglycerides compared to long-chain fats."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL GENE MUTATION&quot;">
      <data key="d0">"GENETIC MUTATION"</data>
      <data key="d1">"Autosomal recessive mutation within exon 5 of the LPL gene causes deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;P.G215E&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Transition from G to A at codon position 644 results in substitution of glycine for glutamic acid."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL P.Q240H&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Transversion from G to T at codon position 721 causes an amino acid change from glutamine to histidine."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL LOCUS&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"Located on chromosome 8p21.3, spanning approximately 30 kb with a mature protein length of 448 amino acids."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PATHOGENIC LPL MUTATIONS&quot;">
      <data key="d0">"CLASSIFICATION"</data>
      <data key="d1">"Over 150 mutations identified as pathogenic in the LPL gene, including missense, nonsense, and other types."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GPIHBP1&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Identified for transporting LPL to capillary lumen by recent studies."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LPL DEFICIENCY MUTATION SPECTRUM&quot;">
      <data key="d0">"CLASSIFICATION"</data>
      <data key="d1">"Mutation in this patient expands known mutations to over 150, including involvement of residue 240 highlighting functional importance."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;BREAST-FEEDING&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Method of infant feeding which may influence lipid profiles."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ENFAPORT LIPIL&quot;">
      <data key="d0">"FORMULA"</data>
      <data key="d1">"Special formula with higher fat content from medium-chain triglycerides and lower long-chain fats."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;84% MEDIUM-CHAIN TRIGLYCERIDES&quot;">
      <data key="d0">"PROPORTION OF FAT CONTENT IN ENFAPORT LIPIL"</data>
      <data key="d1">"Specific composition for dietary intervention in LPL deficiency treatment."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;16% LONG-CHAIN FATS&quot;">
      <data key="d0">"PROPORTION OF FAT CONTENT IN ENFAPORT LIPIL"</data>
      <data key="d1">"Particular type of fat to manage lipid metabolism disorders like LPL deficiency."&lt;SEP&gt;"Specific composition for dietary intervention in LPL deficiency treatment."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;84% MCT (MEDIUM-CHAIN TRIGLYCERIDES)&quot;">
      <data key="d0">"FAT TYPE IN ENFAPORT LIPIL"</data>
      <data key="d1">"Particular type of fat to manage lipid metabolism disorders like LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PUREGENE DNA ISOLATION KIT&quot;">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Kit used for extracting DNA from blood samples during genetic analysis."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GENTRA SYSTEMS, QIAGEN INC&quot;">
      <data key="d0">"MANUFACTURER"</data>
      <data key="d1">"Company that produces the Puregene DNA isolation kit."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PCR AMPLIFICATIONS&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"Polymerase Chain Reaction process for amplifying DNA sequences during genetic studies."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;PRIMERS&quot;">
      <data key="d0">"REAGENTS"</data>
      <data key="d1">"Specific DNA sequences used in PCR to amplify particular parts of the genome."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;CODING REGIONS AND INTRON-EXON BOUNDARIES&quot;">
      <data key="d0">"GENETIC ANALYSIS AREAS"</data>
      <data key="d1">"Targeted regions of LPL gene for mutation detection through Sanger sequencing."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;BI-DIRECTIONAL SANGER SEQUENCING&quot;">
      <data key="d0">"ANALYTICAL TECHNIQUE"</data>
      <data key="d1">"Method used to determine the DNA sequence of PCR products."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;SEQSCAPE V2.6&quot;">
      <data key="d0">"SOFTWARE"</data>
      <data key="d1">"Used software tool for analyzing genetic data obtained from sequencing experiments."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;GENETIC ANALYSIS BOARD PROTOCOL 07920E&quot;">
      <data key="d0">"ETHICAL AND REGULATORY APPROVAL"</data>
      <data key="d1">"Protocol approved by the Western University Ethics Review Board for genetic study."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;INFORMED CONSENT&quot;">
      <data key="d0">"CONSENT PROCESS"</data>
      <data key="d1">"Procedure to ensure participants' agreement before their data is used in research."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;P.Q240H&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a novel mutation in exon 5 of the LPL gene causing severe hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;EXON 5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Exon 5 of the LPL gene contains the p.Q240H mutation causing hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPOPROTEIN LIPASE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LPL performs essential functions including lipolysis and fat metabolism; its malfunction due to mutations leads to hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;EXON 5 MUTATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The p.Q240H mutation in exon 5 affects the protein structure/function, influencing LPL activity."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;P.Q240H MUTATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"This genetic mutation is an inherent factor that predisposes individuals to hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GEMFIBROZIL&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A drug used for treating high triglyceride levels by inhibiting the synthesis of cholesterol and triglycerides."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;OMEGA-3 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"These are recommended in dietary therapy for reducing triglyceride levels due to their beneficial effects on lipid metabolism."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ORLISTAT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An over-the-counter medication that aids weight loss by blocking the absorption of fats from food, which can help manage hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DGAT1 INHIBITORS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"DGAT1 inhibitors target a key enzyme involved in triglyceride synthesis during fat absorption; this approach aims to reduce triglyceride levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GAIN-OF-FUNCTION VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant of the LPL gene that can confer beneficial effects, though it's costly and has limited long-term effectiveness."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;INTRAMUSCULAR INTRODUCTION&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"This procedure involves introducing a therapeutic agent into muscle tissue to treat specific diseases, used here for the LPL gene in Europe."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIACYLGLYCEROL O-ACYLTRANSFERASE 1 (DGAT1)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"DGAT1 facilitates triglyceride synthesis; inhibiting it can be a strategy for managing hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GASTROINTESTINAL HEMORRHAGE&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"A potentially severe complication associated with elevated triglycerides, possibly due to hyperviscosity or other factors."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PANCREATITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inflammation of the pancreas that can occur in individuals with high triglyceride levels; it often requires medical intervention."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LINEAR GROWTH&quot;">
      <data key="d0">"DEVELOPMENTAL OUTCOME"</data>
      <data key="d1">"In individuals with LPL deficiency, dietary fat restriction may not impede linear growth despite potential health challenges."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PUBERTY&quot;">
      <data key="d0">"DEVELOPMENTAL PROCESS"</data>
      <data key="d1">"Children and adolescents with LPL deficiency can experience normal puberty despite restrictions on fatty foods."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;FAT RESTRICTION&quot;">
      <data key="d0">"DIETARY INTERVENTION"</data>
      <data key="d1">"A dietary approach to manage hypertriglyceridemia by reducing fat intake; however, it may have limitations for growing individuals."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;SUNLIGHT EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to sunlight affects vitamin D synthesis, which influences lipid metabolism."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;VITAMIN D SYNTHESIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Vitamin D impacts fat absorption and metabolism, playing a role in managing hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPID METABOLISM&quot;">
      <data key="d0">"BIOMEDICAL PROCESS"</data>
      <data key="d1">"Vitamin D modulates lipid metabolism through interactions with specific enzymes and proteins involved in fat handling."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ENZYMES AND PROTEINS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The actions of these biological catalysts are crucial for vitamin D-mediated effects on lipid metabolism."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PANCREATIC FUNCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Healthy pancreatic function is essential, as it affects fat absorption and other metabolic processes that influence triglyceride levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;FAT ABSORPTION&quot;">
      <data key="d0">"BIOMEDICAL FUNCTION"</data>
      <data key="d1">"The process by which the body absorbs dietary fats plays a role in lipid metabolism and can affect hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ENZYME ACTIVITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Enzyme activities influence fat metabolism, including those that may be modulated by vitamin D or impacted by hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GASTROINTESTINAL TRACT&quot;">
      <data key="d0">"PHYSIOLOGICAL SYSTEM"</data>
      <data key="d1">"The gastrointestinal tract's health affects fat absorption and subsequent lipid levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;FATTY ACID BINDING PROTEINS&quot;">
      <data key="d0">"MOLECULAR COMPONENTS"</data>
      <data key="d1">"These proteins play roles in transporting, storing, and managing fatty acids throughout the body, impacting triglyceride metabolism."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PHARMACODYNAMICS&quot;">
      <data key="d0">"DRUG EFFECT"</data>
      <data key="d1">"The way drugs like gemfibrozil or orlistat affect the body and manage triglycerides is part of their pharmacodynamic profile."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;THERAPEUTIC EFFICACY&quot;">
      <data key="d0">"BIOMEDICAL OUTCOME"</data>
      <data key="d1">"The effectiveness of various therapeutic interventions in managing hypertriglyceridemia is a measure of their therapeutic efficacy."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ADVERSE EFFECTS&quot;">
      <data key="d0">"BIOMEDICAL RESPONSE"</data>
      <data key="d1">"Potential side effects from drug therapies or treatments for hypertriglyceridemia are biomedical responses that need monitoring."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;CLINICAL FEATURES&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Linking genetic disorder to symptoms such as hypertriglyceridemia, xanthomas, abdominal pain, etc.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT FOR LPL DEFICIENCY&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Direct link between lifestyle change and managing the disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AUTOSOMAL RECESSIVE LPL DEFICIENCY MUTATION&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Understanding spectrum of mutations and expanding known cases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATHOGENIC MUTATIONS IN LPL GENE&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Understanding spectrum of mutations and expanding known cases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION WITH LPL&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Role played by GPIHBP1 in transporting the enzyme to capillary lumen.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AUTOSOMAL RECESSIVE LPL DEFICIENCY MUTATION AND CLINICAL MANIFESTATIONS&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Link between genetic mutation causing LPL deficiency and its clinical symptoms such as hypertriglyceridemia, xanthomas, etc.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FORMULA COMPOSITION (ENFAPORT LIPIL) AND TREATMENT EFFICACY&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Association between the specific fat content composition in Enfaport Lipil formula and improvement in lipid profiles as a treatment for LPL deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME RELATIONSHIP&quot;">
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d1">"Association between the specific fat content composition in Enfaport Lipil formula and improvement in lipid profiles as a treatment for LPL deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC DNA ANALYSIS&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"The genomic DNA analysis was performed on the subjects to identify genetic variants like p.Q240H.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Long-term dietary fat restriction is a cornerstone of treatment for LPL deficiency, helping manage hypertriglyceridemia.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAT SUPPLEMENT&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"MCT-based formulas are used as fat supplements because they're absorbed directly into the portal vein, aiding in fat management.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCT-BASED FORMULA&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"MCT-based formulas are used as fat supplements because they're absorbed directly into the portal vein, aiding in fat management.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DGAT1 INHIBITORS AND THERAPY&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"The use of DGAT1 inhibitors to target triglyceride synthesis is an investigational treatment approach for LPL deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GEMFIBROZIL AND OMEGA-3 FATTY ACIDS&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Combined with a fat-restricted diet, drugs like gemfibrozil and omega-3 fatty acids help manage high triglyceride levels in individuals with LPL deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE THERAPY&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"An approved gene therapy procedure for managing hypertriglyceridemia involves introducing a gain-of-function variant of the LPL gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTRAMUSCULAR INTRODUCTION OF GAIN-OF-FUNCTION VARIANT&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"An approved gene therapy procedure for managing hypertriglyceridemia involves introducing a gain-of-function variant of the LPL gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DRUG MANAGEMENT&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Orlistat is used as an over-the-counter weight loss aid, which may also help manage hypertriglyceridemia by blocking fat absorption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORLISTAT AND OVER-THE-COUNTER USE&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Orlistat is used as an over-the-counter weight loss aid, which may also help manage hypertriglyceridemia by blocking fat absorption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABDOMINAL PAIN AND HYPERVISCOSITY&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Elevated triglyceride levels can lead to abdominal pain and hyperviscosity, which may cause gastrointestinal issues.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SYMPTOM AND COMPLICATION RELATIONSHIP&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Elevated triglyceride levels can lead to abdominal pain and hyperviscosity, which may cause gastrointestinal issues.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE AND CAUSE RELATIONSHIP&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"An elevated risk of pancreatitis exists in individuals with high triglyceride levels due to factors like fat metabolism dysfunction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PANCREATITIS AND HIGH TRIGLYCERIDES&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"An elevated risk of pancreatitis exists in individuals with high triglyceride levels due to factors like fat metabolism dysfunction.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOPIRAMATE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A medication used for treating patients during treatment."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;PLACEBO&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A control group in the study which did not receive Topiramate."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant associated with the response to topiramate treatment."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;EUROPEAN-AMERICAN (EA)">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The ethnic group being studied, which experiences a range of responses and adverse events related to treatments."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;HDDS (HEADACHE DAILY DIARY SCORES)&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"A metric used for measuring efficacy in the treatment outcomes."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;NNT (NUMBER NEEDED TO TREAT)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The number of patients who need to be treated with topiramate to prevent one additional headache daily diary score."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ADVERSE EVENTS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Events or symptoms that occur as side effects of treatments."&lt;SEP&gt;"Unwanted effects or symptoms that occur as a result of treatment, including severity and frequency."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;MILD ADVERSE EVENT&quot;">
      <data key="d0">"ADVERSE EVENT LEVEL"</data>
      <data key="d1">"The least severe type of adverse event in the study."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;MODERATE ADVERSE EVENT&quot;">
      <data key="d0">"ADVERSE EVENT LEVEL"</data>
      <data key="d1">"An adverse event that is more significant than mild but not as severe as severe."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;SEVERE ADVERSE EVENT&quot;">
      <data key="d0">"ADVERSE EVENT LEVEL"</data>
      <data key="d1">"A serious and potentially life-threatening adverse effect resulting from treatment."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;NNT-AEMOD+ (ADJUSTED NNT FOR MODERATE EVENTS)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The adjusted number needed to treat considering the presence of moderate or greater adverse events."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;NNT-AESEV+&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The adjusted number needed to treat considering severe adverse events only."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;EFFICACY&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"The measure used to determine how well a treatment is working."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;SEVERE OR GREATER ADVERSE EVENTS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"A subset of adverse events that are considered more severe and potentially life-threatening."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;EUROPEAN-AMERICAN SUBGROUP (N=122)&quot;">
      <data key="d0">"STUDY GROUP"</data>
      <data key="d1">"The subgroup being studied with a defined demographic."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407*C-HOMOZYGOTES&quot;">
      <data key="d0">"GENOMIC VARIANT"*EA PATIENTS"</data>
      <data key="d1">"A genetic variant found in European-American patients."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"*EA PATIENTS"</data>
      <data key="d1">"Individuals carrying the A-allele for rs2832407 genetic variant."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;NNT&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"Number Needed to Treat (NNT) quantifies how many patients need treatment with Topiramate to prevent one additional headache daily diary score.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EUROPEAN-AMERICAN (EA)&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"The EA ethnicity shows differences in response to Topiramate based on the genetic variant rs2832407.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2832407&quot;*TOPIRAMATE&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"The EA ethnicity shows differences in response to Topiramate based on the genetic variant rs2832407.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;92% OF EA PATIENTS&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"A high majority of EA patients experience mild adverse events, which is not statistically different between treatment groups.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MODERATE OR GREATER ADVERSE EVENTS&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"For rs2832407*C-homozygotes, moderate adverse events are more frequent with topiramate compared to placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2832407*C-HOMOZYGOTES&quot;*TOPIRAMATE VS. PLACEBO&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"For rs2832407*C-homozygotes, moderate adverse events are more frequent with topiramate compared to placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2832407*A-ALLELE CARRIERS&quot;*TOPIRAMATE VS. PLACEBO&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"For rs2832407*A-allele carriers, there is a significant difference in the frequency of severe adverse events between topiramate and placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEVERE ADVERSE EVENTS&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"For rs2832407*A-allele carriers, there is a significant difference in the frequency of severe adverse events between topiramate and placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NNT-AEMOD+&quot;">
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d1">"For rs2832407*C-homozygotes, the adjusted number needed to treat considering moderate adverse events is lower for Topiramate.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT CHARACTERISTICS&quot;">
      <data key="d0">"CLINICAL"</data>
      <data key="d1">"A total of 120 eligible patients who were approached signed consent (90%). Of these, 107 (89%) completed the study, genotyping was conducted on 93 patients, and 88 patients had complete self-report and genetic data. Therefore, 88 patients were included in the current analyses."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;INCOME&quot;">
      <data key="d0">"DEMOGRAPHIC"</data>
      <data key="d1">"had an annual household income of at least $40,000 per year (60%)"</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DIAGNOSIS&quot;">
      <data key="d0">"CLINICAL"</data>
      <data key="d1">"Most patients were diagnosed with gastrointestinal (34%), thoracic (27%) or breast malignancies (26%)"</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;STAGE OF DISEASE&quot;">
      <data key="d0">"CLINICAL"</data>
      <data key="d1">"had advanced stage disease (74%)"</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CHEMOTHERAPY REGIMEN&quot;">
      <data key="d0">"CLINICAL"</data>
      <data key="d1">"received highly-emetogenic chemotherapy regimens (65%)"</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ANTI-EMETIC MEDICATIONS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Prescribed anti-emetic medications are shown in Table II. Nearly all participants received palonosetron (99%) and dexamethasone (98%)"</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;SELF-REPORTED NAUSEA&quot;">
      <data key="d0">"PATIENT-REPORTED"</data>
      <data key="d1">"In the univariate analyses examining patient-reported risk factors for CINV, patient-reported severity of acute nausea was associated with younger age (r=−0.32, p&lt;0.01) and fewer hours of sleep the night before chemotherapy (r=−0.34, p&lt;0.01)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CTCAE GRADE 2 OR ABOVE ACUTE NAUSEA&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"3% in the acute period and 11% in the delayed period experienced CTCAE grade of vomiting."&lt;SEP&gt;"A total 12% of patients experienced CTCAE grade 2 or above acute nausea."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;DELAYED NAUSEA&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"30% experienced delayed nausea."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;CTCAE GRADE 3 OR ABOVE NAUSEA&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"The severity of CTCAE grade of acute nausea was associated with younger age (r=−0.24, p=0.02), fewer hours of sleep the night before chemotherapy (r=0.29, p&lt;0.01), and history of nausea and vomiting due to morning sickness (r=0.22, p=0.04)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ADVANCED STAGE CANCER&quot;">
      <data key="d0">"CLINICAL"</data>
      <data key="d1">"Severity of CTCAE grade of delayed nausea was associated with advanced stage cancer (r=−0.22, p=0.04)"</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;RECEIPT OF HIGHLY EMETOGENIC CHEMOTHERAPY&quot;">
      <data key="d0">"CLINICAL"</data>
      <data key="d1">"Receipt of highly emetogenic chemotherapy (65%)"</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;VARIATION IN ABCB1 (RS1045642)&quot;">
      <data key="d0">"GENETIC"</data>
      <data key="d1">"There was an association between variation in ABCB1 (rs1045642), which was associated with acute nausea, and the severity of acute nausea."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;MULTIVARIABLE ANALYSIS OF ACUTE NAUSEA&quot;">
      <data key="d0">"STATISTICAL"</data>
      <data key="d1">"In multivariable analysis, demographic, clinical, and patient-reported risk factors accounted for 13% of variance in acute nausea (p=0.03), while ABCB1 genotype added an additional 5% of variance (p=0.10)."</data>
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
    </node>
    <node id="&quot;ANTI-EMETIC&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Almost all patients were prescribed palonosetron, a common anti-emetic medication.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PALONOSETRON&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Almost all patients were prescribed palonosetron, a common anti-emetic medication.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEXAMETHASONE&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"98% of the participants received dexamethasone, another commonly used anti-emetic drug.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR FOR ACUTE NAUSEA&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Younger age was associated with increased severity of patient-reported acute nausea.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;YOUNGER AGE&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Younger age was associated with increased severity of patient-reported acute nausea.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FEWER HOURS OF SLEEP&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Reduced sleep prior to chemotherapy was significantly linked to higher severity of patient-reported acute nausea.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR FOR ACUTE VOMITING&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The younger age was not associated with acute vomiting, based on CTCAE grading.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR FOR DELAYED NAUSEA&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The association between advanced stage cancer and the severity of delayed nausea.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The receipt of highly emetogenic chemotherapy was significantly linked to increased risk factors for nausea, both acute and delayed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTOR FOR NAUSEA&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The receipt of highly emetogenic chemotherapy was significantly linked to increased risk factors for nausea, both acute and delayed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABCB1 RS1045642 GENOTYPE&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"Genetic variation in ABCB1 (rs1045642) was linked to more severe acute nausea, with heterozygotes reporting more severe symptoms than homozygous wild type or variant genotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEMOGRAPHIC, CLINICAL, PATIENT-REPORTED VARIABLES&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"These factors together explained a significant portion of the variance in acute nausea severity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RISK FACTORS FOR ACUTE NAUSEA&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"These factors together explained a significant portion of the variance in acute nausea severity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ABCB1 GENOTYPE&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The ABCB1 genotype significantly enhanced the risk factors for acute nausea in conjunction with other demographic, clinical, and patient-reported variables.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCER OF ACUTE NAUSEA RISK&quot;">
      <data key="d2">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d1">"The ABCB1 genotype significantly enhanced the risk factors for acute nausea in conjunction with other demographic, clinical, and patient-reported variables.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene related to the study, possibly involved in regulatory interactions with LCT."&lt;SEP&gt;"The MCM6 gene exhibits similar regions of DNA modification when compared to LCT intron 5 and the introns/exon identified in inter-individual analysis."&lt;SEP&gt;"The MCM6 gene interacts with LCT, potentially affecting lactose metabolism and persistence."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LACTOSE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Lactase activity is crucial for lactose digestion, a dietary process relevant to human health."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;DNA MODIFICATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Changes in DNA modification patterns are associated with changes in gene expression and may influence lactase persistence."&lt;SEP&gt;"Such DNA modifications occur within MCM6 intron 13 during embryogenesis."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;ENTEROCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Intestinal epithelial cells play a role in the regulation of gene expression, including that of LCT, affecting lactose metabolism."&lt;SEP&gt;"Regions identified were specific to Enterocytes, showing differences in DNA modifications compared to the enterocyte-deficient jejunum."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;JEJUNUM SAMPLE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Surgical jejunum samples are obtained from unrelated human adults to study genetic and epigenetic factors influencing lactase persistence."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;AFFYMETRIX HIGH DENSITY HUMAN TILING ARRAYS&quot;">
      <data key="d0">"TECHNOLOGICAL TOOL"</data>
      <data key="d1">"High-throughput genotyping platforms used for chromosome-wide investigation of gene regulation and expression."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MTAG-CLICK METHOD&quot;">
      <data key="d0">"TECHNOLOGICAL TOOL"</data>
      <data key="d1">"Method for enriching unmodified DNA fractions to study epigenetic changes in gene expression."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MOUSE TILING MICROARRAYS&quot;">
      <data key="d0">"TECHNOLOGICAL TOOL"</data>
      <data key="d1">"Microarray-based technology allowing for chromosome-wide investigations in mouse genomes."&lt;SEP&gt;"Microarray-based technology utilized for epigenetic analysis of mouse chromosomes, including Lct and related regions."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INTER-INDIVIDUAL DIFFERENCES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Variability among individuals affects lactase expression and may contribute to lactose intolerance or persistence."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CELL TYPE SPECIFIC EXPRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cell-type specific differences in DNA modifications may indicate mechanisms underlying cell-specific expression of genes involved in lactase activity and metabolism, potentially impacting lactase non-persistence or persistence."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;LCT MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Messenger RNA from the Lactase gene which is involved in lactose metabolism."&lt;SEP&gt;"The mRNA transcript of the LCT gene is crucial for lactase activity and metabolism."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INTESTINAL EPITHELIAL CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells lining the digestive tract, primarily involved in nutrient absorption and immune responses."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INBRED C57BL/6N MOUSE LINE&quot;">
      <data key="d0">"GENETIC BACKGROUND"</data>
      <data key="d1">"A specific mouse strain commonly used in biological research due to its genetic stability and consistency."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;DNA MODIFICATION DENSITIES&quot;">
      <data key="d0">"BIOMEDICAL MEASURE"</data>
      <data key="d1">"Quantitative assessment of DNA modification patterns within a genome or region, relevant for gene regulation studies."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;BISULFITE PADLOCK PROBE SEQUENCING&quot;">
      <data key="d0">"MOLECULAR TECHNIQUE"</data>
      <data key="d1">"A method for determining DNA methylation patterns, utilized to fine-map specific regions of the genome."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;GENETIC VARIATION&quot;">
      <data key="d0">"VARIATION TYPE"</data>
      <data key="d1">"Alterations in DNA sequence or structure within a genetic locus that can affect gene expression, protein function, or phenotypic traits."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;REGULATORY REGION&quot;">
      <data key="d0">"BIOLOGICAL COMPONENT"</data>
      <data key="d1">"A segment of DNA, RNA or protein that controls the initiation, rate, and/or specificity of gene expression."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CELLULAR PHENOTYPE&quot;">
      <data key="d0">"OBSERVATION"</data>
      <data key="d1">"The observable characteristics of a cell resulting from its genetic makeup and environmental interactions."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;HUMAN JEJUNUM SAMPLE&quot;">
      <data key="d0">"BIOLOGICAL MATERIAL"</data>
      <data key="d1">"A segment of small intestine tissue obtained for analysis, often used to study gastrointestinal function or disease states."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;DIFFERENTIAL EXPRESSION&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The comparison of gene expression levels between different biological conditions or samples, indicating altered transcriptional activity."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INTER-INDIVIDUAL VARIABILITY&quot;">
      <data key="d0">"GENETIC PHENOMENON"</data>
      <data key="d1">"The variation in genetic characteristics among individuals within a species, contributing to phenotypic diversity."</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;CPG SITES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Significant DNA modification differences were observed at 35 CpG sites when comparing enterocytes with enterocyte-deficient jejunum tissues."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;CPG SITE MODIFICATION&quot;">
      <data key="d0">"DNA MODIFICATION"</data>
      <data key="d1">"Significant DNA modifications observed at CpG sites associated with the LCT gene and MCM6."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;JEJUNUM TISSUE&quot;">
      <data key="d0">"TISSUE"</data>
      <data key="d1">"The jejunum tissue did not show the same DNA modifications as enterocytes, indicating cell-type specific regulation of DNA modifications."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;LONG NON-CODING RNA (LNCRNA) LO100507600&quot;">
      <data key="d0">"LNCRNA"</data>
      <data key="d1">"The identified region in LCT's intron 5 maps to this long non-coding RNA, contributing to its regulation."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;3′-UTR OF MCM6&quot;">
      <data key="d0">"REGULATORY REGION"</data>
      <data key="d1">"The exon and intron regions of the MCM6 gene were found modified and regulatory for chromatin features like DNase I hypersensitivity sites, H3K4me1, and H3K27ac."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;DNASE I HYPERSENSITIVITY SITES&quot;">
      <data key="d0">"CHROMATIN FEATURES"</data>
      <data key="d1">"The identified regions in LCT introns 2 and 3 and MCM6 intron 13, exon 16, and 3′-UTR show DNase I hypersensitivity."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;HISTONE MARKS H3K4ME1 AND H3K27AC&quot;">
      <data key="d0">"CHROMATIN FEATURES"</data>
      <data key="d1">"These histone marks indicate active enhancers at the LCT introns 2 and 3, as well as MCM6 intron 13 and exon 16 to 3′-UTR."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;ACTIVE ENHANCER SITES&quot;">
      <data key="d0">"ENHANCER SITES"</data>
      <data key="d1">"No other enhancer sites were observed elsewhere in a 100 kb region centered over LCT and MCM6, indicating specificity of these identified regions."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;HAPLOTYPES ASSOCIATED WITH LACTASE NON-PERSISTENCE AND PERSISTENCE&quot;">
      <data key="d0">"GENETIC BACKGROUND"</data>
      <data key="d1">"The LCT-MCM6 haplotypes exhibit strong associations with lactase status across genetic backgrounds."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;AGE-DEPENDENT REGULATION OF LCT&quot;">
      <data key="d0">"TEMPORAL CHANGES"</data>
      <data key="d1">"Differential epigenetic modifications occur in different haplotypes leading to age-dependent regulation of LCT expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;SNP C/T-13910&quot;">
      <data key="d0">"SINGLE NUCLEOTIDE POLYMORPHISM (SNP)"</data>
      <data key="d1">"This SNP is associated with the lactase persistence and non-persistence genotypes, and its presence leads to age-related DNA modification changes."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;TERT-INT1 INTERPLAY&quot;">
      <data key="d0">"INTERACTING GENES"</data>
      <data key="d1">"A study found an interplay between TERT and INT1 genes that affects the expression of LCT, suggesting a network regulatory mechanism."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;GENE EXPRESSION PROFILING&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"The approach used to identify genes associated with defects in RPS19 in DBA patients."&lt;SEP&gt;"The researchers used gene expression profiling to understand the impact of DNA modifications on different cell types like enterocytes."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;CPG METHYLATION&quot;">
      <data key="d0">"METHYLATION TYPE"</data>
      <data key="d1">"CpG methylation patterns were specifically analyzed at 35 CpG sites, indicating a link between specific DNA modifications and enterocyte differentiation."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;ENTEROCYTE DEFICIENT TISSUE&quot;">
      <data key="d0">"EXPERIMENTAL MODEL"</data>
      <data key="d1">"The use of enterocyte-deficient jejunum tissues in comparison to normal tissues provided insights into cell-type specific DNA modification effects on LCT expression."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;INTRA-INDIVIDUAL AND INTER-INDIVIDUAL ANALYSIS&quot;">
      <data key="d0">"ANALYTICAL METHOD"</data>
      <data key="d1">"This method was used to identify the regions where DNA modifications occurred consistently within individuals (intra-individual) or across different individuals (inter-individual)."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;CPG SITES 35&quot;">
      <data key="d0">"SPECIFIC CPGS"</data>
      <data key="d1">"These were key sites identified for differences in DNA modifications between enterocytes and enterocyte-deficient jejunum tissues."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;AGE-DEPENDENT EXPRESSION&quot;">
      <data key="d0">"EXPRESSION PATTERN"</data>
      <data key="d1">"Researchers observed that age-dependent changes in expression patterns were associated with epigenetic modifications at specific genomic regions like LCT and MCM6."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Four selected SNPs for analysis in a follow-up cohort related to HLA carrier status."&lt;SEP&gt;"The investigation into SNPs like C/T-13910 highlighted genetic variations that could influence the DNA modification patterns observed in different individuals or tissues."</data>
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;MCM6 INTRON 13&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"A specific intronic region in the MCM6 gene, potentially affecting LCT regulation."&lt;SEP&gt;"Changes at MCM6 intron 13 for haplotypes containing C-13910 must occur after conception."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;C-13910&quot;">
      <data key="d0">"NUTRIENT"/"GENETIC MARKER"</data>
      <data key="d1">"A SNP in this region indicates the presence of a specific genetic variant."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;CT AND TT GENOTYPES&quot;">
      <data key="d0">"DIETARY PATTERN"/"EPIGENETIC FACTOR"</data>
      <data key="d1">"The genotypes CT and TT influence DNA modifications at this region."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;EMBRYOGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of embryonic development where DNA modifications are erased."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;AGE-RELATED CHANGES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"EVOLUTIONARY CONSERVATION"</data>
      <data key="d1">"DNA modification densities change with age, suggesting an evolutionary factor."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;CACO-2&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"A human intestinal epithelial cell line used for studying gene regulation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;SNP -13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic variant at the SNP -13910 location."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LOC100507600&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of an lncRNA (long non-coding RNA) with a specific gene identifier."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The enzyme that breaks down lactose into glucose and galactose."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CTCF&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR"</data>
      <data key="d1">"A protein involved in binding to insulator sites on DNA which can regulate transcription."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;DNA METHYLATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"DNA methylation of 450,000 CpG sites was determined in the same purified cells of 100 of the individuals to add explanations to observed differential expression between cell types."&lt;SEP&gt;"The process of adding a methyl group to DNA, affecting gene expression through chromatin modification."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CRISPR-CAS9 GENOME EDITING TECHNOLOGY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A genome editing tool that uses RNA-guided Cas9 nuclease for precise deletion or addition of genetic material."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;DNA REGIONS&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"Specific areas of the DNA sequence studied, including introns and regulatory elements."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition in which lactose digestion ability is maintained into adulthood."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CRISPR-CAS9N-INDUCED DELETION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Specific deletions induced by CRISPR-Cas9 technology to study gene functions."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT INTRON 2&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"A specific intronic region in the Lactase gene, with evolutionary conservation."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;EPIGENETICALLY-REGULATED REGIONS&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"DNA regions that impact gene expression through modifications such as methylation and histone modification."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;REGULATORY INTERACTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Interactions between regulatory molecules, such as transcription factors or non-coding RNAs with specific DNA sequences."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;DIFFERENTIATION PROCESS&quot;">
      <data key="d0">"CELLULAR PROCESS"</data>
      <data key="d1">"The process of Caco-2 cells transforming into more specialized intestinal cell types after confluence."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;ADULT MICE/INFANT MICE&quot;">
      <data key="d0">"ANATOMICAL LOCATION"</data>
      <data key="d1">"Different developmental stages or age groups in the context of gut physiology and gene expression."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;CULTURED HUMAN INTESTINAL EPITHELIAL CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells derived from human intestine that are cultured for experimental studies."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LCT GENE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The LCT gene exhibits modifications at specific genomic regions contributing to cell-type specific expression and epigenetic regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 44}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANT ASSOCIATION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Significant DNA modification differences occur at CpG sites, linking them as important genetic variants in LCT's expression control.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL-TYPE SPECIFICITY&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Differences in DNA modifications highlight the cell-type specific regulation of LCT expression and DNA modifications.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENTEROCYTES AND JEJUNUM TISSUES&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Differences in DNA modifications highlight the cell-type specific regulation of LCT expression and DNA modifications.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOTYPE ASSOCIATION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"MCM6 gene shows similar regions to LCT's for DNA modification studies, highlighting the genetic linkage between these genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6 GENE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"MCM6 gene shows similar regions to LCT's for DNA modification studies, highlighting the genetic linkage between these genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNCTIONAL LINKAGE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The lncRNA is linked with LCT intron 5 region and plays a role in its regulation, showing interplay between different genomic elements.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6 GENE 3′-UTR&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The MCM6's 3′-UTR is associated with chromatin features that indicate active regulatory functions like enhancer sites and histone marks, demonstrating the gene's role in regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY FUNCTION&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The MCM6's 3′-UTR is associated with chromatin features that indicate active regulatory functions like enhancer sites and histone marks, demonstrating the gene's role in regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY SIGNIFICANCE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The DNase I hypersensitivity sites at LCT introns 2 and 3, as well as MCM6's regions, indicate regulatory significance for gene expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENHANCER ROLES&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"These histone marks are characteristic of active enhancers and play a role in gene regulation at the identified chromatin reference map sites.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC LINKAGE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The LCT-MCM6 haplotypes exhibit strong associations with lactase persistence and non-persistence across genetic backgrounds, highlighting the role of these haplotypes in age-dependent regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCT-MCM6 HAPLOTYPES&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"The LCT-MCM6 haplotypes exhibit strong associations with lactase persistence and non-persistence across genetic backgrounds, highlighting the role of these haplotypes in age-dependent regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP C/T-13910 AND AGE CHANGES&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Age-dependent epigenetic modifications occur at SNP C/T-13910, indicating temporal genomic responses to genetic variations over life stages.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TEMPORAL GENOMIC RESPONSE&quot;">
      <data key="d2">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d1">"Age-dependent epigenetic modifications occur at SNP C/T-13910, indicating temporal genomic responses to genetic variations over life stages.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MAMMALS&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"High conservation of the LCT intron 2 element is observed across mammals, including humans.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LNCRNA LOC100507600&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"The lncRNA regulates LCT mRNA levels, suggesting a potential mechanism for modulating enzyme expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOTYPES&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"SNPs at this position influence the variation in haplotypes associated with lactase non-persistence or persistence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP-13910&quot;">
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d1">"SNPs at this position influence the variation in haplotypes associated with lactase non-persistence or persistence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTCF BINDING&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Increased DNA methylation inhibits CTCF binding at insulator sites, potentially activating gene expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6 INTRON 13 DELETION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The deletion in MCM6 intron 13 did not alter Mcm6 mRNA levels when compared to the negative control.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE-SPECIFIC REGULATION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Evolutionarily conserved LCT intron 2 establishes stronger control of LCT mRNA in adulthood.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOWNREGULATION&quot;/&quot;DECREASE IN LCT MRNA&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions affecting MCM6 intron 13 or LCT intron 2 resulted in significant decreases in LCT mRNA levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6 INTRON 13&quot;/&quot;LCT INTRON 2&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions affecting MCM6 intron 13 or LCT intron 2 resulted in significant decreases in LCT mRNA levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRISPR-CAS9N-INDUCED DELETION/">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions of epigenetically regulated DNA regions impacted human LCT expression, supporting their importance in regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADULT INTESTINE/INFANT GUT RESPONSE&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The mutation in Lct intron 2 produced a significantly greater loss of LCT mRNA expression in adult mice compared to infants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LACTASE PERSISTENCE&quot;/&quot;CRISPR-CAS9 DELETIONS&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The mutation in Lct intron 2 produced a significantly greater loss of LCT mRNA expression in adult mice compared to infants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6 INTRON 13&quot;/&quot;LCT INTRON 2/">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions affecting MCM6 or LCT regulatory regions resulted in a significant decrease in LCT mRNA levels in differentiated human intestinal epithelial cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY IMPACT&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions affecting MCM6 or LCT regulatory regions resulted in a significant decrease in LCT mRNA levels in differentiated human intestinal epithelial cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELLULAR STATE/EXPRESSION LEVELS&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The deletion effects on LCT mRNA varied between undifferentiated and differentiated states of cultured Caco-2 cells, supporting the importance of regulatory regions in human LCT expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRISPR-CAS9 DELETIONS&quot;/&quot;LCT EXPRESSION&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The deletion effects on LCT mRNA varied between undifferentiated and differentiated states of cultured Caco-2 cells, supporting the importance of regulatory regions in human LCT expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DECREASE IN LCT MRNA&quot;">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions affecting MCM6 or LCT regulatory regions resulted in a significant decrease in LCT mRNA levels in differentiated human intestinal epithelial cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCM6&quot;/&quot;LCT REGULATORY REGIONS/">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"Deletions affecting MCM6 or LCT regulatory regions resulted in a significant decrease in LCT mRNA levels in differentiated human intestinal epithelial cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRISPR-CAS9 DELETIONS&quot;/&quot;LCT EXPRESSION/">
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d1">"The deletion effects on LCT mRNA varied between undifferentiated and differentiated states of cultured Caco-2 cells, supporting the importance of regulatory regions in human LCT expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTROLS&quot;">
      <data key="d0">"COMPARISON GROUP"</data>
      <data key="d1">"Group of individuals without the specific condition or characteristic being compared to the subject group."&lt;SEP&gt;"The study participants without genetic data are referred to as 'controls'."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;ROMANIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Population frequency of the persistence allele at rs4988235 is 0.28 in Romania."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;POLAND&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The population frequency for 'T' (persistence) allele at rs4988235 in Poland is observed to be 0.40."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RUSSIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Frequency of the 'T' (persistence) allele at rs4988235 for all populations was consistent with southern and eastern Europe."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CZECH REPUBLIC&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The frequency of lactase persistence driving allele is the highest in the Czech Republic, showing a relationship between genotype and milk consumption."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;UK&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"'C' (non-persistence) allele was found at a frequency of 0.26 in the UK."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK DRINKING PROFILES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Results include descriptive statistics and milk drinking patterns of all study participants."&lt;SEP&gt;"The descriptive statistics and milk consumption patterns of study participants are presented."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;OR 2.39&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genotype rs4988235 was associated with a higher milk drinking rate in controls."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK CONSUMPTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Differences were observed in the consumption patterns of milk based on different rs4988235 genotypes."&lt;SEP&gt;"The association between education and milk consumption was mostly observed in the Czech Republic."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RCC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Risk of RCC (Renal Cell Carcinoma) was found to be elevated among those consuming milk compared to non-consumers."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;OR 1.68&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A strong, observed relationship between milk consumption and cancer risk in the Czech Republic."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RCC OR=1.35&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Odds ratio of RCC was driven by milk consumption."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;EDUCATION ATTAINMENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Educational attainment had an association with milk consumption across all countries."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RS4988235 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Differences were not found between rs4988235 genotype and RCC risk either in analyses by country or as a whole."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;GENOTYPIC GROUP OR=1.01&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Overall odds of RCC did not show substantial differences based on genotypic groups."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK CONSUMPTION PATTERNS FOR DIFFERENT RS4988235 GENOTYPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Variations in milk drinking habits were observed based on the genetic variations at rs4988235."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CONSUMPTION PATTERNS OF MILK&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The study found differences in milk intake between people with different lactase persistence genotypes."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK AND CANCER RISK ASSOCIATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There was a relationship identified between milk consumption and RCC (Renal Cell Carcinoma) risk."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;ASSOCIATION BETWEEN GENOTYPE RS4988235&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The genetic variant rs4988235 was linked with variations in milk drinking profiles."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CANCER RISK ASSOCIATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The RCC risk showed an elevated risk when consuming milk, which was mainly found in the Czech Republic."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;GENETIC DATA FOR CONTROLS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The study considered genetic data from individuals without genetic data to be 'controls'."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK DRINKING TENDENCY ASSOCIATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There wasn't a consistent association found between genotype and milk consumption across all countries."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;RISK OF RCC BY GENOTYPIC GROUP OR=1.01&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The analysis did not find significant differences in RCC risk based on the genotypes of rs4988235 within individual groups."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;COUNTRY SPECIFIC DATA ASSOCIATIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Certain countries showed nominal but not systematic representation of relationships between variables like education and milk consumption."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;GENOTYPE WITH EDUCATION ASSOCIATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genetic variation at rs4988235 had a nominal evidence for association with educational attainment."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CZECH REPUBLIC STRONGEST ASSOCIATIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The Czech Republic showed stronger associations between certain variables and milk consumption patterns compared to other countries."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK CONSUMPTION PATTERN DIFFERENCES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Differences in milk consumption patterns were associated with the risk of developing RCC."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;ASSOCIATION BETWEEN LACTASE PERSISTENCE GENOTYPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The study explored whether different genotypes related to lactase persistence had varying impacts on milk consumption and health outcomes."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;VARIABLES POTENTIALLY CONFOUNDING RESULTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Several factors could potentially have influenced the outcomes of the study, including education attainment."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;CZECH REPUBLIC STRONGEST ASSOCIATIONS IN RCC RISK ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The Czech Republic showed significant associations between different variables and RCC risk when analyzing milk consumption patterns."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;MILK CONSUMPTION PATTERNS&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Differences were observed based on different rs4988235 genotypes related to milk consumption.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RCC OR=1.68&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"Strong relationship found specifically in the Czech Republic between milk consumption and RCC risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASSOCIATIONS&quot;">
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d1">"The strongest representation of associations between variables like education and smoking was found in the Czech Republic.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HU TREATMENT&quot;">
      <data key="d0">"TREATMENT"</data>
      <data key="d1">"We observed statistically significant improvements in several hematological parameters following exposure to Hydroxyurea (HU) in 111 patients."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;SNP RS7482144&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"This variant was not included in the analysis due to its very low frequency."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS1427407&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"One of the BCL11A SNPs associated with increased baseline and MTD HbF levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;RS4671393&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Another BCL11A SNP associated with increased baseline and MTD HbF levels, also showing association with delta HbF."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;T-A-C HAPLOTYPE&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"Compared to the G-G-T reference, patients carrying this haplotype had higher baseline and MTD HbF levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;T-G HAPLOTYPE&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"The most frequent haplotype contained the wild-type alleles for both HMIP-2 SNPs, showing higher baseline HbF levels."</data>
      <data key="d2">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;DELTA HBF&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The text discusses associations of specific BCL11A SNPs and haplotypes with baseline, MTD HbF levels; however, it does not provide information about Delta HbF solely due to these genetic factors."&lt;SEP&gt;"The text discusses associations of specific haplotypes with baseline and MTD HbF levels; however, these are not the same as discussing an interaction between a haplotype and Delta HbF."&lt;SEP&gt;"The text discusses associations of the BCL11A SNPs with baseline and MTD HbF levels; however, it does not explicitly discuss their relationship to Delta HbF."&lt;SEP&gt;"There was no association of any HMIP-2 haplotype with delta HbF, indicating that the SNPs did not influence changes in HbF levels.")&lt;SEP&gt;"There was no statistically significant association between any HMIP-2 haplotype and changes in HbF levels (delta HbF), suggesting that the SNPs do not influence the rate of change of HbF in this context."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce&lt;SEP&gt;chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
    </node>
    <node id="&quot;HMIP-2 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The HMIP-2 SNP is associated with MTD HbF levels."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;C-A HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C-A haplotype of the HMIP-2 SNP is related to MTD HbF levels, but loses significance after adjusting for baseline HbF."&lt;SEP&gt;"The C-A haplotype of the HMIP-2 SNP loses statistical significance when adjusting for baseline HbF levels, indicating that its association with MTD HbF is not independent of pre-existing HbF concentration."</data>
      <data key="d2">chunk-3ae06e9a3330573da28ca0a76aa685ce</data>
    </node>
    <node id="&quot;FA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fanconi anemia (FA) is being considered as a potential condition due to UBE2T deficiency."&lt;SEP&gt;"Subject presented at birth with symptoms like bilateral radial aplasia, absent thumbs, microcephaly, micrognathia, café au lait spots, and an absent left kidney."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f&lt;SEP&gt;chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;UNKNOWN COMPLEMENTATION GROUP OF FANCONI ANEMIA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cellular phenotype of Fanconi anemia cell line of unknown complementation group was observed in this subject."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;BILATERAL RADIAL APLASIA&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Subject presented with bilateral radial aplasia as a symptom."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ABSENT THUMBS&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Subject had absent thumbs as another symptom."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;MICROCEPHALY&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Microcephaly was observed in the subject, a condition characterized by an abnormally small head size."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;MICROGNATHIA&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Micrognathia refers to a small jawbone or underdeveloped lower jaw of the subject."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CAFÉ AU LAIT SPOTS&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Subject had café au lait spots, which are brownish-blue macules on the skin."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ABSENT LEFT KIDNEY&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"The absence of a left kidney was another symptom noted in the subject."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;PERIPHERAL BLOOD SAMPLES&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"Peripheral blood samples were collected and used for various analyses."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;DIEXPOXYBUTANE (DEB)&quot;">
      <data key="d0">"CROSSLINKING AGENT"</data>
      <data key="d1">"RA2627 fibroblasts are hypersensitive to crosslinking agents like DEB in survival assays."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CHROMOSOMAL BREAKAGE&quot;">
      <data key="d0">"EVENT"</data>
      <data key="d1">"Increased chromosomal breakage levels were observed in RA2627 fibroblasts compared to BJ wild type fibroblast and FA-A patient cells (RA3087)."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION DEFICIENCY&quot;">
      <data key="d0">"ABNORMALITY"</data>
      <data key="d1">"RA2627 cells are deficient for FANCD2 monoubiquitination, which is a hallmark of Fanconi anemia."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCD2 FOCUS ABSENCE&quot;">
      <data key="d0">"OBSERVATION"</data>
      <data key="d1">"No FANCD2 foci were observed in RA2627 cells following 24-hour treatment with MMC."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FA PATHWAY ACTIVATION DEFICIENCY&quot;">
      <data key="d0">"OBSERVATION"</data>
      <data key="d1">"The subject’s fibroblasts display a deficiency of FA pathway activation, consistent with the deficiency of the FA core complex or ID2 complex."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCA MUTATION&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"A single FANCA mutation, c.2574C&gt;G/p.Ser858Arg was identified previously in Fanconi anemia, but it did not lead to normal levels of FANCA and rescue the monoubiquitination defect of FANCD2."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;WES DATA ANALYSIS&quot;">
      <data key="d0">"WHOLE EXOME SEQUENCING DATA ANALYSIS"</data>
      <data key="d1">"Whole exome sequencing data analysis revealed a single FANCA mutation in the subject."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;HIGH RESOLUTION ARRAY COMPARATIVE GENOMIC HYBRIDIZATION (ACGH)&quot;">
      <data key="d0">"GENOMIC ANALYSIS METHOD"</data>
      <data key="d1">"Analysis of high-resolution array comparative genomic hybridization did not detect deletions or duplications in known FA genes for this subject’s fibroblasts and peripheral blood samples."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T DECREASED TRANSCRIPT LEVELS&quot;">
      <data key="d0">"TRANSCRIPT LEVEL ABNORMALITY"</data>
      <data key="d1">"RNA sequencing revealed a marked reduction in UBE2T transcript levels compared to a non-FA patient cell line (RA3380)."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;RT-QPCR VALIDATION&quot;">
      <data key="d0">"VALIDATION METHOD"</data>
      <data key="d1">"Decreased UBE2T transcript levels were confirmed by RT-qPCR analysis."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T PROTEIN UNDETECTABLE&quot;">
      <data key="d0">"PROTEIN LEVEL ABNORMALITY"</data>
      <data key="d1">"No detectable UBE2T protein was found in RA2627 fibroblast lysates based on western blot analysis."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS MUTATIONS IN UBE2T&quot;">
      <data key="d0">"MUTATION COMBINATION"</data>
      <data key="d1">"Sanger sequencing of genomic DNA and cDNA from the subject revealed compound heterozygous mutations in UBE2T. The paternally derived deletion, g.202332626_202341295del resulted from recombination of two AluYa5 repeats."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;MATERNALLY DERIVED DUPLICATION&quot;">
      <data key="d0">"MUTATION ORIGIN"</data>
      <data key="d1">"The maternally derived mutation consisted of a large duplication of the genomic region between two AluYa5 repeats."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;TRANSCRIPT WITH HAPLOID MUTATIONS&quot;">
      <data key="d0">"MUTANT TRANSCRIPT"</data>
      <data key="d1">"Cloning of proband cDNA revealed a transcript containing the hypothesized duplication c.-64_468dup (dupEx2_6) that leads to frameshift and premature stop codon due to inclusion of non-coding region from exon 2."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;BONE MARROW FAILURE SYNDROME&quot;">
      <data key="d0">"PATHOLOGY"</data>
      <data key="d1">"The pathology analysis showed reduced hematopoietic stem cells in the bone marrow with dysplasia, indicative of bone marrow failure syndrome."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;PANCYTOPENIA&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Pancytopenia was a symptom noted in this case, which included low counts of red blood cells, white blood cells, and platelets."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;SKIN RASH&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"A skin rash with varying degrees of severity was another presented symptom."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;LYMPH NODE ENLARGEMENT&quot;">
      <data key="d0">"SYMPTOM"</data>
      <data key="d1">"Enlarged lymph nodes were observed as part of the clinical presentation."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;HEMATOPOIETIC STEM CELL REDUCTION&quot;">
      <data key="d0">"PATHOLOGICAL FINDINGS"</data>
      <data key="d1">"Reduction in numbers and quality of hematopoietic stem cells was found in bone marrow biopsies."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;DYSPLASIA&quot;">
      <data key="d0">"PATHOLOGICAL FINDING"</data>
      <data key="d1">"Morphological abnormalities indicating dysplasia were observed in the bone marrow samples."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;GENOMIC SEQUENCING&quot;">
      <data key="d0">"DIAGNOSTIC METHOD"</data>
      <data key="d1">"Whole-genome sequencing was performed to identify genetic mutations related to the syndrome."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CIRH1A MUTATION&quot;">
      <data key="d0">"GENETIC MUTATION"</data>
      <data key="d1">"A novel mutation, c.823G&gt;T/p.Val275Met in CIRH1A gene was identified through genomic analysis."</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The expression of wild type UBE2T gene is being considered as a potential cause for the observed phenotypes."&lt;SEP&gt;"Ube2T interacts with the RING domain of FANCL but not directly with the URD according to preliminary size-exclusion chromatography analysis."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;WILD TYPE UBE2T&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Wild type UBE2T transcript has been introduced into RA2627 fibroblasts."&lt;SEP&gt;"Wild type UBE2T transcript has been introduced into the proband blood sample."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RA2627 FIBROBLASTS&quot;">
      <data key="d0">"CELLULAR"</data>
      <data key="d1">"RA2627 cells are used in the study as they show certain cellular defects associated with FA when UBE2T expression is deficient."&lt;SEP&gt;"RA2627 cellular defects are associated with the FA phenotype."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;MMC&quot;">
      <data key="d0">"CHEMICAL COMPOUND"</data>
      <data key="d1">"MMC, DEB and cisplatin are chemical agents used in assays to test UBE2T's effect on the cell."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CELLULAR HYPERSENSITIVITY&quot;">
      <data key="d0">"PHENOMENON"</data>
      <data key="d1">"RA2627 cells show hypersensitivity to crosslinking agents like MMC when UBE2T is deficient."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;G2 PHASE ACCUMULATION&quot;">
      <data key="d0">"CELL CYCLE"</data>
      <data key="d1">"Accumulation of RA2627 cells in G2 phase was observed following treatment with MMC and was rescued by UBE2T overexpression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCD2 AND FANCI MONOUBIQUITINATION&quot;">
      <data key="d0">"MOLECULAR ACTIVITY"</data>
      <data key="d1">"Monoubiquitination of FANCD2 and FANCI proteins plays a role in FA phenotypes and is restored with UBE2T expression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCD2 FOCI&quot;">
      <data key="d0">"CELLULAR STRUCTURE"</data>
      <data key="d1">"Formation of FANCD2 foci occurs after treatment with MMC, which is crucial for the FA phenotype."&lt;SEP&gt;"Formation of FANCD2 foci was observed after treatment with MMC, which was rescued by UBE2T expression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;MMC, DEB AND CISPLATIN&quot;">
      <data key="d0">"CHEMICAL COMPOUND"</data>
      <data key="d1">"These chemical agents were used to test the effects of UBE2T overexpression on RA2627 cells and their resistance to crosslinking agents."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;G1 PHASE ACCUMULATION&quot;">
      <data key="d0">"CELL CYCLE"</data>
      <data key="d1">"Accumulation of RA2627 cells in G1 phase was observed following treatment with MMC and was not rescued by UBE2T overexpression, indicating cell cycle regulation is altered."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CONSEQUENCE OF MUTATION IN UBE2T&quot;">
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d1">"Decreased transcript levels of the UBE2T gene were detected, which is a consequence of mutations identified in this subject.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS MUTATIONS&quot;">
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d1">"The combination of maternally derived duplication and paternally derived deletion resulted in genetic reversion phenomena observed in the proband's LCLs, supporting normal UBE2T expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC REVERSION PHENOMENON&quot;">
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d1">"The combination of maternally derived duplication and paternally derived deletion resulted in genetic reversion phenomena observed in the proband's LCLs, supporting normal UBE2T expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELLULAR PHENOTYPE RESCUED BY UBE2T&quot;">
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d1">"Wild type UBE2T overexpression was able to rescue cellular defects associated with Fanconi anemia in RA2627 fibroblasts, demonstrating the causality of UBE2T deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVEREXPRESSION OF WILD TYPE UBE2T&quot;">
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d1">"Wild type UBE2T overexpression was able to rescue cellular defects associated with Fanconi anemia in RA2627 fibroblasts, demonstrating the causality of UBE2T deficiency.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVEREXPRESSION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Overexpression of wild type UBE2T gene rescues FA phenotypes in RA2627 fibroblasts.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCONI ANEMIA (FA)&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Insufficient expression or mutation in UBE2T leads to Fanconi anemia.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UBE2T DEFICIENCY&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Insufficient expression or mutation in UBE2T leads to Fanconi anemia.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The expression of wild type UBE2T restores the monoubiquitination status of FANCD2 and FANCI proteins following FA phenotype induction by treatment with MMC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCD2 FOCI FORMATION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"UBE2T overexpression rescues the formation of FANCD2 foci observed after treatment with MMC, associated with FA phenotype rescue.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FA PHENOTYPE RESCUE&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The overexpression of wild type UBE2T rescues cellular defects associated with Fanconi Anemia (FA) in RA2627 fibroblasts, as shown by restored cell cycle distribution and FANCD2 foci formation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WILD TYPE UBE2T OVEREXPRESSION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The overexpression of wild type UBE2T rescues cellular defects associated with Fanconi Anemia (FA) in RA2627 fibroblasts, as shown by restored cell cycle distribution and FANCD2 foci formation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DBA PATIENTS&quot;">
      <data key="d0">"PATIENT SAMPLE"</data>
      <data key="d1">"Results from gene expression profiling study on cells from DBA patients using Affymetrix GeneChip Human Genome U133A 2.0 Arrays."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AFFYMETRIX GENECHIP&quot;">
      <data key="d0">"MICROARRAY"</data>
      <data key="d1">"The microarrays used for the genome-wide expression profiling of DBA patient's dermal fibroblasts."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Cells obtained from DBA patients for gene expression analysis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RPS19&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The focus gene identified in the study, which has mutations linked to the DBA condition."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;LARS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One of several genes involved in aminoacyl-tRNA biosynthesis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;WARS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene related to aminoacyl-tRNA biosynthesis."&lt;SEP&gt;"WARS (Valine tRNA Synthetase) plays a role in amino acid metabolism and was identified as differentially expressed in the study."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;GARS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Part of the group of genes associated with metabolic pathways like glycine, serine, and threonine metabolism."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;SARS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Also involved in the same set of metabolic processes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;QARS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One of multiple enzymes related to aminoacyl-tRNA biosynthesis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;EPRS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in a variety of biological pathways and functions."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PSAT1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with glycine, serine, and threonine metabolism."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;PHGDH&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An enzyme involved in glycolysis and gluconeogenesis."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;CTH&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Part of the set of genes related to aminoacyl-tRNA biosynthesis and metabolic processes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;SHMT2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Related to the regulation or processes within the cell, potentially involved in metabolism."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;CASP9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another key gene involved in cell death processes, specifically apoptosis."&lt;SEP&gt;"Involved in apoptosis signaling pathway, specifically death receptor signaling."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;NFKBIA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A component of the nuclear factor kappa-B (NF-κB) complex."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;NFKBIE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another component of NF-κB involved in inflammation and immune response."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;APAF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in apoptosis regulation, particularly through the caspase cascade."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;NFKB2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Part of the complex that regulates the NF-κB pathway."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;NFKB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A critical component of the NF-κB signaling pathways."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;BIRC3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in apoptosis regulation and anti-apoptosis mechanisms."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RPL22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL22 is a gene involved in protein synthesis. It is part of the large cluster of RP genes that includes several other ribosomal proteins like RPL27A, RPL29, and others."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPS3 is another gene from the same cluster as RPL22, involved in protein synthesis and cell development."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL18 is part of a large cluster of RP genes that play roles in cellular development, lipid metabolism, and molecular transport."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPS2 belongs to the same cluster of genes involved in protein synthesis and other cellular functions."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CANCER RELATED GENES&quot;">
      <data key="d0">"DISEASE CATEGORY"</data>
      <data key="d1">"A category that includes several cancer-related genes has been identified through this study along with other disease categories."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;HAEMATOLOGICAL DISORDERS&quot;">
      <data key="d0">"DISORDER CATEGORY"</data>
      <data key="d1">"The study found clusters of genes involved in haematological disorders, among others."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;IMMUNOLOGICAL DISORDERS&quot;">
      <data key="d0">"DISORDER CATEGORY"</data>
      <data key="d1">"Genes related to immunological disorders are part of the identified disease categories."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RENAL DISORDERS&quot;">
      <data key="d0">"DISORDER CATEGORY"</data>
      <data key="d1">"A cluster of genes associated with renal disorders has been found."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL DISORDERS&quot;">
      <data key="d0">"DISORDER CATEGORY"</data>
      <data key="d1">"Genes involved in the development and function of skeletal tissues are part of this study's findings."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;EMBRYONIC DEVELOPMENT&quot;">
      <data key="d0">"DEVELOPMENTAL FUNCTION"</data>
      <data key="d1">"The cluster includes genes related to embryonic development processes."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;GENE EXPRESSION VALIDATION&quot;">
      <data key="d0">"VALIDATION METHOD"</data>
      <data key="d1">"Validation was performed by real-time RT-PCR on microarray data for selected genes. This method showed a high degree of correlation with the initial microarray results."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;MICROARRAY DATA&quot;">
      <data key="d0">"QUANTITATIVE TECHNIQUE"</data>
      <data key="d1">"Microarrays were used to measure gene expression levels and identify differentially expressed genes in DBA patients compared to controls."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;QRT-PCR&quot;">
      <data key="d0">"VALIDATION TECHNIQUE"</data>
      <data key="d1">"Quantitative real-time PCR was utilized as a validation method for microarray data, demonstrating consistency in gene expression results."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CORRELATION BETWEEN MICROARRAY AND QRT-PCR&quot;">
      <data key="d0">"COMPARISON RESULT"</data>
      <data key="d1">"A correlation coefficient of 0.7 was found between the two methods, suggesting a strong agreement."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;FOLD CHANGE ANALYSIS&quot;">
      <data key="d0">"ANALYSIS OUTCOME"</data>
      <data key="d1">"The microarray data showed consistent trends with qRT-PCR results when comparing fold changes for different genes in each sample."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL27A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL27A is a ribosomal protein gene involved in protein synthesis and cell development."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL29&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL29 is part of the large cluster of RP genes, contributing to functions like cellular development and lipid metabolism."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL31&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL31 plays a role in protein synthesis with contributions to metabolic pathways related to cell growth and maintenance."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL14 is part of the cluster of ribosomal proteins known for their involvement in cellular processes including development and metabolism."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL18A contributes to protein synthesis alongside other RP genes, particularly impacting lipid metabolism."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL28&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RPL28 is a ribosomal protein that helps in protein synthesis and may have roles in cellular development and function."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;AMPD3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"AMPD3 gene expression was found to be up-regulated in DBA patients, suggesting potential involvement in metabolic pathways or disease mechanisms."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CCND2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CCND2 (Cyclin D2) is a cancer-related gene involved in cell cycle regulation and has been detected as differentially expressed."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SOD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SOD2, or Superoxide Dismutase 2, is a key enzyme involved in antioxidant defense and was identified with increased expression in DBA patients."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;TNFAIP3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Tumor Necrosis Factor Alpha-Inducible Protein 3 (TNFAIP3) is an immunological gene found to be up-regulated in DBA patients."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;COMP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Comp, or Colloidosomal Matrix Protein, was down-regulated in DBA patients, potentially impacting tissue development and matrix function."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;ZIC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ZIC1, or Zeste-Waist Homolog 1, is involved in embryonic development and was found to be down-regulated in DBA patients."</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;GENE EXPRESSION DIFFERENCES&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Differential expression was identified for specific genes associated with DBA patients compared to controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME OF STUDY&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Differential expression was identified for specific genes associated with DBA patients compared to controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METHOD COMPARISON&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"The microarray data was validated using qRT-PCR, providing a cross-check on gene expression levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROARRAY DATA VALIDATION&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"The microarray data was validated using qRT-PCR, providing a cross-check on gene expression levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME OF CROSS-VALIDATION&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Both methods showed consistent trends for differentially expressed genes across the samples.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;QRT-PCR AND MICROARRAY RESULTS AGREEMENT&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Both methods showed consistent trends for differentially expressed genes across the samples.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BDNF RS6265&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The BDNF rs6265 polymorphism analysis of the gene is included in studies on migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS6265 G/A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The BDNF rs6265 (G/A) polymorphism refers to a protein variant associated with migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;MIGRAINE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The focus of the studies includes assessing the association between specific genotypes and the development of Migraine headaches."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;BDNF RS2049046&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The BDNF rs2049046 polymorphism assessment is part of migraine studies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;RS2049046 A/T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The BDNF rs2049046 (A/T) polymorphism refers to a protein variant in association with Migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM (HWE)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"All SNPs included studies were in Hardy-Weinberg equilibrium, implying the frequency of genotypes is consistent with theoretical expectations based on allele frequencies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;NOS SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The NOS score indicates quality of the studies, suggesting good performance in terms of study design and analysis."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;GUANINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"One of the nucleobases found in DNA, the G allele in BDNF rs6265."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;THYMINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"One of the nucleobases found in DNA, the T allele in BDNF rs2049046."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;CAUCASIAN POPULATION GROUPS&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">"Refers to groups from Western European ancestry that were included in studies on migraine."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;AUSTRALIAN-BASED COHORTS&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"Indicates the use of Australian populations for certain analyses or data collection."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION BETWEEN SNPS AND MIGRAINE&quot;">
      <data key="d0">"RELATIONSHIPS"</data>
      <data key="d1">"The interaction between single nucleotide polymorphisms (SNPs) in BDNF gene and migraine development."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;FIXED-EFFECTS MODEL&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A method used for meta-analysis to combine results of different studies when there is little heterogeneity."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;HETEROGENEITY DIFFERENCE&quot;">
      <data key="d0">"VARIABILITY"</data>
      <data key="d1">"The degree of difference among the studies included in the meta-analysis; no significant differences were found.</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;BEGG’S TEST&quot;">
      <data key="d0">"STATISTICAL TESTS"</data>
      <data key="d1">"Used in meta-analysis to assess publication bias by examining funnel plot asymmetry."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;EGGER’S TEST&quot;">
      <data key="d0">"STATISTICAL TESTS"</data>
      <data key="d1">"Another method for detecting publication bias by analyzing the relationship between effect size and precision of studies."</data>
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
    </node>
    <node id="&quot;STUDY SELECTION CRITERIA&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"The criterion for selecting studies which were conducted on individuals from a specific geographical region and ancestry group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STUDY COMPONENT&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"A component of the study design involving cohorts or participants from Australia.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIOLOGICAL PROCESS&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"The process by which specific genetic variations affect the risk or development of migraine headaches.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METHODOLOGY IN META-ANALYSIS&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"A statistical model used to analyze combined data from multiple studies with minimal heterogeneity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL ANALYSIS IN META-ANALYSIS&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"The comparison of variance among different studies contributing to the meta-analysis when no significant differences are present.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ROBUSTNESS CHECK&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"An analysis that tests how sensitive results are to individual data point inclusion or exclusion, often used in meta-analyses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DETECTION OF PUBLICATION BIAS&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"A statistical test utilized for identifying potential bias in publication, specifically by examining asymmetry in funnel plots.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIAS DETECTION METHOD&quot;">
      <data key="d2">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d1">"An approach used to identify publication bias through the correlation between effect size and precision across studies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Severe hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurring abscesses and窦道 in affected individuals."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Paradoxical psoriasis refers to the development of psoriasiform reactions as a response to certain treatments, such as adalimumab."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ADALIMUMAB&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Anti-TNF-α therapy (adalimumab) is used for managing inflammatory diseases like HS and psoriasis; however, paradoxical reactions can occur following its administration."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HURLEY III SCALE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hurley III scale is a grading system used to evaluate the severity of hidradenitis suppurativa based on clinical features like abscesses, sinus tracts, and inflammation."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;SARTORIUS SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sartorius score measures the severity of hidradenitis suppurativa by assessing clinical signs such as abscesses,窦道,窦管炎, and erythema."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PASI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Psoriasis Area and Severity Index (PASI) is a measure used to quantify the severity of psoriasis on different body parts, aiding in treatment evaluation."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ERYTHEMATO-SCALY LESIONS&quot;">
      <data key="d0">"PATHOLOGICAL CONDITION"</data>
      <data key="d1">"Characterized by redness (erythema) and scaling on affected skin areas."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PUSTULAR LESIONS&quot;">
      <data key="d0">"PATHOLOGICAL CONDITION"</data>
      <data key="d1">"Bullae-like formations filled with pus, often seen in various skin conditions including psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;NODULES&quot;">
      <data key="d0">"PATHOLOGICAL FEATURE"</data>
      <data key="d1">"Solid, usually non-tender lumps found beneath the skin."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;FISTULAS AND SINUS TRACTS&quot;">
      <data key="d0">"PATHOLOGICAL STRUCTURE"</data>
      <data key="d1">"Abnormal openings connecting cavities or passages within tissues or organs."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ALOPECIA AREATA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An autoimmune condition characterized by hair loss on the scalp, which can also occur in other parts of the body."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ECZEMATOUS-LIKE SKIN LESIONS&quot;">
      <data key="d0">"PATHOLOGICAL CONDITION"</data>
      <data key="d1">"Skin lesions resembling eczema, characterized by redness and itching, often with varying degrees of scaling or oozing."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD15+ NEUTROPHILS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Neutrophils are part of the innate immune system and can play a role in inflammation and tissue damage during skin reactions."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;BDCA2+ PDCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Plasmacytoid dendritic cells (pDC) are a type of myeloid cell found in the skin, with roles in immune responses."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;C-KIT/CD117+ MAST CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Mast cells are involved in allergic reactions and play a role in inflammation through the release of various mediators."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD68+ MACROPHAGES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Macrophages are phagocytic cells that help remove debris, pathogens, and other substances from the body; they can be involved in inflammatory responses."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;MONOCYTES&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A type of white blood cell that circulates in the bloodstream and migrates to sites of inflammation, where it matures into macrophages."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD3+ CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD3+ cells from skin biopsies of HS patients were enriched in CD8+, but not in CD4+ cells."&lt;SEP&gt;"T cells are a class of lymphocytes involved in adaptive immunity; they play various roles depending on their subtype (e.g., CD4+ T-helper cells, CD8+ cytotoxic T-cells)."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;BDCA2+ DCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Dendritic cells (DCs) are antigen-presenting cells that activate the immune response; BDCA2+ refers to a specific subset with certain functions."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;IL-36Γ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Interleukin-36γ is a pro-inflammatory cytokine that can be produced by neutrophils, contributing to immune responses and potentially promoting skin disorders."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CD8+ T CELLS&quot;">
      <data key="d0">"RECOGNITION"</data>
      <data key="d1">"CD8+ T cells also participated in the analysis of differential expressions and eQTLs related to the CTLA4 gene."&lt;SEP&gt;"CD8+ T cells are cytotoxic and play roles in immune responses against viruses, cancer, and other pathogens; they may also contribute to skin inflammation."&lt;SEP&gt;"No significant trans-eQTL effects were found in this region for CD8+ T cells."&lt;SEP&gt;"The frequencies of recognizing neoantigens are nominal, comparable to known immunodominant epitopes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PBMCS&quot;">
      <data key="d0">"BIOLOGICAL SAMPLE"</data>
      <data key="d1">"Peripheral Blood Mononuclear Cells are a type of blood cell found in the bloodstream that includes lymphocytes and monocytes."&lt;SEP&gt;"Peripheral Blood Mononuclear Cells are a type of blood cell found in the bloodstream that includes lymphocytes and monocytes.)("entity"</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;TREG CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"T-regulatory cells (Tregs) play an important role in immune tolerance by suppressing inflammatory responses, particularly in autoimmune diseases like HS and psoriasis."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;FOXP3+ TREGS&quot;">
      <data key="d0">"SUBTYPE OF CELL TYPE"</data>
      <data key="d1">"Foxp3 is a transcription factor that is essential for the development and function of regulatory T cells (Tregs), which help maintain immune tolerance and prevent autoimmunity."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;DIFFERENTIAL DIAGNOSIS&quot;">
      <data key="d0">"CLINICAL CONCEPT"</data>
      <data key="d1">"Identifying HS or psoriasis from other inflammatory skin conditions requires a thorough differential diagnosis process based on symptoms, clinical features, and patient history."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HISTOPATHOLOGICAL FEATURES&quot;">
      <data key="d0">"PATHOLOGY CONCEPT"</data>
      <data key="d1">"Histopathological examination of skin biopsies is crucial for confirming the diagnosis of HS and distinguishing it from similar disorders with overlapping symptoms."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"A mixed population of T cells, responsible for either the psoriasiform or eczematous reactions."&lt;SEP&gt;"Cells targeted by IL-27 and its receptor to induce a STAT1/STAT3 signaling pathway."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CLASSICAL PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CD3+ skin T cells of classical psoriasis showed instead an enrichment of both CD4+ and CD8+ subpopulations."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TYPE I IFN-Β&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"The type I IFN-β was expressed in paradoxical skin lesions, mainly in keratinocytes."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IFN-Κ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"The epidermis of psoriasiform reactions was also immunoreactive for IFN-κ, another keratinocyte-derived type I IFN."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LL-37&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"We finally investigated LT-α and LT-β, two members of the cytokine TNF family, also known as TNF-β and TNF-C 35, possibly deregulated by anti-TNF-α therapy."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;LYMPHOTOXINS (LT-Α AND LT-Β)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Both lymphotoxins were strongly overexpressed in paradoxical skin reactions, especially in keratinocytes of the basal layer epidermis."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ERAP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Among them, we studied SNPs frequent in the psoriatic population, such as polymorphisms of the HLA-C and HLA-B regions and the ERAP1 gene."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;HLA-C REGION&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"We also analyzed genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF-α, IL-17F, IL-17RA, IL-23R, IL-12B, IKBζ, A20, A20 binding protein, Tyk2), and of skin-barrier proteins (i.e. CDSN, CCHCR1)"</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ERAP1 SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Three SNPs in ERAP1 (rs30187/rs30186/rs26653) and nine variants in HLA-C were found in all patients."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CDSN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Two other SNPs in CDSN (rs1062470/rs707913) and three SNPs in CCHCR1 (rs1576/rs130079/rs746647) were carried by patient 3."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ANTIBODY&quot;">
      <data key="d0">"BIOLOGICAL MOLECULE"</data>
      <data key="d1">"In patients with paradoxical psoriasis, the presence of autoantibodies against TNF-α or other cytokines was detected."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;ANTI-TNF-Α THERAPY&quot;">
      <data key="d0">"PHARMACEUTICAL INTERVENTION"</data>
      <data key="d1">"The overexpression of innate immunity molecules and genetic variants in HS patients might suggest a potential mechanism for paradoxical psoriasis to some anti-TNF-α therapies."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNF-Α GENE&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"A SNP (rs11209026) in the IL23R gene has been previously associated with paradoxical psoriasiform reactions to anti-TNFs."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;IL23R SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"We could not find this SNP (rs11209026) in any of the HS patients, but two other SNPs (rs72676067 and rs1004819) were instead detected in patients 2 and 1."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;TNF-Α, IL-17F, IL-17RA, IL-23R GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genetic variants of pathogenic cytokines, such as TNF-α, IL-17F, IL-17RA, and IL-23R were analyzed."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;SKIN-BARRIER PROTEIN CDSN GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs in the skin-barrier protein CDSN were also investigated."</data>
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
    </node>
    <node id="&quot;CCHCR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs (rs1576, rs130079, rs746647) in this gene are mentioned."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Previous studies have associated SNPs in this gene with paradoxical psoriasiform reactions to anti-TNFs and it was found in the provided dataset as well."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS11209026&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP identified in the IL23R gene that has been linked with certain conditions before but could not be found among HS patients."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS72676067&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was detected instead of rs11209026 in patient 2, showcasing genetic diversity."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS1004819&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another variant found specifically in one of the patients, indicating individual differences."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This term suggests a condition related to skin disorders that can occur as an adverse reaction to certain treatments."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;ANTI-TNFS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"A group of drugs used for treating inflammatory conditions, which may sometimes result in paradoxical psoriasiform reactions."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;HS PATIENTS&quot;">
      <data key="d0">"SUBJECT GROUP"</data>
      <data key="d1">"Highly specific group of individuals under study whose genetic profiles were compared to others with different SNPs."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;SNP (RS1576/">
      <data key="d0">RS130079/</data>
      <data key="d1">rs746647)</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene IL23R is mentioned and studied through its different SNPs (rs72676067, rs1004819), highlighting its role or associations in the context."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS130079&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant was mentioned alongside other SNPs associated with CCHCR1."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS746647&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another SNP in the same gene, CCHCR1, as previously identified."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"The type I IFN-β was expressed in paradoxical skin lesions, mainly in keratinocytes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PSORIASIFORM REACTIONS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"The epidermis of psoriasiform reactions was also immunoreactive for IFN-κ, another keratinocyte-derived type I IFN.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDSN SNPS&quot;">
      <data key="d2">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d1">"Two other SNPs in CDSN and three SNPs in CCHCR1 were carried by patient 3.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS72676067/">
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d1">rs1004819"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE/OUTCOME&quot;">
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d1">"The term indicates possible outcomes related to specific SNPs or genes involved, such as adverse effects of certain treatments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPY/DRUG&quot;">
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d1">"Connection to the previously mentioned conditions when discussing alternative treatments or outcomes.")&lt;SEP&gt;"The class of drugs is mentioned in relation to potential side effects observed in the context of genetic variations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SUBJECT GROUP/SAMPLE&quot;">
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d1">"A defined group of subjects whose data contributes to the comparative analysis.")&lt;SEP&gt;"Focus on genetic analysis involving a specific group of subjects, in this context related to SNPs and potential health outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OUTCOME/ADVERSE EFFECT&quot;">
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d1">"Relevance to certain SNPs and potential side effects of treatment, highlighting risks in genetic profiling.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FANCL is a gene that plays an important role in nucleotide excision repair and is composed of two lobes with four α-helices and nine β-strands."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DRWD DOMAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The DRWD domain consists of both N-terminal and C-terminal lobes, each having a four-stranded β-meander followed by an α-helix in the terminal lobe."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DMFANCL&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">"DmFANCL is a gene that corresponds to Drosophila FANCL, which plays a role in DNA repair processes."&lt;SEP&gt;Transcript/</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;Α-HELICES/">
      <data key="d0">Β-STRANDS/</data>
      <data key="d1">β-Meanders"</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HELICES/">
      <data key="d0">STRANDS/</data>
      <data key="d1">Meanders"</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;N-TERMINAL LOBE/">
      <data key="d0">"Α-HELIX/</data>
      <data key="d1">"The N-terminal lobe's structure is compared with DmDRWD domain, revealing differences and similarities in secondary structures like β-meanders and α-helices."&lt;SEP&gt;β-Element"/</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;E2 UBC ENZYMES/">
      <data key="d0">"COMPARISON/</data>
      <data key="d1">"When comparing DmDRWD with known structures, E2 ubiquitin-conjugating enzymes are found to be structurally similar to both N-terminal and C-terminal lobes of human central domain."&lt;SEP&gt;Disease"</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CYSTEINE/">
      <data key="d0">"MOLECULAR INTERACTION"/</data>
      <data key="d1">"Disease"</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;THIOESTER CHARGE ASSAY/">
      <data key="d0">"DISEASE"/</data>
      <data key="d1">"Results of this assay indicate that URD lacks catalytic function by failing to form a thioester linkage with ubiquitin."&lt;SEP&gt;"Test Result"</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;N-">
      <data key="d0">C-TERMINAL LOBES/</data>
      <data key="d1">"Comparison"/</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CONSERVATION/">
      <data key="d0">"DISEASE"/</data>
      <data key="d1">"Stability Requirement"</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DRWD DOMAIN/">
      <data key="d0">"COMPARISON/</data>
      <data key="d1">"A comparison of structures using the DALI server shows similarities between DmFANCL and human FANCL central domain, but notable differences exist in specific regions."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;CATALYTIC CYSTEINE/">
      <data key="d0">"MOLECULAR FUNCTION/</data>
      <data key="d1">"The cysteine residue in the N-terminal lobe is positioned similarly as catalytic residues in E2 enzymes, suggesting potential for forming a thioester bond with ubiquitin."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;Α-HELIX/">
      <data key="d0">Β-ELEMENT"/</data>
      <data key="d1">"Structural Feature/</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;SURFACE CONSERVATION/">
      <data key="d0">"STABILITY PARAMETER/</data>
      <data key="d1">"The conservation levels on different parts of URD indicate potential for stability differences between vertebrate and invertebrate versions of the protein."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;EXTENSIVE HYDROPHOBIC RESIDUES/">
      <data key="d0">"COMPOSITION ANALYSIS/</data>
      <data key="d1">"Hydrophobic patches are identified as part of surface composition, contributing to the protein's interaction dynamics with its environment and other molecules."</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;URD&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The URD (ubiquitin-like domain) interacts with various components including FANCI and FANCD2 through specific hydrophobic patches."&lt;SEP&gt;"Wild type URD was purified to homogeneity and subjected to pulldown arrays with FANCI and FANCD2."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;DMDRWD&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"DmDRWD is a gene that corresponds to the Drosophila DRWD (DNA repair domain)."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;HUMAN URD&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Human URD refers to the ubiquitin-like domain found in humans."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;DROSOPHILA DRWD&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Drosophila DRWD stands for the DNA repair domain found in Drosophila species."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FANCI&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCI protein was used in the pulldown arrays with URD"&lt;SEP&gt;"The protein FANCI is one of the proteins that interacts with the URD during DNA repair processes."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;FANCD2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FANCD2 is another protein involved in DNA repair and binds to the URD, as evidenced by pulldown experiments."&lt;SEP&gt;"FANCD2 protein was also used in the pulldown arrays with URD"</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;PHE-63 IN UBE2T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Mutation at Phe-63 in Ube2T affects its interaction affinity with RING domain of FANCL, as seen through ITC studies."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;DRWD&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"DRWD refers to DNA repair domain found in organisms, like Drosophila."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;L248A/F252A/L254A/I265A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The mutations L248A, F252A, L254A and I265A were present on the C-terminal lobe"</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;W212A/L214A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The mutations W212A and L214A were present on a different area, the N-terminal lobe"</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;COMPONENT B&quot;">
      <data key="d0">"TYPE OF COMPONENT"</data>
      <data key="d1">"Description of Component B"</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;CITRATE SYNTHASE&quot;">
      <data key="d0">"ENZYME"</data>
      <data key="d1">"Citrate synthase is an enzyme that catalyzes the condensation of acetyl-CoA and oxaloacetate to form citrate."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCL/">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"Structure Comparison/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="URD&quot;/">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"Structure Comparison/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRUCTURAL SIMILARITY&quot;/">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"DALI Comparison/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THIOESTER BOND FORMATION/">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"Thioester Charge Assay/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;N-TERMINAL/ C-TERMINAL LOBES&quot;/">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"Comparative Analysis/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SURFACE COMPOSITION/">
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d1">"Comparative Analysis/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCI AND FANCD2&quot;">
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d1">"The URD plays a critical role in facilitating the interaction between FANCI and FANCD2 during DNA repair processes by serving as a binding site.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FGFR4 RS376618&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The exception to Hardy-Weinberg equilibrium satisfaction for five candidate SNPs."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 RS351855&quot;">
      <data key="d0">"FUNCTIONAL GENETIC VARIANT"</data>
      <data key="d1">"Associated with differential colesevelam treatment effect on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS351855 GA/AA GENOTYPE GROUP&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"Increased Colesevelam effect on CT, with increased AC t1/2 and decreased GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS351855 GG GENOTYPE GROUP&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"No significant effect of Colesevelam treatment on CT with either AC t1/2 or GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 SNPS&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Four out of five candidate SNPs evaluated for Hardy-Weinberg equilibrium satisfaction."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS4975017&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Differential treatment effect on CT, associated with lower GC24 value and potentially longer AC t1/2 compared to placebo."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;CA/AA GENOTYPE GROUP&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"Lower GC24 value in this group when treated with Colesevelam versus placebo."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;CC GENOTYPE GROUP&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"No significant treatment effects observed in the CC genotype for GC 24 and AC t1/2."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;KLB RS17618244&quot;">
      <data key="d0">"FUNCTIONAL VARIANT"</data>
      <data key="d1">"Numerical but not statistically significant differential Colesevelam treatment effects on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;GA/AA GENOTYPE GROUP&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"No significant effect of Colesevelam treatment on CT or respective parameters, regardless of genotype."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;RS17618244&quot;">
      <data key="d0">"FUNCTIONAL VARIANT OF KLB GENE"</data>
      <data key="d1">"The variant was numerically associated with differential treatment effects on AC t1/2 and GC24, though not statistically significant."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;COLESEVELAM TREATMENT EFFECT&quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"Significantly delayed CT and numerically decreased GC24 in the GA/AA genotype group, compared to placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS376618&quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"Satisfied except for FGFR4 rs376618; no significant differential treatment effects associated with this SNP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS351855 GA/AA GENOTYPE GROUP AND GG GENOTYPE GROUP&quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"The rs351855 GA/AA genotype group showed a significantly delayed CT, with increased AC t1/2 compared to placebo, while the GG genotype group did not show any significant effect of Colesevelam treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS351855 GA/AA GENOTYPE GROUP AND CC GENOTYPE GROUP&quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"No significant effects of Colesevelam treatment on CT were observed in the CC genotype group, compared to placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KLB GENOTYPE VARIATION&quot;">
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d1">"Both were genetic variants that showed association with differential colesevelam treatment effect.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ESTIMATED DAILY FAT INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Participants' dietary patterns were recorded for daily fat intake during the study."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;CHOLECYSTECTOMY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Previous cholecystectomy was recorded in 23% of IBS-D, approximately 4% of IBS-C, and approximately 4% of HV (P = .05)."&lt;SEP&gt;"Prior cholecystectomy was recorded in participants, differing across subgroups (IBS-D, IBS-C, and HV)."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SYMPTOMS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Participants' symptoms were noted and considered to be related to a diagnosis of either IBS-D, IBS-C or were healthy volunteers (HV), with those in IBS-D not showing significant change after cholecystectomy."&lt;SEP&gt;"Participants' symptoms were noted as part of diagnosis for IBS-D, IBS-C or being healthy volunteers (HV), with those in IBS-D not showing significant change after cholecystectomy."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SERUM FGF19&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"FGF19 is a protein involved in the regulation of bile acid synthesis and metabolism." "Measurements showed no significant association with subgroups, although it can play a role in various metabolic pathways."&lt;SEP&gt;"Serum levels of FGF19 were measured as part of the study but did not show an association with subgroups."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL FAT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"48-hour stool fat was recorded and compared between IBS-D, IBS-C, HV, with IBS-D having lower values than HV, and IBS-C having higher values compared to HV."&lt;SEP&gt;"48-hour stool fat was recorded as part of the study to assess digestive processes and fat absorption."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL WEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The weight of the 48-hour stool sample provides information on fecal output and gastrointestinal transit times."&lt;SEP&gt;"The weight of the 48-hour stool sample was also measured in each participant."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 25}]</data>
    </node>
    <node id="&quot;STOOL BILE ACIDS (BA) SYNTHESIS/EXCRETION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The synthesis and excretion of bile acids are part of digestive processes involving the liver and gallbladder, especially in relation to diet and health conditions like IBS-D."&lt;SEP&gt;"The synthesis and excretion of bile acids were monitored using various tests on stool samples, with IBS-D patients showing increased synthesis or excretion compared to HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;CHOLESTEROL 7Α-HYDROXYLASE (CYP7A1) PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The C4 enzyme is involved in this process of bile acid biosynthesis through the CYP7A1 pathway." "Correlation with serum C4 levels suggests a role in bile acid metabolism and potentially IBD."&lt;SEP&gt;"The C4 enzyme was associated with the synthesis of bile acids via the cholesterol 7α-hydroxylase pathway, indicating its role in bile acid production."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL BA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Stool BA levels were found to be significantly higher in IBS-D patients compared to IBS-C but not compared to HV."&lt;SEP&gt;"Stool BA was used as an indicator for the health status of participants, with differences observed between IBS-D, IBS-C, and HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 25}]</data>
    </node>
    <node id="&quot;FASTING SERUM FGF19&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum levels of fibroblast growth factor 19 (FGF19) were recorded as part of the study, which did not show an association with subgroups."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;IBS-D&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The BMI in IBS-D subgroup was approximately 4 units higher than that in IBS-C and HV, indicating a potential link to body weight regulation and digestive conditions.")&lt;SEP&gt;"The BMI in IBS-D subgroup was approximately 4 units higher than that in IBS-C and HV.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 8}, {"level": 1, "cluster": 34}]</data>
    </node>
    <node id="&quot;SERUM C4&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A significantly higher serum C4 level correlated with a higher stool BA synthesis or excretion.")&lt;SEP&gt;"Increased serum C4 levels were associated with higher stool BA synthesis or excretion, suggesting the role of this protein in bile acid dynamics.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 25}]</data>
    </node>
    <node id="&quot;TOTAL STOOL BA&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"The total content of stool bile acids correlated positively and strongly with the weight of stool samples.")&lt;SEP&gt;"The total content of stool bile acids was positively correlated with stool weight samples, reflecting digestion and fat absorption.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 25}]</data>
    </node>
    <node id="&quot;FAT CONTENT&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A correlation between the weight of stools and fat content indicated differences in digestive efficiency among participants.")&lt;SEP&gt;"A positive correlation between the weight of stools and the fat content was observed.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 25}]</data>
    </node>
    <node id="&quot;FGF19&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A negative correlation between fasting serum FGF19 levels and stool weight suggested possible metabolic differences influencing fecal output.")&lt;SEP&gt;"A negative correlation between fasting serum FGF19 levels and stool weight was observed, indicating less weight could be associated with higher FGF19.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 21}]</data>
    </node>
    <node id="&quot;FAAP20&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20 is a 20 kDa protein that binds to FANCA through its N-terminal region and contains a conserved UBZ domain in its C terminal extremity."&lt;SEP&gt;"In vivo accumulation of FAAP20 at ICL sites is dependent on UBZ domain functionality."&lt;SEP&gt;"The FAAP20 protein hydrophobically interacts with the canonical Ile44-centered hydrophobic patch of Ub, and its second loop participates in the hydrophobic interaction with Ile44. The Asp164 Oδ atoms hydrogen bond with Ala46 and Gly47 side chains of Ub. Trp180 at the C-terminal extremity of FAAP20-UBZ interacts with Ile44 through a hydrophobic interaction, also hydrogen bonding with main-chain CO groups of Leu171, Ser174, Thr175, and Val178 of Ub."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;FANCA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FANCA gene encodes for the FAAP20 protein, which plays an important role in the interaction with UBZ domain."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBZ DOMAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The UBZ domain at C-terminal extremity of FAAP20 facilitates its specific interaction with Ub chains."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UB CHAINS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"FAAP20 interacts and binds to the K63-linked Ub2 in a complex, highlighting its role in the ubiquitination pathway."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;K63-LINKED UB2&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The crystal structure of FAAP20-UBZ with K63-linked Ub2 demonstrates its interaction within the ubiquitination process."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBIQUITINATION PATHWAY&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"FAAP20, through its UBZ domain, is involved in the ubiquitination pathway which is critical for cell cycle progression and maintenance of cellular homeostasis."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;CELLULAR HOMEOSTASIS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The interaction with Ub chains suggests FAAP20's role in maintaining cellular stability under environmental changes."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;SPECIFIC INTERACTION&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH (1:1 STOICHIOMETRY)"</data>
      <data key="d1">"FAAP20-UBZ interacts with one K63-Ub2 molecule, which could be an artifact of crystallization process based on SPR spectroscopy data."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FOLATE METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process that involves folate's interaction with the NOS1 protein to maintain vascular function."&lt;SEP&gt;"Folate metabolism, which involves various enzymes including those found in the one-carbon metabolism pathway, interacts with NOS1 protein to maintain vascular function."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ONE-CARBON METABOLISM PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The one-carbon metabolism pathway is crucial for folate utilization and impacts on cardiovascular health by supporting DNA synthesis and methylation processes."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;DNA SYNTHESIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Folate influences DNA synthesis through its role in providing methyl groups, impacting gene expression related to heart function."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;METHYLATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Proper methylation processes, supported by sufficient folate, are essential for maintaining normal heart function and preventing cardiovascular disease."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;GENETIC FACTORS&quot;">
      <data key="d0">"BIOLOGICAL ATTRIBUTE"</data>
      <data key="d1">"Variants in genes encoding enzymes involved in the one-carbon metabolism pathway can influence cardiovascular health, including those related to folate metabolism."</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UB&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"FAAP20-UBZ binds Ub through its α-helix motif. The interaction is closely related to MIU domain of Rabex5 and Vps27-UIM domains, suggesting convergent evolution of these three distinct Ub-binding motifs."&lt;SEP&gt;"The UBDs (Ubiquitin Binding Domains) such as UIM, MIU, and FAAP20-UBZ bind Ub with close resemblance suggesting convergent evolution of these distinct Ub-binding motifs."&lt;SEP&gt;"Ub (ubiquitin) is bound to FAAP20 through interactions including a hydrophobic interaction with Ile44-centered patch formed by Leu8, Ile44, Val70 side chains and aliphatic portions of Thr66, His68 side chains. The Asp164 Oδ atoms hydrogen bond with Ala46 and Gly47 main-chain amide groups respectively."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;FAAP20-UBZ MUTANTS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Site-directed mutations D164A, A168L and W180A in FAAP20-UBZ do not allow binding to Ub similar to mutation Cys150 which disables bridging between the first loop and central α-helix thus likely destabilizing FAAP20-UBZ structure. Binding affinities of mutants L161A, A172L, D177A are significantly reduced but still measurable."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ICL FORMATION&quot;">
      <data key="d0">"PROCESS"</data>
      <data key="d1">"After intermolecular interactions with Ub, FAAP20 proteins are recruited to DNA damage sites formed by interstrand cross-links (ICLs)."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;CELLULAR LOCALIZATION&quot;">
      <data key="d0">"PROCESS"</data>
      <data key="d1">"Wild-type FAAP20 accumulates at DNA damage sites following UVA irradiation in cells pre-incubated with psoralen. Mutant forms like C150S, D164A, A168L and W180A have diffuse localization throughout the cell."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;IN VIVO STUDY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"FAAP20 protein accumulation at ICL sites is investigated in cells irradiated with UVA after psoralen addition. Localization of GFP-tagged FAAP20 proteins is monitored by confocal imaging."&lt;SEP&gt;"The study involves in vivo treatment of mice with TAG72-BBζ CAR T cells to evaluate their anti-tumor activity."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;WD-REPEAT PROTEIN&quot;">
      <data key="d0">"CATEGORY"</data>
      <data key="d1">"The WD-repeat protein FAAP20 contains a UBZ domain which interacts with Ub, influencing its cellular localization and accumulation at DNA damage sites."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;CONSERVATION OF RESIDUES&quot;">
      <data key="d0">"COMPARISON"</data>
      <data key="d1">"Conservation or replacement of residues involved in Ub interactions is observed among human, mouse, rat, chicken, and pufferfish FAAP20 proteins. The exact sequence conservation cannot be assessed due to high divergence between UBZs."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;3D STRUCTURAL ANALYSIS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"The 3D structures of WRNIP1-, RAD18-, Polη- and NEMO-UBZ are compared with FAAP20-UBZ in complex with Ub. WRNIP1 and RAD18 display the canonical ββα fold whereas Polη and NEMO interact differently."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;POLΗ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Has a β-loop that interacts with Ile44 of Ub similar to FAAP20-UBZ."&lt;SEP&gt;"The Polη protein hydrophobically interacts with Ub and binds through a ββα structure, with interactions involving Pro398-Lys399 in NEMO-UBZ and Glu636-Lys637 in Polη UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591&lt;SEP&gt;chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;RAD18&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The RAD18 protein also adopts the canonical ββα fold for binding to Ub, involving specific residues in both antiparallel β-strands of the β-loop that interact with corresponding residues on Ub."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;NEMO-UBZ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Does not fit in the hydrophobic patch of Ub centered on Ile44 due to the larger side chain of Met415 compared to Ala168 found in FAAP20-UBZ, suggesting a different mode of interaction with Ub."&lt;SEP&gt;"Interacts with Ub in a manner different from RAD18-UBZ and WRNIP1-UBZ, having highly conserved Pro21-Val22 replaced by Pro398-Lys399 and Glu636-Lys637 in Polη-UBZ."&lt;SEP&gt;"The side chain of Met415 is much larger than that of Ala168 of FAAP20-UBZ causing it to fit poorly in the hydrophobic patch centered on Ile44, suggesting different interaction with Ub."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;POLΗ-UBZ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Has charged residues at positions corresponding to Asp164, Leu167, Ala168, and Leu171 of FAAP20-UBZ which help in binding Ub similarly to FAAP20-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;WRNIP1-UBZ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Has sequence conservation suggesting that Polη-UBZ binds Ub similar to FAAP20-UBZ, but this is not observed for NEMO-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;FAAP20-UBZ&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The β-loop region lacks or diverges in FAAP20-UBZ and Polη-UBZ compared to WRNIP1/Rad18 group, which interact with Ile44 of Ub through their β-loop."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;VPS27&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Has UIM (Ub-interacting motif) domain which binds Ub with a polarity opposite to FAAP20-UBZ and Rabex5-MIU but the majority of the Ub-interacting residues on the α-helix are identical or functionally equivalent among Vps27-UIM, FAAP20-UBZ, and Rabex5-MIU."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;RABEX5&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Has MIU (motif interacting with Ub) domain which binds Ub in the same orientation as FAAP20-UBZ. The majority of residues involved in Ub binding are identical or functionally equivalent among Vps27-UIM, FAAP20-UBZ, and Rabex5-MIU."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;UBIQUITIN (UB)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"All UBDs including NEMO-UBZ, Polη-UBZ, WRNIP1-UBZ and FAAP20-UBZ show the capacity to bind with Ub through their respective α-helix motifs indicating ubiquitination pathway involvement."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;FAAP20-UBZ COMPLEX&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"FAAP20 interacts specifically with K63-Ub2 through its UBZ domain, indicating specific targeting of this type of ubiquitin chain in the cell.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;1:1 STOICHIOMETRY INTERACTION&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"SPR data suggests that FAAP20-UBZ might interact with K63-Ub2 in a 1:1 stoichiometry, although this may represent an experimental artifact based on the calculated Rmax.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT INTERACTION&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"The interaction between specific dietary nutrients, like folate from leafy greens, is crucial for maintaining optimal cardiovascular health based on lifestyle factors and genetic predispositions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RELATIONSHIP STRENGTH (5/6)&quot;">
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d1">"The interaction between specific dietary nutrients, like folate from leafy greens, is crucial for maintaining optimal cardiovascular health based on lifestyle factors and genetic predispositions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EFFECT&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Mutations D164A, A168L and W180A in FAAP20-UBZ disable binding to Ub and C150S mutation destabilizes the structure leading to a lack of functional recruitment of FAAP20 proteins.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAAP20-UBZ MUTATIONS&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Mutations D164A, A168L and W180A in FAAP20-UBZ disable binding to Ub and C150S mutation destabilizes the structure leading to a lack of functional recruitment of FAAP20 proteins.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNIFICANCE&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"The intermolecular interactions between FAAP20 protein domain UBZ and Ub are essential for proper cellular localization and accumulation at DNA damage sites in response to intermolecular binding events and ICL formation processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UB INTERACTION&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"The intermolecular interactions between FAAP20 protein domain UBZ and Ub are essential for proper cellular localization and accumulation at DNA damage sites in response to intermolecular binding events and ICL formation processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EVOLUTIONARY INSIGHT&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Conservation of residues involved in Ub interactions is observed among various species but sequence variations are noted due to high divergence between UBZ structures, requiring detailed 3D structural analysis for precise comparisons.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESIDUE CONSERVATION&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Conservation of residues involved in Ub interactions is observed among various species but sequence variations are noted due to high divergence between UBZ structures, requiring detailed 3D structural analysis for precise comparisons.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OBSERVATION&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Comparative analysis reveals differences in the modes and strength of interactions between various UBZs (FAAP20-UBZ, WRNIP1-UBZ, RAD18-UBZ) and Ub based on conserved or replaced key residues.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UB BINDING COMPARISON&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"Comparative analysis reveals differences in the modes and strength of interactions between various UBZs (FAAP20-UBZ, WRNIP1-UBZ, RAD18-UBZ) and Ub based on conserved or replaced key residues.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPLICATION&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"The variations in key interacting residues among UBZ proteins suggest evolutionary adaptations for binding efficiency or specific roles in cellular processes involving Ub.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESIDUE VARIATIONS&quot;">
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d1">"The variations in key interacting residues among UBZ proteins suggest evolutionary adaptations for binding efficiency or specific roles in cellular processes involving Ub.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WRNIP1/RAD18 GROUP&quot;">
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d1">"Interaction with Ile44 of Ub through their β-loop suggests similarities between WRNIP1, Rad18 and Polη-UBZ binding to Ub."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VPS27-UIM&quot;">
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d1">"Similar residues are involved in Ub-binding by Vps27-UIM and FAAP20-UBZ with opposite polarity towards the bound Ub showing convergent evolution among UBDs."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;RABEX5-MIU&quot;">
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d1">"The same critical residues involved in Ub binding are identical between Rabex5-MIU and FAAP20-UBZ suggesting closely related interaction mechanisms."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;RAD18-UBZ&quot;">
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d1">"While FAAP20-UBZ shows interactions with Ub similar to MIU domain of Rabex5 and Vps27-UIM, it differs in its mode of interaction compared to RAD18-UBZ indicating structural diversity among UBDs."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 41}]</data>
    </node>
    <node id="&quot;RS2395182&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor 'G' allele is more prevalent in healthy controls than CD group."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7775228&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor 'C' allele frequency among controls is significantly different from that in CD patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS2187668&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Minor 'T' allele shows a significant difference between 10% of the CD group and 3% of healthy controls."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;RS7454108&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"There was no statistically significant difference between case and control groups."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA-DQ2.5 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"HLA-DQ2.5 haplotype is significantly higher in CD patients compared to healthy controls (10.89 vs 2.91%; p = 0.024)."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DQ8 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The DQ8 heterozygous haplotypes are highly frequent among CD patients (33.66%), with significant differences between the patient and control group (p = 0.014)."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DQ8/DQ2.5 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There were no heterozygous DQ2.5 carriers in either patients or controls."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DQ2.2 HAPLOTYPE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The predicted homozygous DQ2.2 haplotype was frequent among control (5.82%) compared to CD patients (0.99%)."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HLA TAG SNPS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"SNP results show significant differences in the minor allele frequency distribution between CD patients and healthy controls, particularly for rs2395182, rs7775228, and rs2187668."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ANOREXIA&quot;">
      <data key="d0">"CLINICAL SYMPTOM"</data>
      <data key="d1">"Common symptom seen among CD patients characterized by loss of appetite."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ABDOMINAL DISTENSION&quot;">
      <data key="d0">"CLINICAL SYMPTOM"</data>
      <data key="d1">"A common manifestation in CD patients noted as a feeling of fullness or bloating in the abdomen."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An autoimmune disease affecting insulin production found among some CD patients, making up about 32% of cases."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An inflammatory condition targeting the thyroid gland often associated with other autoimmune diseases like CD, seen in about 8% of our patient group."&lt;SEP&gt;"The presence of antibodies against thyroid-related proteins indicates the autoimmune response affecting thyroid tissue."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic autoimmune disease characterized by inflammation and damage to various parts of the body found among about 3% of our patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;OSTEOMALACIA&quot;">
      <data key="d0">"NON-AUTOIMMUNE DISEASE MANIFESTATION"</data>
      <data key="d1">"A bone softening condition often due to vitamin D deficiency observed in less than 5% of participants."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;SEIZURE DISORDERS&quot;">
      <data key="d0">"NON-AUTOIMMUNE DISEASE MANIFESTATION"</data>
      <data key="d1">"Neurological issue characterized by recurrent seizures found among about 4% of patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DOWN SYNDROME&quot;">
      <data key="d0">"NON-AUTOIMMUNE DISEASE MANIFESTATION"</data>
      <data key="d1">"A genetic disorder typically associated with cognitive and physical development delay seen in around 4% of our participants."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;CD PATIENTS&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"HLA-DQ genotypes show a significant difference between CD patients compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DQ HAPLOTYPE&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"HLA-DQ genotypes show a significant difference between CD patients compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEALTHY CONTROLS&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"The distribution of rs179009 genotypes varies between HIV-infected individuals and healthy controls."&lt;SEP&gt;"The group of individuals without any medical condition as a comparison to asthmatic patients."&lt;SEP&gt;"There are significant differences in the minor allele frequency distribution among CD patients compared to healthy controls for these SNPs.")&lt;SEP&gt;"When comparing healthy controls to CD subjects, there were differences in the presence of MAPbacteremia and specific allele combinations."</data>
      <data key="d0">"DISEASE"</data>
    </node>
    <node id="&quot;RS2395182, RS7775228, AND RS2187668&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"There are significant differences in the minor allele frequency distribution among CD patients compared to healthy controls for these SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DQ2.5 HAPLOTYPE&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"No difference exists between the tag SNP predicted homozygous HLA-DQ2.5 haplotype in CD patients and healthy controls, though not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA TAG SNPS AND HAPLOTYPE RESULTS&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"The sequencing analysis with sanger method confirmed the accuracy of Real-time PCR based tagSNPs approach in determining the HLA-DQ haplotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VALIDATION BY SANGER SEQUENCING&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"The sequencing analysis with sanger method confirmed the accuracy of Real-time PCR based tagSNPs approach in determining the HLA-DQ haplotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE GROUP&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"An autoimmune disease that affects insulin production; a part of our disease manifestation group.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NON-AUTOIMMUNE DISEASE GROUP&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"Condition characterized by weak bones often due to vitamin D deficiency; identified among a small percentage of participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEUROLOGICAL CONDITION GROUP&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"Conditions characterized by recurrent seizures, sometimes associated with autoimmune diseases like CD; observed in a subset of patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEVELOPMENTAL DISORDER GROUP&quot;">
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d1">"Genetic disorder leading to cognitive and physical development challenges; identified among approximately 4% of participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1128503&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CABCB1 gene variant C&gt; T was associated with grade 3-4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS12762549&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCC2 gene variant C&gt;G was significantly related to grade 3-4 anemia."&lt;SEP&gt;"This variant, rs12762549 (ABCC2 A &gt; G), was significantly associated with PFI in the fully-adjusted model."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RS363717&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCA1 gene variant A&gt;G showed a significant link with grade 3-4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS11615&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ERCC1 gene variant T&gt;C was associated with grade 3-4 anemia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS4986910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CYP3A4 gene variant T&gt;C correlated with grade 3-4 thrombocytopenia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS2073337&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCC2 gene variant A&gt;G was significantly associated with CSF use."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS671&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"UGT1A1 gene variant C&gt;T showed a link to grade 3-4 thrombocytopenia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS20425&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ABCB1 ABCG2 gene variant T&gt;G correlated with grade 4 neutropenia."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS769108&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TERT promoter variant C&gt;T was associated with an increased risk of anemia and thrombocytopenia in ovarian cancer patients."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS352746&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"GSTP1 gene variant A&gt;G showed a link to an increased use of ESA during chemotherapy."</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RS1799793&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant, rs1799793 (ERCC2 G &gt; A), was significantly correlated with PFI in both cases."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;PFI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"It refers to Platinum-free interval which survived correction for multiple testing"</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RS6104&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant, rs6104 (SERPINB2 C &gt; G), was significantly associated with PFI in the fully-adjusted model."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ABCC2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ABCC2 gene encodes for a transporter that is involved in drug resistance and other cellular processes."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;GTPASE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The ABCC2 protein functions as an efflux pump, which removes certain substances like drugs from cells."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;A/G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs12762549 variant is a genetic mutation characterized by the substitution of nucleotide at position 12762549 leading to an amino acid change in ABCC2 protein."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;G/T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs6104 variant indicates another genetic alteration with a substitution of nucleotide at position 6104 influencing SERPINB2 function."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ABCB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another important gene for drug metabolism and resistance, ABCB1 encodes for the B-cell leukemia/lymphoma 1 (BCL-1) multidrug resistance protein."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;ATP-BINDING CASSETTE TRANSPORTER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"ABCB1 interacts with various proteins to form a transmembrane channel that facilitates drug export from cells."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;PLATINUM-FREE INTERVAL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A measure of the time duration after chemotherapy when no further treatment is required, reflecting tumor control without recurrence."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;FIGO STAGE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A system for classifying cancer stages based on tumor characteristics and extent of spread."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;TUMOR GRADE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An assessment of the degree to which a tumor cell differs from normal cells, reflecting the malignancy level."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;TUMOR HISTOLOGY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A detailed microscopic examination that categorizes cancer based on its origin and cellular structure."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;RESIDUAL DISEASE AFTER DEBULKING SURGERY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The presence of cancer cells remaining in the body post-surgery, indicating incomplete removal or residual burden."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;PFI AND OS&quot;">
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d1">"The rs1799793 ERCC2 G&gt;A variant showed a significant correlation with progression-free interval (PFI) and overall survival (OS) in ovarian cancer.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRECTION FOR MULTIPLE TESTING&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"Correction for multiple testing is used when several statistical tests are performed simultaneously, which helps to reduce type I errors.")&lt;SEP&gt;"This refers to the application of statistical methods used when multiple hypotheses are tested simultaneously, adjusting p-values to control the family-wise error rate.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHR3:121233326–127618464&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"De novo 6.4 Mb deletion on chromosome 3 containing more than 40 RefSeq genes, including UMPS"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;UMPS&quot;">
      <data key="d0">"GENE"/"TRANSCRIPT"</data>
      <data key="d1">"Additionally copy number variations were excluded in individuals 4, 6, and 7"&lt;SEP&gt;"Additionally, in-depth analysis of UMPS variants in the database"&lt;SEP&gt;"Has a de novo 6.4 Mb deletion and contains UMPS gene"&lt;SEP&gt;"Karyotyping, SNP array, and gene-specific deletion/duplication testing did not reveal abnormalities"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;AGENESIS OF THE CORPUS CALLOSUM&quot;">
      <data key="d0">"DISEASE"/"CONDITION"</data>
      <data key="d1">"Not causing agenesis when deleted"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.302DELA (P.LYS101ARGFS*9)&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Found in I4; Premature stop leading to loss of normal protein function via protein truncation or NMD"&lt;SEP&gt;"Found in I4; deletion leading to loss of normal protein function"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I1&quot;">
      <data key="d0">"INDIVIDUAL"/"FAMILY MEMBER"</data>
      <data key="d1">"Deletion contains UMPS gene and may contribute to the patient’s phenotype"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.385G&gt;T (P.GLY129*)&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Maternally inherited and also found in healthy brother S7"&lt;SEP&gt;"UMPS variant, maternally inherited, also found in healthy family member S7"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I7&quot;">
      <data key="d0">"INDIVIDUAL"/"FAMILY MEMBER"</data>
      <data key="d1">"C.385G&gt;T (p.Gly129*) variant found; maternally inherited and present in healthy brother"&lt;SEP&gt;"c.688C&gt;T (p.Arg230Cys) variant found; maternally inherited"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.889G&gt;T (P.GLU297*)&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Detected in I10; maternally inherited"&lt;SEP&gt;"Found in I10 and I11; maternally and paternally inherited respectively"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I10&quot;">
      <data key="d0">"INDIVIDUAL"/"FAMILY MEMBER"</data>
      <data key="d1">"C.889G&gt;T (p.Glu297*) variant found, paternally inherited"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.224C&gt;A (P.PRO75HIS)&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Found in I3 and his healthy mother M3, may be on the same allele"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;PEDIGREE 2&quot;">
      <data key="d0">"FAMILY"</data>
      <data key="d1">"12 family members tested positive for c.224C&gt;A variant"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.286A&gt;G (P.ARG96GLY)&quot;">
      <data key="d0">"VARIANT"/"MUTATION"</data>
      <data key="d1">"Found in I3 and mother M3, may be on the same allele"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I5&quot;">
      <data key="d0">"INDIVIDUAL"/"FAMILY MEMBER"</data>
      <data key="d1">"c.310G&gt;A (Gly104Arg) variant detected; maternally inherited"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.689G&gt;A (P.ARG230HIS)&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Detected in I6, maternally inherited"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I9&quot;">
      <data key="d0">"INDIVIDUAL"/"FAMILY MEMBER"</data>
      <data key="d1">"Detected c.857T&gt;A (p.Ile286Asn) and c.451G&gt;A (p.Val151Met)"&lt;SEP&gt;"c.386T&gt;C (p.Tyr130Ser) variant detected"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I11&quot;">
      <data key="d0">"INDIVIDUAL"/"FAMILY MEMBER"</data>
      <data key="d1">"c.857T&gt;A (p.Ile286Asn) and c.451G&gt;A (p.Val151Met) found"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;P.PRO75HIS&quot;">
      <data key="d0">"VARIANT"/"MUTATION"</data>
      <data key="d1">"Found in pedigree 2, tested positive by family members"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.360A&gt;G (P.LEU120LEU)&quot;">
      <data key="d0">"VARIANT"/"MUTATION"</data>
      <data key="d1">"Synonymous change, heterozygous and maternally inherited in individual 6"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.386T&gt;C (P.TYR130SER)&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Detected in I9; benign single nucleotide polymorphism"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.457C&gt;T (P.ALA153THR)&quot;">
      <data key="d0">"VARIANT"</data>
      <data key="d1">"Detected in I12; benign single nucleotide polymorphism"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;I12&quot;">
      <data key="d0">"INDIVIDUAL"/"FAMILY MEMBER"</data>
      <data key="d1">"c.457C&gt;T (p.Ala153Thr) variant detected"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;EXON SKIPPING MUTATIONS&quot;">
      <data key="d0">"UMPS VARIANTS"</data>
      <data key="d1">"Not identified through exome sequencing"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;COPY NUMBER VARIATIONS&quot;">
      <data key="d0">"UMPS"</data>
      <data key="d1">"Excluded in individuals 4, 6, and 7"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;SPLICE SITE VARIANTS&quot;">
      <data key="d0">"IN UMPS GENE"</data>
      <data key="d1">"Not detected by the next generation sequencing panel"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;INTRONIC MUTATIONS&quot;">
      <data key="d0">"UMPS GENE"</data>
      <data key="d1">"Identified through targeted sequencing"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;UTR (UNTRANSLATED REGION) VARIANT&quot;">
      <data key="d0">"UMPS GENE"</data>
      <data key="d1">"Detected in I3; potentially affecting mRNA stability and translation"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;TAQMAN (VIIA™ 7 REAL-TIME PCR)&quot;">
      <data key="d0">"GENOTYPING METHOD"</data>
      <data key="d1">"The TaqMan method used for genotyping by an allele discrimination assay."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;TGF-SS1 (RS1800469 C/T)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a specific variant of TGFß1 gene, with alleles 'C' and 'T'"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-8 (RS4073)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 8 gene with two alleles, 'T' and 'A', which were studied"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-10 (RS1800896)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Interleukin 10 gene having two alleles, 'A' and 'G', was evaluated for association with CRC."</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-22 (RS1179251 C/G &amp; RS2227485 C/T)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Two polymorphisms of IL-22 gene were studied, one by C/G and another by C/T"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;IL-27 (RS17855750 T/G)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Promoter region of IL-27 gene was analyzed with two alleles 'T' and 'G'"&lt;SEP&gt;"The variant of IL-27 gene has two alleles 'T' and 'G', that may influence inflammation or immune responses"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A family of proteins involved in cell signaling, inflammation, and immune responses"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS4073 T/A&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) within the IL-8 gene"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1800896 A/G&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A SNP in the IL-10 promoter region"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1179251 C/G&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"One of two SNPs found in the IL-22 gene, one by C/G"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS2227485 C/T&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"The second IL-22 polymorphism analyzed with alleles 'C' and 'T'"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS17855750 T/G&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A promoter region SNP in the IL-27 gene"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;RS1800469 C/T&quot;">
      <data key="d0">"SNP (TRANSFORMING GROWTH FACTOR-SS1)"</data>
      <data key="d1">"A genetic variation at this position affects the TGFβ1 gene"</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;CC GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype is associated with an increased risk of Colorectal Cancer (CRC)."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;T ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The T allele has a slightly lower frequency in the CRC patients compared to the control group, but this does not reach statistical significance."&lt;SEP&gt;"The T allele has a slightly lower frequency in the CRC patients compared to the control group."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;CC GENOTYPE VS T ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT RELATIONSHIP"</data>
      <data key="d1">"The comparison between CC genotype and T allele shows a different frequency in CRC patients."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;TGFSS1 (RS1800469 C/T)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The TGFß1 gene polymorphism which was studied in relation to CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSFORMING GROWTH FACTOR Β1&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The TGFß1 gene polymorphism which was studied in relation to CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 (RS4073 T/A)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"A variant of the IL-8 gene and its promoter region SNP were analyzed for its role in CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN 8&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"A variant of the IL-8 gene and its promoter region SNP were analyzed for its role in CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 (RS1800896 A/G)&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"SNP analysis conducted on the promoter region of IL-10 gene and its correlation with CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN 10&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"SNP analysis conducted on the promoter region of IL-10 gene and its correlation with CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN 22&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Two SNPs within the IL-22 gene were studied in association with CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN 27&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"SNP analysis of the promoter region of IL-27 gene and its potential role in CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE RISK&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Decreased CT genotype in the TGFß1 gene was observed to be associated with a lower risk of developing CRC")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRC RISK&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The variant GG genotype and G allele were slightly associated with a decreased risk of CRC development")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE: COLORECTAL CANCER&quot;">
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d1">"Association between specific genotypes (CC) and the risk of developing Colorectal Cancer")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT: CC&quot;">
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d1">"Association between specific genotypes (CC) and the risk of developing Colorectal Cancer")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FREQUENCY DIFFERENCE&quot;">
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d1">"The frequency difference comparison between T allele and other genotypes in CRC patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT: T ALLELE&quot;">
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d1">"The frequency difference comparison between T allele and other genotypes in CRC patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASTHMATIC PATIENTS&quot;">
      <data key="d0">"PATIENT"</data>
      <data key="d1">"The group of individuals with asthma included in the analysis."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NYUBAR POPULATION&quot;">
      <data key="d0">"POPULATION SAMPLE"</data>
      <data key="d1">"The total sample that includes both asthmatic patients and healthy controls for the analysis."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;FEMALE&quot;">
      <data key="d0">"SEXUAL DEMOGRAPHIC"</data>
      <data key="d1">"A majority of the participants were women in this study."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;NEVER-SMOKERS&quot;">
      <data key="d0">"SMOKING STATUS"</data>
      <data key="d1">"All cases and controls were non-smokers, as they were never smokers."&lt;SEP&gt;"Another subgroup within the study, which did not show a significant association with asthma risk despite the presence of SNPs."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;SELF-REPORTED RACE/ETHNICITY&quot;">
      <data key="d0">"CULTURAL OR GENETIC DEMOGRAPHIC"</data>
      <data key="d1">"Differences were noted between asthmatic cases and controls in terms of self-reported race/ethnicity, which could influence genetic studies."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA DIAGNOSIS&quot;">
      <data key="d0">"MEDICAL CONDITION"</data>
      <data key="d1">"The primary diagnosis was asthma for all participants classified as cases."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;LUNG FUNCTION&quot;">
      <data key="d0">"FUNCTIONAL HEALTH MEASUREMENT"</data>
      <data key="d1">"Reduced lung function parameters like FEV1, FVC, and FEV1/FVC were noted in asthmatic patients compared to controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TOTAL IGE&quot;">
      <data key="d0">"BLOOD TEST INDICATOR"</data>
      <data key="d1">"Asthmatic patients had significantly higher total IgE levels than the control group."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ATOPY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"More cases were determined as atopic based on their symptoms and testing results, indicating a potential genetic predisposition to allergies."&lt;SEP&gt;"The frequency of the IL-8 genotypes differing significantly indicated a role in atopic asthma development."&lt;SEP&gt;"The development of allergic symptoms, including chronic eczema and reactive airway disease, is indicative of an atopic phenotype often seen in people with STAT5B deficiency."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ANCESTRY MARKERS&quot;">
      <data key="d0">"GENETIC TRAITS"</data>
      <data key="d1">"Data on ancestry markers that help differentiate between self-reported racial groups, useful in genetic studies."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TSLP SNPS&quot;">
      <data key="d0">"SINGLE NUCLEOTIDE POLYMORPHISM"</data>
      <data key="d1">"Specific genetic variations analyzed for association with asthma susceptibility."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;SNP RS1898671&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"One SNP showing nominal association with asthma, especially in ex-smokers, but not significant in never-smokers."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;APCAT COHORTS&quot;">
      <data key="d0">"COMBINED DATASET OF MULTIPLE STUDIES"</data>
      <data key="d1">"A large cohort combining six cohorts for replication analysis to validate the findings from NYUBAR."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;EX-SMOKERS&quot;">
      <data key="d0">"SMOKING HISTORY CATEGORY"</data>
      <data key="d1">"Subgroup analyzed separately, showing significant association with SNP rs1898671 and asthma risk."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA SUSCEPTIBILITY&quot;">
      <data key="d0">"HEALTH RISK INDICATOR"</data>
      <data key="d1">"The possibility to develop asthma based on genetic and environmental factors, influenced by specific SNPs like rs1898671."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;HAPLOTYPE GAGGGCAAAG&quot;">
      <data key="d0">"GENETIC SEQUENCE CONFIGURATION"</data>
      <data key="d1">"This haplotype had an estimated frequency of 24% and showed a significant increased risk associated with asthma after adjusting for age, BMI, and population stratification."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;REPLICATION COHORT VALIDATION&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Confirmation of findings in a larger combined cohort, validating the associations made with NYUBAR population.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POPULATION STRATIFICATION ADJUSTMENT&quot;">
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d1">"Increased risk of asthma was observed when taking into account population structure differences in the analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN2/22 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The nine SNPs examined in PTPN2/22 found in both CD subjects and healthy controls are analyzed."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS1893217&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the four SNPs found in PTPN2, rs1893217 was not significant in CD."&lt;SEP&gt;"The most significant association was found for rs1893217 under a dominant logistic model. Carriers of at least one copy of a minor allele G (AG or GG) were 2.79 times more likely to be non-responders, compared to those with the homozygous reference genotype (AA)."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;RS2542151&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the four SNPs found in PTPN2, rs2542151 was not significant in CD."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS7234029&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the four SNPs found in PTPN2, rs7234029 was not significant in CD."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant detected in 57/69 (82.6%) of CD compared to 36/59 (61.0%) of healthy controls (OR = 3.03, 95%CI: 1.35-6.84, P-values &lt; 0.05)."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Achieved nominal significance in association with IgM anti-PC GWAS."&lt;SEP&gt;"Five SNPs specific to PTPN22 were considered but none was significant in CD compared to the healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db&lt;SEP&gt;chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS2488457&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"None of these five SNPs were considered significant for PTPN22, though rs2476601 is found significantly in various inflammatory autoimmune diseases."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS33996649&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"None of the five SNPs specific to PTPN22 were considered significant for CD compared to healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS34209542&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the five SNPs specific to PTPN22, but was not found to be significant in CD versus healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;RS2476599&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another one out of these five SNPs for PTPN22 that was not considered significant in CD compared to the healthy controls."</data>
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
    </node>
    <node id="&quot;PTPN2:RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Certain genotypes at the PTPN2 locus were associated with increased IFN-γ gene expression in CD subjects."&lt;SEP&gt;"Heterozygous (TC) and minor (CC) alleles in PTPN2:rs478582 were associated with increased risk of MAPbacteremia."&lt;SEP&gt;"The PTPN2:rs478582 gene has two types of alleles (TC) or minor (CC), and studies have shown that these can impact relative gene expression."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;HEALTHY CONTROL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Healthy controls refer to individuals without the specific SNPs mentioned in PTPN2:rs478582, allowing comparisons with those who carry the gene variants."&lt;SEP&gt;"Healthy controls refer to individuals without the specific SNPs mentioned in PTPN2:rs478582, used as a baseline for comparisons against those carrying gene variants."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;HETEROZYGOUS (TC) ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying heterozygous TC alleles for PTPN2:rs478582 show a significantly lower average relative gene expression of the CD compared to healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;MINOR (CC) ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Similar to heterozygous TC, individuals with minor CC alleles in PTPN2:rs478582 also display notably decreased gene expression in the CD versus healthy control subjects."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;AVERAGE RELATIVE GENE EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This metric measures the average level of gene expression under comparison between subjects carrying specific PTPN2:rs478582 alleles and healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;SIGNIFICANT DIFFERENCE&quot;">
      <data key="d0">"RELATIONSHIP STRENGTH"</data>
      <data key="d1">"Studies have found statistically significant differences in average relative gene expression for both heterozygous (TC) and minor (CC) alleles of PTPN2:rs478582 when compared to the corresponding healthy control groups."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;CD BACTEREMIA PRESENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The detection rate of MAP bacteremia is notably higher in individuals with heterozygous TC or minor CC alleles for PTPN2:rs478582, indicating a potential link between specific gene variants and susceptibility to infection."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;HEALTHY CONTROLS WITH SIMILAR SNPS&quot;">
      <data key="d0">"COMPARISON GROUP"</data>
      <data key="d1">"When comparing CD subjects carrying certain genotypes with healthy controls sharing similar genotypes (like TC or CC for PTPN2:rs478582), distinct differences in MAP bacteremia presence are observed, highlighting the impact of genetic factors."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;OR VALUE (ODDS RATIO)&quot;">
      <data key="d0">"EFFECT STRENGTH"</data>
      <data key="d1">"The odds ratio (17.5 and 21.6) quantifies the strength of association between specific PTPN2:rs478582 genotypes and increased susceptibility to MAP infection in CD subjects, as compared to healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;PTPN2:RS478582:TC ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying PTPN2:rs478582 TC (heterozygous) alleles show a notably decreased gene expression in the CD compared to healthy controls."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;PTPN2:RS478582:CC ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals with minor CC (homozygous) PTPN2:rs478582 alleles also display significantly lower gene expression in the CD versus healthy control subjects."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;MAP BACTEREMIA&quot;">
      <data key="d0">"MEDICAL CONDITION"</data>
      <data key="d1">"The presence of bacteremia due to Mycobacterium avium subspecies paratuberculosis (MAP) infection is notably higher in CD subjects with certain genotypes for PTPN2:rs478582."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;PTPN22:RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Heterozygous (GA) or minor (AA) alleles in PTPN22:rs2476601 were rare and associated with low risk of MAPbacteremia."&lt;SEP&gt;"SNPs (Single Nucleotide Polymorphisms) at this locus were found to influence T-cell functionality and response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The expression levels of PTPN2 gene were significantly lower in CD subjects compared to healthy controls regardless of MAPbacteremia status."</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;MAPBACTEREMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Presence of MAPbacteremia was associated with different allele combinations in PTPN2:rs478582 and PTPN22:rs2476601, which influenced the expression levels of PTPN2/PTPN22 and IFN-γ."&lt;SEP&gt;"The presence of MAPbacteremia was considered as an environmental factor that affects T-cell response in CD subjects."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d0">"MOLECULAR MECHANISM/</data>
      <data key="d1">"Long-term dietary patterns may lead to epigenetic modifications that affect gene expression related to cardiovascular health."&lt;SEP&gt;"Modifications linked to poor dietary patterns that alter the metabolic pathway of nitric oxide synthesis."&lt;SEP&gt;Alteration"/"Factor/Context/</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TP53&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TP53 gene was mentioned as part of the study's analysis on p53 expression and its relation to CD."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;P53&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"p53 protein levels were measured in T-cells from both healthy controls and CD subjects, with a focus on its role in response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PHA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Phytohemagglutinin (PHA) was used as an activator of T-cells for measuring their proliferation response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAP PPD-LIKE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A modified form of Mycobacterium avium subspecies paratuberculosis (MAP PPD-like) was utilized in the study to test T-cell response."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;NOS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This entity plays a critical role in cardiovascular health by regulating nitric oxide production."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This central pathway is influenced by genetic and environmental factors, affecting cardiovascular health."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 39}]</data>
    </node>
    <node id="&quot;DIET&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The diet is a significant environmental factor modulating the relationship between genes and cardiovascular health."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;SNPS COMPARISON&quot;">
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d1">"The analysis of SNPs in both PTPN2/22 shows significant differences between CD subjects and healthy controls, suggesting a potential role of these genetic variations in the development or manifestation of CD.")("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRENGTH OF ASSOCIATION&quot;">
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d1">"The odds ratio quantifies how much more likely it is for CD subjects with specific PTPN2:rs478582 genotypes to develop MAP infection, indicating the strength of their association.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN2 EXPRESSION&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"Decrease in PTPN2 expression level between healthy controls and CD subjects regardless of MAPbacteremia presence.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFN-Γ EXPRESSION&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"Increased IFN-γ expression upon combined effects of specific SNPs, MAPbacteremia presence in CD subjects compared to non-infected controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOMIC VARIANT IN FOLATE METABOLISM PATHWAY&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"Variants influencing folate metabolism pathways are associated with increased risk for certain diseases, including cardiovascular disease.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;MOLECULAR PROCESS&quot;">
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d1">"Interactions between nutrients and specific molecular processes in the body can have significant effects on physiological functions like metabolism and disease risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T-CELL RESPONSE&quot;">
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"T cells respond to neoepitopes when presented by MHC molecules on the surface of cancer cells."&lt;SEP&gt;"The presence of MAPbacteremia was found to impact T-cell response and proliferation in CD patients.")</data>
      <data key="d0">"BIOLOGICAL PROCESS"</data>
    </node>
    <node id="&quot;T-CELL PROLIFERATION&quot;">
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d1">"PHA stimulation led to an increased T-cell proliferation response in both CD subjects and healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Data demonstrate higher expression of PTPN22 in Treg compared to Tconv cells, suggesting potential influence on disease risk via Treg function."&lt;SEP&gt;"PTPN22 is a gene that encodes the LYP protein and plays a role in regulating the activation state of lymphocytes."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD4+ T CELL SUBSET&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD4+ T cells are a type of immune cell that can be divided into different subsets based on their differentiation state, including naïve, memory, and regulatory cells."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;NAÏVE TCONV&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"Naïve CD4+ Tconv (central memory) cells are at rest and have not been previously exposed to an antigen."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MEMORY TCONV&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"Memory CD4+ Tcells were sorted from leukopacks determined to be homozygous for the T1D non-risk allele, which encodes LYP-620R."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;REGULATORY T (TREG)&quot;">
      <data key="d0">"T CELL SUBSET"</data>
      <data key="d1">"Tregs are a subset of CD4+ T cells with immunosuppressive functions that play a role in maintaining immune tolerance and controlling autoimmune responses."</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD69&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"CD69 is dynamically expressed following Tconv activation."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;ICOS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"ICOS expression kinetics involve an intensification followed by a reduction of surface expression."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD25&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"CD25 is upregulated in this time period."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD226&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"CD226 exhibits activation-induced expression kinetics."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CTLA-4&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"CTLA-4 is involved in the Tregs' activation-induced expression kinetics."</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Data suggest LYP gene variants influence cytokine secretion and T-cell regulation."&lt;SEP&gt;"LYP is a gene that encodes tyrosine phosphatase."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d&lt;SEP&gt;chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;IFNΓ&quot;">
      <data key="d0">"CYTOKINE"</data>
      <data key="d1">"Studies show IFNγ secretion was not altered by overexpression of LYP variants, agreeing with Ptpn22 knockout mice studies."&lt;SEP&gt;Molecular Interaction"</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TH1 SIGNATURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Data imply Th1 signature in autoimmune disorders associated with the rs2476601 risk variant; IFNγ secretion was not altered by overexpression of either LYP variant."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG SUPPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hypothesis that PTPN22's risk variant affects disease risk through altering Treg-mediated suppression is tested and supported."&lt;SEP&gt;Molecular Interaction"/"Environmental Factor/</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TCELL SUPPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Transduced Treg showed altered capacity for Tresp suppression when overexpressing LYP variants; 620W variant showed reduced effect compared to 620R."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TCONV INTRINSIC SUSCEPTIBILITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/</data>
      <data key="d1">Lifestyle Factor"</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TRESP PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Overexpression of LYP variants on transduced Tconv led to differences in Tresp proliferation; 620R showed significant repression while 620W showed dramatically reduced effect across the range."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;SUPPRESSION BY TREGS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"LYP variant's impact was assessed on Treg suppressive capacity; LYP-620W slightly enhanced suppressive function compared to LYP-620R and eGFP reporter Tregs, but not due to differences in Treg proliferation."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/</data>
      <data key="d1">Molecular Interaction"</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;620R VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Evidence shows that variant 620R results in similar levels of effector cytokine secretion as compared to the other variant."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;620W VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Findings indicate that variant 620W leads to a somewhat lesser degree of inhibition compared to variant 620R, but this difference was not significant between variants."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TH1 SIGNATURE/">
      <data key="d0">AUTOIMMUNE DISORDERS"</data>
      <data key="d1">"Molecular Interaction"/"Environmental Factor/</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;PTPN22&quot;/&quot;LYP&quot;">
      <data key="d0">"GENE/</data>
      <data key="d1">Genomic Variant/</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TRESP (T-RESPONDING CELLS)">
      <data key="d0">"CELL TYPE/</data>
      <data key="d1">Physiological Process/</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG (REGULATORY T CELLS)">
      <data key="d0">"CELL TYPE/</data>
      <data key="d1">Physiological Process/</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;SUPPRESSION BY TREGS/">
      <data key="d0">TRESP PROLIFERATION/</data>
      <data key="d1">"Molecular Interaction"/"Environmental Factor/</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;BIOLOGICAL FUNCTION&quot;&lt;|&quot;THE PTPN22 GENE CONTRIBUTES TO THE REGULATION OF LYMPHOCYTE ACTIVATION STATE THROUGH MODULATION OF TCR SIGNALING PATHWAYS LIKE CA2+ FLUX AND PERK SIGNALING.&quot;](&quot;ENTITY&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"CD8+ T cell subset"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22 GENE&quot;">
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d1">"CD8+ T cell subset"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACTIVATION MARKER KINETICS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The kinetics of CD69 involve an intensification followed by a reduction of surface expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERNAL MOCK-TRANSFECTED CONTROLS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The expression of CD25 was observed when normalized to internal mock-transfected controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREGS ACTIVATED KINETICS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"CD226 on Tregs exhibited a unique kinetics where it waned before increasing to a level higher than baseline.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP VARIANTS IMPACT&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The PTPN22 risk variant permits proliferation in Tconv, but not in Treg.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;ACTIVATION INDUCED PROLIFERATION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Overexpression of LYP-620R reduced APC-mediated proliferation of Tconv and Treg.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP-620R IMPACT&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Overexpression of LYP-620R reduced APC-mediated proliferation of Tconv and Treg.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP-620W IMPACT&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The LYP-620W variant was capable of blocking Treg proliferation to a similar degree as the LYP-620R variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CELL ACTIVATION BY PMA AND IONOMYCIN&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Overexpression of PTPN22 influences T cell cytokine production, but mitogenic activation by PMA and ionomycin was not altered.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP VARIANTS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Overexpression of PTPN22 influences T cell cytokine production, but mitogenic activation by PMA and ionomycin was not altered.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CYTOKINE PRODUCTION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"The net accumulation of IL-2 was not altered by overexpression of the LYP-620R variant, but increased at the 24-hour time point by the LYP-620W variant.")&lt;SEP&gt;"The secretion of IFNγ and IL-2 cytokines by TAG72-BBζ CAR T cells is indicative of their anti-tumor immune response."</data>
      <data key="d0">"ACTIVITY"</data>
    </node>
    <node id="&quot;IL-2 SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The net accumulation of IL-2 was not altered by overexpression of the LYP-620R variant, but increased at the 24-hour time point by the LYP-620W variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-4 SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The secretion of IL-4 was robustly inhibited for the first 48 hours, but to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-5 SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The secretion of IL-5 was not altered by either variant of LYP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-9 SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The secretion of IL-9 was robustly inhibited for the first 48 hours and to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The secretion of IL-10 was robustly inhibited for the first 48 hours, but to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-13 SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The secretion of IL-13 was robustly inhibited for the first 48 hours and to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFNΓ SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"IFNγ secretion was not altered by overexpression of either variant of LYP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACTIVATION MARKER&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"CD69 is an activation marker expressed on T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CO-STIMULATORY LIGAND&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"CD25, also known as IL-2 receptor alpha chain (CD152), is upregulated on activated T cells and plays a role in costimulation during immune responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CO-INHIBITORY LIGAND&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"CTLA-4 is a co-inhibitory receptor that downregulates the activity of T lymphocytes during autoimmune diseases and transplantation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AUTOIMMUNE DISORDER&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The association between PTPN22 (LYP gene) variations and certain autoimmune disorders, such as ankylosing spondylitis or inflammatory bowel disease.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;REGULATED BY LYP VARIANTS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"LYP variants influence T cell proliferation during activation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T CELL PROLIFERATION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"LYP variants influence T cell proliferation during activation.")&lt;SEP&gt;"The process by which T cells increase in number, often seen during immune responses or cancer treatments."</data>
      <data key="d0">"CELLULAR PROCESS"</data>
    </node>
    <node id="&quot;CYTOKINE SECRETION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Lymphoproteins (LYP, PTPN22) impact the secretion of various cytokines, modulating Th1 and Th2 responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MODULATED BY LYP VARIANTS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Lymphoproteins (LYP, PTPN22) impact the secretion of various cytokines, modulating Th1 and Th2 responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD4+ EFFECTOR T CELLS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"CD4+ effector T cells play a crucial role in regulating host immune responses through the production of cytokines and other effectors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATE HOST IMMUNE RESPONSE&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"CD4+ effector T cells play a crucial role in regulating host immune responses through the production of cytokines and other effectors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APCS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Antigen-presenting cells (APCs) are essential for the activation and proliferation of T cells during immune response stimulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MITOGENIC ACTIVATION&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"Antigen-presenting cells (APCs) are essential for the activation and proliferation of T cells during immune response stimulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCONV INTRINSIC SUSCEPTIBILITY/">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">LYP Variants"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="TRESP PROLIFERATION/">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"LYP Variants"/"Molecular Interaction/&lt;SEP&gt;LYP Variants"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LYP VARIANTS&quot;/&quot;TH1 SIGNATURE/AUTOIMMUNE DISORDERS&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION/">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">Environmental Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG SUPPRESSION/">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"LYP Variants"/"Molecular Interaction/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="TCONV INTRINSIC SUSCEPTIBILITY/">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"LYP Variants"/"Molecular Interaction/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TAG72&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TAG72 gene encodes a protein associated with ovarian cancer."&lt;SEP&gt;"The TAG72 gene expresses TAG72 protein in human ovarian cancer ascites."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CAR T CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"CAR T cells expressing the 4-1BB co-stimulatory domain were developed for targeting ovarian cancer cells."&lt;SEP&gt;"Chimeric Antigen Receptor (CAR) T cells are used for CAR-mediated killing of tumor cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The 4-1BB intracellular co-stimulatory domain enhances CAR T cell activation and anti-tumor activity."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;HUMANIZED SCFV CC49&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The humanized scFv CC49 component of the CAR provides a specific affinity to the TAG72 antigen on cancer cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;HUMAN IGG4 FC EXTRACELLULAR SPACER&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This spacer is part of the engineered CAR structure, facilitating its binding and signaling properties without affecting cell surface expression."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD4 TRANSMEMBRANE DOMAIN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The CD4 transmembrane domain contributes to the proper surface expression and stability of the CAR on T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD19T (CD19 TRUNCATED) FOR CELL TRACKING&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD19t is used for tracking TAG72-BBζ CAR T cells during manufacturing and clinical trials."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;MOCK (UNTRANSDUCED) T CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"These are the control T cells that have not been transduced with the CAR construct, used to compare against CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CD137 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The induction of CD137 expression on TAG72-BBζ CAR T cells is a measure of their activation against the TAG72 antigen."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CELL SURFACE CD69 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"CD69 expression on the surface of T cells is an early indicator of T cell activation and response to stimulation."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;IFNΓ RELEASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Interferon-gamma (IFNγ) release by T cells is a key marker for their cytotoxic function in immune responses."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;E:T RATIO (EFFECTOR:TARGET RATIO)&quot;">
      <data key="d0">"PARAMETER"</data>
      <data key="d1">"The E:T ratio determines the effectiveness of CAR T cell killing activity; higher ratios indicate reduced killing efficiency."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CELL KILING ACTIVITY AGAINST TAG72-POSITIVE CELLS&quot;">
      <data key="d0">"ACTIVITY"</data>
      <data key="d1">"TAG72-BBζ CAR T cells show potent killing against ovarian cancer cells expressing the TAG72 antigen."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVARIAN CANCER ASCITES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Human ovarian cancer ascites provides a source of cells that are used to assess the in vitro activity and specificity of TAG72-BBζ CAR T cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TUMOR CELLS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Tumor cells are the targets of TAG72-BBζ CAR T cells, specifically those expressing the TAG72 antigen."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;A-SPECIFIC ACTIVITY&quot;">
      <data key="d0">"ACTIVITY"</data>
      <data key="d1">"The activity of TAG72-BBζ CAR T cells against ovarian cancer cell lines in vitro."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PROTEIN SYNTHESIS&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which living organisms build proteins using genetic information from DNA or RNA."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OVARIAN CANCER CELLS&quot;">
      <data key="d0">"CANCER TYPE"</data>
      <data key="d1">"A specific type of cancer that originates in the cells lining the ovaries."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PRECLINICAL STUDIES&quot;">
      <data key="d0">"RESEARCH STAGE"</data>
      <data key="d1">"The phase of research conducted prior to clinical trials, where safety and efficacy are tested in laboratory settings."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PHASE I CLINICAL TRIALS&quot;">
      <data key="d0">"CLINICAL TRIAL PHASES"</data>
      <data key="d1">"The first stage of human testing for new drugs or treatments, focusing on safety and dosage."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PHASE II CLINICAL TRIALS&quot;">
      <data key="d0">"CLINICAL TRIAL PHASES"</data>
      <data key="d1">"Evaluates the efficacy and side effects of a drug in a larger patient group than Phase I."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;PHASE III CLINICAL TRIALS&quot;">
      <data key="d0">"CLINICAL TRIAL PHASES"</data>
      <data key="d1">"Large-scale studies that confirm clinical benefit, monitor adverse reactions, and assess overall effectiveness."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;DRUG TOXICITY&quot;">
      <data key="d0">"SAFETY CONCERN"</data>
      <data key="d1">"Potential harmful effects that may occur when taking medications, including at therapeutic doses."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;ANTIBODY-MEDIATED RESPONSE&quot;">
      <data key="d0">"IMMUNE RESPONSE"</data>
      <data key="d1">"The body's defense mechanism against pathogens or foreign substances using antibodies."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CHIMERIC ANTIGEN RECEPTORS (CARS)&quot;">
      <data key="d0">"MOLECULAR COMPONENT"</data>
      <data key="d1">"Artificial receptors engineered to recognize and bind to specific antigens on cancer cells."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;ADAPTIVE IMMUNITY&quot;">
      <data key="d0">"IMMUNE SYSTEM COMPONENT"</data>
      <data key="d1">"A part of the immune system that develops memory after exposure to pathogens, enhancing future responses."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TUMOR REGRESSION&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"The reduction or elimination of tumor size following treatment, indicating therapeutic effectiveness."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;SURVIVAL ANALYSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A set of statistical techniques used to estimate the duration of time until an event occurs (e.g., death, disease recurrence)."&lt;SEP&gt;"The survival of mice treated with TAG72-BBζ CAR T cells was analyzed to evaluate the efficacy of therapy."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0&lt;SEP&gt;chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;QUALITY OF LIFE SURVEYS&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"Assessments conducted to measure patients' subjective well-being and functional status."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;CLINICAL RESPONSE RATE&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"The proportion of patients who respond favorably to a particular treatment regimen."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;TUMOR PROGRESSION&quot;">
      <data key="d0">"DISEASE STATUS INDICATOR"</data>
      <data key="d1">"A worsening condition characterized by tumor growth and spread in the body."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;IMMUNE CHECKPOINT INHIBITORS&quot;">
      <data key="d0">"THERAPEUTIC MODALITY"</data>
      <data key="d1">"Drugs that target immune checkpoints, enhancing T cell activity to combat cancer."</data>
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
    </node>
    <node id="&quot;OAS3, OAS4, OAS7&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Three patients with ovarian cancer have genetic variants that influence TAG72 expression."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;FLOW CYTOMETRY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Flow cytometry is used to quantify the percentage of TAG72 protein in ovarian cancer cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;FRESHLY THAWED ASCITES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Freshly thawed ascites from patients with ovarian cancer are used for vitro assays."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;CYTOLYTIC ACTIVITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"CAR T cells exhibit cytolytic activity against TAG72-positive ovarian cancer cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVCAR3&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"OVCAR3 is a type of ovarian cancer cell line used in vitro assays."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;EGFP/FFLUC&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The OVCAR3 cells were lentivirally transduced to express eGFP/ffluc transcripts for tracking tumor growth via non-invasive optical imaging."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;INTRAPERITONEAL INJECTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Intraperitoneal injection of TAG72-BBζ CAR T cells into mice for the treatment of peritoneal ovarian tumors."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;I.P.&quot;">
      <data key="d0">"REGIONAL INTRAPERITONEAL DELIVERY"</data>
      <data key="d1">"Regional intraperitoneal delivery of TAG72-BBζ CAR T cells exhibits potent anti-tumor activity in mice with peritoneal ovarian tumors."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;INTRAVENOUS INJECTION&quot;">
      <data key="d0">"I.V."</data>
      <data key="d1">"Limited anti-tumor responses were observed when TAG72-BBζ CAR T cells were delivered via intravenous injection."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;MOCK TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Mice treated with Mock showed limited to no therapeutic benefits."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;NSG MICE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Immune compromised NSG (NOD/SCID gamma) mice were used for establishing tumor xenografts."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;MOCK CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Mice treated with Mock cells did not show any therapeutic benefits, which contrasts the response of CAR T cell treatment."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;REGIONAL I.P. DELIVERY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Regional intraperitoneal delivery of TAG72-BBζ CAR T cells was effective against peritoneal ovarian tumors."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;I.V.&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Intravenous administration of CAR T cells showed limited efficacy compared to regional i.p. delivery."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;CAR T CELLS AND MOCK T CELL&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"CAR T cells produced IFNγ and IL-2 against cancerous cells, but mock T cells did not show similar activity."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVCAR3 TUMOR&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"OVCAR3 tumors were established by intraperitoneal injection of OVCAR3 cells in NSG mice to mimic peritoneal ovarian tumors."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OPTICAL IMAGING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Non-invasive optical imaging was used for tracking tumor growth after treatment with CAR T cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;REPEAT DOSING&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Compared with a single dose of TAG72-BBζ CAR T cells, repeat dosing over the course of 1 month demonstrated more durable anti-tumor responses."&lt;SEP&gt;"Repeating dosing of TAG72-BBζ CAR T cells over a month showed more durable anti-tumor responses compared to single dosing."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf&lt;SEP&gt;chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"In this study, the overall survival was extended significantly in mice that received repeat doses of TAG72-BBζ CAR T cells."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;ANTIBODY-DRUG CONJUGATES (ADCS)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The study evaluated the therapeutic efficacy of Antibody-Drug Conjugates (ADCs) in ovarian cancer xenograft models."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OV90 MODEL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This model showed reduced numbers, expansion and persistence of CAR T cells following repeat dosing compared to the OVCAR3 model, suggesting potential suppressive mechanisms affecting T cell function."&lt;SEP&gt;"When plotted as relative tumor growth kinetics, repeat dosing promoted more extensive tumor regression as well as more durable control of tumors compared with single dosing."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OVCAR3 MODEL&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The study indicated that in this model, higher survival benefits were associated with repeated TAG72-BBζ CAR T cell dosing over single dose compared to the OV90 model."&lt;SEP&gt;"The study showed that TAG72-BBζ CAR T cells exhibit potent anti-tumor activity in ovarian cancer xenograft models."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MOCK&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The study evaluated the therapeutic efficacy of Antibody-Drug Conjugates (ADCs) and compared it with mock treatment in ovarian cancer xenograft models."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;T CELL INFUSION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The expression of antigens on tumors was heterogeneous following mock treatment versus infusion with TAG72-BBζ CAR T cells, impacting the efficacy in different time points."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;CAR T CELL ACTIVATION&quot;">
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"CD69 expression on the surface of T cells correlates with early stages of T cell activation and response to stimulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTIGEN-SPECIFIC RESPONSE&quot;">
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"Cytotoxic T cells, such as those expressing TAG72-BBζ CARs, release IFNγ in response to antigen presentation by tumor cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KILLING EFFICIENCY&quot;">
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"The E:T ratio impacts the efficiency of cell killing activity; higher ratios can lead to reduced killing effectiveness.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IN VITRO ASSAYS&quot;">
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"TAG72-BBζ CAR T cells show high efficacy against ovarian cancer cells expressing the TAG72 antigen in vitro.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTIBODY CYTOTOXIC FUNCTION&quot;">
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"The secretion of IFNγ and IL-2 by CAR T cells is indicative of their robust cytotoxic function against tumor targets.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE TARGET&quot;">
      <data key="d2">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d1">"Ovarian cancer cells expressing the TAG72 antigen are targeted by TAG72-BBζ CAR T cells to demonstrate their specificity and potential clinical application.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-TUMOR EFFICACY&quot;">
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d1">"Repeating the dose of TAG72-BBζ CAR T cells over a month improved therapeutic responses compared to single dosing.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVC90 MODEL&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The study demonstrated that repeat dosing of TAG72-BBζ CAR T cells provided greater control of tumors compared to a single dose, based on comparison between the OVCAR3 model and the OV90 model.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TUMOR RECURRENCES&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Antigen loss or escape following mock treatment was observed in tumor recurrences at early time points from mice treated with TAG72-BBζ CAR T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOCK AND TAG72-BBΖ CAR T CELL TREATED MICE&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The expression of antigens on tumors varied following mock treatment versus the infusion of TAG72-BBζ CAR T cells in mice, with different patterns noted at 12 weeks post-infusion.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T CELL PERSISTENCE&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Reduced numbers, expansion and persistence of CAR T cells were observed in the blood of OV90-bearing mice compared to OVCAR3 model, suggesting potential suppressive mechanisms affecting T cell function and overall CAR T cell efficacy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTIGEN HETEROGENEITY&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The major resistance mechanism against CAR T cell therapy is tumor antigen heterogeneity that promotes eventual antigen loss or escape.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE RESISTANCE&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"Antigen loss or escape from tumor cells was observed more frequently at early time points after mock treatment compared to repeated TAG72-BBζ CAR T cell dosing.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SURVIVAL BENEFIT&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The survival benefit associated with repeated TAG72-BBζ CAR T cell infusion over the OV90 model was more pronounced compared to OVCAR3 model due to differences in treatment timing and tumor dynamics.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T CELL INFUSION TIMING&quot;">
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d1">"The survival benefit associated with repeated TAG72-BBζ CAR T cell infusion over the OV90 model was more pronounced compared to OVCAR3 model due to differences in treatment timing and tumor dynamics.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HUTTERITES&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">"A population sample of individuals used for genetic analysis."&lt;SEP&gt;"A total of 1,144 Hutterites (613 females, 53.6%) aged 6–89 years were included."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a&lt;SEP&gt;chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;INTERLEUKIN-37 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An association was found with a SNP located downstream of the IL37 gene on chromosome 2q13 related to FEV1."</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;ASXL3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intron of the ASXL3 gene on chromosome 18q12.1 was found to be associated with FVC.")</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;LOW FEV1/FVC ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The mean residual FEV1/FVC decreased with increasing number of 'low FEV1/FVC alleles', consistent with an additive genetic architecture."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;FEV1/FVC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The mean residual FEV1/FVC was calculated for Hutterites in each bin to measure lung function."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;ADDITIVE GENETIC ARCHITECTURE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An additive genetic architecture was consistent with the decreasing mean residual FEV1/FVC."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;GRAIL ALGORITHM&quot;">
      <data key="d0">"SOFTWARE TOOL"</data>
      <data key="d1">"The GRAIL algorithm was used to mine the Gene Ontology database for functional connections between genes."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;GENE ONTOLOGY&quot;">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"The Gene Ontology database was mined using the GRAIL algorithm to find functional connections."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;Β-DEFENSIN GENES&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Three clusters of β-defensin genes were identified in the subset of significantly related genes."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CCL18&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"One chemokine gene (CCL18) was part of the identified functional connections with SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CXCL12&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Another chemokine gene (CXCL12) was connected to the β-defensin genes and TNFRSF13B in the GRAIL analysis."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;TNFRSF13B&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The gene TNFRSF13B was identified as functionally related through the GRAIL algorithm."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A replicated locus (THSD4-UACA-TLE3) was not functionally connected to any other genes defined by the 80 SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;C10ORF11&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Similarly, another replicated locus (C10orf11) did not show functional connections with other identified genes."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;CCL23-CCL18 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP at the CCL23-CCL18 locus was significantly connected to β-defensin genes, as well as CXCL12 and TNFRSF13B."&lt;SEP&gt;"A specific SNP at this genomic locus was significantly connected to β-defensin genes and TNFRSF13B, as well as CXCL12."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d3">[{"level": 0, "cluster": 11}]</data>
    </node>
    <node id="&quot;5.8% OF RESIDUAL VARIANCE&quot;">
      <data key="d0">"EXPLAINED VARIANCE"</data>
      <data key="d1">"The six SNPs together explained 5.8% of the residual variance in FEV1/FVC in the Hutterites."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;HUTTERITE GWAS&quot;">
      <data key="d0">"GENETIC STUDY"</data>
      <data key="d1">"A genetic study conducted on a population sample, represented by Fig. E3b in the Online Repository."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;Β-DEFENSIN GENE CLUSTER&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Three clusters of β-defensin genes were part of the functional connections found in the analysis."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;CHEMOKINE GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Chemokine genes CCL18 and CXCL12 were identified among functionally related transcripts."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;TNFRSF13B GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The TNFRSF13B gene showed functional links with β-defensin genes and CCL18 through the GRAIL analysis."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
    </node>
    <node id="&quot;THSD4-UACA-TLE3 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One replicated genetic locus (THSD4-UACA-TLE3) was examined but did not show functional connections to other genes identified by the 80 SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d3">[{"level": 0, "cluster": 11}]</data>
    </node>
    <node id="&quot;C10ORF11 LOCUS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another replicated locus (C10orf11), despite being one of two replicated loci, did not display functional connections with other genes defined by the 80 SNPs."</data>
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;GENETIC LOCATION&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"A genome-wide significant association was found at the THSD4-UACA-TLE3 locus on chromosome 15q23.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}]</data>
    </node>
    <node id="&quot;LUNG FUNCTION TRAIT&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The FEV1/FVC ratio showed associations with SNPs at several loci, including the THSD4-UACA-TLE3 and C10orf11 loci.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C10ORF11 GENE&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"SNPs associated with FEV1/FVC were found downstream of the C10orf11 gene on chromosome 10q22.3.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;CHAF1B LOCUS&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The CHAF1B locus on chromosome 21q22.13 showed evidence for association with SNPs related to lung function.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}]</data>
    </node>
    <node id="&quot;PITPNC1 LOCUS&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The PITPNC1 locus on chromosome 17q24.2 showed evidence for association with SNPs related to lung function.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 11}]</data>
    </node>
    <node id="&quot;IL37 GENE&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"A SNP in this gene was associated with FEV1 and FVC.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 23}, {"level": 1, "cluster": 43}]</data>
    </node>
    <node id="&quot;MULTIMARKER MODELING&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"A multimarker model including all SNPs with P &lt; 10−3 was performed using LASSO regression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;80 SNPS&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The minimum set of 80 SNPs providing the best predictive value for FEV1/FVC were identified in the GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC VARIANT SET&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The minimum set of 80 SNPs providing the best predictive value for FEV1/FVC were identified in the GWAS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEAN SQUARE ERROR&quot;">
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d1">"The mean square error of FEV1/FVC was assessed using LASSO regression with a set of 80 SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POPULATION SAMPLE&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"The population sample used for genetic analysis provided insights into the genetic architecture and its impact on lung function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SOFTWARE TOOL&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"The GRAIL algorithm was utilized to discover functional connections between genes, revealing links among β-defensin genes and other identified transcripts.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXPLAINED VARIANCE&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"The 5.8% explained variance in FEV1/FVC by the six SNPs indicated their contribution to understanding the genetic factors influencing lung function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC STUDY&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"A genetic study on Hutterites, represented by Fig. E3b in the Online Repository, helped validate findings related to specific loci and functional gene interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DATABASE&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"The Gene Ontology database provided context for functional connections identified by the GRAIL algorithm.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HUTTERITES GWAS&quot;">
      <data key="d2">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d1">"The Hutterite genome-wide association study provided insights into the genetic basis for variations in lung function through its connections to specific loci and transcripts.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS231775&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SNPs which were mostly consulted were rs231775."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d3">[{"level": 0, "cluster": 17}]</data>
    </node>
    <node id="&quot;RS231725&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was reported in 6 studies."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d3">[{"level": 0, "cluster": 17}]</data>
    </node>
    <node id="&quot;RS3087243&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SNPs which were mostly consulted were rs3087243."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;RS5742909&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP was reported in 5 studies."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d3">[{"level": 0, "cluster": 17}]</data>
    </node>
    <node id="&quot;CTLA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNPs of CTLA4 gene were the focus of this study."&lt;SEP&gt;"The CTLA4 gene was studied in relation to its expression levels and epigenetic DNA methylation."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d3">[{"level": 0, "cluster": 17}]</data>
    </node>
    <node id="&quot;G&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The GG genotype refers to this allele."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This allele is denoted by GA or AA genotypes."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
    </node>
    <node id="&quot;PBC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Primary Biliary Cholangitis (PBC) was the disease focus of this study."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d3">[{"level": 0, "cluster": 17}]</data>
    </node>
    <node id="&quot;CIS REGULATORY SNP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"We identified cis regulatory SNPs for 2605 genes in CD4+ T cells and 2056 genes in CD8+ T cells at probe-level false discovery rate (FDR) &lt; 0.05."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;IMPUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The purified cells were subjected to genome-wide gene expression analysis, genotyping and imputation using the 1000 Genomes reference panel."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;450K CPG SITES&quot;">
      <data key="d0">"CPG SITE"</data>
      <data key="d1">"DNA methylation of these sites was determined for added insights on gene expression differences."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;1000 GENOMES REFERENCE PANEL&quot;">
      <data key="d0">"GENOMIC RESOURCE"</data>
      <data key="d1">"A reference panel used to perform genotyping and imputation in the analysis."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CD4+ T CELLS&quot;/&quot;CD8+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"We purified CD4+ and CD8+ T cells from peripheral blood mononuclear cells (PBMCs) of healthy individuals."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;AUTOIMMUNE T CELL CLONES/">
      <data key="d0">"CELL TYPE/CLONAL POPULATION"</data>
      <data key="d1">"The genetic association was extended to polyclonal populations of CD4+ and CD8+ T cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;GENOTYPE FREQUENCIES/">
      <data key="d0">"SNP DISTRIBUTION"/"POPULATION GENETICS"</data>
      <data key="d1">"The frequency of specific genotypes across the population was assessed for its association with CTLA4 expression levels."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CG26091609&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant in the CTLA4 gene showed an inverse correlation with the expression levels of three probes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;PROBES&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Three different transcripts of the CTLA4 gene were related to its expression differences."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CD4+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD4+ T cells were one of the cell types involved in the study of differential expressions and eQTLs."&lt;SEP&gt;"Trans-eQTL effect detected specifically in CD4+ T cell subtypes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;DIFFERENTIAL SPLICING EFFECTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Epigenetic DNA methylation influences the splicing effects, affecting gene expression levels."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;EQTL EFFECT&quot;">
      <data key="d0">"TRANSCRIPT-SPECIFIC"</data>
      <data key="d1">"Specific eQTL effects were observed in trans-acting regulatory loci of certain genes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;DISTAL GENES&quot;">
      <data key="d0">"PROXIMITY"</data>
      <data key="d1">"GWAS SNPs affecting the expression levels of distantly located genes were identified."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;TRANS-EQTL REGION&quot;">
      <data key="d0">"CHROMOSOME 12Q13.2"</data>
      <data key="d1">"A trans-acting regulatory locus with broad-range impact on gene expression was found in this region."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;GWAS SNPS&quot;">
      <data key="d0">"SINGLE NUCLEOTIDE POLYMORPHISM"</data>
      <data key="d1">"There were genome-wide significant SNPs implicated in T1D, vitiligo, and autoimmune diseases."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;BROAD RANGE IMPACT&quot;">
      <data key="d0">"GENES"</data>
      <data key="d1">"This trans-acting region influenced the expression levels of hundreds of genes."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RPS26 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The lead SNP was located in this gene's 5'UTR, part of the ribosomal small subunit protein."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CD127L (CTLA4) MOLECULE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This trans-eQTL region contained several genes related to T-cell function and immunity."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;GWAS SNPS IMPLICATED IN DISEASES&quot;">
      <data key="d0">"DISEASE ASSOCIATION"</data>
      <data key="d1">"The identified SNPs had associations with autoimmune and inflammatory diseases."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;T1D (TYPE 1 DIABETES)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A trans-acting regulatory locus was found to influence gene expression linked to T1D risk."&lt;SEP&gt;"This disease was shown to have a genetic association with the identified SNPs and their effects on gene expressions."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RS1131017 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"/"SNP"</data>
      <data key="d1">"This specific SNP had associations with several GWAS SNPs related to autoimmune diseases."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;LD (LINKAGE DISEQUILIBRIUM)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Strong linkage disequilibrium was present between the top trans-eQTL SNP and GWAS SNPs."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;OVERLAP OF GENES&quot;">
      <data key="d0">"GENES"</data>
      <data key="d1">"A shared overlap in genes associated with both trans-acting and GWAS SNPs was identified."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;EXPRESSION LEVELS&quot;">
      <data key="d0">"MEASUREMENT"</data>
      <data key="d1">"Changes in expression levels were observed for certain genes in association with SNPs."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;GWAS CATALOG&quot;">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"GWAS SNPs analyzed came from this catalog, indicating genetic associations related to diseases."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;P-VALUE &lt; 5X10-8&quot;">
      <data key="d0">"STATISTICAL SIGNIFICANCE"</data>
      <data key="d1">"SNPs were selected based on a stringent statistical threshold for significance."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RS4788084[T]&quot;">
      <data key="d0">"GENOMIC VARIANT"/"SNP"</data>
      <data key="d1">"This GWAS SNP associated with lower expression of IRF1 and STAT1 genes specifically in CD4+ T cells."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CHR16P11.2&quot;">
      <data key="d0">"CHROMOSOMAL LOCATION"</data>
      <data key="d1">"The IL27 gene region is located on chromosome 16 at this specific location, close to rs4788084[T]."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;IL27 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene was analyzed for trans-eQTL effects related to its expression."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;STAT1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression levels of this protein showed a trans-eQTL effect for rs4788084[T], specifically in CD4+ T cells."&lt;SEP&gt;"IRF1 and STAT1 expression changes are associated with T1D susceptibility."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;REC8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"This gene was also found to be related to trans-eQTL effects associated with the IL27 region and GWAS SNPs."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;RS181206&quot;[G]">
      <data key="d0">"GENOMIC VARIANT"/"SNP"</data>
      <data key="d1">"This SNP caused an amino acid change (Leu119Pro) in the alpha-helical domain of IL-27."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;BAYESIAN TEST FOR COLOCALISATION&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"A Bayesian test was used to assess the hypothesis that multiple factors (T1D, IRF1 expression changes) are influenced by a single causal variant in this region."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;1000 GENOMES PHASE 3 EUROPEAN POPULATION&quot;">
      <data key="d0">"POPULATION SAMPLE"</data>
      <data key="d1">"Genetic data analyzed came from this population sample for LD assessment and frequency analysis."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;CHROMOSOME 16:28,2–29,1 MB REGION&quot;">
      <data key="d0">"CHROMOSOMAL REGION"</data>
      <data key="d1">"This genomic location was extensively analyzed for trans-eQTL effects using all available SNPs within this area."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;ESTONIAN POPULATION&quot;">
      <data key="d0">"POPULATION SAMPLE"</data>
      <data key="d1">"This specific European population sample was used for LD analysis between rs181206[G] and other SNPs."</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;GWAS SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The effect of the missense SNP on IRF1 and STAT1 remains after regressing out the effect of this genomic variant."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;B CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"No signal was detected in B cells and monocytes when re-analyzing Fairfax et al.'s data."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27 SNP RS181206G&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The IL27 SNP rs181206G affects both IRF1 and STAT1 expression, supporting the hypothesis that T1D susceptibility is related to this variant."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL-27 CYTOKINE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"IL-27 interacts with its receptor IL27RA and activates the STAT1/STAT3 pathway in T cells."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INTERFERON STIMULATED RESPONSE ELEMENTS (ISRE)&quot;">
      <data key="d0">"SEQUENCE MOTIF"</data>
      <data key="d1">"Key elements in the genome recognized by the transcription factors STAT1 and STAT3 upon interferon stimulation."&lt;SEP&gt;"The binding of the STAT1/STAT3 pathway to ISRE induces transcription of several interferon-induced genes."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27RA AND IL6ST (GP130)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Together, IL27RA and IL6ST genes act as a receptor for the IL-27 cytokine in CD4+ T cells."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HEK293 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Cells used for transfection to study functional effects of the IL27 missense SNP."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HUMAN PBMCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Human peripheral blood mononuclear cells were analyzed for expression levels after IL-27 exposure."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;TRANS-EQTL ANALYSIS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Statistical method used to identify genetic variants influencing gene expression."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;MODEL 1 OF STRUCTURAL EQUATION MODELING&quot;">
      <data key="d0">"ANALYSIS MODEL"</data>
      <data key="d1">"Best-fitting model used to determine the relationship between IL27 SNP rs181206G, IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;SIMULATION EXPERIMENT&quot;">
      <data key="d0">"EXPERIMENTAL TECHNIQUE"</data>
      <data key="d1">"Simulation conducted to support findings of structural equation modeling."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;MECHANISM FOR EFFECT OF IL-27 ON IRF1 AND STAT1 EXPRESSION&quot;">
      <data key="d0">"MOLECULAR MECHANISM"</data>
      <data key="d1">"Proposed pathway through which IL-27 influences the expression levels of IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HUMAN PBMCS FROM FOUR HEALTHY INDIVIDUALS&quot;">
      <data key="d0">"SAMPLE POPULATION"</data>
      <data key="d1">"Healthy donors providing peripheral blood mononuclear cells for the study."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;INTERFERON-INDUCED GENES&quot;">
      <data key="d0">"GENE CLASS"</data>
      <data key="d1">"Genes whose expression is induced by interferons, including IRF1 and STAT1."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;PATHWAY ACTIVATION&quot;">
      <data key="d0">"MOLECULAR PATHWAY"</data>
      <data key="d1">"Activation of the STAT1/STAT3 signaling pathway by IL-27 binding to its receptor on T cells."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HEK293 CELL TRANSFECTION&quot;">
      <data key="d0">"CELL CULTURE TECHNIQUE"</data>
      <data key="d1">"Process of introducing foreign DNA into HEK293 cells for studying genetic effects."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;FIXED EFFECTS ESTIMATE&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Measure comparing the fixed effects of the rs181206[G] allele on IRF1 and STAT1 transcript levels."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;REAL-TIME PCR&quot;">
      <data key="d0">"MOLECULAR BIOLOGY TECHNIQUE"</data>
      <data key="d1">"Method used to quantify gene expression in human PBMCs after IL-27 exposure."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS)&quot;">
      <data key="d0">"BIOLOGICAL SAMPLE"</data>
      <data key="d1">"Type of biological material used for molecular studies in this research, including leukocytes from blood.</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CPG SITE/">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"Correlation with expression levels"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METHYLATED SITES&quot;">
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d1">"Correlation with expression levels"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CIS-EQTL EFFECTS&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"Gene expression levels were corrected before identifying trans-eQTL associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CORRECTION FACTOR&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"Gene expression levels were corrected before identifying trans-eQTL associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS SNPS AND TRANS-ACTING GWAS SNPS&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"SNPs related to gene expressions in distant genes had a broad impact on multiple genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BROAD-RANGE IMPACT AND OVERLAP OF GENES&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"A region influenced the expression levels of several overlapping genes in CD4+ and CD8+ T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPACT SHARED AMONG GENES&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"A region influenced the expression levels of several overlapping genes in CD4+ and CD8+ T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1131017 SNP AND GWAS SNPS&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"The lead trans-eQTL SNP was in LD with several GWAS SNPs related to autoimmune diseases.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL METHOD&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"This test supported the hypothesis of a shared causal variant associated with T1D susceptibility and gene expression changes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHANGES IN IRF1 AND STAT1 EXPRESSION&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"T1D susceptibility is associated with changes in IRF1 and STAT1 expression, which may be influenced by a specific genomic variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T1D SUSCEPTIBILITY&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"T1D susceptibility is associated with changes in IRF1 and STAT1 expression, which may be influenced by a specific genomic variant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD4+ T CELLS AND CD8+ T CELLS&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Specific trans-eQTL effect detected only in CD4+ T cells but not in CD8+ T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANS-EQTL EFFECTS&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Specific trans-eQTL effect detected only in CD4+ T cells but not in CD8+ T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;B CELLS AND MONOCYTES&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"No signal present in B cells or monocytes when re-analyzing Fairfax et al.'s data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SIGNAL PRESENCE&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"No signal present in B cells or monocytes when re-analyzing Fairfax et al.'s data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANS-EQTL LOCUS EFFECTS&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"IL27 SNP rs181206G has effects on IRF1 and STAT1 expression, confirmed by trans-eQTL analysis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-27 CYTOKINE AND IL27RA&quot;/&quot;GP130&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The IL-27 cytokine interacts with the IL27RA gene (together with gp130, also known as IL6ST) to activate STAT1/STAT3 pathway.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RECEPTOR INTERACTION&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The IL-27 cytokine interacts with the IL27RA gene (together with gp130, also known as IL6ST) to activate STAT1/STAT3 pathway.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BINDING&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Interferon stimulated response elements are bound by STAT1 and STAT3 pathways leading to transcriptional activation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ISRE&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"Interferon stimulated response elements are bound by STAT1 and STAT3 pathways leading to transcriptional activation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL27 GENE PRO119 ALLELE&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The Pro119 variant of the IL27 gene resulted in lower expression levels of IRF1 and STAT1 after transfection experiments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSFECTION EFFECTS&quot;">
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d1">"The Pro119 variant of the IL27 gene resulted in lower expression levels of IRF1 and STAT1 after transfection experiments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-8 protein plays a role in immune response, being involved in the production of inflammatory cytokines."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of IL-8 gene encodes for the IL-8 protein and plays an essential role in regulating its expression."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;PBMC COMPOSITION&quot;">
      <data key="d0">"CELL COMPOSITION"</data>
      <data key="d1">"PBMC stands for Peripheral Blood Mononuclear Cells, which were claimed not to differ between asthma patients and healthy controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Asthma is a chronic inflammatory disease of the airways that can result in wheezing, chest tightness, and shortness of breath."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 GENOTYPES: RS4073 TT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4073 TT genotype was associated with an increased risk of asthma development."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 GENOTYPES: RS2227306 CC/CT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2227306 CC or CT genotypes were significantly different between case and control groups, suggesting its association with asthma susceptibility."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ADVANCED STAGE ASTHMA&quot;">
      <data key="d0">"DISEASE SUBTYPE"</data>
      <data key="d1">"Subject with rs4073 TT had more risk to be diagnosed with advanced stage asthma."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RARE DIPLOTYPE: AT&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"The frequency of the rare diplotype AT was significantly associated with a lower asthma childhood risk."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;RS4073 T ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs4073 T allele is associated with increased asthma risk and severity."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 GENOTYPE FREQUENCIES&quot;">
      <data key="d0">"STATISTICAL ANALYSIS"</data>
      <data key="d1">"The frequencies of IL-8 genotypes were analyzed using the Hardy-Weinberg Equilibrium (HWE)."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;LD TEST (D' VALUE)&quot;">
      <data key="d0">"GENETIC RELATIONSHIP MEASURE"</data>
      <data key="d1">"The Linkage Disequilibrium test evaluated for genetic associations between different IL-8 polymorphisms."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA DISEASE PROGRESSION OVER TIME&quot;">
      <data key="d0">"DISEASE DYNAMICS"</data>
      <data key="d1">"Analysis of disease progression over time aimed to understand patterns and triggers of asthma exacerbations."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;CLINICAL ASSESSMENT AND INTERVENTION&quot;">
      <data key="d0">"TREATMENT AND MANAGEMENT"</data>
      <data key="d1">"Ongoing clinical assessments help in tailoring treatment plans based on individual responses and disease progression."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;CLINICAL OUTCOME AND GENETIC FACTORS&quot;">
      <data key="d0">"INTERPLAY IN ASTHMA MANAGEMENT"</data>
      <data key="d1">"The interplay between clinical outcomes, such as disease severity, and genetic factors influences the management strategies for asthma patients."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;GENETIC RISK ASSESSMENT TOOLS&quot;">
      <data key="d0">"DIAGNOSTIC AND PROGNOSTIC CRITERIA"</data>
      <data key="d1">"Development of tools that combine genetic markers with clinical data aids in personalized asthma management plans."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;LIFESTYLE AND ENVIRONMENTAL FACTORS&quot;">
      <data key="d0">"NON-GENETIC INFLUENCES"</data>
      <data key="d1">"Consideration of lifestyle and environmental factors plays a crucial role in asthma management alongside genetic considerations."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 MRNA LEVELS&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d1">"Significantly increased IL-8 mRNA levels were found in asthmatic patients compared to controls, especially those with moderate-to-severe asthma.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASTHMA RISK&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d1">"rs4073 TT genotype was significantly associated with an increased risk of asthma development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4073 TT GENOTYPE&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d1">"rs4073 TT genotype was significantly associated with an increased risk of asthma development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2227306 CC/CT GENOTYPES&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d1">"The frequencies of rs2227306 CC and CT genotypes were found to be significantly different between case and control groups, suggesting its association with asthma susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-8 PRO-INFLAMMATORY RESPONSE&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d1">"Increased IL-8 mRNA expression was linked with the frequency of atopic asthma among children.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASTHMA SEVERITY IN TUNISIAN CHILDREN&quot;">
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d1">"The rs4073 T allele was considered as a risk factor for asthma severity.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASAH1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ASAH1 gene consists of 86 HapMap SNPs and 14 typed SNPs on the Illumina HumanHap550 array, making it a complex genetic entity."&lt;SEP&gt;"The ASAH1 gene has an effect on certain traits, and its power is tested using different kernels."&lt;SEP&gt;"The ASAH1 gene is on 8p22-p21.3 and consists of 86 HapMap SNPs and 14 typed SNPs on the Illumina HumanHap550 array."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0&lt;SEP&gt;chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;NAT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NAT2 lies on 8p22 and has 22 HapMap SNPs and only 4 typed SNPs from the transcription start to end of the gene."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;FGFR2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"For a much larger gene like FGFR2 (Figure 5), in regions of high LD, the kernel machine method again outperforms the min test. In regions of weak LD, the two methods have comparable power."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;HLA-B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-B gene is a part of a family of genes known as the human leukocyte antigen (HLA) complex and lies on 6p21.3."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS1390358&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1390358 has moderate R2 correlation with the typed SNPs."&lt;SEP&gt;"SNP rs1390358 is one of the HapMap SNPs included in the NAT2 gene region."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS1112005&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1112005 displays a high degree of R2 correlation with other typed SNPs."&lt;SEP&gt;"SNP rs1112005 is another HapMap SNP found within the NAT2 gene region."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS7832071&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs7832071 is one of the typed SNPs from the transcription start to end of the NAT2 gene."&lt;SEP&gt;"SNP rs7832071 shares similar LD properties to rs1112005, showing a 99% R2 correlation."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;RS1208&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1208 is also among those typed SNPs with moderate R2 correlations."&lt;SEP&gt;"SNP rs1208 is among the typed SNPs found in the NAT2 gene region."</data>
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
    </node>
    <node id="&quot;SNP-SET&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"The SNP-set for the ASAH1 gene includes only these 14 typed SNPs that are in good LD with each other and with the causal SNPs.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPED SNPS&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"SNPs 7, 11, 13, and 21 are in good LD with each other and when tested as causal, the power of kernel machine method is higher than min test.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGH LD REGIONS&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"In regions of high LD, the kernel machine method outperforms the min test.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WEAK LD REGIONS&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"In regions of weak LD, the two methods have comparable power.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS 1058026 AND RS2523608&quot;">
      <data key="d2">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d1">"The empirical power for HLA-B gene shows that using MAF as weights in weighted IBS kernel can upweight rare alleles.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IBS KERNEL&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"The weighted IBS kernel outperforms the linear kernel in terms of power when rare variants are important.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LINEAR KERNEL&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"The weighted IBS kernel outperforms the linear kernel in terms of power when rare variants are important.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIGHER MAF&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"When rs2523608 has higher minor allele frequency, it's not as effective as when the more common allele (which is also causal) gets downweighted by a certain kernel function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2523608 SNV&quot;/&quot;CAUSAL SNP&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"When rs2523608 has higher minor allele frequency, it's not as effective as when the more common allele (which is also causal) gets downweighted by a certain kernel function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs1893217 was mapped to the PTPN2 gene."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;CELIAC DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The SNP is associated with autoimmune diseases such as celiac disease."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;INFLAMMATORY BOWEL DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The SNP is also associated with inflammatory bowel disease."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;RS17388568&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Under an additive model, rs17388568 showed a significant association with response rate for anti-PD-1 treatment. Carriers of at least one minor allele (GA or AA) are 74% less likely to resist the treatment compared to those with GG genotype."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;IL2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SNP is mapped near IL2, a gene involved in immunity and inflammation."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ADAD1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene closely associated with rs17388568 through its location on the same locus as IL2 and IL21."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;IL21 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The locus containing IL21 has been previously linked to allergic conditions, colitis, and type 1 diabetes."</data>
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
    </node>
    <node id="&quot;ANTI-CTLA-4&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"anti-CTLA-4 is a drug used in treatment, but no significant association was observed with treatment response."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;ANTI-PD-1&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"anti-PD-1 is another drug tested that did not show a significant association with treatment response."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;COMBINATION THERAPY&quot;">
      <data key="d0">"TREATMENT"</data>
      <data key="d1">"The combination of different therapies was performed on patients, but no significant association with the treatment response was observed after adjustments for age, sex and treatment drugs."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;POOLED ASSOCIATION ANALYSIS&quot;">
      <data key="d0">"ANALYSIS"</data>
      <data key="d1">"A pooled analysis across treatments was conducted to assess associations without any significant findings."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;TREATMENT DRUGS&quot;">
      <data key="d0">"MEDICATION/DRUG"</data>
      <data key="d1">"The different types of treatments (including anti-CTLA-4, anti-PD-1 and combination therapy) were adjusted for during pooled analysis to assess their impact on treatment response."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;RESPONSE RATE&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The association of rs1893217 and response rate was tested in anti-CTLA-4 treated patients, with an OR value of approximately 2.79 for non-responders.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;RESPONSE RATE FOR ANTI-PD-1&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"rs17388568 shows a strong association with response rate specifically in anti-PD-1 treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 13}, {"level": 1, "cluster": 38}]</data>
    </node>
    <node id="&quot;AGE AND SEX&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The effect of rs17388568 on response rate was stronger in younger female patients, although the interactions were not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERACTION EFFECT ON RESPONSE&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"The effect of rs17388568 on response rate was stronger in younger female patients, although the interactions were not statistically significant.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-CTLA-4&quot;/&quot;ANTI-PD-1&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"No significant association was observed between anti-CTLA-4 or anti-PD-1 drugs and treatment response across different treatments, after adjustments for age, sex, and drug types.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMBINATION THERAPY&quot;/&quot;POOLED ASSOCIATION ANALYSIS&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"A pooled analysis of combination therapy outcomes did not yield significant associations with treatment response when adjusting for various covariates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT RESPONSE&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"A pooled analysis of combination therapy outcomes did not yield significant associations with treatment response when adjusting for various covariates.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COVARIATE IMPACT&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"After adjustments for age, sex, treatment drugs, and other covariates, no associations were found with SNPs related to treatment response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNPS&quot;/&quot;AGE/SEX/TREATMENT DRUGS&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"After adjustments for age, sex, treatment drugs, and other covariates, no associations were found with SNPs related to treatment response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-CTLA-4&quot;/&quot;ANTI-PD-1/COMBINATION THERAPY/">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"No significant association was observed between the type of drug (anti-CTLA-4, anti-PD-1 or combination therapy) and treatment response after adjusting for age, sex and different types of treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT TYPE IMPACT&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"No significant association was observed between the type of drug (anti-CTLA-4, anti-PD-1 or combination therapy) and treatment response after adjusting for age, sex and different types of treatment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE/SEX/TREATMENT DRUGS/">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Adjustments made to account for covariates like age, sex and specific treatments did not reveal significant associations with factors being tested (SNPs, drug therapies) related to response or outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COVARIATE ADJUSTMENT&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Adjustments made to account for covariates like age, sex and specific treatments did not reveal significant associations with factors being tested (SNPs, drug therapies) related to response or outcomes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EBNA2 binds chromatin at MS risk loci dependent on the risk allele."&lt;SEP&gt;"EBNA2 binds one allele more than the other and interacts with MS risk loci."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7&lt;SEP&gt;chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;SNP&quot;/&quot;RISK ALLELE&quot;/&quot;LOCUS&quot;/&quot;EBV LATENCY III&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"ENVIRONMENTAL FACTOR"/"DISEASE"</data>
      <data key="d1">"Of the six MS risk SNPs investigated, EBNA2 was found to bind dependent on MS risk allele at five loci (TRAF3/RCOR1 rs1258869, CD40 rs1883832, TNFAIP8 locus rs32658, TNFRSF1A locus rs180069, TBX6 rs3809627)."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBNA2-TAT&quot;">
      <data key="d0">"PROTEIN"/"DRUG"</data>
      <data key="d1">"We undertook ChIP for EBNA2 in 33 samples and investigated the effects of EBNA2-TAT on LCLs."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LCL PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LCL proliferation was reduced significantly by all concentrations tested with increasing doses of EBNA2-TAT (40% at 50µM, approximately 50% at 100µM, over 50% at 200µM)."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LMP1 EXPRESSION&quot;/&quot;EBV LMP1&quot;">
      <data key="d0">"GENE"/"MOLECULAR INTERACTION"</data>
      <data key="d1">"Expression of the EBNA2 regulated EBV gene LMP1 was reduced significantly by EBNA2-TAT (p &lt; 0·05) at concentrations of 50µM."</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;SEVEN MS-ASSOCIATED GENES&quot;">
      <data key="d0">"GENES/</data>
      <data key="d1">Disease"/"EBNA2 Inhibition Effect"</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;EBV DNA COPY NUMBER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"GENETIC TRAIT/</data>
      <data key="d1">Disease"/"Environmental Factor/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;GENOTYPE EFFECT/">
      <data key="d0">ALLELIC ASSOCIATION"/"EBNA2 INHIBITION/</data>
      <data key="d1">Genotype/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;RNA POL II&quot;">
      <data key="d0">"MOLECULAR COMPLEX/</data>
      <data key="d1">Activity"/"Environmental Factor/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;CHROMATIN REMODELING&quot;">
      <data key="d0">"BIOLOGICAL PROCESS/</data>
      <data key="d1">Molecular Mechanism"/"Pathway"</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;HIV-1 REPLICATION&quot;">
      <data key="d0">"VIRAL FUNCTION/</data>
      <data key="d1">Effect on Cells/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;IMMUNE CELL PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/</data>
      <data key="d1">Pathway"/"Molecular Interaction"/"Disease/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;VIRUS/HOST INTERACTIONS&quot;">
      <data key="d0">"INTERACTION/</data>
      <data key="d1">Relationship"/"Evolutionary Dynamics/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;B-CELL ACTIVATION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS/</data>
      <data key="d1">Pathway"/"Response to Stimuli/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TRANSCRIPTIONAL REGULATION&quot;">
      <data key="d0">"MOLECULAR FUNCTION/</data>
      <data key="d1">Process"/"Control Mechanism/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;NEUROINFLAMMATION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS/</data>
      <data key="d1">Pathway"/"Response to Injury/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;VIRAL LATENCY&quot;">
      <data key="d0">"STATE OF VIRUS/</data>
      <data key="d1">Status/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;NEURODEGENERATION&quot;">
      <data key="d0">"OUTCOME OF DISEASE/</data>
      <data key="d1">Damage/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;CELL CYCLE REGULATION&quot;">
      <data key="d0">"BIOLOGICAL PROCESS/</data>
      <data key="d1">Pathway"/"Control Mechanism/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;GENE EXPRESSION PROFILE&quot;">
      <data key="d0">"QUANTITATIVE MEASURE/</data>
      <data key="d1">Attribute/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;RISK ALLELE FREQUENCIES&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Data Type/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;NEUROINFLAMMATORY RESPONSE&quot;">
      <data key="d0">"BIOLOGICAL PROCESS/</data>
      <data key="d1">Pathway/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;LATENT INFECTION DYNAMICS&quot;">
      <data key="d0">"STATE OF VIRUS/</data>
      <data key="d1">Infection Stage/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;AUTOIMMUNITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"STAT5B deficiency can lead to the autoimmune response where immune cells attack healthy tissues."&lt;SEP&gt;Disease Subcategory/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;GENETIC SUSCEPTIBILITY&quot;">
      <data key="d0">"RISK FACTOR/</data>
      <data key="d1">Variable/</data>
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;MS RISK LOCI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"MS risk loci are regions in the genome that increase the risk of developing multiple sclerosis when there is a certain genotype."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;ALLELIC ASSOCIATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The allelic association with expression was altered by EBNA2, potentially impacting genetic predispositions to disease."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EXPRESSION LEVEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"EBNA2 changes the expression levels of certain genes in lymphoblastoid cell lines (LCLs) compared to uninfected B cells."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;RELATIVE ALLELIC EXPRESSION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The direction of effect on risk gene expression is inferred based on relative allelic expression in LCLs."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBV LATENCY III PROGRAM&quot;">
      <data key="d0">"MOLECULAR PROCESS"</data>
      <data key="d1">"Some MS risk genes are involved in the EBV latency III program, which interacts with EBNA2 and may influence immune evasion processes."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;LMP1 AND LMP2 SIGNALLING&quot;">
      <data key="d0">"SIGNALING PATHWAY"</data>
      <data key="d1">"These signaling pathways are part of the EBV latency III program that can be affected by EBNA2's interaction with MS risk loci."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;IMMUNE EVASION&quot;">
      <data key="d0">"MOLECULAR FUNCTION"</data>
      <data key="d1">"Enhanced EBNA2 function in relation to MS risk genes could lead to evasion of the host immune response."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;RISK ALLELE PREFERENCE&quot;">
      <data key="d0">"GENETIC FACTOR"</data>
      <data key="d1">"EBNA2's preference for certain risk alleles suggests a genetic predisposition factor in its impact on gene expression."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;BIOLOGICAL PATHWAY&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"The biological pathways these MS risk genes are part of can be disrupted by EBNA2, affecting cellular functions and disease susceptibility."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;MOLECULAR FUNCTION&quot;">
      <data key="d0">"MOLECULAR FUNCTION"</data>
      <data key="d1">"Certain molecular functions related to immune response or disease are influenced by the expression levels or activities of these MS risk genes."</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;MS RISK ALLELES&quot;/&quot;SNPS&quot;/&quot;GENOMIC VARIANT&quot;/&quot;DISEASE&quot;/&quot;ENVIRONMENTAL FACTOR/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2-TAT/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Environmental Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="DRUG&quot;/&quot;EFFECT ON EBV DNA COPY NUMBER&quot;/&quot;MOLECULAR INTERACTION&quot;/&quot;GENETIC TRAIT/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Environmental Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2 BINDING&quot;/&quot;ALLELIC ASSOCIATION&quot;/&quot;MS RISK ALLELES/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="EXPRESSION/GENETIC TRAIT/DISEASE/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LCL PROLIFERATION&quot;/&quot;EBNA2-TAT/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Environmental Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="EFFECT ON GENE EXPRESSION&quot;/&quot;MOLECULAR INTERACTION&quot;/&quot;GENETIC TRAIT/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Environmental Factor/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNFAIP8&quot;/&quot;EXPRESSION/EBNA2 INHIBITION/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="EBV DNA COPY NUMBER&quot;/&quot;MOLECULAR INTERACTION&quot;/&quot;GENETIC TRAIT/DISEASE/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE EFFECT&quot;/&quot;ALLELIC ASSOCIATION/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="EBNA2 BINDING&quot;/&quot;EXPRESSION/EBNA2 INHIBITION/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2 BINDING/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="ALLELIC ASSOCIATION&quot;/&quot;EXPRESSION/GENETIC TRAIT/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Disease"/"Therapy"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2 INHIBITION/EBNA2-TAT/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Genetic Trait/Disease/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="EFFECT ON LCLS&quot;/&quot;MOLECULAR INTERACTION/">
      <data key="d2">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d1">Genetic Trait/Disease/</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2 EFFECT&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The genotype effect of EBNA2 involves altering allelic association with expression compared to that found in uninfected B cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MS RISK GENES INTERACTION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2's impact on gene expression correlates with specific MS risk genes and their role in the EBV latency III program.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALLELIC EXPRESSION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The alteration of allelic expression based on EBNA2 interaction is inferred from comparison to uninfected B cells and has implications for gene regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFERRED EFFECT&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The alteration of allelic expression based on EBNA2 interaction is inferred from comparison to uninfected B cells and has implications for gene regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EFFECT ON IMMUNE EVASION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The program involving LMP1 and LMP2 signaling can be influenced by EBNA2's interaction with MS risk loci, potentially impacting immune evasion through alteration of gene expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLUENCE ON GENE EXPRESSION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2's preference for certain risk alleles has implications on altering the direction of allelic association with expression in specific MS risk genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBV INFECTION&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The expression levels of these genes are affected by EBV infection, which can be influenced by factors such as EBNA2 interaction and genotype.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC DRIFT&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The relationship between the risk allele preference and genetic drift could impact the overall expression pattern of MS risk genes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS3842787&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"</data>
      <data key="d1">"The initial search revealed rs3842787 genetic polymorphism in association studies."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20417&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"</data>
      <data key="d1">"The genomic variant rs20417 showed significant differences in percentage of CAD between patients and controls, contributing to a large part of heterogeneity."&lt;SEP&gt;"This polymorphism was found to be associated with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;RS20118426&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"</data>
      <data key="d1">"The examination of this genetic variant also revealed its association with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS1126643&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"</data>
      <data key="d1">"The genomic variant rs1126643 was another significant source of heterogeneity related to averaged platelet number."&lt;SEP&gt;"This polymorphism was significantly associated with aspirin insensitivity in the analysis."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The association of genetic variants with aspirin insensitivity was a central topic of investigation."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;AVERAGED PLATELET NUMBER&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Averaged platelet number was a significant factor in the heterogeneity observed for the genomic variant rs1126643.")&lt;SEP&gt;"The mean number of platelets in a sample, reflecting normal or abnormal platelet counts which may affect blood clotting and thus be relevant to cardiovascular health."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;RS20417&quot; AND &quot;RS1126643&quot;">
      <data key="d0">"GENOMIC VARIANTS"</data>
      <data key="d1">"Single nucleotide polymorphisms that were studied in relation to the meta-regression model's outcomes."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;PERCENTAGE OF CAD&quot;">
      <data key="d0">"DISEASE MEASURE"</data>
      <data key="d1">"A quantifiable indicator measuring coronary artery disease."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;PATIENTS&quot;">
      <data key="d0">"SUBJECT GROUP"</data>
      <data key="d1">"Individuals under examination, usually those with a condition or characteristic being studied."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;P-VALUE (0.034 AND 0.012)&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"Results from statistical tests indicating significance, with lower values suggesting stronger evidence against the null hypothesis."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;SIGNIFICANCE (P-VALUES OF RS20417 AND RS1126643)&quot;">
      <data key="d0">"BIOLOGICAL SIGNIFICANCE"</data>
      <data key="d1">"Statistical indication that observed differences are not due to chance, implying importance in the context of the study's biological or clinical question."</data>
      <data key="d2">chunk-734cac289b42d37dad32bd51ea24a1ea</data>
    </node>
    <node id="&quot;P.W631*&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This variant converts a tryptophan residue at position 631 into an alternative amino acid causing premature termination (nonsense)."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;STAT5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene coding for this protein and is associated with growth disorders."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;C.1892G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant affects codon 1892 of the STAT5B gene, resulting in a premature stop codon (p.W631*)."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;W631*&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The p.W631* variant results in an altered protein structure that affects its function."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;P.A630P&quot;">
      <data key="d0">"EXISTING VARIANT"</data>
      <data key="d1">"This is another known mutation in STAT5B, located nearby the new mutation."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Growth Hormone, produced by the pituitary gland, regulates growth and metabolism."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;IGFBP3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Insulin-like growth factor binding protein 3 (IGFBP3), which binds IGFs, modulating their effects on cells."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ALS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Acid labile subunit (ALS) is a component of the complex that regulates IGF activity."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Recombinant human insulin-like growth factor 1 used for treatment in GHI phenotype."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;WES&quot;">
      <data key="d0">"CLINICAL TEST"</data>
      <data key="d1">"Whole Exome Sequencing, used to identify genetic variants linked to the clinical presentation."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;HEK-GHRS&quot;">
      <data key="d0">"CELL MODEL"</data>
      <data key="d1">"Human embryonic kidney cells transfected with growth hormone receptors used for reconstitution analyses."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;TAD&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR"</data>
      <data key="d1">"The transactivation domain (TAD) of STAT proteins regulates transcriptional activation in response to cytokine signals."</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;STAT5B P.W631* VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The STAT5B gene has a variant that leads to the production of an altered protein, resulting in reduced expression."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;SUSTAINED B CELL HYPERACTIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sustained activation and proliferation of B cells are associated with atopy (a type of allergic reaction) and autoimmunity in individuals with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IMMUNOGLOBULIN PRODUCTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There is an increase in immunoglobulins, which are antibodies produced by B cells, especially IgE, indicating heightened B cell activity."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IGE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Increased levels of Immunoglobulin E (IgE) can be considered a type of nutrient that contributes to allergic reactions and immune hyperactivity."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;CHRONIC ECZEMA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic skin condition characterized by inflammation, itching, and redness, which is frequently associated with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;REACTIVE AIRWAY DISEASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An interaction between increased IgE levels and the development of respiratory symptoms that lead to conditions such as asthma."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Decreased platelet count (thrombocytopenia) may occur in patients with STAT5B deficiency, affecting blood clotting abilities."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;NEUTROPHILIA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An elevated level of neutrophils (white blood cells), known as neutrophilia, can be observed as a characteristic immunological feature in individuals with STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;TCM CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"TCM cells remained within normal ranges."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ TEM CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"No alterations in the proportion CD4+ TEM cells were identified."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEM CELLS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Increases in CD8+ TEM cell proportions became clinically significant with age in each sibling."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;INFANCY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Elevated proportions of CD8+ memory T cells beginning in infancy suggest a role in CD8+ T cell activation and homeostasis associated with this LOF STAT5B variant.")("entity"&lt;SEP&gt;"Elevations in the percentage of CD8+ TEMRA cells detected during infancy."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;P2 AND P3&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Elevations in the percentage of CD8+ TEMRA cells detected specifically in P2 and P3."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;AGE 4&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A normalization point around age 4 for elevated percentages of CD8+ TEMRA cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;P1&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Remained normal in P1 regarding elevation of CD8+ TEMRA cell percentages."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;STAT5B DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An observation not previously reported for STAT5B deficiency related to dysregulation of CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;AGE SIGNIFICANCE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Increases in CD8+ TEM cell proportions showed clinical significance as age progressed in siblings (Figures not specifically mentioned but implied from context)."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;INFANCY OBSERVATION&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Elevations in the percentage of CD8+ TEMRA cells were detected during infancy, as specified for P2 and P3, but normalized around age 4."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;NORMALITY&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Emphasizes that some variables remained normal over time (P1), while others showed significant deviations (P2, P3) as described by Figures S4C, Figure 3C and their corresponding text."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ T CELL DYSREGULATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Noted alongside normal CD4+ memory T cell subsets, indicating a unique aspect of STAT5B deficiency (context implies dysregulated process but specific figure or reference not provided)."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;LOF STAT5B VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Suggests that an LOF (loss-of-function) variant in STAT5B could influence CD8+ T cell activation and homeostasis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;EXISTING VARIANT&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"This existing mutation is in proximity to the newly identified p.W631* variant in STAT5B.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENE MUTATION&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"A homozygous variant in STAT5B gene results in a loss-of-function mutation leading to altered protein function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DOMAIN&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Src Homology 2 (SH2) domain is critical for STAT5B activation and homodimer formation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SH2&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"Src Homology 2 (SH2) domain is critical for STAT5B activation and homodimer formation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTATION EFFECT&quot;">
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d1">"The p.W631* mutation results in reduced expression, inability for phosphorylation and nuclear localization impairment.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA-DRB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-DRB1 gene was sequenced based on genotyping results."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;EXON 2 HLA-DRB1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Exon 2 of the HLA-DRB1 gene was used in a previous investigation for genotyping."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DQB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Exons 2 and 3 of the HLA-DQB1 gene were sequenced based on previous genotyping results."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;CUSTOM TAQMAN SNP GENOTYPING ASSAY&quot;">
      <data key="d0">"ASSAY"</data>
      <data key="d1">"The success rate of genotyping rs28383172 using this assay was 98%."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;KASPAR-ON-DEMAND PREVALIDATED ASSAYS&quot;">
      <data key="d0">"ASSAY"</data>
      <data key="d1">"Three SNPs (rs2395182, rs4713586 and rs7775228) had genotypes available for all 233 patients using these assays."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;LINKED DISEQUILIBRIUM (LD) COEFFICIENTS&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"These were calculated between the four SNPs and several super populations based on the 1000 Genomes dataset."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HUNGARIAN POPULATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The LD coefficients in the Hungarian population matched most closely with those of the EUR super population."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172 AG OR GG GENOTYPES&quot;">
      <data key="d0">"PREDICTOR"</data>
      <data key="d1">"This was associated with HLA-DRB1*07:01 carrier status and DQA1*02:01–DQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS2395182 TT OR TG GENOTYPES&quot;">
      <data key="d0">"PREDICTOR"</data>
      <data key="d1">"This was associated with the rs4713586 TT and rs7775228 TC or CC genotypes in relation to DQA1*02:01–DQB1*02:02 haplotype carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d0">"PREDICTOR"</data>
      <data key="d1">"This was associated with HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype carrier status in patients with rs28383172 AG or GG genotypes."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01 ALLELE CARRIER STATUS&quot;">
      <data key="d0">"ASSOCIATION"</data>
      <data key="d1">"Carrying the G allele of rs28383172 was associated with HLA-DRB1*07:01 allele carrier status."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DQB1*02:02 ALLELE&quot;">
      <data key="d0">"ASSOCIATION"</data>
      <data key="d1">"The presence of the rest of the patients without carrying the HLA-DQB1*02:02 allele was observed."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB5/DRB6 LOCUS&quot;">
      <data key="d0">"GENOMIC REGION"</data>
      <data key="d1">"Single nucleotide polymorphism (SNP) analysis was performed at this genomic location, which is part of the Human Leukocyte Antigen (HLA) complex."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172 AND RS2274697&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"These two SNPs were genotyped using the Custom TaqMan SNP Genotyping Assay in this study."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;DQA1*02:01–DQB1*03:02 HAPLOTYPE&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"This specific combination of DQA1 and DQB1 alleles was found among the patients with certain genotypes."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB7/">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA-DRB7 gene was also part of the analysis, although its exact exons or SNPs were not specified in this context."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS2395182, RS4713586, AND RS7775228&quot;">
      <data key="d0">"SNPS"</data>
      <data key="d1">"These three specific SNPs from the HLA region underwent genotyping using KASPar-on-Demand prevalidated assays."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;SUPER POPULATIONS&quot;">
      <data key="d0">"POPULATION GROUPING"</data>
      <data key="d1">"The LD coefficients were calculated based on comparisons among super-populations, including the Hungarian population and EUR (European) super population."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172 AG OR GG GENOTYPES, RS2395182 TT OR TG GENOTYPES, RS4713586 TT GENOTYPE, RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d0">"GENOTYPE DISTRIBUTION"</data>
      <data key="d1">"Specific distributions of these genotypes were observed in relation to certain patient characteristics or statuses."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01–DQA1*03:01–DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d0">"HAPLOTYPE"</data>
      <data key="d1">"This particular HLA haplotype was identified among the patients with specific genotype distributions."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1 AND HLA-DPB1 PROTEINS&quot;">
      <data key="d0">"PROTEIN PRODUCTS"</data>
      <data key="d1">"The study also involved analysis of protein products encoded by these HLA genes, which are important for antigen presentation in immune responses."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172 G ALLELE&quot;">
      <data key="d0">"ALLELE TYPE"</data>
      <data key="d1">"The genetic variants identified on the rs28383172 locus include this specific G allele."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01 AND HLA-DQB1*02:02 ALLELES&quot;">
      <data key="d0">"ALLELE COMPOSITION"</data>
      <data key="d1">"These specific alleles were found together in certain patient samples, indicating specific HLA types or haplotypes."</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;1000 GENOMES DATASET&quot;">
      <data key="d0">"DATASET/</data>
      <data key="d1">Genomic Data"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;EUR SUPER POPULATION&quot;">
      <data key="d0">"POPULATION SAMPLE"</data>
      <data key="d1">"The EUR super population had a significantly higher sensitivity and negative predictive value of algorithm V compared to other algorithms."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM III&quot;">
      <data key="d0">"ALGORITHM/</data>
      <data key="d1">Statistical Algorithm"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM IV&quot;">
      <data key="d0">"ALGORITHM/</data>
      <data key="d1">Statistical Algorithm"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM II&quot;">
      <data key="d0">"ALGORITHM/</data>
      <data key="d1">Statistical Algorithm"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM V&quot;">
      <data key="d0">"ALGORITHM/</data>
      <data key="d1">Statistical Algorithm"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SNP-GENOTYPED SUBPOPULATION&quot;">
      <data key="d0">"SUBPOPULATION SAMPLE/</data>
      <data key="d1">Genetic Data"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">SNP Haplotype"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SURROGATE MARKERS&quot;">
      <data key="d0">"GENOMIC VARIANT/</data>
      <data key="d1">SNP Markers"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d0">"DISEASE/</data>
      <data key="d1">Disease"&lt;SEP&gt;Medical Condition"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SENSITIVITY VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SPECIFICITY VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;POSITIVE PREDICTIVE VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;NEGATIVE PREDICTIVE VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM V PERFORMANCE&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HAPLOTYPE CARRIER STATUS&quot;">
      <data key="d0">"GENOMIC DATA/</data>
      <data key="d1">Individual Data"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM V MISSES&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;FALSE POSITIVES AND NEGATIVES&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Classification Error"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM V SENSITIVITY AND SPECIFICITY&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;FALSE HAPLOTYPE CARRIERS&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;FALSE NEGATIVES AND FALSE POSITIVES&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Performance Metric"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;PERFORMANCE MEASURES COMPARISON&quot;">
      <data key="d0">"STATISTICAL MEASURE/</data>
      <data key="d1">Comparative Analysis"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;1000 GENOMES DATASET/">
      <data key="d0">GENOMIC DATA SAMPLE"</data>
      <data key="d1">"The large-scale genomic dataset used for comparisons and analyses."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;EUR SUPER POPULATION/">
      <data key="d0">GEOGRAPHIC POPULATION"</data>
      <data key="d1">"A subset of the European genetic population analyzed for its unique genetic markers."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM III/">
      <data key="d0">COMPARATIVE ALGORITHM"</data>
      <data key="d1">"One of several algorithms being evaluated for performance in comparison to others."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM IV/">
      <data key="d0">COMPARATIVE ALGORITHM"</data>
      <data key="d1">"Another algorithm used alongside algorithms II and V for comparative analysis."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM II/">
      <data key="d0">COMPARATIVE ALGORITHM"</data>
      <data key="d1">"An additional statistical algorithm part of the study to compare against algorithm V."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE/">
      <data key="d0">GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic sequence variant associated with E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SURROGATE MARKERS/">
      <data key="d0">GENOMIC MARKERS"</data>
      <data key="d1">"Additional genomic markers used alongside the primary SNP haplotype in screening tests for hypersensitivity identification."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;E. COLI ASP HYPERSENSITIVITY/">
      <data key="d0">MEDICAL CONDITION"</data>
      <data key="d1">"A medical condition being screened for using genetic data and markers."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SENSITIVITY VALUE/">
      <data key="d0">STATISTICAL MEASURE"</data>
      <data key="d1">"The percentage indicating how well the test correctly identifies those with E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SPECIFICITY VALUE/">
      <data key="d0">STATISTICAL MEASURE"</data>
      <data key="d1">"The percentage indicating how well the test correctly identifies individuals without E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;POSITIVE PREDICTIVE VALUE/">
      <data key="d0">STATISTICAL MEASURE"</data>
      <data key="d1">"The ratio of true positives to all positive results in a screening for E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;NEGATIVE PREDICTIVE VALUE/">
      <data key="d0">STATISTICAL MEASURE"</data>
      <data key="d1">"The probability that those identified as negative truly do not have E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;ALGORITHM V PERFORMANCE/">
      <data key="d0">STATISTICAL MEASURE"</data>
      <data key="d1">"An evaluation of algorithm V's performance against benchmarks and other algorithms in the study."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HAPLOTYPE CARRIER STATUS/">
      <data key="d0">GENOMIC DATA ANALYSIS"</data>
      <data key="d1">"The status identifying individuals who carry the specific HLA haplotype."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;E. COLI ASP HYPERSENSITIVITY SCREENING/">
      <data key="d0">DIAGNOSTIC TEST"</data>
      <data key="d1">"A process for diagnosing E. coli ASP hypersensitivity using genetic information and markers."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;RS2395182 TT OR TG GENOTYPES&quot;&amp;&quot;RS4713586 TT AND RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"were associated with DQA1*02:01–DQB1*02:02 haplotype carrier status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;G ALLELE OF RS28383172&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"had perfect concordance with HLA-DRB1*07:01 allele carrier status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA TYPE&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"had perfect concordance with HLA-DRB1*07:01 allele carrier status.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM V VS. ALGORITHMS II, III, IV&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Statistical Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PERFORMANCE COMPARISON/">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Statistical Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM V VS. HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Statistical Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENSITIVITY VALUE AND E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Correlation Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL MEASURE/">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Correlation Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SPECIFICITY VALUE AND FALSE POSITIVES&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Error Rate"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POSITIVE PREDICTIVE VALUE AND TRUE CASES&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Accuracy Rate"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEGATIVE PREDICTIVE VALUE AND FALSE NEGATIVES&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Error Rate"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM V AND ALGORITHM V HAPLOTYPE ACCURACY&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Statistical Analysis"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALGORITHM V AND FALSE HAPLOTYPE CARRIERS&quot;">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Performance Metric"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MISCLASSIFICATION/">
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d1">Performance Metric"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TLR7 gene plays a role in the response to pathogens by producing Toll-like receptors that mediate innate immune responses."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;RS179008&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism rs179008 in the TLR7 gene is associated with HIV-infected individuals."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;RS179009&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms rs179009 are found in the TLR7 gene, which follows Hardy-Weinberg equilibrium."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;HIV-INFECTED INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The distribution of rs179009 AG genotype is significantly reduced in HIV-infected individuals compared to healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;HIV DISEASE STAGES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The prevalence of the TLR7 rs179009 AG genotype is lower in early, intermediate, and advanced HIV disease stages compared to healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;EARLY HIV DISEASE STAGE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"In early HIV disease stage individuals, the prevalence of the TLR7 rs179009 AG genotype shows reduced frequency as compared to healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;INTERMEDIATE HIV DISEASE STAGE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The frequency of the TLR7 rs179009 AG genotype is decreased in intermediate HIV disease stage individuals compared with healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;ADVANCED HIV DISEASE STAGE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"In advanced HIV disease stages, the prevalence of the TLR7 rs179009 GG genotype decreases as compared to healthy controls."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TOBACCO AND ALCOHOL USERS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The distribution of TLR7 polymorphisms was not different between HIV-infected individuals with or without tobacco and alcohol use."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TOBACCO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tobacco usage is identified as an environmental factor potentially influencing HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;ALCOHOL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol use is considered another environmental factor that may impact the progression of HIV disease."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 31}]</data>
    </node>
    <node id="&quot;BASELINE CD4 COUNTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Baseline CD4 cell count was found to have a correlation with HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;TLR7 (RS179008 AND RS179009)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms in the TLR7 gene were considered as genetic factors related to HIV disease progression."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d3">[{"level": 0, "cluster": 5}, {"level": 1, "cluster": 30}]</data>
    </node>
    <node id="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HIV disease progression is the outcome being analyzed using various factors and genetic polymorphisms."</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;TLR7 (RS179008, RS179009)&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"Polymorphisms in the TLR7 gene are associated with decreased AG genotype prevalence in HIV-infected individuals compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TLR7 POLYMORPHISM&quot;">
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d1">"The prevalence of specific TLR7 rs179009 genotypes decreases across different stages of HIV disease compared to healthy controls.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK R1275Q&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ALK R1275Q is a gene that plays a major role in determining the outcome of targeted cancer immunotherapies."&lt;SEP&gt;"Among these are two well-known hotspot mutations, NRAS Q61K and ALK R1275Q."&gt;&lt;SEP&gt;"We find at least one neoepitope-generating mutation persisting in the relapsed tumor for five of six patients (Table S1 and Supplementary Data S1 in Supplementary Material)."&gt;</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179&lt;SEP&gt;chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NRAS Q61K&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A reduced version of our software, ProTECT (Figure 1), was initially run on a batch of six primary:relapsed NBL sample pairs from the TARGET cohort."&gt;</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NRAS Q61K MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A reduced version of our software, ProTECT (Figure 1), was initially run on a batch of six primary:relapsed NBL sample pairs from the TARGET cohort."&gt;</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NEUROBLASTOMA (NBL)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"We find at least one neoepitope-generating mutation persisting in the relapsed tumor for five of six patients (Table S1 and Supplementary Data S1 in Supplementary Material)."&gt;</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;ALK NEOEPITOPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Lower affinity indicates potential for ALK neoepitopes to be involved in diseases related to HLA-A*01:01 interaction."&lt;SEP&gt;"The presence of the ALK neoepitopes was confirmed after performing liquid chromatography–mass spectroscopy (LC–MS)."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;PEPTIDE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The correct peptide with observed masses of 1,086.70 and 1,249.71 Da corresponds to the nonamer and decamer peptides."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;NONAMER&quot;">
      <data key="d0">"DECAMER"</data>
      <data key="d1">"Both ALK neoepitopes have a lower affinity for HLA-A*01:01 as indicated by the binding energy calculations."&lt;SEP&gt;"The nonamer peptide adopts a canonical extended conformation promoted by specific anchors within the HLA groove, resulting in a 'curved' conformation."&lt;SEP&gt;"The thermal stability of both is different, with decamer having higher stability (47.9°C) than nonamer (46.7°C)."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;ALK NEOEPITOPES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"/"MOLECULAR INTERACTION"</data>
      <data key="d1">"The binding affinity and stability of the decamer complex indicate it forms a higher affinity complex with HLA-B*15:01, differing from the nonamer's characteristics."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
      <data key="d3">[{"level": 0, "cluster": 20}, {"level": 1, "cluster": 40}]</data>
    </node>
    <node id="&quot;HLA-B*15:01/Β2M/AQDIYRASY (NONAMER)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"/"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The structural analysis of the X-ray structures suggests a trend where peptide backbone conformation is influenced by its length and anchor motifs."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;PEPTIDE AMINO ACID SEQUENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Comparisons with previously deposited HLA-B*15:01-restricted antigens indicate that nonamer epitopes are generally in extended conformations, consistent with the ALK-derived nonamer neoepitope's structure."</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;ILE4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Ile4 residue"</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TYR5&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Y5 is a Tyrine residue"</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SER8&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"S8 represents Serine"</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TYR9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Y9 indicates Tyrine"</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLA&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"2,904 HLA alleles were selected and their interactions with the ALK peptides were predicted using Rosetta comparative modeling calculations."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PEPTIDE/HLA INTERACTIONS&quot;">
      <data key="d0">"INTERACTION AMONG MOLECULES"</data>
      <data key="d1">"The approach exploits high-resolution X-ray structures to predict peptide/HLA interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;ROSETTA COMPARATIVE MODELING&quot;">
      <data key="d0">"CALCULATION METHOD"</data>
      <data key="d1">"Detailed calculations were carried out using Rosetta comparative modeling for predicting interactions."&lt;SEP&gt;"The Rosetta comparative modeling method was used for the simulation and prediction of peptide/HLA interactions."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PEPTIDE BACKBONE THREADING&quot;">
      <data key="d0">"MODELING APPROACH"</data>
      <data key="d1">"The fixed-peptide backbone threading approach was used to confine the docking degrees of freedom."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;X-RAY STRUCTURES&quot;">
      <data key="d0">"STRUCTURAL DATA SOURCE"</data>
      <data key="d1">"The nonamer and decamer ALK peptides were modeled based on high-resolution X-ray structures."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;RMSD (ROOT MEAN SQUARE DEVIATION)&quot;">
      <data key="d0">"QUANTITATIVE METRIC"</data>
      <data key="d1">"Minimal variance in peptide backbone conformation was observed across all nonamer/HLA-B*15:01 structures."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;BINDING ENERGIES&quot;">
      <data key="d0">"ENERGY MEASURE"</data>
      <data key="d1">"Reproducible binding energies were extracted for both the nonamer and decamer peptides."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA ALLELES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"116 HLA alleles showed lower binding energies compared to initial templates, suggesting broader display potential."&lt;SEP&gt;"The HLA alleles selected play an essential role in presenting peptides derived from mutated oncogenes."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;SEQUENCE BIAS&quot;">
      <data key="d0">"RESIDUE SEQUENCE ANALYSIS"</data>
      <data key="d1">"A sequence bias for specific residues in the HLA-binding groove was identified based on sequence identity score."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;KULLBACK–LEIBLER SEQUENCE LOGO&quot;">
      <data key="d0">"DATA VISUALIZATION"</data>
      <data key="d1">"The Kullback-Leibler sequence logo was used to highlight preferred residues in the MHC-binding groove."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;P/MHC COMPLEX&quot;">
      <data key="d0">"MOLECULAR ASSEMBLY"</data>
      <data key="d1">"A stable p/MHC complex formed upon refolding of HLA-A*01:01 with ALK-derived peptides."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;ALK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALK is an oncogene that, when mutated, plays a significant role in cancer development."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NEOPEPITOPES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The ALK R1275Q neoepitopes are derived from this mutation and interact with HLA molecules to trigger T-cell responses."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PEPTIDE BINDING AFFINITY&quot;">
      <data key="d0">"AFFINITY MEASURE"</data>
      <data key="d1">"The affinity between peptides and HLA molecules affects their interaction stability and biological function."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE&quot;">
      <data key="d0">"MOLECULAR STRUCTURE"</data>
      <data key="d1">"The decamer ALK peptide consists of 10 amino acids involved in cancer immunotherapy."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE&quot;">
      <data key="d0">"MOLECULAR STRUCTURE"</data>
      <data key="d1">"The nonamer ALK peptide is a shorter, nine-amino-acid version of the ALK-derived neoepitopes."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-A*01:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Refolding of HLA-A*01:01 with decamer or nonamer peptide results in a stable p/MHC complex."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;DECAMER&quot;">
      <data key="d0">"NONAMER"</data>
      <data key="d1">"The decamer complex crystallizes at 2.9 Å resolution and shows a short 310 helix conformation of the peptide backbone when bound to HLA-A*01:01."&lt;SEP&gt;"The thermal stability is 47.9°C for the decamer and 46.7°C for the nonamer, indicating lower affinity of both ALK neoepitopes for HLA-A*01:01 compared to HLA-B*15:01."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;310 HELIX CONFORMATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The conformation is indicative of peptide interaction with groove of MHC molecule."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;X-RAY STRUCTURE&quot;">
      <data key="d0">"ALLOPHYCOCYANIN (APC) OR PHYCOERYTHRIN (PE)"</data>
      <data key="d1">"Double staining assay using HLA-matched tetramers reveals reactive CD8+ T cells to both nonamer and decamer peptides."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;NONAMER/DECAMER&quot;">
      <data key="d0">"DOUBLE STAINING"</data>
      <data key="d1">"Simultaneous staining experiments with nonamer and decamer tetramers did not identify CD8+ T cells recognizing both epitopes simultaneously."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;HLA-B*15:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HLA and MHC allele has been previously reported to yield partially folded, peptide-free molecules with measurable thermal stabilities."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;DECAMER COMPLEX&quot;">
      <data key="d0">"X-RAY STRUCTURE"</data>
      <data key="d1">"Crystallizes in the P32221 space group at a resolution of 2.9 Å and reveals that the peptide backbone adopts a short 310 helix conformation when bound to HLA-A*01:01."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;TRYPTOPHAN (TRP)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The side-chain hydroxyl group of the peptide Tyr10 is in contact with Trp, Lys, and Tyr side-chain atoms from the F-pocket of the MHC groove."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;ARGININE (ARG)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"When bound to HLA-A*01:01, the side chain of Arg6 flips outwards altering the peptide surface displayed to TCRs compared to its binding when it binds with HLA-B*15:01."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;T CELL RECEPTOR (TCR)&quot;">
      <data key="d0">"RECEPTOR"</data>
      <data key="d1">"The CD8+ T cells interact with the altered-self neoepitopes through their TCRs as a part of immune response."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;KNOWN IMMUNODOMINANT EPITOPE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease associated with immune response and antigen presentation."</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;UNKNOWN GENE X&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Description of unknown gene X"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;UNKNOWN VARIANT Y&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Description of genomic variant Y"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;TRANSCRIPT Z&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Description of transcript Z"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;PROTEIN A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Description of protein A"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;NUTRIENT B&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Description of nutrient B"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;DIETARY PATTERN C&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Description of dietary pattern C"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS D&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Description of physiological process D"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY E&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Description of metabolic pathway E"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION F&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Description of molecular interaction F"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR G&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Description of environmental factor G"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;DISEASE H&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Description of disease H"</data>
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
    </node>
    <node id="&quot;SELF-PEPTIDE/HLA-B*15:01 COMPLEX&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Asp46"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRUCTURAL EXCLUSION AND IMMUNE TOLERANCE&quot;&lt;|&quot;INABILITY OF SELF-PEPTIDE TO FORM STABLE COMPLEXES WITH HLA DUE TO STRUCTURAL CONSTRAINTS LEADING TO IMMUNE TOLERANCE.&quot;)(&quot;ENTITY&quot;">
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d1">"Asp46"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEPTIDE/HLA MODELING&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Structure-based modeling methods were previously applied to predict peptide/HLA interactions using this template.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEPTIDE BACKBONE CONFORMATION&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The peptide backbone conformation showed minimal variance in all nonamer/HLA-B*15:01 structures.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VARIANCE ANALYSIS&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The peptide backbone conformation showed minimal variance in all nonamer/HLA-B*15:01 structures.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BINDING AFFINITY&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"An allele with mutated residues exhibited a high binding energy and was distant from the best binder.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOCK POLYALA HLA&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"An allele with mutated residues exhibited a high binding energy and was distant from the best binder.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RESIDUES IN MHC BINDING GROOVE&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"A trend for specific residues contributing to overall binding energy was observed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEQUENCE BIAS EVALUATION&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"A trend for specific residues contributing to overall binding energy was observed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INVARIANT RESIDUES&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Highly invariant residues were consistently found in HLA alleles with high affinity binding.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KEY FEATURES&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Highly invariant residues were consistently found in HLA alleles with high affinity binding.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONTACT PATTERN&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Similar polar contacts, primarily in the F-pocket of MHC, correlated well with positions of invariant MHC residues.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;F-POCKET&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Similar polar contacts, primarily in the F-pocket of MHC, correlated well with positions of invariant MHC residues.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STABILITY MEASURE&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"A stable p/MHC complex formed after refolding nonamer and decamer peptides with HLA-A*01:01.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK R1275Q MUTATION&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"This mutation in the ALK gene serves as an indicator for potential cancer development or progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CANCER MARKER&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"This mutation in the ALK gene serves as an indicator for potential cancer development or progression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HLA ALLELES SELECTION&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The selection of HLA alleles aims to broaden the display repertoire that can accommodate neoepitopes and enhance immune response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REPERTOIRE EXPANSION&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The selection of HLA alleles aims to broaden the display repertoire that can accommodate neoepitopes and enhance immune response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEPTIDE SEQUENCE SIMILARITY&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Comparative analysis of peptide sequences helps identify those with higher affinity or potential for stronger T-cell responses.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KULLBACK-LEIBLER DIVERGENCE&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The Kullback-Leibler divergence measure is used to quantify sequence diversity among HLA alleles involved in peptide binding.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEQUENCE DIVERSITY METRIC&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The Kullback-Leibler divergence measure is used to quantify sequence diversity among HLA alleles involved in peptide binding.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION DETAIL&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Analyze the nature and specificity of polar contacts between peptides, MHC molecules, and T cells during immune response interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POLAR CONTACTS ANALYSIS&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"Analyze the nature and specificity of polar contacts between peptides, MHC molecules, and T cells during immune response interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BIOPHYSICAL PROPERTY&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The thermal stability test confirms the robustness of p/MHC complexes formed with selected HLA alleles under physiological conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERMAL STABILITY ASSESSMENT&quot;">
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
      <data key="d1">"The thermal stability test confirms the robustness of p/MHC complexes formed with selected HLA alleles under physiological conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RECOGNITION&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"Frequency of recognition is comparable for neoepitopes and an immunodominant epitope, indicating similar interaction potential.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T CELL RECOGNITION&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"Both peptides have nominal frequencies comparable to known immunodominant epitopes when recognized by CD8+ T cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALK NEOEPITOPE (NONAMER AND DECAMER)&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"The lower affinity for HLA-A*01:01 might imply involvement in disease mechanisms related to these neoepitopes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DISEASE MECHANISMS&quot;">
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d1">"The lower affinity for HLA-A*01:01 might imply involvement in disease mechanisms related to these neoepitopes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EPITHELIAL CELLS&quot;">
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d1">"This epitope is present on the surface of epithelial cells, participating in the immune response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KNOWN IMMUNE RESPONSE I&quot;">
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d1">"Gene X is involved in a known immune response process.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UNKNOWN GENETIC CONDITION J&quot;">
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d1">"Genomic variant Y may contribute to an unknown genetic condition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEINS K, L&quot;">
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d1">"Transcript Z codes for multiple proteins, including K and L.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY D&quot;">
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d1">"Dietary pattern C influences metabolic pathway D through nutrient intake.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION E&quot;">
      <data key="d2">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d1">"Physiological process D depends on molecular interaction E for its function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS74420772&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) that showed genome-wide significance in TwinGene GWAS."&lt;SEP&gt;"A single nucleotide polymorphism in 3p14.1 achieved genome-wide significance in the TwinGene study."&lt;SEP&gt;"The expression level of this genomic variant is associated with the risk of cardiovascular disease."&lt;SEP&gt;"This variant may influence protein function and potentially lead to cardiovascular disease."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGM ANTI-PC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A small nested case–control study found IgM anti-PC to be lower in prevalent CLL cases than in matched controls (P = 0.006)."&lt;SEP&gt;"Inflammatory response against PC (Phosphatidylcholine) which is associated with various diseases including autoimmune disorders."&lt;SEP&gt;"Polygenic risk scores for IgM levels may inform the choice of therapies targeting autoimmunity or inflammatory conditions."&lt;SEP&gt;"The expression levels of IgM antibodies against PC are potentially influenced by genetic variants such as rs735665 and rs9392504."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b&lt;SEP&gt;chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS735665&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Identified as a top risk allele for Chronic Lymphocytic Leukemia (CLL) and significant for general IgM levels."&lt;SEP&gt;"Recognized as a top risk allele for CLL (Chronic lymphocytic leukemia) and specific for general IgM."&lt;SEP&gt;"The variant rs735665 has been found to be linked with specific dietary patterns affecting general IgM levels."&lt;SEP&gt;"This genomic variant has regulatory effects on transcription factors and histone modifications in leukemia or immune-cell lines."&lt;SEP&gt;"This variant plays a significant role in polygenic risk score calculations related to immunoglobulin levels."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS9392504&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the 33 independent genome-wide significant SNPs identified in the study related to CLL."&lt;SEP&gt;"One of the genome-wide significant SNPs for CLL identified in this study."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS35923643&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Switching from the major allele T/A at rs35923643 to the minor C/G allele impeded the predicted binding affinity of RUNX3, making the P-value increase 10-fold."&lt;SEP&gt;"The genomic variant located at the LD block was scanned for regulatory marks in leukemia- or immune-cell lines."&lt;SEP&gt;"This variant is located within the GRAM domain containing 1B (GRAMD1B) gene."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b&lt;SEP&gt;chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGM&quot;">
      <data key="d0">"IMMUNE SYSTEM COMPONENT"</data>
      <data key="d1">"A type of immunoglobulin that plays a role in various immune responses, including autoimmune diseases and cancer risk."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;DNASEI HYPERSENSITIVITY SITES&quot;">
      <data key="d0">"EPIGENETIC LANDMARK"</data>
      <data key="d1">"Indicates regions with increased accessibility to DNase I enzyme, which is associated with transcriptional regulation, including regulatory functions of genomic variants like rs735665."</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;H3K4ME1&quot;">
      <data key="d0">"HISTONE MARK"</data>
      <data key="d1">"Peaks of histone mark monomethylated histone H3 lysine 4 (H3K4Me1) were found at the position of rs35923643."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;DNASEI HYPERSENSITIVITY&quot;">
      <data key="d0">"DNASEI HYPERSENSITIVITY"</data>
      <data key="d1">"Deoxyribonuclease I (DNaseI) hypersensitivity was also detected at that location."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;TFS&quot;">
      <data key="d0">"TRANSCRIPTION FACTORS"</data>
      <data key="d1">"There were suggested binding sites for 22 different transcription factors within the ~700bp region around rs35923643."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RUNX3&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR"</data>
      <data key="d1">"The strongest signals among matched sequences from Find Individual Motif Occurrences (FIMO) tool were observed for Runt-related TF 3 (RUNX3)."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;SPI1&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR"</data>
      <data key="d1">"Another transcription factor was SPI1."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RUNX3 BINDING MOTIFS&quot;">
      <data key="d0">"MOTIF"</data>
      <data key="d1">"RUNX3 binding motifs included the SNP rs35923643 (at position 391 bp)."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;HAIB_RUNX3_GM12878_MOTIF1_FW_IC0&quot;">
      <data key="d0">"TRANSCRIPTION FACTOR BINDING"</data>
      <data key="d1">"Haib_RUNX3_GM12878_Motif1_fw_ic0 was found from a B-cell line when binding RUNX3."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;REGULOMEDB DATABASE&quot;">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"The RegulomeDB database gave support for rs35923643 affecting the binding of transcription factors in general."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;PREVALENT CLL CASES&quot;">
      <data key="d0">"CASES"</data>
      <data key="d1">"The difference of IgM anti-PC levels between CLL cases and matched controls was dependent on the time between sampling and diagnosis."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;INCIDENT CLL CASES&quot;">
      <data key="d0">"CASES"</data>
      <data key="d1">"No association between IgM anti-PC and incident CLL risk estimated from stratified Cox proportional hazards model (P = 0.354)."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;TIME BETWEEN SAMPLING AND DIAGNOSIS&quot;">
      <data key="d0">"TEMPORAL FACTOR"</data>
      <data key="d1">"The difference of IgM anti-PC levels showed a declining trend but was not statistically significant (β = –0.08, P = 0.10)."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;GM12878&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"The cell line GM12878 was used for histone mark monomethylated histone H3 lysine 4 (H3K4Me1) and deoxyribonuclease I (DNaseI) hypersensitivity scans."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CD34+ CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"The cell line CD34+ was used for deoxyribonuclease I (DNaseI) hypersensitivity scan."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;GM12865&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"The cell line GM12865 was also used for deoxyribonuclease I (DNaseI) hypersensitivity scan."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CHROMATIN IMMUNOPRECIPITATION-SEQUENCING (CHIP-SEQ)">
      <data key="d0">"TECHNIQUE"</data>
      <data key="d1">"Chromatin immunoprecipitation-sequencing (ChIP-seq) experiments from Encyclopedia of DNA Elements (ENCODE) were used to detect suggested binding sites for transcription factors."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;ENCYCLOPEDIA OF DNA ELEMENTS (ENCODE)">
      <data key="d0">"DATABASE"</data>
      <data key="d1">"The Chromatin immunoprecipitation-sequencing (ChIP-seq) data came from the Encyclopedia of DNA Elements (ENCODE) database."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;FIND INDIVIDUAL MOTIF OCCURRENCES (FIMO)">
      <data key="d0">"TOOL"</data>
      <data key="d1">"The tool used for finding individual transcription factor motifs was Find Individual Motif Occurrences (FIMO)."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;NESTED CASE-CONTROL STUDY">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"A small nested case-control study design was utilized to compare IgM anti-PC levels between prevalent CLL cases and matched controls."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;STRATIFIED COX PROPORTIONAL HAZARDS MODEL&quot;">
      <data key="d0">"STATISTICAL METHOD"</data>
      <data key="d1">"The stratified Cox proportional hazards model was used to estimate the association between IgM anti-PC and incident CLL risk."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;CLL&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"rs735665 is significantly associated with the risk of CLL, indicating its role in this disease.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENERAL IGM&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"rs735665 affects the expression level of general IgM, suggesting a genetic basis for this immune response.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POLYGENIC RISK SCORE FOR IGM&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"rs735665 contributes substantially to the polygenic risk scores for increasing IgM, highlighting its genetic influence on this measure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS735665, RS9392504&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"Genetic variations like rs735665 and rs9392504 can influence the expression of IgM antibodies against PC.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GRAMD1B&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The genetic variation rs35923643 resides in the GRAMD1B gene, indicating a possible role of this variant within the gene's function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;REGULATORY MARK&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The variant rs735665 is linked to changes in epigenetic marks like H3K4Me1, indicating its potential role in gene regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POLYGENIC RISK SCORE&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The polygenic risk scores associated with IgM levels can guide personalized treatment strategies for autoimmune disorders like CLL.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERAPIES FOR AUTOIMMUNE DISEASES&quot;">
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d1">"The polygenic risk scores associated with IgM levels can guide personalized treatment strategies for autoimmune disorders like CLL.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <edge source="&quot;ENDOPLASMIC RETICULUM&quot;" target="&quot;GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The expression of SEC16B gene may be influenced by its interaction with endoplasmic reticulum processes.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELLULAR PROCESSES&quot;" target="&quot;DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNP rs713586 affects the activity levels of DNAJC27 involved in cellular stress response and protein folding.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC REGULATION&quot;" target="&quot;CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1 (CDKAL1)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNP rs9356744 impacts the function of CDKAL1, influencing metabolic pathways and energy balance.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPTION FACTOR ACTIVITY&quot;" target="&quot;TRANSCRIPTION FACTOR AP-2 BETA (TFAP2B)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SNP variants affect TFAP2B's ability to regulate gene expression related to obesity risk.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS&quot;" target="&quot;MENARCHE AGE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"PRS interacts with menarche age to influence obesity risk.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MENARCHE AGE&quot;" target="&quot;BMI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"BMI varies by menarche age in participants, influenced by PRS.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In individuals without a university education, the FTO rs9939609 polymorphism was linked with higher BMI. Conversely, in those with university studies, no such association or even an inverse effect of A-allele was noted.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;T2D-ESRD&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Type 2 diabetes and end-stage renal disease (T2D-ESRD) case subjects showed different mean BMI levels compared to nondiabetic control subjects, indicating potential influence or interaction.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Evidence for interaction with BMI in relation to the association between TCF7L2 gene and the number of risk alleles was not found.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;CHANGE IN 2HPG LEVELS&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"Increased two-hour post-meal glucose levels are negatively correlated with baseline BMI but positively related to BMI change over time, suggesting different impacts on obesity risk factors.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;RS1011527 SNP IN LEPR&quot;">
      <data key="d4">1.44</data>
      <data key="d5">"No significant main effect was observed for the rs1011527 SNP in LEPR on BMI without considering interaction terms.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;MD ADHERENCE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Lower BMI was linked to higher adherence to the Mediterranean diet.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;GENOTYPE GROUP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The association between genotype and BMI in the baseline demographics.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SNP HERITABILITY&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The SNP heritability for BMI showed a positive association with the trait of snoring, though not statistically significant (rG=0.695, SE=0.184, p-value=2*10^(-3)[ldsc χ2-test]).")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SNP HERITABILITY FOR SLEEP APNOEA&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The SNP heritability for sleep apnoea was positively correlated with BMI's heritability (rG = 0.683), reflecting obesity as a risk factor.")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SNORING&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"After adjusting for body mass index (BMI), a significant amount of predisposition to snoring is not fully explained by BMI.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;WHOLE-BODY FAT MASS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"BMI was found to exert a causal effect on snoring, and whole-body fat mass also showed bidirectional relationships.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;HEART ATTACK&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"GWAS results suggest a possible bidirectional causal relationship between BMI and heart attack; BMI causes an increase in the risk of heart attack, which could be linked to snoring through sleep disruption or other factors.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;PCOS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased BMI was observed among women with PCOS compared to control subjects.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;LCT (BIFIDOBACTERIUM)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Gene-based PheWAS analysis for LCT locus shows strong links with BMI, suggesting potential impact on metabolic traits.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;RS10399931&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs10399931 showed a significant association (p = 0.03) with BMI, indicating its relevance to body mass index.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;IBS-D&quot;">
      <data key="d4">0.722</data>
      <data key="d5">"The BMI in IBS-D subgroup was approximately 4 units higher than that in IBS-C and HV, indicating a potential link to body weight regulation and digestive conditions.")&lt;SEP&gt;"The BMI in IBS-D subgroup was approximately 4 units higher than that in IBS-C and HV.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;SERUM C4&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"There was a positive association between BMI and serum C4 levels, though not statistically significant.")&lt;SEP&gt;"While there was no significant association between BMI and serum C4 levels, they may still play roles independently in body weight regulation and metabolic processes.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW PLANT-BASED DIET INTAKE &amp; HIGH PRS&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In low plant-based diet, genetic impact on BMI is higher in those with high PRS compared to others.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;PLANT-BASED DIET INTAKE&quot;&amp; &quot;PRS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Plant-based diet intake and PRS have an interaction influencing obesity risk.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;HIGH FRIED-FOOD INTAKE&quot;&amp; &quot;PRS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Fried-food intake and PRS show interaction where PRS offset the obesity risk effect of high fried-food intake.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"In GP subjects, obesity risk was inversely proportional to educational level; university-educated individuals had a lower obesity risk.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;EDUCATION LEVEL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Influence of educational attainment on obesity risk, as it interacts with the presence of certain genotypes (such as FTO rs9939609) to impact health outcomes like BMI and obesity prevalence.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;DISEASE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The determination of obesity risk involves multiple factors including genetic variations and education levels.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COVARIATES&quot;" target="&quot;EDUCATION STATUS, HYPERTENSION, DIABETES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The inclusion of these covariates is to adjust for confounding factors when assessing the association between alcohol consumption and cortisol levels.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO SNP shows significant association with BMI; higher BMI values are observed among individuals carrying specific allele variations of the polymorphism.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;GENOMIC VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs within these genes may influence their function and impact the obesity risk.")</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;CFB/C2 GENE&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The CFB/C2 gene variants were also explored in relation to AMD, but their main effects did not significantly influence AMD risk in combination with HLS.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;PEMT M175V MINOR V ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The PEMT M175V minor V allele was associated with male infertility status among homozygous individuals.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;TCBLR (CD320) VARIANT RS173665 IN HETEROZYGOUS SUBJECTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TCblR variant rs173665 was negatively associated with male infertility status among heterozygous subjects.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;P1001L MUTATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Molecular analyses identified mosaicism for a specific P1001L mutation affecting the ATP7A gene, which might indicate Menkes disease in the child.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;SNP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNPs can be related to genes when they influence their methylation, as in the case of rs726430 with BCL2L11 and rs16861015 with CPB1.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;CPG SITE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A CpG site can be related to a gene if it's annotated to that gene, as seen with cg07547695 and BCL2L11.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;C10ORF11 GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNPs associated with FEV1/FVC were found downstream of the C10orf11 gene on chromosome 10q22.3.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;IL37 GENE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"A SNP in this gene was associated with FEV1 and FVC.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;MINOR ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The text seems to be discussing one genomic variant and not describing relationships between variants.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;MOLECULAR ANALYSES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Mosaicism for a P1001L mutation was confirmed in genomic DNA, but not detected in the mother's DNA; this mutation is associated with Menkes disease.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;FA&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Subject's Fanconi anemia phenotype can be attributed to the combination of genomic variants, including mutations in UBE2T.")</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;COLORECTAL CANCER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There is an association between specific genotypes and the occurrence of Colorectal Cancer (CRC).")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A genomic variant in the NOS1 gene is linked to an increased risk of cardiovascular disease.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;LOW FEV1/FVC ALLELES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The 'low FEV1/FVC alleles' showed an additive genetic architecture that affected lung function measurements.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;THSD4-UACA-TLE3&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A replicated locus (THSD4-UACA-TLE3), despite being one of two replicated loci, did not show functional connections with other genes defined by the 80 SNPs.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;C10ORF11&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Replicated locus (C10orf11) was another example where no functional connection to other identified genes existed.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CCL23-CCL18 LOCUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A specific genetic locus, CCL23-CCL18 SNP, demonstrated significant functional interactions with β-defensin genes and TNFRSF13B along with CXCL12.")&lt;SEP&gt;"The SNP at the CCL23-CCL18 locus demonstrated significant connections with β-defensin genes and TNFRSF13B, as well as CXCL12.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;SNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Single Nucleotide Polymorphisms were analyzed to identify specific genetic variations connected through functional gene interactions.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;THSD4-UACA-TLE3 LOCUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Although a replicated genetic locus, THSD4-UACA-TLE3 was found not to be functionally connected with other genes identified by the 80 SNPs.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;C10ORF11 LOCUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Another replicated genomic region (C10orf11) did not show any functional connections to the other genes defined through the analysis of the 80 SNPs.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;RESPONSE RATE&quot;">
      <data key="d4">0.005</data>
      <data key="d5">"The association of rs1893217 and response rate was tested in anti-CTLA-4 treated patients, with an OR value of approximately 2.79 for non-responders.")</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;RESPONSE RATE FOR ANTI-PD-1&quot;">
      <data key="d4">0.0002</data>
      <data key="d5">"rs17388568 shows a strong association with response rate specifically in anti-PD-1 treatment.")</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;&amp; &quot;LOW PRS&quot;" target="&quot;REDUCTION IN OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A plant-based diet may mitigate obesity risk for individuals with low PRS.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH FRIED-FOOD INTAKE&quot;&amp; &quot;HIGH PRS&quot;" target="&quot;OFFSET OF OBESOGENIC EFFECTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Despite high PRS, high fried-food intake might not significantly increase obesity risk due to counterbalancing factors.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;WEIGHT&quot;">
      <data key="d4">3.64</data>
      <data key="d5">"The risk allele (A) was significantly associated with a 1.51-kg greater weight loss in the high-protein group.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;WAIST&quot;">
      <data key="d4">2.73</data>
      <data key="d5">"The risk allele (A) was significantly associated with a smaller change in waist circumference compared to other groups.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;BODY COMPOSITION CHANGE OVER TIME&quot;">
      <data key="d4">4.6</data>
      <data key="d5">"The risk allele carriers who followed a high-protein diet had greater loss in body composition over time.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;WEIGHT LOSS&quot;">
      <data key="d4">3.64</data>
      <data key="d5">"The risk allele (A) was significantly associated with a 1.51-kg greater weight loss in the high-protein group.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;WAIST CIRCUMFERENCE&quot;">
      <data key="d4">2.73</data>
      <data key="d5">"The risk allele (A) was significantly associated with a smaller change in waist circumference compared to other groups.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;BODY COMPOSITION CHANGE OVER TIME RESPONSE&quot;">
      <data key="d4">4.6</data>
      <data key="d5">"The risk allele carriers who followed a high-protein diet showed greater loss in body composition over time.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRUNK FAT&quot;" target="&quot;DIETARY PATTERN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The response to different diets is influenced by trunk fat percentage dynamics, which are a measure of body composition changes.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Participants with the AA genotype experienced less loss in TAT and SAT when following a low-protein diet.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;LOW-FAT DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genotype did not show significant interactions with changes in fat distribution when following low-fat diet, as opposed to other dietary patterns.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;LOW-FAT DIET INTERACTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"No significant genotype-time interactions on changes in fat distribution were found when following low-fat diets, highlighting the role of genetic background in dietary responses.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There were differences by genotype in TAG levels in both strata for each of the three factors mentioned.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;RESPONSE BIAS&quot;">
      <data key="d4">0.89</data>
      <data key="d5">"A Genotype × Condition interaction was observed for response bias, with val carriers having significantly lower response bias in the stress condition.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;CONTROLS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genotype rs4988235 was associated with milk drinking in controls.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;MILK CONSUMPTION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"No substantial differences were observed between rs4988235 genotype and RCC risk based on milk consumption.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;EBNA2 EFFECT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genotype effect of EBNA2 involves altering allelic association with expression compared to that found in uninfected B cells.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;DISEASE RISK&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The specific genotypes at these MS risk loci increase the individual's susceptibility to diseases like multiple sclerosis (MS), including those related to immune evasion or other disorders.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;FAT LOSS&quot;">
      <data key="d4">4.6</data>
      <data key="d5">"Individuals with the AA genotype experienced less fat loss when consuming a low-protein diet compared to those carrying the variant.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;DIAZOXIDE TREATMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Diazoxide treatment was used in combination with a low-protein diet for patients with HI/HA syndrome.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;FAT LOSS&quot;">
      <data key="d4">4.7</data>
      <data key="d5">"When following a high-protein diet, participants carrying the AA genotype of the FTO rs1558902 showed greater fat loss compared to other genotypes.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;AA GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals having the AA genotype showed greater decrease in fat distribution upon consumption of high-protein diets compared to others.")</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN INTAKE&quot;" target="&quot;WEIGHT LOSS&quot;">
      <data key="d4">4.56</data>
      <data key="d5">"High-protein intake was associated with greater weight loss when the AA genotype of the FTO rs1558902 variant is present.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN INTAKE&quot;" target="&quot;WEIGHT LOSS RESPONSE&quot;">
      <data key="d4">4.56</data>
      <data key="d5">"High-protein intake was associated with greater weight loss when the AA genotype of the FTO rs1558902 variant is present.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT LOSS IN HIGH-PROTEIN DIET INTAKE&quot;">
      <data key="d4">8.6</data>
      <data key="d5">"The risk allele carriers in the high-protein group had greater fat loss compared to non-carriers of the AA genotype.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT LOSS IN LOW-PROTEIN DIET INTAKE&quot;">
      <data key="d4">8.4</data>
      <data key="d5">"Participants with the AA genotype had less fat loss when assigned to the low-protein diet compared to those without this genotype.")&lt;SEP&gt;"Participants with the AA genotype had less loss of trunk fat and SAT when assigned to the low-protein diet compared to those without this genotype.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT DISTRIBUTION IN HIGH-PROTEIN DIET INTAKE&quot;">
      <data key="d4">8.8</data>
      <data key="d5">"The risk allele carriers in the high-protein group had greater fat loss in TAT and VAT compared to non-carriers.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT DISTRIBUTION IN LOW-PROTEIN DIET INTAKE&quot;">
      <data key="d4">8.6</data>
      <data key="d5">"Participants with the AA genotype were associated with less fat loss of trunk fat when assigned to the low-protein diet compared to those without this genotype.")&lt;SEP&gt;"Participants with the AA genotype were associated with less loss of SAT when assigned to the low-protein diet compared to those without this genotype.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT LOSS RESPONSE TO HIGH-PROTEIN DIET&quot;">
      <data key="d4">4.7</data>
      <data key="d5">"Participants with the AA genotype experienced greater fat loss when consuming a high-protein diet compared to those without this variant.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT LOSS RESPONSE TO LOW-PROTEIN DIET&quot;">
      <data key="d4">4.6</data>
      <data key="d5">"Individuals with the AA genotype experienced less fat loss when consuming a low-protein diet compared to those without this variant.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT LOSS IN HIGH-PROTEIN DIET RESPONSE&quot;">
      <data key="d4">4.7</data>
      <data key="d5">"Participants with the AA genotype experienced greater fat loss when consuming a high-protein diet compared to those without this variant.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE (FTO RS1558902)" target="&quot;FAT LOSS IN LOW-PROTEIN DIET RESPONSE&quot;">
      <data key="d4">4.6</data>
      <data key="d5">"Individuals with the AA genotype experienced less fat loss when consuming a low-protein diet compared to those carrying the variant.")</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;RS4988235 AND POTATO INTAKE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Consumption of potatoes was higher in individuals with the LP genetic variant.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;RS4988235 AND CEREAL INTAKE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The intake of cereals was inversely related to the presence of rs4988235 genotype.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;RS4988235 AND NON-ALCOHOLIC BEVERAGE INTAKE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The consumption of non-alcoholic beverages was higher in individuals carrying the LP variant.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;NUTRIENT INTAKE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Improper dietary patterns can lead to nutrient deficiencies or excesses influencing health.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Certain dietary patterns may interact with specific molecules like nitric oxide to impact health.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;RISK FACTOR&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Eating specific types of poultry (excluding chicken and turkey) was identified as a risk factor for quinolone-resistant C. jejuni infection based on the case-comparison study.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The influence of dietary patterns on environmental factors, such as exposure to certain chemicals, affects overall health outcomes including cardiovascular disease risk.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;TRANSCRIPT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The transcript of the NOS1 gene is influenced by dietary patterns, particularly folate intake.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Poor dietary patterns can lead to epigenetic modifications that alter nitric oxide synthesis.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The association between the FTO SNP and anthropometric measurements like BMI was different across educational levels, with stronger associations observed among those with primary or secondary studies compared to university-level subjects.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">0.023</data>
      <data key="d5">"An interaction term was found between the FTO SNP and education in determining obesity risk, as per statistical analysis.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;OBESITY RISK DETERMINATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO SNP plays a role in determining obesity risk, considering factors like education and physical activity.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;CRP SNPS IN CAD GWAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The lead SNP in CAD GWAS shows low LD (r^2 = 0.52) with top hit in CRP GWAS, indicating potential pleiotropic effects.")("entity"</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;SNP AND COFFEE CONSUMPTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic polymorphisms identified by GWAS were associated with habitual coffee consumption.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;COFFEE CONSUMPTION AND ALCOHOL INTAKE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Coffee consumers tended to have higher rates of alcohol consumption.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;CZECH REPUBLIC&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"In the Czech Republic, an association between genotype and milk consumption was seen.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;EDUCATION ATTAINMENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Educational attainment showed association with milk consumption across all countries.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;GWAS SNPS AND TRANS-ACTING GWAS SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNPs related to gene expressions in distant genes had a broad impact on multiple genes.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;RS1131017 SNP AND GWAS SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The lead trans-eQTL SNP was in LD with several GWAS SNPs related to autoimmune diseases.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;RS28383172 AG OR GG GENOTYPES&quot;">
      <data key="d4">95.0</data>
      <data key="d5">"were associated with DQA1*02:01–DQB1*02:02 haplotype carrier status")</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;RS28383172 G ALLELE&quot;">
      <data key="d4">100.0</data>
      <data key="d5">"was in perfect concordance with HLA-DRB1*07:01 allele carrier status.")</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;RS2395182 TT OR TG GENOTYPES&quot;&amp;&quot;RS4713586 TT AND RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d4">95.0</data>
      <data key="d5">"were associated with DQA1*02:01–DQB1*02:02 haplotype carrier status.")</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d4">95.0</data>
      <data key="d5">"was associated with HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype carrier status.")</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION&quot;" target="&quot;G ALLELE OF RS28383172&quot;">
      <data key="d4">100.0</data>
      <data key="d5">"had perfect concordance with HLA-DRB1*07:01 allele carrier status.")</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION LEVEL AND FTO RS9939609 POLYMORPHISM&quot;" target="&quot;INTERACTION EFFECT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The interaction between the FTO SNP and education significantly impacted BMI in GP subjects.")</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION LEVEL&quot;" target="&quot;ASSOCIATION WITH OBESITY RISK&quot;">
      <data key="d4">0.957</data>
      <data key="d5">"Education level is associated with the relationship between genetic variations like the FTO SNP and obesity risk.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION LEVEL&quot;" target="&quot;MD ADHERENCE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Higher education level correlated with increased adherence to Mediterranean diet.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;IL-10RΑTDEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Selective deletion of IL-10 receptor restricted to T cells has no impact on colitis development.")</data>
      <data key="d6">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;TH17 CELL TRANSFER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Transferring Th17 cells into Rag1−/− mice results in colitis development. It also implies a crucial role for Th17 cells in disease pathogenesis, as they are necessary and sufficient for disease progression.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;RAG1−/− AND IL-10RΑMDELRAG1−/− RECIPIENTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There was a difference in disease development between Rag1−/− and IL-10RαMdelRag1−/− recipients.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;MINOR ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No specific relationship with diseases mentioned in the given text.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;BIOCHEMICAL FINDINGS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The patient's biochemical tests did not align with Menkes disease characteristics, indicating discrepancies between serum copper levels and catecholamine ratios compared to the typical profile of Menkes disease.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;RSK8&quot;">
      <data key="d4">0.6</data>
      <data key="d5">"Variants of RGS14/locus, which modulates downstream effects of Gα subunits in kidneys, might influence disease risk and potentially have a role in conditions associated with longer lifespan and stress resistance.")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;SOCIAL DISINHIBITION SCORE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Social disinhibition was positively and negatively associated with specific SNPs, indicating disease risk or protection.")</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;FANCA MUTATION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The FANCA mutation, c.2574C&gt;G/p.Ser858Arg identified by whole exome sequencing was previously associated with Fanconi anemia, but it did not lead to normal FANCA levels or monoubiquitination of FANCD2.")</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;UB&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The interaction between different UBDs like NEMO-UBZ, Polη-UBZ etc. and Ub may have implications for disease development due to altered protein functions."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;GENOMIC VARIANT IN FOLATE METABOLISM PATHWAY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Variants influencing folate metabolism pathways are associated with increased risk for certain diseases, including cardiovascular disease.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;LYP VARIANTS IMPACT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The PTPN22 risk variant permits proliferation in Tconv, but not in Treg.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;AUTOIMMUNE DISORDER&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The association between PTPN22 (LYP gene) variations and certain autoimmune disorders, such as ankylosing spondylitis or inflammatory bowel disease.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;RS3087243&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No association was identified between rs3087243 and PBC susceptibility.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;ALK NEOEPITOPES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The lower affinity to HLA-A*01:01 suggests potential involvement in disease related to neoepitope interaction mechanisms.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE ASSOCIATION&quot;" target="&quot;STATISTICAL SIGNIFICANCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The statistical estimations regarding disease association do not change after certain adjustments, indicating robustness of findings.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL SIGNIFICANCE&quot;" target="&quot;DIETARY EXPOSURE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"19 out of 66 eligible publications reported statistically significant G × E interactions for incident T2D risk.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEME IRON INTAKE&quot;" target="&quot;INTERACTION WITH SLC40A1 RS744653 VARIANT IN MEN AND TMPRSS6 RS855791 IN TOTAL SAMPLE (BORDERLINE SIGNIFICANCE)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Heme iron intake showed interactions with the SLC40A1 variant rs744653 for men, and with TMPRSS6 variant rs855791 across both sexes when not reaching a strong significance.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFE VARIANTS RS1799945 AND RS1800562&quot;/" target="&quot;HEME IRON INTAKE&quot;/">
      <data key="d4">13.0</data>
      <data key="d5">"Higher heme iron intake was associated with increased T2D risk among women carrying specific HFE gene variants but not for men.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HECTD4 VARIANTS&quot;/" target="&quot;ALCOHOL CONSUMPTION&quot;/">
      <data key="d4">15.0</data>
      <data key="d5">"The T2D gene risk score and two HECTD4 variants showed no interaction with alcohol consumption.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFE RS1799945 VARIANT&quot;" target="&quot;T2D RISK IN WOMEN&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The H63D variant was found to increase the risk of T2D specifically among women, based on data from EPIC-InterAct and DPP studies.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPIC-INTERACT STUDY&quot;" target="&quot;INTERACTION WITH HFE RS1799945 VARIANT IN WOMEN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A similar trend to increased risk of T2D was observed for women with the H63D variant, though not statistically significant.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPIC-INTERACT STUDY&quot;" target="&quot;INTERACTION WITH HFE RS1800562 VARIANT IN WOMEN (TREND BUT NOT SIGNIFICANT)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While a similar trend was noted for women and the C282Y variant, the interaction did not reach significance.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">0.4</data>
      <data key="d5">"Estimation of heritability (H2) shows that among the 159 bacterial taxa present in over 10% of twin pairs, 19 taxa showed evidence for heritability with Pnominal&lt;0.05.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY&quot;" target="&quot;STATISTICAL MEASURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The heritabilities of lung function measures indicated that genetic variation contributed to phenotypic variance.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC PREDISPOSITION&quot;" target="&quot;SNPS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNPs are markers for genetic predispositions influencing age at first tooth and number of teeth.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION&quot;" target="&quot;TRANSFECTED CACO-2 CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The transfection process leads to an up to 10-fold range of expression of the rat IDI gene between various cell clones.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION&quot;" target="&quot;MS RISK GENES INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"EBNA2's impact on gene expression correlates with specific MS risk genes and their role in the EBV latency III program.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION&quot;" target="&quot;EBV INFECTION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The expression levels of these genes are affected by EBV infection, which can be influenced by factors such as EBNA2 interaction and genotype.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LTPA&quot;" target="&quot;GENETIC VARIANTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Certain genetic variants are associated with LTPA responsiveness.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK ALLELE&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The risk allele within CARD9 associated with rs10781499 is connected to reduced AHR activation by microbiota-derived metabolites in patients with IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT LOSS INTERVENTIONS&quot;" target="&quot;GENETIC VARIANTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Interaction between specific genetic variants and weight loss interventions can influence diabetes risk.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT LOSS INTERVENTIONS&quot;" target="&quot;DIABETES PREVENTION PROGRAM (DPP)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Weight loss intervention affects diabetes risk according to DPP findings.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT LOSS INTERVENTIONS&quot;" target="&quot;DOUBLE PODOCYTE STUDY (DPS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"DPS study indicates that weight loss interventions can reduce T2D incidence for specific genetic variants.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT LOSS INTERVENTIONS&quot;" target="&quot;RISK GENOTYPES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Certain weight loss interventions impact diabetes risk among individuals with different genotypes, as observed in multiple studies.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES PREVENTION PROGRAM (DPP)&quot;" target="&quot;GENETIC VARIANTS &amp; WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The DPP study indicates that certain genetic variants influence the effectiveness of weight loss interventions in diabetes risk reduction.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOUBLE PODOCYTE STUDY (DPS)&quot;" target="&quot;GENETIC VARIANTS &amp; WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The DPS analysis found that specific genetic variants and weight loss interventions have a combined effect on reducing T2D incidence.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT&quot;" target="&quot;T2D RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Potential G × D interaction was found with genetic variants in the TCF7L2 gene.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT&quot;" target="&quot;SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genome-wide significant associations were identified with Single Nucleotide Polymorphisms (SNPs) at various loci.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G × E INTERACTION&quot;" target="&quot;WHOLE GRAIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Interaction of fiber and whole grain with genetic variants was frequently investigated.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EUROPEAN DESCENDANTS&quot;" target="&quot;SAMPLE RECRUITMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mainly European descendants were included in NHS and HPFS.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARTICIPANTS AGE&quot;" target="&quot;SAMPLE SIZE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Most studies had participants aged over 40 years.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SAMPLE SIZE&quot;" target="&quot;SUBJECTS NUMBER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Total sample size was comprised of cases and controls amounting to 590 participants.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLLOW-UP TIME&quot;" target="&quot;YEARS RANGE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Follow-up time ranged from four to 26 years, with more than eight years in most studies.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ETHNICITY&quot;" target="&quot;POPULATIONS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Studies were conducted on populations of mainly or only European ethnicity.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ETHNICITY&quot;" target="&quot;RS182549&quot;&amp; &quot;BIFIDOBACTERIUM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both ethnicity and rs182549 are related to the abundance of Bifidobacterium.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERVENTION IN DPP&quot;" target="&quot;LIFESTYLE-INTERVENTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"In DPP, participants received individual advice to reduce weight through lower fat and calorie intake along with higher physical activity.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE-INTERVENTION&quot;" target="&quot;INTERVENTION IN DPS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"In DPS, the intervention guided participants to reduce weight by increasing physical activity and following a recommended diet.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY RECOMMENDATIONS&quot;" target="&quot;LIFESTYLE FACTORS - DPP&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"In DPP, participants were advised on Mediterranean dietary patterns with extra-virgin olive oil or mixed nuts as alternatives to low-fat diets.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTORS - PREDIMED&quot;" target="&quot;MEDITERRANEAN-DIET GROUPS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"PREDIMED participants were randomized into two Mediterranean-diet groups which consumed extra virgin olive oil (1 L/week) or mixed nuts (30 g/day).")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBER INTAKE&quot;/" target="&quot;RS7903146 VARIANT&quot;/">
      <data key="d4">3.0</data>
      <data key="d5">"Higher intake of cereal fiber is associated with lower T2D incidence among individuals carrying the rs7903146 CC-genotype but not for those with the risk T-allele.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBRE INTAKE&quot;/" target="&quot;RS10923931 VARIANT&quot;/">
      <data key="d4">6.0</data>
      <data key="d5">"The variants rs10923931 in NOTCH2 and rs4457053 in ZBED3 have been associated with interactions involving fibre intake but were not consistently replicated across studies.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN SENSITIVITY&quot;/" target="&quot;RS2943641 VARIANT&quot;/">
      <data key="d4">7.0</data>
      <data key="d5">"The IRS1 rs2943641 genetic variant has been associated with insulin sensitivity and type 2 diabetes, though its findings have not been validated in other studies.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN SECRETION&quot;/" target="&quot;RS10423928 VARIANT&quot;/">
      <data key="d4">8.0</data>
      <data key="d5">"The GIPR rs10423928 variant has shown interaction with insulin secretion and type 2 diabetes but could not be replicated in all studies.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT INTAKE&quot;/" target="&quot;RS1801282 AND RS3856806 VARIANTS&quot;/">
      <data key="d4">9.0</data>
      <data key="d5">"The PPARγ variants were linked to a trend for interaction with fat intake but could not be consistently replicated.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADH1C *1/*2 VARIANT&quot;/" target="&quot;ALCOHOL CONSUMPTION&quot;/">
      <data key="d4">10.0</data>
      <data key="d5">"The ADH1C*2-allele was associated with lower diabetes risk among alcohol-consuming US women, contrasting its role in men.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEME IRON INTAKE&quot;/" target="&quot;T2D (TYPE 2 DIABETES)&quot;/">
      <data key="d4">11.0</data>
      <data key="d5">"Higher heme iron intake was associated with increased T2D risk among women carrying specific HFE gene variants but not for men.")</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC FACTOR INTERACTION/" target="&quot;PPARGC1A VARIANT&quot;/">
      <data key="d4">1.0</data>
      <data key="d5">Environmental Factor"/</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION WITH HFE RS1799945 VARIANT IN MEN&quot;" target="&quot;MEN POPULATION GROUP (EPIC-INTERACT)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"In EPIC-InterAct study for men population group, an interaction was found to be significant between the H63D variant and T2D risk.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION WITH HFE RS1799945 VARIANT IN MEN&quot;" target="&quot;MEN POPULATION GROUP (DPP)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A similar but not confirmed trend of increased T2D risk was found among men carrying the H63D variant through DPP study.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERNS: WESTERN &amp; MEDITERRANEAN&quot;" target="&quot;INTERACTION WITH GENETIC VARIANTS IN T2D RISK&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Dietary patterns that reflect either Western or Mediterranean diet were associated differently with T2D risk, influenced by specific genetic variants.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION WITH T2D-GRS IN MEN&quot;" target="&quot;RED AND PROCESSED MEAT INTAKE (HPFS)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"High intake of red and processed meat increased T2D risk among men with high genetic risk scores.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MARGINALLY NONSIGNIFICANT INTERACTION WITH GIPR VARIANT RS10423928 IN MEN&quot;" target="&quot;OLIVE OIL INTAKE (EPIC-INTERACT)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A marginally nonsignificant interaction was found between olive oil intake and the GIPR variant rs10423928.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTASE PERSISTENCE LCT GENE VARIANTS (DANISH STUDY)&quot;" target="&quot;MILK CONSUMPTION IN T2D RISK&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Carriers of the lactase persistence LCT rs4988235 T-allele had higher T2D risk than lactose nonpersistence CC-genotype carriers, with differences observed based on milk consumption.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COFFEE INTAKE (EPIC-INTERACT &amp; KARE)&quot;" target="&quot;INTERACTION WITH SOME GENETIC VARIANTS IN T2D RISK&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Findings from EPIC-InterAct and KARE suggest that coffee intake interacts differently with certain genetic variants for T2D risk, either reducing or increasing the risk.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COFFEE INTAKE (EPIC-INTERACT)&quot;" target="&quot;INTERACTION WITH TCF7L2 VARIANT RS12255372 IN MEN&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"A stronger T2D risk-lowering effect of coffee intake was observed among individuals carrying the T allele of the TCF7L2 variant.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK CONSUMPTION (KARE)&quot;" target="&quot;REDUCTION IN COMBINED PREDIABETES AND T2D RISK FOR COFFEE CONSUMERS&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Coffee consumers with specific genetic variants (rs4402960 T-allele, rs7754840 G-allele, rs5215 CC-genotype) showed a reduced combined prediabetes and T2D risk compared to non-consumers.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION WITH HIGH T2D-GRS IN MEN&quot;" target="&quot;WESTERN DIETARY PATTERN (HPFS)&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"A Western dietary pattern was associated with higher T2D risk only among individuals with a high genetic score for T2D, but not among those with a low score.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET (EPIC-INTERACT)&quot;" target="&quot;NO INTERACTION WITH T2D-GRS&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"A Mediterranean diet score showed no interaction with the risk of developing type 2 diabetes according to genetic scores.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MODIFYING EFFECT ON T2D RISK BY GENETIC VARIANTS&quot;" target="&quot;PA (PHYSICAL ACTIVITY)&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"The protective effect of physical activity against T2D was modified by certain genetic variants, with stronger effects observed in individuals not adhering to a high genetic risk score for T2D.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PA (PHYSICAL ACTIVITY)&quot;" target="&quot;WEAKENED PROTECTIVE EFFECT OF HIGHER PA ON T2D INCIDENCE (SWEDISH MALMÖ PROGRAM)&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"In the Swedish Malmö preventive program, lower protective effects of higher physical activity against T2D incidence were observed among individuals with a specific genetic variant for HNF1B.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PA (PHYSICAL ACTIVITY)&quot;" target="&quot;INCREASED LTPA RESULTING IN LOWER T2D INCIDENCE&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"An increase in leisure-time physical activity was associated with lower T2D incidence among individuals with certain genetic variants, such as the Glu12 allele of ADRA2B, GG genotype of ABCC8 rs3758947, and non-risk haplotype of four SLC2A2 variants.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PA (PHYSICAL ACTIVITY)&quot;" target="&quot;REDUCED LEISURE-TIME PHYSICAL ACTIVITY ASSOCIATED WITH HIGHER T2D INCIDENCE&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"Decreased leisure-time physical activity was associated with higher T2D incidence among individuals carrying the PPARγ rs1801282 Ala- and rs17036314 C-alleles, GG genotype of PPARγ, or non-risk haplotype of four SLC2A2 variants.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLYCOGEN STORAGE DISEASE PROTEIN 1 (IRS1)&quot;" target="&quot;INCREASED RISK WITH LOW PA AND T2D RISK A1 ALLELE IN WOMEN&quot;">
      <data key="d4">21.0</data>
      <data key="d5">"In NHS, women carrying the IRS1 rs1522813 A-allele who were physically inactive had a higher risk of developing T2D compared to those with GG-genotype but active.")</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;RISK FACTOR FOR IA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs miR-34b/c rs4938723 and TP53 Arg72Pro were considered in the IA risk assessment.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;ERAP1 SNPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Three SNPs in ERAP1 were found in all patients.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;CDSN SNPS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Two other SNPs in CDSN and three SNPs in CCHCR1 were carried by patient 3.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES INCIDENCE&quot;" target="&quot;RISK GENOTYPES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Participants with certain risk genotypes showed reduced T2D incidence after weight loss intervention.")</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;RS7903146&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TCF7L2 gene includes the genomic variant rs7903146 that was analyzed in this study for its association with risk alleles.")&lt;SEP&gt;"The rs7903146 variant found in TCF7L2 gene showed a significant association with type 2 diabetes (T2D) through this study's analysis.")&lt;SEP&gt;"The rs7903146 variant found within the TCF7L2 gene is associated with type 2 diabetes (T2D), as indicated in this analysis.")&lt;SEP&gt;"The rs7903146 variant in TCF7L2 gene showed consistent association with type 2 diabetes (T2D), as underlined by this study's findings.")&lt;SEP&gt;"The rs7903146 variant was found associated with T2D through this study's analyses and meta-analysis, underlining its significance in diabetes risk assessment.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;T2D&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study's meta-analysis showed consistent results across sets 1 and 2 for rs7903146 variant in TCF7L2 gene, indicating a robust association with type 2 diabetes (T2D).")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;T2D&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs7903146 variant found in TCF7L2 gene showed association with type 2 diabetes (T2D), underlining genetic contributions to diabetes risk assessment.")&lt;SEP&gt;"The rs7903146 variant found in TCF7L2 gene was associated with type 2 diabetes (T2D), as confirmed by this study's analyses and findings.")&lt;SEP&gt;"The rs7903146 variant found in TCF7L2 gene was associated with type 2 diabetes (T2D), as shown through the study's meta-analysis and analyses.")&lt;SEP&gt;"The rs7903146 variant within TCF7L2 gene was associated with type 2 diabetes (T2D), as confirmed by the study's analyses and meta-analysis results.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;ADAMTS9&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs7903146 variant in ADAMTS9 gene showed association with T2D, indicating genetic interactions influencing diabetes risk.")&lt;SEP&gt;"This variant within ADAMTS9 gene was found associated with type 2 diabetes (T2D), though its effect direction was at variance from European studies.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;CDKAL1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs7903146 variant found within CDKAL1 gene showed association with type 2 diabetes (T2D), as indicated by this study's results.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;NUMBER OF TCF7L2 RISK VARIANTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The count of risk alleles associated with the TCF7L2 gene's genetic variants, including rs7903146, was part of the study's analysis.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WFS1&quot;" target="&quot;RS10010131&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs10010131 in the WFS1 gene was associated with type 2 diabetes (T2D), showing a consistent association despite variations compared to European studies.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1&quot;" target="&quot;RS10946398&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNP rs10946398 in CDKAL1 gene was found associated with T2D, replicating results from previous studies and analyses.")&lt;SEP&gt;"SNP rs10946398 was found associated with T2D through this study, underlining genetic factors in diabetes risk.")&lt;SEP&gt;"This SNP in the CDKAL1 gene was found associated with T2D, indicating an alignment of findings consistent with previous research.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1&quot;" target="&quot;T2D&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs10946398 variant in CDKAL1 gene was associated with T2D, supporting the existing body of research on this connection.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10946398&quot;" target="&quot;T2D&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs10946398 in CDKAL1 gene was found associated with T2D, aligning with previous research findings.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10946398&quot;" target="&quot;JAZF1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs10946398 found in JAZF1 gene was associated with T2D, reinforcing findings from previous research.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;JAZF1&quot;" target="&quot;RS864745&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs864745 variant found in JAZF1 gene was associated with T2D, as underlined by this study's results and analyses.")&lt;SEP&gt;"The rs864745 variant found within JAZF1 gene showed association with type 2 diabetes (T2D), as confirmed by this study's findings.")&lt;SEP&gt;"The rs864745 variant in JAZF1 gene showed association with T2D, replicating results from prior studies and analyses.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;JAZF1&quot;" target="&quot;T2D&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs864745 variant in JAZF1 gene was associated with type 2 diabetes (T2D), as indicated by the study's findings and analyses.")&lt;SEP&gt;"The rs864745 variant of JAZF1 gene showed association with type 2 diabetes (T2D), replicating results from earlier studies and analyses.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9&quot;" target="&quot;RS4607103&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A variant in the ADAMTS9 gene was associated with T2D, but its effect direction was opposite to previous European findings.")&lt;SEP&gt;"SNP rs4607103 found in ADAMTS9 gene was associated with type 2 diabetes (T2D), but showed an opposing effect direction compared to European studies.")&lt;SEP&gt;"SNP rs4607103 in ADAMTS9 gene was associated with T2D, but its effect direction was opposite to that observed in European studies.")&lt;SEP&gt;"SNP rs4607103 in ADAMTS9 gene was associated with T2D, though its effect direction was opposite that reported in European studies.")&lt;SEP&gt;"SNP rs4607103 was found associated with T2D through this study's findings, highlighting genetic linkages.")&lt;SEP&gt;"SNP rs4607103 was found associated with T2D through this study, indicating genetic overlap in diabetes risk.")&lt;SEP&gt;"The rs4607103 variant found in ADAMTS9 gene showed association with T2D, but its effect direction differed from European studies.")&lt;SEP&gt;"The rs4607103 variant of ADAMTS9 gene was associated with T2D, though its direction of effect differed from European reports.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9&quot;" target="&quot;T2D&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A single nucleotide polymorphism found in ADAMTS9 gene was associated with type 2 diabetes (T2D), with its effect direction differing from European studies.")&lt;SEP&gt;"Type 2 diabetes (T2D) was associated with a variant in the ADAMTS9 gene, highlighting genetic factors contributing to T2D risk.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D-ESRD&quot;" target="&quot;AGE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Type 2 diabetes and end-stage renal disease (T2D-ESRD) case subjects had an older mean age at enrollment compared to controls, highlighting a possible temporal or health condition correlation.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D-ESRD&quot;" target="&quot;SEX RATIO&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Set 1 had a higher percentage of women compared to controls, indicating potential sex-based disparities in T2D and ESRD associations.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D-ESRD&quot;" target="&quot;AGE AT ENROLLMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The enrollment age difference between T2D-ESRD case subjects and controls was observed, potentially influencing study outcomes or the progression of conditions.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D-ESRD&quot;" target="&quot;AGE AT DIAGNOSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Diagnosis age disparity between T2D and ESRD subjects was observed, possibly influencing outcomes or disease management.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D-ESRD&quot;" target="&quot;RISK FACTOR CONTRIBUTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This study's results highlighted contributions of various risk factors to T2D and ESRD, underscoring interplay between conditions.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D-ESRD&quot;" target="&quot;CLINICAL PARAMETERS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This study's findings underscored the importance of clinical parameters in assessing T2D and ESRD, emphasizing their interrelation.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D-ESRD&quot;" target="&quot;RS7903146+ADAMTS9+CDKAL1+JAZF1+RS864745+RS10946398+RS4607103+RS10946398+RS864745&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The combined genetic variants rs7903146 in TCF7L2, ADAMTS9, CDKAL1, JAZF1, rs864745 and rs10946398 showed association with type 2 diabetes (T2D), indicating complex genetic interplay.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS7903146+ADAMTS9+CDKAL1+JAZF1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The combined variants rs7903146 in TCF7L2, ADAMTS9, CDKAL1 and JAZF1 genes showed association with type 2 diabetes (T2D), highlighting genetic contributions to multiple risk factors.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS864745+JAZF1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The combined variants rs864745 in JAZF1 gene showed association with T2D through this study, emphasizing genetic factors in diabetes risk assessment.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS7903146+ADAMTS9+CDKAL1+JAZF1+RS864745+RS10946398&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The combined genetic variants rs7903146 in TCF7L2, ADAMTS9, CDKAL1, JAZF1 and rs864745 and rs10946398 in other genes were associated with type 2 diabetes (T2D), emphasizing the role of genetic polymorphisms.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS4420638&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs4420638, located near APOC1 gene, shows a strong association with type 2 diabetes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;CRP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Type 2 diabetes shows associations that may involve CRP and pleiotropic SNPs, with some estimates decreasing after adjustment.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS12581299&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNP rs12581299 in FABP2 gene is associated with increased risk of T2D.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS638982&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNP rs638982 near SREBF1 gene shows association with T2D susceptibility.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS10399931&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs10399931 did not show significant associations with T2D after adjustment for covariates.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS4950928&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Similar to rs10399931, rs4950928 was also not associated with Type 2 Diabetes.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;RS10546972&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The association between rs10546972 and T2D was not significant after adjustment for covariates.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;CHI3LI HAPLOTYPE BLOCK 1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Haplotype block 1 of CHI3LI did not show any association with Type 2 Diabetes.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;CHI3LI HAPLOTYPE BLOCK 2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Haplotype block 2 of the CHI3LI gene also showed no significant associations with T2D.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;EGFR&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Diabetic nephropathy in type 2 diabetes impacts eGFR levels through a combination of genetic and metabolic factors.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No evidence for interaction between age and the association between TCF7L2 gene and the number of risk alleles was found.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;MD ADHERENCE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Younger age correlated with higher adherence to the Mediterranean diet.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;SOCIAL DISINHIBITION&quot;">
      <data key="d4">1.001</data>
      <data key="d5">"An increase in age is correlated with a higher social disinhibition score.")&lt;SEP&gt;"Increasing age is positively associated with increased social disinhibition score.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;RESPONSE RATE&quot;">
      <data key="d4">6.43</data>
      <data key="d5">"The effect of rs1893217 on response rate was stronger in the younger age group.")</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;SEX&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age and sex are related entities considered in multivariate logistic regression analysis for HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;TOBACCO&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Age is correlated with tobacco usage, both being factors analyzed for their impact on HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;ALCOHOL&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Age and alcohol consumption are related entities that might influence the risk of HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;BASELINE CD4 COUNTS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Age is correlated with baseline CD4 counts, which play a role in assessing HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;TLR7 (RS179008 AND RS179009)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The entity 'age' correlates with the genetic polymorphisms of TLR7, which are factors studied for HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There is no evidence of interaction between sex and the relationship between the TCF7L2 gene's genetic variants and count of risk alleles.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;MD ADHERENCE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Women were observed to adhere more to the Mediterranean diet compared to men.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;RATIO BETWEEN GROUPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The sex ratio differed, with a higher proportion of female cases relative to male participants.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;RESPONSE RATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"None of the interactions with age or sex were statistically significant for rs1893217, indicating that there is no evidence suggesting gender-specific associations.")</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;TOBACCO&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Sex is related to tobacco usage in terms of their combined influence on HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;ALCOHOL&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Sex and alcohol consumption have a connection that might affect the risk associated with HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEGREE OF AFRICAN ANCESTRY&quot;" target="&quot;INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The degree of African ancestry did not show an effect on the relationship between the TCF7L2 gene's genetic variants and count of risk alleles.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9+CDKAL1+JAZF1&quot;" target="&quot;RS4607103+RS10946398&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs rs4607103 and rs10946398 were found associated with T2D through this study, indicating genetic variability in diabetes risk.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9+CDKAL1+T2D-ESRD CLINICAL PARAMETERS&quot;" target="&quot;RS864745+JAZF1+RS4607103+RS10946398&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs rs864745, JAZF1, rs4607103 and rs10946398 were found associated with T2D and ESRD through this study, highlighting the importance of genetic factors in disease assessments.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTION&quot;" target="&quot;GENETIC RISK SCORES AND COFFEE CONSUMPTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"An inverse association was more pronounced among individuals with high genetic risk scores for black coffee consumption, but the interaction was not statistically significant.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLYCEMIC STATUS TRANSITION&quot;" target="&quot;DISEASE PROGRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Transitioning from NGT to IFG/IGT or T2D is associated with disease progression and increased health risks.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHANGE IN FPG LEVELS&quot;" target="&quot;BMIC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An increase in fasting plasma glucose levels shows a positive association with BMI changes, possibly through metabolic pathways affecting fat accumulation.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTORS&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Lifestyle choices like physical activity can modulate the molecular interaction between dietary components and gene expression related to cardiovascular health.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN RESISTANCE&quot;" target="&quot;PCOS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased insulin resistance as indicated by HOMA-IR score was present among women with PCOS compared to controls.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN RESISTANCE&quot;" target="&quot;PATS/">
      <data key="d4">4.0</data>
      <data key="d5">|&gt;HFD/</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO&quot;" target="&quot;MEDIATED PLEIOTROPY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"After adjusting for CRP, the effect of SNP associated with FTO on cardiometabolic phenotypes mainly goes through BMI, suggesting mediated pleiotropy.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTB&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A GRS ≥ 6 was associated with lower mean scores on TMTB compared to a GRS &lt; 6"</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI CHANGE&quot;" target="&quot;FPG AND 2HPG LEVELS&quot;">
      <data key="d4">-0.1</data>
      <data key="d5">"Fasting plasma glucose and two-hour post-meal glucose levels are negatively correlated with BMI at baseline but positively related to BMI change, indicating complex metabolic interactions.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE GLYCEMIC STATUS&quot;" target="&quot;CHANGE IN BMI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Participants with NGT display lower changes in BMI compared to IFG/IGT or T2D subjects, highlighting protective effects of normal glucose tolerance on body weight maintenance.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT TRANSITION&quot;" target="&quot;INCREASED RISK&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Transitioning from NGT to IFG/IGT increases the risk of developing obesity and metabolic disorders due to higher baseline BMI and BMI change.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREVENTIVE EFFECT&quot;" target="&quot;STABLE NGT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Maintaining normal glucose tolerance over time has a protective effect on body weight management compared to transitioning stages of impaired glycemic status.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;" target="&quot;RS1011527 SNP IN LEPR&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs1011527 SNP in the LEPR gene interacts significantly with FPG on baseline BMI.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMTA&quot;" target="&quot;MTX&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Early MTX-related neurotoxicity may have affected performance on TMTA as per the study")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREATMENT EFFECT&quot;" target="&quot;ACTIVE INTERVENTION GROUPS (LIFESTYLE, METFORMIN, TROGLITAZONE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The active interventions had a significant impact on lowering fasting proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING INSULIN&quot;" target="&quot;PCOS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased fasting insulin levels were found among women with PCOS, indicative of insulin resistance.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN EXPOSURE&quot;" target="&quot;DPP COHORT INDIVIDUALS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The DPP cohort was exposed to certain dietary patterns.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADJUSTMENT FACTOR&quot;" target="&quot;BASELINE FASTING INSULIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Baseline fasting insulin was used as an adjustment factor for statistical analysis.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRUG RESPONSE COMPARISON&quot;" target="&quot;METFORMIN AND TROGLITAZONE INTERVENTION GROUPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The metformin and troglitazone intervention groups showed similar but distinct drug responses in terms of decreasing proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION AFTER TREATMENT&quot;" target="&quot;GENOTYPE AT SLC30A8 LOCUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"After DPP interventions, the association between SLC30A8 risk alleles and fasting proinsulin levels was no longer statistically significant.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPACT&quot;" target="&quot;LIFESTYLE INTERVENTION EFFECTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Impact of lifestyle changes on fasting proinsulin levels following DPP interventions.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPARISON&quot;" target="&quot;METFORMIN VS. TROGLITAZONE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Comparative analysis between the drug effects of metformin and troglitazone on proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE AT SLC30A8 LOCUS INTERACTION&quot;" target="&quot;MODULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The influence of specific genotypes on the effectiveness of diabetes interventions over time.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE-DEPENDENCY&quot;" target="&quot;TREATMENT RESPONSES WITH AGE ADJUSTMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"How different treatment responses are influenced by varying age levels within study participants.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER-EFFECT&quot;" target="&quot;SEX DIFFERENCES IN PROINSULIN RESPONSE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The influence of sex on the body's response to proinsulin levels post-intervention.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CULTURAL-EFFECT&quot;" target="&quot;ETHNICITY-BASED TREATMENT OUTCOMES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"How ethnicity impacts the effectiveness of diabetes prevention interventions and outcomes.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HC DIET&quot;" target="&quot;PNPLA3&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The high carbohydrate diet increases PNPLA3 mRNA and protein levels in mouse liver, which is attenuated by lipid emulsions.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HC DIET&quot;" target="&quot;SREBP1C MRNA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High carbohydrate diet increases expression of SREBP1c transcription compared to NC and controlled by LE.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;HF DIET&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mice fed HF diet have elevated hepatic TG content but suppressed PNPLA3 gene expression compared to mice on LF diet.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;EXERCISE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Voluntary exercise reduces PNPLA3 mRNA levels in mice fed HF diet, suggesting a relationship between physical activity and gene expression in lipogenesis.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;GLUCOSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Glucose regulates PNPLA3 gene expression through depletion-refeeding conditions in HepG2 cells, indicating metabolic pathways influencing the expression of this gene.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;EXOGENOUS FATTY ACID&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The treatment of HepG2 cells with exogenous fatty acids like OA showed no effect on lipid content when oil red O staining was used, but a significant increase in FAS mRNA expression was observed instead, highlighting the dual regulation effects of fatty acids on both PNPLA3 and other genes involved in lipid metabolism.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HF DIET&quot;" target="&quot;FAS (FATTY ACID SYNTHASE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Mice fed HF diet have similar FAS gene expression compared to LF, but other genes like SREBP1c and ACC-1 are modulated by diet.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXERCISE&quot;" target="&quot;SREBP1C MRNA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Physical activity reduces the transcription of SREBP1c on HF diet in mice, indicating a metabolic pathway influenced by lifestyle activities.")</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXERCISE&quot;" target="&quot;GLUCAGON&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The hypothesis suggested that exercise may stimulate glucagon secretion, thereby decreasing the expression of PNPLA3 gene but our data showed no effect of 100 nM glucagon on PNPLA3 mRNA expression under low glucose conditions.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Studies indicated that insulin increased promoter activity of PNPLA3 gene in Chinese hamster ovary cells but incubation with 10 nM insulin for 24 h did not increase PNPLA3 mRNA compared to control cells.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;PATS/">
      <data key="d4">3.0</data>
      <data key="d5">|&gt;SENP1-aP2KO"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCAGON&quot;" target="&quot;FATTY ACIDS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Exercise was hypothesized to stimulate glucagon secretion which could decrease PNPLA3 gene expression but our data showed no effect of 100 nM glucagon on PNPLA3 mRNA under low glucose conditions.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FATTY ACIDS&quot;" target="&quot;PNPLA3 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Several unsaturated fatty acids investigated showed effects on PNPLA3 gene expression when added directly to HepG2 cells, with some significantly suppressing its expression.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;STRESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FoxO1 gene is activated following stress exposure and cortisol treatment, indicating a role in mediating negative effects on neurogenesis.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;AS1842856&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The cell-permeable inhibitor AS1842856 can inhibit the upregulation of FoxO1 by cortisol, suggesting it mediates the effect of stress on this gene.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FoxO1 signaling mediates the effect of stress on neuronal proliferation.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISOC1&quot;" target="&quot;LDLRAP1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The gene ISOC1 interacts with LDLRAP1 through physical interaction or co-expression, contributing possibly to lipid metabolism or other cellular functions.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LRRN3&quot;" target="&quot;MYO1D&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"LRRN3 may show interactions with MYO1D as part of common pathways or biological processes related to cell regulation and dynamics.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MYO1D&quot;" target="&quot;PIK3C2B&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"MYO1D interacts with PIK3C2B, possibly influencing signaling pathways or cellular responses based on their combined expression or functions.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPAP2A&quot;" target="&quot;SAMD12&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The gene PPAP2A might interact with SAMD12 in specific cellular processes or pathways related to biochemical reactions or regulatory mechanisms.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERINC5&quot;" target="&quot;TGF-Β1&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SERINC5 interacts with TGF-β1, possibly contributing to cytokine signaling or other biological responses associated with this pathway.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGF-Β1&quot;" target="&quot;PGAP1&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The glycosylation process facilitated by PGAP1 might interact with TGF-β1 to regulate extracellular matrix dynamics or other biological responses.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEF1&quot;" target="&quot;LIN54&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Transcriptional factors like LEF1 could interact with LIN54, influencing gene expression patterns in various cellular contexts.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;BASELINE CHARACTERISTICS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The relationship between the presence of a specific SNP and various baseline characteristics (gender, race, age, BMI).")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;PATHWAY ANALYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Evaluation of the over-representation of genes in pathways associated with variants related to 'Age at first tooth'.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;C3 RS2230199&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Variants like C3 rs2230199 were investigated for potential interactions with lifestyle on AMD risk, but they showed no strong main effects.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;CFI RS10033900&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The CFI rs10033900 SNP was considered in the study of joint effects with lifestyle factors on AMD, but its combined effect with HLS did not yield reliable estimates.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;TYPE 2 DIABETES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A specific SNP has an inverse relationship with the development or severity of type 2 diabetes.")</data>
      <data key="d6">chunk-b803830d07bff8ae14550f6458048707</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1 MRNA&quot;" target="&quot;STRESS-INDUCED UPREGULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The mRNA levels of FoxO1 are upregulated following stress and cortisol exposure.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AS1842856&quot;" target="&quot;CORTISOL-INDUCED CHANGES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"AS1842856 is able to counteract cortisol-induced reduction in neuronal proliferation, indicating its role in modulating glucocorticoid effects.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUPPLEMENTARY TABLE 9&quot;" target="&quot;EMOTIONAL ABUSE (SEE SUPPLEMENTARY TABLE 9)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The table may provide details about dietary patterns associated with emotional abuse, although not explicitly mentioned.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS&quot;" target="&quot;CONDITION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The stress manipulation had a significant effect on reducing response bias toward the more frequently rewarded stimulus.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS&quot;" target="&quot;CONDITION 3 AND CONDITION 2&quot;">
      <data key="d4">1.41</data>
      <data key="d5">"An elevated discriminability was found in Conditions 3 and 2, indicating better performance than in Condition 1.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL-INDUCED CHANGES IN NEUROGENESIS&quot;" target="&quot;SGK-1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SGK-1 is involved in mediating glucocorticoid effects, specifically cortisol's negative impact on neurogenesis.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL-INDUCED REDUCTION IN NEURONAL PROLIFERATION (BRDU + CELLS)&quot;" target="&quot;OUTCOME/EFFECT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Cortisol was found to reduce neuronal proliferation, as indicated by decreased BrdU+ cells.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;24 H CORTISOL TREATMENT&quot;" target="&quot;EFFECT ON SGK1 MRNA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A 24-hour exposure to cortisol led to an increase in the expression of SGK1 mRNA.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADDITIONAL COPIES OF THE MINOR (G) ALLELE&quot;" target="&quot;PRE-SURGICAL WEIGHT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Additional copies were associated with increased pre-surgical weight in this study.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NADIR PERCENT WEIGHT LOSS&quot;" target="&quot;SNP RS4771122&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"rs4771122 was nominally significantly associated with nadir percent weight loss.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS4771122&quot;" target="&quot;2 YEAR PERCENT WEIGHT LOSS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNP rs4771122 showed association with 2-year percent weight loss.")</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A gene-diet interaction was examined to see if there were significant interactions between genetics and diet, however no such interactions were found.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;ACAC&quot;&amp; &quot;INSULIN SENSITIVITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"AcAc levels are inversely associated with insulin sensitivity.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;BHB&quot;&amp; &quot;INSULIN SENSITIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"BHB levels remain inversely associated with insulin sensitivity.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;ACAC&quot;&amp; &quot;INSULIN SECRETION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High AcAc levels could weaken or eliminate the association of insulin secretion and development of hyperglycemia and diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;BHB&quot;&amp; &quot;INSULIN SECRETION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Similar results are obtained when comparing highest quartile of glucose AUC to three lowest quartiles, indicating an inverse relationship with BHB levels.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;GENUS RUMINICLOSTRIDIUM 9&quot;&amp;&quot;FAMILY PEPTOSTREPTOCOCCAEAE&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"The estimation of heritability and SNP-based heritability showed significant correlation across the tested taxa, with correlation coefficient R=0.244.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;RS4988235 AND MILK INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The LP genetic variant was positively related to milk consumption, affecting the F-statistic for predicting milk intake.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;B12&quot;&amp;&quot;FOLATE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"B12 and Folate are nutrients that might have a molecular interaction affecting maternal health and offspring development.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;GENOMIC VARIANT&quot;&amp;&quot;B12 METABOLISM&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A genomic variant may influence B12 metabolism, affecting its physiological process and levels.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;BSMAI RESTRICTION SITE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The presence of a novel BsmAI restriction site was confirmed through molecular analysis as a result of the P1001L mutation.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;WILD TYPE: MUTANT ALLELE RATIO&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The analysis of DNA from different tissues showed distinct wild type:mutant allele ratios that help to assess genetic variations and mosaicism in the patient.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;QUANTITATIVE REAL-TIME PCR (Q-RT-PCR)&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The results of Q-RT-PCR experiments demonstrated consistent wild type:mutant allele ratios across different tissues, contributing to a clearer understanding of genetic mosaicism.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;ADDITIVE GENETIC ARCHITECTURE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An additive genetic architecture was consistent with the observation that FEV1/FVC decreased with increasing number of 'low FEV1/FVC alleles'.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;W631*&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The W631* variant results in a truncated protein that affects its ability to function correctly.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;X-RAY STRUCTURE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The X-ray structure confirms the conformation of peptide bound to MHC groove and supports the fixed-backbone modeling approach.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL INFORMATION&quot;" target="&quot;PROBANDS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Clinical findings were similar for probands who carry GCK variants, compared to those described previously.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROBANDS&quot;" target="&quot;CLINICAL PHENOTYPE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"One proband had mild fasting hyperglycemia and stable HbA1c level despite being identified with this genetic change, indicating that the clinical manifestation might not always match genetic data.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK VARIANTS&quot;" target="&quot;SEQUENCE ANALYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Sequence analysis identified 134 GCK variants in probands from the year 2008 to 2018.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEQUENCE ANALYSIS&quot;" target="&quot;PEPTIDE SEQUENCE SIMILARITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Comparative analysis of peptide sequences helps identify those with higher affinity or potential for stronger T-cell responses.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CO-SEGREGATION WITH THE DIABETES PHENOTYPE&quot;" target="&quot;PARENTAL OR EXTENDED FAMILY DNA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Establishing co-segregation confirmed that the diabetes phenotype is indeed associated with specific genetic variants.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREDICTIVE TOOLS&quot;" target="&quot;VUS (VARIANTS OF UNCERTAIN SIGNIFICANCE)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Seven VUS were predicted to be damaging by in-silico tools, but they did not satisfy pathogenic or likely pathogenic classification requirements due to lack of segregation and/or phenotypic data.")</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;TAG CONCENTRATIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In medium and high MD adherence, TAG concentrations were significantly lower.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;HDL-C CONCENTRATIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"HDL-C (high-density lipoprotein cholesterol) concentrations were higher with increased Mediterranean diet adherence.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The apoB:apoA-1 ratio was significantly lower in medium and high MD adherence categories.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;HBA1C CONCENTRATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"HbA1c concentration was lower as the Mediterranean diet adherence increased.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Physical activity was associated with higher adherence to the Mediterranean diet.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MD ADHERENCE&quot;" target="&quot;WC (WAIST CIRCUMFERENCE)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Lower waist circumference was associated with increased adherence to Mediterranean diet.")</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;GENETIC FACTORS AND LIFESTYLE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic predisposition may influence how individuals engage in lifestyle behaviors such as physical activity.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;DIET&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Diet and physical activity are lifestyle and environmental factors that modulate cardiovascular health.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN AND SMOKING STATUS&quot;" target="&quot;LIFESTYLE/ENVIRONMENTAL FACTOR INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Smoking status was considered alongside dietary patterns to assess potential interactions on health outcomes.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HETEROZYGOUS MUTATION&quot;" target="&quot;AUTOSOMAL DOMINANT INHERITANCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A specific heterozygous mutation follows an autosomal dominant inheritance pattern.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.ARG322 HIS&quot;" target="&quot;DIAZOXIDE TREATMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The p.Arg322 His mutation is associated with a response to diazoxide treatment in patients.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.SER498LEU&quot;" target="&quot;HI/HA SYNDROME&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The p.Ser498Leu mutation contributes to the HI/HA syndrome in patient 52.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM AMMONIA CONCENTRATION&quot;" target="&quot;GASTROINTESTINAL DISTURBANCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased serum ammonia concentration may be associated with gastrointestinal disturbances and poor appetite.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUBTOTAL PANCREATECTOMY&quot;" target="&quot;SURGERY RESPONSE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Subtotal pancreatectomy is effective in patients unresponsive to drug therapy, such as diazoxide.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS&quot;" target="&quot;OUTCOME OF SURGERY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Some patients developed diabetes mellitus after surgery and required insulin treatment.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEVERE HYPOGLYCAEMIA&quot;" target="&quot;DIAZOXIDE UNRESPONSIVENESS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Three patients were unresponsive to diazoxide therapy, leading to severe hypoglycemia and subsequent death.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COGNITIVE FUNCTION&quot;" target="&quot;DIETARY PATTERNS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Dietary choices and intake of certain nutrients can influence how NOS1 functions, affecting cognitive health.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR DISEASE RISK FACTORS&quot;" target="&quot;NOS1 GENE VARIANTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variations in NOS1 may exacerbate or mitigate risk for cardiovascular diseases through interaction with lifestyle factors.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRUG RESISTANCE&quot;" target="&quot;C. JEJUNI&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Five of the quinolone-resistant C. jejuni isolates found among retail food products or broiler chickens were also found in human isolates, highlighting possible environmental sources for drug resistance.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN DEPENDENCY&quot;" target="&quot;THERAPY RESPONSE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Treatment outcomes can involve insulin dependency as a result of the management strategies for diabetes mellitus post-surgery.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MULTIORGAN FAILURE&quot;" target="&quot;COMORBIDITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Multiorgan failure might be linked to other underlying health conditions or complications in patients undergoing complex surgical procedures.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRUG THERAPY EFFECTIVENESS&quot;" target="&quot;EPIGENETIC MODIFICATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Changes in GLUD1 gene expression through epigenetic mechanisms can impact the effectiveness of diazoxide treatment for HI/HA syndrome.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY INTERVENTIONS&quot;" target="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Implementing a low-protein diet is an effective management strategy for patients experiencing hypoglycemia due to GLUD1 mutations.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS DEVELOPMENT&quot;" target="&quot;SURGERY OUTCOME&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The development of diabetes mellitus after surgery indicates a possible long-term complication requiring specific therapeutic interventions.")</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC&quot;" target="&quot;FPG&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"AcAc levels decrease significantly in IFG and increase significantly in diabetes compared to the reference category (FPG ≤5.4 mmol/L).")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC&quot;" target="&quot;2HPG&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"AcAc level increases significantly in IGT and newly diagnosed diabetes as compared with the reference category (2hPG ≤5.9 mmol/L).")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BHB&quot;" target="&quot;FPG&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"BHB level decreases significantly in IFG and increases significantly in diabetes compared to the reference category (FPG ≤5.4 mmol/L).")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BHB&quot;" target="&quot;2HPG&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"BHB level nominally increases slightly in IGT but significantly in newly diagnosed diabetes, compared to the reference category (2hPG ≤5.9 mmol/L).")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1 PROTEIN&quot;" target="&quot;FOLATE METABOLISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The NOS1 protein interacts with folate metabolism to maintain vascular function.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;NOS1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The NOS1 gene interacts with folate metabolism to regulate nitric oxide production.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE&quot;" target="&quot;LEAFY GREENS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Folate is a nutrient found in leafy greens, which are important for cardiovascular health.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;GENDER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Stratification analysis by gender did not find any association between the two SNPs and IA risk.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;RS4988235 AND PLASMA C15:0/C17:0&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There was a minor association between rs4988235 and increased levels of saturated fats (C15:0 and C17:0).")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;SERUM FOLATE CONCENTRATION BELOW STUDY POPULATION MEDIAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An analysis focusing on individuals with serum folate concentrations below the median revealed no association between these levels and male infertility.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;GENETIC FACTOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The ALDH2 genotype's influence extends into environmental factors like smoking status in determining alcohol consumption patterns.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;UK&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Frequency of non-persistence allele was observed differently in comparison to other populations.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;MILK CONSUMPTION PATTERNS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Differences were observed based on different rs4988235 genotypes related to milk consumption.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;NOS1&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The relationship between the NOS1 gene and environmental factors can influence its activity in maintaining vascular function.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;OVARIAN CANCER ASCITES&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Human ovarian cancer ascites provides an in vitro model for testing the specificity, efficacy, and activity of TAG72-BBζ CAR T cells.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATINS&quot;" target="&quot;PERSONALIZATION OF THERAPY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Not specified in the text, no relationship mentioned.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATINS&quot;" target="&quot;PERSONALIZED THERAPY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Statins are a drug therapy that may be part of personalized therapies for managing cardiovascular disease risk.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC&quot;&amp; &quot;DEVELOPMENT OF HYPERGLYCEMIA&quot;" target="&quot;PREDICTOR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Highest quartile AcAc predicts conversion to type 2 diabetes (OR 1.32 [95% CI 1.00–1.74], P = 0.047).")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREDICTOR&quot;" target="&quot;BHB&quot;&amp; &quot;DEVELOPMENT OF HYPERGLYCEMIA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Highest quartile BHB also predicts conversion to type 2 diabetes, albeit with less statistical significance.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1&quot;" target="&quot;CRP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNPs located near APOC1 show associations with CRP and other cardiometabolic phenotypes including T2D and CAD.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A&quot;" target="&quot;CAD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNPs in the HNF1A gene are associated with risk reduction for CAD but increased serum CRP levels when carrying G-allele of rs1183910.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PABPC4&quot;" target="&quot;TRIGLYCERIDES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Adjustments for CRP led to a considerable decrease in the estimate of association between PABPC4 and triglyceride levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B&quot;" target="&quot;HDL-CHOLESTEROL&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"After adjusting for multiple factors, the effect of BCL7B on HDL-cholesterol is still noticeable but mostly mediated through lipid variables.")&lt;SEP&gt;"For BCL7B and HDL-cholesterol levels, lipid variables appear to be the most important mediators after adjustment.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMEM18&quot;" target="&quot;MEDIATED PLEIOTROPY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Similarly to FTO, adjusted effects of SNP related to TMEM18 for pleiotropic outcomes are mainly mediated by BMI.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;G-ALLELE OF RS1183910&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The G-allele of the SNP rs1183910 in HNF1A gene is associated with lower risk of coronary artery disease, while its A-allele increases serum CRP levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;G-ALLELE OF RS7041&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The G-allele of SNP rs7041 in LPL gene shows association with CAD susceptibility.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;RS17429505&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNP rs17429505 in ADAMTS7 gene is associated with CAD risk through pleiotropic mechanisms.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;RS20417&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A statistically significant association was observed between rs20417 polymorphism and CAD.")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAD&quot;" target="&quot;RS20118426&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The study identified a strong link between rs20118426 polymorphism and the presence of CAD.")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP&quot;" target="&quot;RS3764260&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs3764260 near IL1F10 gene shows significant association with CRP levels and inflammation.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP&quot;" target="&quot;LACK OF CONSISTENT ASSOCIATION&quot;">
      <data key="d4">3.6</data>
      <data key="d5">"The relationship between CRP and ovarian cancer risk was ambiguous due to inconsistent findings across study phases.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP&quot;" target="&quot;DIABETES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Individuals who develop diabetes typically have higher CRP levels.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLESTEROL&quot;" target="&quot;MEDITERRANEAN GROUP&quot;">
      <data key="d4">0.72</data>
      <data key="d5">"Mean serum 18:2 n-6 significantly decreased (p=0.02), and both MUFA and n-3 PUFA significantly increased in the Mediterranean group.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HDL-CHOLESTEROL&quot;" target="&quot;RS5698321&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNP rs5698321 near MTHFD1L gene affects HDL-cholesterol levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;IA&quot;">
      <data key="d4">0.006</data>
      <data key="d5">"The CC genotype of miR-34b/c rs4938723 was associated with a decreased risk of IA compared to the TT genotype.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;NUMBER OF ANEURYSMS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No association between the number of aneurysms and miR-34b/c rs4938723 genotypes was observed.")&lt;SEP&gt;"No significant association between miR-34b/c rs4938723 and the number of aneurysms was observed.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;NUMBER OF ANEURYSMS IN CASES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Association between miR-34b/c rs4938723 genotypes and IA, but not with the number of aneurysms.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;HARDY WEINBERG EQUILIBRIUM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genotype frequencies of miR-34b/c rs4938723 met the Hardy Weinberg equilibrium requirements.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;DECREASE RISK OF IA&quot;">
      <data key="d4">0.006</data>
      <data key="d5">"The CC genotype of miR-34b/c rs4938723 was associated with a lower risk of IA compared to TT genotype.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;IA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No association between TP53 Arg72Pro and IA risk was observed in genotypic or allelic association analysis.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;NUMBER OF ANEURYSMS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant association between TP53 Arg72Pro and the number of aneurysms was found.")&lt;SEP&gt;"No significant link found between TP53 Arg72Pro and the number of aneurysms in the study.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;NUMBER OF ANEURYSMS IN CASES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No association found between TP53 Arg72Pro and either IA risk or the number of aneurysms.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;HARDY WEINBERG EQUILIBRIUM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genotype frequency distribution for TP53 Arg72Pro also met the Hardy-Weinberg equilibrium criteria.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IA&quot;" target="&quot;MIR-34B/C RS4938723 AND TP53 ARG72PRO&quot;">
      <data key="d4">0.004</data>
      <data key="d5">"Carriers with the combined genotypes of miR-34b/c rs4938723CC and TP53 Arg72Pro CG/CC/GG had a decreased risk of IA compared to other combined genotypes.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IA&quot;" target="&quot;COMBINED GENOTYPES&quot;">
      <data key="d4">0.004</data>
      <data key="d5">"Carriers with the combined genotypes rs4938723CC and TP53 Arg72Pro CG/CC/GG had a reduced risk of IA.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER&quot;" target="&quot;ANALYSIS METHOD&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Gender was used as a variable for stratified analysis.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER&quot;" target="&quot;ASSOCIATION BETWEEN GENOTYPES AND SUA LEVEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The T allele of rs2231142 ABCG2 was associated with sUA levels and HUA in both males and females, while the C risk allele of SLC2A9 was only related to females. The G risk allele of SLC22A12 was associated with sUA level only in males.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER&quot;" target="&quot;ASSOCIATION BETWEEN GENOTYPES AND HUA RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The association between different genotypes and HUA risk differed by gender: the T allele of rs2231142 ABCG2 showed significance, while there was no significant association with SLC22A12 rs893006 variants.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEVEL OF SIGNIFICANCE&quot;" target="&quot;P-VALUE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"P-values for significant associations ranged from 0.004 to 0.006.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P-VALUE&quot;" target="&quot;SIGNIFICANCE LEVEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A p-value less than 0.05 was considered statistically significant for some associations, as seen in miR-34b/c rs4938723 association with IA risk.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P-VALUE&quot;" target="&quot;STATISTICAL MEASURE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Suggestive significance (p &lt; 1 × 10−5) for genotyped SNPs in GWAS.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION WITH DISEASE&quot;" target="&quot;SNPS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Two SNPs—miR-34b/c rs4938723 and TP53 Arg72Pro were analyzed for their potential association with IA.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;AGE AT FIRST TOOTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Association was identified between common SNPs and age at first tooth.")&lt;SEP&gt;"Genetic variation at SNPs was associated with age at first tooth.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;NUMBER OF TEETH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Association was identified between common SNPs and number of teeth.")&lt;SEP&gt;"Genetic variation at SNPs was associated with number of teeth.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;LOCI&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNPs associated with the identification of genome-wide significant loci.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;NOVEL ASSOCIATIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"SNPs were associated with novel gene/region for age at first tooth.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;PREVIOUSLY REPORTED GENES/REGIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNPs associated with the confirmation of previously reported genes/regions.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;GENOME-WIDE SIGNIFICANCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs were associated with genome-wide significance in the phenotype.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;ALLELIC SCORE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"SNPs used in the creation of an allelic score that could inform therapeutic intervention.")&lt;SEP&gt;"SNPs were used to create an allelic score that explained variation in phenotype.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;SUGGESTIVE LEVELS OF ASSOCIATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNPs showed suggestive associations beyond the genome-wide significance threshold.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;SECONDARY SIGNALS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"SNPs were associated with the identification of secondary genomic variants within each locus.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;SECONDARY ANALYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs underwent additional analyses to discern underlying genetic influences beyond the primary associations.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;BIOLOGICAL PATHWAYS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"SNPs implicated specific pathways related to tooth development and maturation.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;PHENOTYPIC PLASTICITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNPs were linked with changes in phenotype due to environmental exposure influencing development of dentition.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;HERITABILITY ESTIMATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Estimations were based on correlations between SNPs and trait variability." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;ENVIRONMENTAL INFLUENCE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNPs showed responsiveness to environmental factors that modify dentition development timelines." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;CLINICAL RELEVANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNPs were indicative of potential clinical applications in assessing risk or influencing prognosis of dental health issues related to age at first tooth and number of teeth." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;GENETIC ARCHITECTURE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNPs provided insights into the complex genetic structure influencing dental development timelines across diverse populations." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;POPULATION STRATIFICATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNPs were analyzed considering population-specific genetic variations that might contribute to or mask associations with dentition development." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;META-ANALYSIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNPs were identified through a comprehensive analysis across various datasets, increasing the robustness of findings related to dentition development traits." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;LONGITUDINAL DYNAMICS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNPs were tracked across different developmental stages to uncover temporal patterns influencing dentition development." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;PUBLIC HEALTH IMPLICATIONS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNPs were used as a basis for developing policies and guidelines that consider genetic predispositions in dental health management and public health initiatives." )</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;MINOR ALLELES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Three of the SNPs were associated with increased risk while three had protective effects on the social disinhibition score.")</data>
      <data key="d6">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;COMBINATION THERAPY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There were no associations found between the 23 SNPs and combination therapy outcomes, even after adjustments for multiple testing methods and covariates.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;TEST TYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Assessment of genotypic frequencies to confirm random mating and no evolutionary pressures.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;STATISTICAL ANALYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The statistical analysis for Hardy-Weinberg equilibrium was performed to check the validity of certain subgroup results in relation to genetic studies on ovarian cancer risk.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;ROMANIA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Nominal evidence for departure from Hardy-Weinberg equilibrium was found only in Romania.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;RS376618&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Satisfied except for FGFR4 rs376618; no significant differential treatment effects associated with this SNP.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GROUP FOCUS&quot;" target="&quot;INDIVIDUALS ANCESTRY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No specific emphasis was placed on ancestry groups, with the study including participants from diverse backgrounds.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUMBER OF CONTROLS&quot;" target="&quot;SAMPLE SIZE COMPARISON&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The control group was substantially larger than the case group (164 vs. 426 participants).")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STUDY POPULATION DIVERSITY&quot;" target="&quot;VARIETY OF PARTICIPANTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study involved individuals from different demographic groups, though no specific diversity measures were stated.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGES RANGE&quot;" target="&quot;CHARACTERISTICS OF SAMPLE POPULATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study did not specify the age distribution among either cases or controls.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHARACTERISTICS OF SAMPLE POPULATION&quot;" target="&quot;GENDER PROPORTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The sex ratio showed an imbalance, with more females than males among the study participants.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHARACTERISTICS OF SAMPLE POPULATION&quot;" target="&quot;ANCESTRY BACKGROUND&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study did not include any data regarding the ancestral backgrounds of participants.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHARACTERISTICS OF SAMPLE POPULATION&quot;" target="&quot;HERITAGE VARIABILITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study did not specify the ethnic or ancestral diversity among participants.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUMBER OF CASES&quot;" target="&quot;SPECIFIC GROUP SIZE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The number of cases with IA was 164, which constituted a smaller subgroup compared to the control population (426).")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESEARCH METHODOLOGY&quot;" target="&quot;STUDY DESIGN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study utilized a case-control approach to compare individuals with IA against those without it.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STUDY DESIGN&quot;" target="&quot;GWAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study included genome-wide genotyping and spirometry phenotypes in a GWAS.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESEARCH ANALYTICAL PROCESS&quot;" target="&quot;STATISTICAL METHODOLOGY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study likely involved statistical tools including Hardy Weinberg equilibrium test, P-value computation for assessing significance, etc., although specific details were not given.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL METHODOLOGY&quot;" target="&quot;MULTIMARKER MODELING&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"A multimarker model including all SNPs with P &lt; 10−3 was performed using LASSO regression.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESEARCH OBJECTIVE&quot;" target="&quot;SCIENTIFIC INQUIRY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study aimed at determining if genetic variants could predict or influence the incidence of IA.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK DETERMINANTS FOR DISEASE&quot;" target="&quot;SNP VARIABLES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study included genetic variables like miR-34b/c rs4938723 and TP53 Arg72Pro, alongside other potential risk factors.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DATA ANALYSIS PROCESS&quot;" target="&quot;STATISTICAL EVALUATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Findings were interpreted statistically, comparing case and control groups for identifying potential risk factors.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLUENCE ON RESEARCH OUTCOMES&quot;" target="&quot;SEX FACTOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While the study included gender as an analysis variable, it found no consistent sex-specific associations with IA risk based on genetic markers.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHARACTERISTICS OF PARTICIPANTS&quot;" target="&quot;STUDY SAMPLE PROFILES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The sample encompassed both case and control groups that differed in terms of genetic risk factors, sex ratio, age range, etc., though exact details were not provided.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DETERMINING STATISTICAL RELEVANCE&quot;" target="&quot;SIGNIFICANCE THRESHOLD FOR P-VALUES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Results with P-values less than 0.05 were considered statistically significant and worthy of further investigation.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC DATA ANALYSIS RIGOR&quot;" target="&quot;QUALITY ASSURANCE IN RESEARCH METHODOLOGY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Rigorous approaches were taken with genetic data validation and statistical significance determination to ensure the robustness of findings.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITAGE INFLUENCE&quot;" target="&quot;OUTCOME DETERMINANTS IN GENETIC RESEARCH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While ancestry was indirectly relevant through the sample's diversity, its direct impact on genetic findings for IA was not specifically addressed or analyzed.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER-SPECIFIC ANALYSIS&quot;" target="&quot;SNP INFLUENCE ON DISEASE RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In the context of IA risk, no distinct gender-specific effects were discerned in relation to genetic markers such as miR-34b/c rs4938723 or TP53 Arg72Pro.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP INFLUENCE ON DISEASE RISK&quot;" target="&quot;SEX DISTRIBUTION IMPACT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Analysis of genetic markers did not highlight any sex-specific patterns or differences that could significantly influence IA risk based on the data provided.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXAMINATION TECHNIQUES FOR VARIABLES&quot;" target="&quot;STATISTICAL TOOLS USED&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A mix of statistical analyses was employed to identify patterns or associations in the data related to genetic markers and IA disease prevalence.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITAGE GENETICS&quot;" target="&quot;INFLUENCE ON DISEASE SUSCEPTIBILITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While the impact of specific genes was explored through SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro, ancestral genetic influences were not a focal point.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DETERMINING GENETIC ASSOCIATIONS&quot;" target="&quot;STATISTICAL SIGNIFICANCE CRITERION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genetic links identified required a statistical significance ascertained through P-values below the established threshold to be considered reliable.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER ROLE IN HEREDITARY IMPACT&quot;" target="&quot;MEDIATION OF GENETIC INFLUENCE ON DISEASE RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While sex could indirectly affect how genetic heritage influences IA risk, its specific effect was not a central focus given the study's concentration on SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSESSING GENETIC MARKER ASSOCIATIONS WITH DISEASE RISK&quot;" target="&quot;HERITAGE DIVERSITY INTERPRETATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Ancestry diversity was not considered in the assessment of genetic markers' relevance to IA risk, potentially missing nuanced insights into how different populations may differently respond based on their unique genetic makeup.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DETERMINING CORRELATION WITH DISEASE&quot;" target="&quot;STATISTICAL SIGNIFICANCE CRITERIA FOR GENOMIC FACTORS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Finding a correlation between genomic factors and IA disease states required statistical evidence with P-values below the specified threshold for reliability.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC MARKERS FOR RISK ASSESSMENT&quot;" target="&quot;POTENTIAL INFLUENCERS IN DISEASE STATE DETERMINATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs were considered possible influencers of IA risk through statistical methods, seeking evidence that they could be linked to disease prevalence or predisposition within the sample populations.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER INFLUENCE ON GENETIC MARKER CORRELATIONS&quot;" target="&quot;POTENTIAL MODIFIERS IN SNP-AIA RISK ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While sex could theoretically affect the correlations between specific SNPs and IA, its impact was not a primary focus given the study's emphasis on establishing associations rather than exploring nuanced gender-related dynamics.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANCESTRY CONSIDERATION IN GENETIC MARKER CORRELATION&quot;" target="&quot;RELEVANCE TO DISEASE RISK ASSESSMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Given the primary focus on SNPs, no explicit analysis was conducted into how ancestral backgrounds might influence the relevance or predictive power of genetic markers in IA risk determination.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION WITH DISEASE PREVALENCE DETERMINATION&quot;" target="&quot;STATISTICAL ASSESSMENT IN GENOMIC FACTOR EVALUATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genomic factors were evaluated for their correlation with disease prevalence using statistical methods like P-values and the Hardy Weinberg equilibrium test, seeking evidence that they could be predictive of IA risk based on data from case versus control groups.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFLUENCE IN DISEASE RISK ASSESSMENT THROUGH SNPS&quot;" target="&quot;SEX ROLE IN GENETIC MARKER CORRELATION EVALUATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While sex was acknowledged as part of the population characteristics, its role did not feature prominently in the direct correlation assessments between genetic markers and IA risk based on the methodology employed by the study.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITAGE DIVERSITY'S ROLE IN GENETIC MARKER CORRELATION EVALUATION&quot;" target="&quot;RELEVANCE TO DISEASE RISK THROUGH STATISTICAL ASSESSMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Given the study's focus on establishing correlations rather than exploring nuanced population dynamics, heritage diversity was not a primary factor considered when assessing the relevance of genetic markers like miR-34b/c rs4938723 and TP53 Arg72Pro in IA risk determinations through statistical means.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SIGNIFICANCE IN DISEASE STATE EVALUATION THROUGH COMPARATIVE ANALYSIS&quot;" target="&quot;STATISTICAL CRITERIA FOR GENETIC FACTOR IMPACT DETERMINATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"To assess the meaningful impact of genetic factors on IA disease states, P-value thresholds were applied during comparative case-control analyses involving SNPs like miR-34b/c rs4938723 and TP53 Arg72Pro to determine if they significantly correlated with disease prevalence or predisposition.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION DETERMINATION FOR DISEASE PREVALENCE THROUGH STATISTICAL ANALYSIS&quot;" target="&quot;GENETIC MARKER EVALUATION IN RISK ASSESSMENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The evaluation process sought to ascertain if specific genetic markers could contribute meaningfully to IA risk determinations by analyzing their correlations with case versus control populations, potentially factoring in sex or heritage diversity as secondary considerations.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION ASSESSMENT FOR DISEASE STATE DETERMINATION THROUGH STATISTICAL ANALYSIS&quot;" target="&quot;STATISTICAL SIGNIFICANCE IN GENETIC MARKER CORRELATION EVALUATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The process involved applying statistical tools like P-values and Hardy Weinberg equilibrium tests to assess if correlations exist between specific SNPs and IA disease states, with sex or heritage diversity factored into secondary analyses rather than being the primary focus in determining genetic marker significance.")</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS&quot;" target="&quot;ALLELIC SCORE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Construction of allelic scores from genome-wide significant SNPs for 'Age at first tooth' and 'Number of teeth' as part of GWAS.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS&quot;" target="&quot;STATISTICAL ANALYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A Genome-Wide Association Study was conducted to find the genetic polymorphisms associated with habitual coffee consumption.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARHGAP11A&quot;" target="&quot;SLEEP DURATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The intronic variant in ARHGAP11A on chromosome 15 was associated with sleep duration.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C21ORF34&quot;" target="&quot;RQ (RESPIRATORY QUOTIENT)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A SNP in the intronic region of C21orf34 detected for RQ during sleep.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;FREE TESTOSTERONE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Significantly higher free testosterone levels were noted in women with PCOS.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;BIOACTIVE TESTOSTERONE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Women with PCOS showed differences in bioactive testosterone compared to control subjects.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;HOMA-IR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Elevated HOMA-IR was seen in women with PCOS, reflecting insulin resistance.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;SHBG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Lower levels of SHBG were noted among women with PCOS compared to controls.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;TSH&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Although within the normal range, TSH was higher among women with PCOS compared to control subjects.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;SENP1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The assays described above suggest that type-1-like diabetic phenotypes developed in the adipocyte-specific SENP1-deficient mice.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;Β CELLS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There was a sharp decline in insulin staining and CD31+ vascular area in the islets in SENP1-aP2KO mice (Fig. 3d with quantifications in Fig. 3e), indicating a loss of function in the β cell with disrupted vasculatures.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;Β-HYDROXYBUTYRATE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Beta-hydroxybutyrate is classified as ketones that are produced in the body when the body loses its ability to absorb glucose properly.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;MHCII+CD11B+CD11C− MACROPHAGES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The distribution of immune cells in the pancreases was determined by fluorescence-activated cell sorting (FACS) analyses with specific surface markers. MHCII+CD11b+CD11c− macrophages, CD3e+ T cells and CD19+ B cells were markedly increased in the pancreases of SENP1-aP2KO versus the Ctrl mice.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES&quot;" target="&quot;CAUSE OF&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased proinflammatory cytokines, cardiac function changes and vascular reactivity issues are potential causes leading to diabetes in SENP1-deficient mice.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;PRO-INFLAMMATORY CYTOKINE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-6, like IL-1β, plays an important role in exacerbating inflammation through its ability to stimulate the production of other pro-inflammatory cytokines such as TNF-α.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;IL-10 TREATMENT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Inhibition of IL-6 activity by blocking its receptor partially abrogates Th17 formation with Rag1−/− LPMφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&quot;PROINFLAMMATORY CYTOKINES&quot;/&quot;PATS/">
      <data key="d4">5.0</data>
      <data key="d5">|&gt;SENP1-aP2KO"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPIRATORY QUOTIENT (RQ)&quot;" target="&quot;C21ORF34 INTRONIC REGION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A SNP in the C21orf34 intronic region detected for RQ during sleep.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP DURATION&quot;" target="&quot;ARHGAP11A 15TH CHROMOSOME&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"An intronic variant in ARHGAP11A on chromosome 15 was associated with sleep duration.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIGHT ACTIVITY&quot;" target="&quot;RPL7P3 5′UTR&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Accelerometer-measured light activity variant was found in the 5′UTR region of RPL7P3.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIGHT ACTIVITY&quot;" target="&quot;RPL7P3 5′UTR REGION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Accelerometer-measured light activity variant found in the RPL7P3 5′UTR region.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCFL 3′UTR&quot;" target="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Sedentary-light activity was measured in the 3′UTR of CTCFL on chromosome 20.")&lt;SEP&gt;"Sedentary-light activity was measured using CTCFL's 3′UTR sequence on chromosome 20.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATK CHROMOSOME 19&quot;" target="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A highly significant variant identified for total energy expenditure (p = 2.7E-08) was associated with MATK on chromosome 19.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL ENERGY EXPENDITURE&quot;" target="&quot;MATK 19TH CHROMOSOME&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A highly significant variant associated with total energy expenditure (p = 2.7E-08) was identified for MATK on chromosome 19.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHRNA3 CHROMOSOME 15&quot;" target="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Sleeping energy expenditure variant identified for CHRNA3 on chromosome 15.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEPING ENERGY EXPENDITURE&quot;" target="&quot;CHRNA3 15TH CHROMOSOME&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Sleeping energy expenditure variant identified for CHRNA3 on chromosome 15.")</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SPLICING REGULATOR&quot;" target="&quot;GENOMIC VARIANT RS61737565&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"rs61737565 variant affects splicing by potentially altering binding sites for splicing regulators.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT RS61737565&quot;" target="&quot;TUFM GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs61737565 affects the TUFM gene by altering splicing regulator or transcription factor binding sites.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM GENE&quot;" target="&quot;GENOMIC VARIANT RS8061877&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs8061877 disrupts the binding of transcription factors SRY, HFH 2, and HMG-IY in the TUFM gene.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM GENE&quot;" target="&quot;GENOMIC VARIANT G.28854194C/G&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant g.28854194C/G causes changes in splice enhancer and splicing silencer sites within the TUFM gene.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM GENE&quot;" target="&quot;NON-CODING 3’ UTR OF TUFM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The non-coding 3’ UTR region of TUFM contains genomic variant g.28854194C/G which affects the gene function.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT RS8061877&quot;" target="&quot;TRANSCRIPTION FACTOR BINDING SITES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Disruption of transcription factor binding sites occurs due to rs8061877 variant, influencing gene regulation.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT G.28854194C/G&quot;" target="&quot;SPLICE ENHANCER AND SPLICING SILENCER SITES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"g.28854194C/G affects splice sites via changes in enhancer and silencer regions.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NON-CODING 3’ UTR OF TUFM&quot;" target="&quot;GENE EXPRESSION REGULATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The non-coding 3’ UTR can impact gene expression independently or through interactions with genomic variants like g.28854194C/G.")</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALOX15&quot;" target="&quot;LACK OF ASSOCIATION&quot;">
      <data key="d4">3.4</data>
      <data key="d5">"No strong evidence suggests that ALOX15 plays a significant role in increasing the risk of ovarian cancer as per the study phases.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL18&quot;" target="&quot;PHASE OF STUDIES&quot;">
      <data key="d4">3.7</data>
      <data key="d5">"The relationship between IL18 and ovarian cancer risk was unclear due to varying results across different stages of research phases.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1&quot;" target="&quot;RS2282169&quot;">
      <data key="d4">3.3</data>
      <data key="d5">"The variant rs2282169 within the PTGS1 gene is linked to an association with increased risk for ovarian cancer, indicating its role in this disease's etiology.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1&quot;" target="&quot;RS2282169&quot;&amp; &quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">3.9</data>
      <data key="d5">"The variant rs2282169 in PTGS1 gene appears to be linked with ovarian cancer risk, although this was not explicitly stated in the text.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1&quot;" target="&quot;RS2282169&quot;&amp;&quot;POTENTIAL OVARIAN CANCER LINKAGE&quot;">
      <data key="d4">3.11</data>
      <data key="d5">"A potential connection exists between rs2282169 variant in PTGS1 gene and ovarian cancer, though this was not extensively detailed.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B&quot;" target="&quot;RS7596684&quot;">
      <data key="d4">3.2</data>
      <data key="d5">"A strong genetic relationship exists between the IL1B gene and ovarian cancer risk due to the specific genomic variant rs7596684.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B&quot;" target="&quot;RS7596684&quot;&amp;&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">3.1</data>
      <data key="d5">"A possible link exists between rs7596684 variant within IL1B gene and increased risk of ovarian cancer based on some findings, though this was not fully elucidated.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B&quot;" target="&quot;RS7596684&quot;&amp;&quot;POTENTIAL INCREASED OVARIAN CANCER RISK&quot;">
      <data key="d4">3.12</data>
      <data key="d5">"A preliminary linkage between rs7596684 variant in IL1B gene and potential increase in risk of ovarian cancer is suggested by some observations, though these were not thoroughly explained.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL2&quot;" target="&quot;STUDY PHASES&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"Results on the relationship between CCL2 and ovarian cancer risk were mixed throughout different study phases, indicating uncertain associations.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6&quot;" target="&quot;LACK OF CONSISTENT ASSOCIATION&quot;">
      <data key="d4">3.8</data>
      <data key="d5">"The relationship between IL6 and ovarian cancer risk was uncertain due to inconsistent findings throughout different research phases.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HETEROGENEITY FOR CLEAR CELL, MUCINOUS, AND ENDOMETRIOID SUBTYPES (IL1A RS17561)&quot;" target="&quot;P=0.03&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Significant associations were present in clear cell, mucinous, and endometrioid subtypes, suggesting different risk profiles.")("entity"</data>
      <data key="d6">chunk-089bcdf055eb2f007db49dbe2409429b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD2&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"MTHFD2 gene is part of the folate metabolic pathway being analyzed in relation to childhood ALL risk.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BHMT2&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"BHMT2 gene contributes to the overall folate metabolic pathway evaluated for its association with childhood ALL.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SLC19A1 is involved in a component of the folate metabolic pathway that was assessed for its role in childhood ALL risk.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA&quot;" target="&quot;NOS3 RS3918186&quot;">
      <data key="d4">7.38</data>
      <data key="d5">"NOS3 rs3918186 showed a significant association with an increased risk of childhood ALL based on Bayes Factors and odds ratios.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA&quot;" target="&quot;SLC19A1 RS1051266&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"While SLC19A1 rs1051266 had some evidence for association, the strength was weaker than that of NOS3 rs3918186.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INITIAL SCREENING CRITERIA&quot;" target="&quot;TABLE 2 POPULATION CHARACTERISTICS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The data from Table 2 were used as criteria for selecting which SNPs would proceed to initial screening based on their relevance and completeness.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INITIAL SCREENING PROCESS&quot;" target="&quot;SNP INITIAL IDENTIFICATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNPs initially identified in the study underwent an initial screening process, where those with a high posterior probability were selected for further analysis.")</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1/2 HAPLOTYPE&quot;" target="&quot;MINOR ALLELE FREQUENCY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The distribution of minor alleles within the FADS gene cluster defined by the haplotype.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPA&quot;" target="&quot;NO GENOTYPE-DIET INTERACTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant genotype-by-diet interactions were found for EPA concentration.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON FATTY ACID CONCENTRATIONS&quot;" target="&quot;HEALTHY EATING GROUP&quot;">
      <data key="d4">0.01</data>
      <data key="d5">"Long chain n-3 PUFA significantly increased in both Healthy Eating and Mediterranean groups.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON FATTY ACID CONCENTRATIONS&quot;" target="&quot;MEDITERRANEAN GROUP&quot;">
      <data key="d4">0.77</data>
      <data key="d5">"Mean serum 18:2 n-6 significantly decreased (p=0.02), and both MUFA and n-3 PUFA significantly increased in the Mediterranean group.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;20:4, N-6 (AA)&quot;" target="&quot;COLON CONCENTRATIONS&quot;">
      <data key="d4">0.004</data>
      <data key="d5">"There was a significant interaction of genotype by diet for AA concentrations in the colon.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;20:4, N-6 (AA)&quot;" target="&quot;MEDITERRANEAN GROUP&quot;">
      <data key="d4">0.02</data>
      <data key="d5">"Serum 20:4, n-6 (AA) concentration significantly decreased in the Mediterranean group.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUFA&quot;" target="&quot;MEDITERRANEAN GROUP&quot;">
      <data key="d4">0.77</data>
      <data key="d5">"Both MUFA and n-3 PUFA significantly increased (p=0.0005 and p=0.01, respectively) in the Mediterranean arm only.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;N-3 PUFA&quot;" target="&quot;HEALTHY EATING GROUP&quot;">
      <data key="d4">0.72</data>
      <data key="d5">"Both MUFA and n-3 PUFA significantly increased (p=0.0005 and p=0.01, respectively) in the Mediterranean arm only.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM 18:2 N-6&quot;" target="&quot;MEDITERRANEAN GROUP&quot;">
      <data key="d4">0.72</data>
      <data key="d5">"Mean serum 18:2 n-6 significantly decreased (p=0.02) in the Mediterranean group.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPING SUCCESS RATE&quot;" target="&quot;MINOR ALLELE FREQUENCIES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The correlation between successful genotyping and minor allele frequency in SNPs.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY INTAKES&quot;" target="&quot;SERUM FATTY ACID CONCENTRATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The predictive relationship of dietary intake on serum levels of specific fatty acids (AA, EPA).")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM FATTY ACID CONCENTRATIONS&quot;" target="&quot;DIETARY INTERVENTION EFFECTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"How changes in dietary intake during an intervention affect serum levels of various fatty acids.")</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON AA CONCENTRATIONS&quot;" target="&quot;DIET ARM&quot;">
      <data key="d4">0.004</data>
      <data key="d5">"Mean colon AA concentrations differed significantly between diet arms at 6 months for subjects without minor alleles in the FADS1/2 gene cluster.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON AA CONCENTRATIONS&quot;" target="&quot;MEDITERRANEAN GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mean colon AA concentrations were estimated to be 16% lower in the Mediterranean arm than the Healthy Eating arm at 6 months.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON AA CONCENTRATIONS&quot;" target="&quot;NO MINOR ALLELES&quot;">
      <data key="d4">0.01</data>
      <data key="d5">"Mean colon AA concentrations were estimated to be 16% (95% CI = [5%, 26%]) lower for the Healthy Eating arm than the Mediterranean arm at 6 months.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;ADJUSTED GWAS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetic correlation between the adjusted genome-wide association study (GWAS) and snoring shows high consistency.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;NOCTURNAL HYPOXIA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genetic correlation between nocturnal hypoxia measures such as minimum SpO2 and average SpO2 shows small increases in relation with snoring after adjusting for BMI.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP APNOEA&quot;" target="&quot;GENETIC CORRELATION WITH SNORING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Sleep apnoea showed a high genetic correlation (rG = 0.78) with snoring, indicating shared genetic factors.")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING FREQUENCY&quot;" target="&quot;SNP HERITABILITY FOR SLEEP APNOEA&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"There was no significant genetic correlation between smoking frequency and sleep apnoea, indicating different etiologies.")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CONSUMPTION FREQUENCY&quot;" target="&quot;GENETIC CORRELATION WITH SLEEP APNOEA&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"While alcohol consumption was not significantly genetically correlated with snoring, it might have had an indirect effect on sleep apnoea through shared risk factors.")</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEAD SNPS&quot;" target="&quot;EGFR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Lead single nucleotide polymorphisms (SNPs) at eGFR loci are significantly associated with kidney function and disease.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDBP POLYMORPHISMS&quot;" target="&quot;GENOTYPE PERCENTAGE DISTRIBUTIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Percentage distribution of genotypes based on VDBP polymorphisms for mothers and neonates are presented (Table 2).")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDBP POLYMORPHISMS&quot;" target="&quot;MATERNAL VITAMIN D STATUS DURING DELIVERY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Certain maternal VDBP genotypes were associated with higher vitamin D levels when the mother delivered (Table 8).")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VDBP GENOTYPES (CC FOR RS2298850 AND CC FOR RS4588)&quot;" target="&quot;HIGHER VITAMIN D CONCENTRATIONS DURING DELIVERY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mothers with specific VDBP genotypes tended to have higher vitamin D concentrations at birth compared to other genotypes (p = 0.05 and p = 0.04 respectively, as seen in Table 8).")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VDBP GENOTYPES (CC FOR RS2298850 AND CC FOR RS4588)&quot;" target="&quot;MATERNAL VITAMIN D CONCENTRATIONS DURING DELIVERY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Specific maternal VDBP genotypes tended to have higher vitamin D levels at the time of delivery compared to other genotypes.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEONATAL 25(OH)D CONCENTRATIONS, WITH RESPECT TO MATERNAL VDBP GENOTYPE DISTRIBUTION&quot;" target="&quot;ASSOCIATION BETWEEN GENOTYPE AND OUTCOME&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Neonatal vitamin D statuses varied based on maternal VDBP polymorphisms when compared using cut-offs of 25 and 50 nmol/L (Tables 9 and 10).")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VITAMIN D STATUS&quot;" target="&quot;MOTHERS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Maternal vitamin D concentrations were analyzed in relation to her genotypes for VDBP polymorphisms.")&lt;SEP&gt;"The vitamin D status of mothers was analyzed in relation to their VDBP polymorphisms.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL VITAMIN D STATUS&quot;" target="&quot;CUT-OFFS AT BIRTH (≥50 NMOL/L VS. ≤50 NMOL/L AND ≥25 VS. ≤25 NMOL/L)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Vitamin D cut-offs at birth were compared with maternal VDBP polymorphisms (Table 7).")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEONATAL VITAMIN D STATUS&quot;" target="&quot;NEONATES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The health and developmental outcomes of neonates were compared with their mothers' VDBP genotypes, looking at cut-offs of 25 and 50 nmol/L for vitamin D.")&lt;SEP&gt;"Vitamin D status of neonates was also assessed with respect to their VDBP polymorphisms.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEONATAL VITAMIN D STATUS&quot;" target="&quot;MATERNAL VDBP POLYMORPHISMS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Neonatal vitamin D status was not significantly different based on maternal VDBP genotypes with cut-offs of 25 and 50 nmol/L at birth (Table 9 and Table 10).")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION BETWEEN GENOTYPE AND OUTCOME&quot;" target="&quot;NEONATAL VITAMIN D CUT-OFFS AT BIRTH (25 VS. 50 NMOL/L)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Neonatal vitamin D statuses were compared with different maternal VDBP genotypes based on birth cut-offs for vitamin D.")</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;ANTI-INFLAMMATORY IL-10&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"No correlation was found between the VEGFA SNP rs3025020 and levels of anti-inflammatory cytokine IL-10 among women with PCOS.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;PRO-INFLAMMATORY TNFΑ&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Correlation analysis revealed no link between the VEGFA SNP rs2010963 and levels of pro-inflammatory cytokine TNFα among PCOS women.")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;ESR&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Among the model including rs2010963, women with the minor allele (C) showed lower erythrocyte sedimentation rate (ESR).")</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS CONDITION&quot;" target="&quot;NO-STRESS CONDITION&quot;">
      <data key="d4">2.3200000000000003</data>
      <data key="d5">"Val carriers had a distinct pattern of response bias reduction in the stress condition relative to no-stress conditions; this relationship held even after accounting for various factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")&lt;SEP&gt;"Val carriers tended to have lower response bias in the stress condition compared to no-stress conditions; this difference was not statistically significant for iso homozygotes.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOCK DISCRIMINABILITY&quot;" target="&quot;CONDITION 3 AND CONDITION 2&quot;">
      <data key="d4">1.62</data>
      <data key="d5">"Differences in discriminability were evident between Conditions 3 and 2, both of which showed elevated values compared to Condition 1.")&lt;SEP&gt;"Enhanced performance was noted in Conditions/Blocks with elevated discriminability compared to the baseline condition.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 3 AND CONDITION 2&quot;" target="&quot;ELEVATED DISCRIMINABILITY&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"An elevated discriminability emerged specifically in Conditions 3 and 2; performance was better than in Condition 1.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 3 AND CONDITION 2&quot;" target="&quot;BLOCK 2 AND BLOCK 3&quot;">
      <data key="d4">0.78</data>
      <data key="d5">"Improved performance was noted specifically in Conditions/Blocks where discriminability was elevated.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 3 AND CONDITION 2&quot;" target="&quot;IMPROVED PERFORMANCE&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Enhanced performance was noted specifically in Conditions/Blocks where the discriminability metric was elevated; these blocks showed better performance compared to baseline conditions.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COHORT COMPARISON&quot;" target="&quot;STRESS CONDITION AND NO-STRESS CONDITION&quot;">
      <data key="d4">1.22</data>
      <data key="d5">"Val carriers tended to have lower response bias in the stress condition compared to no-stress conditions; this difference was not statistically significant for iso homozygotes.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS CONDITION AND NO-STRESS CONDITION&quot;" target="&quot;GENOTYPE-SPECIFIC RESPONSE BIAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Val carriers showed a reduced response bias in the stress condition relative to no-stress conditions; this was observed even after considering various factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS CONDITION AND NO-STRESS CONDITION&quot;" target="&quot;COHORT COMPARISON OF RESPONSE BIAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Val carriers had reduced response bias specifically in the stress condition when compared to no-stress conditions; this relationship held after factoring in discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOCK SEQUENCE EFFECTS&quot;" target="&quot;CONDITION 1, CONDITION 2 AND CONDITION 3&quot;">
      <data key="d4">0.55</data>
      <data key="d5">"There were differences between Blocks 1, 2, and 3 in terms of discriminability; Block 2 and Block 3 showed improved performance compared to Block 1.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOCK SEQUENCE EFFECTS&quot;" target="&quot;CONDITION 1, CONDITION 2, AND CONDITION 3&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"Performance varied between Conditions/Blocks due to differences in discriminability; Blocks showed enhanced performance compared to the first block.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 1&quot;" target="&quot;CONDITION 1&quot;">
      <data key="d4">1.63</data>
      <data key="d5">"For discriminability, a main effect of Block emerged due to elevated discriminability in Blocks 3 and 2 relative to Block 1, both p &lt; .02.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRHR1 SNPS&quot;" target="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d4">1.66</data>
      <data key="d5">"These SNPs were recently associated with stress-induced reward learning deficits, which influenced the findings on response bias.")&lt;SEP&gt;"Three CRHR1 SNPs were associated with stress-induced reward learning deficits, which were taken into account as part of the control analyses.")&lt;SEP&gt;"Three CRHR1 SNPs were associated with stress-induced reward learning deficits; these were considered as covariates.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISCRIMINABILITY, SHOCK INTENSITY, SKIN CONDUCTANCE RESPONSES&quot;" target="&quot;RESPONSE BIAS REDUCTIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Unique variance in response bias reductions was determined after accounting for discriminability, shock intensity, and skin conductance responses.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS REDUCTIONS&quot;" target="&quot;DISCRIMINABILITY AND SHOCK INTENSITY, SKIN CONDUCTANCE RESPONSES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Unique variance was explained by response bias reductions even after factoring in the effects of discriminability and skin conductance responses along with shock intensity.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 3, CONDITION 2, AND CONDITION 1&quot;" target="&quot;SEQUENCE OF CONDITIONS EFFECTS&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"The sequence of conditions influenced performance outcomes; improvements were noted specifically in Conditions/Blocks where performance was enhanced due to increased discriminability.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRHR1 SNPS AND STRESSED CONDITION RESPONSE BIAS REDUCTIONS&quot;" target="&quot;UNIQUE VARIANCE IN STRESS-INDUCED CHANGES&quot;">
      <data key="d4">0.6</data>
      <data key="d5">"After considering the association of specific CRHR1 SNPs with stress-induced changes, unique variance was identified in response bias reductions during stressed conditions.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS CONDITION COMPARISON BETWEEN GROUPS&quot;" target="&quot;VAL AND ISO HETEROZYGOTES RESPONSE BIAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Val carriers showed reduced response bias specifically in the stress condition compared to no-stress conditions; this relationship was observed even after considering factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs for both groups.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 3 AND CONDITION 2 EFFECTS COMPARISON&quot;" target="&quot;PERFORMANCE ENHANCEMENT IN ELEVATED DISCRIMINABILITY CONDITIONS&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Within Conditions/Blocks where performance was enhanced due to elevated discriminability, improvements were observed; these conditions showed superior performance compared to baseline states after adjusting for various factors.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 3 AND CONDITION 2 EFFECTS COMPARISON&quot;" target="&quot;PERFORMANCE ENHANCEMENT IN SPECIFIC BLOCKS/DAYS/">
      <data key="d4">0.9</data>
      <data key="d5">"Elevated performance within Conditions/Blocks that featured elevated discriminability indicated enhanced outcomes; these instances showed superior performance compared to baseline states, adjusting for various factors.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION 3 AND CONDITION 2 EFFECTS COMPARISON&quot;" target="&quot;PERFORMANCE ENHANCEMENT IN SPECIFIC BLOCKS/CONDITIONS AND DISCRIMINABILITY ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Elevated performance within Conditions/Blocks that featured elevated discriminability indicated enhanced outcomes; these instances showed superior performance compared to baseline states, adjusted for various factors including CRHR1 SNPs.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE-SPECIFIC RESPONSE BIAS REDUCTIONS DURING STRESSED CONDITIONS&quot;" target="&quot;STRESS CONDITION AND NO-STRESS CONDITION COMPARISON&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Val carriers exhibited reduced response bias specifically in the stress condition relative to no-stress conditions, a relationship that was maintained after adjusting for factors like discriminability, shock intensity, skin conductance responses, and CRHR1 SNPs.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STRESS CONDITION AND NO-STRESS CONDITION COMPARISON&quot;" target="&quot;GENOTYPE-SPECIFIC RESPONSE BIAS REDUCTIONS DURING STRESSED CONDITIONS AND CRHR1 SNPS ASSOCIATION&quot;">
      <data key="d4">0.9</data>
      <data key="d5">"Val carriers' reduced response bias specifically in the stress condition relative to no-stress conditions, which maintained after adjusting for factors like discriminability, shock intensity, skin conductance responses, was further informed by considering specific CRHR1 SNPs.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AT FIRST TOOTH&quot;" target="&quot;PATHWAY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP associated with pathway analysis using the ALLIGATOR software.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUMBER OF TEETH&quot;" target="&quot;PATHWAY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant over-representation of pathways was found for 'number of teeth' GWAS, despite SNP association P-values.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELIC SCORE&quot;" target="&quot;PATHWAY&quot;">
      <data key="d4">0.004</data>
      <data key="d5">"SNP association P-value threshold of 0.005 gave significant over-representation of genes in pathways for 'Age at first tooth' GWAS.")</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY ESTIMATION&quot;" target="&quot;TWINSUK COHORT&quot;&amp;&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"In TwinsUK, heritability estimation was performed using the ACE model, which includes additive genetic variance (A), shared environmental factors (C), and non-shared factors plus error (E).")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY ESTIMATION&quot;" target="&quot;TWINSUK COHORT&quot;&amp;&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d4">0.8</data>
      <data key="d5">"SNP-based heritability estimation from mbQTL summary statistics was performed using linkage disequilibrium (LD) score regression on the TwinsUK cohort.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HERITABILITY ESTIMATION&quot;" target="&quot;NETHERLANDS TWIN REGISTRY (NTR)&quot;&amp;&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"The NTR cohort provided replication for the SNP-based heritability estimation done on the TwinsUK cohort.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EFFECTIVE NUMBER OF STATISTICAL TESTS&quot;" target="&quot;LOCUS/">
      <data key="d4">6.0</data>
      <data key="d5">Analysis"</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY&quot;" target="&quot;TH17 CELL PERCENTAGES AMONG CD4+TCR+ T CELLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Th17 response was found to be reduced in the MLNs of Rag1−/− and IL-10RαMdelRag1−/− recipients.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY&quot;" target="&quot;ABSOLUTE NUMBERS OF TH17 CELLS ACROSS ORGANS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There was a difference in absolute numbers of Th17 cells present between Rag1−/− and IL-10RαMdelRag1−/− recipients.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY&quot;" target="&quot;RAG1−/− MICE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Rag1−/− mice demonstrated a broad requirement for IL-6 for T cell expansion and development of colitis.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY&quot;" target="&quot;IL-10RΑMDELRAG1−/− MICE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"In contrast, IL-10RαMdelRag1−/− mice showed dispensable IL-6 for the development of colitis.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY&quot;" target="&quot;IL-6RΑ−/− T CELLS AND RAG1−/− COMBINATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The absence of IL-6Rα signaling in T cells induced impaired expansion and lesser disease effect compared to WT T cell transfers.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/−&quot;" target="&quot;INCREASED DISEASE SEVERITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IL-10RαMdelRag1−/− mice exhibit exacerbated colitis due to an elevated Th17 response and increased levels of pro-inflammatory cytokines, indicating that the loss of IL-10Rα function influences disease severity.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/− LPMΦS&quot;" target="&quot;INCREASED NUMBERS AND ACTIVATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These cells showed a uniformly elevated surface expression of activation markers like CD40, CD80 and CD86.")</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10RΑMDELRAG1−/− LPMΦS&quot;" target="&quot;INCREASED ACTIVATION MARKERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The cells had a heightened expression of CD40, CD80 and CD86 on their surface.")</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;MACROPHAGE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of IL-10 on macrophages suppresses their pro-inflammatory cytokine production, such as IL-1β and IL-6, which is critical in the regulation of Th17 cell response.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10&quot;" target="&quot;CASPASE-1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"IL-10 suppresses caspase-1 activation by Rag1−/− Mφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;PRO-INFLAMMATORY CYTOKINE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IL-1β acts as a pro-inflammatory cytokine that is upregulated during colitis, contributing to inflammation by inducing other pro-inflammatory cytokines and cell recruitment.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1Β&quot;" target="&quot;PROINFLAMMATORY CYTOKINES&quot;/&quot;PATS/">
      <data key="d4">5.0</data>
      <data key="d5">|&gt;SENP1-aP2KO"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNF-Α&quot;" target="&quot;PROINFLAMMATORY CYTOKINES&quot;/&quot;PATS/">
      <data key="d4">5.0</data>
      <data key="d5">|&gt;SENP1-aP2KO"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Γ&quot;" target="&quot;PTPN2:RS478582&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The gene expression of IFN-γ is influenced by genotypes at the PTPN2:rs478582 locus.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 RESPONSE&quot;" target="&quot;INFLAMED COLONS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased Th17 cell presence in inflamed colonic tissues correlates with the development and progression of colitis, highlighting their role in inflammatory bowel disease.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;MOCK (UNTRANSDUCED) T CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The comparison with untransduced T cells helps to assess the enhanced function of CAR T cells expressing the 4-1BB domain and TAG72-specific components.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;Β-DEFENSIN GENES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Three clusters of β-defensin genes were found to be associated with SNPs through the GRAIL analysis.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;CCL18&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CCL18 gene was one among several chemokine genes identified by the GRAIL algorithm and linked to other specific transcripts.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;CXCL12&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CXCL12 gene showed connections with β-defensin genes, TNFRSF13B, and CCL18 according to the analysis performed by GRAIL.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;TNFRSF13B&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TNFRSF13B gene was among those identified as functionally connected via the GRAIL algorithm.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;Β-DEFENSIN GENE CLUSTER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The clusters of β-defensin genes were found to be functionally related to other transcripts via the GRAIL algorithm.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;CHEMOKINE GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Chemokine genes such as CCL18 and CXCL12 were connected with β-defensin genes through the analysis.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;TNFRSF13B GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TNFRSF13B transcript was found to interact functionally with β-defensin genes and CCL18 as per the GRAIL analysis results.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;EBNA2&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The transcriptional regulation of these MS risk genes by EBNA2 influences their expression and potential for immune evasion.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;RS4988235 AND FRUIT INTAKE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Fruit consumption showed a positive association with LP variant.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;MTHFR 677C&gt;T&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was no association between MTHFR 677C&gt;T and male infertility; however, this result remained unchanged when analyzing individuals with serum folate concentrations below the study population median.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIAL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Normal values for median nerve compound motor action potential were measured, indicating a physiological process within the patient's nervous system.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The conduction velocity of the median nerve was also assessed, demonstrating normal values in comparison to infants aged 1-2 years.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A measurement of median nerve sensory action potential fell within expected ranges for a child aged 1-2 years old.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;FEV1/FVC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A measure of forced expiratory volume in one second to the forced vital capacity was taken for each individual.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;ANTI-IL-10R ANTIBODY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Anti-IL-10Rα Ab markedly increases activated caspase-1 in Rag1−/− Mφs, indicating normal restraint by IL-10.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;LPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"LPS stimulation modestly increases activated caspase-1 in Rag1−/− Mφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;ATP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"ATP also stimulates activation of caspase-1 by LPS-stimulated Rag1−/− Mφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;IL-10 TREATMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Pre-treatment with IL-10 abrogates induction of activated caspase-1 in Rag1−/− Mφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASPASE-1&quot;" target="&quot;ANTI-IL-10RΑ AB&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Anti-IL-10Rα Ab markedly increases activated caspase-1, indicating normal restraint by IL-10 in Rag1−/− Mφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL MATURATION&quot;" target="&quot;LPMΦS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased IL-1 and IL-6 from LPMφs can impact Th17 cell maturation in the presence of naïve T cells with added TGFβ.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH17 CELL MATURATION&quot;" target="&quot;ANTI-IL-6RΑ AB&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Blocking IL-6 receptor substantially inhibits Th17 development in diseased mice, as shown by IL-6R−/− T cell transfer results.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ΑIL-6RΑ BLOCKING ANTIBODY&quot;" target="&quot;TH17 FORMATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Blocking IL-6 receptor partially inhibits Th17 formation from Rag1−/− LPMφs, but less so from IL-10RαMdelRag1−/−-derived LPMφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1 SIGNALING&quot;" target="&quot;TH17 CELL MATURATION/">
      <data key="d4">10.0</data>
      <data key="d5">"Blocking IL-1 signaling leads to more substantial inhibition of Th17 development in IL-10RαMdel Rag1−/−-derived LPMφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1 SIGNALING&quot;" target="&quot;TH17 CELL FORMATION/">
      <data key="d4">10.0</data>
      <data key="d5">"Blockage of IL-1 receptor pathway leads to more substantial inhibition of Th17 cell development in diseased mice, particularly with IL-10RαMdelRag1−/− LPMφs.")</data>
      <data key="d6">chunk-b971aa450a9b220806bdc000eb5efaad</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EFFECT ON IL-10RΑMDELRAG1−/− MICE&quot;" target="&quot;NEUTROPHIL DEPLETION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Though no significant difference in histopathology was identified (Fig. 1e, f).")</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SUPPRESSION&quot;" target="&quot;TREG&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Treg transfers led to a &gt;2-fold increase in Treg in the spleens of recipient mice and Treg percentages did not differ between IL-10RαMdelRag1−/− and Rag1−/− recipients.")</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE MAGNITUDE&quot;" target="&quot;IL-10 PRODUCTION BY TRANSFERRED T CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No influence on disease magnitude when T cell IL-10 production was performed.")</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SEVERITY COMPARISON&quot;" target="&quot;IL-10RΑMDELRAG1−/− MICE VS. RAG1−/− CONTROLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Significant increase in LPMφ numbers was observed in IL-10RαMdelRag1−/− mice compared to Rag1−/− controls.")</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE SUPPRESSION CAPABILITY&quot;" target="&quot;TREGS VS. T CELLS WITH/WITHOUT IL-10 PRODUCTION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Transferred Treg were able to fully suppress disease development regardless of whether the transferred T cells produced IL-10 or not.")</data>
      <data key="d6">chunk-380a8a6e0d08cd28068a146ae5e00ce4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE&quot;" target="&quot;IL-23&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased levels of IL-23 are identified alongside IL-1β and IL-6, suggesting a significant role in intensifying the Th17 response during colitis.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+IL-17A+ T CELLS&quot;" target="&quot;INCREASE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The percent and absolute numbers of CD4+IL-17A+ T cells are significantly increased in IL-10RαMdel Rag1−/− compared to Rag1−/− mice, indicating an enhanced Th17 response.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INCREASE&quot;" target="&quot;GFP+ T CELLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"After induction of disease with CD4+CD25−CD45RBhi RORγT-GFP reporter T cells, there is an increased identification of GFP+ T cells in colons at weeks 4 and 8, suggesting the involvement of Th17 cells in the disease process.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INCREASED EXPRESSION&quot;" target="&quot;TH17-ASSOCIATED CYTOKINES&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Elevated production of Th17-promoting cytokines (IL-1β, IL-6, IL-23p19), and other pro-inflammatory markers like iNOS indicates a heightened Th17 response in colitis.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MΦS&quot;" target="&quot;SPECIFIC EXPRESSION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Increased expression of IL-1β, IL-6, IL-23p19, and iNOS specifically within macrophages suggests they are the primary source for increased Th17-associated cytokines and implicates a suppressive role played by IL-10 on these cells.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREVENT OR ATTENUATE DISEASE&quot;" target="&quot;RORΓT−/− T CELLS TRANSFER&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The transfer of RORγT−/− (Th17 cells deficient) T cells into Rag1−/− and IL-10RαMdelRag1−/− recipients prevents or attenuates colitis, indicating that Th17 cell involvement is essential for disease development.")</data>
      <data key="d6">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE&quot;" target="&quot;TH17 CELL DEVELOPMENT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IL-6Rα signaling supports but is not essential for Th17 formation specifically in the MLNs of both recipient lines.")</data>
      <data key="d6">chunk-35d8a4ea86cb92d18ee1c857a318d2d8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE PROTECTION&quot;" target="&quot;IL-6RΑ TRANSFER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Transfer of IL-6Rα deficient T cells shows virtually complete disease protection.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1R TRANSFER&quot;" target="&quot;REDUCED DISEASE SEVERITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Transfers of IL-1R deficient T cells show diminished clinical measures compared to WT transfers in Rag1−/− colitis models.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISTINCT DOSE RESPONSE&quot;" target="&quot;IL-6RΑ VS. IL-1R TRANSFER IMPACT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While IL-6 responsiveness affects disease severity in Rag1−/−, IL-1 response impacts both Rag1−/− and IL-10RαMdelRag1−/− models.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REDUCED IN T CELL TRANSFER MODELS&quot;" target="&quot;TH17 CELL PROPORTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Transfers of IL-6Rα deficient T cells show reduced Th17 cell proportions compared to WT T cells transfers, specifically in colonic environment.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIFFERENCES BETWEEN IL-10RΑMDELRAG1−/− AND RAG1−/− MICE&quot;" target="&quot;IL-1Β PRODUCTION IMPACT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In diseased IL-10RαMdelRag1−/− mice, there's a higher amount of pro-IL-1β compared to Rag1−/− mice in colons.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10'S EFFECT ON PRO-IL-1Β LEVELS&quot;" target="&quot;REGULATION BY IL-10 IN MΦS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-10 reduces the levels of pro-IL-1β and prevents mature IL-1β formation, as shown in cultured Rag1−/− macrophages.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE INFLUENCE&quot;" target="&quot;IL-6 AND DISEASE SEVERITY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"In both Rag1−/− and IL-10RαMdelRag1−/− mice models, IL-6 plays a more critical role in colitis when compared to IL-10 suppression of LPMφs' IL-1β production.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-INFLAMMATORY ACTION&quot;" target="&quot;IL-10'S ROLE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"IL-10 inhibits the production and maturation of pro-inflammatory cytokines like IL-1β, reducing disease severity in colitis models.")</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TWINSUK&quot;" target="&quot;NETHERLANDS TWIN REGISTRY (NTR)&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"The TwinsUK cohort (1,176 samples) was used to estimate heritability using the ACE model and NTR cohort (312 MZ twins) was used for replication of MZ intraclass correlation coefficient (ICC).")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALPHA DIVERSITY&quot;" target="&quot;META-GWAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"No significant hits were found in the meta-GWAS analysis for alpha diversity indices, indicating low genetic influence.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT&quot;" target="&quot;MCM6&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The LCT and MCM6 genes exhibit inter-relationships, with MCM6 influencing regulation of LCT expression related to lactose metabolism and persistence.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;FUNCTIONAL LCT VARIANT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"rs182549 is a proxy for the functional LCT variant.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549&quot;" target="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The rs182549 SNP showed a significant impact on Bifidobacterium abundance in individuals homozygous for the low-function LCT haplotype.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM&quot;" target="&quot;LCT LOCUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An LCT locus associated with abundance of Bifidobacterium.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COPSAC2010 COHORT&quot;" target="&quot;HETEROGENEITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The COPSAC2010 cohort contributed to the heterogeneity in rs182549 association signal.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;R. TORQUES GROUP&quot;" target="&quot;RS601338&quot;*&quot;RS35866622&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The tagging NC_000019.9:g.49218060C&gt;T (rs35866622 non-secretor) allele was associated with a reduced abundance of the R. torques group and a decreased presence of the R. gnavus group.")</data>
      <data key="d6">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7574352&quot;" target="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs7574352 has been shown to be associated with ulcerative colitis, potentially linking gut inflammation markers chromogranin A and calprotectin.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7574352&quot;" target="&quot;TYPE 2 DIABETES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genomic variant rs7574352 is linked to type 2 diabetes susceptibility through its proximity to the gene IRF1 involved in insulin resistance.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIFIDOBACTERIUM ABUNDANCE&quot;" target="&quot;RAW VEGETABLE INTAKE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A nominally significant correlation between Bifidobacterium abundance and raw vegetable intake was observed before multiple testing correction.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549 (LCT)&quot;" target="&quot;LACTOSE INTOLERANCE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"rs182549 variant predisposes individuals to lactose intolerance, negatively correlated with obesity and positively associated with T2DM.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS182549 (LCT)&quot;" target="&quot;T2DM DIAGNOSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The SNP rs182549 was found to be significantly associated with multiple dietary and metabolic phenotypes including T2DM diagnosis.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLYCEMIC VARIABILITY&quot;" target="&quot;RS4988235 VARIANT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Functional LCT variant rs4988235 is associated with glycemic variability, an indicator of insulin sensitivity.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GUT MICROBIAL TAXA&quot;" target="&quot;DISEASES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Gut microbial taxa were analyzed for potential causal links with autoimmune, cardiovascular, metabolic and psychiatric diseases using Mendelian Randomization.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOST GENETICS&quot;" target="&quot;MICROBIOME COMPOSITION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Host genetics influenced microbiome composition during the analysis of gut microbial taxa using MR.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTINOBACTERIA&quot;" target="&quot;DIFFERENCES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Card9−/− mouse microbiota showed decreased Actinobacteria phylum according to LEfSe analysis.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINKAGE DISEQUILIBRIUM (LD) SCORE REGRESSION&quot;" target="&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d4">0.6</data>
      <data key="d5">"The SNP-based heritability calculated from mbQTL summary statistics using linkage disequilibrium (LD) score regression showed two bacterial taxa, genus Ruminiclostridium 9 and family Peptostreptococcaeae, passing the significance threshold given the number of 211 taxa tested.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NETHERLANDS TWIN REGISTRY (NTR)&quot;&amp;&quot;HERITABILITY ESTIMATION&quot;" target="&quot;REPLICATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Netherlands Twin Registry cohort was used to replicate the MZ intraclass correlation coefficient (ICC) for heritability estimation.")</data>
      <data key="d6">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT LOCUS&quot;" target="&quot;METABOLIC TRAITS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Gene-based PheWAS enrichment analysis indicated strong links between the LCT locus and metabolic traits, including BMI.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AND GENOTYPE INTERACTION&quot;" target="&quot;AGE&quot;&amp; &quot;RS182549&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age shows an interaction with rs182549, affecting Bifidobacterium abundance differently in different age groups.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT LOCUS - BIFIDOBACTERIUM&quot;" target="&quot;MBQTL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The LCT locus, associated with abundance of Bifidobacterium through mbQTL mapping.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MBBTL&quot;" target="&quot;PRESENCE/ABSENCE OF BACTERIAL TAXA&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"mbBTL mapping identified loci associated with the presence or absence of specific bacterial taxa in the gut microbiota.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COCHRAN’S Q&quot;" target="&quot;RS182549 HETEROGENEITY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Cochran's Q test showed evidence of heterogeneity across cohorts related to rs182549 association with Bifidobacterium abundance.")</data>
      <data key="d6">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT (BIFIDOBACTERIUM)&quot;" target="&quot;T2DM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNP rs182549, associated with Bifidobacterium abundance, has been positively linked to T2DM diagnosis and a family history of the disease.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2DM&quot;" target="&quot;PATS/">
      <data key="d4">4.0</data>
      <data key="d5">|&gt;HFD/</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2DM&quot;" target="&quot;HEPATIC STEATOSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Hepatic fat accumulation contributes to the development and exacerbation of Type 2 Diabetes Mellitus.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FISH INTAKE HEIGHT&quot;" target="&quot;FUT1/FUT2 LOCUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The secretor allele at the FUT1/FUT2 locus is associated with fish intake and height in dietary patterns.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLELITHIASIS&quot;" target="&quot;RS35866622, FUT1/FUT2 LOCUS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The secretor allele at the FUT1/FUT2 locus is negatively associated with risks of cholelithiasis.")</data>
      <data key="d6">chunk-938d8bf2e56584de9dd556be5eb70964</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIMITED IMPACT OF GENETIC VARIANTS&quot;" target="&quot;MICROBIAL TAXA VARIABILITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The limited effect of genetic variants on microbial taxa variability was considered in sensitivity analyses during our causality estimation process.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL RELATIONSHIPS IDENTIFIED&quot;" target="&quot;THREE OR MORE SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Causal relationships were only considered if supported by three or more Single Nucleotide Polymorphisms (SNPs).")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGHER ABUNDANCE OF ACTINOBACTERIA AND BIFIDOBACTERIUM&quot;" target="&quot;PROTECTIVE EFFECT ON ULCERATIVE COLITIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Actinobacteria and the genus Bifidobacterium may have a protective effect against ulcerative colitis.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGHER ABUNDANCE OF OXALOBACTERACEAE FAMILY&quot;" target="&quot;PROTECTIVE EFFECT ON RHEUMATOID ARTHRITIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The Oxalobacteraceae family's higher abundance may be protective against rheumatoid arthritis, according to our study results.")</data>
      <data key="d6">chunk-159d4c797dae6eb825c74067af703228</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOOD&quot;" target="&quot;RS4988235 AND POULTRY INTAKE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Poultry intake was associated with the presence of rs4988235 genotype.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOOD&quot;" target="&quot;RS4988235 AND WINE INTAKE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Wine consumption showed a negative relationship with rs4988235 genotype.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE&quot;" target="&quot;MATERNAL PEMT ENZYME INTERACTION WITH CHOLINE INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Influence of maternal dietary choline status on endogenous choline synthesis when carrying rs12325817 variant.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS12325817 VARIANT&quot;" target="&quot;INFLUENCE OF GENOMIC VARIANT ON ENDOGENOUS CHOLINE SYNTHESIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"How genetic differences influence how a mother's body produces choline internally during pregnancy, affecting dietary requirements.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANTS&quot;" target="&quot;FASD DIAGNOSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The diagnosis of FASD was applied to 32.3% of infants in the choline group compared to 22.6% in the placebo group.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL DIETARY CHOLINE STATUS&quot;" target="&quot;INSUFFICIENT VS. ADEQUATE MATERNAL CHOLINE INTAKE DURING PREGNANCY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The impact of different dietary standards for choline on the health and development of infants.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANTS' HEALTH OUTCOMES&quot;" target="&quot;MATERNAL CHOLINE STATUS IMPACT ON INFANT HEALTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"How maternal dietary choline status affects outcomes for their infants, including growth, development, and disease risk.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASD DIAGNOSIS&quot;" target="&quot;CHOLINE SUPPLEMENTATION AND FASD DIAGNOSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The relationship between choline intake during pregnancy and the prevalence of fetal alcohol spectrum disorders among infants.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATERNAL PEMT ENZYME INTERACTION WITH CHOLINE INTAKE&quot;" target="&quot;CHOLINE SUPPLEMENTATION AND MATERNAL ENZYME INTERACTIONS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The study explores the synergistic effects of choline supplementation on enzyme function related to choline metabolism in pregnant mothers carrying a specific genetic variant.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE SUPPLEMENTATION IN PREGNANCY&quot;" target="&quot;INFANTS' NUTRITIONAL AND HEALTH OUTCOMES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Differences in infants' outcomes between those given choline supplements during their mothers' pregnancies versus placebo.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLINE INTAKE VS. MATERNAL NUTRITIONAL STATUS&quot;" target="&quot;NUTRIENT INTAKE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The impact of different levels of choline consumption compared to other nutrients in the diet on pregnancy health and infant development.")</data>
      <data key="d6">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10886471 SNP&quot;" target="&quot;ALLELE FREQUENCIES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genetic variation at rs10886471 influences the frequency of different 'CA' repeat alleles based on glucose levels.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELE (CA)16&quot;" target="&quot;RISK FOR PREDIABETES AND T2DM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CA16 allele shows an increased risk associated with prediabetes and type 2 diabetes compared to other alleles.")</data>
      <data key="d6">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONTROL GROUP&quot;" target="&quot;NFG GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The NFG group was designated as the control group in relation to comparing with case groups (IFG, IGT, T2DM).")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;(CA)16 ALLELE&quot;" target="&quot;REFERENCE ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The (CA)16 allele was used as a reference for comparison when assessing the association of multiple alleles with different blood glucose groups.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CASE GROUPS&quot;" target="&quot;IFG, IGT, AND T2DM GROUPS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"These groups were identified based on their association with genetic variants in relation to abnormal blood glucose levels.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS&quot;" target="&quot;IFG GROUP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Specific genotypes are negatively correlated with the IFG group based on their association with abnormal blood glucose levels.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS&quot;" target="&quot;IGT GROUP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Specific genotypes show a negative correlation with the IGT group, relating to genetic variants and abnormal blood glucose levels.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS&quot;" target="&quot;T2DM GROUP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variants are significantly associated with T2DM, as identified in statistical analyses.")</data>
      <data key="d6">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM SELENIUM&quot;" target="&quot;LIFESTYLE FACTORS (INCLUDING SMOKING AND HORMONE USE)&quot;">
      <data key="d4">0.12</data>
      <data key="d5">"There is an inverse relationship between serum selenium concentrations and lifestyle factors such as smoking and postmenopausal hormone use.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER&quot;" target="&quot;GPX4 GENE POLYMORPHISM&quot;">
      <data key="d4">0.02</data>
      <data key="d5">"SNP rs8178974 in GPX4 gene is linked to increased colorectal cancer risk.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL TUMOR&quot;" target="&quot;SERUM SELENIUM CONCENTRATION&quot;">
      <data key="d4">0.595</data>
      <data key="d5">"An inverse association exists between serum selenium concentration and the risk of colorectal tumors.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PUBLICATION BIAS&quot;" target="&quot;STATISTICAL ANALYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Begg’s test and Egger’s test indicate no publication bias in the meta-analysis.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER EFFECT&quot;" target="&quot;SELENIUM CONCENTRATION&quot;">
      <data key="d4">0.58</data>
      <data key="d5">"An increased protective effect against colorectal tumors exists for men compared to women, indicating a potential gender-specific differential response to selenium intake.")&lt;SEP&gt;"Selenium's protective effect against colorectal tumors is stronger in men compared to women.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC INTERACTION&quot;" target="&quot;GPX4 SNPS AND COLORECTAL CANCER&quot;">
      <data key="d4">0.29</data>
      <data key="d5">"SNP rs8178974 in GPX4 gene interacts with the risk of colorectal cancer, suggesting genetic predisposition.")</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9&quot;" target="&quot;DEXTRAN SULFATE SODIUM (DSS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Card9 plays a role in modulating the response to DSS-induced colitis, impacting recovery mechanisms.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9&quot;" target="&quot;BACTERIAL MICROBIOTA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CARD9 has a role in shaping the bacterial microbiota and controlling fungal expansion during colitis.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9&quot;" target="&quot;IBD&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Variants in CARD9 are linked to reduced AHR activation by microbiota-derived metabolites extracted from fecal samples in individuals with IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9&quot;" target="&quot;MICROBIOTA&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"There is a connection between CARD9, gut microbiota function, and the ability of the microbiota to produce AHR agonists.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;CARD9−/− MICE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Impaired tryptophan metabolism leading to defective AHR activation contributes to colitis susceptibility in Card9−/− mice.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22&quot;" target="&quot;AHR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-22 is required for the production of AHR ligands by the microbiota.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GUT MICROBIOTA&quot;" target="&quot;AHR ACTIVATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Alteration of the gut microbiota's function affects AHR activation through tryptophan metabolism and IL-22 pathway.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADLERCREUTZIA&quot;" target="&quot;DIFFERENCES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Decreases in Adlercreutzia were revealed between baseline Card9−/− mouse microbiota compared to WT microbiota.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LACTOBACILLUS REUTERI&quot;" target="&quot;DECREASES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Decreased levels of Lactobacillus reuteri were identified in the Card9−/− mouse microbiota based on LEfSe results.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BACTERIAL BIODIVERSITY&quot;" target="&quot;CORRELATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A negative correlation between bacterial biodiversity was observed between WT and Card9−/− mice across various time points.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUNGAL BIODIVERSITY&quot;" target="&quot;NO DIFFERENCES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No notable differences were found in fungal biodiversity between baseline WT and Card9−/− mouse microbiota at any time point.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTER-KINGDOM RELATIONSHIP&quot;" target="&quot;CORRELATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A negative correlation was noted between bacterial and fungal biodiversity in WT mice, implying an inter-kingdom relationship.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOTA&quot;" target="&quot;AHR AGONISTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ability of the microbiota to produce AHR ligands is associated with CARD9, IBD and their metabolic pathways.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOTA&quot;" target="&quot;TRYPTOPHAN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The gut microbiota alters tryptophan metabolism, impacting the production of Kyn and subsequent AHR activation.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KYN&quot;" target="&quot;TRYPTOPHAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Subjects with IBD use tryptophan to produce Kyn via IDO1 activity in their gut immune cells.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDO1&quot;" target="&quot;GUT IMMUNE CELLS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Gut immune cells utilize tryptophan via IDO1 to produce Kyn when it comes to AHR activation in individuals with IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUNGAL MICROBIOTA&quot;" target="&quot;GUT HEALTH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Alterations in the gut fungal microbiota are observed at both baseline and during colitis, with Card9−/− mice showing a less resilient microbiota compared to WT mice.")</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION&quot;" target="&quot;AGE AND COFFEE CONSUMPTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"There was a correlation between age and coffee consumption, with younger participants being more likely to consume black or sugared coffee.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;&amp;&quot;DIETARY PATTERN&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"This environmental factor might correlate with certain dietary patterns that influence nutrient intake.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORRELATION&quot;" target="&quot;AUTOSOMAL RECESSIVE LPL DEFICIENCY MUTATION AND CLINICAL MANIFESTATIONS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Link between genetic mutation causing LPL deficiency and its clinical symptoms such as hypertriglyceridemia, xanthomas, etc.")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARD9−/− MICE&quot;" target="&quot;AHR LIGAND PRODUCTION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Impaired tryptophan metabolism in Card9−/− mice affects AHR ligand production, thus impacting colitis susceptibility.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION&quot;" target="&quot;FECAL SAMPLES&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Healthy subjects' fecal samples induce higher levels of AHR activation compared to those from patients with IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR ACTIVATION&quot;" target="&quot;RS10781499&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The genetic variant rs10781499 within CARD9 impacts the interaction with the gut microbiota, affecting AHR activation in IBD patients.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AHR LIGATION&quot;" target="&quot;TRYPTOPHAN METABOLITES&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The microbiota's tryptophan metabolites are required for the proper AHR ligation process in individuals without IBD.")</data>
      <data key="d6">chunk-c791a4e35844d642ba0c69774072f7cd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β2M&quot;" target="&quot;PREVALENT HYPERTENSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Baseline β2M concentration is positively associated with prevalent hypertension, as shown by the odds ratio.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β2M&quot;" target="&quot;NEW-ONSET HYPERTENSION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A higher baseline β2M concentration predicts a greater risk of new-onset hypertension over time.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;Β2M&quot;" target="&quot;DISCRIMINATION FOR NEW-ONSET HYPERTENSION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The addition of β2M to the clinical model improves its ability to discriminate between individuals who will develop new onset hypertension.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CLINICAL COVARIATES&quot;" target="&quot;ADJUSTMENT FOR CONFOUNDING FACTORS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The clinical model adjusts for various confounding factors to assess the independent association between β2M and hypertension.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;ANCESTRY GROUPS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Variability in allele frequencies between different ancestry groups does not affect the allelic effects on eGFR, suggesting a shared genetic basis for this measurement across populations.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;RS77924615&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This variant at the PDILT-UMOD locus is crucial for eGFR measurements across diverse populations.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGFR&quot;" target="&quot;DCDC5-MPPED2&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Associations at the DCDC5-MPPED2 locus suggest mechanisms for genetic influences on kidney function.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SH2B3 EXPRESSION&quot;" target="&quot;CAUSAL EFFECT ON Β2M LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Decreased SH2B3 expression leads to higher β2M levels, as indicated by the inverse variance weighted MR analysis.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3184504 POLYMORPHISM&quot;" target="&quot;MEDIATION THROUGH SH2B3 EXPRESSION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The rs3184504 genetic variant may influence β2M levels through its impact on SH2B3 expression.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3184504 POLYMORPHISM&quot;" target="&quot;ASSOCIATION WITH SH2B3 EXPRESSION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The rs3184504 polymorphism influences SH2B3 expression, as indicated by the association between it and SH2B3 gene function in the Mendelian randomization study.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE Β2M CONCENTRATION&quot;" target="&quot;LONGITUDINAL ASSOCIATION WITH NEW-ONSET HYPERTENSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In a longitudinal study, increased baseline β2M concentration is associated with an elevated risk of new-onset hypertension.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INCREASED HYPERTENSIVE RESPONSE&quot;" target="&quot;SH2B3−/− MOUSE MODEL&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Deficiency in SH2B3 function is associated with a more severe hypertensive response and renal dysfunction.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLIC ACID SUPPLEMENTS&quot;" target="&quot;MATERNAL AGE AT DELIVERY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There was an age difference between non-Hispanic White and Hispanic mothers based on supplement use.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SHMT1 SNP RS669340 CG GENOTYPE&quot;" target="&quot;RISK REDUCTION FOR NTDS IN MOTHERS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"CG genotype was associated with a 31% risk reduction of NTD-affected pregnancies compared to CC genotypes among mothers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISPANIC MOTHER EDUCATION LEVEL&quot;" target="&quot;NON-HISPANIC WHITE MOTHER EDUCATION LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was a disparity in formal education attainment between Hispanic and non-Hispanic White mothers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIFFERENCES ACROSS SUBGROUPS&quot;" target="&quot;FOLATE INTAKE VARIABLE COMPOSITE MEASURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The composite measure showed subtle differences but more consistency compared to single nutrient intake measures.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DHFR GENE VARIANT AND NTD-AFFECTED PREGNANCIES&quot;" target="&quot;GENETIC POLYMORPHISM ASSOCIATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"No evidence of association between DHFR gene variants and risk for NTD pregnancies in studied population.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INFANT RISK FACTOR&quot;" target="&quot;MTHFD1 SNPS RS2236224 AND RS2236225 CT GENOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CT genotype was associated with increased risk compared to CC genotypes for infants in lower folate intake groups.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFD1 SNP RS11627387 AG/AA GENOTYPES AND LOW FOLATE INTAKE&quot;" target="&quot;NTD RISK FACTOR&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"AG genotype was associated with four-fold increase risk of NTDs when maternal folate intake was low compared to GG genotypes.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE INTAKE AND RISK OF NTDS&quot;" target="&quot;MTHFR SNPS RS1476413, RS1801131 AND RS1801133 HETEROZYGOUS VS COMMON HOMOZYGOUS MOTHERS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Low folate intake was associated with a decreased risk of an NTD-affected pregnancy if mothers carried heterozygous MTHFR SNPs compared to common homozygous mothers.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK FOR NTDS INTERACTION EFFECT&quot;" target="&quot;SHMT1 SNP RS12939757 AG/AA GENOTYPES AND LOW FOLATE INTAKE IN INFANTS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"An interaction effect was observed with AG vs AA genotypes in infants depending on maternal folate intake.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK REDUCTION FOR NTDS INTERACTION EFFECT&quot;" target="&quot;TYMS SNP RS502396 OR RS699517 HETEROZYGOUS GENOTYPES AND LOW FOLATE INTAKE IN MOTHERS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Gene-folate interaction was associated with reduced risk of NTDs among mothers on low folate intake compared to high intake group.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK FOR NTDS INTERACTION EFFECT IN INFANTS&quot;" target="&quot;TYMS SNPS RS2847153 AND LOW FOLATE INTAKE IN INFANTS, INTERACTION EFFECT FOR AG GENOTYPES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An interaction effect was protective for infants with AG genotypes compared to AA genotypes when mothers were on low folate intake.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10399931&quot;" target="&quot;SERUM C-PEPTIDE CONCENTRATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A significant association was found between rs10399931 and serum C-peptide concentration after a 2-hour mark, indicating its impact on insulin response.")</data>
      <data key="d6">chunk-44a871da300abc9be525b468f502f5cb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;Y402H CFH RISK ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Having the Y402H variant of CFH gene increases the odds for AMD.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;A69S RISK ALLELE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"An additional copy of the A69S risk allele increases the odds of AMD relative to women with zero copies.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;G ALLELE OF RS641153 (CFB/C2)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The G allele for the rs641153 variant in CFB/C2 gene is associated with increased AMD risk.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;RS10033900&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No main effect was observed within CAREDS for rs10033900, related to AMD risk.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;RS2230199&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Similarly, no main effect was found for rs2230199 in relation to AMD.")</data>
      <data key="d6">chunk-23a090455f50ab98c53e8b90941c6da5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMD&quot;" target="&quot;LIFESTYLE&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"There was no evidence for multiplicative interactions between lifestyle factors and genetic risks like the ARMS2 genotype on AMD development.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;CFB/C2&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"There was no evidence for joint effects between lifestyle and variants in the CFB/C2 gene on AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;C3 RS2230199&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The main effects for SNPs in C3 were absent when examining interactions with lifestyle, indicating limited influence on AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE&quot;" target="&quot;CFI RS10033900&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Similar to the C3 SNP, there were no strong indications of interaction between lifestyle and this variant in CFI for AMD risk.")</data>
      <data key="d6">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL ANALYSIS&quot;" target="&quot;CORRECTION FOR MULTIPLE TESTING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Correction for multiple testing is used when several statistical tests are performed simultaneously, which helps to reduce type I errors.")&lt;SEP&gt;"This refers to the application of statistical methods used when multiple hypotheses are tested simultaneously, adjusting p-values to control the family-wise error rate.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL MEASURE&quot;" target="&quot;MEAN SQUARE ERROR&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"The mean square error of FEV1/FVC was assessed using LASSO regression with a set of 80 SNPs.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC POLYMORPHISMS&quot;" target="&quot;GWAS RESULTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A total of 18 SNPs located in different genomic regions achieved suggestive significance.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COFFEE CONSUMPTION AND DIABETES RISK&quot;" target="&quot;PREVENTION EFFECT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Participants who consumed ≥2 cups/day of black or sugared coffee had a lower risk of prediabetes and type 2 diabetes.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COFFEE TYPE AND DIETARY PREFERENCE&quot;" target="&quot;PREFERENCE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Coffee preferences could indicate different dietary patterns or habits.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHARACTERISTICS ANALYSIS&quot;" target="&quot;STUDY POPULATION ANALYSIS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Detailed examination was conducted on the baseline characteristics of the participants for various analyses.")</data>
      <data key="d6">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPONECTIN, PDGFRΑ OR AP2/FABP4&quot;" target="&quot;SENP1 DEFICIENCY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"the adipocyte-specific deletion of SENP1")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATS&quot;" target="&quot;T1DM&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"developed a diabetic phenotype (Fig.")</data>
      <data key="d6">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATS&quot;" target="&quot;HFD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High Fat Diet leads to increased fat weight in PAT adipose depots of SENP1-aP2KO mice under normal chow diet.")</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-CELL&quot;" target="&quot;AUTOIMMUNE RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Immune cell-specific effector T-cell invasion in the pancreatic tissue attacks the islets and induces cell death.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOANTIGEN NRP-V7-POSITIVE CD8+ T CELLS&quot;" target="&quot;AUTOIMMUNE RESPONSE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An autoantigen NRP-V7-positive CD8+ T cells, targeting a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein, were detected in the pancreatic lymph nodes and the spleen of SENP1-aP2KO mice at the age of 12 weeks.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN DEFICIENCY&quot;" target="&quot;TYPE 1 DIABETES/">
      <data key="d4">6.0</data>
      <data key="d5">|&gt;Hepatic Steatosis"/"T2DM/</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETIC PHENOTYPE&quot;" target="&quot;HIGH-FAT DIET (HFD)&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"HFD conditions augment the diabetic phenotype in SENP1 deficient mice, affecting fat weight, cell size and number of adipocytes.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADIPOSE TISSUE&quot;" target="&quot;HFD/">
      <data key="d4">8.0</data>
      <data key="d5">|&gt;SENP1-aP2KO"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROINFLAMMATORY CYTOKINES IL-6, TNF-Α AND IL-IΒ&quot;" target="&quot;EFFECT ON&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"High levels of pro-inflammatory cytokines secreted from peri-pancreatic adipocytes contribute directly to the upregulation of CCL5 expression in pancreatic islets.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5&quot;" target="&quot;AUTOIMMUNE RESPONSE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CCL5 contributes to autoimmune responses by recruiting immune cells that damage pancreatic β cells, leading to insulin deficiency and diabetes.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL5&quot;" target="&quot;UPREGULATION AND LOCALIZATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The expression of CCL5 mRNA significantly increases in islets due to secreted cytokines from peri-pancreatic adipocytes, specifically before the onset of diabetes in SENP1-deficient mice.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM&quot;" target="&quot;IL-8 PROTEIN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-8 protein levels in serum were significantly higher in patients compared to controls.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HFD&quot;" target="&quot;PATS/">
      <data key="d4">4.0</data>
      <data key="d5">|&gt;Control Condition/</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENP1-AP2KO&quot;" target="&quot;DISEASE&quot;/&quot;T1DM/">
      <data key="d4">5.0</data>
      <data key="d5">|&gt;T2DM"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FATTY LIVER DISEASE&quot;" target="&quot;INSULIN RESISTANCE/">
      <data key="d4">3.0</data>
      <data key="d5">|&gt;Hyperglycaemia"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 1 DIABETES&quot;" target="&quot;GENETIC TRAIT&quot;/&quot;T2DM/">
      <data key="d4">5.0</data>
      <data key="d5">|&gt;Comorbidity"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BETA CELL LOSS&quot;" target="&quot;TYPE 1 DIABETES/">
      <data key="d4">3.0</data>
      <data key="d5">|&gt;Insulin Deficiency"</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T1DM&quot;" target="&quot;PRO-INFLAMMATORY CYTOKINE LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased plasma levels of proinflammatory cytokines are significantly higher in T1DM patients compared to healthy controls.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE RESPONSE&quot;" target="&quot;TH1 (IFN-Γ+CD4+) AND TH17 (IL-17+CD4+) EFFECTOR T-CELL SUBSETS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"We observed that Th1 (IFN-γ+CD4+) and Th17 (IL-17+CD4+) effector T-cell subsets expanded concomitant with reduction of regulatory T-cell subset (CD4+CD25+Foxp3+) in the pancreatic lymph nodes of SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE RESPONSE&quot;" target="&quot;ACTIVATED DENDRITIC CELLS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"We also observed an increase in activated dendritic cells in the lymph node of pancreases.")</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINES IL-6, TNF-Α AND IL-IΒ&quot;" target="&quot;EFFECT ON&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Proinflammatory cytokine overproduction serves as the main reason for immunologic tolerance break leading to diabetes.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENHANCEMENT OF&quot;" target="&quot;SENP1 DELETION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Deletion of SENP1 gene strongly enhances the expression of pro-inflammatory cytokines in peri-pancreatic adipocytes compared to other adipose depots.")</data>
      <data key="d6">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULATE PHOSPHO-IKK&quot;" target="&quot;SENP1 SIRNA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SENP1 siRNA increased phosphorylation of IKK in adipocytes.")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INCREASE PROINFLAMMATORY CYTOKINE EXPRESSION&quot;" target="&quot;SENP1 KNOCKDOWN CELLS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SENP1 knockdown cells showed significantly higher gene expressions of IL-6, TNF-α and IL-1β compared to Ctrl cells.")</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERGLYCAEMIA&quot;" target="&quot;SENP1 EXPRESSION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Age-dependent reduction in SENP1 expression correlates with the progression of spontaneous diabetes in NOD mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES PROGRESSION&quot;" target="&quot;TH1 DOMINANT RESPONSE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The Th1 dominant response due to IFN-γ-induced insulitis is associated with diabetes progression in NOD mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATIC CELL DEATH&quot;" target="&quot;SERUM FROM T1DM PATIENTS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Serum from human T1DM patients and NOD mice induces disruption and cell death in pancreatic islets.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES PHENOTYPES&quot;" target="&quot;PROPHYLACTIC INSULIN THERAPY&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Prophylactic insulin therapy only partially ameliorates the development of diabetes phenotypes in SENP1-deficient mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOOD GLUCOSE&quot;" target="&quot;NF-ΚB INHIBITORS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Administration of an NF-κB activation inhibitor reduces blood glucose levels and attenuates islet damages in SENP1-aP2KO mice.")</data>
      <data key="d6">chunk-8382a49b61215482f9fc75e3a86cb987</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATS/" target="&quot;LIVER INSULIN RESISTANCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">|&gt;HFD/</data>
      <data key="d6">chunk-174831b97ed170039b374ba254d4f506</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APAI&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The ApaI and BsmI variants were not significantly associated with ovarian cancer risk based on the meta-analysis.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APAI&quot;" target="&quot;FOKI&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Both FokI and ApaI variants were assessed in the same studies regarding their association with ovarian cancer, indicating potential genetic interaction.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BSMI&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was no significant association for the variant (rs1544410) and ovarian cancer risk as determined by both fixed-effect model and exclusion of heterogeneity-contributing subgroup.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BSMI&quot;" target="&quot;CAUCASIANS&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"The meta-analysis restricted to Caucasian population yielded different results for BsmI compared to other ethnic groups, suggesting a possible influence of ethnicity on the variant's association with ovarian cancer.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOKI&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FokI variant was significantly associated with an increased risk of ovarian cancer.")</data>
      <data key="d6">chunk-1c470c93632f3704d6f3566de7a1dd0c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDX-2&quot;" target="&quot;RS11568820&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs11568820 was evaluated as part of genetic studies related to Cdx-2 and its potential impact on ovarian cancer risk.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAQI&quot;" target="&quot;RS731236&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genomic variant rs731236 was studied for its relation with the TaqI gene and the risk of developing ovarian cancer.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1A -889C&gt;T TT GENOTYPE&quot;" target="&quot;HNP PATIENT FREQUENCY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TT genotype of IL-1A -889C&gt;T was found to be more frequent in HNP patients.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROL FREQUENCY&quot;" target="&quot;TNF-A 238G&gt;A CT GENOTYPE AND T ALLELE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CT and T allele of TNF-A 238G&gt;A were found more frequent among healthy controls compared to HNP cases.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NO ASSOCIATION WITH HNP&quot;" target="&quot;VDR TAQI TT VS. TC+CC, TC VS. TT+CC AND OR: 2.65; 95%CI: 0.60, 11.85&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genotypes of VDR TaqI were not associated with susceptibility to degenerative disc disease HNP.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-1A -889C&gt;T GENOTYPES CC VS. CT+TT, CT VS. CC+TT AND TT VS. CT+CC&quot;" target="&quot;NO ASSOCIATION WITH RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genotypes models of IL-1A -889C&gt;T were not associated with the risk for HNP.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NO ASSOCIATION WITH RISK&quot;" target="&quot;TNF-A 238G&gt;A GENOTYPES GG VS. GA+AA, GA VS. GG+AA AND AA VS. GG+GA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Pooled estimates of TNF-A 238G&gt;A genotypes were not associated with the risk for HNP.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NO ASSOCIATION WITH RISK&quot;" target="&quot;VDR TAQI GENOTYPES TT VS. TC+CC, TC VS. TT+CC AND OR: 1.01; 95%CI: 0.55, 1.85&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"None of the genotypes for VDR TaqI were associated with susceptibility to degenerative disc disease HNP.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASSOCIATION WITH RISK&quot;" target="&quot;C ALLELE OF IL-1A -889C&gt;T&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was no significant association between the C allele and T allele in relation to the risk of HNPs for IL-1A -889C&gt;T.")</data>
      <data key="d6">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL RELATIONSHIP&quot;" target="&quot;MATERNAL B12 LEVELS&quot;&amp;&quot;OFFSPRING BIRTHWEIGHT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"There is no evidence suggesting a causal effect of maternal B12 levels on offspring birthweight, which indicates that other factors might be more influential in this relationship.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL RELATIONSHIP&quot;" target="&quot;FOLATE LEVELS&quot;&amp;&quot;B12 LEVELS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"There was a small causal effect detected between folate levels and B12 levels suggesting their interplay in maternal health.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL RELATIONSHIP&quot;" target="&quot;TRANSCRIPT&quot;&amp;&quot;NUTRIENT LEVELS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The expression of this transcript could be related to the levels or regulation of nutrients like B12 and folate.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUSAL RELATIONSHIP&quot;" target="&quot;NUTRIENT LEVELS&quot;&amp;&quot;GESTATIONAL DURATION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Alterations in nutrient levels, such as B12 and folate, could potentially affect gestational duration or have been studied for this relationship.")</data>
      <data key="d6">chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d4">99.5</data>
      <data key="d5">"The study assessed MTHFR C677T alongside Prothrombin G20210A in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;FACTOR V G1691A&quot;">
      <data key="d4">189.60000000000002</data>
      <data key="d5">"The study evaluated MTHFR C677T and Factor V G1691A together in LV patients, alongside other SNPs.")&lt;SEP&gt;"The study evaluated both MTHFR C677T and Factor V G1691A together in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR C677T&quot;" target="&quot;PAI-1 A844G&quot;">
      <data key="d4">95.3</data>
      <data key="d5">"Both MTHFR C677T and PAI-1 A844G were assessed for their prevalence in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;FACTOR V G1691A&quot;">
      <data key="d4">189.2</data>
      <data key="d5">"Both PAI-1 -675 4G/5G and Factor V G1691A were assessed for their prevalence in LV patients.")&lt;SEP&gt;"The assessment of PAI-1 -675 4G/5G was compared to Factor V G1691A.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 -675 4G/5G&quot;" target="&quot;PROTHROMBIN G20210A&quot;">
      <data key="d4">190.1</data>
      <data key="d5">"Both PAI-1 -675 4G/5G and Prothrombin G20210A were assessed in the same studies.")&lt;SEP&gt;"The study evaluated the prevalence of PAI-1 -675 4G/5G and Prothrombin G20210A in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;PAI-1 A844G&quot;">
      <data key="d4">93.1</data>
      <data key="d5">"Compared to other SNPs, PAI-1 A844G and Prothrombin G20210A were both assessed for their prevalence in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTHROMBIN G20210A&quot;" target="&quot;FACTOR V G1691A&quot;">
      <data key="d4">89.5</data>
      <data key="d5">"The study compared the carriers of Prothrombin G20210A and Factor V G1691A in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;MTHFR A1298C&quot;">
      <data key="d4">91.7</data>
      <data key="d5">"The study compared the prevalence of MTHFR A1298C and Factor V G1691A in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FACTOR V G1691A&quot;" target="&quot;PAI-1 A844G&quot;">
      <data key="d4">90.2</data>
      <data key="d5">"The study evaluated PAI-1 A844G and Factor V G1691A together for their prevalence in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PAI-1 A844G&quot;" target="&quot;MTHFR A1298C&quot;">
      <data key="d4">94.5</data>
      <data key="d5">"The study compared the carriers of MTHFR A1298C and PAI-1 A844G in LV patients.")</data>
      <data key="d6">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR DISEASE&quot;" target="&quot;NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Alterations in the nitric oxide synthesis pathway are associated with cardiovascular disease.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE-SPECIFIC NUTRIENT INTERACTION&quot;" target="&quot;MTHFR 677C&gt;T VARIANT IN INDIVIDUALS WITH SERUM FOLATE BELOW MEDIAN&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"When focusing on the MTHFR 677C&gt;T variant, individuals with serum folate levels below the study population median showed no association with male infertility.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION AND GENETIC POLYMORPHISM&quot;" target="&quot;PEMT M175V MINOR V ALLELE AND TCBLR RS173665 VARIANT IN NON-USERS OF VITAMINS TO FERTILITY STATUS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In individuals who did not take vitamin supplements, the PEMT M175V minor V allele and the TCblR rs173665 genetic variants showed significant associations with infertility status.")</data>
      <data key="d6">chunk-c9badb9a0fb813f42383cc8afc57ad45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1801394&quot;" target="&quot;MTRR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Substitution of A by G results in an enzyme with less affinity for the substrate. The frequency of the A allele increased among TMD patients.")</data>
      <data key="d6">chunk-382f24e5db6941e2e3db379fe499b223</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GROUP 2 LABORATORIES&quot;" target="&quot;S-FOL&quot;/&quot;WB-FOL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Labs that used folic acid calibrator")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARMONIZED CONDITION&quot;" target="&quot;DIFFERENCES BETWEEN DAY 1 AND DAY 2&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Differences were expected to be approximately ±10–30% for S-FOL and approximately ±20–40% for WB-FOL with harmonized conditions.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC HPLC-MS/MS&quot;" target="&quot;CDC MBA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A high Pearson correlation (r = 0.999) was observed between the results of the CDC MBA and CDC HPLC-MS/MS methods for serum folate measurement.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LABORATORY PROCEDURES&quot;" target="&quot;SERUM SAMPLES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"All participating laboratories reported their results using different procedures, such as sample dilution techniques and incubation periods.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LABORATORY VARIABILITY&quot;" target="&quot;SAMPLE DILUTIONS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The use of different sample dilutions (1:100 for serum and 1:140 for whole-blood hemolysate by CDC recommended, or lab-specific dilution) influenced the within-laboratory imprecision.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;37°C INCUBATION&quot;" target="&quot;ASSAY STABILITY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Labs incubated their assay plates at 37°C for 42–45 h; an exception was Lab #3 which used only an 18-h incubation period.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DATA CONSISTENCY&quot;" target="&quot;READ PLATES AT 590 NM&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Most laboratories read their plates at 590 nm and carefully controlled timing to ensure consistency across all plates.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALIBRATION ACCURACY&quot;" target="&quot;POLYNOMIAL REGRESSION FIT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A third-order polynomial regression was most commonly used for calibration curve fitting, but other methods were reported as well.")</data>
      <data key="d6">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;5-METHYLTHF&quot;/&quot;FOLIC ACID&quot;" target="&quot;NUTRIENT/NUTRIENT RELATIONSHIP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Comparison between two types of nutrients (5-methylTHF vs. folic acid) to evaluate their impact on laboratory test results.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC MBA TARGET CONCENTRATION&quot;/&quot;S-FOL&quot;" target="&quot;DISEASE/PHYSIOLOGICAL PROCESS-NUTRIENT RELATIONSHIP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"S-FOL's comparison against the CDC MBA target value as a reference physiological or health standard.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE/PHYSIOLOGICAL PROCESS-NUTRIENT RELATIONSHIP&quot;" target="&quot;CDC MBA TARGET CONCENTRATION&quot;/&quot;WB-FOL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Similar relationship for WB-FOL in comparison with the CDC MBA target.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;S-FOL&quot;/&quot;WB-FOL&quot;" target="&quot;TRANSCRIPT/TRANSCRIPT RELATIONSHIP&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Comparison of two transcript forms (S-FOL and WB-FOL) in laboratory conditions.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;S-FOL&quot;/&quot;WB-FOL&quot;" target="&quot;USE OF IH REAGENTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"1. When all labs used IH reagents, the mean difference to CDC MBA target decreased.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;S-FOL&quot;/&quot;WB-FOL&quot;" target="&quot;USE OF CDC REAGENTS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"When CDC reagents were used by all laboratories, the mean ± SD difference to the CDC MBA target decreased.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDC MO CONDITION&quot;/&quot;CDC CAL CONDITION&quot;" target="&quot;ENVIRONMENTAL FACTOR/ENVIRONMENTAL FACTOR RELATIONSHIP&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Relation between two different environmental contexts tested for their impact on laboratory results (CDC MO vs CDC CAL).")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR/ENVIRONMENTAL FACTOR RELATIONSHIP&quot;" target="&quot;IH MO CONDITION&quot;/&quot;IH CAL CONDITION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Comparison of outcomes influenced by distinct environmental conditions (IH MO and IH CAL)." )</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROORGANISM&quot;/&quot;S-FOL&quot;" target="&quot;MOLECULAR INTERACTION-NUTRIENT RELATIONSHIP&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Role of microorganisms in influencing S-FOL results when compared against the CDC MBA target.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION-NUTRIENT RELATIONSHIP&quot;" target="&quot;MICROORGANISM&quot;/&quot;WB-FOL&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Similar interaction for WB-FOL and microorganisms during comparisons.")</data>
      <data key="d6">chunk-257a38a8ce6582c434f31b023b4a9704</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIMITS OF AGREEMENT&quot;" target="&quot;RANGE WITHIN WHICH 95% OF RESULTS EXPECTED&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The limits indicate where 95% of lab results are expected compared with CDC MBA when using CDC reagents.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARMONIZED CONDITION AND SAME MICROORGANISM/CALIBRATOR&quot;" target="&quot;REASONABLE AGREEMENT&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"All labs, except #6 and #9 showed good agreement under harmonized conditions.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LAB #8 - WB-FOL&quot;" target="&quot;LACK OF AGREEMENT&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Lab #8 showed discrepancies in WB-FOL results between day 1 and day 2.")</data>
      <data key="d6">chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1695&quot;" target="&quot;GENOTYPE AA, AG, AND GG FOR CONTROLS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The frequency ratios were found as 50.00%, 44.00% and 6.00% respectively.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1138272&quot;" target="&quot;GENOTYPE CC, CT AND TT FOR CONTROLS AND CASES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The frequency ratios were found as 92.00%, 08.00% and 00.00% respectively for control group whereas these ratios for cases were calculated 88.00%, 11.00% and 01.00%")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ILE105VAL&quot;" target="&quot;WALTZ OUTPUT&quot;">
      <data key="d4">-456.0</data>
      <data key="d5">"The Ile105Val polymorphism decreases the amyloid propensity of the GSTP1 enzyme (dWALTZ was -228.00")&lt;SEP&gt;"The Ile105Val polymorphism reduces the amyloid propensity of the GSTP1 enzyme (dWALTZ was -228.00")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTP1&quot;" target="&quot;FUNCTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"We evaluated effects of Ile105Val SNP on the GSTP1 function using SNPeffects online software.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GSTP1&quot;" target="&quot;FUNCTION AND ENZYME ACTIVITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The WALTZ algorithm specifically predicts that Ile105Val polymorphism decreases the amyloid propensity of GSTP1 enzyme.")</data>
      <data key="d6">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.T935M&quot;" target="&quot;HAPLOGROUP J&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genetic analysis identified a uniform association of p.T935M with haplogroup J on WD chromosomes.")("entity"</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC MARKER&quot;" target="&quot;HAPLOGROUP ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Associations between specific alleles at different markers and various haplogroups underscore the interplay between genetic drift, natural selection, and demographic history in shaping genetic diversity within the WD population.")("entity"</data>
      <data key="d6">chunk-047f259db19cbb4de945706a1bd1b450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM&quot;" target="&quot;CYP2C9 STAR VARIANT GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CYP2C9 genetic variants were grouped due to low frequency, impacting the prediction models.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM&quot;" target="&quot;RS1799853, RS1057910, RS9923231 SNPS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Algorithms considered the impact of low-frequency SNPs on predicting warfarin doses.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM&quot;" target="&quot;CYP2C9 ENZYME&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CYP2C9 gene polymorphisms influence how algorithms predict drug metabolism.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM&quot;" target="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The novel AA algorithm outperforms the IWPC pharmacogenomics algorithm by assigning a significantly greater percentage of high-dose patients correctly.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM&quot;" target="&quot;IWPC CLINICAL ALGORITHM&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The incorporation of our novel AA algorithm into practice provides a higher net numerical gain compared to the use of the IWPC clinical algorithm.")&lt;SEP&gt;"The novel AA algorithm outperforms the IWPC clinical algorithm by assigning a much higher percentage of high-dose patients correctly.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM&quot;" target="&quot;PRECISION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The novel AA algorithm provides higher precision in predicting doses.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM&quot;" target="&quot;ACCURATE MEASUREMENT OF ADMIXTURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The novel AA algorithm performs well when evaluated with accurate measurements of admixture provided by AIMs.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM&quot;" target="&quot;POPULATION-SPECIFIC VARIABLES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The novel AA algorithm accounts for and incorporates population-specific variables, which results in better performance when dealing with the broad range of WAA among AAs.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;" target="&quot;INVERSELY CORRELATED PERFORMANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The IWPC pharmacogenomics algorithm exhibits inversely correlated performance with percent WAA in predicting doses for high-dose patients (≥60 mg/week), unlike our novel AA algorithm.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IWPC CLINICAL ALGORITHM&quot;" target="&quot;LOWER CORRELATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Compared to the IWPC pharmacogenomics algorithm, our novel AA algorithm has a higher correlation with percent WAA and predicted doses for high-dose patients (≥60 mg/week), indicating superior performance.")</data>
      <data key="d6">chunk-b2730f3087aee6d9cff6e4939b229323</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PREVIOUS STUDIES&quot;" target="&quot;RS1799853, RS1057910, AND RS9923231 SNPS AND LOW FREQUENCIES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Studies previously observed low minor allele frequencies for these SNPs.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM ACCURACY&quot;" target="&quot;IWPC ALGORITHMS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Comparisons of algorithm performance against IWPC methods to assess its validity in predicting warfarin doses.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM PREDICTIVE POWER&quot;" target="&quot;NOVEL AA ALGORITHM, IWPC PHARMACOGENOMICS AND CLINICAL ALGORITHMS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Evaluation of how well each algorithm predicts dosing requirements within the target range.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM, IWPC PHARMACOGENOMICS AND CLINICAL ALGORITHMS&quot;" target="&quot;ALGORITHM PERFORMANCE FOR LOW-DOSE PATIENTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Specific comparison of accuracy in predicting lower doses among the algorithms.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOVEL AA ALGORITHM, IWPC PHARMACOGENOMICS AND CLINICAL ALGORITHMS&quot;" target="&quot;ALGORITHM PERFORMANCE FOR INTERMEDIATE-DOSE GROUP&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Similar focus on assessing accuracy with regards to mid-range warfarin dosages.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-, INTERMEDIATE- AND HIGH-DOSE PATIENTS&quot;" target="&quot;PREDICTIVE ACCURACY IN DOSE SUBGROUPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Analysis performed for different groups based on warfarin dosage needs.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM PERFORMANCE FOR HIGH-DOSE PATIENTS&quot;" target="&quot;NOVEL AA ALGORITHM COMPARED AGAINST IWPC METHODS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A detailed comparison of how well each algorithm performs in predicting higher doses.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM, CYP2C9 GENE&quot;" target="&quot;CYP2C9 ENZYME POLYMORPHISMS AND WARFARIN DOSE PREDICTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The algorithms considered the impact of CYP2C9 genetic variants on predicting appropriate warfarin dosing.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM, SNPS&quot;" target="&quot;SNP FREQUENCIES AND ALGORITHM PERFORMANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Some algorithms were more accurate when considering lower-frequency SNPs associated with reduced CYP2C9 activity.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM 1 VS. ALGORITHM 2 (IWPC, AA NOVEL)&quot;" target="&quot;ALGORITHM ACCURACY COMPARISON&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The performance of the AA novel algorithm was compared to that of IWPC algorithms in terms of dose prediction precision.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NITRIC OXIDE&quot;" target="&quot;CARDIOVASCULAR HEALTH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Nitric oxide plays a critical role in regulating blood pressure and the health of cardiovascular systems.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NITRIC OXIDE&quot;" target="&quot;DRUG THERAPY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Statins can help manage nitric oxide levels to reduce cardiovascular risks.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS&quot;" target="&quot;CHAT EXPRESSION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Changes in environmental conditions could impact the expression levels of CHAT proteins.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRUG THERAPY&quot;" target="&quot;GEMFIBROZIL AND OMEGA-3 FATTY ACIDS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Combined with a fat-restricted diet, drugs like gemfibrozil and omega-3 fatty acids help manage high triglyceride levels in individuals with LPL deficiency.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTOR&quot;" target="&quot;NUTRIENT PROFILE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A balanced nutrient profile can influence lifestyle choices in an individual.")</data>
      <data key="d6">chunk-f05ecc979eea31a1ab844c2c7de12432</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD-TYPE (WT)&quot;" target="&quot;VALIDATION/">
      <data key="d4">1.0</data>
      <data key="d5">sensitivity study"</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD-TYPE (WT)&quot;" target="&quot;DUPLEX-PCR/HRMA RESULTS/">
      <data key="d4">1.0</data>
      <data key="d5">sequencing results"</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;/&quot;TM DIFFERENCE/" target="&quot;RS777676129 AMPLICONS&quot;/&quot;RS114368325 AMPLICONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">metabolic pathway"</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS777676129 AMPLICONS&quot;/&quot;RS114368325 AMPLICONS&quot;" target="&quot;SPECIFIC GENOTYPING/">
      <data key="d4">1.0</data>
      <data key="d5">amplicon differentiation"</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE ASSOCIATION/" target="&quot;NORMALIZED AND TEMPERATURE-SHIFTED AND DIFFERENT PLOT&quot;/&quot;CYP24A1 GENOTYPES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">physiological process"</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAGNOSTIC VALIDATION/" target="&quot;DUPLEX-PCR/HRMA&quot;/&quot;10 DNA SAMPLES WITH THE SUSPICION OF IIH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">confirmation"</data>
      <data key="d6">chunk-1327975b50e4a0aac1792cb595041ee5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCR AND BSMAI DIGESTION&quot;" target="&quot;BIOCHEMICAL PROCESS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Differences were observed in PCR and BsmAI digestion results between blood and skin fibroblast samples, which may indicate variations in mosaicism levels for the P1001L mutation.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONTROL FOR COMPLETENESS OF BSMAI DIGESTION&quot;" target="&quot;QUALITY ASSURANCE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"A control test was used to ensure the accuracy and completeness of BsmAI digestion through Q-RT-PCR, providing quality assurance in molecular analysis results.")</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE-DEPLETED MEDIUM&quot;" target="&quot;EFFECT ON CELL VIABILITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Cells under Se-depleted conditions show a greater reduction in viability when challenged with tert-butylhydroperoxide compared to normal medium conditions.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SE COMPETITION THEORY&quot;" target="&quot;THEORETICAL MODEL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Hypothesis suggesting that differing expression levels of rat IDI under se-depleted conditions could influence selenoprotein production differently compared to normal conditions.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXIDATIVE STRESS&quot;" target="&quot;TERT-BUTYLHYDROPEROXIDE EXPOSURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Exposure to tert-butylhydroperoxide leads to an increase in ROS levels, particularly under Se-depleted conditions and differing 3'UTR variants.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELLULAR RESPONSE&quot;" target="&quot;TRANSFECTED CACO-2 CELLS EXPRESSING IDI-T AND IDI-C TRANSCRIPTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Cell lines over-expressing either the IDI-T or IDI-C transcripts show lower viability after tert-butylhydroperoxide challenge compared to untransfected cells.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEIODINASE EXPRESSION LEVELS&quot;" target="&quot;INFLUENCE ON SELENOPROTEIN H MRNA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression level of the deiodinase gene (both human IDI and rat IDI) affects selenoprotein H mRNA levels under varying selenium supply conditions.")</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONSENSE MUTATION&quot;" target="&quot;DISEASE PREVALENCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"None of the mutations were detected in control subjects, suggesting a low prevalence.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THERMAL STABILITY&quot;" target="&quot;STABILITY MEASURE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A stable p/MHC complex formed after refolding nonamer and decamer peptides with HLA-A*01:01.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EVOLUTIONARY CONSERVATION&quot;" target="&quot;CONSERVED RESIDUES&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Conserved residues across species like Drosophila and C. elegans indicate that certain functions are evolutionarily preserved.")&lt;SEP&gt;"The conserved residues are present across species, including Drosophila and C. elegans, indicating evolutionary conservation.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN STABILITY&quot;" target="&quot;THERMAL STABILITY OF MUTANTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Mutation-induced changes might lead to compromised thermal stability under different temperatures.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC ENGINEERING&quot;" target="&quot;WILD-TYPE COMPARISON&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Comparisons were made between wild-type and mutated CHAT proteins to evaluate the impact on expression levels.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUNCTIONAL IMPACT&quot;" target="&quot;MISSENSE MUTATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression of eight mutants was significantly lower than wild-type; five expressed at less than 50% of wild-type levels.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAT EXPRESSION&quot;" target="&quot;PROTEIN LEVEL IMPACT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Eight mutants expressed at significantly lower levels than wild-type; five of these (p.Trp421Ser, p.Ser498Pro, p.Thr553Asn, p.Ala557Thr, p.Ser572Trp) expressed at &lt;50% of wild-type.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KINETIC PARAMETER EFFECT&quot;" target="&quot;MUTATION RATE CONSTANTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Ten mutations alter rate constants for ChAT activation; two compromise thermal stability of mutant proteins.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONTROL SUBJECT MUTATIONS&quot;" target="&quot;MUTATION PREVALENCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The absence of mutations in control subjects suggests a limited genetic predisposition towards these mutations.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FUNCTIONAL PARAMETERS&quot;" target="&quot;KINETIC ACTIVATION CHANGES&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Mutations altered kinetic parameters involved in ChAT activation, affecting its catalytic efficiency.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ATOMIC STRUCTURAL MODEL&quot;" target="&quot;STRUCTURAL INSIGHTS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The atomic structural model offered insights into how mutations affect the protein's 3D structure and function.")</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL2L11&quot;" target="&quot;TGSH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A CpG site in BCL2L11 was associated with TGSH levels.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL2L11&quot;" target="&quot;RS726430&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs726430 linked to the BCL2L11 gene via CpG site cg07547695.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFS7&quot;" target="&quot;GSH&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"One CpG site in NDUFS7 was significantly linked to GSH levels.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EIF3J&quot;" target="&quot;GSSG/GSH RATIO&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The methylation at a CpG annotated to EIF3J was found associated with the GSSG/GSH ratio.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZNF761&quot;" target="&quot;GSSG/GSH RATIO&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Methylation in the promoter region of ZNF761 showed the strongest association with GSSG/GSH ratio.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PSMG3&quot;" target="&quot;GSSG/GSH RATIO&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Psmg3 CpGs were associated with the GSSG/GSH ratio.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEMFA6A&quot;" target="&quot;OXLDL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"CpG methylation in SEMFA6A was related to oxLDL levels.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAPBP&quot;" target="&quot;CD&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher methylation at TAPBP CpGs was found associated with CD marker levels.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RGL2&quot;" target="&quot;BCD-LDL&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Methylation in the promoter region of RGL2 was found related to BCD-LDL levels.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKAP5&quot;" target="&quot;BCD-LDL&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Methylation at six CpGs linked with BCD-LDL was annotated to CKAP5.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOSL2&quot;" target="&quot;BCD-LDL&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Methylation in FOSL2 CpG sites showed a strong association with BCD-LDL levels.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAM20C&quot;" target="&quot;BCD-LDL&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"CpGs annotated to FAM20C were found significant for BCD-LDL methylation.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRMD6&quot;" target="&quot;BCD-LDL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Methylation sites in FRMD6 showed association with BCD-LDL levels.")</data>
      <data key="d6">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CEP55&quot;" target="&quot;RS12782691&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNP rs12782691 is associated with CEP55 and CpG site cg24371383.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPB1&quot;" target="&quot;RS16861015&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNP rs16861015 linked to CPB1 gene through CpG site cg04072156.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD&quot;" target="&quot;SNPS COMPARISON&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The analysis of SNPs in both PTPN2/22 shows significant differences between CD subjects and healthy controls, suggesting a potential role of these genetic variations in the development or manifestation of CD.")("entity"</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD&quot;" target="&quot;PTPN2:RS478582&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Subjects with specific genotypes at PTPN2:rs478582 have a higher probability of experiencing MAPbacteremia in CD cases.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD&quot;" target="&quot;MAPBACTEREMIA&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Increased probability of having MAPbacteremia in CD cases compared to healthy controls.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD&quot;" target="&quot;IFN-Γ EXPRESSION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Increased IFN-γ expression upon combined effects of specific SNPs, MAPbacteremia presence in CD subjects compared to non-infected controls.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD&quot;" target="&quot;TP53&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Celiac Disease (CD) subjects showed variations in TP53 expression compared to healthy individuals.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPGS ASSOCIATED WITH OXIDATIVE STRESS&quot;" target="&quot;FUNCTIONAL REGULATORY ELEMENTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"CpGs associated with oxidative stress were enriched in CpG island shores and functional regulatory regions based on the analysis using RegulomeDB.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE-PHENOTYPE, GENOTYPE-CPG, AND CPG-PHENOTYPE ASSOCIATIONS&quot;" target="&quot;OVERLAP BETWEEN ASSOCIATIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was modest suggestive evidence of overlap between genotype-phenotype, genotype-CpG, and CpG-phenotype associations for certain CpGs.")</data>
      <data key="d6">chunk-b05610f4a9a1033449b92655bfb67b28</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPG SITE&quot;" target="&quot;CPG SITE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CpG sites are related when they share SNPs, such as cg07547695 associated with rs726430 and cg04072156 linked to rs16861015.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPG SITE&quot;" target="&quot;DNA MODIFICATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Specific CpG sites influence DNA modification levels, thereby impacting gene expression patterns associated with lactase activity and lactose tolerance.")</data>
      <data key="d6">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE INCIDENCE&quot;" target="&quot;METHYLATION LEVEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased risk of diseases is associated with specific methylation levels at CpG sites; e.g., higher T2D risk related to hypomethylation in DVL1 and HIST1H4D.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METHYLATION LEVEL&quot;" target="&quot;CVD EVENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"No significant association was found between methylation levels and incident CVD events.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CVD EVENT&quot;" target="&quot;HEART FAILURE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Methylation at a specific CpG site (cg11842944 in ZNF341 gene) showed the strongest association to heart failure among CVD events.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CG11842944&quot;" target="&quot;ZNF341&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The body of ZNF341 gene is associated with incident T2D, shown by its CpG site cg11842944 methylation level.")</data>
      <data key="d6">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEIGH SYNDROME&quot;" target="&quot;MT-ATP6&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The MT-ATP6 transcript is associated with Leigh syndrome due to the presence of a known disease-causing mutation 8993T&gt;G in ATP synthase activity.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP)&quot;" target="&quot;VALIDATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A validated RFLP assay confirmed the findings on DNA from blood and urine samples from the child.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAPILLARY SEQUENCING&quot;" target="&quot;CONFIRMATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Capillary sequencing methods were used to confirm the presence of mutations in both maternal urine and blood, though it may fail for heteroplasmy detection at low levels.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAPILLARY SEQUENCING&quot;" target="&quot;DETECTION LIMIT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Capillary sequencing methods might fail to detect heteroplasmy below 10% even when mutations are present in blood samples.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXOME SEQUENCING&quot;" target="&quot;DATA GENERATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Exome enrichment and sequencing on Illumina HiSeq 2000 was performed to generate comprehensive variant data for accurate genotyping.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFV1 GENE&quot;" target="&quot;ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The NDUFV1 gene is responsible for functions related to electron transport chain complex 1 and energy metabolism within the mitochondria.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.736G&gt;A, P.GLU246LYS&quot;" target="&quot;NDUFV1 PROTEIN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A missense variant in NDUFV1 gene resulting in a change at codon Glu246 to Lys potentially affecting the function of the protein.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.349G&gt;A, P.ALA117THR&quot;" target="&quot;NDUFV1 PROTEIN&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A second missense variant in NDUFV1 gene leading to a change at codon Ala117 to Thr, which may also be damaging based on in silico analysis.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NDUFV1 PROTEIN&quot;" target="&quot;ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The NDUFV1 protein functions as part of complex 1 of the electron transport chain and contains sites for NADH binding and iron-sulfur cluster binding essential for proper energy metabolism in mitochondria.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECESSIVE INHERITANCE MODEL&quot;" target="&quot;VARIANTS FILTERING&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Application of a recessive inheritance model helped filter variants to identify two missense mutations in NDUFV1 gene shared by affected siblings, suggesting potential disease causation.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPOUND HETEROZYGOTES&quot;" target="&quot;GENOTYPE INTERPRETATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Identifying both infants as compound heterozygotes for the missense variants in NDUFV1 gene suggests they each carry one variant on opposite alleles, further supporting the pathogenicity of these mutations.")</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NADH&quot;" target="&quot;COMPLEX I OF ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Complex I functions by releasing electrons from NADH and is critical for energy metabolism.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLU246LYS MUTATION&quot;" target="&quot;COQ2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The Glu246Lys mutation in the FMN binding site could potentially affect COQ2 function, leading to potential disease.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEAN TARGET NUCLEAR EXOME COVERAGE&quot;" target="&quot;NUCLEAR DNA SEQUENCING DEPTH&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The depth of nuclear exome sequencing determines the comprehensiveness and accuracy of genetic data analysis.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CATEGORY 1–3 VARIANTS&quot;" target="&quot;RECESSIVE INHERITANCE PATTERN&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants classified as category 1-3 are often associated with recessive inheritance patterns leading to genetic diseases.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HOMOZYGOUS VARIANTS&quot;&amp; &quot;TWO OR MORE VARIANTS&quot;" target="&quot;GENETIC DISORDERS (RECESSIVE INHERITANCE)&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Genes carrying two homozygous variants or two or more variants are often linked to recessive genetic disorders.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COENZYME Q10 DEFICIENCY (OMIM #609825)&quot;" target="&quot;COQ2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in COQ2 have been linked to coenzyme Q10 deficiency, affecting the body's ability to produce essential compounds.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;3754C&gt;A MUTATION IN MT-ND1&quot;" target="&quot;HETEROPLASMY LEVEL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The heteroplasmic level indicates the mixture of normal and mutant mtDNA, affecting its expression within cells.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY&quot;" target="&quot;DIETARY PATTERN (SPECIFICALLY DIET AFFECTING MTDNA)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Poor dietary choices may contribute to conditions involving defects in the respiratory chain components of mitochondria.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS (INCLUDING DIET)&quot;" target="&quot;MITOCHONDRIAL VARIANTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Changes in dietary patterns can influence the number and type of mitochondrial variants found.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUTATIONS IN MT-ND1&quot;" target="&quot;NADH DEHYDROGENASE SUBUNIT 1 (MT-ND1)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Mutations in this gene lead to disorders like Leber optic atrophy, mitochondrial complex I deficiency, and MELAS.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUTATIONS IN MT-ND1&quot;" target="&quot;LEBER OPTIC ATROPHY, MITOCHONDRIAL COMPLEX I DEFICIENCY, MELAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"These genetic disorders are associated with mutations within the MT-ND1 gene that is a part of complex I.")</data>
      <data key="d6">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUDIT SCORE&quot;" target="&quot;NUMBER OF DRINKING DAYS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both AUDIT score and number of drinking days are measures related to alcohol use.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRINKS PER DRINKING DAY&quot;" target="&quot;BRAC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The quantity consumed per drinking day affects the rising BrAC levels.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRINKS PER DRINKING DAY&quot;" target="&quot;CT GENOTYPE AND TT GENOTYPE&quot;">
      <data key="d4">39.0</data>
      <data key="d5">"In the recent clinical trial, individuals with the CT genotype reported more drinks per drinking day than those with the TT genotype when they were treated with both placebo vs. olanzapine.")&lt;SEP&gt;"Individuals with CT genotype reported more drinks per drinking day than those with TT genotype when treated with placebo versus olanzapine.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;ADH1B GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Two genetic variants related in influencing alcohol metabolism, drug response.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 GENOTYPE&quot;" target="&quot;COVARIATE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ALDH2 genotype is a statistical covariate affecting alcohol consumption in the models.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAIN EFFECT&quot;" target="&quot;STATISTICAL INTERACTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In the context of the experiments, medication × genotype interaction is not a significant factor for all outcomes as evidenced by analysis results.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDICATION (NALTREXONE/PLACEBO)&quot;" target="&quot;SIDE EFFECTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Differences in side effects experienced when taking naltrexone compared to placebo.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDICATION EFFECTS&quot;" target="&quot;STATISTICAL ANALYSIS OUTCOME&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The medication's impact on various outcomes was analyzed using chi-square tests for significance.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LATENCY TO DRINK&quot;" target="&quot;OUTCOME MEASURE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Latency to first drink is a key outcome measure in evaluating the timing of alcohol consumption patterns.")</data>
      <data key="d6">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OUTCOME MEASURE&quot;" target="&quot;LUNG FUNCTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Lung function measures, including FEV1, FVC, and the FEV1/FVC ratio, were used as outcome measures.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DAILY ALCOHOL CONSUMPTION&quot;" target="&quot;BLOOD CORTISOL LEVELS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In both sexes, daily alcohol consumption was positively associated with blood cortisol levels.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNIVARIATE MODEL&quot;" target="&quot;MULTIVARIATE LINEAR REGRESSION MODELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"After adjusting for covariates like age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol levels remained similar in men but was higher in women.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETICALLY PREDICTED ALCOHOL CONSUMPTION&quot;" target="&quot;CORTISOL LEVEL (MR ANALYSIS)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In MR analysis for men, one standard drink/day of genetically predicted alcohol consumption was associated with an increase of 0.36 in cortisol levels.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY ANALYSIS&quot;" target="&quot;CORTISOL LEVEL (GENETICALLY PREDICTED ALCOHOL CONSUMPTION)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"In sensitivity analysis for men, one standard drink/day elevates cortisol by 0.27.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY ANALYSIS&quot;" target="&quot;ROBUSTNESS CHECK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An analysis that tests how sensitive results are to individual data point inclusion or exclusion, often used in meta-analyses.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STANDARD DRINK/DAY&quot;" target="&quot;GENETIC PREDISPOSITION AND ALCOHOL CONSUMPTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genetically predicted alcohol consumption likely refers to the difference between the actual reported intake and a statistical estimate based on genetic factors.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS671 POLYMORPHISM&quot;" target="&quot;BODY MASS INDEX (BMI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The BMI differed according to the rs671 polymorphism significantly among men.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS671 POLYMORPHISM&quot;" target="&quot;ALDH2 RS671&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both terms refer to different aspects of the same ALDH2 gene polymorphism, with 'ALDH2' being more common in literature but 'rs671' specifying a particular SNP.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 RS671 GENOTYPES&quot;" target="&quot;CORTISOL LEVEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The pattern of cortisol levels varied based on the ALDH2 rs671 genotypes by sex.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE DISTRIBUTION&quot;" target="&quot;GENOTYPIC VARIANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There was a significant difference in age distribution among different genotypes.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EX-DRINKERS&quot;" target="&quot;RS671 GENOTYPES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Ex-drinkers could be included in sensitivity analyses considering their genotypic status.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUBJECT&quot;" target="&quot;GENOMIC DNA ANALYSIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genomic DNA analysis was performed on the subjects to identify genetic variants like p.Q240H.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR RISK FACTORS&quot;" target="&quot;HUA RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Cardiovascular risk factors such as obesity and hypertension increase the risk of hyperuricemia (HUA).")</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR RISK FACTORS&quot;" target="&quot;SUA LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher sUA level may be associated with increased cardiovascular risk factors among rs2231142 T allele carriers.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CARDIOVASCULAR RISK FACTORS&quot;" target="&quot;RS2231142 T ALLELE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The rs2231142 T allele is associated with other cardiovascular risk factors besides sUA level.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;" target="&quot;ABCG2 RS2231142&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was a strong association between the ABCG2 variant's T allele and sUA levels and HUA risk." )</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;" target="&quot;ABCOR2 RS2231142 POLYMORPHISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The polymorphism of ABCG2 rs2231142 was significantly associated with sUA levels (p=6.98e-8).")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;" target="&quot;G/G GENOTYPES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In males, the G/G genotypes of the ABCG2 rs2231142 polymorphism had significantly lower sUA levels compared to T/T genotypes (p=4.40e-6).")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;" target="&quot;T/T GENOTYPES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The G/G genotypes of the ABCG2 rs2231142 polymorphism had significantly lower sUA levels compared to T/T genotypes across all populations (p=6.98e-8).")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUA LEVEL&quot;" target="&quot;RS2231142 T ALLELE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The sUA level is influenced by the rs2231142 T allele in certain individuals.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2231142 T ALLELE&quot;" target="&quot;HUA RISK&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Individuals with the rs2231142 T allele may have an increased risk for HUA.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA RISK&quot;" target="&quot;SLC22A12 RS893006&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The distribution of SLC22A12 variants showed no significant association with HUA risk.")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUA RISK&quot;" target="&quot;HYPERTENSION - ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"High blood pressure heightens the risk for hyperuricemia, which might be due in part to increased serum uric acid concentrations.")</data>
      <data key="d6">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC2A9 RS3733591&quot;" target="&quot;URIC ACID LEVEL&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Increased sUA levels showed a significant association with the Beta coefficient of each copy of risk allele (p=0.002).")</data>
      <data key="d6">chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1&quot;" target="&quot;T2D, T1D&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The NFATC1 gene shows evidence of association with diabetic nephropathy and altered eGFR in both type 1 and type 2 diabetes.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NFATC1&quot;" target="&quot;DROSOPHILA MELANOGASTER (LOCUS)&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"The single NFAT family member in Drosophila plays a potential role in ionic or osmotic regulation, similar to the role suggested for human NFATC1.")</data>
      <data key="d6">chunk-45a965c3c3013c70d0fa0f1680283083</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ESRD&quot;" target="&quot;RS7587577&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The variant at the ALMS1 gene may lead to ESRD when present, indicating genetic predisposition for end-stage renal disease.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PDILT-UMOD&quot;" target="&quot;CKD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The PDILT-UMOD locus, containing rs77924615, contributes significantly to CKD risk through multiple associated SNPs.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SURVIVAL&quot;" target="&quot;MOCK TREATMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Mice treated with Mock showed no significant improvement in overall survival.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKD&quot;" target="&quot;RS62435145&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNP rs62435145 associated with increased risk of CKD through its influence on kidney function.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CKD, EGFR&quot;" target="&quot;UNCX, ALMS1, PDILT-UMOD, NFATC1&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A collective of genes and specific genetic variations contribute to the complex interplay between CKD risk, eGFR measurements, and underlying pathologies.")</data>
      <data key="d6">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;TRAVEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Foreign travel was found to be significantly associated with a higher prevalence of quinolone-resistant Campylobacter infections, as evidenced by statistical analysis.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE RESISTANCE&quot;" target="&quot;PREVALENCE COMPARISON&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The prevalence of fluoroquinolone resistance was notably higher among travelers compared to domestically acquired cases, as indicated by the study's data analysis.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SWIMMING&quot;" target="&quot;RISK FACTOR&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Swimming was recognized as another activity associated with an increased risk of acquiring quinolone-resistant C. jejuni infections.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FLUOROQUINOLONES&quot;" target="&quot;TREATMENT APPROACH&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Fluoroquinolones were recommended as a primary treatment for C. jejuni infections until their ineffectiveness against resistant strains was recognized.")</data>
      <data key="d6">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;QUINOLONE-RESISTANT CASES&quot;" target="&quot;DOMESTICALLY ACQUIRED&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Infections treated with fluoroquinolones before specimen collection were excluded, indicating a distinction between domestically acquired and travel-related infections.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMOXICILLIN-CLAVULANATE&quot;, &quot;AZITHROMYCIN&quot;, &quot;DOXYCYCLINE&quot;, &quot;CLARITHROMYCIN&quot;, &quot;LEVOFLOXACIN&quot;, &quot;COTRIMOXAZOLE&quot;, &quot;SULFAMETHOXAZOLE/TRIMETHOPRIM&quot;, &quot;TETRACYCLINE&quot;" target="&quot;DOMESTICALLY ACQUIRED&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The study compared antimicrobial drug information from patients with domestically acquired C. jejuni infections to those without travel-related infections.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. JEJUNI&quot;" target="&quot;FOODBORNE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The majority of human isolates came from Danish-bred food animals, suggesting a connection to foodborne transmission.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RETAIL FOOD PRODUCTS&quot;" target="&quot;ORIGIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Of the retail food products compared with broiler chickens, most were from domestic sources, which was different than imported isolates.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RETAIL FOOD PRODUCTS&quot;" target="&quot;BROILER CHICKENS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The study compared isolates from both retail food products and broiler chickens with those from human patients to assess similarities in serotypes and RiboGroups (subtypes).")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BROILER CHICKENS&quot;" target="&quot;DOMESTICALLY ACQUIRED&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A comparison of isolates from broiler chicken fecal samples and human isolates showed differences in resistance patterns, indicating a potential source for domestically acquired infections.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C. JEJUNI ISOLATES FROM RETAIL FOOD PRODUCTS AND BROILER CHICKENS&quot;" target="&quot;SIMILARITY OR COHORT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Several of the isolates identified as quinolone-resistant or -sensitive matched those found in human patients, indicating a potential shared source.")</data>
      <data key="d6">chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOCIAL DISINHIBITION&quot;" target="&quot;LINGUISTIC ACCULTURATION&quot;">
      <data key="d4">1.001</data>
      <data key="d5">"Higher linguistic acculturation scores are positively related to higher mean social disinhibition scores.")&lt;SEP&gt;"Increased linguistic acculturation positively correlates with social disinhibition scores.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOCIAL DISINHIBITION&quot;" target="&quot;TAS&quot;">
      <data key="d4">1.001</data>
      <data key="d5">"The total anxiety score (TAS) is significantly and positively associated with social disinhibition.")&lt;SEP&gt;"Total Anxiety Scale (TAS) score is significantly correlated to higher social disinhibition scores.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SOCIAL DISINHIBITION&quot;" target="&quot;DAS&quot;">
      <data key="d4">1.001</data>
      <data key="d5">"Depression Anxiety Scale (DAS) score shows a positive correlation with the social disinhibition measure.")&lt;SEP&gt;"Depression anxiety score (DAS) is significantly related to increased risk of social disinhibition.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CNR1&quot;" target="&quot;ALCOHOL SEEKING BEHAVIOR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants of CNR1 receptors may influence alcohol seeking behavior and neurocircuitry.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239&quot;" target="&quot;CB1 RECEPTOR LEVEL&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genetic variant rs2023239 is linked to CB1 receptor levels.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239&quot;" target="&quot;BRAIN ACTIVATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The rs2023239 variant has been associated with altered brain activation patterns during alcohol exposure.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239&quot;" target="&quot;MEDICATION × GENOTYPE × CUE INTERACTION ON CRAVING&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"In a recent clinical trial, the CT genotype showed greater cue-elicited craving when treated with placebo compared to olanzapine.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDICATION: OLANZAPINE&quot;" target="&quot;GENOTYPE × DRINK INTERACTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The analyses revealed a genotype-drink interaction when individuals were treated with olanzapine.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL USE DISORDER SCORE&quot;" target="&quot;CT GROUP&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CT group had a significant correlation between alcohol use disorder scores and certain neural activations.")</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CT GROUP&quot;" target="&quot;REWARD RESPONSE&quot;&lt;|&quot;THE CT GROUP DEMONSTRATED A SIGNIFICANT INCREASE IN REWARD RESPONSE COMPARED TO THE TT GROUP AFTER CONSUMING ALCOHOL.&quot;)">
      <data key="d4">1.0</data>
      <data key="d5">14)("entity"</data>
      <data key="d6">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE CT&quot;" target="&quot;REWARDING EFFECTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals with the CT genotype reported greater reward from alcoholic beverages.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE CT AND CC&quot;" target="&quot;MEDICATION × GENOTYPE × DRINK INTERACTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In an earlier study, individuals with genotypes CT or CC showed this interaction when receiving active control medication (cyproheptadine).")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CNR1 VARIATION AND OLANZAPINE&quot;" target="&quot;INTERACTION ON REWARDING EFFECTS OF ALCOHOL&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"There might be an interaction between CNR1 variation and the effect of olanzapine on alcohol's rewarding impact.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE × MEDICATION INTERACTIONS&quot;" target="&quot;MEDICATION: OLANZAPINE AND CYPROHEPTADINE HYDROCHLORIDE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"There were no significant genotype x medication interactions on reward from alcohol beverages when cyproheptadine was compared to olanzapine.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDICATION: OLANZAPINE AND CYPROHEPTADINE HYDROCHLORIDE&quot;" target="&quot;MEDICATION × GENOTYPE × CUE INTERACTION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"In a recent study, there was a significant medication-genotype-cue interaction for craving when individuals were given different medications (cyproheptadine vs. placebo) compared to olanzapine.")</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPL DEFICIENCY&quot;" target="&quot;CLINICAL FEATURES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Linking genetic disorder to symptoms such as hypertriglyceridemia, xanthomas, abdominal pain, etc.")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LPL DEFICIENCY&quot;" target="&quot;DGAT1 INHIBITORS AND THERAPY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The use of DGAT1 inhibitors to target triglyceride synthesis is an investigational treatment approach for LPL deficiency.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;TREATMENT FOR LPL DEFICIENCY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Direct link between lifestyle change and managing the disease.")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;TREATMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Long-term dietary fat restriction is a cornerstone of treatment for LPL deficiency, helping manage hypertriglyceridemia.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENFAPORT LIPIL FORMULA&quot;" target="&quot;LPL GENE MUTATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Formula choice based on understanding of genetic factors in treatment")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPIHBP1&quot;" target="&quot;MOLECULAR INTERACTION WITH LPL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Role played by GPIHBP1 in transporting the enzyme to capillary lumen.")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOSOMAL RECESSIVE LPL DEFICIENCY MUTATION&quot;" target="&quot;PATHOGENIC MUTATIONS IN LPL GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Understanding spectrum of mutations and expanding known cases.")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FORMULA COMPOSITION (ENFAPORT LIPIL) AND TREATMENT EFFICACY&quot;" target="&quot;OUTCOME RELATIONSHIP&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Association between the specific fat content composition in Enfaport Lipil formula and improvement in lipid profiles as a treatment for LPL deficiency.")</data>
      <data key="d6">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREATMENT&quot;" target="&quot;RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR 1 (RHIGF-1)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"rhIGF-1 is a medical intervention for growth disorders associated with GHI phenotype.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT SUPPLEMENT&quot;" target="&quot;MCT-BASED FORMULA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"MCT-based formulas are used as fat supplements because they're absorbed directly into the portal vein, aiding in fat management.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE THERAPY&quot;" target="&quot;INTRAMUSCULAR INTRODUCTION OF GAIN-OF-FUNCTION VARIANT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"An approved gene therapy procedure for managing hypertriglyceridemia involves introducing a gain-of-function variant of the LPL gene.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRUG MANAGEMENT&quot;" target="&quot;ORLISTAT AND OVER-THE-COUNTER USE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Orlistat is used as an over-the-counter weight loss aid, which may also help manage hypertriglyceridemia by blocking fat absorption.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABDOMINAL PAIN AND HYPERVISCOSITY&quot;" target="&quot;SYMPTOM AND COMPLICATION RELATIONSHIP&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Elevated triglyceride levels can lead to abdominal pain and hyperviscosity, which may cause gastrointestinal issues.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE AND CAUSE RELATIONSHIP&quot;" target="&quot;PANCREATITIS AND HIGH TRIGLYCERIDES&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"An elevated risk of pancreatitis exists in individuals with high triglyceride levels due to factors like fat metabolism dysfunction.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;RS2832407&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genetic variant rs2832407 moderates the effect of topiramate on efficacy for EA patients.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;NNT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Number Needed to Treat (NNT) quantifies how many patients need treatment with Topiramate to prevent one additional headache daily diary score.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;RS2832407*C-HOMOZYGOTES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"For rs2832407*C-homozygotes, Topiramate significantly reduces the risk of HDDs compared to placebo group.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There is a small difference in the likelihood of no HDDs between topiramate and placebo groups for A-allele carriers.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOPIRAMATE&quot;" target="&quot;EFFICACY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Topiramate is effective in reducing HDDs based on the study results.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLACEBO&quot;" target="&quot;NNT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Number Needed to Treat (NNT) for the placebo group, which experiences a different response rate compared to topiramate.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLACEBO&quot;" target="&quot;ADVERSE EVENTS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The placebo group experiences adverse events that differ in frequency and severity from Topiramate group.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILD ADVERSE EVENT&quot;" target="&quot;92% OF EA PATIENTS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A high majority of EA patients experience mild adverse events, which is not statistically different between treatment groups.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NNT-AEMOD+ (ADJUSTED NNT FOR MODERATE EVENTS)&quot;" target="&quot;RS2832407*C-HOMOZYGOTES&quot;*TOPIRAMATE VS. PLACEBO&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The adjusted number needed to treat considering moderate adverse events shows a different efficacy between topiramate and placebo.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NNT-AESEV+&quot;" target="&quot;RS2832407*A-ALLELE CARRIERS&quot;*TOPIRAMATE VS. PLACEBO&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The adjusted number needed to treat considering severe adverse events highlights a distinct difference in efficacy between topiramate and placebo for rs2832407*A-allele carriers.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NNT-AESEV+&quot;" target="&quot;A-ALLELE CARRIERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The adjusted number needed to treat considering severe adverse events is higher for rs2832407*A-allele carriers on topiramate compared to placebo.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2832407*C-HOMOZYGOTES&quot;" target="&quot;NNT-AEMOD+&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"For rs2832407*C-homozygotes, the adjusted number needed to treat considering moderate adverse events is lower for Topiramate.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EUROPEAN-AMERICAN (EA)&quot;" target="&quot;RS2832407&quot;*TOPIRAMATE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The EA ethnicity shows differences in response to Topiramate based on the genetic variant rs2832407.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MODERATE OR GREATER ADVERSE EVENTS&quot;" target="&quot;RS2832407*C-HOMOZYGOTES&quot;*TOPIRAMATE VS. PLACEBO&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"For rs2832407*C-homozygotes, moderate adverse events are more frequent with topiramate compared to placebo.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2832407*A-ALLELE CARRIERS&quot;*TOPIRAMATE VS. PLACEBO&quot;" target="&quot;SEVERE ADVERSE EVENTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"For rs2832407*A-allele carriers, there is a significant difference in the frequency of severe adverse events between topiramate and placebo.")</data>
      <data key="d6">chunk-0c7ab28db433187759e760725a105836</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADVANCED STAGE CANCER&quot;" target="&quot;RISK FACTOR FOR DELAYED NAUSEA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The association between advanced stage cancer and the severity of delayed nausea.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-EMETIC&quot;" target="&quot;PALONOSETRON&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Almost all patients were prescribed palonosetron, a common anti-emetic medication.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-EMETIC&quot;" target="&quot;DEXAMETHASONE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"98% of the participants received dexamethasone, another commonly used anti-emetic drug.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK FACTOR FOR ACUTE NAUSEA&quot;" target="&quot;YOUNGER AGE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Younger age was associated with increased severity of patient-reported acute nausea.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK FACTOR FOR ACUTE NAUSEA&quot;" target="&quot;FEWER HOURS OF SLEEP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Reduced sleep prior to chemotherapy was significantly linked to higher severity of patient-reported acute nausea.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK FACTOR FOR ACUTE NAUSEA&quot;" target="&quot;ABCB1 RS1045642 GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic variation in ABCB1 (rs1045642) was linked to more severe acute nausea, with heterozygotes reporting more severe symptoms than homozygous wild type or variant genotypes.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;YOUNGER AGE&quot;" target="&quot;RISK FACTOR FOR ACUTE VOMITING&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The younger age was not associated with acute vomiting, based on CTCAE grading.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGHLY EMETOGENIC CHEMOTHERAPY&quot;" target="&quot;RISK FACTOR FOR NAUSEA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The receipt of highly emetogenic chemotherapy was significantly linked to increased risk factors for nausea, both acute and delayed.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEMOGRAPHIC, CLINICAL, PATIENT-REPORTED VARIABLES&quot;" target="&quot;RISK FACTORS FOR ACUTE NAUSEA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"These factors together explained a significant portion of the variance in acute nausea severity.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCB1 GENOTYPE&quot;" target="&quot;ENHANCER OF ACUTE NAUSEA RISK&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The ABCB1 genotype significantly enhanced the risk factors for acute nausea in conjunction with other demographic, clinical, and patient-reported variables.")</data>
      <data key="d6">chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA MODIFICATION&quot;" target="&quot;LCT GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The LCT gene exhibits modifications at specific genomic regions contributing to cell-type specific expression and epigenetic regulation.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA MODIFICATION&quot;" target="&quot;CT AND TT GENOTYPES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CT and TT genotypes are associated with specific changes in DNA modifications within the analyzed region.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA&quot;" target="&quot;AGE-RELATED CHANGES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Age-dependent changes affect LCT mRNA levels, indicating a dynamic regulatory process.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT MRNA&quot;" target="&quot;LNCRNA LOC100507600&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The lncRNA regulates LCT mRNA levels, suggesting a potential mechanism for modulating enzyme expression.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPG SITES&quot;" target="&quot;GENOMIC VARIANT ASSOCIATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Significant DNA modification differences occur at CpG sites, linking them as important genetic variants in LCT's expression control.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG NON-CODING RNA (LNCRNA) LO100507600&quot;" target="&quot;FUNCTIONAL LINKAGE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The lncRNA is linked with LCT intron 5 region and plays a role in its regulation, showing interplay between different genomic elements.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNASE I HYPERSENSITIVITY SITES&quot;" target="&quot;REGULATORY SIGNIFICANCE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The DNase I hypersensitivity sites at LCT introns 2 and 3, as well as MCM6's regions, indicate regulatory significance for gene expression.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTONE MARKS H3K4ME1 AND H3K27AC&quot;" target="&quot;ENHANCER ROLES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"These histone marks are characteristic of active enhancers and play a role in gene regulation at the identified chromatin reference map sites.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION PROFILING&quot;" target="&quot;AFFYMETRIX GENECHIP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The Affymetrix GeneChips used for gene profiling are specific and allow screening of thousands of transcripts.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 INTRON 13&quot;" target="&quot;C-13910&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The haplotypes containing C-13910 in MCM6 intron 13 influence DNA modifications after conception.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNA METHYLATION&quot;" target="&quot;CTCF BINDING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Increased DNA methylation inhibits CTCF binding at insulator sites, potentially activating gene expression.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRISPR-CAS9 GENOME EDITING TECHNOLOGY&quot;" target="&quot;MCM6 INTRON 13 DELETION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The deletion in MCM6 intron 13 did not alter Mcm6 mRNA levels when compared to the negative control.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT INTRON 2&quot;" target="&quot;MAMMALS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High conservation of the LCT intron 2 element is observed across mammals, including humans.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCT INTRON 2&quot;" target="&quot;AGE-SPECIFIC REGULATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Evolutionarily conserved LCT intron 2 establishes stronger control of LCT mRNA in adulthood.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPIGENETICALLY-REGULATED REGIONS&quot;" target="&quot;CRISPR-CAS9N-INDUCED DELETION/">
      <data key="d4">2.0</data>
      <data key="d5">"Deletions of epigenetically regulated DNA regions impacted human LCT expression, supporting their importance in regulation.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL-TYPE SPECIFICITY&quot;" target="&quot;ENTEROCYTES AND JEJUNUM TISSUES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Differences in DNA modifications highlight the cell-type specific regulation of LCT expression and DNA modifications.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOTYPE ASSOCIATION&quot;" target="&quot;MCM6 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"MCM6 gene shows similar regions to LCT's for DNA modification studies, highlighting the genetic linkage between these genes.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 GENE 3′-UTR&quot;" target="&quot;REGULATORY FUNCTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The MCM6's 3′-UTR is associated with chromatin features that indicate active regulatory functions like enhancer sites and histone marks, demonstrating the gene's role in regulation.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC LINKAGE&quot;" target="&quot;LCT-MCM6 HAPLOTYPES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The LCT-MCM6 haplotypes exhibit strong associations with lactase persistence and non-persistence across genetic backgrounds, highlighting the role of these haplotypes in age-dependent regulation.")</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP C/T-13910 AND AGE CHANGES&quot;" target="&quot;TEMPORAL GENOMIC RESPONSE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Age-dependent epigenetic modifications occur at SNP C/T-13910, indicating temporal genomic responses to genetic variations over life stages.")("entity"</data>
      <data key="d6">chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOTYPES&quot;" target="&quot;SNP-13910&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNPs at this position influence the variation in haplotypes associated with lactase non-persistence or persistence.")</data>
      <data key="d6">chunk-ea45644d73f260cf365527dcc3af86e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOWNREGULATION&quot;/&quot;DECREASE IN LCT MRNA&quot;" target="&quot;MCM6 INTRON 13&quot;/&quot;LCT INTRON 2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Deletions affecting MCM6 intron 13 or LCT intron 2 resulted in significant decreases in LCT mRNA levels.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOWNREGULATION&quot;/&quot;DECREASE IN LCT MRNA&quot;" target="&quot;MCM6 INTRON 13&quot;/&quot;LCT INTRON 2/">
      <data key="d4">1.0</data>
      <data key="d5">"Deletions affecting MCM6 intron 13 or LCT intron 2 resulted in significant decreases in LCT mRNA levels.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADULT INTESTINE/INFANT GUT RESPONSE&quot;" target="&quot;LACTASE PERSISTENCE&quot;/&quot;CRISPR-CAS9 DELETIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The mutation in Lct intron 2 produced a significantly greater loss of LCT mRNA expression in adult mice compared to infants.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MCM6 INTRON 13&quot;/&quot;LCT INTRON 2/" target="&quot;REGULATORY IMPACT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Deletions affecting MCM6 or LCT regulatory regions resulted in a significant decrease in LCT mRNA levels in differentiated human intestinal epithelial cells.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELLULAR STATE/EXPRESSION LEVELS&quot;" target="&quot;CRISPR-CAS9 DELETIONS&quot;/&quot;LCT EXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The deletion effects on LCT mRNA varied between undifferentiated and differentiated states of cultured Caco-2 cells, supporting the importance of regulatory regions in human LCT expression.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELLULAR STATE/EXPRESSION LEVELS&quot;" target="&quot;CRISPR-CAS9 DELETIONS&quot;/&quot;LCT EXPRESSION/">
      <data key="d4">1.0</data>
      <data key="d5">"The deletion effects on LCT mRNA varied between undifferentiated and differentiated states of cultured Caco-2 cells, supporting the importance of regulatory regions in human LCT expression.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DECREASE IN LCT MRNA&quot;" target="&quot;MCM6&quot;/&quot;LCT REGULATORY REGIONS/">
      <data key="d4">1.0</data>
      <data key="d5">"Deletions affecting MCM6 or LCT regulatory regions resulted in a significant decrease in LCT mRNA levels in differentiated human intestinal epithelial cells.")</data>
      <data key="d6">chunk-512b044cf65a4e519d519c6239959c6c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CZECH REPUBLIC&quot;" target="&quot;MILK CONSUMPTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The highest frequency of lactase persistence allele showed the strongest association between genotype and milk consumption.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CZECH REPUBLIC&quot;" target="&quot;ASSOCIATIONS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The strongest representation of associations between variables like education and smoking was found in the Czech Republic.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK CONSUMPTION&quot;" target="&quot;RCC&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Elevated risk of RCC was found associated with milk consumption.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MILK CONSUMPTION&quot;" target="&quot;RCC OR=1.68&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Strong relationship found specifically in the Czech Republic between milk consumption and RCC risk.")</data>
      <data key="d6">chunk-7a423a439657efc1126fb6a075919ea5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T-A-C HAPLOTYPE&quot;" target="&quot;DELTA HBF&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Also associated with increased delta HbF compared to the T-G reference haplotype.")</data>
      <data key="d6">chunk-3cf4e094a5312845a1cc4da4304d4bdf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T DECREASED TRANSCRIPT LEVELS&quot;" target="&quot;CONSEQUENCE OF MUTATION IN UBE2T&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Decreased transcript levels of the UBE2T gene were detected, which is a consequence of mutations identified in this subject.")</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBE2T&quot;" target="&quot;URD&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While Ube2T interacts with the RING domain of FANCL in a 1:1 stoichiometry, it does not interact directly with URD as confirmed by size-exclusion chromatography.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;OVEREXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Overexpression of wild type UBE2T gene rescues FA phenotypes in RA2627 fibroblasts.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;CELLULAR HYPERSENSITIVITY&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The overexpression of wild type UBE2T rescues the cellular hypersensitivity shown by RA2627 cells to crosslinking agents like MMC.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;G2 PHASE ACCUMULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"UBE2T overexpression in RA2627 cells reduces G2 phase cell cycle accumulation induced by MMC treatment.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;FANCD2 MONOUBIQUITINATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression of wild type UBE2T restores the monoubiquitination status of FANCD2 and FANCI proteins following FA phenotype induction by treatment with MMC.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WILD TYPE UBE2T&quot;" target="&quot;FANCD2 FOCI FORMATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"UBE2T overexpression rescues the formation of FANCD2 foci observed after treatment with MMC, associated with FA phenotype rescue.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMPOUND HETEROZYGOUS MUTATIONS&quot;" target="&quot;GENETIC REVERSION PHENOMENON&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The combination of maternally derived duplication and paternally derived deletion resulted in genetic reversion phenomena observed in the proband's LCLs, supporting normal UBE2T expression.")</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELLULAR PHENOTYPE RESCUED BY UBE2T&quot;" target="&quot;OVEREXPRESSION OF WILD TYPE UBE2T&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Wild type UBE2T overexpression was able to rescue cellular defects associated with Fanconi anemia in RA2627 fibroblasts, demonstrating the causality of UBE2T deficiency.")</data>
      <data key="d6">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCONI ANEMIA (FA)&quot;" target="&quot;UBE2T DEFICIENCY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Insufficient expression or mutation in UBE2T leads to Fanconi anemia.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FA PHENOTYPE RESCUE&quot;" target="&quot;WILD TYPE UBE2T OVEREXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The overexpression of wild type UBE2T rescues cellular defects associated with Fanconi Anemia (FA) in RA2627 fibroblasts, as shown by restored cell cycle distribution and FANCD2 foci formation.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;RPS19&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"DBA patients carrying mutations in RPS19 were the focus of the gene expression profiling study.")&lt;SEP&gt;"Mutations in RPS19 were identified as significant in DBA patients through the gene expression study.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;LARS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"DBA patients showed differentially expressed LARS compared to controls.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;WARS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"WARS was found differently expressed in DBA patients' gene expression profiles.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;GARS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variations in GARS expression were identified among DBA patient samples.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;SARS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Significant differential expression of SARS was noted in DBA patients compared to healthy individuals.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;QARS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Differences in QARS mRNA levels were detected between DBA patient groups and controls.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;EPRS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Alterations in EPRS expression was observed specifically in DBA patients through the study.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;PSAT1&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Statistically significant differential PSAT1 expression in DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;PHGDH&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"DBA patients showed differences in PHGDH gene expression compared to controls.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;CTH&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"CTH expression varied between DBA patient and control samples, indicating possible involvement.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;SHMT2&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"SHMT2 was differentially expressed in the gene profiling of DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;CASP9&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Differences in CASP9 expression were found specifically among DBA patient groups compared to controls.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;NFKBIA&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Variations in NFKBIA mRNA levels were identified between DBA patients and healthy individuals.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;NFKBIE&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Differential expression of NFKBIE was found among DBA patient samples compared to controls.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;APAF1&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Alterations in APAF1 mRNA levels were detected specifically in DBA patients.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;NFKB2&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Differences in NFKB2 expression were noted among DBA patient samples compared to control individuals.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;NFKB1&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"NFKB1 showed variations in expression levels specifically within the DBA patient group.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DBA PATIENTS&quot;" target="&quot;BIRC3&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"Differential BIRC3 expression was detected between DBA patients and controls during gene profiling.")</data>
      <data key="d6">chunk-34ffb077c584b98555081f882f8f8b94</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE EXPRESSION DIFFERENCES&quot;" target="&quot;OUTCOME OF STUDY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Differential expression was identified for specific genes associated with DBA patients compared to controls.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METHOD COMPARISON&quot;" target="&quot;MICROARRAY DATA VALIDATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The microarray data was validated using qRT-PCR, providing a cross-check on gene expression levels.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OUTCOME OF CROSS-VALIDATION&quot;" target="&quot;QRT-PCR AND MICROARRAY RESULTS AGREEMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both methods showed consistent trends for differentially expressed genes across the samples.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF RS6265&quot;" target="&quot;MIGRAINE&quot;">
      <data key="d4">0.03</data>
      <data key="d5">"A significant association between rs6265 polymorphism and migraine is observed using the fixed-effects model.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF RS6265&quot;" target="&quot;GUANINE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The guanine nucleobase component of the rs6265 polymorphism.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIGRAINE&quot;" target="&quot;RS2049046 A/T&quot;">
      <data key="d4">0.02</data>
      <data key="d5">"The data suggests a significant association of rs2049046 polymorphism with migraine in allele, recessive and additive models.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF RS2049046&quot;" target="&quot;THYMINE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The thymine nucleobase component of the rs2049046 polymorphism.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAUCASIAN POPULATION GROUPS&quot;" target="&quot;STUDY SELECTION CRITERIA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The criterion for selecting studies which were conducted on individuals from a specific geographical region and ancestry group.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUSTRALIAN-BASED COHORTS&quot;" target="&quot;STUDY COMPONENT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A component of the study design involving cohorts or participants from Australia.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION BETWEEN SNPS AND MIGRAINE&quot;" target="&quot;BIOLOGICAL PROCESS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The process by which specific genetic variations affect the risk or development of migraine headaches.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIXED-EFFECTS MODEL&quot;" target="&quot;METHODOLOGY IN META-ANALYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A statistical model used to analyze combined data from multiple studies with minimal heterogeneity.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HETEROGENEITY DIFFERENCE&quot;" target="&quot;STATISTICAL ANALYSIS IN META-ANALYSIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The comparison of variance among different studies contributing to the meta-analysis when no significant differences are present.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BEGG’S TEST&quot;" target="&quot;DETECTION OF PUBLICATION BIAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A statistical test utilized for identifying potential bias in publication, specifically by examining asymmetry in funnel plots.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EGGER’S TEST&quot;" target="&quot;BIAS DETECTION METHOD&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An approach used to identify publication bias through the correlation between effect size and precision across studies.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ T CELLS&quot;" target="&quot;RECOGNITION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Frequency of recognition is comparable for neoepitopes and an immunodominant epitope, indicating similar interaction potential.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELLS&quot;" target="&quot;CLASSICAL PSORIASIS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CD3+ skin T cells of classical psoriasis showed instead an enrichment of both CD4+ and CD8+ subpopulations.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE I IFN-Β&quot;" target="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The type I IFN-β was expressed in paradoxical skin lesions, mainly in keratinocytes.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFN-Κ&quot;" target="&quot;PSORIASIFORM REACTIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The epidermis of psoriasiform reactions was also immunoreactive for IFN-κ, another keratinocyte-derived type I IFN.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LL-37&quot;" target="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"We finally investigated LT-α and LT-β, two members of the cytokine TNF family, also known as TNF-β and TNF-C 35, possibly deregulated by anti-TNF-α therapy.")</data>
      <data key="d6">chunk-56c37d6045382dda8cc6037b2680282a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCHCR1&quot;" target="&quot;IL23R&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A comparison between genes is performed here with respect to their SNPs, indicating a possible genetic linkage or functional association.")&lt;SEP&gt;"Comparison between these two genes emphasizes their role or potential interactions related to specific SNPs.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS11209026&quot;" target="&quot;RS72676067/">
      <data key="d4">1.0</data>
      <data key="d5">rs1004819"</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS72676067&quot;" target="&quot;RS1004819&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Illustrates genetic diversity among HS patients through comparison of SNPs found in the IL23R gene.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;" target="&quot;DISEASE/OUTCOME&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The term indicates possible outcomes related to specific SNPs or genes involved, such as adverse effects of certain treatments.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;" target="&quot;OUTCOME/ADVERSE EFFECT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Relevance to certain SNPs and potential side effects of treatment, highlighting risks in genetic profiling.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-TNFS&quot;" target="&quot;THERAPY/DRUG&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Connection to the previously mentioned conditions when discussing alternative treatments or outcomes.")&lt;SEP&gt;"The class of drugs is mentioned in relation to potential side effects observed in the context of genetic variations.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HS PATIENTS&quot;" target="&quot;SUBJECT GROUP/SAMPLE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A defined group of subjects whose data contributes to the comparative analysis.")&lt;SEP&gt;"Focus on genetic analysis involving a specific group of subjects, in this context related to SNPs and potential health outcomes.")</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DMFANCL&quot;" target="&quot;DMDRWD&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The DmDRWD is associated with the function of DmFANCL, although they are not directly interacting proteins.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;E2 UBC ENZYMES/" target="&quot;STRUCTURAL SIMILARITY&quot;/">
      <data key="d4">1.0</data>
      <data key="d5">"DALI Comparison/</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CATALYTIC CYSTEINE/" target="&quot;THIOESTER BOND FORMATION/">
      <data key="d4">1.0</data>
      <data key="d5">"Thioester Charge Assay/</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCI&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The URD interacts with FANCI to facilitate substrate binding during DNA repair processes.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCD2&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The URD binds with FANCD2 in a similar mechanism as it does for FANCI, supporting its role in DNA repair and recombination.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;PHE-63 IN UBE2T&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The mutation at Phe-63 in the Ube2T protein affects its binding affinity to the RING domain of FANCL, impacting interactions indirectly through the URD.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;FANCI AND FANCD2&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The URD plays a critical role in facilitating the interaction between FANCI and FANCD2 during DNA repair processes by serving as a binding site.")</data>
      <data key="d6">chunk-e097891654194982dfc0ef87401d3aa9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;L248A/F252A/L254A/I265A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in this variant of URD showed reduced binding with FANCI and FANCD2.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;URD&quot;" target="&quot;W212A/L214A&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in this variant of URD behaved as wild type when tested against pulldown arrays.")</data>
      <data key="d6">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCL/" target="URD&quot;/">
      <data key="d4">1.0</data>
      <data key="d5">"Structure Comparison/</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;N-TERMINAL/ C-TERMINAL LOBES&quot;/" target="&quot;SURFACE COMPOSITION/">
      <data key="d4">1.0</data>
      <data key="d5">"Comparative Analysis/</data>
      <data key="d6">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS351855&quot;" target="&quot;COLESEVELAM TREATMENT EFFECT&quot;">
      <data key="d4">0.46</data>
      <data key="d5">"Significantly delayed CT and numerically decreased GC24 in the GA/AA genotype group, compared to placebo.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR4 RS351855&quot;" target="&quot;KLB GENOTYPE VARIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Both were genetic variants that showed association with differential colesevelam treatment effect.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS4975017&quot;" target="&quot;COLESEVELAM TREATMENT EFFECT&quot;">
      <data key="d4">0.048</data>
      <data key="d5">"Lower GC24 value and potentially longer AC t1/2 were observed in the CA/AA genotype group, compared to placebo.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLB RS17618244&quot;" target="&quot;COLESEVELAM TREATMENT EFFECT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Numerical but not statistically significant differential Colesevelam treatment effects on AC t1/2 and GC24, with moderate effects in the GG genotype.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS17618244&quot;" target="&quot;COLESEVELAM TREATMENT EFFECT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This variant showed numerical, though not statistically significant association with differential colesevelam treatment effects on AC t1/2 and GC24.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM TREATMENT EFFECT&quot;" target="&quot;RS351855 GA/AA GENOTYPE GROUP AND GG GENOTYPE GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs351855 GA/AA genotype group showed a significantly delayed CT, with increased AC t1/2 compared to placebo, while the GG genotype group did not show any significant effect of Colesevelam treatment.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLESEVELAM TREATMENT EFFECT&quot;" target="&quot;RS351855 GA/AA GENOTYPE GROUP AND CC GENOTYPE GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant effects of Colesevelam treatment on CT were observed in the CC genotype group, compared to placebo.")</data>
      <data key="d6">chunk-5c78814fb7c198ee95071ee5a8462070</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL WEIGHT&quot;" target="&quot;TOTAL STOOL BA&quot;">
      <data key="d4">1.842</data>
      <data key="d5">"The total content of stool bile acids correlated positively and strongly with the weight of stool samples.")&lt;SEP&gt;"The total content of stool bile acids was positively correlated with stool weight samples, reflecting digestion and fat absorption.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL WEIGHT&quot;" target="&quot;FAT CONTENT&quot;">
      <data key="d4">1.712</data>
      <data key="d5">"A correlation between the weight of stools and fat content indicated differences in digestive efficiency among participants.")&lt;SEP&gt;"A positive correlation between the weight of stools and the fat content was observed.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL WEIGHT&quot;" target="&quot;FGF19&quot;">
      <data key="d4">-0.732</data>
      <data key="d5">"A negative correlation between fasting serum FGF19 levels and stool weight suggested possible metabolic differences influencing fecal output.")&lt;SEP&gt;"A negative correlation between fasting serum FGF19 levels and stool weight was observed, indicating less weight could be associated with higher FGF19.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STOOL BA&quot;" target="&quot;SERUM C4&quot;">
      <data key="d4">1.474</data>
      <data key="d5">"A significantly higher serum C4 level correlated with a higher stool BA synthesis or excretion.")&lt;SEP&gt;"Increased serum C4 levels were associated with higher stool BA synthesis or excretion, suggesting the role of this protein in bile acid dynamics.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM C4&quot;" target="&quot;TOTAL STOOL BA&quot;">
      <data key="d4">1.056</data>
      <data key="d5">"Bile acid synthesis was moderately correlated with serum C4 levels, indicating its influence on bile acid metabolism in participants.")&lt;SEP&gt;"The total content of bile acids in stools correlated positively but moderately with serum C4 levels.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;FANCA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The FAAP20 protein binds to FANCA through its N-terminal region, demonstrating their interplay in cellular processes.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;UBZ DOMAIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The UBZ domain of FAAP20 plays a critical role in the binding and interaction with Ub chains.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20&quot;" target="&quot;1:1 STOICHIOMETRY INTERACTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SPR data suggests that FAAP20-UBZ might interact with K63-Ub2 in a 1:1 stoichiometry, although this may represent an experimental artifact based on the calculated Rmax.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;K63-LINKED UB2&quot;" target="&quot;FAAP20-UBZ COMPLEX&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FAAP20 interacts specifically with K63-Ub2 through its UBZ domain, indicating specific targeting of this type of ubiquitin chain in the cell.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UBIQUITINATION PATHWAY&quot;" target="&quot;CELLULAR HOMEOSTASIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The role of FAAP20 in the ubiquitination pathway highlights its importance for maintaining cellular stability and homeostasis, which is a fundamental process influenced by environmental factors.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UB&quot;" target="&quot;FAAP20-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"α-helix mediated Ub interaction is closely related to MIU domain of Rabex5 which shows convergent evolution with FAAP20-UBZ among different UBDs."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO-UBZ&quot;" target="&quot;POLΗ-UBZ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The interaction mode between NEMO-UBZ and Ub is different from Polη-UBZ due to differences in the β-loop sequence."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ-UBZ&quot;" target="&quot;WRNIP1/RAD18 GROUP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Interaction with Ile44 of Ub through their β-loop suggests similarities between WRNIP1, Rad18 and Polη-UBZ binding to Ub."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ-UBZ&quot;" target="&quot;WRNIP1-UBZ&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The β-loop region of Polη-UBZ shares similarities with WRNIP1/Rad18 group proteins in interaction with Ile44 of Ub, highlighting common mechanisms among these UBDs."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;VPS27-UIM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Similar residues are involved in Ub-binding by Vps27-UIM and FAAP20-UBZ with opposite polarity towards the bound Ub showing convergent evolution among UBDs."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;RABEX5-MIU&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The same critical residues involved in Ub binding are identical between Rabex5-MIU and FAAP20-UBZ suggesting closely related interaction mechanisms."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAAP20-UBZ&quot;" target="&quot;RAD18-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While FAAP20-UBZ shows interactions with Ub similar to MIU domain of Rabex5 and Vps27-UIM, it differs in its mode of interaction compared to RAD18-UBZ indicating structural diversity among UBDs."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT INTERACTION&quot;" target="&quot;RELATIONSHIP STRENGTH (5/6)&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The interaction between specific dietary nutrients, like folate from leafy greens, is crucial for maintaining optimal cardiovascular health based on lifestyle factors and genetic predispositions.")</data>
      <data key="d6">chunk-cc528af98598e1adb4684c0166430cf4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT INTERACTION&quot;" target="&quot;MOLECULAR PROCESS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Interactions between nutrients and specific molecular processes in the body can have significant effects on physiological functions like metabolism and disease risk.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EFFECT&quot;" target="&quot;FAAP20-UBZ MUTATIONS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Mutations D164A, A168L and W180A in FAAP20-UBZ disable binding to Ub and C150S mutation destabilizes the structure leading to a lack of functional recruitment of FAAP20 proteins.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SIGNIFICANCE&quot;" target="&quot;UB INTERACTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The intermolecular interactions between FAAP20 protein domain UBZ and Ub are essential for proper cellular localization and accumulation at DNA damage sites in response to intermolecular binding events and ICL formation processes.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EVOLUTIONARY INSIGHT&quot;" target="&quot;RESIDUE CONSERVATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Conservation of residues involved in Ub interactions is observed among various species but sequence variations are noted due to high divergence between UBZ structures, requiring detailed 3D structural analysis for precise comparisons.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBSERVATION&quot;" target="&quot;UB BINDING COMPARISON&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Comparative analysis reveals differences in the modes and strength of interactions between various UBZs (FAAP20-UBZ, WRNIP1-UBZ, RAD18-UBZ) and Ub based on conserved or replaced key residues.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IMPLICATION&quot;" target="&quot;RESIDUE VARIATIONS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The variations in key interacting residues among UBZ proteins suggest evolutionary adaptations for binding efficiency or specific roles in cellular processes involving Ub.")</data>
      <data key="d6">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VPS27-UIM&quot;" target="&quot;RAD18-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While Vps27-UIM has a different polarity towards the bound Ub compared to FAAP20-UBZ and Rabex5-MIU, it shares some identical residues involved in Ub-binding suggesting possible functional similarities."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RABEX5-MIU&quot;" target="&quot;RAD18-UBZ&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Interaction with Ub by Rabex5-MIU closely resembles FAAP20-UBZ despite having opposite polarity towards bound Ub, indicating evolutionary conservation of interaction motifs among UBDs."</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DQ8 HAPLOTYPE&quot;" target="&quot;CD PATIENTS&quot;">
      <data key="d4">0.014</data>
      <data key="d5">"The DQ8 heterozygous haplotypes are highly frequent among CD patients compared to control group.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DQ2.2 HAPLOTYPE&quot;" target="&quot;CD PATIENTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The predicted homozygous DQ2.2 haplotype was found more frequently among control group compared to CD patients.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANOREXIA&quot;" target="&quot;CD PATIENTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Commonly observed as a clinical symptom among CD patients, often linked to weight loss or malnutrition.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABDOMINAL DISTENSION&quot;" target="&quot;CD PATIENTS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Often reported by CD patients, reflecting the body's response to inflammation in the gut.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 1 DIABETES MELLITUS&quot;" target="&quot;DISEASE GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"An autoimmune disease that affects insulin production; a part of our disease manifestation group.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUTOIMMUNE THYROIDITIS&quot;" target="&quot;DISEASE GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A chronic condition involving the thyroid gland; another autoimmune condition observed among CD patients.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS&quot;" target="&quot;DISEASE GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Chronic inflammatory disease affecting multiple organs; one of several autoimmune disorders in our patient group.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OSTEOMALACIA&quot;" target="&quot;NON-AUTOIMMUNE DISEASE GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Condition characterized by weak bones often due to vitamin D deficiency; identified among a small percentage of participants.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEIZURE DISORDERS&quot;" target="&quot;NEUROLOGICAL CONDITION GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Conditions characterized by recurrent seizures, sometimes associated with autoimmune diseases like CD; observed in a subset of patients.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOWN SYNDROME&quot;" target="&quot;DEVELOPMENTAL DISORDER GROUP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genetic disorder leading to cognitive and physical development challenges; identified among approximately 4% of participants.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD PATIENTS&quot;" target="&quot;HLA-DQ HAPLOTYPE&quot;">
      <data key="d4">0.024</data>
      <data key="d5">"HLA-DQ genotypes show a significant difference between CD patients compared to healthy controls.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;RS2395182, RS7775228, AND RS2187668&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There are significant differences in the minor allele frequency distribution among CD patients compared to healthy controls for these SNPs.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;DQ2.5 HAPLOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No difference exists between the tag SNP predicted homozygous HLA-DQ2.5 haplotype in CD patients and healthy controls, though not statistically significant.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;PTPN22:RS2476601&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Rare presence of specific genotypes at PTPN22:rs2476601 among healthy controls implies lower risk for MAPbacteremia.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY CONTROLS&quot;" target="&quot;PTPN2 EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Decrease in PTPN2 expression level between healthy controls and CD subjects regardless of MAPbacteremia presence.")</data>
      <data key="d6">chunk-6a657cd0a000b6df4db8f1305b795021</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA TAG SNPS AND HAPLOTYPE RESULTS&quot;" target="&quot;VALIDATION BY SANGER SEQUENCING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The sequencing analysis with sanger method confirmed the accuracy of Real-time PCR based tagSNPs approach in determining the HLA-DQ haplotype.")</data>
      <data key="d6">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1799793&quot;" target="&quot;PFI AND OS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The rs1799793 ERCC2 G&gt;A variant showed a significant correlation with progression-free interval (PFI) and overall survival (OS) in ovarian cancer.")</data>
      <data key="d6">chunk-561eacb5d916258d3ed4f08f53587404</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-22 (RS1179251 C/G &amp; RS2227485 C/T)&quot;" target="&quot;INTERLEUKIN 22&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Two SNPs within the IL-22 gene were studied in association with CRC")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 (RS17855750 T/G)&quot;" target="&quot;INTERLEUKIN 27&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNP analysis of the promoter region of IL-27 gene and its potential role in CRC")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 (RS17855750 T/G)&quot;" target="&quot;CRC RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The variant GG genotype and G allele were slightly associated with a decreased risk of CRC development")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1800469 C/T&quot;" target="&quot;DISEASE RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Decreased CT genotype in the TGFß1 gene was observed to be associated with a lower risk of developing CRC")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE&quot;" target="&quot;T ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The T allele has a slightly lower frequency compared to the CC genotype in CRC patients.")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGFSS1 (RS1800469 C/T)&quot;" target="&quot;TRANSFORMING GROWTH FACTOR Β1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TGFß1 gene polymorphism which was studied in relation to CRC")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-8 (RS4073 T/A)&quot;" target="&quot;INTERLEUKIN 8&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A variant of the IL-8 gene and its promoter region SNP were analyzed for its role in CRC")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 (RS1800896 A/G)&quot;" target="&quot;INTERLEUKIN 10&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNP analysis conducted on the promoter region of IL-10 gene and its correlation with CRC")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE: COLORECTAL CANCER&quot;" target="&quot;GENOMIC VARIANT: CC&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Association between specific genotypes (CC) and the risk of developing Colorectal Cancer")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FREQUENCY DIFFERENCE&quot;" target="&quot;GENOMIC VARIANT: T ALLELE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The frequency difference comparison between T allele and other genotypes in CRC patients.")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEVER-SMOKERS&quot;" target="&quot;SNP RS1898671&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"No significant association between this SNP and asthma risk was found among never-smokers.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ATOPY&quot;" target="&quot;IL-8 PRO-INFLAMMATORY RESPONSE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased IL-8 mRNA expression was linked with the frequency of atopic asthma among children.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP RS1898671&quot;" target="&quot;EX-SMOKERS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Increased risk association with asthma specifically observed when analyzing ex-smokers.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA SUSCEPTIBILITY&quot;" target="&quot;REPLICATION COHORT VALIDATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Confirmation of findings in a larger combined cohort, validating the associations made with NYUBAR population.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA SUSCEPTIBILITY&quot;" target="&quot;RS2227306 CC/CT GENOTYPES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The frequencies of rs2227306 CC and CT genotypes were found to be significantly different between case and control groups, suggesting its association with asthma susceptibility.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HAPLOTYPE GAGGGCAAAG&quot;" target="&quot;POPULATION STRATIFICATION ADJUSTMENT&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Increased risk of asthma was observed when taking into account population structure differences in the analysis.")</data>
      <data key="d6">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OR VALUE (ODDS RATIO)&quot;" target="&quot;STRENGTH OF ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The odds ratio quantifies how much more likely it is for CD subjects with specific PTPN2:rs478582 genotypes to develop MAP infection, indicating the strength of their association.")</data>
      <data key="d6">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAPBACTEREMIA&quot;" target="&quot;T-CELL RESPONSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The presence of MAPbacteremia was found to impact T-cell response and proliferation in CD patients.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHA&quot;" target="&quot;T-CELL PROLIFERATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"PHA stimulation led to an increased T-cell proliferation response in both CD subjects and healthy controls.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAP PPD-LIKE&quot;" target="&quot;T-CELL RESPONSE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The use of MAP PPD-like as a stimulus showed different effects on the T-cell response across various subject groups.")</data>
      <data key="d6">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD69&quot;" target="&quot;ACTIVATION MARKER KINETICS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The kinetics of CD69 involve an intensification followed by a reduction of surface expression.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD69&quot;" target="&quot;ACTIVATION MARKER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CD69 is an activation marker expressed on T cells.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ICOS&quot;" target="&quot;ACTIVATION MARKER KINETICS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"ICOS expression kinetics involve an intensification followed by a reduction of surface expression.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ICOS&quot;" target="&quot;ACTIVATION MARKER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"ICOS is a co-stimulatory molecule involved in the activation of T lymphocytes.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD25&quot;" target="&quot;INTERNAL MOCK-TRANSFECTED CONTROLS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The expression of CD25 was observed when normalized to internal mock-transfected controls.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD25&quot;" target="&quot;CO-STIMULATORY LIGAND&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"CD25, also known as IL-2 receptor alpha chain (CD152), is upregulated on activated T cells and plays a role in costimulation during immune responses.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD226&quot;" target="&quot;TREGS ACTIVATED KINETICS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CD226 on Tregs exhibited a unique kinetics where it waned before increasing to a level higher than baseline.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD226&quot;" target="&quot;ACTIVATION MARKER&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"CD226 (also known as KLRB1 or NKG2D) is an activation receptor expressed on various types of immune cells.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA-4&quot;" target="&quot;TREGS ACTIVATED KINETICS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Tregs also exhibited activation-induced expression kinetics for CTLA-4.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA-4&quot;" target="&quot;CO-INHIBITORY LIGAND&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CTLA-4 is a co-inhibitory receptor that downregulates the activity of T lymphocytes during autoimmune diseases and transplantation.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREG SUPPRESSION&quot;" target="&quot;TCONV INTRINSIC SUSCEPTIBILITY/">
      <data key="d4">7.0</data>
      <data key="d5">LYP Variants"</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TH1 SIGNATURE/" target="&quot;LYP VARIANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">Autoimmune Disorders"</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SUPPRESSION BY TREGS/" target="TRESP PROLIFERATION/">
      <data key="d4">16.0</data>
      <data key="d5">"LYP Variants"/"Molecular Interaction/&lt;SEP&gt;LYP Variants"</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIOLOGICAL FUNCTION&quot;&lt;|&quot;THE PTPN22 GENE CONTRIBUTES TO THE REGULATION OF LYMPHOCYTE ACTIVATION STATE THROUGH MODULATION OF TCR SIGNALING PATHWAYS LIKE CA2+ FLUX AND PERK SIGNALING.&quot;](&quot;ENTITY&quot;" target="&quot;PTPN22 GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"CD8+ T cell subset"</data>
      <data key="d6">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTIVATION INDUCED PROLIFERATION&quot;" target="&quot;LYP-620R IMPACT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Overexpression of LYP-620R reduced APC-mediated proliferation of Tconv and Treg.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACTIVATION INDUCED PROLIFERATION&quot;" target="&quot;LYP-620W IMPACT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The LYP-620W variant was capable of blocking Treg proliferation to a similar degree as the LYP-620R variant.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL ACTIVATION BY PMA AND IONOMYCIN&quot;" target="&quot;LYP VARIANTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Overexpression of PTPN22 influences T cell cytokine production, but mitogenic activation by PMA and ionomycin was not altered.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;IL-2 SECRETION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The net accumulation of IL-2 was not altered by overexpression of the LYP-620R variant, but increased at the 24-hour time point by the LYP-620W variant.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;IL-4 SECRETION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The secretion of IL-4 was robustly inhibited for the first 48 hours, but to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;IL-5 SECRETION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The secretion of IL-5 was not altered by either variant of LYP.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;IL-9 SECRETION&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The secretion of IL-9 was robustly inhibited for the first 48 hours and to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;IL-10 SECRETION&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The secretion of IL-10 was robustly inhibited for the first 48 hours, but to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;IL-13 SECRETION&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"The secretion of IL-13 was robustly inhibited for the first 48 hours and to a somewhat lesser degree by LYP-620W at the 72-hour time point.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;IFNΓ SECRETION&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"IFNγ secretion was not altered by overexpression of either variant of LYP.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE PRODUCTION&quot;" target="&quot;ANTIBODY CYTOTOXIC FUNCTION&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The secretion of IFNγ and IL-2 by CAR T cells is indicative of their robust cytotoxic function against tumor targets.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REGULATED BY LYP VARIANTS&quot;" target="&quot;T CELL PROLIFERATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"LYP variants influence T cell proliferation during activation.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CYTOKINE SECRETION&quot;" target="&quot;MODULATED BY LYP VARIANTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Lymphoproteins (LYP, PTPN22) impact the secretion of various cytokines, modulating Th1 and Th2 responses.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ EFFECTOR T CELLS&quot;" target="&quot;REGULATE HOST IMMUNE RESPONSE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"CD4+ effector T cells play a crucial role in regulating host immune responses through the production of cytokines and other effectors.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APCS&quot;" target="&quot;MITOGENIC ACTIVATION&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Antigen-presenting cells (APCs) are essential for the activation and proliferation of T cells during immune response stimulation.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP VARIANTS&quot;/&quot;TH1 SIGNATURE/AUTOIMMUNE DISORDERS&quot;" target="&quot;MOLECULAR INTERACTION/">
      <data key="d4">5.0</data>
      <data key="d5">Environmental Factor/</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TREG SUPPRESSION/" target="TCONV INTRINSIC SUSCEPTIBILITY/">
      <data key="d4">7.0</data>
      <data key="d5">"LYP Variants"/"Molecular Interaction/</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72&quot;" target="&quot;4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The 4-1BB co-stimulatory domain enhances the activation and anti-tumor efficacy of CAR T cells expressing TAG72.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72&quot;" target="&quot;OVCAR3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The TAG72 gene influences the cytolytic activity against OVCAR3 ovarian cancer cells through CAR T cell treatment.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELLS&quot;" target="&quot;HUMANIZED SCFV CC49&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The humanized scFv CC49 contributes to specificity by binding to the TAG72 antigen on cancer cells.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELLS&quot;" target="&quot;CD19T (CD19 TRUNCATED) FOR CELL TRACKING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"CD19t is a component of the CAR that facilitates the tracking and monitoring of TAG72-BBζ CAR T cells during treatment.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAR T CELLS&quot;" target="&quot;INTRAPERITONEAL INJECTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Regional intraperitoneal delivery of CAR T cells demonstrated more potent anti-tumor effects compared to intravenous injection.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD137 EXPRESSION&quot;" target="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Induction of CD137 expression on TAG72-BBζ CAR T cells is a measure of their activation against the TAG72 antigen.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL SURFACE CD69 EXPRESSION&quot;" target="&quot;CAR T CELL ACTIVATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"CD69 expression on the surface of T cells correlates with early stages of T cell activation and response to stimulation.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFNΓ RELEASE&quot;" target="&quot;ANTIGEN-SPECIFIC RESPONSE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Cytotoxic T cells, such as those expressing TAG72-BBζ CARs, release IFNγ in response to antigen presentation by tumor cells.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;E:T RATIO (EFFECTOR:TARGET RATIO)&quot;" target="&quot;KILLING EFFICIENCY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The E:T ratio impacts the efficiency of cell killing activity; higher ratios can lead to reduced killing effectiveness.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CELL KILING ACTIVITY AGAINST TAG72-POSITIVE CELLS&quot;" target="&quot;IN VITRO ASSAYS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"TAG72-BBζ CAR T cells show high efficacy against ovarian cancer cells expressing the TAG72 antigen in vitro.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUMOR CELLS&quot;" target="&quot;DISEASE TARGET&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Ovarian cancer cells expressing the TAG72 antigen are targeted by TAG72-BBζ CAR T cells to demonstrate their specificity and potential clinical application.")</data>
      <data key="d6">chunk-bdeb2c0c1ba80048874f6dedb2c2b619</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOCK TREATMENT&quot;" target="&quot;TUMOR RECURRENCES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Antigen loss or escape following mock treatment was observed in tumor recurrences at early time points from mice treated with TAG72-BBζ CAR T cells.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOCK TREATMENT&quot;" target="&quot;DISEASE RESISTANCE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Antigen loss or escape from tumor cells was observed more frequently at early time points after mock treatment compared to repeated TAG72-BBζ CAR T cell dosing.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REPEAT DOSING&quot;" target="&quot;ANTI-TUMOR EFFICACY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Repeating the dose of TAG72-BBζ CAR T cells over a month improved therapeutic responses compared to single dosing.")</data>
      <data key="d6">chunk-183db5c908df609bb5289896b4ba09d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;REPEAT DOSING&quot;" target="&quot;OVCAR3 MODEL&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Repeating the dose course over 1 month led to more durable anti-tumor responses compared to single dosing with TAG72-BBζ CAR T cells in the OVCAR3 model.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-BBΖ CAR T CELLS&quot;" target="&quot;ANTIBODY-DRUG CONJUGATES (ADCS)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study compared the therapeutic responses of repeat dosing of TAG72-BBζ CAR T cells with a single dose of Antibody-Drug Conjugates in ovarian cancer xenograft models.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OV90 MODEL&quot;" target="&quot;OVC90 MODEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The study demonstrated that repeat dosing of TAG72-BBζ CAR T cells provided greater control of tumors compared to a single dose, based on comparison between the OVCAR3 model and the OV90 model.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T CELL INFUSION&quot;" target="&quot;MOCK AND TAG72-BBΖ CAR T CELL TREATED MICE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression of antigens on tumors varied following mock treatment versus the infusion of TAG72-BBζ CAR T cells in mice, with different patterns noted at 12 weeks post-infusion.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUMOR RECURRENCES&quot;" target="&quot;T CELL PERSISTENCE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Reduced numbers, expansion and persistence of CAR T cells were observed in the blood of OV90-bearing mice compared to OVCAR3 model, suggesting potential suppressive mechanisms affecting T cell function and overall CAR T cell efficacy.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUMOR RECURRENCES&quot;" target="&quot;ANTIGEN HETEROGENEITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The major resistance mechanism against CAR T cell therapy is tumor antigen heterogeneity that promotes eventual antigen loss or escape.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SURVIVAL BENEFIT&quot;" target="&quot;T CELL INFUSION TIMING&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The survival benefit associated with repeated TAG72-BBζ CAR T cell infusion over the OV90 model was more pronounced compared to OVCAR3 model due to differences in treatment timing and tumor dynamics.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUTTERITES&quot;" target="&quot;POPULATION SAMPLE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The population sample used for genetic analysis provided insights into the genetic architecture and its impact on lung function.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FEV1/FVC&quot;" target="&quot;LUNG FUNCTION TRAIT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The FEV1/FVC ratio showed associations with SNPs at several loci, including the THSD4-UACA-TLE3 and C10orf11 loci.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRAIL ALGORITHM&quot;" target="&quot;SOFTWARE TOOL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The GRAIL algorithm was utilized to discover functional connections between genes, revealing links among β-defensin genes and other identified transcripts.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE ONTOLOGY&quot;" target="&quot;DATABASE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Gene Ontology database provided context for functional connections identified by the GRAIL algorithm.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL23-CCL18 LOCUS&quot;" target="&quot;GENETIC LOCATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"SNPs at the CCL23-CCL18 locus on chromosome 17q12 had associations with FEV1/FVC.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;5.8% OF RESIDUAL VARIANCE&quot;" target="&quot;EXPLAINED VARIANCE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The 5.8% explained variance in FEV1/FVC by the six SNPs indicated their contribution to understanding the genetic factors influencing lung function.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUTTERITE GWAS&quot;" target="&quot;GENETIC STUDY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A genetic study on Hutterites, represented by Fig. E3b in the Online Repository, helped validate findings related to specific loci and functional gene interactions.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THSD4-UACA-TLE3 LOCUS&quot;" target="&quot;GENETIC LOCATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A genome-wide significant association was found at the THSD4-UACA-TLE3 locus on chromosome 15q23.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC LOCATION&quot;" target="&quot;CHAF1B LOCUS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CHAF1B locus on chromosome 21q22.13 showed evidence for association with SNPs related to lung function.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC LOCATION&quot;" target="&quot;PITPNC1 LOCUS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The PITPNC1 locus on chromosome 17q24.2 showed evidence for association with SNPs related to lung function.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;80 SNPS&quot;" target="&quot;GENETIC VARIANT SET&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The minimum set of 80 SNPs providing the best predictive value for FEV1/FVC were identified in the GWAS.")</data>
      <data key="d6">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC STUDY&quot;" target="&quot;HUTTERITES GWAS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Hutterite genome-wide association study provided insights into the genetic basis for variations in lung function through its connections to specific loci and transcripts.")</data>
      <data key="d6">chunk-7efd4f037425eeac77e329347b16beb2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231775&quot;" target="&quot;CTLA4&quot;">
      <data key="d4">0.0002</data>
      <data key="d5">"rs231775 polymorphism of CTLA4 showed significant association with PBC susceptibility.")&lt;SEP&gt;"rs231775 polymorphism of CTLA4 was significantly associated with PBC susceptibility.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS231725&quot;" target="&quot;CTLA4&quot;">
      <data key="d4">0.1</data>
      <data key="d5">"The rs231725 polymorphism also showed significant association with PBC susceptibility.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3087243&quot;" target="&quot;PBC&quot;">
      <data key="d4">-1.0</data>
      <data key="d5">"No association was identified between rs3087243 and PBC susceptibility.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS5742909&quot;" target="&quot;PBC&quot;">
      <data key="d4">0.06</data>
      <data key="d5">"The study found no association between rs5742909 polymorphisms and PBC susceptibility.")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTLA4&quot;" target="&quot;PBC&quot;">
      <data key="d4">0.05</data>
      <data key="d5">"The results showed that the CTLA4 gene was significantly associated with susceptibility to Primary Biliary Cholangitis (PBC).")</data>
      <data key="d6">chunk-f02653cb486dbf68cc259f74ea8b2b2e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BAYESIAN TEST FOR COLOCALISATION&quot;" target="&quot;STATISTICAL METHOD&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This test supported the hypothesis of a shared causal variant associated with T1D susceptibility and gene expression changes.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL27 SNP RS181206G&quot;" target="&quot;TRANS-EQTL LOCUS EFFECTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"IL27 SNP rs181206G has effects on IRF1 and STAT1 expression, confirmed by trans-eQTL analysis.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPG SITE/" target="&quot;METHYLATED SITES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Correlation with expression levels"</data>
      <data key="d6">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CIS-EQTL EFFECTS&quot;" target="&quot;CORRECTION FACTOR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Gene expression levels were corrected before identifying trans-eQTL associations.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BROAD-RANGE IMPACT AND OVERLAP OF GENES&quot;" target="&quot;IMPACT SHARED AMONG GENES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A region influenced the expression levels of several overlapping genes in CD4+ and CD8+ T cells.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHANGES IN IRF1 AND STAT1 EXPRESSION&quot;" target="&quot;T1D SUSCEPTIBILITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"T1D susceptibility is associated with changes in IRF1 and STAT1 expression, which may be influenced by a specific genomic variant.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD4+ T CELLS AND CD8+ T CELLS&quot;" target="&quot;TRANS-EQTL EFFECTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Specific trans-eQTL effect detected only in CD4+ T cells but not in CD8+ T cells.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;B CELLS AND MONOCYTES&quot;" target="&quot;SIGNAL PRESENCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No signal present in B cells or monocytes when re-analyzing Fairfax et al.'s data.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-27 CYTOKINE AND IL27RA&quot;/&quot;GP130&quot;" target="&quot;RECEPTOR INTERACTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The IL-27 cytokine interacts with the IL27RA gene (together with gp130, also known as IL6ST) to activate STAT1/STAT3 pathway.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING&quot;" target="&quot;ISRE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Interferon stimulated response elements are bound by STAT1 and STAT3 pathways leading to transcriptional activation.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL27 GENE PRO119 ALLELE&quot;" target="&quot;TRANSFECTION EFFECTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The Pro119 variant of the IL27 gene resulted in lower expression levels of IRF1 and STAT1 after transfection experiments.")</data>
      <data key="d6">chunk-1b40d071abac0ba432a9fb0096796f45</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PBMC COMPOSITION&quot;" target="&quot;ASTHMA&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant difference in PBMC composition was claimed between asthma patients and healthy controls.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA&quot;" target="&quot;IL-8 MRNA LEVELS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Significantly increased IL-8 mRNA levels were found in asthmatic patients compared to controls, especially those with moderate-to-severe asthma.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4073 T ALLELE&quot;" target="&quot;ASTHMA SEVERITY IN TUNISIAN CHILDREN&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The rs4073 T allele was considered as a risk factor for asthma severity.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASTHMA RISK&quot;" target="&quot;RS4073 TT GENOTYPE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"rs4073 TT genotype was significantly associated with an increased risk of asthma development.")</data>
      <data key="d6">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ASAH1 GENE&quot;" target="&quot;SNP-SET&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SNP-set for the ASAH1 gene includes only these 14 typed SNPs that are in good LD with each other and with the causal SNPs.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NAT2 GENE&quot;" target="&quot;TYPED SNPS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SNPs 7, 11, 13, and 21 are in good LD with each other and when tested as causal, the power of kernel machine method is higher than min test.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR2 GENE&quot;" target="&quot;HIGH LD REGIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In regions of high LD, the kernel machine method outperforms the min test.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FGFR2 GENE&quot;" target="&quot;WEAK LD REGIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"In regions of weak LD, the two methods have comparable power.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B GENE&quot;" target="&quot;SNPS 1058026 AND RS2523608&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The empirical power for HLA-B gene shows that using MAF as weights in weighted IBS kernel can upweight rare alleles.")</data>
      <data key="d6">chunk-2e31819d63b80079cb6422efd6e684e0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS KERNEL&quot;" target="&quot;LINEAR KERNEL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The weighted IBS kernel outperforms the linear kernel in terms of power when rare variants are important.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGHER MAF&quot;" target="&quot;RS2523608 SNV&quot;/&quot;CAUSAL SNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"When rs2523608 has higher minor allele frequency, it's not as effective as when the more common allele (which is also causal) gets downweighted by a certain kernel function.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POOLED ASSOCIATION ANALYSIS&quot;" target="&quot;ANTI-CTLA-4&quot;/&quot;ANTI-PD-1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant association was observed between anti-CTLA-4 or anti-PD-1 drugs and treatment response across different treatments, after adjustments for age, sex, and drug types.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AND SEX&quot;" target="&quot;INTERACTION EFFECT ON RESPONSE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The effect of rs17388568 on response rate was stronger in younger female patients, although the interactions were not statistically significant.")</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMBINATION THERAPY&quot;/&quot;POOLED ASSOCIATION ANALYSIS&quot;" target="&quot;TREATMENT RESPONSE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A pooled analysis of combination therapy outcomes did not yield significant associations with treatment response when adjusting for various covariates.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COVARIATE IMPACT&quot;" target="&quot;SNPS&quot;/&quot;AGE/SEX/TREATMENT DRUGS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"After adjustments for age, sex, treatment drugs, and other covariates, no associations were found with SNPs related to treatment response.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-CTLA-4&quot;/&quot;ANTI-PD-1/COMBINATION THERAPY/" target="&quot;TREATMENT TYPE IMPACT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant association was observed between the type of drug (anti-CTLA-4, anti-PD-1 or combination therapy) and treatment response after adjusting for age, sex and different types of treatment.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE/SEX/TREATMENT DRUGS/" target="&quot;COVARIATE ADJUSTMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Adjustments made to account for covariates like age, sex and specific treatments did not reveal significant associations with factors being tested (SNPs, drug therapies) related to response or outcomes.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;MS RISK ALLELES&quot;/&quot;SNPS&quot;/&quot;GENOMIC VARIANT&quot;/&quot;DISEASE&quot;/&quot;ENVIRONMENTAL FACTOR/">
      <data key="d4">1.0</data>
      <data key="d5">Therapy"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;MS RISK LOCI&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The EBNA2 effect on gene expression is dependent on specific genotypes at MS risk loci and interacts with the direction of allelic expression.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELIC ASSOCIATION&quot;" target="&quot;GENETIC DRIFT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The relationship between the risk allele preference and genetic drift could impact the overall expression pattern of MS risk genes.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBV LATENCY III PROGRAM&quot;" target="&quot;EFFECT ON IMMUNE EVASION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The program involving LMP1 and LMP2 signaling can be influenced by EBNA2's interaction with MS risk loci, potentially impacting immune evasion through alteration of gene expression.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RISK ALLELE PREFERENCE&quot;" target="&quot;INFLUENCE ON GENE EXPRESSION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"EBNA2's preference for certain risk alleles has implications on altering the direction of allelic association with expression in specific MS risk genes.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2-TAT/" target="DRUG&quot;/&quot;EFFECT ON EBV DNA COPY NUMBER&quot;/&quot;MOLECULAR INTERACTION&quot;/&quot;GENETIC TRAIT/">
      <data key="d4">1.0</data>
      <data key="d5">Disease"/"Environmental Factor/</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2 BINDING&quot;/&quot;ALLELIC ASSOCIATION&quot;/&quot;MS RISK ALLELES/" target="EXPRESSION/GENETIC TRAIT/DISEASE/">
      <data key="d4">1.0</data>
      <data key="d5">Therapy"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LCL PROLIFERATION&quot;/&quot;EBNA2-TAT/" target="EFFECT ON GENE EXPRESSION&quot;/&quot;MOLECULAR INTERACTION&quot;/&quot;GENETIC TRAIT/">
      <data key="d4">1.0</data>
      <data key="d5">Disease"/"Environmental Factor/</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFAIP8&quot;/&quot;EXPRESSION/EBNA2 INHIBITION/" target="EBV DNA COPY NUMBER&quot;/&quot;MOLECULAR INTERACTION&quot;/&quot;GENETIC TRAIT/DISEASE/">
      <data key="d4">1.0</data>
      <data key="d5">Therapy"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE EFFECT&quot;/&quot;ALLELIC ASSOCIATION/" target="EBNA2 BINDING&quot;/&quot;EXPRESSION/EBNA2 INHIBITION/">
      <data key="d4">1.0</data>
      <data key="d5">Disease"/"Therapy"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2 BINDING/" target="ALLELIC ASSOCIATION&quot;/&quot;EXPRESSION/GENETIC TRAIT/">
      <data key="d4">1.0</data>
      <data key="d5">Disease"/"Therapy"</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2 INHIBITION/EBNA2-TAT/" target="EFFECT ON LCLS&quot;/&quot;MOLECULAR INTERACTION/">
      <data key="d4">1.0</data>
      <data key="d5">Genetic Trait/Disease/</data>
      <data key="d6">chunk-bb351b97d99fce93d17df522db92dda7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALLELIC EXPRESSION&quot;" target="&quot;INFERRED EFFECT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The alteration of allelic expression based on EBNA2 interaction is inferred from comparison to uninfected B cells and has implications for gene regulation.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS20417&quot;" target="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Polymorphism rs20417 was found to be significantly associated with aspirin insensitivity.")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS1126643&quot;" target="&quot;ASPIRIN INSENSITIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The risk allele of rs1126643 is strongly linked to aspirin insensitivity, as evident from the analysis.")</data>
      <data key="d6">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.W631*&quot;" target="&quot;MUTATION EFFECT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The p.W631* mutation results in reduced expression, inability for phosphorylation and nuclear localization impairment.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B&quot;" target="&quot;W631*&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The W631* variant occurs in the gene coding for STAT5B protein.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAT5B&quot;" target="&quot;GENE MUTATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A homozygous variant in STAT5B gene results in a loss-of-function mutation leading to altered protein function.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.A630P&quot;" target="&quot;EXISTING VARIANT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This existing mutation is in proximity to the newly identified p.W631* variant in STAT5B.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOMAIN&quot;" target="&quot;SH2&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Src Homology 2 (SH2) domain is critical for STAT5B activation and homodimer formation.")</data>
      <data key="d6">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS28383172 AG OR GG GENOTYPES&quot;" target="&quot;HAPLOTYPE CARRIER STATUS&quot;">
      <data key="d4">95.0</data>
      <data key="d5">"were associated with DQA1*02:01–DQB1*02:02 haplotype carrier status.")</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS28383172 G ALLELE&quot;" target="&quot;HLA TYPE&quot;">
      <data key="d4">100.0</data>
      <data key="d5">"had perfect concordance with HLA-DRB1*07:01 allele carrier status.")</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM V VS. ALGORITHMS II, III, IV&quot;" target="&quot;PERFORMANCE COMPARISON/">
      <data key="d4">2.0</data>
      <data key="d5">Statistical Analysis"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERFORMANCE COMPARISON/" target="&quot;ALGORITHM V VS. HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 HAPLOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">Statistical Analysis"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERFORMANCE COMPARISON/" target="&quot;ALGORITHM V AND ALGORITHM V HAPLOTYPE ACCURACY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">Statistical Analysis"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SENSITIVITY VALUE AND E. COLI ASP HYPERSENSITIVITY&quot;" target="&quot;STATISTICAL MEASURE/">
      <data key="d4">1.0</data>
      <data key="d5">Correlation Analysis"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL MEASURE/" target="&quot;SPECIFICITY VALUE AND FALSE POSITIVES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">Error Rate"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL MEASURE/" target="&quot;POSITIVE PREDICTIVE VALUE AND TRUE CASES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">Accuracy Rate"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STATISTICAL MEASURE/" target="&quot;NEGATIVE PREDICTIVE VALUE AND FALSE NEGATIVES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">Error Rate"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALGORITHM V AND FALSE HAPLOTYPE CARRIERS&quot;" target="&quot;MISCLASSIFICATION/">
      <data key="d4">3.0</data>
      <data key="d5">Performance Metric"</data>
      <data key="d6">chunk-1f50436a36721971a0a256131d7fca62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV-INFECTED INDIVIDUALS&quot;" target="&quot;TLR7 (RS179008, RS179009)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Polymorphisms in the TLR7 gene are associated with decreased AG genotype prevalence in HIV-infected individuals compared to healthy controls.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIV DISEASE STAGES&quot;" target="&quot;TLR7 POLYMORPHISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The prevalence of specific TLR7 rs179009 genotypes decreases across different stages of HIV disease compared to healthy controls.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOBACCO AND ALCOHOL USERS&quot;" target="&quot;TLR7 POLYMORPHISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Polymorphisms in the TLR7 gene are not affected by tobacco or alcohol use among HIV-infected individuals, but distribution of AG genotype is higher among those who consume tobacco.")</data>
      <data key="d6">chunk-05d583f893b703816ad8de9561aa5292</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOBACCO&quot;" target="&quot;ALCOHOL&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Tobacco usage is related to alcohol use, both being potential factors influencing HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE CD4 COUNTS&quot;" target="&quot;TLR7 (RS179008 AND RS179009)&quot;">
      <data key="d4">20.0</data>
      <data key="d5">"The baseline CD4 cell count correlates with genetic polymorphisms of TLR7, which could influence HIV disease progression.")</data>
      <data key="d6">chunk-2c91cdebb36ef064eb01a7021a961302</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER&quot;" target="&quot;DECAMER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Comparing frequencies of CD8+ T cell recognition indicates similarity between both peptides and an immunodominant epitope.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-A*01:01&quot;" target="&quot;DECAMER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The thermal stability suggests lower affinity for decamer compared to HLA-B*15:01, supporting the potential role in disease mechanisms.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONAMER/DECAMER&quot;" target="&quot;T CELL RECOGNITION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Both peptides have nominal frequencies comparable to known immunodominant epitopes when recognized by CD8+ T cells.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA-B*15:01&quot;" target="&quot;PEPTIDE/HLA MODELING&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Structure-based modeling methods were previously applied to predict peptide/HLA interactions using this template.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KNOWN IMMUNODOMINANT EPITOPE&quot;" target="&quot;EPITHELIAL CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This epitope is present on the surface of epithelial cells, participating in the immune response.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNKNOWN GENE X&quot;" target="&quot;KNOWN IMMUNE RESPONSE I&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Gene X is involved in a known immune response process.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UNKNOWN VARIANT Y&quot;" target="&quot;UNKNOWN GENETIC CONDITION J&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variant Y may contribute to an unknown genetic condition.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT Z&quot;" target="&quot;PROTEINS K, L&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Transcript Z codes for multiple proteins, including K and L.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN A&quot;" target="&quot;NUTRIENT B&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Protein A interacts with nutrient B in biological processes.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT B&quot;" target="&quot;DIETARY PATTERN C&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Nutrient B is abundant in dietary pattern C.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN C&quot;" target="&quot;METABOLIC PATHWAY D&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Dietary pattern C influences metabolic pathway D through nutrient intake.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS D&quot;" target="&quot;MOLECULAR INTERACTION E&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Physiological process D depends on molecular interaction E for its function.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR G&quot;" target="&quot;DISEASE H&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Environmental factor G is a risk factor for disease H.")</data>
      <data key="d6">chunk-41c7131af28e2a745ef6b88b8601860f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-PEPTIDE/HLA-B*15:01 COMPLEX&quot;" target="&quot;STRUCTURAL EXCLUSION AND IMMUNE TOLERANCE&quot;&lt;|&quot;INABILITY OF SELF-PEPTIDE TO FORM STABLE COMPLEXES WITH HLA DUE TO STRUCTURAL CONSTRAINTS LEADING TO IMMUNE TOLERANCE.&quot;)(&quot;ENTITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Asp46"</data>
      <data key="d6">chunk-de413ae6100407d8dadd5bdee87c1074</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PEPTIDE BACKBONE CONFORMATION&quot;" target="&quot;VARIANCE ANALYSIS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The peptide backbone conformation showed minimal variance in all nonamer/HLA-B*15:01 structures.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BINDING AFFINITY&quot;" target="&quot;MOCK POLYALA HLA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"An allele with mutated residues exhibited a high binding energy and was distant from the best binder.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESIDUES IN MHC BINDING GROOVE&quot;" target="&quot;SEQUENCE BIAS EVALUATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A trend for specific residues contributing to overall binding energy was observed.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INVARIANT RESIDUES&quot;" target="&quot;KEY FEATURES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Highly invariant residues were consistently found in HLA alleles with high affinity binding.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONTACT PATTERN&quot;" target="&quot;F-POCKET&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Similar polar contacts, primarily in the F-pocket of MHC, correlated well with positions of invariant MHC residues.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK R1275Q MUTATION&quot;" target="&quot;CANCER MARKER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This mutation in the ALK gene serves as an indicator for potential cancer development or progression.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HLA ALLELES SELECTION&quot;" target="&quot;REPERTOIRE EXPANSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The selection of HLA alleles aims to broaden the display repertoire that can accommodate neoepitopes and enhance immune response.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KULLBACK-LEIBLER DIVERGENCE&quot;" target="&quot;SEQUENCE DIVERSITY METRIC&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The Kullback-Leibler divergence measure is used to quantify sequence diversity among HLA alleles involved in peptide binding.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION DETAIL&quot;" target="&quot;POLAR CONTACTS ANALYSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Analyze the nature and specificity of polar contacts between peptides, MHC molecules, and T cells during immune response interactions.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIOPHYSICAL PROPERTY&quot;" target="&quot;THERMAL STABILITY ASSESSMENT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The thermal stability test confirms the robustness of p/MHC complexes formed with selected HLA alleles under physiological conditions.")</data>
      <data key="d6">chunk-614333487e4b92705503909d34155179</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALK NEOEPITOPE (NONAMER AND DECAMER)&quot;" target="&quot;DISEASE MECHANISMS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The lower affinity for HLA-A*01:01 might imply involvement in disease mechanisms related to these neoepitopes.")</data>
      <data key="d6">chunk-d3a9c93928447522ce3df4209f8ac803</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS74420772&quot;" target="&quot;IGM ANTI-PC&quot;">
      <data key="d4">3.1</data>
      <data key="d5">"The genomic variant rs74420772 is significantly associated with the expression level of IgM antibodies against PC, potentially influencing disease risk.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGM ANTI-PC&quot;" target="&quot;RS735665, RS9392504&quot;">
      <data key="d4">1.6</data>
      <data key="d5">"Genetic variations like rs735665 and rs9392504 can influence the expression of IgM antibodies against PC.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665&quot;" target="&quot;CLL&quot;">
      <data key="d4">1.2</data>
      <data key="d5">"rs735665 is significantly associated with the risk of CLL, indicating its role in this disease.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665&quot;" target="&quot;GENERAL IGM&quot;">
      <data key="d4">1.3</data>
      <data key="d5">"rs735665 affects the expression level of general IgM, suggesting a genetic basis for this immune response.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665&quot;" target="&quot;POLYGENIC RISK SCORE FOR IGM&quot;">
      <data key="d4">1.4</data>
      <data key="d5">"rs735665 contributes substantially to the polygenic risk scores for increasing IgM, highlighting its genetic influence on this measure.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS735665&quot;" target="&quot;REGULATORY MARK&quot;">
      <data key="d4">2.2</data>
      <data key="d5">"The variant rs735665 is linked to changes in epigenetic marks like H3K4Me1, indicating its potential role in gene regulation.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS9392504&quot;" target="&quot;CLL&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"rs9392504 has a nominal significance level associated with CLL, contributing to its risk prediction.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS35923643&quot;" target="&quot;GRAMD1B&quot;">
      <data key="d4">3.2</data>
      <data key="d5">"The genetic variation rs35923643 resides in the GRAMD1B gene, indicating a possible role of this variant within the gene's function.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYGENIC RISK SCORE&quot;" target="&quot;THERAPIES FOR AUTOIMMUNE DISEASES&quot;">
      <data key="d4">2.3</data>
      <data key="d5">"The polygenic risk scores associated with IgM levels can guide personalized treatment strategies for autoimmune disorders like CLL.")</data>
      <data key="d6">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
      <data key="d7">1</data>
    </edge>
  </graph>
</graphml>
